,id,Procedure type,Document type,Language code,Display code,Name,parent_id,Mandatory,heading_id
0,1,CAP,SmPC,bg,,КРАТКА ХАРАКТЕРИСТИКА НА ПРОДУКТА,,True,1
1,2,CAP,SmPC,bg,,qТози лекарствен продукт подлежи на допълнително наблюдение. Това ще позволи бързото установяване на нова информация относно безопасността. От медицинските специалисти се изисква да съобщават всяка подозирана нежелана реакция. За начина на съобщаване на нежелани реакции вижте точка 4.8,1.0,False,2
2,3,CAP,SmPC,bg,1,ИМЕ НА ЛЕКАРСТВЕНИЯ ПРОДУКТ,1.0,True,3
3,4,CAP,SmPC,bg,2,КАЧЕСТВЕН И КОЛИЧЕСТВЕН СЪСТАВ,1.0,True,4
4,5,CAP,SmPC,bg,2.1,Общо описание,4.0,False,5
5,6,CAP,SmPC,bg,2.2,Качествен и количествен състав,4.0,False,6
6,7,CAP,SmPC,bg,,Помощно(и) вещество(а) с известно действие,6.0,False,7
7,8,CAP,SmPC,bg,3,ЛЕКАРСТВЕНА ФОРМА,1.0,True,8
8,9,CAP,SmPC,bg,4,КЛИНИЧНИ ДАННИ,1.0,True,9
9,10,CAP,SmPC,bg,4.1,Терапевтични показания ,9.0,True,10
10,11,CAP,SmPC,bg,4.2,Дозировка и начин на приложение,9.0,True,11
11,12,CAP,SmPC,bg,,Дозировка,11.0,True,12
12,13,CAP,SmPC,bg,,Педиатрична популация,12.0,True,13
13,14,CAP,SmPC,bg,,Начин на приложение,11.0,True,14
14,15,CAP,SmPC,bg,,"Предпазни мерки, които трябва да бъдат взети преди работа със или приложение на лекарствения продукт",14.0,False,15
15,16,CAP,SmPC,bg,4.3,Противопоказания,9.0,True,16
16,17,CAP,SmPC,bg,4.4,Специални предупреждения и предпазни мерки при употреба,9.0,True,17
17,18,CAP,SmPC,bg,,Проследимост,17.0,False,18
18,19,CAP,SmPC,bg,,Педиатрична популация,17.0,False,19
19,20,CAP,SmPC,bg,4.5,Взаимодействие с други лекарствени продукти и други форми на взаимодействие,9.0,True,20
20,21,CAP,SmPC,bg,,Педиатрична популация,20.0,False,21
21,22,CAP,SmPC,bg,4.6,"Фертилитет, бременност и кърмене",9.0,True,22
22,23,CAP,SmPC,bg,,Бременност,22.0,False,23
23,24,CAP,SmPC,bg,,Кърмене,22.0,False,24
24,25,CAP,SmPC,bg,,Фертилитет,22.0,False,25
25,26,CAP,SmPC,bg,4.7,Ефекти върху способността за шофиране и работа с машини,9.0,True,26
26,27,CAP,SmPC,bg,4.8,Нежелани лекарствени реакции,9.0,True,27
27,28,CAP,SmPC,bg,,Педиатрична популация,27.0,False,28
28,29,CAP,SmPC,bg,,Съобщаване на подозирани нежелани реакции,27.0,True,29
29,30,CAP,SmPC,bg,4.9,Предозиране,9.0,True,30
30,31,CAP,SmPC,bg,,Педиатрична популация,30.0,False,31
31,32,CAP,SmPC,bg,5,ФАРМАКОЛОГИЧНИ СВОЙСТВА,1.0,True,32
32,33,CAP,SmPC,bg,5.1,Фармакодинамични свойства,32.0,True,33
33,34,CAP,SmPC,bg,,Механизъм на действие,33.0,False,34
34,35,CAP,SmPC,bg,,Фармакодинамични ефекти,33.0,False,35
35,36,CAP,SmPC,bg,,Клинична ефикасност и безопасност,33.0,False,36
36,37,CAP,SmPC,bg,,Педиатрична популация,33.0,False,37
37,38,CAP,SmPC,bg,5.2,Фармакокинетични свойства,32.0,True,38
38,39,CAP,SmPC,bg,,Абсорбция,38.0,False,39
39,40,CAP,SmPC,bg,,Разпределение,38.0,False,40
40,41,CAP,SmPC,bg,,Биотрансформация,38.0,False,41
41,42,CAP,SmPC,bg,,Елиминиране,38.0,False,42
42,43,CAP,SmPC,bg,,Линейност/нелинейност,38.0,False,43
43,44,CAP,SmPC,bg,,Връзка(и) фармакокинетика-фармакодинамика,38.0,False,44
44,45,CAP,SmPC,bg,5.3,Предклинични данни за безопасност,32.0,True,45
45,46,CAP,SmPC,bg,,Оценка на риска за околната среда (ERA),45.0,False,46
46,47,CAP,SmPC,bg,6,ФАРМАЦЕВТИЧНИ ДАННИ,1.0,True,47
47,48,CAP,SmPC,bg,6.1,Списък на помощните вещества,47.0,True,48
48,49,CAP,SmPC,bg,6.2,Несъвместимости,47.0,True,49
49,50,CAP,SmPC,bg,6.3,Срок на годност,47.0,True,50
50,51,CAP,SmPC,bg,6.4,Специални условия на съхранение,47.0,True,51
51,52,CAP,SmPC,bg,6.5,"Вид и съдържание на опаковката <и специални приспособления за употреба, приложение или имплантиране>",47.0,True,52
52,53,CAP,SmPC,bg,6.6,Специални предпазни мерки при изхвърляне <и работа>,47.0,True,53
53,54,CAP,SmPC,bg,,Употреба при педиатричната популация,53.0,False,54
54,55,CAP,SmPC,bg,7,ПРИТЕЖАТЕЛ НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,1.0,True,55
55,56,CAP,SmPC,bg,8,НОМЕР(А) НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,1.0,True,56
56,57,CAP,SmPC,bg,9,ДАТА НА ПЪРВО РАЗРЕШАВАНЕ/ПОДНОВЯВАНЕ НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,1.0,True,57
57,58,CAP,SmPC,bg,10,ДАТА НА АКТУАЛИЗИРАНЕ НА ТЕКСТА,1.0,True,58
58,59,CAP,SmPC,bg,11,ДОЗИМЕТРИЯ,1.0,False,59
59,60,CAP,SmPC,bg,12,ИНСТРУКЦИИ ЗА ПРИГОТВЯНЕ НА РАДИОФАРМАЦЕВТИЦИ ,1.0,False,60
60,1001,CAP,AnnexII,bg,,ПРИЛОЖЕНИЕ II,,True,1
61,1002,CAP,AnnexII,bg,A.,"<ПРОИЗВОДИТЕЛ(И) НА БИОЛОГИЧНО АКТИВНОТО(ИТЕ) ВЕЩЕСТВО(А) И>ПРОИЗВОДИТЕЛ(И), ОТГОВОРЕН(НИ) ЗА ОСВОБОЖДАВАНЕ НА ПАРТИДИ ",1001.0,True,2
62,1003,CAP,AnnexII,bg,,Име и адрес на производителя(ите) на биологично активното(ите) вещество(а),1002.0,False,3
63,1004,CAP,AnnexII,bg,,"Име и адрес на производителя(ите), отговорен(ни) за освобождаване на партидите",1002.0,True,4
64,1005,CAP,AnnexII,bg,Б.,УСЛОВИЯ ИЛИ ОГРАНИЧЕНИЯ ЗА ДОСТАВКА И УПОТРЕБА,1001.0,True,5
65,1006,CAP,AnnexII,bg,,Официално освобождаване на партиди,1005.0,False,6
66,1007,CAP,AnnexII,bg,В.,ДРУГИ УСЛОВИЯ И ИЗИСКВАНИЯ НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,1001.0,True,7
67,1008,CAP,AnnexII,bg,,Периодични актуализирани доклади за безопасност (ПАДБ),1007.0,True,8
68,1009,CAP,AnnexII,bg,Г.,УСЛОВИЯ ИЛИ ОГРАНИЧЕНИЯ ЗА БЕЗОПАСНА И ЕФЕКТИВНА УПОТРЕБА НА ЛЕКАРСТВЕНИЯ ПРОДУКТ,1001.0,True,9
69,1010,CAP,AnnexII,bg,,План за управление на риска (ПУР),1009.0,True,10
70,1011,CAP,AnnexII,bg,,Допълнителни мерки за свеждане на риска до минимум,1009.0,False,11
71,1012,CAP,AnnexII,bg,,Задължение за провеждане на мерки след разрешаване за употреба,1009.0,False,12
72,1013,CAP,AnnexII,bg,Д.,КОНКРЕТНО ЗАДЪЛЖЕНИЕ ЗА ИЗПЪЛНЕНИЕ НА МЕРКИ СЛЕД <РАЗРЕШАВАНЕ ЗА УПОТРЕБА ПОД УСЛОВИЕ> <РАЗРЕШАВАНЕ ЗА УПОТРЕБА ПРИ ИЗВЪНРЕДНИ ОБСТОЯТЕЛСТВА>,1001.0,False,13
73,2001,CAP,Labelling,bg,,ДАННИ ВЪРХУ ОПАКОВКАТА,,True,1
74,2002,CAP,Labelling,bg,,"ДАННИ, КОИТО ТРЯБВА ДА СЪДЪРЖА <ВТОРИЧНАТА ОПАКОВКА> <И> <ПЪРВИЧНАТА ОПАКОВКА>",2001.0,True,2
75,2003,CAP,Labelling,bg,1,ИМЕ НА ЛЕКАРСТВЕНИЯ ПРОДУКТ,2002.0,True,3
76,2004,CAP,Labelling,bg,2,ОБЯВЯВАНЕ НА АКТИВНОТО(ИТЕ) ВЕЩЕСТВО(А),2002.0,True,4
77,2005,CAP,Labelling,bg,3,СПИСЪК НА ПОМОЩНИТЕ ВЕЩЕСТВА,2002.0,True,5
78,2006,CAP,Labelling,bg,4,ЛЕКАРСТВЕНА ФОРМА И КОЛИЧЕСТВО В ЕДНА ОПАКОВКА,2002.0,True,6
79,2007,CAP,Labelling,bg,5,НАЧИН НА ПРИЛОЖЕНИЕ И ПЪТ(ИЩА) НА ВЪВЕЖДАНЕ,2002.0,True,7
80,2008,CAP,Labelling,bg,6,"СПЕЦИАЛНО ПРЕДУПРЕЖДЕНИЕ, ЧЕ ЛЕКАРСТВЕНИЯТ ПРОДУКТ ТРЯБВА ДА СЕ СЪХРАНЯВА НА МЯСТО ДАЛЕЧЕ ОТ ПОГЛЕДА И ДОСЕГА НА ДЕЦА ",2002.0,True,8
81,2009,CAP,Labelling,bg,7,"ДРУГИ СПЕЦИАЛНИ ПРЕДУПРЕЖДЕНИЯ, АКО Е НЕОБХОДИМО",2002.0,True,9
82,2010,CAP,Labelling,bg,8,ДАТА НА ИЗТИЧАНЕ НА СРОКА НА ГОДНОСТ,2002.0,True,10
83,2011,CAP,Labelling,bg,9,СПЕЦИАЛНИ УСЛОВИЯ НА СЪХРАНЕНИЕ,2002.0,True,11
84,2012,CAP,Labelling,bg,10,"СПЕЦИАЛНИ ПРЕДПАЗНИ МЕРКИ ПРИ ИЗХВЪРЛЯНЕ НА НЕИЗПОЛЗВАНА ЧАСТ ОТ ЛЕКАРСТВЕНИТЕ ПРОДУКТИ ИЛИ ОТПАДЪЧНИ МАТЕРИАЛИ ОТ ТЯХ, АКО СЕ ИЗИСКВАТ ТАКИВА",2002.0,True,12
85,2013,CAP,Labelling,bg,11,ИМЕ И АДРЕС НА ПРИТЕЖАТЕЛЯ НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,2002.0,True,13
86,2014,CAP,Labelling,bg,12,НОМЕР(А) НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,2002.0,True,14
87,2015,CAP,Labelling,bg,13,"ПАРТИДЕН НОМЕР<, КОДОВЕ НА ДАРЕНИЕТО И НА ПРОДУКТА>",2002.0,True,15
88,2016,CAP,Labelling,bg,14,НАЧИН НА ОТПУСКАНЕ,2002.0,True,16
89,2017,CAP,Labelling,bg,15,УКАЗАНИЯ ЗА УПОТРЕБА,2002.0,True,17
90,2018,CAP,Labelling,bg,16,ИНФОРМАЦИЯ НА БРАЙЛОВА АЗБУКА,2002.0,True,18
91,2019,CAP,Labelling,bg,17,УНИКАЛЕН ИДЕНТИФИКАТОР — ДВУИЗМЕРЕН БАРКОД,2002.0,True,19
92,2020,CAP,Labelling,bg,18,УНИКАЛЕН ИДЕНТИФИКАТОР — ДАННИ ЗА ЧЕТЕНЕ ОТ ХОРА,2002.0,True,20
93,2021,CAP,Labelling,bg,,"МИНИМУМ ДАННИ, КОИТО ТРЯБВА ДА СЪДЪРЖАТ БЛИСТЕРИТЕ И ЛЕНТИТЕ",2001.0,True,21
94,2022,CAP,Labelling,bg,1,ИМЕ НА ЛЕКАРСТВЕНИЯ ПРОДУКТ,2021.0,True,22
95,2023,CAP,Labelling,bg,2,ИМЕ НА ПРИТЕЖАТЕЛЯ НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,2021.0,True,23
96,2024,CAP,Labelling,bg,3,ДАТА НА ИЗТИЧАНЕ НА СРОКА НА ГОДНОСТ,2021.0,True,24
97,2025,CAP,Labelling,bg,4,"ПАРТИДЕН НОМЕР<, КОДОВЕ НА ДАРЕНИЕТО И НА ПРОДУКТА>",2021.0,True,25
98,2026,CAP,Labelling,bg,5,ДРУГО,2021.0,True,26
99,2027,CAP,Labelling,bg,,"МИНИМУМ ДАННИ, КОИТО ТРЯБВА ДА СЪДЪРЖАТ МАЛКИТЕ ЕДИНИЧНИ ПЪРВИЧНИ ОПАКОВКИ",2001.0,True,27
100,2028,CAP,Labelling,bg,1,ИМЕ НА ЛЕКАРСТВЕНИЯ ПРОДУКT И ПЪТ(ИЩА) НА ВЪВЕЖДАНЕ,2027.0,True,28
101,2029,CAP,Labelling,bg,2,НАЧИН НА ПРИЛОЖЕНИЕ,2027.0,True,29
102,2030,CAP,Labelling,bg,3,ДАТА НА ИЗТИЧАНЕ НА СРОКА НА ГОДНОСТ,2027.0,True,30
103,2031,CAP,Labelling,bg,4,"ПАРТИДЕН НОМЕР<, КОДОВЕ НА ДАРЕНИЕТО И НА ПРОДУКТА>",2027.0,True,31
104,2032,CAP,Labelling,bg,5,"СЪДЪРЖАНИЕ КАТО МАСА, ОБЕМ ИЛИ ЕДИНИЦИ",2027.0,True,32
105,2033,CAP,Labelling,bg,6,ДРУГО,2027.0,True,33
106,3001,CAP,Package leaflet,bg,, ЛИСТОВКА,,True,1
107,3002,CAP,Package leaflet,bg,,"q Този лекарствен продукт подлежи на допълнително наблюдение. Това ще позволи бързото установяване на нова информация относно безопасността. Можете да дадете своя принос като съобщите всяка нежелана реакция, която сте получили. За начина на съобщаване на нежелани реакции вижте края на точка 4. ",3001.0,False,2
108,3003,CAP,Package leaflet,bg,,Какво съдържа тази листовка,3001.0,True,3
109,3004,CAP,Package leaflet,bg,1,Какво представлява Х и за какво се използва,3001.0,True,4
110,3005,CAP,Package leaflet,bg,2,"Какво трябва да знаете, преди да <приемете> <използвате> Х",3001.0,True,5
111,3006,CAP,Package leaflet,bg,,Не <приемайте> <използвайте> X,3005.0,True,6
112,3007,CAP,Package leaflet,bg,,Предупреждения и предпазни мерки,3005.0,True,7
113,3008,CAP,Package leaflet,bg,,Деца <и юноши>,3005.0,True,8
114,3009,CAP,Package leaflet,bg,,Други лекарства и Х,3005.0,True,9
115,3010,CAP,Package leaflet,bg,,"X с <храна> <и> <,> <напитки> <и> <алкохол>",3005.0,True,10
116,3011,CAP,Package leaflet,bg,,"Бременност <и> <,> кърмене <и фертилитет>",3005.0,True,11
117,3012,CAP,Package leaflet,bg,,Шофиране и работа с машини,3005.0,True,12
118,3013,CAP,Package leaflet,bg,,X съдържа {име на помощното(ите) вещество(а)},3005.0,False,13
119,3014,CAP,Package leaflet,bg,3,Как да <приемате> <използвате> Х,3001.0,True,14
120,3015,CAP,Package leaflet,bg,,Употреба при деца <и юноши>,3014.0,False,15
121,3016,CAP,Package leaflet,bg,,Ако сте <приели> <използвали> повече от необходимата доза X,3014.0,False,16
122,3017,CAP,Package leaflet,bg,,Ако сте пропуснали да <приемете> <използвате> X,3014.0,False,17
123,3018,CAP,Package leaflet,bg,,Ако сте спрели <приема> <употребата> на X,3014.0,False,18
124,3019,CAP,Package leaflet,bg,4,Възможни нежелани реакции,3001.0,True,19
125,3020,CAP,Package leaflet,bg,,Допълнителни нежелани реакции при деца <и юноши,3019.0,False,20
126,3021,CAP,Package leaflet,bg,,Съобщаване на нежелани реакции,3019.0,True,21
127,3022,CAP,Package leaflet,bg,5,Как да съхранявате X,3001.0,True,22
128,3023,CAP,Package leaflet,bg,6,Съдържание на опаковката и допълнителна информация,3001.0,True,23
129,3024,CAP,Package leaflet,bg,,Какво съдържа X,3023.0,True,24
130,3025,CAP,Package leaflet,bg,,Как изглежда X и какво съдържа опаковката ,3023.0,True,25
131,3026,CAP,Package leaflet,bg,,Притежател на разрешението за употреба и производител,3023.0,True,26
132,3027,CAP,Package leaflet,bg,,"За допълнителна информация относно това лекарствo, моля, свържете се с локалния представител на притежателя на разрешението за употреба:",3023.0,False,27
133,3028,CAP,Package leaflet,bg,,Дата на последно преразглеждане на листовката <{ММ /ГГГГ}> <{месец ГГГГ}>.,3023.0,True,28
134,3029,CAP,Package leaflet,bg,,Други източници на информация,3023.0,False,29
135,3030,CAP,Package leaflet,bg,,Посочената по-долу информация е предназначена само за медицински специалисти:,3001.0,False,30
136,4001,CAP,SmPC,cs,,SOUHRN ÚDAJŮ O PŘÍPRAVKU,,True,1
137,4002,CAP,SmPC,cs,,"qTento léčivý přípravek podléhá dalšímu sledování. To umožní rychlé získání nových informací o bezpečnosti. Žádáme zdravotnické pracovníky, aby hlásili jakákoli podezření na nežádoucí účinky. Podrobnosti o hlášení nežádoucích účinků viz bod 4.8.",4001.0,False,2
138,4003,CAP,SmPC,cs,1,NÁZEV PŘÍPRAVKU,4001.0,True,3
139,4004,CAP,SmPC,cs,2,KVALITATIVNÍ A KVANTITATIVNÍ SLOŽENÍ,4001.0,True,4
140,4005,CAP,SmPC,cs,2.1,Obecný popis,4004.0,False,5
141,4006,CAP,SmPC,cs,2.2,Kvalitativní a kvantitativní složení,4004.0,False,6
142,4007,CAP,SmPC,cs,,<Pomocná látka> <Pomocné látky> se známým účinkem,4006.0,False,7
143,4008,CAP,SmPC,cs,3,LÉKOVÁ FORMA,4001.0,True,8
144,4009,CAP,SmPC,cs,4,KLINICKÉ ÚDAJE,4001.0,True,9
145,4010,CAP,SmPC,cs,4.1,Terapeutické indikace,4009.0,True,10
146,4011,CAP,SmPC,cs,4.2,Dávkování a způsob podání,4009.0,True,11
147,4012,CAP,SmPC,cs,,Dávkování,4011.0,True,12
148,4013,CAP,SmPC,cs,,Pediatrická populace,4012.0,True,13
149,4014,CAP,SmPC,cs,,Způsob podání,4011.0,True,14
150,4015,CAP,SmPC,cs,,"Opatření, která je nutno učinit před zacházením s léčivým přípravkem nebo před jeho podáním",4014.0,False,15
151,4016,CAP,SmPC,cs,4.3,Kontraindikace,4009.0,True,16
152,4017,CAP,SmPC,cs,4.4,Zvláštní upozornění a opatření pro použití,4009.0,True,17
153,4018,CAP,SmPC,cs,,Sledovatelnost,4017.0,False,18
154,4019,CAP,SmPC,cs,,Pediatrická populace,4017.0,False,19
155,4020,CAP,SmPC,cs,4.5,Interakce s jinými léčivými přípravky a jiné formy interakce,4009.0,True,20
156,4021,CAP,SmPC,cs,,Pediatrická populace,4020.0,False,21
157,4022,CAP,SmPC,cs,4.6,"Fertilita, těhotenství a kojení",4009.0,True,22
158,4023,CAP,SmPC,cs,,Těhotenství,4022.0,False,23
159,4024,CAP,SmPC,cs,,Kojení,4022.0,False,24
160,4025,CAP,SmPC,cs,,Fertilita,4022.0,False,25
161,4026,CAP,SmPC,cs,4.7,Účinky na schopnost řídit a obsluhovat stroje,4009.0,True,26
162,4027,CAP,SmPC,cs,4.8,Nežádoucí účinky,4009.0,True,27
163,4028,CAP,SmPC,cs,,Pediatrická populace,4027.0,False,28
164,4029,CAP,SmPC,cs,,Hlášení podezření na nežádoucí účinky,4027.0,True,29
165,4030,CAP,SmPC,cs,4.9,Předávkování,4009.0,True,30
166,4031,CAP,SmPC,cs,,Pediatrická populace,4030.0,False,31
167,4032,CAP,SmPC,cs,5,FARMAKOLOGICKÉ VLASTNOSTI,4001.0,True,32
168,4033,CAP,SmPC,cs,5.1,Farmakodynamické vlastnosti,4032.0,True,33
169,4034,CAP,SmPC,cs,,Mechanismus účinku,4033.0,False,34
170,4035,CAP,SmPC,cs,,Farmakodynamické účinky,4033.0,False,35
171,4036,CAP,SmPC,cs,,Klinická účinnost a bezpečnost,4033.0,False,36
172,4037,CAP,SmPC,cs,,Pediatrická populace,4033.0,False,37
173,4038,CAP,SmPC,cs,5.2,Farmakokinetické vlastnosti,4032.0,True,38
174,4039,CAP,SmPC,cs,,Absorpce,4038.0,False,39
175,4040,CAP,SmPC,cs,,Distribuce,4038.0,False,40
176,4041,CAP,SmPC,cs,,Biotransformace,4038.0,False,41
177,4042,CAP,SmPC,cs,,Eliminace,4038.0,False,42
178,4043,CAP,SmPC,cs,,Linearita/nelinearita,4038.0,False,43
179,4044,CAP,SmPC,cs,,Farmakokinetické/farmakodynamické vztahy,4038.0,False,44
180,4045,CAP,SmPC,cs,5.3,Předklinické údaje vztahující se k bezpečnosti,4032.0,True,45
181,4046,CAP,SmPC,cs,,Posouzení rizika pro životní prostředí,4045.0,False,46
182,4047,CAP,SmPC,cs,6,FARMACEUTICKÉ ÚDAJE,4001.0,True,47
183,4048,CAP,SmPC,cs,6.1,Seznam pomocných látek,4047.0,True,48
184,4049,CAP,SmPC,cs,6.2,Inkompatibility,4047.0,True,49
185,4050,CAP,SmPC,cs,6.3,Doba použitelnosti,4047.0,True,50
186,4051,CAP,SmPC,cs,6.4,Zvláštní opatření pro uchovávání,4047.0,True,51
187,4052,CAP,SmPC,cs,6.5,"Druh obalu a obsah balení <a zvláštní vybavení pro použití, podání nebo implantaci>",4047.0,True,52
188,4053,CAP,SmPC,cs,6.6,Zvláštní opatření pro likvidaci přípravku <a pro zacházení s ním>,4047.0,True,53
189,4054,CAP,SmPC,cs,,Použití u pediatrické populace,4053.0,False,54
190,4055,CAP,SmPC,cs,7,DRŽITEL ROZHODNUTÍ O REGISTRACI,4001.0,True,55
191,4056,CAP,SmPC,cs,8,REGISTRAČNÍ ČÍSLO/REGISTRAČNÍ ČÍSLA ,4001.0,True,56
192,4057,CAP,SmPC,cs,9,DATUM PRVNÍ REGISTRACE/PRODLOUŽENÍ REGISTRACE,4001.0,True,57
193,4058,CAP,SmPC,cs,10,DATUM REVIZE TEXTU,4001.0,True,58
194,4059,CAP,SmPC,cs,11,DOZIMETRIE,4001.0,False,59
195,4060,CAP,SmPC,cs,12,NÁVOD PRO PŘÍPRAVU RADIOFARMAK,4001.0,False,60
196,5001,CAP,AnnexII,cs,,PŘÍLOHA II,,True,1
197,5002,CAP,AnnexII,cs,A,<VÝROBCE/VÝROBCI BIOLOGICKÉ LÉČIVÉ LÁTKY/BIOLOGICKÝCH LÉČIVÝCH LÁTEK A> VÝROBCE ODPOVĚDNÝ/VÝROBCI ODPOVĚDNÍ ZA PROPOUŠTĚNÍ ŠARŽÍ,5001.0,True,2
198,5003,CAP,AnnexII,cs,,Název a adresa výrobce/výrobců biologické léčivé látky/biologických léčivých látek,5002.0,False,3
199,5004,CAP,AnnexII,cs,,Název a adresa výrobce odpovědného/výrobců odpovědných za propouštění šarží,5002.0,True,4
200,5005,CAP,AnnexII,cs,B,PODMÍNKY NEBO OMEZENÍ VÝDEJE A POUŽITÍ ,5001.0,True,5
201,5006,CAP,AnnexII,cs,,Úřední propouštění šarží,5005.0,False,6
202,5007,CAP,AnnexII,cs,C,DALŠÍ PODMÍNKY A POŽADAVKY REGISTRACE,5001.0,True,7
203,5008,CAP,AnnexII,cs,,Pravidelně aktualizované zprávy o bezpečnosti (PSUR),5007.0,True,8
204,5009,CAP,AnnexII,cs,D,PODMÍNKY NEBO OMEZENÍ S OHLEDEM NA BEZPEČNÉ A ÚČINNÉ POUŽÍVÁNÍ LÉČIVÉHO PŘÍPRAVKU,5001.0,True,9
205,5010,CAP,AnnexII,cs,,Plán řízení rizik (RMP),5009.0,True,10
206,5011,CAP,AnnexII,cs,,Další opatření k minimalizaci rizik,5009.0,False,11
207,5012,CAP,AnnexII,cs,,Povinnost uskutečnit poregistrační opatření,5009.0,False,12
208,5013,CAP,AnnexII,cs,E,ZVLÁŠTNÍ POVINNOST USKUTEČNIT POREGISTRAČNÍ OPATŘENÍ PRO <PODMÍNĚNOU REGISTRACI PŘÍPRAVKU> <REGISTRACI PŘÍPRAVKU ZA VÝJIMEČNÝCH OKOLNOSTÍ>,5001.0,False,13
209,6001,CAP,Labelling,cs,,OZNAČENÍ NA OBALU,,True,1
210,6002,CAP,Labelling,cs,,ÚDAJE UVÁDĚNÉ NA <VNĚJŠÍM OBALU> <A> <VNITŘNÍM OBALU>,6001.0,True,2
211,6003,CAP,Labelling,cs,1,NÁZEV LÉČIVÉHO PŘÍPRAVKU,6002.0,True,3
212,6004,CAP,Labelling,cs,2,OBSAH LÉČIVÉ LÁTKY/LÉČIVÝCH LÁTEK,6002.0,True,4
213,6005,CAP,Labelling,cs,3,SEZNAM POMOCNÝCH LÁTEK,6002.0,True,5
214,6006,CAP,Labelling,cs,4,LÉKOVÁ FORMA A OBSAH BALENÍ,6002.0,True,6
215,6007,CAP,Labelling,cs,5,ZPŮSOB A CESTA/CESTY PODÁNÍ,6002.0,True,7
216,6008,CAP,Labelling,cs,6,"ZVLÁŠTNÍ UPOZORNĚNÍ, ŽE LÉČIVÝ PŘÍPRAVEK MUSÍ BÝT UCHOVÁVÁN MIMO DOHLED A DOSAH DĚTÍ",6002.0,True,8
217,6009,CAP,Labelling,cs,7,"DALŠÍ ZVLÁŠTNÍ UPOZORNĚNÍ, POKUD JE POTŘEBNÉ",6002.0,True,9
218,6010,CAP,Labelling,cs,8,POUŽITELNOST,6002.0,True,10
219,6011,CAP,Labelling,cs,9,ZVLÁŠTNÍ PODMÍNKY PRO UCHOVÁVÁNÍ,6002.0,True,11
220,6012,CAP,Labelling,cs,10,"ZVLÁŠTNÍ OPATŘENÍ PRO LIKVIDACI NEPOUŽITÝCH LÉČIVÝCH PŘÍPRAVKŮ NEBO ODPADU Z NICH, POKUD JE TO VHODNÉ",6002.0,True,12
221,6013,CAP,Labelling,cs,11,NÁZEV A ADRESA DRŽITELE ROZHODNUTÍ O REGISTRACI,6002.0,True,13
222,6014,CAP,Labelling,cs,12,REGISTRAČNÍ ČÍSLO/ČÍSLA,6002.0,True,14
223,6015,CAP,Labelling,cs,13,"ČÍSLO ŠARŽE <, KÓD DÁRCE A KÓD LÉČIVÉHO PŘÍPRAVKU>",6002.0,True,15
224,6016,CAP,Labelling,cs,14,KLASIFIKACE PRO VÝDEJ,6002.0,True,16
225,6017,CAP,Labelling,cs,15,NÁVOD K POUŽITÍ,6002.0,True,17
226,6018,CAP,Labelling,cs,16,INFORMACE V BRAILLOVĚ PÍSMU,6002.0,True,18
227,6019,CAP,Labelling,cs,17,JEDINEČNÝ IDENTIFIKÁTOR – 2D ČÁROVÝ KÓD,6002.0,True,19
228,6020,CAP,Labelling,cs,18,JEDINEČNÝ IDENTIFIKÁTOR – DATA ČITELNÁ OKEM,6002.0,True,20
229,6021,CAP,Labelling,cs,,MINIMÁLNÍ ÚDAJE UVÁDĚNÉ NA BLISTRECH NEBO STRIPECH,6001.0,True,21
230,6022,CAP,Labelling,cs,1,NÁZEV LÉČIVÉHO PŘÍPRAVKU,6021.0,True,22
231,6023,CAP,Labelling,cs,2,NÁZEV DRŽITELE ROZHODNUTÍ O REGISTRACI,6021.0,True,23
232,6024,CAP,Labelling,cs,3,POUŽITELNOST,6021.0,True,24
233,6025,CAP,Labelling,cs,4,"ČÍSLO ŠARŽE <, KÓD DÁRCE A KÓD LÉČIVÉHO PŘÍPRAVKU>",6021.0,True,25
234,6026,CAP,Labelling,cs,5,JINÉ,6021.0,True,26
235,6027,CAP,Labelling,cs,,MINIMÁLNÍ ÚDAJE UVÁDĚNÉ NA MALÉM VNITŘNÍM OBALU,6001.0,True,27
236,6028,CAP,Labelling,cs,1,NÁZEV LÉČIVÉHO PŘÍPRAVKU A CESTA/CESTY PODÁNÍ,6027.0,True,28
237,6029,CAP,Labelling,cs,2,ZPŮSOB PODÁNÍ,6027.0,True,29
238,6030,CAP,Labelling,cs,3,POUŽITELNOST,6027.0,True,30
239,6031,CAP,Labelling,cs,4,"ČÍSLO ŠARŽE <, KÓD DÁRCE A KÓD LÉČIVÉHO PŘÍPRAVKU",6027.0,True,31
240,6032,CAP,Labelling,cs,5,"OBSAH UDANÝ JAKO HMOTNOST, OBJEM NEBO POČET",6027.0,True,32
241,6033,CAP,Labelling,cs,6,JINÉ,6027.0,True,33
242,7001,CAP,Package leaflet,cs,,PŘÍBALOVÁ INFORMACE,,True,1
243,7002,CAP,Package leaflet,cs,,"qTento přípravek podléhá dalšímu sledování. To umožní rychlé získání nových informací o bezpečnosti. Můžete přispět tím, že nahlásíte jakékoli nežádoucí účinky, které se u Vás vyskytnou. Jak hlásit nežádoucí účinky je popsáno v závěru bodu 4.",7001.0,False,2
244,7003,CAP,Package leaflet,cs,,Co naleznete v této příbalové informaci,7001.0,True,3
245,7004,CAP,Package leaflet,cs,1,Co je <přípravek> X a k čemu se používá,7001.0,True,4
246,7005,CAP,Package leaflet,cs,2,"Čemu musíte věnovat pozornost, než začnete <přípravek> X <užívat> <používat> ",7001.0,True,5
247,7006,CAP,Package leaflet,cs,,<Neužívejte> <Nepoužívejte> <přípravek> X,7005.0,True,6
248,7007,CAP,Package leaflet,cs,,Upozornění a opatření ,7005.0,True,7
249,7008,CAP,Package leaflet,cs,,Děti <a dospívající>,7005.0,True,8
250,7009,CAP,Package leaflet,cs,,Další léčivé přípravky a <přípravek> X,7005.0,True,9
251,7010,CAP,Package leaflet,cs,,"<Přípravek> X s <jídlem> <a> <,> <pitím> <a> <alkoholem>",7005.0,True,10
252,7011,CAP,Package leaflet,cs,,"Těhotenství <a> <,> kojení <a plodnost>",7005.0,True,11
253,7012,CAP,Package leaflet,cs,,Řízení dopravních prostředků a obsluha strojů,7005.0,True,12
254,7013,CAP,Package leaflet,cs,,<Přípravek> X obsahuje {název pomocné látky/pomocných látek},7005.0,False,13
255,7014,CAP,Package leaflet,cs,3,Jak se <přípravek> X <užívá> <používá>,7001.0,True,14
256,7015,CAP,Package leaflet,cs,,Použití u dětí <a dospívajících>,7014.0,False,15
257,7016,CAP,Package leaflet,cs,,"Jestliže jste <užil(a)> <použil(a)> více <přípravku>X, než jste měl(a)",7014.0,False,16
258,7017,CAP,Package leaflet,cs,,Jestliže jste zapomněl(a) <užít> <použít> <přípravek>X,7014.0,False,17
259,7018,CAP,Package leaflet,cs,,Jestliže jste přestal(a) <užívat> <používat> <přípravek>X,7014.0,False,18
260,7019,CAP,Package leaflet,cs,4,Možné nežádoucí účinky,7001.0,True,19
261,7020,CAP,Package leaflet,cs,,Další nežádoucí účinky u dětí <a dospívajících>,7019.0,False,20
262,7021,CAP,Package leaflet,cs,,Hlášení nežádoucích účinků,7019.0,True,21
263,7022,CAP,Package leaflet,cs,5,Jak <přípravek> X uchovávat,7001.0,True,22
264,7023,CAP,Package leaflet,cs,6,Obsah balení a další informace,7001.0,True,23
265,7024,CAP,Package leaflet,cs,,Co <přípravek> X obsahuje ,7023.0,True,24
266,7025,CAP,Package leaflet,cs,,Jak<přípravek> X vypadá a co obsahuje toto balení,7023.0,True,25
267,7026,CAP,Package leaflet,cs,,Držitel rozhodnutí o registraci a výrobce,7023.0,True,26
268,7027,CAP,Package leaflet,cs,,Další informace o tomto přípravku získáte u místního zástupce držitele rozhodnutí o registraci:,7023.0,False,27
269,7028,CAP,Package leaflet,cs,,Tato příbalová informace byla naposledy revidována <{DD. MM. RRRR}> <{MM/RRRR}> <{měsíc RRRR}>.,7023.0,True,28
270,7029,CAP,Package leaflet,cs,,Další zdroje informací,7023.0,False,29
271,7030,CAP,Package leaflet,cs,,Následující informace jsou určeny pouze pro zdravotnické pracovníky:,7001.0,False,30
272,8001,CAP,SmPC,da,,PRODUKTRESUMÉ,,True,1
273,8002,CAP,SmPC,da,,"qDette lægemiddel er underlagt supplerende overvågning. Dermed kan nye sikkerhedsoplysninger hurtigt tilvejebringes. Sundhedspersoner anmodes om at indberette alle formodede bivirkninger. Se i pkt. 4.8, hvordan bivirkninger indberettes.",8001.0,False,2
274,8003,CAP,SmPC,da,1,LÆGEMIDLETS NAVN,8001.0,True,3
275,8004,CAP,SmPC,da,2,KVALITATIV OG KVANTITATIV SAMMENSÆTNING,8001.0,True,4
276,8005,CAP,SmPC,da,2.1,Generel beskrivelse,8004.0,False,5
277,8006,CAP,SmPC,da,2.2,Kvalitativ og kvantitativ sammensætning,8004.0,False,6
278,8007,CAP,SmPC,da,,"Hjælpestof(fer), som behandleren skal være opmærksom på",8006.0,False,7
279,8008,CAP,SmPC,da,3,LÆGEMIDDELFORM,8001.0,True,8
280,8009,CAP,SmPC,da,4,KLINISKE OPLYSNINGER,8001.0,True,9
281,8010,CAP,SmPC,da,4.1,Terapeutiske indikationer,8009.0,True,10
282,8011,CAP,SmPC,da,4.2,Dosering og administration,8009.0,True,11
283,8012,CAP,SmPC,da,,Dosering,8011.0,True,12
284,8013,CAP,SmPC,da,,Pædiatrisk population,8012.0,True,13
285,8014,CAP,SmPC,da,,Administration,8011.0,True,14
286,8015,CAP,SmPC,da,,"Sikkerhedsforanstaltninger, der skal tages før håndtering og administration af lægemidlet",8014.0,False,15
287,8016,CAP,SmPC,da,4.3,Kontraindikationer,8009.0,True,16
288,8017,CAP,SmPC,da,4.4,Særlige advarsler og forsigtighedsregler vedrørende brugen,8009.0,True,17
289,8018,CAP,SmPC,da,,Sporbarhed,8017.0,False,18
290,8019,CAP,SmPC,da,,Pædiatrisk population,8017.0,False,19
291,8020,CAP,SmPC,da,4.5,Interaktion med andre lægemidler og andre former for interaktion,8009.0,True,20
292,8021,CAP,SmPC,da,,Pædiatrisk population,8020.0,False,21
293,8022,CAP,SmPC,da,4.6,"Fertilitet, graviditet og amning",8009.0,True,22
294,8023,CAP,SmPC,da,,Graviditet,8022.0,False,23
295,8024,CAP,SmPC,da,,Amning,8022.0,False,24
296,8025,CAP,SmPC,da,,Fertilitet,8022.0,False,25
297,8026,CAP,SmPC,da,4.7,Virkning på evnen til at føre motorkøretøj og betjene maskiner,8009.0,True,26
298,8027,CAP,SmPC,da,4.8,Bivirkninger,8009.0,True,27
299,8028,CAP,SmPC,da,,Pædiatrisk population,8027.0,False,28
300,8029,CAP,SmPC,da,,Indberetning af formodede bivirkninger,8027.0,True,29
301,8030,CAP,SmPC,da,4.9,Overdosering,8009.0,True,30
302,8031,CAP,SmPC,da,,Pædiatrisk population,8030.0,False,31
303,8032,CAP,SmPC,da,5,FARMAKOLOGISKE EGENSKABER,8001.0,True,32
304,8033,CAP,SmPC,da,5.1,Farmakodynamiske egenskaber,8032.0,True,33
305,8034,CAP,SmPC,da,,Virkningsmekanisme,8033.0,False,34
306,8035,CAP,SmPC,da,,Farmakodynamisk virkning,8033.0,False,35
307,8036,CAP,SmPC,da,,Klinisk virkning og sikkerhed,8033.0,False,36
308,8037,CAP,SmPC,da,,Pædiatrisk population,8033.0,False,37
309,8038,CAP,SmPC,da,5.2,Farmakokinetiske egenskaber,8032.0,True,38
310,8039,CAP,SmPC,da,,Absorption,8038.0,False,39
311,8040,CAP,SmPC,da,,Fordeling,8038.0,False,40
312,8041,CAP,SmPC,da,,Biotransformation,8038.0,False,41
313,8042,CAP,SmPC,da,,Elimination,8038.0,False,42
314,8043,CAP,SmPC,da,,Linearitet/non-linearitet,8038.0,False,43
315,8044,CAP,SmPC,da,,Farmakokinetiske/farmakodynamiske forhold,8038.0,False,44
316,8045,CAP,SmPC,da,5.3,Non-kliniske sikkerhedsdata,8032.0,True,45
317,8046,CAP,SmPC,da,,Miljørisikovurdering,8045.0,False,46
318,8047,CAP,SmPC,da,6,FARMACEUTISKE OPLYSNINGER,8001.0,True,47
319,8048,CAP,SmPC,da,6.1,Hjælpestoffer,8047.0,True,48
320,8049,CAP,SmPC,da,6.2,Uforligeligheder,8047.0,True,49
321,8050,CAP,SmPC,da,6.3,Opbevaringstid,8047.0,True,50
322,8051,CAP,SmPC,da,6.4,Særlige opbevaringsforhold,8047.0,True,51
323,8052,CAP,SmPC,da,6.5,"Emballagetype og pakningsstørrelser <og specielt udstyr til anvendelse, administration eller implantation>",8047.0,True,52
324,8053,CAP,SmPC,da,6.6,Regler for bortskaffelse <og anden håndtering>,8047.0,True,53
325,8054,CAP,SmPC,da,,Brug i den pædiatriske population,8053.0,False,54
326,8055,CAP,SmPC,da,7,INDEHAVER AF MARKEDSFØRINGSTILLADELSEN,8001.0,True,55
327,8056,CAP,SmPC,da,8,MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE),8001.0,True,56
328,8057,CAP,SmPC,da,9,DATO FOR FØRSTE MARKEDSFØRINGSTILLADELSE/FORNYELSE AF TILLADELSEN,8001.0,True,57
329,8058,CAP,SmPC,da,10,DATO FOR ÆNDRING AF TEKSTEN,8001.0,True,58
330,8059,CAP,SmPC,da,11,DOSIMETRI,8001.0,False,59
331,8060,CAP,SmPC,da,12,INSTRUKTIONER FOR FREMSTILLING AF RADIOAKTIVE LÆGEMIDLER,8001.0,False,60
332,9001,CAP,BILAG II,da,,BILAG II,,True,1
333,9002,CAP,BILAG II,da,A,<FREMSTILLER(E) AF DET (DE) BIOLOGISK AKTIVE STOF(FER) OG> FREMSTILLER(E) ANSVARLIG(E) FOR BATCHFRIGIVELSE,9001.0,True,2
334,9003,CAP,BILAG II,da,,Navn og adresse på fremstilleren (fremstillerne) af det (de) biologisk aktive stof(fer),9002.0,False,3
335,9004,CAP,BILAG II,da,,"Navn og adresse på den fremstiller (de fremstillere), der er ansvarlig(e) for batchfrigivelse",9002.0,True,4
336,9005,CAP,BILAG II,da,B,BETINGELSER ELLER BEGRÆNSNINGER VEDRØRENDE UDLEVERING OG ANVENDELSE,9001.0,True,5
337,9006,CAP,BILAG II,da,,Officiel batchfrigivelse,9005.0,False,6
338,9007,CAP,BILAG II,da,C,ANDRE FORHOLD OG BETINGELSER FOR MARKEDSFØRINGSTILLADELSEN,9001.0,True,7
339,9008,CAP,BILAG II,da,,"Periodiske, opdaterede sikkerhedsindberetninger (PSUR’er)",9007.0,True,8
340,9009,CAP,BILAG II,da,D,BETINGELSER ELLER BEGRÆNSNINGER MED HENSYN TIL SIKKER OG EFFEKTIV ANVENDELSE AF LÆGEMIDLET ,9001.0,True,9
341,9010,CAP,BILAG II,da,,Risikostyringsplan (RMP) ,9009.0,True,10
342,9011,CAP,BILAG II,da,,Yderligere risikominimeringsforanstaltninger,9009.0,False,11
343,9012,CAP,BILAG II,da,,Forpligtelse til at gennemføre foranstaltninger efter udstedelse af markedsføringstilladelse,9009.0,False,12
344,9013,CAP,BILAG II,da,E,SÆRLIG FORPLIGTELSE TIL AT AFSLUTTE FORANSTALTNINGER EFTER UDSTEDELSE AF MARKEDSFØRINGSTILLADELSE TIL LÆGEMIDLER GODKENDT UNDER <BETINGEDE OMSTÆNDIGHEDER> <SÆRLIGE VILKÅR>,9001.0,False,13
345,10001,CAP,ETIKETTERING ,da,,ETIKETTERING ,,True,1
346,10002,CAP,ETIKETTERING ,da,,"MÆRKNING, DER SKAL ANFØRES <PÅ DEN YDRE EMBALLAGE> <OG> <PÅ DEN INDRE EMBALLAGE>",10001.0,True,2
347,10003,CAP,ETIKETTERING ,da,1,LÆGEMIDLETS NAVN,10002.0,True,3
348,10004,CAP,ETIKETTERING ,da,2,ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER,10002.0,True,4
349,10005,CAP,ETIKETTERING ,da,3,LISTE OVER HJÆLPESTOFFER,10002.0,True,5
350,10006,CAP,ETIKETTERING ,da,4,LÆGEMIDDELFORM OG INDHOLD (PAKNINGSSTØRRELSE),10002.0,True,6
351,10007,CAP,ETIKETTERING ,da,5,ANVENDELSESMÅDE OG ADMINISTRATIONSVEJ€,10002.0,True,7
352,10008,CAP,ETIKETTERING ,da,6,"SÆRLIG ADVARSEL OM, AT LÆGEMIDLET SKAL OPBEVARES UTILGÆNGELIGT FOR BØRN",10002.0,True,8
353,10009,CAP,ETIKETTERING ,da,7,EVENTUELLE ANDRE SÆRLIGE ADVARSLER,10002.0,True,9
354,10010,CAP,ETIKETTERING ,da,8,UDLØBSDATO,10002.0,True,10
355,10011,CAP,ETIKETTERING ,da,9,SÆRLIGE OPBEVARINGSBETINGELSER,10002.0,True,11
356,10012,CAP,ETIKETTERING ,da,10,EVENTUELLE SÆRLIGE FORHOLDSREGLER VED BORTSKAFFELSE AF IKKE ANVENDT LÆGEMIDDEL SAMT AFFALD HERAF,10002.0,True,12
357,10013,CAP,ETIKETTERING ,da,11,NAVN OG ADRESSE PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN,10002.0,True,13
358,10014,CAP,ETIKETTERING ,da,12,MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE),10002.0,True,14
359,10015,CAP,ETIKETTERING ,da,13,"BATCHNUMMER <, DONATIONS- OG PRODUKTKODER>",10002.0,True,15
360,10016,CAP,ETIKETTERING ,da,14,GENEREL KLASSIFIKATION FOR UDLEVERING ,10002.0,True,16
361,10017,CAP,ETIKETTERING ,da,15,INSTRUKTIONER VEDRØRENDE ANVENDELSEN,10002.0,True,17
362,10018,CAP,ETIKETTERING ,da,16,INFORMATION I BRAILLESKRIFT,10002.0,True,18
363,10019,CAP,ETIKETTERING ,da,17,ENTYDIG IDENTIFIKATOR – 2D-STREGKODE,10002.0,True,19
364,10020,CAP,ETIKETTERING ,da,18,ENTYDIG IDENTIFIKATOR - MENNESKELIGT LÆSBARE DATA,10002.0,True,20
365,10021,CAP,ETIKETTERING ,da,,MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP,10001.0,True,21
366,10022,CAP,ETIKETTERING ,da,1,LÆGEMIDLETS NAVN,10021.0,True,22
367,10023,CAP,ETIKETTERING ,da,2,NAVN PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN,10021.0,True,23
368,10024,CAP,ETIKETTERING ,da,3,UDLØBSDATO,10021.0,True,24
369,10025,CAP,ETIKETTERING ,da,4,"BATCHNUMMER<, DONATIONS- OG PRODUKTKODER>",10021.0,True,25
370,10026,CAP,ETIKETTERING ,da,5,ANDET,10021.0,True,26
371,10027,CAP,ETIKETTERING ,da,,MINDSTEKRAV TIL MÆRKNING PÅ SMÅ INDRE EMBALLAGER,10001.0,True,27
372,10028,CAP,ETIKETTERING ,da,1,LÆGEMIDLETS NAVN OG ADMINISTRATIONSVEJ€,10027.0,True,28
373,10029,CAP,ETIKETTERING ,da,2,ADMINISTRATIONSMETODE,10027.0,True,29
374,10030,CAP,ETIKETTERING ,da,3,UDLØBSDATO,10027.0,True,30
375,10031,CAP,ETIKETTERING ,da,4,"BATCHNUMMER<, DONATIONS- OG PRODUKTKODER>",10027.0,True,31
376,10032,CAP,ETIKETTERING ,da,5,"INDHOLD ANGIVET SOM VÆGT, VOLUMEN ELLER ENHEDER",10027.0,True,32
377,10033,CAP,ETIKETTERING ,da,6,ANDET,10027.0,True,33
378,11001,CAP,INDLÆGSSEDDEL,da,,INDLÆGSSEDDEL,,True,1
379,11002,CAP,INDLÆGSSEDDEL,da,,"q Dette lægemiddel er underlagt supplerende overvågning. Dermed kan der hurtigt tilvejebringes nye oplysninger om sikkerheden. <De> <Du> kan hjælpe ved at indberette alle de bivirkninger, <De> <du> får. Se sidst i <afsnit> <punkt> 4, hvordan <De> <du> indberetter bivirkninger",11001.0,False,2
380,11003,CAP,INDLÆGSSEDDEL,da,,Oversigt over indlægssedlen,11001.0,True,3
381,11004,CAP,INDLÆGSSEDDEL,da,1,Virkning og anvendelse,11001.0,True,4
382,11005,CAP,INDLÆGSSEDDEL,da,2,"Det skal <De> <du> vide, før <De> <du> begynder at <tage> <bruge> {X}",11001.0,True,5
383,11006,CAP,INDLÆGSSEDDEL,da,,<Tag> <Brug> ikke {X},11005.0,True,6
384,11007,CAP,INDLÆGSSEDDEL,da,,Advarsler og forsigtighedsregler,11005.0,True,7
385,11008,CAP,INDLÆGSSEDDEL,da,,Børn <og unge> ,11005.0,True,8
386,11009,CAP,INDLÆGSSEDDEL,da,,Brug af anden medicin sammen med {X},11005.0,True,9
387,11010,CAP,INDLÆGSSEDDEL,da,,"Brug af {X} sammen med <mad> <og> <,> <drikke> <og> <alkohol>",11005.0,True,10
388,11011,CAP,INDLÆGSSEDDEL,da,,"Graviditet <og> <,> amning <og frugtbarhed>",11005.0,True,11
389,11012,CAP,INDLÆGSSEDDEL,da,,Trafik- og arbejdssikkerhed,11005.0,True,12
390,11013,CAP,INDLÆGSSEDDEL,da,,"{X} indeholder {nævn de(t) hjælpestof(fer), hvor advarsel er påkrævet}",11005.0,False,13
391,11014,CAP,INDLÆGSSEDDEL,da,3,Sådan skal <De> <du> <tage> <bruge> {X},11001.0,True,14
392,11015,CAP,INDLÆGSSEDDEL,da,,Brug til børn <og unge>,11014.0,False,15
393,11016,CAP,INDLÆGSSEDDEL,da,,Hvis <De> <du> har <taget> <brugt> for meget {X},11014.0,False,16
394,11017,CAP,INDLÆGSSEDDEL,da,,Hvis <De> <du> har glemt at <tage> <bruge> {X},11014.0,False,17
395,11018,CAP,INDLÆGSSEDDEL,da,,Hvis <De> <du> holder op med at <tage> <bruge> {X},11014.0,False,18
396,11019,CAP,INDLÆGSSEDDEL,da,4,Bivirkninger,11001.0,True,19
397,11020,CAP,INDLÆGSSEDDEL,da,,Hos børn <og unge> kan endvidere ses følgende bivirkninger:,11019.0,False,20
398,11021,CAP,INDLÆGSSEDDEL,da,,Indberetning af bivirkninger,11019.0,True,21
399,11022,CAP,INDLÆGSSEDDEL,da,5,Opbevaring,11001.0,True,22
400,11023,CAP,INDLÆGSSEDDEL,da,6,Pakningsstørrelser og yderligere oplysninger,11001.0,True,23
401,11024,CAP,INDLÆGSSEDDEL,da,,{X} indeholder:,11023.0,True,24
402,11025,CAP,INDLÆGSSEDDEL,da,,Udseende og pakningsstørrelser,11023.0,True,25
403,11026,CAP,INDLÆGSSEDDEL,da,,Indehaver af markedsføringstilladelsen og fremstiller,11023.0,True,26
404,11027,CAP,INDLÆGSSEDDEL,da,,"Hvis <De> <du> ønsker yderligere oplysninger om <{X}> <dette lægemiddel>, skal <De> <du> henvende <Dem> <dig> til den lokale repræsentant for indehaveren af markedsføringstilladelsen:",11023.0,False,27
405,11028,CAP,INDLÆGSSEDDEL,da,,Denne indlægsseddel blev senest ændret <{MM/ÅÅÅÅ}> <{måned ÅÅÅÅ}.>,11023.0,True,28
406,11029,CAP,INDLÆGSSEDDEL,da,,Andre informationskilder,11023.0,False,29
407,11030,CAP,INDLÆGSSEDDEL,da,,Nedenstående oplysninger er til læger og sundhedspersonale:,11001.0,False,30
408,12001,CAP,SmPC,de,,ZUSAMMENFASSUNG DER MERKMALE DES ARZNEIMITTELS,,True,1
409,12002,CAP,SmPC,de,,"Dieses Arzneimittel unterliegt einer zusätzlichen Überwachung. Dies ermöglicht eine schnelle Identifizierung neuer Erkenntnisse über die Sicherheit. Angehörige von Gesundheitsberufen sind aufgefordert, jeden Verdachtsfall einer Nebenwirkung zu melden. Hinweise zur Meldung von Nebenwirkungen, siehe Abschnitt 4.8.",12001.0,False,2
410,12003,CAP,SmPC,de,1,BEZEICHNUNG DES ARZNEIMITTELS,12001.0,True,3
411,12004,CAP,SmPC,de,2,QUALITATIVE UND QUANTITATIVE ZUSAMMENSETZUNG,12001.0,True,4
412,12005,CAP,SmPC,de,2.1,Allgemeine Beschreibung,12004.0,False,5
413,12006,CAP,SmPC,de,2.2,Qualitative und quantitative Zusammensetzung,12004.0,False,6
414,12007,CAP,SmPC,de,,Sonstige(r) Bestandteil(e) mit bekannter Wirkung,12006.0,False,7
415,12008,CAP,SmPC,de,3,DARREICHUNGSFORM,12001.0,True,8
416,12009,CAP,SmPC,de,4,KLINISCHE ANGABEN,12001.0,True,9
417,12010,CAP,SmPC,de,4.1,Anwendungsgebiete,12009.0,True,10
418,12011,CAP,SmPC,de,4.2,Dosierung und Art der Anwendung,12009.0,True,11
419,12012,CAP,SmPC,de,,Dosierung,12011.0,True,12
420,12013,CAP,SmPC,de,,Kinder und Jugendliche,12012.0,True,13
421,12014,CAP,SmPC,de,,Art der Anwendung,12011.0,True,14
422,12015,CAP,SmPC,de,,Vorsichtsmaßnahmen vor / bei der Handhabung bzw. vor / während der Anwendung des Arzneimittels,12014.0,False,15
423,12016,CAP,SmPC,de,4.3,Gegenanzeigen,12009.0,True,16
424,12017,CAP,SmPC,de,4.4,Besondere Warnhinweise und Vorsichtsmaßnahmen für die Anwendung,12009.0,True,17
425,12018,CAP,SmPC,de,,Rückverfolgbarkeit,12017.0,False,18
426,12019,CAP,SmPC,de,,Kinder und Jugendliche,12017.0,False,19
427,12020,CAP,SmPC,de,4.5,Wechselwirkungen mit anderen Arzneimitteln und sonstige Wechselwirkungen,12009.0,True,20
428,12021,CAP,SmPC,de,,Kinder und Jugendliche,12020.0,False,21
429,12022,CAP,SmPC,de,4.6,"Fertilität, Schwangerschaft und Stillzeit",12009.0,True,22
430,12023,CAP,SmPC,de,,Schwangerschaft,12022.0,False,23
431,12024,CAP,SmPC,de,,Stillzeit,12022.0,False,24
432,12025,CAP,SmPC,de,,Fertilität,12022.0,False,25
433,12026,CAP,SmPC,de,4.7,Auswirkungen auf die Verkehrstüchtigkeit und die Fähigkeit zum Bedienen von Maschinen,12009.0,True,26
434,12027,CAP,SmPC,de,4.8,Nebenwirkungen,12009.0,True,27
435,12028,CAP,SmPC,de,,Kinder und Jugendliche,12027.0,False,28
436,12029,CAP,SmPC,de,,Meldung des Verdachts auf Nebenwirkungen,12027.0,True,29
437,12030,CAP,SmPC,de,4.9,Überdosierung,12009.0,True,30
438,12031,CAP,SmPC,de,,Kinder und Jugendliche,12030.0,False,31
439,12032,CAP,SmPC,de,5,PHARMAKOLOGISCHE EIGENSCHAFTEN,12001.0,True,32
440,12033,CAP,SmPC,de,5.1,Pharmakodynamische Eigenschaften,12032.0,True,33
441,12034,CAP,SmPC,de,,Wirkmechanismus,12033.0,False,34
442,12035,CAP,SmPC,de,,Pharmakodynamische Wirkungen,12033.0,False,35
443,12036,CAP,SmPC,de,,Klinische Wirksamkeit und Sicherheit,12033.0,False,36
444,12037,CAP,SmPC,de,,Kinder und Jugendliche,12033.0,False,37
445,12038,CAP,SmPC,de,5.2,Pharmakokinetische Eigenschaften,12032.0,True,38
446,12039,CAP,SmPC,de,,Resorption,12038.0,False,39
447,12040,CAP,SmPC,de,,Verteilung,12038.0,False,40
448,12041,CAP,SmPC,de,,Biotransformation,12038.0,False,41
449,12042,CAP,SmPC,de,,Elimination,12038.0,False,42
450,12043,CAP,SmPC,de,,Linearität/Nicht-Linearität,12038.0,False,43
451,12044,CAP,SmPC,de,,Pharmakokinetische/pharmakodynamische Zusammenhänge,12038.0,False,44
452,12045,CAP,SmPC,de,5.3,Präklinische Daten zur Sicherheit,12032.0,True,45
453,12046,CAP,SmPC,de,,Beurteilung der Risiken für die Umwelt (Environmental risk assessment [ERA]),12045.0,False,46
454,12047,CAP,SmPC,de,6,PHARMAZEUTISCHE ANGABEN,12001.0,True,47
455,12048,CAP,SmPC,de,6.1,Liste der sonstigen Bestandteile,12047.0,True,48
456,12049,CAP,SmPC,de,6.2,Inkompatibilitäten,12047.0,True,49
457,12050,CAP,SmPC,de,6.3,Dauer der Haltbarkeit,12047.0,True,50
458,12051,CAP,SmPC,de,6.4,Besondere Vorsichtsmaßnahmen für die Aufbewahrung,12047.0,True,51
459,12052,CAP,SmPC,de,6.5,"Art und Inhalt des Behältnisses <und spezielles Zubehör für den Gebrauch, die Anwendung oder die Implantation>",12047.0,True,52
460,12053,CAP,SmPC,de,6.6,Besondere Vorsichtsmaßnahmen für die Beseitigung <und sonstige Hinweise zur Handhabung>,12047.0,True,53
461,12054,CAP,SmPC,de,,Anwendung bei Kindern und Jugendlichen,12053.0,False,54
462,12055,CAP,SmPC,de,7,INHABER DER ZULASSUNG,12001.0,True,55
463,12056,CAP,SmPC,de,8,ZULASSUNGSNUMMER(N),12001.0,True,56
464,12057,CAP,SmPC,de,9,DATUM DER ERTEILUNG DER ZULASSUNG/VERLÄNGERUNG DER ZULASSUNG,12001.0,True,57
465,12058,CAP,SmPC,de,10,STAND DER INFORMATION,12001.0,True,58
466,12059,CAP,SmPC,de,11,DOSIMETRIE,12001.0,False,59
467,12060,CAP,SmPC,de,12,ANWEISUNGEN ZUR ZUBEREITUNG VON RADIOAKTIVEN ARZNEIMITTELN,12001.0,False,60
468,13001,CAP,ANHANG II,de,,ANHANG II,,True,1
469,13002,CAP,ANHANG II,de,A,"<HERSTELLER DES WIRKSTOFFS/DER WIRKSTOFFE BIOLOGISCHEN URSPRUNGS UND> HERSTELLER, DER (DIE) FÜR DIE CHARGENFREIGABE VERANTWORTLICH IST (SIND)",13001.0,True,2
470,13003,CAP,ANHANG II,de,,Name und Anschrift des (der) Hersteller(s) des Wirkstoffs/der Wirkstoffe biologischen Ursprungs,13002.0,False,3
471,13004,CAP,ANHANG II,de,,"Name und Anschrift des (der) Hersteller(s), der (die) für die Chargenfreigabe verantwortlich ist (sind)",13002.0,True,4
472,13005,CAP,ANHANG II,de,B,BEDINGUNGEN ODER EINSCHRÄNKUNGEN FÜR DIE ABGABE UND DEN GEBRAUCH ,13001.0,True,5
473,13006,CAP,ANHANG II,de,,Amtliche Chargenfreigabe,13005.0,False,6
474,13007,CAP,ANHANG II,de,C,SONSTIGE BEDINGUNGEN UND AUFLAGEN DER GENEHMIGUNG FÜR DAS INVERKEHRBRINGEN,13001.0,True,7
475,13008,CAP,ANHANG II,de,,Regelmäßig aktualisierte Unbedenklichkeitsberichte [Periodic Safety Update Reports (PSURs)],13007.0,True,8
476,13009,CAP,ANHANG II,de,D,BEDINGUNGEN ODER EINSCHRÄNKUNGEN FÜR DIE SICHERE UND WIRKSAME ANWENDUNG DES ARZNEIMITTELS,13001.0,True,9
477,13010,CAP,ANHANG II,de,,Risikomanagement-Plan (RMP),13009.0,True,10
478,13011,CAP,ANHANG II,de,,Zusätzliche Maßnahmen zur Risikominimierung,13009.0,False,11
479,13012,CAP,ANHANG II,de,,Verpflichtung zur Durchführung von Maßnahmen nach der Zulassung ,13009.0,False,12
480,13013,CAP,ANHANG II,de,E,SPEZIFISCHE VERPFLICHTUNG ZUM ABSCHLUSS VON MASSNAHMEN NACH DER ZULASSUNG <UNTER „BESONDEREN BEDINGUNGEN“> <UNTER „AUSSERGEWÖHNLICHEN UMSTÄNDEN“,13001.0,False,13
481,14001,CAP,Etikettierung,de,,ETIKETTIERUNG ,,True,1
482,14002,CAP,Etikettierung,de,,ANGABEN <AUF DER ÄUSSEREN UMHÜLLUNG> <UND> <AUF DEM BEHÄLTNIS>,14001.0,True,2
483,14003,CAP,Etikettierung,de,1,BEZEICHNUNG DES ARZNEIMITTELS,14002.0,True,3
484,14004,CAP,Etikettierung,de,2,WIRKSTOFF(E),14002.0,True,4
485,14005,CAP,Etikettierung,de,3,SONSTIGE BESTANDTEILE,14002.0,True,5
486,14006,CAP,Etikettierung,de,4,DARREICHUNGSFORM UND INHALT,14002.0,True,6
487,14007,CAP,Etikettierung,de,5,HINWEISE ZUR UND ART(EN) DER ANWENDUNG,14002.0,True,7
488,14008,CAP,Etikettierung,de,6,"WARNHINWEIS, DASS DAS ARZNEIMITTEL FÜR KINDER UNZUGÄNGLICH AUFZUBEWAHREN IST",14002.0,True,8
489,14009,CAP,Etikettierung,de,7,"WEITERE WARNHINWEISE, FALLS ERFORDERLICH",14002.0,True,9
490,14010,CAP,Etikettierung,de,8,VERFALLDATUM,14002.0,True,10
491,14011,CAP,Etikettierung,de,9,BESONDERE VORSICHTSMASSNAHMEN FÜR DIE AUFBEWAHRUNG,14002.0,True,11
492,14012,CAP,Etikettierung,de,10,GEGEBENENFALLS BESONDERE VORSICHTSMASSNAHMEN FÜR DIE BESEITIGUNG VON NICHT VERWENDETEM ARZNEIMITTEL ODER DAVON STAMMENDEN ABFALLMATERIALIEN,14002.0,True,12
493,14013,CAP,Etikettierung,de,11,NAME UND ANSCHRIFT DES PHARMAZEUTISCHEN UNTERNEHMERS,14002.0,True,13
494,14014,CAP,Etikettierung,de,12,ZULASSUNGSNUMMER(N) ,14002.0,True,14
495,14015,CAP,Etikettierung,de,13,"CHARGENBEZEICHNUNG<, SPENDER- UND PRODUKTCODE>",14002.0,True,15
496,14016,CAP,Etikettierung,de,14,VERKAUFSABGRENZUNG,14002.0,True,16
497,14017,CAP,Etikettierung,de,15,HINWEISE FÜR DEN GEBRAUCH,14002.0,True,17
498,14018,CAP,Etikettierung,de,16,ANGABEN IN BLINDENSCHRIFT,14002.0,True,18
499,14019,CAP,Etikettierung,de,17,INDIVIDUELLES ERKENNUNGSMERKMAL – 2D-BARCODE,14002.0,True,19
500,14020,CAP,Etikettierung,de,18,INDIVIDUELLES ERKENNUNGSMERKMAL – VOM MENSCHEN LESBARES FORMAT,14002.0,True,20
501,14021,CAP,Etikettierung,de,,MINDESTANGABEN AUF BLISTERPACKUNGEN ODER FOLIENSTREIFEN,14001.0,True,21
502,14022,CAP,Etikettierung,de,1,BEZEICHNUNG DES ARZNEIMITTELS,14021.0,True,22
503,14023,CAP,Etikettierung,de,2,NAME DES PHARMAZEUTISCHEN UNTERNEHMERS,14021.0,True,23
504,14024,CAP,Etikettierung,de,3,VERFALLDATUM,14021.0,True,24
505,14025,CAP,Etikettierung,de,4,"CHARGENBEZEICHNUNG<, SPENDER- UND PRODUKTCODE>",14021.0,True,25
506,14026,CAP,Etikettierung,de,5,WEITERE ANGABEN,14021.0,True,26
507,14027,CAP,Etikettierung,de,,MINDESTANGABEN AUF KLEINEN BEHÄLTNISSEN,14001.0,True,27
508,14028,CAP,Etikettierung,de,1,BEZEICHNUNG DES ARZNEIMITTELS SOWIE ART(EN) DER ANWENDUNG,14027.0,True,28
509,14029,CAP,Etikettierung,de,2,HINWEISE ZUR ANWENDUNG,14027.0,True,29
510,14030,CAP,Etikettierung,de,3,VERFALLDATUM,14027.0,True,30
511,14031,CAP,Etikettierung,de,4,"CHARGENBEZEICHNUNG<, SPENDER- UND PRODUKTCODE>",14027.0,True,31
512,14032,CAP,Etikettierung,de,5,"INHALT NACH GEWICHT, VOLUMEN ODER EINHEITEN",14027.0,True,32
513,14033,CAP,Etikettierung,de,6,WEITERE ANGABEN,14027.0,True,33
514,15001,CAP,Packungsbeilage,de,,PACKUNGSBEILAGE,,True,1
515,15002,CAP,Packungsbeilage,de,,"q Dieses Arzneimittel unterliegt einer zusätzlichen Überwachung. Dies ermöglicht eine schnelle Identifizierung neuer Erkenntnisse über die Sicherheit. Sie können dabei helfen, indem Sie jede auftretende Nebenwirkung melden. Hinweise zur Meldung von Nebenwirkungen, siehe Ende Abschnitt 4",15001.0,False,2
516,15003,CAP,Packungsbeilage,de,,Was in dieser Packungsbeilage steht,15001.0,True,3
517,15004,CAP,Packungsbeilage,de,1,Was ist X und wofür wird es angewendet?,15001.0,True,4
518,15005,CAP,Packungsbeilage,de,2,Was sollten Sie vor der <Einnahme> <Anwendung> von X beachten?,15001.0,True,5
519,15006,CAP,Packungsbeilage,de,,"X darf nicht <eingenommen> <angewendet> werden<,>",15005.0,True,6
520,15007,CAP,Packungsbeilage,de,,Warnhinweise und Vorsichtsmaßnahmen,15005.0,True,7
521,15008,CAP,Packungsbeilage,de,,Kinder <und Jugendliche>,15005.0,True,8
522,15009,CAP,Packungsbeilage,de,,<Einnahme> <Anwendung> von X zusammen mit anderen Arzneimitteln,15005.0,True,9
523,15010,CAP,Packungsbeilage,de,,"<Einnahme> <Anwendung> von X zusammen mit <Nahrungsmitteln> <und> <,> <Getränken> <und> <Alkohol>",15005.0,True,10
524,15011,CAP,Packungsbeilage,de,,"Schwangerschaft <und> <,> Stillzeit <und Fortpflanzungsfähigkeit>",15005.0,True,11
525,15012,CAP,Packungsbeilage,de,,Verkehrstüchtigkeit und Fähigkeit zum Bedienen von Maschinen,15005.0,True,12
526,15013,CAP,Packungsbeilage,de,,X enthält {Bezeichnung <des> <der> sonstigen Bestandteil(s)(e)},15005.0,False,13
527,15014,CAP,Packungsbeilage,de,3,Wie ist X <einzunehmen> <anzuwenden>?,15001.0,True,14
528,15015,CAP,Packungsbeilage,de,,Anwendung bei Kindern <und Jugendlichen>,15014.0,False,15
529,15016,CAP,Packungsbeilage,de,,"Wenn Sie eine größere Menge von X <eingenommen> <angewendet> haben, als Sie sollten",15014.0,False,16
530,15017,CAP,Packungsbeilage,de,,Wenn Sie die <Einnahme> <Anwendung> von X vergessen haben,15014.0,False,17
531,15018,CAP,Packungsbeilage,de,,Wenn Sie die <Einnahme> <Anwendung> von X abbrechen,15014.0,False,18
532,15019,CAP,Packungsbeilage,de,4,Welche Nebenwirkungen sind möglich?,15001.0,True,19
533,15020,CAP,Packungsbeilage,de,,Zusätzliche Nebenwirkungen bei Kindern <und Jugendlichen>,15019.0,False,20
534,15021,CAP,Packungsbeilage,de,,Meldung von Nebenwirkungen,15019.0,True,21
535,15022,CAP,Packungsbeilage,de,5,Wie ist X aufzubewahren?,15001.0,True,22
536,15023,CAP,Packungsbeilage,de,6,Inhalt der Packung und weitere Informationen,15001.0,True,23
537,15024,CAP,Packungsbeilage,de,,Was X enthält,15023.0,True,24
538,15025,CAP,Packungsbeilage,de,,Wie X aussieht und Inhalt der Packung,15023.0,True,25
539,15026,CAP,Packungsbeilage,de,,Pharmazeutischer Unternehmer und Hersteller,15023.0,True,26
540,15027,CAP,Packungsbeilage,de,,"Falls Sie weitere Informationen über das Arzneimittel wünschen, setzen Sie sich bitte mit dem örtlichen Vertreter des pharmazeutischen Unternehmers in Verbindung:",15023.0,False,27
541,15028,CAP,Packungsbeilage,de,,Diese Packungsbeilage wurde zuletzt überarbeitet im <{MM.JJJJ}> <{Monat JJJJ}>.,15023.0,True,28
542,15029,CAP,Packungsbeilage,de,,Weitere Informationsquellen,15023.0,False,29
543,15030,CAP,Packungsbeilage,de,,Die folgenden Informationen sind für medizinisches Fachpersonal bestimmt:,15001.0,False,30
544,16001,CAP,SmPC,el,,ΠΕΡΙΛΗΨΗ ΤΩΝ ΧΑΡΑΚΤΗΡΙΣΤΙΚΩΝ ΤΟΥ ΠΡΟΪΟΝΤΟΣ,,True,1
545,16002,CAP,SmPC,el,,qΤο φάρμακο αυτό τελεί υπό συμπληρωματική παρακολούθηση. Αυτό θα επιτρέψει το γρήγορο προσδιορισμό νέων πληροφοριών ασφάλειας. Ζητείται από τους επαγγελματίες υγείας να αναφέρουν οποιεσδήποτε πιθανολογούμενες ανεπιθύμητες ενέργειες. Βλ. παράγραφο 4.8 για τον τρόπο αναφοράς ανεπιθύμητων ενεργειών.,16001.0,False,2
546,16003,CAP,SmPC,el,1,ΟΝΟΜΑΣΙΑ ΤΟΥ ΦΑΡΜΑΚΕΥΤΙΚΟΥ ΠΡΟΪΟΝΤΟΣ,16001.0,True,3
547,16004,CAP,SmPC,el,2,ΠΟΙΟΤΙΚΗ ΚΑΙ ΠΟΣΟΤΙΚΗ ΣΥΝΘΕΣΗ,16001.0,True,4
548,16005,CAP,SmPC,el,2.1,Γενική περιγραφή,16004.0,False,5
549,16006,CAP,SmPC,el,2.2,Ποιοτική και ποσοτική σύνθεση,16004.0,False,6
550,16007,CAP,SmPC,el,,Έκδοχο(α) με γνωστή δράση,16006.0,False,7
551,16008,CAP,SmPC,el,3,ΦΑΡΜΑΚΟΤΕΧΝΙΚΗ ΜΟΡΦΗ,16001.0,True,8
552,16009,CAP,SmPC,el,4,ΚΛΙΝΙΚΕΣ ΠΛΗΡΟΦΟΡΙΕΣ,16001.0,True,9
553,16010,CAP,SmPC,el,4.1,Θεραπευτικές ενδείξεις,16009.0,True,10
554,16011,CAP,SmPC,el,4.2,Δοσολογία και τρόπος χορήγησης,16009.0,True,11
555,16012,CAP,SmPC,el,,Δοσολογία,16011.0,True,12
556,16013,CAP,SmPC,el,,Παιδιατρικός πληθυσμός,16012.0,True,13
557,16014,CAP,SmPC,el,,Τρόπος χορήγησης,16011.0,True,14
558,16015,CAP,SmPC,el,,Προφυλάξεις που πρέπει να ληφθούν πριν από τον χειρισμό ή τη χορήγηση του φαρμακευτικού προϊόντος,16014.0,False,15
559,16016,CAP,SmPC,el,4.3,Αντενδείξεις,16009.0,True,16
560,16017,CAP,SmPC,el,4.4,Ειδικές προειδοποιήσεις και προφυλάξεις κατά τη χρήση,16009.0,True,17
561,16018,CAP,SmPC,el,,Ιχνηλασιμότητα,16017.0,False,18
562,16019,CAP,SmPC,el,,Παιδιατρικός πληθυσμός,16017.0,False,19
563,16020,CAP,SmPC,el,4.5,Αλληλεπιδράσεις με άλλα φαρμακευτικά προϊόντα και άλλες μορφές αλληλεπίδρασης,16009.0,True,20
564,16021,CAP,SmPC,el,,Παιδιατρικός πληθυσμός,16020.0,False,21
565,16022,CAP,SmPC,el,4.6,"Γονιμότητα, κύηση και γαλουχία",16009.0,True,22
566,16023,CAP,SmPC,el,,Κύηση,16022.0,False,23
567,16024,CAP,SmPC,el,,Θηλασμός,16022.0,False,24
568,16025,CAP,SmPC,el,,Γονιμότητα,16022.0,False,25
569,16026,CAP,SmPC,el,4.7,Επιδράσεις στην ικανότητα οδήγησης και χειρισμού μηχανημάτων,16009.0,True,26
570,16027,CAP,SmPC,el,4.8,Ανεπιθύμητες ενέργειες,16009.0,True,27
571,16028,CAP,SmPC,el,,Παιδιατρικός πληθυσμός,16027.0,False,28
572,16029,CAP,SmPC,el,,Αναφορά πιθανολογούμενων ανεπιθύμητων ενεργειών,16027.0,True,29
573,16030,CAP,SmPC,el,4.9,Υπερδοσολογία,16009.0,True,30
574,16031,CAP,SmPC,el,,Παιδιατρικός πληθυσμός,16030.0,False,31
575,16032,CAP,SmPC,el,5,ΦΑΡΜΑΚΟΛΟΓΙΚΕΣ ΙΔΙΟΤΗΤΕΣ,16001.0,True,32
576,16033,CAP,SmPC,el,5.1,Φαρμακοδυναμικές ιδιότητες,16032.0,True,33
577,16034,CAP,SmPC,el,,Μηχανισμός δράσης,16033.0,False,34
578,16035,CAP,SmPC,el,,Φαρμακοδυναμικές επιδράσεις,16033.0,False,35
579,16036,CAP,SmPC,el,,Κλινική αποτελεσματικότητα και ασφάλεια,16033.0,False,36
580,16037,CAP,SmPC,el,,Παιδιατρικός πληθυσμός,16033.0,False,37
581,16038,CAP,SmPC,el,5.2,Φαρμακοκινητικές ιδιότητες,16032.0,True,38
582,16039,CAP,SmPC,el,,Απορρόφηση,16038.0,False,39
583,16040,CAP,SmPC,el,,Κατανομή,16038.0,False,40
584,16041,CAP,SmPC,el,,Βιομετασχηματισμός,16038.0,False,41
585,16042,CAP,SmPC,el,,Αποβολή,16038.0,False,42
586,16043,CAP,SmPC,el,,Γραμμικότητα/μη γραμμικότητα,16038.0,False,43
587,16044,CAP,SmPC,el,,Φαρμακοκινητικές/φαρμακοδυναμικές σχέσεις,16038.0,False,44
588,16045,CAP,SmPC,el,5.3,Προκλινικά δεδομένα για την ασφάλεια,16032.0,True,45
589,16046,CAP,SmPC,el,,Αξιολόγηση περιβαλλοντικού κινδύνου,16045.0,False,46
590,16047,CAP,SmPC,el,6,ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΠΛΗΡΟΦΟΡΙΕΣ,16001.0,True,47
591,16048,CAP,SmPC,el,6.1,Κατάλογος εκδόχων,16047.0,True,48
592,16049,CAP,SmPC,el,6.2,Ασυμβατότητες,16047.0,True,49
593,16050,CAP,SmPC,el,6.3,Διάρκεια ζωής,16047.0,True,50
594,16051,CAP,SmPC,el,6.4,Ιδιαίτερες προφυλάξεις κατά τη φύλαξη του προϊόντος,16047.0,True,51
595,16052,CAP,SmPC,el,6.5,"Φύση και συστατικά του περιέκτη <και ειδικός εξοπλισμός για τη χρήση, τη χορήγηση ή την εμφύτευση>",16047.0,True,52
596,16053,CAP,SmPC,el,6.6,Ιδιαίτερες προφυλάξεις απόρριψης <και άλλος χειρισμός>,16047.0,True,53
597,16054,CAP,SmPC,el,,Χρήση στον παιδιατρικό πληθυσμό,16053.0,False,54
598,16055,CAP,SmPC,el,7,ΚΑΤΟΧΟΣ ΤΗΣ ΑΔΕΙΑΣ ΚΥΚΛΟΦΟΡΙΑΣ,16001.0,True,55
599,16056,CAP,SmPC,el,8,ΑΡΙΘΜΟΣ(ΟΙ) ΑΔΕΙΑΣ ΚΥΚΛΟΦΟΡΙΑΣ,16001.0,True,56
600,16057,CAP,SmPC,el,9,ΗΜΕΡΟΜΗΝΙΑ ΠΡΩΤΗΣ ΕΓΚΡΙΣΗΣ/ΑΝΑΝΕΩΣΗΣ ΤΗΣ ΑΔΕΙΑΣ,16001.0,True,57
601,16058,CAP,SmPC,el,10,ΗΜΕΡΟΜΗΝΙΑ ΑΝΑΘΕΩΡΗΣΗΣ ΤΟΥ ΚΕΙΜΕΝΟΥ,16001.0,True,58
602,16059,CAP,SmPC,el,11,ΔΟΣΙΜΕΤΡΙΑ,16001.0,False,59
603,16060,CAP,SmPC,el,12,ΟΔΗΓΙΕΣ ΠΑΡΑΣΚΕΥΗΣ ΡΑΔΙΟΦΑΡΜΑΚΩΝ,16001.0,False,60
604,17001,CAP,ΠΑΡΑΡΤΗΜΑ ΙΙ,el,,ΠΑΡΑΡΤΗΜΑ ΙΙ,,True,1
605,17002,CAP,ΠΑΡΑΡΤΗΜΑ ΙΙ,el,A,< ΠΑΡΑΣΚΕΥΑΣΤΗΣ(ΕΣ) ΤΗΣ(ΤΩΝ) ΒΙΟΛΟΓΙΚΩΣ ΔΡΑΣΤΙΚΗΣ(ΩΝ) ΟΥΣΙΑΣ(ΩΝ) ΚΑΙ> ΠΑΡΑΣΚΕΥΑΣΤΗΣ(ΕΣ) ΥΠΕΥΘΥΝΟΣ(ΟΙ) ΓΙΑ ΤΗΝ ΑΠΟΔΕΣΜΕΥΣΗ ΤΩΝ ΠΑΡΤΙΔΩΝ,17001.0,True,2
606,17003,CAP,ΠΑΡΑΡΤΗΜΑ ΙΙ,el,,Όνομα και διεύθυνση του(των) παρασκευαστή(ών) της(των) βιολογικώς δραστικής(ών) ουσίας(ών),17002.0,False,3
607,17004,CAP,ΠΑΡΑΡΤΗΜΑ ΙΙ,el,,Όνομα και διεύθυνση του(των) παρασκευαστή(ών) που είναι υπεύθυνος(οι) για την αποδέσμευση των παρτίδων,17002.0,True,4
608,17005,CAP,ΠΑΡΑΡΤΗΜΑ ΙΙ,el,B,ΟΡΟΙ Ή ΠΕΡΙΟΡΙΣΜΟΙ ΣΧΕΤΙΚΑ ΜΕ ΤΗ ΔΙΑΘΕΣΗ ΚΑΙ ΤΗ ΧΡΗΣΗ ,17001.0,True,5
609,17006,CAP,ΠΑΡΑΡΤΗΜΑ ΙΙ,el,,Επίσημη αποδέσμευση παρτίδων,17005.0,False,6
610,17007,CAP,ΠΑΡΑΡΤΗΜΑ ΙΙ,el,C,ΑΛΛΟΙ ΟΡΟΙ ΚΑΙ ΑΠΑΙΤΗΣΕΙΣ ΤΗΣ ΑΔΕΙΑΣ ΚΥΚΛΟΦΟΡΙΑΣ,17001.0,True,7
611,17008,CAP,ΠΑΡΑΡΤΗΜΑ ΙΙ,el,,Εκθέσεις περιοδικής παρακολούθησης της ασφάλειας (PSURs),17007.0,True,8
612,17009,CAP,ΠΑΡΑΡΤΗΜΑ ΙΙ,el,D,ΟΡΟΙ Ή ΠΕΡΙΟΡΙΣΜΟΙ ΣΧΕΤΙΚΑ ΜΕ ΤΗΝ ΑΣΦΑΛΗ ΚΑΙ ΑΠΟΤΕΛΕΣΜΑΤΙΚΗ ΧΡΗΣΗ ΤΟΥ ΦΑΡΜΑΚΕΥΤΙΚΟΥ ΠΡΟΪΟΝΤΟΣ,17001.0,True,9
613,17010,CAP,ΠΑΡΑΡΤΗΜΑ ΙΙ,el,,Σχέδιο διαχείρισης κινδύνου (ΣΔΚ),17009.0,True,10
614,17011,CAP,ΠΑΡΑΡΤΗΜΑ ΙΙ,el,,Επιπρόσθετα μέτρα ελαχιστοποίησης κινδύνου,17009.0,False,11
615,17012,CAP,ΠΑΡΑΡΤΗΜΑ ΙΙ,el,,Υποχρέωση λήψης μετεγκριτικών μέτρων ,17009.0,False,12
616,17013,CAP,ΠΑΡΑΡΤΗΜΑ ΙΙ,el,E,ΕΙΔΙΚΗ ΥΠΟΧΡΕΩΣΗ ΟΛΟΚΛΗΡΩΣΗΣ ΜΕΤΕΓΚΡΙΤΙΚΩΝ ΜΕΤΡΩΝ ΓΙΑ <ΤΗΝ ΑΔΕΙΑ ΚΥΚΛΟΦΟΡΙΑΣ ΜΕ ΕΓΚΡΙΣΗ ΥΠΟ ΟΡΟΥΣ> <ΤΗΝ ΑΔΕΙΑ ΚΥΚΛΟΦΟΡΙΑΣ ΥΠΟ ΕΞΑΙΡΕΤΙΚΕΣ ΠΕΡΙΣΤΑΣΕΙΣ>,17001.0,False,13
617,18001,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,,ΕΠΙΣΗΜΑΝΣΗ,,True,1
618,18002,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,,ΕΝΔΕΙΞΕΙΣ ΠΟΥ ΠΡΕΠΕΙ ΝΑ ΑΝΑΓΡΑΦΟΝΤΑΙ <ΣΤΗΝ ΕΞΩΤΕΡΙΚΗ ΣΥΣΚΕΥΑΣΙΑ> <ΚΑΙ> < ΣΤΗ ΣΤΟΙΧΕΙΩΔΗ ΣΥΣΚΕΥΑΣΙΑ>,18001.0,True,2
619,18003,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,1,ΟΝΟΜΑΣΙΑ ΤΟΥ ΦΑΡΜΑΚΕΥΤΙΚΟΥ ΠΡΟΪΟΝΤΟΣ,18002.0,True,3
620,18004,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,2,ΣΥΝΘΕΣΗ ΣΕ ΔΡΑΣΤΙΚΗ(ΕΣ) ΟΥΣΙΑ(ΕΣ),18002.0,True,4
621,18005,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,3,ΚΑΤΑΛΟΓΟΣ ΕΚΔΟΧΩΝ,18002.0,True,5
622,18006,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,4,ΦΑΡΜΑΚΟΤΕΧΝΙΚΗ ΜΟΡΦΗ ΚΑΙ ΠΕΡΙΕΧΟΜΕΝΟ,18002.0,True,6
623,18007,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,5,ΤΡΟΠΟΣ ΚΑΙ ΟΔΟΣ(ΟΙ) ΧΟΡΗΓΗΣΗΣ,18002.0,True,7
624,18008,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,6,ΕΙΔΙΚΗ ΠΡΟΕΙΔΟΠΟΙΗΣΗ ΣΥΜΦΩΝΑ ΜΕ ΤΗΝ ΟΠΟΙΑ ΤΟ ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ ΠΡΕΠΕΙ ΝΑ ΦΥΛΑΣΣΕΤΑΙ ΣΕ ΘΕΣΗ ΤΗΝ ΟΠΟΙΑ ΔΕΝ ΒΛΕΠΟΥΝ ΚΑΙ ΔΕΝ ΠΡΟΣΕΓΓΙΖΟΥΝ ΤΑ ΠΑΙΔΙΑ,18002.0,True,8
625,18009,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,7,"ΑΛΛΗ(ΕΣ) ΕΙΔΙΚΗ(ΕΣ) ΠΡΟΕΙΔΟΠΟΙΗΣΗ(ΕΙΣ), ΕΑΝ ΕΙΝΑΙ ΑΠΑΡΑΙΤΗΤΗ(ΕΣ)",18002.0,True,9
626,18010,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,8,ΗΜΕΡΟΜΗΝΙΑ ΛΗΞΗΣ,18002.0,True,10
627,18011,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,9,ΕΙΔΙΚΕΣ ΣΥΝΘΗΚΕΣ ΦΥΛΑΞΗΣ,18002.0,True,11
628,18012,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,10,"ΙΔΙΑΙΤΕΡΕΣ ΠΡΟΦΥΛΑΞΕΙΣ ΓΙΑ ΤΗΝ ΑΠΟΡΡΙΨΗ ΤΩΝ ΜΗ 
ΧΡΗΣΙΜΟΠΟΙΗΘΕΝΤΩΝ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ Ή ΤΩΝ   
ΥΠΟΛΕΙΜΜΑΤΩΝ ΠΟΥ ΠΡΟΕΡΧΟΝΤΑΙ ΑΠΟ ΑΥΤΑ, ΕΦΟΣΟΝ ΑΠΑΙΤΕΙΤΑΙ",18002.0,True,12
629,18013,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,11,ΟΝΟΜΑ ΚΑΙ ΔΙΕΥΘΥΝΣΗ ΚΑΤΟΧΟΥ ΤΗΣ ΑΔΕΙΑΣ ΚΥΚΛΟΦΟΡΙΑΣ,18002.0,True,13
630,18014,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,12,ΑΡΙΘΜΟΣ(ΟΙ) ΑΔΕΙΑΣ ΚΥΚΛΟΦΟΡΙΑΣ,18002.0,True,14
631,18015,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,13,"ΑΡΙΘΜΟΣ ΠΑΡΤΙΔΑΣ<, ΣΤΟΙΧΕΙΑ ΔΟΤΗ ΚΑΙ ΚΩΔΙΚΟΙ ΠΡΟΪΟΝΤΟΣ>",18002.0,True,15
632,18016,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,14,ΓΕΝΙΚΗ ΚΑΤΑΤΑΞΗ ΓΙΑ ΤΗ ΔΙΑΘΕΣΗ,18002.0,True,16
633,18017,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,15,ΟΔΗΓΙΕΣ ΧΡΗΣΗΣ,18002.0,True,17
634,18018,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,16,ΠΛΗΡΟΦΟΡΙΕΣ ΣΕ BRAILLE,18002.0,True,18
635,18019,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,17,ΜΟΝΑΔΙΚΟΣ ΑΝΑΓΝΩΡΙΣΤΙΚΟΣ ΚΩΔΙΚΟΣ – ΔΙΣΔΙΑΣΤΑΤΟΣ ΓΡΑΜΜΩΤΟΣ ΚΩΔΙΚΑΣ (2D),18002.0,True,19
636,18020,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,18,ΜΟΝΑΔΙΚΟΣ ΑΝΑΓΝΩΡΙΣΤΙΚΟΣ ΚΩΔΙΚΟΣ – ΔΕΔΟΜΕΝΑ ΑΝΑΓΝΩΣΙΜΑ ΑΠΟ ΤΟΝ ΑΝΘΡΩΠΟ,18002.0,True,20
637,18021,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,,ΕΛΑΧΙΣΤΕΣ ΕΝΔΕΙΞΕΙΣ ΠΟΥ ΠΡΕΠΕΙ ΝΑ ΑΝΑΓΡΑΦΟΝΤΑΙ ΣΤΙΣ ΣΥΣΚΕΥΑΣΙΕΣ ΚΥΨΕΛΗΣ (BLISTER) Ή ΣΤΙΣ ΤΑΙΝΙΕΣ (STRIPS),18001.0,True,21
638,18022,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,1,ΟΝΟΜΑΣΙΑ ΤΟΥ ΦΑΡΜΑΚΕΥΤΙΚΟΥ ΠΡΟΪΟΝΤΟΣ,18021.0,True,22
639,18023,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,2,ΟΝΟΜΑ ΚΑΤΟΧΟΥ ΤΗΣ ΑΔΕΙΑΣ ΚΥΚΛΟΦΟΡΙΑΣ,18021.0,True,23
640,18024,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,3,ΗΜΕΡΟΜΗΝΙΑ ΛΗΞΗΣ,18021.0,True,24
641,18025,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,4,"ΑΡΙΘΜΟΣ ΠΑΡΤΙΔΑΣ<, ΣΤΟΙΧΕΙΑ ΔΟΤΗ ΚΑΙ ΚΩΔΙΚΟΙ ΠΡΟΪΟΝΤΟΣ>",18021.0,True,25
642,18026,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,5,ΑΛΛΑ ΣΤΟΙΧΕΙΑ,18021.0,True,26
643,18027,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,,ΕΛΑΧΙΣΤΕΣ ΕΝΔΕΙΞΕΙΣ ΠΟΥ ΠΡΕΠΕΙ ΝΑ ΑΝΑΓΡΑΦΟΝΤΑΙ ΣΤΙΣ ΜΙΚΡΕΣ ΣΤΟΙΧΕΙΩΔΕΙΣ ΣΥΣΚΕΥΑΣΙΕΣ,18001.0,True,27
644,18028,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,1,ΟΝΟΜΑΣΙΑ ΤΟΥ ΦΑΡΜΑΚΕΥΤΙΚΟΥ ΠΡΟΪΟΝΤΟΣ ΚΑΙ ΟΔΟΣ(ΟΙ) ΧΟΡΗΓΗΣΗΣ,18027.0,True,28
645,18029,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,2,ΤΡΟΠΟΣ ΧΟΡΗΓΗΣΗΣ,18027.0,True,29
646,18030,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,3,ΗΜΕΡΟΜΗΝΙΑ ΛΗΞΗΣ,18027.0,True,30
647,18031,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,4,"ΑΡΙΘΜΟΣ ΠΑΡΤΙΔΑΣ<, ΣΤΟΙΧΕΙΑ ΔΟΤΗ ΚΑΙ ΚΩΔΙΚΟΙ ΠΡΟΪΟΝΤΟΣ>",18027.0,True,31
648,18032,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,5,"ΠΕΡΙΕΧΟΜΕΝΟ ΚΑΤΑ ΒΑΡΟΣ, ΚΑΤ' ΟΓΚΟ Ή ΚΑΤΑ ΜΟΝΑΔΑ",18027.0,True,32
649,18033,CAP,ΕΠΙΣΗΜΑΝΣΗ,el,6,ΑΛΛΑ ΣΤΟΙΧΕΙΑ,18027.0,True,33
650,19001,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,,True,1
651,19002,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,q Το φάρμακο αυτό τελεί υπό συμπληρωματική παρακολούθηση. Αυτό θα επιτρέψει το γρήγορο προσδιορισμό νέων πληροφοριών ασφάλειας. Μπορείτε να βοηθήσετε μέσω της αναφοράς πιθανών ανεπιθύμητων ενεργειών που ενδεχομένως παρουσιάζετε. Βλ. τέλος της παραγράφου 4 για τον τρόπο αναφοράς ανεπιθύμητων ενεργειών.,19001.0,False,2
652,19003,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Τι περιέχει το παρόν φύλλο οδηγιών:,19001.0,True,3
653,19004,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,1,Τι είναι το Χ και ποια είναι η χρήση του,19001.0,True,4
654,19005,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,2,Τι πρέπει να γνωρίζετε πριν <πάρετε> <χρησιμοποιήσετε> το Χ,19001.0,True,5
655,19006,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Μην <πάρετε> <χρησιμοποιήσετε> το Χ,19005.0,True,6
656,19007,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Προειδοποιήσεις και προφυλάξεις,19005.0,True,7
657,19008,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Παιδιά <και έφηβοι> ,19005.0,True,8
658,19009,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Άλλα φάρμακα και Χ,19005.0,True,9
659,19010,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,"Το Χ με <τροφή> <και> <,> <ποτό> <και> <οινοπνευματώδη>",19005.0,True,10
660,19011,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,"Κύηση<,> <και> θηλασμός <και γονιμότητα>",19005.0,True,11
661,19012,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Οδήγηση και χειρισμός μηχανημάτων,19005.0,True,12
662,19013,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Το Χ περιέχει {όνομα(τα) εκδόχου(ων)},19005.0,False,13
663,19014,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,3,Πώς να <πάρετε> <χρησιμοποιήσετε> το Χ,19001.0,True,14
664,19015,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Χρήση σε παιδιά> <και εφήβους>,19014.0,False,15
665,19016,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Εάν <πάρετε> <χρησιμοποιήσετε> μεγαλύτερη δόση Χ από την κανονική,19014.0,False,16
666,19017,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Εάν ξεχάσετε να <πάρετε> <χρησιμοποιήσετε> το Χ,19014.0,False,17
667,19018,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Εάν σταματήσετε να <παίρνετε> <χρησιμοποιείτε> το Χ,19014.0,False,18
668,19019,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,4,Πιθανές ανεπιθύμητες ενέργειες,19001.0,True,19
669,19020,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Συμπληρωματικές ανεπιθύμητες ενέργειες σε παιδιά <και εφήβους>,19019.0,False,20
670,19021,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Αναφορά ανεπιθύμητων ενεργειών,19019.0,True,21
671,19022,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,5,Πώς να φυλάσσετε το  Χ,19001.0,True,22
672,19023,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,6,Περιεχόμενα της συσκευασίας και λοιπές πληροφορίες,19001.0,True,23
673,19024,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Τι περιέχει το Χ,19023.0,True,24
674,19025,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Εμφάνιση του Χ και περιεχόμενα της συσκευασίας,19023.0,True,25
675,19026,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Κάτοχος Άδειας Κυκλοφορίας και Παρασκευαστής,19023.0,True,26
676,19027,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,"Για οποιαδήποτε πληροφορία σχετικά με το παρόν φαρμακευτικό προϊόν, παρακαλείστε να απευθυνθείτε στον τοπικό αντιπρόσωπο του Κατόχου της Άδειας Κυκλοφορίας:",19023.0,False,27
677,19028,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Το παρόν φύλλο οδηγιών χρήσης αναθεωρήθηκε για τελευταία φορά στις <{ΜΜ/ΕΕΕΕ}> <{μήνας ΕΕΕΕ}.>,19023.0,True,28
678,19029,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Άλλες πηγές πληροφοριών,19023.0,False,29
679,19030,CAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Οι πληροφορίες που ακολουθούν απευθύνονται μόνο σε επαγγελματίες υγείας:,19001.0,False,30
680,20001,CAP,SmPC,en,,SUMMARY OF PRODUCT CHARACTERISTICS,,True,1
681,20002,CAP,SmPC,en,,qThis medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.,20001.0,False,2
682,20003,CAP,SmPC,en,1,NAME OF THE MEDICINAL PRODUCT,20001.0,True,3
683,20004,CAP,SmPC,en,2,QUALITATIVE AND QUANTITATIVE COMPOSITION,20001.0,True,4
684,20005,CAP,SmPC,en,2.1,General description,20004.0,False,5
685,20006,CAP,SmPC,en,2.2,Qualitative and quantitative composition,20004.0,False,6
686,20007,CAP,SmPC,en,,Excipient(s) with known effect,20006.0,False,7
687,20008,CAP,SmPC,en,3,PHARMACEUTICAL FORM,20001.0,True,8
688,20009,CAP,SmPC,en,4,CLINICAL PARTICULARS,20001.0,True,9
689,20010,CAP,SmPC,en,4.1,Therapeutic indications,20009.0,True,10
690,20011,CAP,SmPC,en,4.2,Posology and method of administration,20009.0,True,11
691,20012,CAP,SmPC,en,,Posology,20011.0,True,12
692,20013,CAP,SmPC,en,,Paediatric population,20012.0,True,13
693,20014,CAP,SmPC,en,,Method of administration ,20011.0,True,14
694,20015,CAP,SmPC,en,,Precautions to be taken before handling or administering the medicinal product,20014.0,False,15
695,20016,CAP,SmPC,en,4.3,Contraindications,20009.0,True,16
696,20017,CAP,SmPC,en,4.4,Special warnings and precautions for use,20009.0,True,17
697,20018,CAP,SmPC,en,,Traceability,20017.0,False,18
698,20019,CAP,SmPC,en,,Paediatric population,20017.0,False,19
699,20020,CAP,SmPC,en,4.5,Interaction with other medicinal products and other forms of interaction,20009.0,True,20
700,20021,CAP,SmPC,en,,Paediatric population,20020.0,False,21
701,20022,CAP,SmPC,en,4.6,"Fertility, pregnancy and lactation",20009.0,True,22
702,20023,CAP,SmPC,en,,Pregnancy,20022.0,False,23
703,20024,CAP,SmPC,en,,Breast-feeding,20022.0,False,24
704,20025,CAP,SmPC,en,,Fertility,20022.0,False,25
705,20026,CAP,SmPC,en,4.7,Effects on ability to drive and use machines,20009.0,True,26
706,20027,CAP,SmPC,en,4.8,Undesirable effects,20009.0,True,27
707,20028,CAP,SmPC,en,,Paediatric population,20027.0,False,28
708,20029,CAP,SmPC,en,,Reporting of suspected adverse reactions,20027.0,True,29
709,20030,CAP,SmPC,en,4.9,Overdose,20009.0,True,30
710,20031,CAP,SmPC,en,,Paediatric population,20030.0,False,31
711,20032,CAP,SmPC,en,5,PHARMACOLOGICAL PROPERTIES,20001.0,True,32
712,20033,CAP,SmPC,en,5.1,Pharmacodynamic properties,20032.0,True,33
713,20034,CAP,SmPC,en,,Mechanism of action,20033.0,False,34
714,20035,CAP,SmPC,en,,Pharmacodynamic effects,20033.0,False,35
715,20036,CAP,SmPC,en,,Clinical efficacy and safety,20033.0,False,36
716,20037,CAP,SmPC,en,,Paediatric population,20033.0,False,37
717,20038,CAP,SmPC,en,5.2,Pharmacokinetic properties,20032.0,True,38
718,20039,CAP,SmPC,en,,Absorption,20038.0,False,39
719,20040,CAP,SmPC,en,,Distribution,20038.0,False,40
720,20041,CAP,SmPC,en,,Biotransformation,20038.0,False,41
721,20042,CAP,SmPC,en,,Elimination,20038.0,False,42
722,20043,CAP,SmPC,en,,Linearity/non-linearity,20038.0,False,43
723,20044,CAP,SmPC,en,,Pharmacokinetic/pharmacodynamic relationship(s),20038.0,False,44
724,20045,CAP,SmPC,en,5.3,Preclinical safety data,20032.0,True,45
725,20046,CAP,SmPC,en,,Environmental risk assessment (ERA),20045.0,False,46
726,20047,CAP,SmPC,en,6,PHARMACEUTICAL PARTICULARS,20001.0,True,47
727,20048,CAP,SmPC,en,6.1,List of excipients,20047.0,True,48
728,20049,CAP,SmPC,en,6.2,Incompatibilities,20047.0,True,49
729,20050,CAP,SmPC,en,6.3,Shelf life,20047.0,True,50
730,20051,CAP,SmPC,en,6.4,Special precautions for storage,20047.0,True,51
731,20052,CAP,SmPC,en,6.5,Nature and contents of container <and special equipment for use administration or implantation>,20047.0,True,52
732,20053,CAP,SmPC,en,6.6,Special precautions for disposal <and other handling>,20047.0,True,53
733,20054,CAP,SmPC,en,,Use in the paediatric population,20053.0,False,54
734,20055,CAP,SmPC,en,7,MARKETING AUTHORISATION HOLDER,20001.0,True,55
735,20056,CAP,SmPC,en,8,MARKETING AUTHORISATION NUMBER(S),20001.0,True,56
736,20057,CAP,SmPC,en,9,DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION,20001.0,True,57
737,20058,CAP,SmPC,en,10,DATE OF REVISION OF THE TEXT,20001.0,True,58
738,20059,CAP,SmPC,en,11,DOSIMETRY,20001.0,False,59
739,20060,CAP,SmPC,en,12,INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS,20001.0,False,60
740,21001,CAP,AnnexII,en,,ANNEX II,,True,1
741,21002,CAP,AnnexII,en,A,<MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND> MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE,21001.0,True,2
742,21003,CAP,AnnexII,en,,Name and address of the manufacturer(s) of the biological active substance(s),21002.0,False,3
743,21004,CAP,AnnexII,en,,Name and address of the manufacturer(s) responsible for batch release,21002.0,True,4
744,21005,CAP,AnnexII,en,B,CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE,21001.0,True,5
745,21006,CAP,AnnexII,en,,Official batch release,21005.0,False,6
746,21007,CAP,AnnexII,en,C,OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION,21001.0,True,7
747,21008,CAP,AnnexII,en,,Periodic safety update reports (PSURs),21007.0,True,8
748,21009,CAP,AnnexII,en,D,CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT,21001.0,True,9
749,21010,CAP,AnnexII,en,,Risk management plan (RMP),21009.0,True,10
750,21011,CAP,AnnexII,en,,Additional risk minimisation measures,21009.0,False,11
751,21012,CAP,AnnexII,en,,Obligation to conduct post-authorisation measures,21009.0,False,12
752,21013,CAP,AnnexII,en,E,"SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES FOR
<THE CONDITIONAL MARKETING AUTHORISATION> <THE MARKETING AUTHORISATION UNDER EXCEPTIONAL CIRCUMSTANCES>",21001.0,False,13
753,22001,CAP,Labelling,en,,LABELLING ,,True,1
754,22002,CAP,Labelling,en,,PARTICULARS TO APPEAR ON <THE OUTER PACKAGING> <AND> <THE IMMEDIATE PACKAGING>,22001.0,True,2
755,22003,CAP,Labelling,en,1,NAME OF THE MEDICINAL PRODUCT,22002.0,True,3
756,22004,CAP,Labelling,en,2,STATEMENT OF ACTIVE SUBSTANCE(S),22002.0,True,4
757,22005,CAP,Labelling,en,3,LIST OF EXCIPIENTS,22002.0,True,5
758,22006,CAP,Labelling,en,4,PHARMACEUTICAL FORM AND CONTENTS,22002.0,True,6
759,22007,CAP,Labelling,en,5,METHOD AND ROUTE(S) OF ADMINISTRATION,22002.0,True,7
760,22008,CAP,Labelling,en,6,SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN,22002.0,True,8
761,22009,CAP,Labelling,en,7,"OTHER SPECIAL WARNING(S), IF NECESSARY",22002.0,True,9
762,22010,CAP,Labelling,en,8,EXPIRY DATE,22002.0,True,10
763,22011,CAP,Labelling,en,9,SPECIAL STORAGE CONDITIONS,22002.0,True,11
764,22012,CAP,Labelling,en,10,"SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE",22002.0,True,12
765,22013,CAP,Labelling,en,11,NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER,22002.0,True,13
766,22014,CAP,Labelling,en,12,MARKETING AUTHORISATION NUMBER(S) ,22002.0,True,14
767,22015,CAP,Labelling,en,13,"BATCH NUMBER<, DONATION AND PRODUCT CODES>",22002.0,True,15
768,22016,CAP,Labelling,en,14,GENERAL CLASSIFICATION FOR SUPPLY,22002.0,True,16
769,22017,CAP,Labelling,en,15,INSTRUCTIONS ON USE,22002.0,True,17
770,22018,CAP,Labelling,en,16,INFORMATION IN BRAILLE,22002.0,True,18
771,22019,CAP,Labelling,en,17,UNIQUE IDENTIFIER – 2D BARCODE,22002.0,True,19
772,22020,CAP,Labelling,en,18,UNIQUE IDENTIFIER - HUMAN READABLE DATA,22002.0,True,20
773,22021,CAP,Labelling,en,,MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS,22001.0,True,21
774,22022,CAP,Labelling,en,1,NAME OF THE MEDICINAL PRODUCT,22021.0,True,22
775,22023,CAP,Labelling,en,2,NAME OF THE MARKETING AUTHORISATION HOLDER,22021.0,True,23
776,22024,CAP,Labelling,en,3,EXPIRY DATE,22021.0,True,24
777,22025,CAP,Labelling,en,4,"BATCH NUMBER<, DONATION AND PRODUCT CODES>",22021.0,True,25
778,22026,CAP,Labelling,en,5,OTHER,22021.0,True,26
779,22027,CAP,Labelling,en,,MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS,22001.0,True,27
780,22028,CAP,Labelling,en,1,NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION,22027.0,True,28
781,22029,CAP,Labelling,en,2,METHOD OF ADMINISTRATION,22027.0,True,29
782,22030,CAP,Labelling,en,3,EXPIRY DATE,22027.0,True,30
783,22031,CAP,Labelling,en,4,"BATCH NUMBER<, DONATION AND PRODUCT CODES>",22027.0,True,31
784,22032,CAP,Labelling,en,5,"CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT",22027.0,True,32
785,22033,CAP,Labelling,en,6,OTHER,22027.0,True,33
786,23001,CAP,Package leaflet,en,,PACKAGE LEAFLET,,True,1
787,23002,CAP,Package leaflet,en,,q This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.,23001.0,False,2
788,23003,CAP,Package leaflet,en,,What is in this leaflet,23001.0,True,3
789,23004,CAP,Package leaflet,en,1,What X is and what it is used for,23001.0,True,4
790,23005,CAP,Package leaflet,en,2,What you need to know before you <take> <use> X ,23001.0,True,5
791,23006,CAP,Package leaflet,en,,Do not <take> <use> X,23005.0,True,6
792,23007,CAP,Package leaflet,en,,Warnings and precautions ,23005.0,True,7
793,23008,CAP,Package leaflet,en,,Children <and adolescents>,23005.0,True,8
794,23009,CAP,Package leaflet,en,,Other medicines and X,23005.0,True,9
795,23010,CAP,Package leaflet,en,,"X with <food> <and> <,> <drink> <and> <alcohol>",23005.0,True,10
796,23011,CAP,Package leaflet,en,,"Pregnancy <and> <,> breast-feeding <and fertility>",23005.0,True,11
797,23012,CAP,Package leaflet,en,,Driving and using machines,23005.0,True,12
798,23013,CAP,Package leaflet,en,,X contains {name the excipient(s)},23005.0,False,13
799,23014,CAP,Package leaflet,en,3,How to <take> <use> X ,23001.0,True,14
800,23015,CAP,Package leaflet,en,,Use in children <and adolescents>,23014.0,False,15
801,23016,CAP,Package leaflet,en,,If you <take> <use> more X than you should,23014.0,False,16
802,23017,CAP,Package leaflet,en,,If you forget to <take> <use> X>,23014.0,False,17
803,23018,CAP,Package leaflet,en,,If you stop <taking> <using> X>,23014.0,False,18
804,23019,CAP,Package leaflet,en,4,Possible side effects,23001.0,True,19
805,23020,CAP,Package leaflet,en,,Additional side effects in children <and adolescents>,23019.0,False,20
806,23021,CAP,Package leaflet,en,,Reporting of side effects,23019.0,True,21
807,23022,CAP,Package leaflet,en,5,How to store X,23001.0,True,22
808,23023,CAP,Package leaflet,en,6,Contents of the pack and other information,23001.0,True,23
809,23024,CAP,Package leaflet,en,,What X contains ,23023.0,True,24
810,23025,CAP,Package leaflet,en,,What X looks like and contents of the pack,23023.0,True,25
811,23026,CAP,Package leaflet,en,,Marketing Authorisation Holder <and Manufacturer>,23023.0,True,26
812,23027,CAP,Package leaflet,en,,"For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:",23023.0,False,27
813,23028,CAP,Package leaflet,en,,This leaflet was last revised in <{MM/YYYY}><{month YYYY}>.,23023.0,True,28
814,23029,CAP,Package leaflet,en,,Other sources of information,23023.0,False,29
815,23030,CAP,Package leaflet,en,,The following information is intended for healthcare professionals only:,23001.0,False,30
816,24001,CAP,SmPC,es,,FICHA TÉCNICA O RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO,,True,1
817,24002,CAP,SmPC,es,,"qEste medicamento está sujeto a seguimiento adicional, lo que agilizará la detección de nueva información sobre su seguridad. Se invita a los profesionales sanitarios a notificar las sospechas de reacciones adversas. Ver  la sección 4.8, en la que se incluye información sobre cómo notificarlas.",24001.0,False,2
818,24003,CAP,SmPC,es,1,NOMBRE DEL MEDICAMENTO,24001.0,True,3
819,24004,CAP,SmPC,es,2,COMPOSICIÓN CUALITATIVA Y CUANTITATIVA,24001.0,True,4
820,24005,CAP,SmPC,es,2.1,Descripción general,24004.0,False,5
821,24006,CAP,SmPC,es,2.2,Composición cualitativa y cuantitativa,24004.0,False,6
822,24007,CAP,SmPC,es,,Excipiente(s) con efecto conocido,24006.0,False,7
823,24008,CAP,SmPC,es,3,FORMA FARMACÉUTICA,24001.0,True,8
824,24009,CAP,SmPC,es,4,DATOS CLÍNICOS,24001.0,True,9
825,24010,CAP,SmPC,es,4.1,Indicaciones terapéuticas,24009.0,True,10
826,24011,CAP,SmPC,es,4.2,Posología y forma de administración,24009.0,True,11
827,24012,CAP,SmPC,es,,Posología,24011.0,True,12
828,24013,CAP,SmPC,es,,Población pediátrica,24012.0,True,13
829,24014,CAP,SmPC,es,,Forma de administración ,24011.0,True,14
830,24015,CAP,SmPC,es,,Precauciones que se deben tomar antes de manipular o administrar el medicamento,24014.0,False,15
831,24016,CAP,SmPC,es,4.3,Contraindicaciones,24009.0,True,16
832,24017,CAP,SmPC,es,4.4,Advertencias y precauciones especiales de empleo,24009.0,True,17
833,24018,CAP,SmPC,es,,Trazabilidad,24017.0,False,18
834,24019,CAP,SmPC,es,,Población pediátrica,24017.0,False,19
835,24020,CAP,SmPC,es,4.5,Interacción con otros medicamentos y otras formas de interacción,24009.0,True,20
836,24021,CAP,SmPC,es,,Población pediátrica,24020.0,False,21
837,24022,CAP,SmPC,es,4.6,"Fertilidad, embarazo y lactancia",24009.0,True,22
838,24023,CAP,SmPC,es,,Embarazo,24022.0,False,23
839,24024,CAP,SmPC,es,,Lactancia,24022.0,False,24
840,24025,CAP,SmPC,es,,Fertilidad,24022.0,False,25
841,24026,CAP,SmPC,es,4.7,Efectos sobre la capacidad para conducir y utilizar máquinas,24009.0,True,26
842,24027,CAP,SmPC,es,4.8,Reacciones adversas,24009.0,True,27
843,24028,CAP,SmPC,es,,Población pediátrica,24027.0,False,28
844,24029,CAP,SmPC,es,,Notificación de sospechas de reacciones adversas,24027.0,True,29
845,24030,CAP,SmPC,es,4.9,Sobredosis,24009.0,True,30
846,24031,CAP,SmPC,es,,Población pediátrica,24030.0,False,31
847,24032,CAP,SmPC,es,5,PROPIEDADES FARMACOLÓGICAS,24001.0,True,32
848,24033,CAP,SmPC,es,5.1,Propiedades farmacodinámicas,24032.0,True,33
849,24034,CAP,SmPC,es,,Mecanismo de acción,24033.0,False,34
850,24035,CAP,SmPC,es,,Efectos farmacodinámicos,24033.0,False,35
851,24036,CAP,SmPC,es,,Eficacia clínica y seguridad,24033.0,False,36
852,24037,CAP,SmPC,es,,Población pediátrica,24033.0,False,37
853,24038,CAP,SmPC,es,5.2,Propiedades farmacocinéticas,24032.0,True,38
854,24039,CAP,SmPC,es,,Absorción,24038.0,False,39
855,24040,CAP,SmPC,es,,Distribución,24038.0,False,40
856,24041,CAP,SmPC,es,,Biotransformación,24038.0,False,41
857,24042,CAP,SmPC,es,,Eliminación,24038.0,False,42
858,24043,CAP,SmPC,es,,Linealidad/No linealidad,24038.0,False,43
859,24044,CAP,SmPC,es,,Relación(es) farmacocinéticas/farmacodinámica(s),24038.0,False,44
860,24045,CAP,SmPC,es,5.3,Datos preclínicos sobre seguridad,24032.0,True,45
861,24046,CAP,SmPC,es,,"Evaluación del riesgo medioambiental (ERA, por sus siglas en inglés)",24045.0,False,46
862,24047,CAP,SmPC,es,6,DATOS FARMACÉUTICOS,24001.0,True,47
863,24048,CAP,SmPC,es,6.1,Lista de excipientes,24047.0,True,48
864,24049,CAP,SmPC,es,6.2,Incompatibilidades,24047.0,True,49
865,24050,CAP,SmPC,es,6.3,Periodo de validez,24047.0,True,50
866,24051,CAP,SmPC,es,6.4,Precauciones especiales de conservación,24047.0,True,51
867,24052,CAP,SmPC,es,6.5,"Naturaleza y contenido del envase <y de los equipos especiales para su utilización, administración o implantación>",24047.0,True,52
868,24053,CAP,SmPC,es,6.6,Precauciones especiales de eliminación <y otras manipulaciones>,24047.0,True,53
869,24054,CAP,SmPC,es,,Uso en la población pediátrica ,24053.0,False,54
870,24055,CAP,SmPC,es,7,TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN,24001.0,True,55
871,24056,CAP,SmPC,es,8,NÚMERO(S) DE AUTORIZACIÓN DE COMERCIALIZACIÓN ,24001.0,True,56
872,24057,CAP,SmPC,es,9,FECHA DE LA PRIMERA AUTORIZACIÓN/RENOVACIÓN DE LA AUTORIZACIÓN,24001.0,True,57
873,24058,CAP,SmPC,es,10,FECHA DE LA REVISIÓN DEL TEXTO,24001.0,True,58
874,24059,CAP,SmPC,es,11,DOSIMETRÍA,24001.0,False,59
875,24060,CAP,SmPC,es,12,INSTRUCCIONES PARA LA PREPARACIÓN DE RADIOFÁRMACOS,24001.0,False,60
876,25001,CAP,AnnexII,es,,ANEXO II,,True,1
877,25002,CAP,AnnexII,es,A,<FABRICANTE(S) DEL (DE LOS) PRINCIPIO(S) ACTIVO(S) BIOLÓGICO(S) Y> FABRICANTE(S) RESPONSABLE(S) DE LA LIBERACIÓN DE LOS LOTES,25001.0,True,2
878,25003,CAP,AnnexII,es,,Nombre y dirección del (de los) fabricante(s) del (de los) principio(s) activo(s) biológico(s).,25002.0,False,3
879,25004,CAP,AnnexII,es,,Nombre y dirección del (de los) fabricante(s) responsable(s) de la liberación de los lotes,25002.0,True,4
880,25005,CAP,AnnexII,es,B,CONDICIONES O RESTRICCIONES DE SUMINISTRO Y USO ,25001.0,True,5
881,25006,CAP,AnnexII,es,,Liberación oficial de los lotes,25005.0,False,6
882,25007,CAP,AnnexII,es,C,OTRAS CONDICIONES Y REQUISITOS DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN,25001.0,True,7
883,25008,CAP,AnnexII,es,,Informes periódicos de seguridad (IPSs),25007.0,True,8
884,25009,CAP,AnnexII,es,D,CONDICIONES O RESTRICCIONES EN RELACIÓN CON LA UTILIZACIÓN SEGURA Y EFICAZ DEL MEDICAMENTO  ,25001.0,True,9
885,25010,CAP,AnnexII,es,,Plan de gestión de riesgos (PGR),25009.0,True,10
886,25011,CAP,AnnexII,es,,Medidas adicionales de minimización de riesgos,25009.0,False,11
887,25012,CAP,AnnexII,es,,Obligación de llevar a cabo medidas posautorización,25009.0,False,12
888,25013,CAP,AnnexII,es,E,OBLIGACIÓN ESPECÍFICA DE LLEVAR A CABO MEDIDAS POSAUTORIZACIÓN EN RELACIÓN <CON UNA AUTORIZACIÓN DE COMERCIALIZACIÓN CONDICIONAL><CON UNA AUTORIZACIÓN DE COMERCIALIZACIÓN EN CIRCUNSTANCIAS EXCEPCIONALES,25001.0,False,13
889,26001,CAP,Labelling,es,,ETIQUETADO,,True,1
890,26002,CAP,Labelling,es,,INFORMACIÓN QUE DEBE FIGURAR EN <EL EMBALAJE EXTERIOR><Y><EL ACONDICIONAMIENTO PRIMARIO>,26001.0,True,2
891,26003,CAP,Labelling,es,1,NOMBRE DEL MEDICAMENTO,26002.0,True,3
892,26004,CAP,Labelling,es,2,PRINCIPIO(S) ACTIVO(S),26002.0,True,4
893,26005,CAP,Labelling,es,3,LISTA DE EXCIPIENTES,26002.0,True,5
894,26006,CAP,Labelling,es,4,FORMA FARMACÉUTICA Y CONTENIDO DEL ENVASE,26002.0,True,6
895,26007,CAP,Labelling,es,5,FORMA Y VÍA(S) DE ADMINISTRACIÓN,26002.0,True,7
896,26008,CAP,Labelling,es,6,ADVERTENCIA ESPECIAL DE QUE EL MEDICAMENTO DEBE MANTENERSE FUERA DE LA VISTA Y DEL ALCANCE DE LOS NIÑOS,26002.0,True,8
897,26009,CAP,Labelling,es,7,"OTRA(S) ADVERTENCIA(S) ESPECIAL(ES), SI ES NECESARIO",26002.0,True,9
898,26010,CAP,Labelling,es,8,FECHA DE CADUCIDAD,26002.0,True,10
899,26011,CAP,Labelling,es,9,CONDICIONES ESPECIALES DE CONSERVACIÓN,26002.0,True,11
900,26012,CAP,Labelling,es,10,"PRECAUCIONES ESPECIALES DE ELIMINACIÓN DEL MEDICAMENTO NO UTILIZADO Y DE LOS MATERIALES DERIVADOS DE SU USO, CUANDO CORRESPONDA",26002.0,True,12
901,26013,CAP,Labelling,es,11,NOMBRE Y DIRECCIÓN DEL TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN,26002.0,True,13
902,26014,CAP,Labelling,es,12,NÚMERO(S) DE AUTORIZACIÓN DE COMERCIALIZACIÓN ,26002.0,True,14
903,26015,CAP,Labelling,es,13,"NÚMERO DE LOTE <, CÓDIGO DE DONACIÓN Y DEL PRODUCTO >",26002.0,True,15
904,26016,CAP,Labelling,es,14,CONDICIONES GENERALES DE DISPENSACIÓN,26002.0,True,16
905,26017,CAP,Labelling,es,15,INSTRUCCIONES DE USO,26002.0,True,17
906,26018,CAP,Labelling,es,16,INFORMACIÓN EN BRAILLE,26002.0,True,18
907,26019,CAP,Labelling,es,17,IDENTIFICADOR ÚNICO - CÓDIGO DE BARRAS 2D,26002.0,True,19
908,26020,CAP,Labelling,es,18,IDENTIFICADOR ÚNICO - INFORMACIÓN EN CARACTERES VISUALES,26002.0,True,20
909,26021,CAP,Labelling,es,,INFORMACIÓN MÍNIMA A INCLUIR EN BLÍSTERES O TIRAS,26001.0,True,21
910,26022,CAP,Labelling,es,1,NOMBRE DEL MEDICAMENTO,26021.0,True,22
911,26023,CAP,Labelling,es,2,NOMBRE DEL TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN,26021.0,True,23
912,26024,CAP,Labelling,es,3,FECHA DE CADUCIDAD,26021.0,True,24
913,26025,CAP,Labelling,es,4,"NÚMERO DE LOTE <, CÓDIGO DE DONACIÓN Y DEL PRODUCTO >",26021.0,True,25
914,26026,CAP,Labelling,es,5,OTROS,26021.0,True,26
915,26027,CAP,Labelling,es,,INFORMACIÓN MÍNIMA QUE DEBE INCLUIRSE EN PEQUEÑOS ACONDICIONAMIENTOS PRIMARIOS,26001.0,True,27
916,26028,CAP,Labelling,es,1,NOMBRE DEL MEDICAMENTO Y VÍA(S) DE ADMINISTRACIÓN,26027.0,True,28
917,26029,CAP,Labelling,es,2,FORMA DE ADMINISTRACIÓN,26027.0,True,29
918,26030,CAP,Labelling,es,3,FECHA DE CADUCIDAD,26027.0,True,30
919,26031,CAP,Labelling,es,4,"NÚMERO DE LOTE <, CÓDIGO DE DONACIÓN Y DEL PRODUCTO >",26027.0,True,31
920,26032,CAP,Labelling,es,5,"CONTENIDO EN PESO, EN VOLUMEN O EN UNIDADES",26027.0,True,32
921,26033,CAP,Labelling,es,6,OTROS,26027.0,True,33
922,27001,CAP,Package leaflet,es,,PROSPECTO,,True,1
923,27002,CAP,Package leaflet,es,,"q Este medicamento está sujeto a seguimiento adicional, lo que agilizará la detección de nueva información sobre su seguridad. Puede contribuir comunicando los efectos adversos que pudiera usted tener. La parte final de la sección 4 incluye información sobre cómo comunicar estos efectos adversos.",27001.0,False,2
924,27003,CAP,Package leaflet,es,,Contenido del prospecto,27001.0,True,3
925,27004,CAP,Package leaflet,es,1,Qué es X y para qué se utiliza,27001.0,True,4
926,27005,CAP,Package leaflet,es,2,Qué necesita saber antes de empezar a <tomar><usar> X,27001.0,True,5
927,27006,CAP,Package leaflet,es,,No <tome><use> X,27005.0,True,6
928,27007,CAP,Package leaflet,es,,Advertencias y precauciones ,27005.0,True,7
929,27008,CAP,Package leaflet,es,,Niños <y adolescentes>,27005.0,True,8
930,27009,CAP,Package leaflet,es,,Otros medicamentos y X,27005.0,True,9
931,27010,CAP,Package leaflet,es,,"<Uso><Toma> de X con <alimentos><y><,><bebidas><y><alcohol>",27005.0,True,10
932,27011,CAP,Package leaflet,es,,"Embarazo <y><,> lactancia <y fertilidad>",27005.0,True,11
933,27012,CAP,Package leaflet,es,,Conducción y uso de máquinas,27005.0,True,12
934,27013,CAP,Package leaflet,es,,X contiene {nombre del (de los) excipiente(s)},27005.0,False,13
935,27014,CAP,Package leaflet,es,3,Cómo <tomar><usar> X,27001.0,True,14
936,27015,CAP,Package leaflet,es,,Uso en niños <y adolescentes>,27014.0,False,15
937,27016,CAP,Package leaflet,es,,Si <toma><usa> más X del que debe,27014.0,False,16
938,27017,CAP,Package leaflet,es,,Si olvidó <tomar><usar> X,27014.0,False,17
939,27018,CAP,Package leaflet,es,,Si interrumpe el tratamiento con X,27014.0,False,18
940,27019,CAP,Package leaflet,es,4,Posibles efectos adversos,27001.0,True,19
941,27020,CAP,Package leaflet,es,,Otros efectos adversos en niños <y adolescentes>,27019.0,False,20
942,27021,CAP,Package leaflet,es,,Comunicación de efectos adversos,27019.0,True,21
943,27022,CAP,Package leaflet,es,5,Conservación de X,27001.0,True,22
944,27023,CAP,Package leaflet,es,6,Contenido del envase e información adicional,27001.0,True,23
945,27024,CAP,Package leaflet,es,,Composición de X ,27023.0,True,24
946,27025,CAP,Package leaflet,es,,Aspecto del producto y contenido del envase,27023.0,True,25
947,27026,CAP,Package leaflet,es,,Titular de la autorización de comercialización y responsable de la fabricación,27023.0,True,26
948,27027,CAP,Package leaflet,es,,Pueden solicitar más información respecto a este medicamento dirigiéndose al representante local del titular de la autorización de comercialización:,27023.0,False,27
949,27028,CAP,Package leaflet,es,,Fecha de la última revisión de este prospecto: <{MM/AAAA}><{mes AAAA}>.,27023.0,True,28
950,27029,CAP,Package leaflet,es,,Otras fuentes de información,27023.0,False,29
951,27030,CAP,Package leaflet,es,,Esta información está destinada únicamente a profesionales sanitarios:,27001.0,False,30
952,28001,CAP,SmPC,et,,RAVIMI OMADUSTE KOKKUVÕTE,,True,1
953,28002,CAP,SmPC,et,,"qSellele ravimile kohaldatakse täiendavat järelevalvet, mis võimaldab kiiresti tuvastada uut ohutusteavet. Tervishoiutöötajatel palutakse teatada kõigist võimalikest kõrvaltoimetest. Kõrvaltoimetest teatamise kohta vt lõik 4.8.>",28001.0,False,2
954,28003,CAP,SmPC,et,1,RAVIMPREPARAADI NIMETUS,28001.0,True,3
955,28004,CAP,SmPC,et,2,KVALITATIIVNE JA KVANTITATIIVNE KOOSTIS,28001.0,True,4
956,28005,CAP,SmPC,et,2.1,Üldkirjeldus,28004.0,False,5
957,28006,CAP,SmPC,et,2.2,Kvalitatiivne ja kvantitatiivne koostis,28004.0,False,6
958,28007,CAP,SmPC,et,,Teadaolevat toimet omav(ad) abiaine(d),28006.0,False,7
959,28008,CAP,SmPC,et,3,RAVIMVORM,28001.0,True,8
960,28009,CAP,SmPC,et,4,KLIINILISED ANDMED,28001.0,True,9
961,28010,CAP,SmPC,et,4.1,Näidustused,28009.0,True,10
962,28011,CAP,SmPC,et,4.2,Annustamine ja manustamisviis,28009.0,True,11
963,28012,CAP,SmPC,et,,Annustamine,28011.0,True,12
964,28013,CAP,SmPC,et,,Lapsed,28012.0,True,13
965,28014,CAP,SmPC,et,,Manustamisviis,28011.0,True,14
966,28015,CAP,SmPC,et,,Enne ravimi käsitsemist või manustamist tuleb järgida ettevaatusabinõusid,28014.0,False,15
967,28016,CAP,SmPC,et,4.3,Vastunäidustused,28009.0,True,16
968,28017,CAP,SmPC,et,4.4,Erihoiatused ja ettevaatusabinõud kasutamisel,28009.0,True,17
969,28018,CAP,SmPC,et,,Jälgitavus,28017.0,False,18
970,28019,CAP,SmPC,et,,Lapsed,28017.0,False,19
971,28020,CAP,SmPC,et,4.5,Koostoimed teiste ravimitega ja muud koostoimed,28009.0,True,20
972,28021,CAP,SmPC,et,,Lapsed,28020.0,False,21
973,28022,CAP,SmPC,et,4.6,"Fertiilsus, rasedus ja imetamine",28009.0,True,22
974,28023,CAP,SmPC,et,,Rasedus,28022.0,False,23
975,28024,CAP,SmPC,et,,Imetamine,28022.0,False,24
976,28025,CAP,SmPC,et,,Fertiilsus,28022.0,False,25
977,28026,CAP,SmPC,et,4.7,Toime reaktsioonikiirusele,28009.0,True,26
978,28027,CAP,SmPC,et,4.8,Kõrvaltoimed,28009.0,True,27
979,28028,CAP,SmPC,et,,Lapsed,28027.0,False,28
980,28029,CAP,SmPC,et,,Võimalikest kõrvaltoimetest teatamine,28027.0,True,29
981,28030,CAP,SmPC,et,4.9,Üleannustamine,28009.0,True,30
982,28031,CAP,SmPC,et,,Lapsed,28030.0,False,31
983,28032,CAP,SmPC,et,5,FARMAKOLOOGILISED OMADUSED,28001.0,True,32
984,28033,CAP,SmPC,et,5.1,Farmakodünaamilised omadused,28032.0,True,33
985,28034,CAP,SmPC,et,,Toimemehhanism,28033.0,False,34
986,28035,CAP,SmPC,et,,Farmakodünaamilised toimed,28033.0,False,35
987,28036,CAP,SmPC,et,,Kliiniline efektiivsus ja ohutus,28033.0,False,36
988,28037,CAP,SmPC,et,,Lapsed,28033.0,False,37
989,28038,CAP,SmPC,et,5.2,Farmakokineetilised omadused,28032.0,True,38
990,28039,CAP,SmPC,et,,Imendumine,28038.0,False,39
991,28040,CAP,SmPC,et,,Jaotumine,28038.0,False,40
992,28041,CAP,SmPC,et,,Biotransformatsioon,28038.0,False,41
993,28042,CAP,SmPC,et,,Eritumine,28038.0,False,42
994,28043,CAP,SmPC,et,,Lineaarsus/mittelineaarsus,28038.0,False,43
995,28044,CAP,SmPC,et,,Farmakokineetilised/farmakodünaamilised toimed,28038.0,False,44
996,28045,CAP,SmPC,et,5.3,Prekliinilised ohutusandmed,28032.0,True,45
997,28046,CAP,SmPC,et,,Keskkonnariski hindamine,28045.0,False,46
998,28047,CAP,SmPC,et,6,FARMATSEUTILISED ANDMED,28001.0,True,47
999,28048,CAP,SmPC,et,6.1,Abiainete loetelu,28047.0,True,48
1000,28049,CAP,SmPC,et,6.2,Sobimatus,28047.0,True,49
1001,28050,CAP,SmPC,et,6.3,Kõlblikkusaeg,28047.0,True,50
1002,28051,CAP,SmPC,et,6.4,Säilitamise eritingimused,28047.0,True,51
1003,28052,CAP,SmPC,et,6.5,"Pakendi iseloomustus ja sisu <ja kasutamise, manustamise või implanteerimise erivahendid>",28047.0,True,52
1004,28053,CAP,SmPC,et,6.6,Erihoiatused ravimpreparaadi hävitamiseks <ja käsitlemiseks>,28047.0,True,53
1005,28054,CAP,SmPC,et,,Kasutamine lastel,28053.0,False,54
1006,28055,CAP,SmPC,et,7,MÜÜGILOA HOIDJA,28001.0,True,55
1007,28056,CAP,SmPC,et,8,MÜÜGILOA NUMBER (NUMBRID) ,28001.0,True,56
1008,28057,CAP,SmPC,et,9,ESMASE MÜÜGILOA VÄLJASTAMISE/MÜÜGILOA UUENDAMISE KUUPÄEV,28001.0,True,57
1009,28058,CAP,SmPC,et,10,TEKSTI LÄBIVAATAMISE KUUPÄEV,28001.0,True,58
1010,28059,CAP,SmPC,et,11,DOSIMEETRIA,28001.0,False,59
1011,28060,CAP,SmPC,et,12,RADIOFARMATSEUTILISE PREPARAADI VALMISTAMISE JUHEND,28001.0,False,60
1012,29001,CAP,AnnexII,et,,II LISA,,True,1
1013,29002,CAP,AnnexII,et,A,<BIOLOOGILIS(T)E TOIMEAINE(TE) TOOTJA(D) JA> RAVIMIPARTII KASUTAMISEKS VABASTAMISE EEST VASTUTAV(AD) TOOTJA(D),29001.0,True,2
1014,29003,CAP,AnnexII,et,,Bioloogilis(t)e toimeaine(te) tootja(te) nimi (nimed) ja aadress(id),29002.0,False,3
1015,29004,CAP,AnnexII,et,,Ravimipartii kasutamiseks vabastamise eest vastutava(te) tootja(te) nimi ja aadress,29002.0,True,4
1016,29005,CAP,AnnexII,et,B,HANKE- JA KASUTUSTINGIMUSED VÕI PIIRANGUD,29001.0,True,5
1017,29006,CAP,AnnexII,et,,Ravimipartii ametlik kasutamiseks vabastamine,29005.0,False,6
1018,29007,CAP,AnnexII,et,C,MÜÜGILOA MUUD TINGIMUSED JA NÕUDED,29001.0,True,7
1019,29008,CAP,AnnexII,et,,Perioodilised ohutusaruanded,29007.0,True,8
1020,29009,CAP,AnnexII,et,D,RAVIMPREPARAADI OHUTU JA EFEKTIIVSE KASUTAMISE TINGIMUSED JA PIIRANGUD,29001.0,True,9
1021,29010,CAP,AnnexII,et,,Riskijuhtimiskava,29009.0,True,10
1022,29011,CAP,AnnexII,et,,Riski minimeerimise lisameetmed,29009.0,False,11
1023,29012,CAP,AnnexII,et,,Müügiloajärgsed kohustused,29009.0,False,12
1024,29013,CAP,AnnexII,et,E,ERIKOHUSTUSED <TINGIMUSLIKU MÜÜGILOA> <ERANDLIKEL ASJAOLUDEL VÄLJAANTUD MÜÜGILOA> JÄRGSETE MEETMETE TÄITMISEKS,29001.0,False,13
1025,30001,CAP,Labelling,et,,PAKENDI MÄRGISTUS,,True,1
1026,30002,CAP,Labelling,et,,<VÄLISPAKENDIL> <JA> <SISEPAKENDIL> PEAVAD OLEMA JÄRGMISED ANDMED,30001.0,True,2
1027,30003,CAP,Labelling,et,1,RAVIMPREPARAADI NIMETUS,30002.0,True,3
1028,30004,CAP,Labelling,et,2,TOIMEAINE(TE) SISALDUS,30002.0,True,4
1029,30005,CAP,Labelling,et,3,ABIAINED,30002.0,True,5
1030,30006,CAP,Labelling,et,4,RAVIMVORM JA PAKENDI SUURUS,30002.0,True,6
1031,30007,CAP,Labelling,et,5,MANUSTAMISVIIS JA -TEE(D),30002.0,True,7
1032,30008,CAP,Labelling,et,6,"ERIHOIATUS, ET RAVIMIT TULEB HOIDA LASTE EEST VARJATUD JA KÄTTESAAMATUS KOHAS",30002.0,True,8
1033,30009,CAP,Labelling,et,7,TEISED ERIHOIATUSED (VAJADUSEL),30002.0,True,9
1034,30010,CAP,Labelling,et,8,KÕLBLIKKUSAEG,30002.0,True,10
1035,30011,CAP,Labelling,et,9,SÄILITAMISE ERITINGIMUSED,30002.0,True,11
1036,30012,CAP,Labelling,et,10,"ERINÕUDED KASUTAMATA JÄÄNUD RAVIMPREPARAADI VÕI SELLEST TEKKINUD JÄÄTMEMATERJALI HÄVITAMISEKS, VASTAVALT VAJADUSELE",30002.0,True,12
1037,30013,CAP,Labelling,et,11,MÜÜGILOA HOIDJA NIMI JA AADRESS,30002.0,True,13
1038,30014,CAP,Labelling,et,12,MÜÜGILOA NUMBER (NUMBRID),30002.0,True,14
1039,30015,CAP,Labelling,et,13,PARTII NUMBER <ANNETUSE KOOD(ID) JA TOOTEKOOD(ID)>,30002.0,True,15
1040,30016,CAP,Labelling,et,14,RAVIMI VÄLJASTAMISTINGIMUSED,30002.0,True,16
1041,30017,CAP,Labelling,et,15,KASUTUSJUHEND,30002.0,True,17
1042,30018,CAP,Labelling,et,16,TEAVE BRAILLE’ KIRJAS (PUNKTKIRJAS),30002.0,True,18
1043,30019,CAP,Labelling,et,17,AINULAADNE IDENTIFIKAATOR – 2D-vöötkood,30002.0,True,19
1044,30020,CAP,Labelling,et,18,AINULAADNE IDENTIFIKAATOR – INIMLOETAVAD ANDMED,30002.0,True,20
1045,30021,CAP,Labelling,et,,"MINIMAALSED ANDMED, MIS PEAVAD OLEMA BLISTER- VÕI RIBAPAKENDIL",30001.0,True,21
1046,30022,CAP,Labelling,et,1,RAVIMPREPARAADI NIMETUS,30021.0,True,22
1047,30023,CAP,Labelling,et,2,MÜÜGILOA HOIDJA NIMI,30021.0,True,23
1048,30024,CAP,Labelling,et,3,KÕLBLIKKUSAEG,30021.0,True,24
1049,30025,CAP,Labelling,et,4,PARTII NUMBER <ANNETUSE KOOD(ID) JA TOOTEKOOD(ID)>,30021.0,True,25
1050,30026,CAP,Labelling,et,5,MUU,30021.0,True,26
1051,30027,CAP,Labelling,et,,"MINIMAALSED ANDMED, MIS PEAVAD OLEMA VÄIKESEL VAHETUL SISEPAKENDIL",30001.0,True,27
1052,30028,CAP,Labelling,et,1,RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE(D),30027.0,True,28
1053,30029,CAP,Labelling,et,2,MANUSTAMISVIIS,30027.0,True,29
1054,30030,CAP,Labelling,et,3,KÕLBLIKKUSAEG,30027.0,True,30
1055,30031,CAP,Labelling,et,4,PARTII NUMBER <ANNETUSE KOOD(ID) JA TOOTEKOOD(ID)>,30027.0,True,31
1056,30032,CAP,Labelling,et,5,"PAKENDI SISU KAALU, MAHU VÕI ÜHIKUTE JÄRGI",30027.0,True,32
1057,30033,CAP,Labelling,et,6,MUU,30027.0,True,33
1058,31001,CAP,Package leaflet,et,,PAKENDI INFOLEHT,,True,1
1059,31002,CAP,Package leaflet,et,,"qSellele ravimile kohaldatakse täiendavat järelevalvet, mis võimaldab kiiresti tuvastada uut ohutusteavet. Te saate sellele kaasa aidata, teatades ravimi kõigist võimalikest kõrvaltoimetest. Kõrvaltoimetest teatamise kohta vt lõik 4.> ",31001.0,False,2
1060,31003,CAP,Package leaflet,et,,Infolehe sisukord,31001.0,True,3
1061,31004,CAP,Package leaflet,et,1,Mis ravim on X ja milleks seda kasutatakse,31001.0,True,4
1062,31005,CAP,Package leaflet,et,2,Mida on vaja teada enne X’i <võtmist> <kasutamist> ,31001.0,True,5
1063,31006,CAP,Package leaflet,et,,X’i ei tohi <võtta> <kasutada>,31005.0,True,6
1064,31007,CAP,Package leaflet,et,,Hoiatused ja ettevaatusabinõud,31005.0,True,7
1065,31008,CAP,Package leaflet,et,,Lapsed <ja noorukid>,31005.0,True,8
1066,31009,CAP,Package leaflet,et,,Muud ravimid ja X,31005.0,True,9
1067,31010,CAP,Package leaflet,et,,"X koos <toidu> <ja> <,> <joogi> <ja> <alkoholiga>",31005.0,True,10
1068,31011,CAP,Package leaflet,et,,"Rasedus <ja> <,> imetamine <ja viljakus>",31005.0,True,11
1069,31012,CAP,Package leaflet,et,,Autojuhtimine ja masinatega töötamine,31005.0,True,12
1070,31013,CAP,Package leaflet,et,,X sisaldab {abiaine(te) nimetus},31005.0,False,13
1071,31014,CAP,Package leaflet,et,3,Kuidas X’i <võtta> <kasutada>,31001.0,True,14
1072,31015,CAP,Package leaflet,et,,Kasutamine lastel <ja noorukitel>,31014.0,False,15
1073,31016,CAP,Package leaflet,et,,"Kui te <võtate> <kasutate> X’i rohkem, kui ette nähtud",31014.0,False,16
1074,31017,CAP,Package leaflet,et,,Kui te unustate X’i <võtta> <kasutada>,31014.0,False,17
1075,31018,CAP,Package leaflet,et,,Kui te lõpetate X’i <võtmise> <kasutamise>,31014.0,False,18
1076,31019,CAP,Package leaflet,et,4,Võimalikud kõrvaltoimed,31001.0,True,19
1077,31020,CAP,Package leaflet,et,,Täiendavad kõrvaltoimed lastel <ja noorukitel>,31019.0,False,20
1078,31021,CAP,Package leaflet,et,,Kõrvaltoimetest teatamine,31019.0,True,21
1079,31022,CAP,Package leaflet,et,5,Kuidas X’i säilitada,31001.0,True,22
1080,31023,CAP,Package leaflet,et,6,Pakendi sisu ja muu teave,31001.0,True,23
1081,31024,CAP,Package leaflet,et,,Mida X sisaldab,31023.0,True,24
1082,31025,CAP,Package leaflet,et,,Kuidas X välja näeb ja pakendi sisu,31023.0,True,25
1083,31026,CAP,Package leaflet,et,,Müügiloa hoidja ja tootja,31023.0,True,26
1084,31027,CAP,Package leaflet,et,,Lisaküsimuste tekkimisel selle ravimi kohta pöörduge palun müügiloa hoidja kohaliku esindaja poole:,31023.0,False,27
1085,31028,CAP,Package leaflet,et,,Infoleht on viimati uuendatud <KK.AAAA> <kuu AAAA>.,31023.0,True,28
1086,31029,CAP,Package leaflet,et,,Muud teabeallikad,31023.0,False,29
1087,31030,CAP,Package leaflet,et,,Järgmine teave on ainult tervishoiutöötajatele:,31001.0,False,30
1088,32001,CAP,SmPC,fi,,VALMISTEYHTEENVETO,,True,1
1089,32002,CAP,SmPC,fi,,"qTähän lääkevalmisteeseen kohdistuu lisäseuranta. Tällä tavalla voidaan havaita nopeasti turvallisuutta koskevaa uutta tietoa. Terveydenhuollon ammattilaisia pyydetään ilmoittamaan epäillyistä lääkkeen haittavaikutuksista. Ks. kohdasta 4.8, miten haittavaikutuksista ilmoitetaan.",32001.0,False,2
1090,32003,CAP,SmPC,fi,1,LÄÄKEVALMISTEEN NIMI,32001.0,True,3
1091,32004,CAP,SmPC,fi,2,VAIKUTTAVAT AINEET JA NIIDEN MÄÄRÄT,32001.0,True,4
1092,32005,CAP,SmPC,fi,2.1,Yleiskuvaus,32004.0,False,5
1093,32006,CAP,SmPC,fi,2.2,Vaikuttavat aineet ja niiden määrät,32004.0,False,6
1094,32007,CAP,SmPC,fi,,"Apuaine(et), joiden vaikutus tunnetaan",32006.0,False,7
1095,32008,CAP,SmPC,fi,3,LÄÄKEMUOTO,32001.0,True,8
1096,32009,CAP,SmPC,fi,4,KLIINISET TIEDOT,32001.0,True,9
1097,32010,CAP,SmPC,fi,4.1,Käyttöaiheet,32009.0,True,10
1098,32011,CAP,SmPC,fi,4.2,Annostus ja antotapa,32009.0,True,11
1099,32012,CAP,SmPC,fi,,Annostus,32011.0,True,12
1100,32013,CAP,SmPC,fi,,Pediatriset potilaat,32012.0,True,13
1101,32014,CAP,SmPC,fi,,Antotapa,32011.0,True,14
1102,32015,CAP,SmPC,fi,,Ennen lääkkeen käsittelyä tai antoa huomioon otettavat varotoimet,32014.0,False,15
1103,32016,CAP,SmPC,fi,4.3,Vasta-aiheet,32009.0,True,16
1104,32017,CAP,SmPC,fi,4.4,Varoitukset ja käyttöön liittyvät varotoimet,32009.0,True,17
1105,32018,CAP,SmPC,fi,,Jäljitettävyys,32017.0,False,18
1106,32019,CAP,SmPC,fi,,Pediatriset potilaat,32017.0,False,19
1107,32020,CAP,SmPC,fi,4.5,Yhteisvaikutukset muiden lääkevalmisteiden kanssa sekä muut yhteisvaikutukset,32009.0,True,20
1108,32021,CAP,SmPC,fi,,Pediatriset potilaat,32020.0,False,21
1109,32022,CAP,SmPC,fi,4.6,"Hedelmällisyys, raskaus ja imetys",32009.0,True,22
1110,32023,CAP,SmPC,fi,,Raskaus,32022.0,False,23
1111,32024,CAP,SmPC,fi,,Imetys,32022.0,False,24
1112,32025,CAP,SmPC,fi,,Hedelmällisyys,32022.0,False,25
1113,32026,CAP,SmPC,fi,4.7,Vaikutus ajokykyyn ja koneidenkäyttökykyyn,32009.0,True,26
1114,32027,CAP,SmPC,fi,4.8,Haittavaikutukset,32009.0,True,27
1115,32028,CAP,SmPC,fi,,Pediatriset potilaat,32027.0,False,28
1116,32029,CAP,SmPC,fi,,Epäillyistä haittavaikutuksista ilmoittaminen,32027.0,True,29
1117,32030,CAP,SmPC,fi,4.9,Yliannostus,32009.0,True,30
1118,32031,CAP,SmPC,fi,,Pediatriset potilaat,32030.0,False,31
1119,32032,CAP,SmPC,fi,5,FARMAKOLOGISET OMINAISUUDET,32001.0,True,32
1120,32033,CAP,SmPC,fi,5.1,Farmakodynamiikka,32032.0,True,33
1121,32034,CAP,SmPC,fi,,Vaikutusmekanismi,32033.0,False,34
1122,32035,CAP,SmPC,fi,,Farmakodynaamiset vaikutukset,32033.0,False,35
1123,32036,CAP,SmPC,fi,,Kliininen teho ja turvallisuus,32033.0,False,36
1124,32037,CAP,SmPC,fi,,Pediatriset potilaat,32033.0,False,37
1125,32038,CAP,SmPC,fi,5.2,Farmakokinetiikka,32032.0,True,38
1126,32039,CAP,SmPC,fi,,Imeytyminen,32038.0,False,39
1127,32040,CAP,SmPC,fi,,Jakautuminen,32038.0,False,40
1128,32041,CAP,SmPC,fi,,Biotransformaatio,32038.0,False,41
1129,32042,CAP,SmPC,fi,,Eliminaatio,32038.0,False,42
1130,32043,CAP,SmPC,fi,,Lineaarisuus/ei-lineaarisuus,32038.0,False,43
1131,32044,CAP,SmPC,fi,,Farmakokineettiset/farmakodynaamiset suhteet,32038.0,False,44
1132,32045,CAP,SmPC,fi,5.3,Prekliiniset tiedot turvallisuudesta,32032.0,True,45
1133,32046,CAP,SmPC,fi,,Ympäristöön kohdistuvien riskien arviointi,32045.0,False,46
1134,32047,CAP,SmPC,fi,6,FARMASEUTTISET TIEDOT,32001.0,True,47
1135,32048,CAP,SmPC,fi,6.1,Apuaineet,32047.0,True,48
1136,32049,CAP,SmPC,fi,6.2,Yhteensopimattomuudet,32047.0,True,49
1137,32050,CAP,SmPC,fi,6.3,Kestoaika,32047.0,True,50
1138,32051,CAP,SmPC,fi,6.4,Säilytys ,32047.0,True,51
1139,32052,CAP,SmPC,fi,6.5,"Pakkaustyyppi ja pakkauskoko (pakkauskoot) <sekä erityiset välineet lääkkeen käyttöä, antoa tai paikalleen asettamista varten>",32047.0,True,52
1140,32053,CAP,SmPC,fi,6.6,Erityiset varotoimet hävittämiselle <ja muut käsittelyohjeet>,32047.0,True,53
1141,32054,CAP,SmPC,fi,,Käyttö pediatrisille potilaille,32053.0,False,54
1142,32055,CAP,SmPC,fi,7,MYYNTILUVAN HALTIJA,32001.0,True,55
1143,32056,CAP,SmPC,fi,8,MYYNTILUVAN NUMERO(T),32001.0,True,56
1144,32057,CAP,SmPC,fi,9,MYYNTILUVAN MYÖNTÄMISPÄIVÄMÄÄRÄ/UUDISTAMISPÄIVÄMÄÄRÄ,32001.0,True,57
1145,32058,CAP,SmPC,fi,10,TEKSTIN MUUTTAMISPÄIVÄMÄÄRÄ,32001.0,True,58
1146,32059,CAP,SmPC,fi,11,DOSIMETRIA ,32001.0,False,59
1147,32060,CAP,SmPC,fi,12,RADIOFARMASEUTTISTEN VALMISTEIDEN VALMISTUSOHJEET,32001.0,False,60
1148,33001,CAP,LIITE II ,fi,,LIITE II ,,True,1
1149,33002,CAP,LIITE II ,fi,A,<BIOLOGISEN (BIOLOGISTEN) VAIKUTTAVAN (VAIKUTTAVIEN) AINEEN (AINEIDEN) VALMISTAJA (VALMISTAJAT) JA> ERÄN VAPAUTTAMISESTA VASTAAVA(T) VALMISTAJA(T),33001.0,True,2
1150,33003,CAP,LIITE II ,fi,,Biologisen (biologisten) vaikuttavan aineen (vaikuttavien aineiden) valmistajan (valmistajien) nimi (nimet) ja osoite (osoitteet),33002.0,False,3
1151,33004,CAP,LIITE II ,fi,,Erän vapauttamisesta vastaavan (vastaavien) valmistajan (valmistajien) nimi (nimet) ja osoite (osoitteet),33002.0,True,4
1152,33005,CAP,LIITE II ,fi,B,TOIMITTAMISEEN JA KÄYTTÖÖN LIITTYVÄT EHDOT TAI RAJOITUKSET,33001.0,True,5
1153,33006,CAP,LIITE II ,fi,,Erän virallinen vapauttaminen,33005.0,False,6
1154,33007,CAP,LIITE II ,fi,C,MYYNTILUVAN MUUT EHDOT JA EDELLYTYKSET,33001.0,True,7
1155,33008,CAP,LIITE II ,fi,,Määräaikaiset turvallisuuskatsaukset,33007.0,True,8
1156,33009,CAP,LIITE II ,fi,D,"EHDOT TAI RAJOITUKSET, JOTKA KOSKEVAT LÄÄKEVALMISTEEN TURVALLISTA JA TEHOKASTA KÄYTTÖÄ",33001.0,True,9
1157,33010,CAP,LIITE II ,fi,,Riskienhallintasuunnitelma (RMP),33009.0,True,10
1158,33011,CAP,LIITE II ,fi,,Lisätoimenpiteet riskien minimoimiseksi,33009.0,False,11
1159,33012,CAP,LIITE II ,fi,,Velvoite toteuttaa myyntiluvan myöntämisen jälkeisiä toimenpiteitä,33009.0,False,12
1160,33013,CAP,LIITE II ,fi,E,"ERITYISVELVOITE TOTEUTTAA MYYNTILUVAN MYÖNTÄMISEN JÄLKEISIÄ TOIMENPITEITÄ, KUN KYSEESSÄ ON <EHDOLLINEN MYYNTILUPA> <POIKKEUSOLOSUHTEISSA MYÖNNETTY MYYNTILUPA > ",33001.0,False,13
1161,34001,CAP,LIITE III,fi,,MYYNTIPÄÄLLYSMERKINNÄT,,True,1
1162,34002,CAP,LIITE III,fi,,<ULKOPAKKAUKSESSA> <JA> <SISÄPAKKAUKSESSA> ON OLTAVA SEURAAVAT MERKINNÄT,34001.0,True,2
1163,34003,CAP,LIITE III,fi,1,LÄÄKEVALMISTEEN NIMI,34002.0,True,3
1164,34004,CAP,LIITE III,fi,2,VAIKUTTAVA(T) AINE(ET),34002.0,True,4
1165,34005,CAP,LIITE III,fi,3,LUETTELO APUAINEISTA,34002.0,True,5
1166,34006,CAP,LIITE III,fi,4,LÄÄKEMUOTO JA SISÄLLÖN MÄÄRÄ,34002.0,True,6
1167,34007,CAP,LIITE III,fi,5,ANTOTAPA JA TARVITTAESSA ANTOREITTI (ANTOREITIT),34002.0,True,7
1168,34008,CAP,LIITE III,fi,6,ERITYISVAROITUS VALMISTEEN SÄILYTTÄMISESTÄ POISSA LASTEN ULOTTUVILTA JA NÄKYVILTÄ,34002.0,True,8
1169,34009,CAP,LIITE III,fi,7,"MUU ERITYISVAROITUS (MUUT ERITYISVAROITUKSET), JOS TARPEEN",34002.0,True,9
1170,34010,CAP,LIITE III,fi,8,VIIMEINEN KÄYTTÖPÄIVÄMÄÄRÄ,34002.0,True,10
1171,34011,CAP,LIITE III,fi,9,ERITYISET SÄILYTYSOLOSUHTEET,34002.0,True,11
1172,34012,CAP,LIITE III,fi,10,"ERITYISET VAROTOIMET KÄYTTÄMÄTTÖMIEN LÄÄKEVALMISTEIDEN TAI NIISTÄ PERÄISIN OLEVAN JÄTEMATERIAALIN HÄVITTÄMISEKSI, JOS TARPEEN",34002.0,True,12
1173,34013,CAP,LIITE III,fi,11,MYYNTILUVAN HALTIJAN NIMI JA OSOITE,34002.0,True,13
1174,34014,CAP,LIITE III,fi,12,MYYNTILUVAN NUMERO(T),34002.0,True,14
1175,34015,CAP,LIITE III,fi,13,"ERÄNUMERO <, LUOVUTUS- JA TUOTEKOODIT>",34002.0,True,15
1176,34016,CAP,LIITE III,fi,14,YLEINEN TOIMITTAMISLUOKITTELU,34002.0,True,16
1177,34017,CAP,LIITE III,fi,15,KÄYTTÖOHJEET,34002.0,True,17
1178,34018,CAP,LIITE III,fi,16,TIEDOT PISTEKIRJOITUKSELLA ,34002.0,True,18
1179,34019,CAP,LIITE III,fi,17,YKSILÖLLINEN TUNNISTE – 2D-VIIVAKOODI,34002.0,True,19
1180,34020,CAP,LIITE III,fi,18,YKSILÖLLINEN TUNNISTE – LUETTAVISSA OLEVAT TIEDOT,34002.0,True,20
1181,34021,CAP,LIITE III,fi,,LÄPIPAINOPAKKAUKSISSA TAI LEVYISSÄ ON OLTAVA VÄHINTÄÄN SEURAAVAT MERKINNÄT,34001.0,True,21
1182,34022,CAP,LIITE III,fi,1,LÄÄKEVALMISTEEN NIMI,34021.0,True,22
1183,34023,CAP,LIITE III,fi,2,MYYNTILUVAN HALTIJAN NIMI,34021.0,True,23
1184,34024,CAP,LIITE III,fi,3,VIIMEINEN KÄYTTÖPÄIVÄMÄÄRÄ,34021.0,True,24
1185,34025,CAP,LIITE III,fi,4,"ERÄNUMERO <, LUOVUTUS- JA TUOTEKOODIT>",34021.0,True,25
1186,34026,CAP,LIITE III,fi,5,MUUTA,34021.0,True,26
1187,34027,CAP,LIITE III,fi,,PIENISSÄ SISÄPAKKAUKSISSA ON OLTAVA VÄHINTÄÄN SEURAAVAT MERKINNÄT,34001.0,True,27
1188,34028,CAP,LIITE III,fi,1,LÄÄKEVALMISTEEN NIMI JA TARVITTAESSA ANTOREITTI (ANTOREITIT),34027.0,True,28
1189,34029,CAP,LIITE III,fi,2,ANTOTAPA,34027.0,True,29
1190,34030,CAP,LIITE III,fi,3,VIIMEINEN KÄYTTÖPÄIVÄMÄÄRÄ,34027.0,True,30
1191,34031,CAP,LIITE III,fi,4,"ERÄNUMERO <, LUOVUTUS- JA TUOTEKOODIT>",34027.0,True,31
1192,34032,CAP,LIITE III,fi,5,"SISÄLLÖN MÄÄRÄ PAINONA, TILAVUUTENA TAI YKSIKKÖINÄ",34027.0,True,32
1193,34033,CAP,LIITE III,fi,6,MUUTA,34027.0,True,33
1194,35001,CAP,PAKKAUSSELOSTE,fi,,PAKKAUSSELOSTE,,True,1
1195,35002,CAP,PAKKAUSSELOSTE,fi,,"q Tähän lääkevalmisteeseen kohdistuu lisäseuranta. Tällä tavalla voidaan havaita nopeasti turvallisuutta koskevaa uutta tietoa. Voit auttaa ilmoittamalla kaikista mahdollisesti saamistasi haittavaikutuksista. Ks. kohdan 4 lopusta, miten haittavaikutuksista ilmoitetaan",35001.0,False,2
1196,35003,CAP,PAKKAUSSELOSTE,fi,,Tässä pakkausselosteessa kerrotaan:,35001.0,True,3
1197,35004,CAP,PAKKAUSSELOSTE,fi,1,Mitä X on ja mihin sitä käytetään,35001.0,True,4
1198,35005,CAP,PAKKAUSSELOSTE,fi,2,"Mitä sinun on tiedettävä, ennen kuin <otat> <käytät> <X:ää> <X-valmistetta>",35001.0,True,5
1199,35006,CAP,PAKKAUSSELOSTE,fi,,Älä <ota> <käytä> <X:ää> <X-valmistetta>,35005.0,True,6
1200,35007,CAP,PAKKAUSSELOSTE,fi,,Varoitukset ja varotoimet,35005.0,True,7
1201,35008,CAP,PAKKAUSSELOSTE,fi,,Lapset <ja nuoret>,35005.0,True,8
1202,35009,CAP,PAKKAUSSELOSTE,fi,,Muut lääkevalmisteet ja X,35005.0,True,9
1203,35010,CAP,PAKKAUSSELOSTE,fi,,"X <ruuan> <ja> <,> <juoman> <ja> <alkoholin> kanssa",35005.0,True,10
1204,35011,CAP,PAKKAUSSELOSTE,fi,,"Raskaus <ja> <,> imetys <ja hedelmällisyys>",35005.0,True,11
1205,35012,CAP,PAKKAUSSELOSTE,fi,,Ajaminen ja koneiden käyttö,35005.0,True,12
1206,35013,CAP,PAKKAUSSELOSTE,fi,,X sisältää {apuaineen(apuaineiden) nimi(nimet)},35005.0,False,13
1207,35014,CAP,PAKKAUSSELOSTE,fi,3,Miten <X:ää> <X-valmistetta> <otetaan> <käytetään>,35001.0,True,14
1208,35015,CAP,PAKKAUSSELOSTE,fi,,Käyttö lapsille <ja nuorille>,35014.0,False,15
1209,35016,CAP,PAKKAUSSELOSTE,fi,,Jos <otat> <käytät> enemmän <X:ää> <X-valmistetta> kuin sinun pitäisi,35014.0,False,16
1210,35017,CAP,PAKKAUSSELOSTE,fi,,Jos unohdat <ottaa> <käyttää> <X:ää> <X-valmistetta>,35014.0,False,17
1211,35018,CAP,PAKKAUSSELOSTE,fi,,Jos lopetat <X:n> <X-valmisteen> <oton> <käytön>,35014.0,False,18
1212,35019,CAP,PAKKAUSSELOSTE,fi,4,Mahdolliset haittavaikutukset,35001.0,True,19
1213,35020,CAP,PAKKAUSSELOSTE,fi,,Muut haittavaikutukset lapsilla <ja nuorilla>,35019.0,False,20
1214,35021,CAP,PAKKAUSSELOSTE,fi,,Haittavaikutuksista ilmoittaminen,35019.0,True,21
1215,35022,CAP,PAKKAUSSELOSTE,fi,5,<X:n> <X-valmisteen> säilyttäminen,35001.0,True,22
1216,35023,CAP,PAKKAUSSELOSTE,fi,6,Pakkauksen sisältö ja muuta tietoa,35001.0,True,23
1217,35024,CAP,PAKKAUSSELOSTE,fi,,Mitä X sisältää,35023.0,True,24
1218,35025,CAP,PAKKAUSSELOSTE,fi,,Lääkevalmisteen kuvaus ja pakkauskoko (-koot),35023.0,True,25
1219,35026,CAP,PAKKAUSSELOSTE,fi,,Myyntiluvan haltija ja valmistaja,35023.0,True,26
1220,35027,CAP,PAKKAUSSELOSTE,fi,,Lisätietoja tästä lääkevalmisteesta antaa myyntiluvan haltijan paikallinen edustaja:,35023.0,False,27
1221,35028,CAP,PAKKAUSSELOSTE,fi,,Tämä pakkausseloste on tarkistettu viimeksi <{KK.VVVV}> <{kuukausi VVVV}>.,35023.0,True,28
1222,35029,CAP,PAKKAUSSELOSTE,fi,,Muut tiedonlähteet,35023.0,False,29
1223,35030,CAP,PAKKAUSSELOSTE,fi,,Seuraavat tiedot on tarkoitettu vain terveydenhuollon ammattilaisille:,35001.0,False,30
1224,36001,CAP,SmPC,fr,,RÉSUMÉ DES CARACTÉRISTIQUES DU PRODUIT,,True,1
1225,36002,CAP,SmPC,fr,,qCe médicament fait l'objet d'une surveillance supplémentaire qui permettra l'identification rapide de nouvelles informations relatives à la sécurité. Les professionnels de la santé déclarent tout effet indésirable suspecté. Voir rubrique 4.8 pour les modalités de déclaration des effets indésirables.>,36001.0,False,2
1226,36003,CAP,SmPC,fr,1,DÉNOMINATION DU MÉDICAMENT,36001.0,True,3
1227,36004,CAP,SmPC,fr,2,COMPOSITION QUALITATIVE ET QUANTITATIVE,36001.0,True,4
1228,36005,CAP,SmPC,fr,2.1,Description générale,36004.0,False,5
1229,36006,CAP,SmPC,fr,2.2,Composition qualitative et quantitative,36004.0,False,6
1230,36007,CAP,SmPC,fr,,Excipient(s) à effet notoire:,36006.0,False,7
1231,36008,CAP,SmPC,fr,3,FORME PHARMACEUTIQUE,36001.0,True,8
1232,36009,CAP,SmPC,fr,4,INFORMATIONS CLINIQUES,36001.0,True,9
1233,36010,CAP,SmPC,fr,4.1,Indications thérapeutiques,36009.0,True,10
1234,36011,CAP,SmPC,fr,4.2,Posologie et mode d’administration,36009.0,True,11
1235,36012,CAP,SmPC,fr,,Posologie,36011.0,True,12
1236,36013,CAP,SmPC,fr,,Population pédiatrique,36012.0,True,13
1237,36014,CAP,SmPC,fr,,Mode d’administration,36011.0,True,14
1238,36015,CAP,SmPC,fr,,Précautions à prendre avant la manipulation ou l’administration du médicament,36014.0,False,15
1239,36016,CAP,SmPC,fr,4.3,Contre-indications,36009.0,True,16
1240,36017,CAP,SmPC,fr,4.4,Mises en garde spéciales et précautions d’emploi,36009.0,True,17
1241,36018,CAP,SmPC,fr,,Traçabilité,36017.0,False,18
1242,36019,CAP,SmPC,fr,,Population pédiatrique,36017.0,False,19
1243,36020,CAP,SmPC,fr,4.5,Interactions avec d’autres médicaments et autres formes d’interactions,36009.0,True,20
1244,36021,CAP,SmPC,fr,,Population pédiatrique,36020.0,False,21
1245,36022,CAP,SmPC,fr,4.6,"Fertilité, grossesse et allaitement",36009.0,True,22
1246,36023,CAP,SmPC,fr,,Grossesse,36022.0,False,23
1247,36024,CAP,SmPC,fr,,Allaitement,36022.0,False,24
1248,36025,CAP,SmPC,fr,,Fertilité,36022.0,False,25
1249,36026,CAP,SmPC,fr,4.7,Effets sur l’aptitude à conduire des véhicules et à utiliser des machines,36009.0,True,26
1250,36027,CAP,SmPC,fr,4.8,Effets indésirables,36009.0,True,27
1251,36028,CAP,SmPC,fr,,Population pédiatrique,36027.0,False,28
1252,36029,CAP,SmPC,fr,,Déclaration des effets indésirables suspectés,36027.0,True,29
1253,36030,CAP,SmPC,fr,4.9,Surdosage,36009.0,True,30
1254,36031,CAP,SmPC,fr,,Population pédiatrique,36030.0,False,31
1255,36032,CAP,SmPC,fr,5,PROPRIÉTÉS PHARMACOLOGIQUES,36001.0,True,32
1256,36033,CAP,SmPC,fr,5.1,Propriétés pharmacodynamiques ,36032.0,True,33
1257,36034,CAP,SmPC,fr,,Mécanisme d’action,36033.0,False,34
1258,36035,CAP,SmPC,fr,,Effets pharmacodynamiques,36033.0,False,35
1259,36036,CAP,SmPC,fr,,Efficacité et sécurité cliniques,36033.0,False,36
1260,36037,CAP,SmPC,fr,,Population pédiatrique,36033.0,False,37
1261,36038,CAP,SmPC,fr,5.2,Propriétés pharmacocinétiques,36032.0,True,38
1262,36039,CAP,SmPC,fr,,Absorption,36038.0,False,39
1263,36040,CAP,SmPC,fr,,Distribution,36038.0,False,40
1264,36041,CAP,SmPC,fr,,Biotransformation,36038.0,False,41
1265,36042,CAP,SmPC,fr,,Élimination,36038.0,False,42
1266,36043,CAP,SmPC,fr,,Linéarité/non-linéarité,36038.0,False,43
1267,36044,CAP,SmPC,fr,,Relations pharmacocinétique/pharmacodynamique,36038.0,False,44
1268,36045,CAP,SmPC,fr,5.3,Données de sécurité préclinique,36032.0,True,45
1269,36046,CAP,SmPC,fr,,Évaluation du risque environnemental,36045.0,False,46
1270,36047,CAP,SmPC,fr,6,DONNÉES PHARMACEUTIQUES,36001.0,True,47
1271,36048,CAP,SmPC,fr,6.1,Liste des excipients,36047.0,True,48
1272,36049,CAP,SmPC,fr,6.2,Incompatibilités,36047.0,True,49
1273,36050,CAP,SmPC,fr,6.3,Durée de conservation,36047.0,True,50
1274,36051,CAP,SmPC,fr,6.4,Précautions particulières de conservation,36047.0,True,51
1275,36052,CAP,SmPC,fr,6.5,"Nature et contenu de l’emballage extérieur <et équipement spécial pour l’utilisation, l’administration ou la greffe>",36047.0,True,52
1276,36053,CAP,SmPC,fr,6.6,Précautions particulières d’élimination <et manipulation>,36047.0,True,53
1277,36054,CAP,SmPC,fr,,Utilisation dans la population pédiatrique,36053.0,False,54
1278,36055,CAP,SmPC,fr,7,TITULAIRE DE L’AUTORISATION DE MISE SUR LE MARCHÉ,36001.0,True,55
1279,36056,CAP,SmPC,fr,8,NUMÉRO(S) D’AUTORISATION DE MISE SUR LE MARCHÉ ,36001.0,True,56
1280,36057,CAP,SmPC,fr,9,DATE DE PREMIÈRE AUTORISATION/DE RENOUVELLEMENT DE L’AUTORISATION,36001.0,True,57
1281,36058,CAP,SmPC,fr,10,DATE DE MISE À JOUR DU TEXTE,36001.0,True,58
1282,36059,CAP,SmPC,fr,11,DOSIMÉTRIE,36001.0,False,59
1283,36060,CAP,SmPC,fr,12,INSTRUCTIONS POUR LA PRÉPARATION DES RADIOPHARMACEUTIQUES,36001.0,False,60
1284,37001,CAP,AnnexII,fr,,ANNEXE II,,True,1
1285,37002,CAP,AnnexII,fr,A,<FABRICANT(S) DE LA/DES SUBSTANCE(S) ACTIVE(S) D’ORIGINE BIOLOGIQUE ET > FABRICANT(S) RESPONSABLE(S) DE LA LIBÉRATION DES LOTS,37001.0,True,2
1286,37003,CAP,AnnexII,fr,,Nom et adresse du (des) fabricant(s) de la (des) substance(s) active(s) d’origine biologique,37002.0,False,3
1287,37004,CAP,AnnexII,fr,,Nom et adresse du (des) fabricant(s) responsable(s) de la libération des lots,37002.0,True,4
1288,37005,CAP,AnnexII,fr,B,CONDITIONS OU RESTRICTIONS DE DÉLIVRANCE ET D’UTILISATION ,37001.0,True,5
1289,37006,CAP,AnnexII,fr,,Libération officielle des lots,37005.0,False,6
1290,37007,CAP,AnnexII,fr,C,AUTRES CONDITIONS ET OBLIGATIONS DE L’AUTORISATION DE MISE SUR LE MARCHÉ,37001.0,True,7
1291,37008,CAP,AnnexII,fr,,Rapports périodiques actualisés de sécurité (PSURs),37007.0,True,8
1292,37009,CAP,AnnexII,fr,D,CONDITIONS OU RESTRICTIONS EN VUE D’UNE UTILISATION SÛRE ET EFFICACE DU MÉDICAMENT  ,37001.0,True,9
1293,37010,CAP,AnnexII,fr,,Plan de gestion des risques (PGR),37009.0,True,10
1294,37011,CAP,AnnexII,fr,,Mesures additionnelles de réduction du risque,37009.0,False,11
1295,37012,CAP,AnnexII,fr,,Obligation de mise en place de mesures post-autorisation ,37009.0,False,12
1296,37013,CAP,AnnexII,fr,E,OBLIGATION SPÉCIFIQUE RELATIVE AUX MESURES POST-AUTORISATION CONCERNANT <L’AUTORISATION DE MISE SUR LE MARCHÉ CONDITIONNELLE> <L’AUTORISATION DE MISE SUR LE MARCHÉ «SOUS CIRCONSTANCES EXCEPTIONNELLES»>,37001.0,False,13
1297,38001,CAP,Labelling,fr,,ÉTIQUETAGE,,True,1
1298,38002,CAP,Labelling,fr,,MENTIONS DEVANT FIGURER SUR <L’EMBALLAGE EXTÉRIEUR> <ET SUR> <LE CONDITIONNEMENT PRIMAIRE>,38001.0,True,2
1299,38003,CAP,Labelling,fr,1,DÉNOMINATION DU MÉDICAMENT,38002.0,True,3
1300,38004,CAP,Labelling,fr,2,COMPOSITION EN SUBSTANCE(S) ACTIVE(S),38002.0,True,4
1301,38005,CAP,Labelling,fr,3,LISTE DES EXCIPIENTS,38002.0,True,5
1302,38006,CAP,Labelling,fr,4,FORME PHARMACEUTIQUE ET CONTENU,38002.0,True,6
1303,38007,CAP,Labelling,fr,5,MODE ET VOIE(S) D’ADMINISTRATION,38002.0,True,7
1304,38008,CAP,Labelling,fr,6,MISE EN GARDE SPÉCIALE INDIQUANT QUE LE MÉDICAMENT DOIT ÊTRE CONSERVÉ HORS DE VUE ET DE PORTÉE DES ENFANTS,38002.0,True,8
1305,38009,CAP,Labelling,fr,7,"AUTRE(S) MISE(S) EN GARDE SPÉCIALE(S), SI NÉCESSAIRE",38002.0,True,9
1306,38010,CAP,Labelling,fr,8,DATE DE PÉREMPTION,38002.0,True,10
1307,38011,CAP,Labelling,fr,9,PRÉCAUTIONS PARTICULIÈRES DE CONSERVATION,38002.0,True,11
1308,38012,CAP,Labelling,fr,10,PRÉCAUTIONS PARTICULIÈRES D’ÉLIMINATION DES MÉDICAMENTS NON UTILISÉS OU DES DÉCHETS PROVENANT DE CES MÉDICAMENTS S’IL Y A LIEU,38002.0,True,12
1309,38013,CAP,Labelling,fr,11,NOM ET ADRESSE DU TITULAIRE DE L’AUTORISATION DE MISE SUR LE MARCHÉ,38002.0,True,13
1310,38014,CAP,Labelling,fr,12,NUMÉRO(S) D’AUTORISATION DE MISE SUR LE MARCHÉ,38002.0,True,14
1311,38015,CAP,Labelling,fr,13,NUMÉRO DU LOT<CODES DON ET PRODUIT>,38002.0,True,15
1312,38016,CAP,Labelling,fr,14,CONDITIONS DE PRESCRIPTION ET DE DÉLIVRANCE,38002.0,True,16
1313,38017,CAP,Labelling,fr,15,INDICATIONS D’UTILISATION,38002.0,True,17
1314,38018,CAP,Labelling,fr,16,INFORMATIONS EN BRAILLE,38002.0,True,18
1315,38019,CAP,Labelling,fr,17,IDENTIFIANT UNIQUE - CODE-BARRES 2D,38002.0,True,19
1316,38020,CAP,Labelling,fr,18,IDENTIFIANT UNIQUE - DONNÉES LISIBLES PAR LES HUMAINS,38002.0,True,20
1317,38021,CAP,Labelling,fr,,MENTIONS MINIMALES DEVANT FIGURER SUR LES PLAQUETTES OU LES FILMS THERMOSOUDÉS,38001.0,True,21
1318,38022,CAP,Labelling,fr,1,DÉNOMINATION DU MÉDICAMENT,38021.0,True,22
1319,38023,CAP,Labelling,fr,2,NOM DU TITULAIRE DE L’AUTORISATION DE MISE SUR LE MARCHÉ,38021.0,True,23
1320,38024,CAP,Labelling,fr,3,DATE DE PÉREMPTION,38021.0,True,24
1321,38025,CAP,Labelling,fr,4,"NUMÉRO DU LOT<, CODES DON ET PRODUIT>",38021.0,True,25
1322,38026,CAP,Labelling,fr,5,AUTRE,38021.0,True,26
1323,38027,CAP,Labelling,fr,,MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES,38001.0,True,27
1324,38028,CAP,Labelling,fr,1,DÉNOMINATION DU MÉDICAMENT ET VOIE(S) D’ADMINISTRATION,38027.0,True,28
1325,38029,CAP,Labelling,fr,2,MODE D’ADMINISTRATION,38027.0,True,29
1326,38030,CAP,Labelling,fr,3,DATE DE PÉREMPTION,38027.0,True,30
1327,38031,CAP,Labelling,fr,4,"NUMÉRO DU LOT<, CODES DON ET PRODUIT>",38027.0,True,31
1328,38032,CAP,Labelling,fr,5,"CONTENU EN POIDS, VOLUME OU UNITÉ",38027.0,True,32
1329,38033,CAP,Labelling,fr,6,AUTRE,38027.0,True,33
1330,39001,CAP,Package leaflet,fr,,NOTICE,,True,1
1331,39002,CAP,Package leaflet,fr,,qCe médicament fait l'objet d'une surveillance supplémentaire qui permettra l'identification rapide de nouvelles informations relatives à la sécurité. Vous pouvez y contribuer en signalant tout effet indésirable que vous observez. Voir en fin de rubrique 4 comment déclarer les effets indésirables. ,39001.0,False,2
1332,39003,CAP,Package leaflet,fr,,Que contient cette notice?:,39001.0,True,3
1333,39004,CAP,Package leaflet,fr,1,Qu’est-ce que X et dans quels cas est-il utilisé,39001.0,True,4
1334,39005,CAP,Package leaflet,fr,2,Quelles sont les informations à connaître avant <de prendre> <d’utiliser> ,39001.0,True,5
1335,39006,CAP,Package leaflet,fr,,<Ne prenez> <N’utilisez> jamais X,39005.0,True,6
1336,39007,CAP,Package leaflet,fr,,Avertissements et précautions ,39005.0,True,7
1337,39008,CAP,Package leaflet,fr,,Enfants <et adolescents>,39005.0,True,8
1338,39009,CAP,Package leaflet,fr,,Autres médicaments et X,39005.0,True,9
1339,39010,CAP,Package leaflet,fr,,"X avec <des aliments> <et> <,> <boissons> <et> <de l’alcool>",39005.0,True,10
1340,39011,CAP,Package leaflet,fr,,"Grossesse <et> <,> allaitement <et fertilité>",39005.0,True,11
1341,39012,CAP,Package leaflet,fr,,Conduite de véhicules et utilisation de machines,39005.0,True,12
1342,39013,CAP,Package leaflet,fr,,X contient {nommer le/les excipient(s)},39005.0,False,13
1343,39014,CAP,Package leaflet,fr,3,Comment <prendre> <utiliser> X,39001.0,True,14
1344,39015,CAP,Package leaflet,fr,,Utilisation chez les enfants <et les adolescents>,39014.0,False,15
1345,39016,CAP,Package leaflet,fr,,Si vous avez <pris> <utilisé> plus de X que vous n’auriez dû,39014.0,False,16
1346,39017,CAP,Package leaflet,fr,,Si vous oubliez <de prendre> <d’utiliser> X,39014.0,False,17
1347,39018,CAP,Package leaflet,fr,,Si vous arrêtez <de prendre> <d’utiliser> X,39014.0,False,18
1348,39019,CAP,Package leaflet,fr,4,Quels sont les effets indésirables éventuels?,39001.0,True,19
1349,39020,CAP,Package leaflet,fr,,Effets indésirables supplémentaires chez les enfants <et les adolescents>,39019.0,False,20
1350,39021,CAP,Package leaflet,fr,,Déclaration des effets secondaires,39019.0,True,21
1351,39022,CAP,Package leaflet,fr,5,Comment conserver X,39001.0,True,22
1352,39023,CAP,Package leaflet,fr,6,Contenu de l’emballage et autres informations,39001.0,True,23
1353,39024,CAP,Package leaflet,fr,,Ce que contient X ,39023.0,True,24
1354,39025,CAP,Package leaflet,fr,,Comment se présente X et contenu de l’emballage extérieur,39023.0,True,25
1355,39026,CAP,Package leaflet,fr,,Titulaire de l’Autorisation de mise sur le marché et fabricant,39023.0,True,26
1356,39027,CAP,Package leaflet,fr,,"Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’autorisation de mise sur le marché :",39023.0,False,27
1357,39028,CAP,Package leaflet,fr,,La dernière date à laquelle cette notice a été révisée est <{MM/AAAA}> <{mois AAAA}.>,39023.0,True,28
1358,39029,CAP,Package leaflet,fr,,Autres sources d’informations,39023.0,False,29
1359,39030,CAP,Package leaflet,fr,,Les informations suivantes sont destinées exclusivement aux professionnels de la santé:,39001.0,False,30
1360,40001,CAP,SmPC,hr,,SAŽETAK OPISA SVOJSTAVA LIJEKA,,True,1
1361,40002,CAP,SmPC,hr,,qOvaj je lijek pod dodatnim praćenjem. Time se omogućuje brzo otkrivanje novih sigurnosnih informacija. Od zdravstvenih radnika se traži da prijave svaku sumnju na nuspojavu za ovaj lijek. Za postupak prijavljivanja nuspojava vidjeti dio 4.8.,40001.0,False,2
1362,40003,CAP,SmPC,hr,1,NAZIV LIJEKA,40001.0,True,3
1363,40004,CAP,SmPC,hr,2,KVALITATIVNI I KVANTITATIVNI SASTAV,40001.0,True,4
1364,40005,CAP,SmPC,hr,2.1,Opći opis,40004.0,False,5
1365,40006,CAP,SmPC,hr,2.2,Kvalitativni i kvantitativni sastav,40004.0,False,6
1366,40007,CAP,SmPC,hr,,Pomoćna(e) tvar(i) s poznatim učinkom,40006.0,False,7
1367,40008,CAP,SmPC,hr,3,FARMACEUTSKI OBLIK,40001.0,True,8
1368,40009,CAP,SmPC,hr,4,KLINIČKI PODACI,40001.0,True,9
1369,40010,CAP,SmPC,hr,4.1,Terapijske indikacije,40009.0,True,10
1370,40011,CAP,SmPC,hr,4.2,Doziranje i način primjene,40009.0,True,11
1371,40012,CAP,SmPC,hr,,Doziranje,40011.0,True,12
1372,40013,CAP,SmPC,hr,,Pedijatrijska populacija,40012.0,True,13
1373,40014,CAP,SmPC,hr,,Način primjene,40011.0,True,14
1374,40015,CAP,SmPC,hr,,Mjere opreza koje je potrebno poduzeti prije rukovanja ili primjene lijeka.,40014.0,False,15
1375,40016,CAP,SmPC,hr,4.3,Kontraindikacije,40009.0,True,16
1376,40017,CAP,SmPC,hr,4.4,Posebna upozorenja i mjere opreza pri uporabi,40009.0,True,17
1377,40018,CAP,SmPC,hr,,Sljedivost,40017.0,False,18
1378,40019,CAP,SmPC,hr,,Pedijatrijska populacija,40017.0,False,19
1379,40020,CAP,SmPC,hr,4.5,Interakcije s drugim lijekovima i drugi oblici interakcija,40009.0,True,20
1380,40021,CAP,SmPC,hr,,Pedijatrijska populacija,40020.0,False,21
1381,40022,CAP,SmPC,hr,4.6,"Plodnost, trudnoća i dojenje",40009.0,True,22
1382,40023,CAP,SmPC,hr,,Trudnoća,40022.0,False,23
1383,40024,CAP,SmPC,hr,,Dojenje,40022.0,False,24
1384,40025,CAP,SmPC,hr,,Plodnost,40022.0,False,25
1385,40026,CAP,SmPC,hr,4.7,Utjecaj na sposobnost upravljanja vozilima i rada sa strojevima,40009.0,True,26
1386,40027,CAP,SmPC,hr,4.8,Nuspojave,40009.0,True,27
1387,40028,CAP,SmPC,hr,,Pedijatrijska populacija,40027.0,False,28
1388,40029,CAP,SmPC,hr,,Prijavljivanje sumnji na nuspojavu,40027.0,True,29
1389,40030,CAP,SmPC,hr,4.9,Predoziranje,40009.0,True,30
1390,40031,CAP,SmPC,hr,,Pedijatrijska populacija,40030.0,False,31
1391,40032,CAP,SmPC,hr,5,FARMAKOLOŠKA SVOJSTVA,40001.0,True,32
1392,40033,CAP,SmPC,hr,5.1,Farmakodinamička svojstva,40032.0,True,33
1393,40034,CAP,SmPC,hr,,Mehanizam djelovanja,40033.0,False,34
1394,40035,CAP,SmPC,hr,,Farmakodinamički učinci,40033.0,False,35
1395,40036,CAP,SmPC,hr,,Klinička djelotvornost i sigurnost,40033.0,False,36
1396,40037,CAP,SmPC,hr,,Pedijatrijska populacija,40033.0,False,37
1397,40038,CAP,SmPC,hr,5.2,Farmakokinetička svojstva,40032.0,True,38
1398,40039,CAP,SmPC,hr,,Apsorpcija,40038.0,False,39
1399,40040,CAP,SmPC,hr,,Distribucija,40038.0,False,40
1400,40041,CAP,SmPC,hr,,Biotransformacija,40038.0,False,41
1401,40042,CAP,SmPC,hr,,Eliminacija,40038.0,False,42
1402,40043,CAP,SmPC,hr,,Linearnost/nelinearnost,40038.0,False,43
1403,40044,CAP,SmPC,hr,,Farmakokinetički/farmakodinamički odnos(i),40038.0,False,44
1404,40045,CAP,SmPC,hr,5.3,Neklinički podaci o sigurnosti primjene,40032.0,True,45
1405,40046,CAP,SmPC,hr,,Procjena rizika za okoliš (ERA),40045.0,False,46
1406,40047,CAP,SmPC,hr,6,FARMACEUTSKI PODACI,40001.0,True,47
1407,40048,CAP,SmPC,hr,6.1,Popis pomoćnih tvari,40047.0,True,48
1408,40049,CAP,SmPC,hr,6.2,Inkompatibilnosti,40047.0,True,49
1409,40050,CAP,SmPC,hr,6.3,Rok valjanosti,40047.0,True,50
1410,40051,CAP,SmPC,hr,6.4,Posebne mjere pri čuvanju lijeka,40047.0,True,51
1411,40052,CAP,SmPC,hr,6.5,"Vrsta i sadržaj spremnika <i posebna oprema za uporabu, primjenu ili ugradnju>",40047.0,True,52
1412,40053,CAP,SmPC,hr,6.6,Posebne mjere za zbrinjavanje <i druga rukovanja lijekom>,40047.0,True,53
1413,40054,CAP,SmPC,hr,,Primjena u pedijatrijskoj populaciji,40053.0,False,54
1414,40055,CAP,SmPC,hr,7,NOSITELJ ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET,40001.0,True,55
1415,40056,CAP,SmPC,hr,8,BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET,40001.0,True,56
1416,40057,CAP,SmPC,hr,9,DATUM PRVOG ODOBRENJA / DATUM OBNOVE ODOBRENJA,40001.0,True,57
1417,40058,CAP,SmPC,hr,10,DATUM REVIZIJE TEKSTA,40001.0,True,58
1418,40059,CAP,SmPC,hr,11,DOZIMETRIJA,40001.0,False,59
1419,40060,CAP,SmPC,hr,12,UPUTE ZA PRIPREMU RADIOFARMACEUTIKA,40001.0,False,60
1420,41001,CAP,PRILOG II,hr,,PRILOG II,,True,1
1421,41002,CAP,PRILOG II,hr,A,PROIZVOĐAČ(I) BIOLOŠKE(IH) DJELATNE(IH) TVARI I> PROIZVOĐAČ(I) ODGOVORAN(NI) ZA PUŠTANJE SERIJE LIJEKA U PROMET,41001.0,True,2
1422,41003,CAP,PRILOG II,hr,,Naziv(i) i adresa(e) proizvođača biološke(ih) djelatne(ih) tvari,41002.0,False,3
1423,41004,CAP,PRILOG II,hr,,Naziv(i) i adresa(e) proizvođača odgovornog(ih) za puštanje serije lijeka u promet,41002.0,True,4
1424,41005,CAP,PRILOG II,hr,B,UVJETI ILI OGRANIČENJA VEZANI UZ OPSKRBU I PRIMJENU ,41001.0,True,5
1425,41006,CAP,PRILOG II,hr,,Službeno puštanje serije lijeka u promet,41005.0,False,6
1426,41007,CAP,PRILOG II,hr,C,OSTALI UVJETI I ZAHTJEVI ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET,41001.0,True,7
1427,41008,CAP,PRILOG II,hr,,Periodička izvješća o neškodljivosti lijeka (PSUR-evi),41007.0,True,8
1428,41009,CAP,PRILOG II,hr,D,UVJETI ILI OGRANIČENJA VEZANI UZ SIGURNU I UČINKOVITU PRIMJENU LIJEKA,41001.0,True,9
1429,41010,CAP,PRILOG II,hr,,Plan upravljanja rizikom (RMP),41009.0,True,10
1430,41011,CAP,PRILOG II,hr,,Dodatne mjere minimizacije rizika,41009.0,False,11
1431,41012,CAP,PRILOG II,hr,,Obveza provođenja mjera nakon davanja odobrenja,41009.0,False,12
1432,41013,CAP,PRILOG II,hr,E,POSEBNE OBVEZE ZA PROVEDBE MJERA NAKON DAVANJA ODOBRENJA KOD <UVJETNOG ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET> <ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET U IZNIMNIM OKOLNOSTIMA>,41001.0,False,13
1433,42001,CAP,OZNAČIVANJE,hr,,OZNAČIVANJE,,True,1
1434,42002,CAP,OZNAČIVANJE,hr,,PODACI KOJI SE MORAJU NALAZITI NA < VANJSKOM PAKIRANJU> <I> <UNUTARNJEM PAKIRANJU>,42001.0,True,2
1435,42003,CAP,OZNAČIVANJE,hr,1,NAZIV LIJEKA,42002.0,True,3
1436,42004,CAP,OZNAČIVANJE,hr,2,NAVOĐENJE DJELATNE(IH) TVARI,42002.0,True,4
1437,42005,CAP,OZNAČIVANJE,hr,3,POPIS POMOĆNIH TVARI,42002.0,True,5
1438,42006,CAP,OZNAČIVANJE,hr,4,FARMACEUTSKI OBLIK I SADRŽAJ,42002.0,True,6
1439,42007,CAP,OZNAČIVANJE,hr,5,NAČIN I PUT(EVI) PRIMJENE LIJEKA,42002.0,True,7
1440,42008,CAP,OZNAČIVANJE,hr,6,POSEBNO UPOZORENJE O ČUVANJU LIJEKA IZVAN POGLEDA I DOHVATA DJECE,42002.0,True,8
1441,42009,CAP,OZNAČIVANJE,hr,7,"DRUGO(A) POSEBNO(A) UPOZORENJE(A), AKO JE POTREBNO",42002.0,True,9
1442,42010,CAP,OZNAČIVANJE,hr,8,ROK VALJANOSTI,42002.0,True,10
1443,42011,CAP,OZNAČIVANJE,hr,9,POSEBNE MJERE ČUVANJA,42002.0,True,11
1444,42012,CAP,OZNAČIVANJE,hr,10,"POSEBNE MJERE ZA ZBRINJAVANJE NEISKORIŠTENOG LIJEKA ILI OTPADNIH MATERIJALA KOJI POTJEČU OD LIJEKA, AKO JE POTREBNO",42002.0,True,12
1445,42013,CAP,OZNAČIVANJE,hr,11,NAZIV I ADRESA NOSITELJA ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET,42002.0,True,13
1446,42014,CAP,OZNAČIVANJE,hr,12,BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET,42002.0,True,14
1447,42015,CAP,OZNAČIVANJE,hr,13,"BROJ SERIJE<, OZNAKE DONACIJE I PROIZVODA>",42002.0,True,15
1448,42016,CAP,OZNAČIVANJE,hr,14,NAČIN IZDAVANJA LIJEKA,42002.0,True,16
1449,42017,CAP,OZNAČIVANJE,hr,15,UPUTE ZA UPORABU,42002.0,True,17
1450,42018,CAP,OZNAČIVANJE,hr,16,PODACI NA BRAILLEOVOM PISMU,42002.0,True,18
1451,42019,CAP,OZNAČIVANJE,hr,17,JEDINSTVENI IDENTIFIKATOR – 2D BARKOD,42002.0,True,19
1452,42020,CAP,OZNAČIVANJE,hr,18,JEDINSTVENI IDENTIFIKATOR – PODACI ČITLJIVI LJUDSKIM OKOM,42002.0,True,20
1453,42021,CAP,OZNAČIVANJE,hr,,PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP,42001.0,True,21
1454,42022,CAP,OZNAČIVANJE,hr,1,NAZIV LIJEKA,42021.0,True,22
1455,42023,CAP,OZNAČIVANJE,hr,2,NAZIV NOSITELJA ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET,42021.0,True,23
1456,42024,CAP,OZNAČIVANJE,hr,3,ROK VALJANOSTI,42021.0,True,24
1457,42025,CAP,OZNAČIVANJE,hr,4,"BROJ SERIJE<, OZNAKE DONACIJE I PROIZVODA>",42021.0,True,25
1458,42026,CAP,OZNAČIVANJE,hr,5,DRUGO,42021.0,True,26
1459,42027,CAP,OZNAČIVANJE,hr,,PODACI KOJE MORA NAJMANJE SADRŽAVATI MALO UNUTARNJE PAKIRANJE,42001.0,True,27
1460,42028,CAP,OZNAČIVANJE,hr,1,NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA,42027.0,True,28
1461,42029,CAP,OZNAČIVANJE,hr,2,NAČIN PRIMJENE LIJEKA,42027.0,True,29
1462,42030,CAP,OZNAČIVANJE,hr,3,ROK VALJANOSTI,42027.0,True,30
1463,42031,CAP,OZNAČIVANJE,hr,4,"BROJ SERIJE<, OZNAKE DONACIJE I PROIZVODA>",42027.0,True,31
1464,42032,CAP,OZNAČIVANJE,hr,5,"SADRŽAJ PO TEŽINI, VOLUMENU ILI DOZNOJ JEDINICI LIJEKA",42027.0,True,32
1465,42033,CAP,OZNAČIVANJE,hr,6,DRUGO,42027.0,True,33
1466,43001,CAP,UPUTA O LIJEKU,hr,,UPUTA O LIJEKU,,True,1
1467,43002,CAP,UPUTA O LIJEKU,hr,,"q Ovaj je lijek pod dodatnim praćenjem. Time se omogućuje brzo otkrivanje novih sigurnosnih informacija. Prijavom svih sumnji na nuspojavu i Vi možete pomoći. Za postupak prijavljivanja nuspojava, pogledajte dio 4.",43001.0,False,2
1468,43003,CAP,UPUTA O LIJEKU,hr,,Što se nalazi u ovoj uputi:,43001.0,True,3
1469,43004,CAP,UPUTA O LIJEKU,hr,1,Što je X i za što se koristi,43001.0,True,4
1470,43005,CAP,UPUTA O LIJEKU,hr,2,Što morate znati prije nego počnete <uzimati> <primjenjivati> X,43001.0,True,5
1471,43006,CAP,UPUTA O LIJEKU,hr,,Nemojte <uzimati> <primjenjivati> X,43005.0,True,6
1472,43007,CAP,UPUTA O LIJEKU,hr,,Upozorenja i mjere opreza ,43005.0,True,7
1473,43008,CAP,UPUTA O LIJEKU,hr,,Djeca <i adolescenti>,43005.0,True,8
1474,43009,CAP,UPUTA O LIJEKU,hr,,Drugi lijekovi i X,43005.0,True,9
1475,43010,CAP,UPUTA O LIJEKU,hr,,"X s <hranom> <i> <,> <pićem> <i> <alkoholom>",43005.0,True,10
1476,43011,CAP,UPUTA O LIJEKU,hr,,"Trudnoća <i> <,> dojenje <i plodnost>",43005.0,True,11
1477,43012,CAP,UPUTA O LIJEKU,hr,,Upravljanje vozilima i strojevima,43005.0,True,12
1478,43013,CAP,UPUTA O LIJEKU,hr,,X sadrži {naziv pomoćne(ih) tvari},43005.0,False,13
1479,43014,CAP,UPUTA O LIJEKU,hr,3,Kako <uzimati> <primjenjivati> X,43001.0,True,14
1480,43015,CAP,UPUTA O LIJEKU,hr,,Primjena u djece <i adolescenata>,43014.0,False,15
1481,43016,CAP,UPUTA O LIJEKU,hr,,Ako <uzmete> <primijenite> više X nego što ste trebali,43014.0,False,16
1482,43017,CAP,UPUTA O LIJEKU,hr,,Ako ste zaboravili <uzeti> <primijeniti> X,43014.0,False,17
1483,43018,CAP,UPUTA O LIJEKU,hr,,Ako prestanete <uzimati> <primjenjivati> X,43014.0,False,18
1484,43019,CAP,UPUTA O LIJEKU,hr,4,Moguće nuspojave,43001.0,True,19
1485,43020,CAP,UPUTA O LIJEKU,hr,,Dodatne nuspojave u djece <i adolescenata>,43019.0,False,20
1486,43021,CAP,UPUTA O LIJEKU,hr,,Prijavljivanje nuspojava,43019.0,True,21
1487,43022,CAP,UPUTA O LIJEKU,hr,5,Kako čuvati X,43001.0,True,22
1488,43023,CAP,UPUTA O LIJEKU,hr,6,Sadržaj pakiranja i druge informacije,43001.0,True,23
1489,43024,CAP,UPUTA O LIJEKU,hr,,Što X sadrži ,43023.0,True,24
1490,43025,CAP,UPUTA O LIJEKU,hr,,Kako X izgleda i sadržaj pakiranja,43023.0,True,25
1491,43026,CAP,UPUTA O LIJEKU,hr,,Nositelj odobrenja za stavljanje lijeka u promet i proizvođač,43023.0,True,26
1492,43027,CAP,UPUTA O LIJEKU,hr,,Za sve informacije o ovom lijeku obratite se lokalnom predstavniku nositelja odobrenja za stavljanje lijeka u promet:,43023.0,False,27
1493,43028,CAP,UPUTA O LIJEKU,hr,,Ova uputa je zadnji puta revidirana u <{MM/GGGG}> <{mjesec GGGG}>.,43023.0,True,28
1494,43029,CAP,UPUTA O LIJEKU,hr,,Ostali izvori informacija,43023.0,False,29
1495,43030,CAP,UPUTA O LIJEKU,hr,,Sljedeće informacije namijenjene su samo zdravstvenim radnicima:,43001.0,False,30
1496,44001,CAP,SmPC,hu,,ALKALMAZÁSI ELŐÍRÁS,,True,1
1497,44002,CAP,SmPC,hu,,"qEz a gyógyszer fokozott felügyelet alatt áll, mely lehetővé teszi az új gyógyszerbiztonsági információk gyors azonosítását. Az egészségügyi szakembereket arra kérjük, hogy jelentsenek bármilyen feltételezett mellékhatást. A mellékhatások jelentésének módjairól a 4.8 pontban kaphatnak további tájékoztatást.",44001.0,False,2
1498,44003,CAP,SmPC,hu,1,A GYÓGYSZER NEVE,44001.0,True,3
1499,44004,CAP,SmPC,hu,2,MINŐSÉGI ÉS MENNYISÉGI ÖSSZETÉTEL,44001.0,True,4
1500,44005,CAP,SmPC,hu,2.1,Általános leírás,44004.0,False,5
1501,44006,CAP,SmPC,hu,2.2,Minőségi és mennyiségi összetétel,44004.0,False,6
1502,44007,CAP,SmPC,hu,,Ismert hatású segédanyag(ok),44006.0,False,7
1503,44008,CAP,SmPC,hu,3,GYÓGYSZERFORMA,44001.0,True,8
1504,44009,CAP,SmPC,hu,4,KLINIKAI JELLEMZŐK,44001.0,True,9
1505,44010,CAP,SmPC,hu,4.1,Terápiás javallatok,44009.0,True,10
1506,44011,CAP,SmPC,hu,4.2,Adagolás és alkalmazás,44009.0,True,11
1507,44012,CAP,SmPC,hu,,Adagolás,44011.0,True,12
1508,44013,CAP,SmPC,hu,,Gyermekek és serdülők,44012.0,True,13
1509,44014,CAP,SmPC,hu,,Az alkalmazás módja,44011.0,True,14
1510,44015,CAP,SmPC,hu,,Óvintézkedések a gyógyszer felhasználása vagy alkalmazása előtt,44014.0,False,15
1511,44016,CAP,SmPC,hu,4.3,Ellenjavallatok,44009.0,True,16
1512,44017,CAP,SmPC,hu,4.4,Különleges figyelmeztetések és az alkalmazással kapcsolatos óvintézkedések,44009.0,True,17
1513,44018,CAP,SmPC,hu,,Nyomonkövethetőség,44017.0,False,18
1514,44019,CAP,SmPC,hu,,Gyermekek és serdülők,44017.0,False,19
1515,44020,CAP,SmPC,hu,4.5,Gyógyszerkölcsönhatások és egyéb interakciók,44009.0,True,20
1516,44021,CAP,SmPC,hu,,Gyermekek és serdülők,44020.0,False,21
1517,44022,CAP,SmPC,hu,4.6,"Termékenység, terhesség és szoptatás",44009.0,True,22
1518,44023,CAP,SmPC,hu,,Terhesség,44022.0,False,23
1519,44024,CAP,SmPC,hu,,Szoptatás,44022.0,False,24
1520,44025,CAP,SmPC,hu,,Termékenység,44022.0,False,25
1521,44026,CAP,SmPC,hu,4.7,A készítmény hatásai a gépjárművezetéshez és a gépek kezeléséhez szükséges képességekre,44009.0,True,26
1522,44027,CAP,SmPC,hu,4.8,"Nemkívánatos hatások, mellékhatások",44009.0,True,27
1523,44028,CAP,SmPC,hu,,Gyermekek és serdülők,44027.0,False,28
1524,44029,CAP,SmPC,hu,,Feltételezett mellékhatások bejelentése,44027.0,True,29
1525,44030,CAP,SmPC,hu,4.9,Túladagolás,44009.0,True,30
1526,44031,CAP,SmPC,hu,,Gyermekek és serdülők,44030.0,False,31
1527,44032,CAP,SmPC,hu,5,FARMAKOLÓGIAI TULAJDONSÁGOK,44001.0,True,32
1528,44033,CAP,SmPC,hu,5.1,Farmakodinámiás tulajdonságok,44032.0,True,33
1529,44034,CAP,SmPC,hu,,Hatásmechanizmus,44033.0,False,34
1530,44035,CAP,SmPC,hu,,Farmakodinámiás hatások,44033.0,False,35
1531,44036,CAP,SmPC,hu,,Klinikai hatásosság és biztonságosság,44033.0,False,36
1532,44037,CAP,SmPC,hu,,Gyermekek és serdülők,44033.0,False,37
1533,44038,CAP,SmPC,hu,5.2,Farmakokinetikai tulajdonságok,44032.0,True,38
1534,44039,CAP,SmPC,hu,,Felszívódá,44038.0,False,39
1535,44040,CAP,SmPC,hu,,Eloszlás,44038.0,False,40
1536,44041,CAP,SmPC,hu,,Biotranszformáció,44038.0,False,41
1537,44042,CAP,SmPC,hu,,Elimináció,44038.0,False,42
1538,44043,CAP,SmPC,hu,,Linearitás/nem-linearitás,44038.0,False,43
1539,44044,CAP,SmPC,hu,,Farmakokinetikai/farmakodinámiás összefüggés(ek),44038.0,False,44
1540,44045,CAP,SmPC,hu,5.3,A preklinikai biztonságossági vizsgálatok eredményei,44032.0,True,45
1541,44046,CAP,SmPC,hu,,Környezeti kockázatbecslés,44045.0,False,46
1542,44047,CAP,SmPC,hu,6,GYÓGYSZERÉSZETI JELLEMZŐK,44001.0,True,47
1543,44048,CAP,SmPC,hu,6.1,Segédanyagok felsorolása,44047.0,True,48
1544,44049,CAP,SmPC,hu,6.2,Inkompatibilitások,44047.0,True,49
1545,44050,CAP,SmPC,hu,6.3,Felhasználhatósági időtartam,44047.0,True,50
1546,44051,CAP,SmPC,hu,6.4,Különleges tárolási előírások,44047.0,True,51
1547,44052,CAP,SmPC,hu,6.5,"Csomagolás típusa és kiszerelése <és speciális eszköz(ök) a használathoz, alkalmazáshoz vagy az implantációhoz>",44047.0,True,52
1548,44053,CAP,SmPC,hu,6.6,"A megsemmisítésre vonatkozó különleges óvintézkedések <és egyéb, a készítmény kezelésével kapcsolatos információk>",44047.0,True,53
1549,44054,CAP,SmPC,hu,,Alkalmazása gyermekek és serdülők esetén,44053.0,False,54
1550,44055,CAP,SmPC,hu,7,A FORGALOMBA HOZATALI ENGEDÉLY JOGOSULTJA,44001.0,True,55
1551,44056,CAP,SmPC,hu,8,A FORGALOMBA HOZATALI ENGEDÉLY SZÁMA(I),44001.0,True,56
1552,44057,CAP,SmPC,hu,9,A FORGALOMBA HOZATALI ENGEDÉLY ELSŐ KIADÁSÁNAK/ MEGÚJÍTÁSÁNAK DÁTUMA,44001.0,True,57
1553,44058,CAP,SmPC,hu,10,A SZÖVEG ELLENŐRZÉSÉNEK DÁTUMA,44001.0,True,58
1554,44059,CAP,SmPC,hu,11,VÁRHATÓ SUGÁRTERHELÉS,44001.0,False,59
1555,44060,CAP,SmPC,hu,12,RADIOAKTÍV GYÓGYSZEREK ELKÉSZÍTÉSÉRE VONATKOZÓ ÚTMUTATÁSOK,44001.0,False,60
1556,45001,CAP,AnnexII,hu,,II. MELLÉKLET,,True,1
1557,45002,CAP,AnnexII,hu,A,<A BIOLÓGIAI EREDETŰ HATÓANYAG(OK) GYÁRTÓJA/GYÁRTÓI ÉS>A GYÁRTÁSI TÉTELEK VÉGFELSZABADÍTÁSÁÉRT FELELŐS GYÁRTÓ(K),45001.0,True,2
1558,45003,CAP,AnnexII,hu,,A biológiai eredetű hatóanyag(ok) gyártójának/gyártóinak neve és címe,45002.0,False,3
1559,45004,CAP,AnnexII,hu,,A gyártási tételek végfelszabadításáért felelős gyártó(k) neve és címe,45002.0,True,4
1560,45005,CAP,AnnexII,hu,B,FELTÉTELEK VAGY KORLÁTOZÁSOK AZ ELLÁTÁS ÉS HASZNÁLAT KAPCSÁN ,45001.0,True,5
1561,45006,CAP,AnnexII,hu,,Gyártási tételek hivatalos végfelszabadítása,45005.0,False,6
1562,45007,CAP,AnnexII,hu,C,A FORGALOMBA HOZATALI ENGEDÉLY EGYÉB FELTÉTELEI ÉS KÖVETELMÉNYEI  ,45001.0,True,7
1563,45008,CAP,AnnexII,hu,,"Időszakos gyógyszerbiztonsági jelentések (Periodic safety update report, PSUR)",45007.0,True,8
1564,45009,CAP,AnnexII,hu,D,FELTÉTELEK VAGY KORLÁTOZÁSOK A GYÓGYSZER BIZTONSÁGOS ÉS HATÉKONY ALKALMAZÁSÁRA VONATKOZÓAN,45001.0,True,9
1565,45010,CAP,AnnexII,hu,,Kockázatkezelési terv ,45009.0,True,10
1566,45011,CAP,AnnexII,hu,,Kockázat-minimalizálásra irányuló további intézkedések,45009.0,False,11
1567,45012,CAP,AnnexII,hu,,Forgalomba hozatalt követő intézkedések teljesítésére vonatkozó speciális kötelezettség,45009.0,False,12
1568,45013,CAP,AnnexII,hu,E,FORGALOMBA HOZATALT KÖVETŐ INTÉZKEDÉSEK TELJESÍTÉSÉRE VONATKOZÓ SPECIÁLIS KÖTELEZETTSÉG <A FELTÉTELES FORGALOMBA HOZATALI ENGEDÉLY MEGADÁSA ÉRDEKÉBEN> <A KIVÉTELES KÖRÜLMÉNYEK KÖZÖTTMEGADOTT FORGALOMBA HOZATALI ENGEDÉLY ESETÉBEN>,45001.0,False,13
1569,46001,CAP,Labelling,hu,,CÍMKESZÖVEG,,True,1
1570,46002,CAP,Labelling,hu,,<KÜLSŐ CSOMAGOLÁSON><ÉS><A KÖZVETLEN CSOMAGOLÁSON> FELTÜNTETENDŐ ADATOK,46001.0,True,2
1571,46003,CAP,Labelling,hu,1,A GYÓGYSZER NEVE,46002.0,True,3
1572,46004,CAP,Labelling,hu,2,HATÓANYAG(OK) MEGNEVEZÉSE,46002.0,True,4
1573,46005,CAP,Labelling,hu,3,SEGÉDANYAGOK FELSOROLÁSA,46002.0,True,5
1574,46006,CAP,Labelling,hu,4,GYÓGYSZERFORMA ÉS TARTALOM,46002.0,True,6
1575,46007,CAP,Labelling,hu,5,AZ ALKALMAZÁSSAL KAPCSOLATOS TUDNIVALÓK ÉS AZ ALKALMAZÁS MÓDJA(I),46002.0,True,7
1576,46008,CAP,Labelling,hu,6,"KÜLÖN FIGYELMEZTETÉS, MELY SZERINT A GYÓGYSZERT GYERMEKEKTŐL ELZÁRVA KELL TARTANI",46002.0,True,8
1577,46009,CAP,Labelling,hu,7,"TOVÁBBI FIGYELMEZTETÉS(EK), AMENNYIBEN SZÜKSÉGES",46002.0,True,9
1578,46010,CAP,Labelling,hu,8,LEJÁRATI IDŐ,46002.0,True,10
1579,46011,CAP,Labelling,hu,9,KÜLÖNLEGES TÁROLÁSI ELŐÍRÁSOK,46002.0,True,11
1580,46012,CAP,Labelling,hu,10,"KÜLÖNLEGES ÓVINTÉZKEDÉSEK A FEL NEM HASZNÁLT GYÓGYSZEREK VAGY AZ ILYEN TERMÉKEKBŐL KELETKEZETT HULLADÉKANYAGOK ÁRTALMATLANNÁ TÉTELÉRE, HA ILYENEKRE SZÜKSÉG VAN",46002.0,True,12
1581,46013,CAP,Labelling,hu,11,A FORGALOMBA HOZATALI ENGEDÉLY JOGOSULTJÁNAK NEVE ÉS CÍME,46002.0,True,13
1582,46014,CAP,Labelling,hu,12,A FORGALOMBA HOZATALI ENGEDÉLY SZÁMA(I),46002.0,True,14
1583,46015,CAP,Labelling,hu,13,A GYÁRTÁSI TÉTEL SZÁMA <DONÁCIÓ ÉS KÉSZÍTMÉNY KÓDJA>,46002.0,True,15
1584,46016,CAP,Labelling,hu,14,A GYÓGYSZER RENDELHETŐSÉGE,46002.0,True,16
1585,46017,CAP,Labelling,hu,15,AZ ALKALMAZÁSRA VONATKOZÓ UTASÍTÁSOK,46002.0,True,17
1586,46018,CAP,Labelling,hu,16,BRAILLE ÍRÁSSAL FELTÜNTETETT INFORMÁCIÓK,46002.0,True,18
1587,46019,CAP,Labelling,hu,17,EGYEDI AZONOSÍTÓ – 2D VONALKÓD,46002.0,True,19
1588,46020,CAP,Labelling,hu,18,EGYEDI AZONOSÍTÓ OLVASHATÓ FORMÁTUMA,46002.0,True,20
1589,46021,CAP,Labelling,hu,,A BUBORÉKCSOMAGOLÁSON VAGY A FÓLIACSÍKON MINIMÁLISAN FELTÜNTETENDŐ ADATOK,46001.0,True,21
1590,46022,CAP,Labelling,hu,1,A GYÓGYSZER NEVE,46021.0,True,22
1591,46023,CAP,Labelling,hu,2,A FORGALOMBA HOZATALI ENGEDÉLY JOGOSULTJÁNAK NEVE,46021.0,True,23
1592,46024,CAP,Labelling,hu,3,LEJÁRATI IDŐ,46021.0,True,24
1593,46025,CAP,Labelling,hu,4,A GYÁRTÁSI TÉTEL SZÁMA <DONÁCIÓ ÉS KÉSZÍTMÉNY KÓDJA>,46021.0,True,25
1594,46026,CAP,Labelling,hu,5,EGYÉB INFORMÁCIÓK,46021.0,True,26
1595,46027,CAP,Labelling,hu,,A KIS KÖZVETLEN CSOMAGOLÁSI EGYSÉGEKEN MINIMÁLISAN FELTÜNTETENDŐ ADATOK,46001.0,True,27
1596,46028,CAP,Labelling,hu,1,A GYÓGYSZER NEVE ÉS AZ ALKALMAZÁS MÓDJA(I),46027.0,True,28
1597,46029,CAP,Labelling,hu,2,AZ ALKALMAZÁSSAL KAPCSOLATOS TUDNIVALÓK,46027.0,True,29
1598,46030,CAP,Labelling,hu,3,LEJÁRATI IDŐ,46027.0,True,30
1599,46031,CAP,Labelling,hu,4,A GYÁRTÁSI TÉTEL SZÁMA <DONÁCIÓ ÉS KÉSZÍTMÉNY KÓDJA>,46027.0,True,31
1600,46032,CAP,Labelling,hu,5,"A TARTALOM SÚLYRA, TÉRFOGATRA, VAGY EGYSÉGRE VONATKOZTATVA",46027.0,True,32
1601,46033,CAP,Labelling,hu,6,EGYÉB INFORMÁCIÓK,46027.0,True,33
1602,47001,CAP,Package leaflet,hu,,BETEGTÁJÉKOZTATÓ,,True,1
1603,47002,CAP,Package leaflet,hu,,"qEz a gyógyszer fokozott felügyelet alatt áll, mely lehetővé teszi az új gyógyszerbiztonsági információk gyors azonosítását. Ehhez Ön is hozzájárulhat a tudomására jutó bármilyen mellékhatás bejelentésével. 
A mellékhatások jelentésének módjairól a 4. pont végén (Mellékhatások bejelentése) talál további tájékoztatást.",47001.0,False,2
1604,47003,CAP,Package leaflet,hu,,A betegtájékoztató tartalma:,47001.0,True,3
1605,47004,CAP,Package leaflet,hu,1,Milyen típusú gyógyszer az X és milyen betegségek esetén alkalmazható?,47001.0,True,4
1606,47005,CAP,Package leaflet,hu,2,Tudnivalók az X <szedése><alkalmazása> előtt,47001.0,True,5
1607,47006,CAP,Package leaflet,hu,,Ne <szedje><alkalmazza> az X-et<:>,47005.0,True,6
1608,47007,CAP,Package leaflet,hu,,Figyelmeztetések és óvintézkedések,47005.0,True,7
1609,47008,CAP,Package leaflet,hu,,Gyermekek <és serdülők>,47005.0,True,8
1610,47009,CAP,Package leaflet,hu,,Egyéb gyógyszerek és a(z) X,47005.0,True,9
1611,47010,CAP,Package leaflet,hu,,"Az X egyidejű <bevétele><alkalmazása><étellel><és><,><itallal><és><alkohollal>",47005.0,True,10
1612,47011,CAP,Package leaflet,hu,,"Terhesség <és><,>  szoptatás  < és termékenység>",47005.0,True,11
1613,47012,CAP,Package leaflet,hu,,A készítmény hatásai a gépjárművezetéshez és a gépek kezeléséhez szükséges képességekre,47005.0,True,12
1614,47013,CAP,Package leaflet,hu,,Az X {segédanyag(ok) neve}-t tartalmaz,47005.0,False,13
1615,47014,CAP,Package leaflet,hu,3,Hogyan kell <szedni><alkalmazni> az X-et?,47001.0,True,14
1616,47015,CAP,Package leaflet,hu,,Alkalmazása gyermekeknél <és serdülőknél>,47014.0,False,15
1617,47016,CAP,Package leaflet,hu,,Ha az előírtnál több X-et <vett be><alkalmazott>,47014.0,False,16
1618,47017,CAP,Package leaflet,hu,,Ha elfelejtette <bevenni><alkalmazni> az X-et,47014.0,False,17
1619,47018,CAP,Package leaflet,hu,,Ha idő előtt abbahagyja az X <szedését><alkalmazását>,47014.0,False,18
1620,47019,CAP,Package leaflet,hu,4,Lehetséges mellékhatások,47001.0,True,19
1621,47020,CAP,Package leaflet,hu,,További mellékhatások gyermekeknél <és serdülőknél>,47019.0,False,20
1622,47021,CAP,Package leaflet,hu,,Mellékhatások bejelentése,47019.0,True,21
1623,47022,CAP,Package leaflet,hu,5,Hogyan kell az X-et tárolni?,47001.0,True,22
1624,47023,CAP,Package leaflet,hu,6,A csomagolás tartalma és egyéb információk,47001.0,True,23
1625,47024,CAP,Package leaflet,hu,,Mit tartalmaz az X?,47023.0,True,24
1626,47025,CAP,Package leaflet,hu,,Milyen az X külleme és mit tartalmaz a csomagolás?,47023.0,True,25
1627,47026,CAP,Package leaflet,hu,,A forgalomba hozatali engedély jogosultja és a gyártó,47023.0,True,26
1628,47027,CAP,Package leaflet,hu,,A készítményhez kapcsolódó további kérdéseivel forduljon a forgalomba hozatali engedély jogosultjának helyi képviseletéhez:,47023.0,False,27
1629,47028,CAP,Package leaflet,hu,,A betegtájékoztató legutóbbi felülvizsgálatának dátuma:<{ÉÉÉÉ. hónap}>,47023.0,True,28
1630,47029,CAP,Package leaflet,hu,,Egyéb információforrások,47023.0,False,29
1631,47030,CAP,Package leaflet,hu,,Az alábbi információk kizárólag egészségügyi szakembereknek szólnak:,47001.0,False,30
1632,48001,CAP,SmPC,ic,,SAMANTEKT Á EIGINLEIKUM LYFS,,True,1
1633,48002,CAP,SmPC,ic,,qÞetta lyf er undir sérstöku eftirliti til að nýjar upplýsingar um öryggi lyfsins komist fljótt og örugglega til skila. Heilbrigðisstarfsmenn eru hvattir til að tilkynna allar aukaverkanir sem grunur er um að tengist lyfinu. Í kafla 4.8 eru upplýsingar um hvernig tilkynna á aukaverkanir.,48001.0,False,2
1634,48003,CAP,SmPC,ic,1,HEITI LYFS,48001.0,True,3
1635,48004,CAP,SmPC,ic,2,INNIHALDSLÝSING,48001.0,True,4
1636,48005,CAP,SmPC,ic,2.1,Almenn lýsing,48004.0,False,5
1637,48006,CAP,SmPC,ic,2.2,Innihaldslýsing,48004.0,False,6
1638,48007,CAP,SmPC,ic,,Hjálparefni með þekkta verkun,48006.0,False,7
1639,48008,CAP,SmPC,ic,3,LYFJAFORM,48001.0,True,8
1640,48009,CAP,SmPC,ic,4,KLÍNÍSKAR UPPLÝSINGAR,48001.0,True,9
1641,48010,CAP,SmPC,ic,4.1,Ábendingar,48009.0,True,10
1642,48011,CAP,SmPC,ic,4.2,Skammtar og lyfjagjöf,48009.0,True,11
1643,48012,CAP,SmPC,ic,,Skammtar,48011.0,True,12
1644,48013,CAP,SmPC,ic,,Börn,48012.0,True,13
1645,48014,CAP,SmPC,ic,,Lyfjagjöf,48011.0,True,14
1646,48015,CAP,SmPC,ic,,Varúðarráðstafanir sem þarf að gera áður en lyfið er meðhöndlað eða gefið,48014.0,False,15
1647,48016,CAP,SmPC,ic,4.3,Frábendingar,48009.0,True,16
1648,48017,CAP,SmPC,ic,4.4,Sérstök varnaðarorð og varúðarreglur við notkun,48009.0,True,17
1649,48018,CAP,SmPC,ic,,Rekjanleiki,48017.0,False,18
1650,48019,CAP,SmPC,ic,,Börn,48017.0,False,19
1651,48020,CAP,SmPC,ic,4.5,Milliverkanir við önnur lyf og aðrar milliverkanir,48009.0,True,20
1652,48021,CAP,SmPC,ic,,Börn,48020.0,False,21
1653,48022,CAP,SmPC,ic,4.6,"Frjósemi, meðganga og brjóstagjöf",48009.0,True,22
1654,48023,CAP,SmPC,ic,,Meðganga,48022.0,False,23
1655,48024,CAP,SmPC,ic,,Brjóstagjöf,48022.0,False,24
1656,48025,CAP,SmPC,ic,,Frjósemi,48022.0,False,25
1657,48026,CAP,SmPC,ic,4.7,Áhrif á hæfni til aksturs og notkunar véla,48009.0,True,26
1658,48027,CAP,SmPC,ic,4.8,Aukaverkanir,48009.0,True,27
1659,48028,CAP,SmPC,ic,,Börn,48027.0,False,28
1660,48029,CAP,SmPC,ic,,Tilkynning aukaverkana sem grunur er um að tengist lyfinu,48027.0,True,29
1661,48030,CAP,SmPC,ic,4.9,Ofskömmtun,48009.0,True,30
1662,48031,CAP,SmPC,ic,,Börn,48030.0,False,31
1663,48032,CAP,SmPC,ic,5,LYFJAFRÆÐILEGAR UPPLÝSINGAR,48001.0,True,32
1664,48033,CAP,SmPC,ic,5.1,Lyfhrif,48032.0,True,33
1665,48034,CAP,SmPC,ic,,Verkunarháttur,48033.0,False,34
1666,48035,CAP,SmPC,ic,,Lyfhrif,48033.0,False,35
1667,48036,CAP,SmPC,ic,,Verkun og öryggi,48033.0,False,36
1668,48037,CAP,SmPC,ic,,Börn,48033.0,False,37
1669,48038,CAP,SmPC,ic,5.2,Lyfjahvörf,48032.0,True,38
1670,48039,CAP,SmPC,ic,,Frásog,48038.0,False,39
1671,48040,CAP,SmPC,ic,,Dreifing,48038.0,False,40
1672,48041,CAP,SmPC,ic,,Umbrot,48038.0,False,41
1673,48042,CAP,SmPC,ic,,Brotthvarf,48038.0,False,42
1674,48043,CAP,SmPC,ic,,Línulegt/ólínulegt samband,48038.0,False,43
1675,48044,CAP,SmPC,ic,,Tengsl lyfjahvarfa og lyfhrifa,48038.0,False,44
1676,48045,CAP,SmPC,ic,5.3,Forklínískar upplýsingar,48032.0,True,45
1677,48046,CAP,SmPC,ic,,Mat á áhættu fyrir lífríkið,48045.0,False,46
1678,48047,CAP,SmPC,ic,6,LYFJAGERÐARFRÆÐILEGAR UPPLÝSINGAR,48001.0,True,47
1679,48048,CAP,SmPC,ic,6.1,Hjálparefni,48047.0,True,48
1680,48049,CAP,SmPC,ic,6.2,Ósamrýmanleiki,48047.0,True,49
1681,48050,CAP,SmPC,ic,6.3,Geymsluþol,48047.0,True,50
1682,48051,CAP,SmPC,ic,6.4,Sérstakar varúðarreglur við geymslu,48047.0,True,51
1683,48052,CAP,SmPC,ic,6.5,"Gerð íláts og innihald<, sérstakur búnaður til notkunar lyfsins, lyfjagjafar eða ísetningar þess>",48047.0,True,52
1684,48053,CAP,SmPC,ic,6.6,Sérstakar varúðarráðstafanir við förgun <og önnur meðhöndlun>,48047.0,True,53
1685,48054,CAP,SmPC,ic,,Ef lyfið er notað handa börnum,48053.0,False,54
1686,48055,CAP,SmPC,ic,7,MARKAÐSLEYFISHAFI,48001.0,True,55
1687,48056,CAP,SmPC,ic,8,MARKAÐSLEYFISNÚMER,48001.0,True,56
1688,48057,CAP,SmPC,ic,9,DAGSETNING FYRSTU ÚTGÁFU MARKAÐSLEYFIS / ENDURNÝJUNAR MARKAÐSLEYFIS,48001.0,True,57
1689,48058,CAP,SmPC,ic,10,DAGSETNING ENDURSKOÐUNAR TEXTANS,48001.0,True,58
1690,48059,CAP,SmPC,ic,11,GEISLUNARMÆLINGAR,48001.0,False,59
1691,48060,CAP,SmPC,ic,12,LEIÐBEININGAR UM BLÖNDUN GEISLAVIRKRA LYFJA,48001.0,False,60
1692,49001,CAP,VIÐAUKI II,ic,,VIÐAUKI II,,True,1
1693,49002,CAP,VIÐAUKI II,ic,A,<FRAMLEIÐENDUR LÍFFRÆÐILEGRA VIRKRA EFNA OG >FRAMLEIÐENDUR SEM ERU ÁBYRGIR FYRIR LOKASAMÞYKKT,49001.0,True,2
1694,49003,CAP,VIÐAUKI II,ic,,Heiti og heimilisfang framleiðenda líffræðilegra virkra efna,49002.0,False,3
1695,49004,CAP,VIÐAUKI II,ic,,Heiti og heimilisfang framleiðenda sem eru ábyrgir fyrir lokasamþykkt,49002.0,True,4
1696,49005,CAP,VIÐAUKI II,ic,B,"FORSENDUR FYRIR, EÐA TAKMARKANIR Á, AFGREIÐSLU OG NOTKUN",49001.0,True,5
1697,49006,CAP,VIÐAUKI II,ic,,Opinber lokasamþykkt,49005.0,False,6
1698,49007,CAP,VIÐAUKI II,ic,C,AÐRAR FORSENDUR OG SKILYRÐI MARKAÐSLEYFIS,49001.0,True,7
1699,49008,CAP,VIÐAUKI II,ic,,Samantektir um öryggi lyfsins (PSUR),49007.0,True,8
1700,49009,CAP,VIÐAUKI II,ic,D,FORSENDUR EÐA TAKMARKANIR ER VARÐA ÖRYGGI OG VERKUN VIÐ NOTKUN LYFSINS,49001.0,True,9
1701,49010,CAP,VIÐAUKI II,ic,,Áætlun um áhættustjórnun,49009.0,True,10
1702,49011,CAP,VIÐAUKI II,ic,,Viðbótaraðgerðir til að lágmarka áhættu,49009.0,False,11
1703,49012,CAP,VIÐAUKI II,ic,,Skylda til aðgerða eftir útgáfu markaðsleyfis,49009.0,False,12
1704,49013,CAP,VIÐAUKI II,ic,E,SÉRSTÖK SKYLDA TIL AÐ LJÚKA AÐGERÐUM EFTIR ÚTGÁFU <SKILYRTS MARKAÐSLEYFIS><MARKAÐSLEYFIS SEM GEFIÐ HEFUR VERIÐ ÚT SAMKVÆMT FERLI UM UNDANTEKNINGARTILVIK>,49001.0,False,13
1705,50001,CAP,ÁLETRANIR,ic,,ÁLETRANIR,,True,1
1706,50002,CAP,ÁLETRANIR,ic,,UPPLÝSINGAR SEM EIGA AÐ KOMA FRAM Á <YTRI UMBÚÐUM> <OG> <INNRI UMBÚÐUM>,50001.0,True,2
1707,50003,CAP,ÁLETRANIR,ic,1,HEITI LYFS,50002.0,True,3
1708,50004,CAP,ÁLETRANIR,ic,2,VIRK(T) EFNI,50002.0,True,4
1709,50005,CAP,ÁLETRANIR,ic,3,HJÁLPAREFNI,50002.0,True,5
1710,50006,CAP,ÁLETRANIR,ic,4,LYFJAFORM OG INNIHALD,50002.0,True,6
1711,50007,CAP,ÁLETRANIR,ic,5,AÐFERÐ VIÐ LYFJAGJÖF OG ÍKOMULEIÐ(IR),50002.0,True,7
1712,50008,CAP,ÁLETRANIR,ic,6,SÉRSTÖK VARNAÐARORÐ UM AÐ LYFIÐ SKULI GEYMT ÞAR SEM BÖRN HVORKI NÁ TIL NÉ SJÁ,50002.0,True,8
1713,50009,CAP,ÁLETRANIR,ic,7,"ÖNNUR SÉRSTÖK VARNAÐARORÐ, EF MEÐ ÞARF",50002.0,True,9
1714,50010,CAP,ÁLETRANIR,ic,8,FYRNINGARDAGSETNING,50002.0,True,10
1715,50011,CAP,ÁLETRANIR,ic,9,SÉRSTÖK GEYMSLUSKILYRÐI,50002.0,True,11
1716,50012,CAP,ÁLETRANIR,ic,10,SÉRSTAKAR VARÚÐARRÁÐSTAFANIR VIÐ FÖRGUN LYFJALEIFA EÐA ÚRGANGS VEGNA LYFSINS ÞAR SEM VIÐ Á,50002.0,True,12
1717,50013,CAP,ÁLETRANIR,ic,11,NAFN OG HEIMILISFANG MARKAÐSLEYFISHAFA,50002.0,True,13
1718,50014,CAP,ÁLETRANIR,ic,12,MARKAÐSLEYFISNÚMER,50002.0,True,14
1719,50015,CAP,ÁLETRANIR,ic,13,"LOTUNÚMER<, AUÐKENNI GJAFAR OG LYFS>",50002.0,True,15
1720,50016,CAP,ÁLETRANIR,ic,14,AFGREIÐSLUTILHÖGUN,50002.0,True,16
1721,50017,CAP,ÁLETRANIR,ic,15,NOTKUNARLEIÐBEININGAR,50002.0,True,17
1722,50018,CAP,ÁLETRANIR,ic,16,UPPLÝSINGAR MEÐ BLINDRALETRI,50002.0,True,18
1723,50019,CAP,ÁLETRANIR,ic,17,EINKVÆMT AUÐKENNI – TVÍVÍTT STRIKAMERKI,50002.0,True,19
1724,50020,CAP,ÁLETRANIR,ic,18,EINKVÆMT AUÐKENNI – UPPLÝSINGAR SEM FÓLK GETUR LESIÐ,50002.0,True,20
1725,50021,CAP,ÁLETRANIR,ic,,LÁGMARKS UPPLÝSINGAR SEM SKULU KOMA FRAM Á ÞYNNUM EÐA STRIMLUM,50001.0,True,21
1726,50022,CAP,ÁLETRANIR,ic,1,HEITI LYFS,50021.0,True,22
1727,50023,CAP,ÁLETRANIR,ic,2,NAFN MARKAÐSLEYFISHAFA,50021.0,True,23
1728,50024,CAP,ÁLETRANIR,ic,3,FYRNINGARDAGSETNING,50021.0,True,24
1729,50025,CAP,ÁLETRANIR,ic,4,"LOTUNÚMER<, AUÐKENNI GJAFAR OG LYFS>",50021.0,True,25
1730,50026,CAP,ÁLETRANIR,ic,5,ANNAÐ,50021.0,True,26
1731,50027,CAP,ÁLETRANIR,ic,,LÁGMARKS UPPLÝSINGAR SEM SKULU KOMA FRAM Á INNRI UMBÚÐUM LÍTILLA EININGA,50001.0,True,27
1732,50028,CAP,ÁLETRANIR,ic,1,HEITI LYFS OG ÍKOMULEIÐ(IR),50027.0,True,28
1733,50029,CAP,ÁLETRANIR,ic,2,AÐFERÐ VIÐ LYFJAGJÖF,50027.0,True,29
1734,50030,CAP,ÁLETRANIR,ic,3,FYRNINGARDAGSETNING,50027.0,True,30
1735,50031,CAP,ÁLETRANIR,ic,4,"LOTUNÚMER<, AUÐKENNI GJAFAR OG LYFS>",50027.0,True,31
1736,50032,CAP,ÁLETRANIR,ic,5,"INNIHALD TILGREINT SEM ÞYNGD, RÚMMÁL EÐA FJÖLDI EININGA",50027.0,True,32
1737,50033,CAP,ÁLETRANIR,ic,6,ANNAÐ,50027.0,True,33
1738,51001,CAP,FYLGISEÐILL,ic,,FYLGISEÐILL,,True,1
1739,51002,CAP,FYLGISEÐILL,ic,,q Þetta lyf er undir sérstöku eftirliti til að nýjar upplýsingar um öryggi lyfsins komist fljótt og örugglega til skila. Allir geta hjálpað til við þetta með því að tilkynna aukaverkanir sem koma fram. Aftast í kafla 4 eru upplýsingar um hvernig tilkynna á aukaverkanir.,51001.0,False,2
1740,51003,CAP,FYLGISEÐILL,ic,,Í fylgiseðlinum eru eftirfarandi kaflar:,51001.0,True,3
1741,51004,CAP,FYLGISEÐILL,ic,1,Upplýsingar um X og við hverju það er notað,51001.0,True,4
1742,51005,CAP,FYLGISEÐILL,ic,2,Áður en byrjað er að nota X,51001.0,True,5
1743,51006,CAP,FYLGISEÐILL,ic,,Ekki má nota X,51005.0,True,6
1744,51007,CAP,FYLGISEÐILL,ic,,Varnaðarorð og varúðarreglur,51005.0,True,7
1745,51008,CAP,FYLGISEÐILL,ic,,Börn <og unglingar>,51005.0,True,8
1746,51009,CAP,FYLGISEÐILL,ic,,Notkun annarra lyfja samhliða X,51005.0,True,9
1747,51010,CAP,FYLGISEÐILL,ic,,"Notkun X með <mat> <eða> <,> <drykk> <eða> <áfengi>",51005.0,True,10
1748,51011,CAP,FYLGISEÐILL,ic,,"Meðganga <og> <,> brjóstagjöf <og frjósemi>",51005.0,True,11
1749,51012,CAP,FYLGISEÐILL,ic,,Akstur og notkun véla,51005.0,True,12
1750,51013,CAP,FYLGISEÐILL,ic,,X inniheldur {tilgreinið viðkomandi hjálparefni},51005.0,False,13
1751,51014,CAP,FYLGISEÐILL,ic,3,Hvernig nota á X,51001.0,True,14
1752,51015,CAP,FYLGISEÐILL,ic,,Notkun handa börnum <og unglingum>,51014.0,False,15
1753,51016,CAP,FYLGISEÐILL,ic,,Ef <tekinn> <notaður> er stærri skammtur en mælt er fyrir um,51014.0,False,16
1754,51017,CAP,FYLGISEÐILL,ic,,Ef gleymist að <taka> <nota> X,51014.0,False,17
1755,51018,CAP,FYLGISEÐILL,ic,,Ef hætt er að nota X,51014.0,False,18
1756,51019,CAP,FYLGISEÐILL,ic,4,Hugsanlegar aukaverkanir,51001.0,True,19
1757,51020,CAP,FYLGISEÐILL,ic,,Aðrar aukaverkanir sem geta komið fyrir hjá börnum <og unglingum>,51019.0,False,20
1758,51021,CAP,FYLGISEÐILL,ic,,Tilkynning aukaverkana,51019.0,True,21
1759,51022,CAP,FYLGISEÐILL,ic,5,Hvernig geyma á X,51001.0,True,22
1760,51023,CAP,FYLGISEÐILL,ic,6,Pakkningar og aðrar upplýsingar,51001.0,True,23
1761,51024,CAP,FYLGISEÐILL,ic,,X inniheldur,51023.0,True,24
1762,51025,CAP,FYLGISEÐILL,ic,,Lýsing á útliti X og pakkningastærðir,51023.0,True,25
1763,51026,CAP,FYLGISEÐILL,ic,,Markaðsleyfishafi og framleiðandi,51023.0,True,26
1764,51027,CAP,FYLGISEÐILL,ic,,Hafið samband við fulltrúa markaðsleyfishafa á hverjum stað ef óskað er upplýsinga um lyfið:,51023.0,False,27
1765,51028,CAP,FYLGISEÐILL,ic,,Þessi fylgiseðill var síðast uppfærður <{MM/ÁÁÁÁ}> <í {mánuður ÁÁÁÁ}>.,51023.0,True,28
1766,51029,CAP,FYLGISEÐILL,ic,,Upplýsingar sem hægt er að nálgast annars staðar,51023.0,False,29
1767,51030,CAP,FYLGISEÐILL,ic,,Eftirfarandi upplýsingar eru einungis ætlaðar heilbrigðisstarfsmönnum:,51001.0,False,30
1768,52001,CAP,SmPC,it,,RIASSUNTO DELLE CARATTERISTICHE DEL PRODOTTO,,True,1
1769,52002,CAP,SmPC,it,,qMedicinale sottoposto a monitoraggio addizionale. Ciò permetterà la rapida identificazione di nuove informazioni sulla sicurezza. Agli operatori sanitari è richiesto di segnalare qualsiasi reazione avversa sospetta. Vedere paragrafo 4.8 per informazioni sulle modalità di segnalazione delle reazioni avverse.>,52001.0,False,2
1770,52003,CAP,SmPC,it,1,DENOMINAZIONE DEL MEDICINALE,52001.0,True,3
1771,52004,CAP,SmPC,it,2,COMPOSIZIONE QUALITATIVA E QUANTITATIVA,52001.0,True,4
1772,52005,CAP,SmPC,it,2.1,Descrizione generale,52004.0,False,5
1773,52006,CAP,SmPC,it,2.2,Composizione qualitativa e quantitativa,52004.0,False,6
1774,52007,CAP,SmPC,it,,Eccipiente(i) con effetti noti,52006.0,False,7
1775,52008,CAP,SmPC,it,3,FORMA FARMACEUTICA,52001.0,True,8
1776,52009,CAP,SmPC,it,4,INFORMAZIONI CLINICHE,52001.0,True,9
1777,52010,CAP,SmPC,it,4.1,Indicazioni terapeutiche,52009.0,True,10
1778,52011,CAP,SmPC,it,4.2,Posologia e modo di somministrazione,52009.0,True,11
1779,52012,CAP,SmPC,it,,Posologia,52011.0,True,12
1780,52013,CAP,SmPC,it,,Popolazione pediatrica,52012.0,True,13
1781,52014,CAP,SmPC,it,,Modo di somministrazione,52011.0,True,14
1782,52015,CAP,SmPC,it,,Precauzioni che devono essere prese prima della manipolazione o della somministrazione del medicinale,52014.0,False,15
1783,52016,CAP,SmPC,it,4.3,Controindicazioni,52009.0,True,16
1784,52017,CAP,SmPC,it,4.4,Avvertenze speciali e precauzioni d’impiego,52009.0,True,17
1785,52018,CAP,SmPC,it,,Tracciabilità,52017.0,False,18
1786,52019,CAP,SmPC,it,,Popolazione pediatrica,52017.0,False,19
1787,52020,CAP,SmPC,it,4.5,Interazioni con altri medicinali ed altre forme d’interazione,52009.0,True,20
1788,52021,CAP,SmPC,it,,Popolazione pediatrica,52020.0,False,21
1789,52022,CAP,SmPC,it,4.6,"Fertilità, gravidanza e allattamento",52009.0,True,22
1790,52023,CAP,SmPC,it,,Gravidanza,52022.0,False,23
1791,52024,CAP,SmPC,it,,Allattamento,52022.0,False,24
1792,52025,CAP,SmPC,it,,Fertilità,52022.0,False,25
1793,52026,CAP,SmPC,it,4.7,Effetti sulla capacità di guidare veicoli e sull’uso di macchinari,52009.0,True,26
1794,52027,CAP,SmPC,it,4.8,Effetti indesiderati,52009.0,True,27
1795,52028,CAP,SmPC,it,,Popolazione pediatrica,52027.0,False,28
1796,52029,CAP,SmPC,it,,Segnalazione delle reazioni avverse sospette,52027.0,True,29
1797,52030,CAP,SmPC,it,4.9,Sovradosaggio,52009.0,True,30
1798,52031,CAP,SmPC,it,,Popolazione pediatrica,52030.0,False,31
1799,52032,CAP,SmPC,it,5,PROPRIETÀ FARMACOLOGICHE,52001.0,True,32
1800,52033,CAP,SmPC,it,5.1,Proprietà farmacodinamiche,52032.0,True,33
1801,52034,CAP,SmPC,it,,Meccanismo d’azione,52033.0,False,34
1802,52035,CAP,SmPC,it,,Effetti farmacodinamici,52033.0,False,35
1803,52036,CAP,SmPC,it,,Efficacia e sicurezza clinica,52033.0,False,36
1804,52037,CAP,SmPC,it,,Popolazione pediatrica,52033.0,False,37
1805,52038,CAP,SmPC,it,5.2,Proprietà farmacocinetiche,52032.0,True,38
1806,52039,CAP,SmPC,it,,Assorbimento,52038.0,False,39
1807,52040,CAP,SmPC,it,,Distribuzione,52038.0,False,40
1808,52041,CAP,SmPC,it,,Biotrasformazione,52038.0,False,41
1809,52042,CAP,SmPC,it,,Eliminazione,52038.0,False,42
1810,52043,CAP,SmPC,it,,Linearità/Non linearità,52038.0,False,43
1811,52044,CAP,SmPC,it,,Relazione(i) farmacocinetica(che)/farmacodinamica(che),52038.0,False,44
1812,52045,CAP,SmPC,it,5.3,Dati preclinici di sicurezza,52032.0,True,45
1813,52046,CAP,SmPC,it,,"Valutazione del rischio ambientale (Environmental risk assessment, ERA)",52045.0,False,46
1814,52047,CAP,SmPC,it,6,INFORMAZIONI FARMACEUTICHE,52001.0,True,47
1815,52048,CAP,SmPC,it,6.1,Elenco degli eccipienti,52047.0,True,48
1816,52049,CAP,SmPC,it,6.2,Incompatibilità,52047.0,True,49
1817,52050,CAP,SmPC,it,6.3,Periodo di validità,52047.0,True,50
1818,52051,CAP,SmPC,it,6.4,Precauzioni particolari per la conservazione,52047.0,True,51
1819,52052,CAP,SmPC,it,6.5,"Natura e contenuto del contenitore <e strumentazione particolare per l’uso, la somministrazione o l’impianto>",52047.0,True,52
1820,52053,CAP,SmPC,it,6.6,Precauzioni particolari per lo smaltimento <e la manipolazione>,52047.0,True,53
1821,52054,CAP,SmPC,it,,Uso nella popolazione pediatrica,52053.0,False,54
1822,52055,CAP,SmPC,it,7,TITOLARE DELL’AUTORIZZAZIONE ALL’IMMISSIONE IN COMMERCIO,52001.0,True,55
1823,52056,CAP,SmPC,it,8,NUMERO(I) DELL’AUTORIZZAZIONE ALL’IMMISSIONE IN COMMERCIO ,52001.0,True,56
1824,52057,CAP,SmPC,it,9,DATA DELLA PRIMA AUTORIZZAZIONE/RINNOVO DELL’AUTORIZZAZIONE,52001.0,True,57
1825,52058,CAP,SmPC,it,10,DATA DI REVISIONE DEL TESTO,52001.0,True,58
1826,52059,CAP,SmPC,it,11,DOSIMETRIA,52001.0,False,59
1827,52060,CAP,SmPC,it,12,ISTRUZIONI PER LA PREPARAZIONE DI RADIOFARMACI,52001.0,False,60
1828,53001,CAP,AnnexII,it,,ALLEGATO II,,True,1
1829,53002,CAP,AnnexII,it,A,<PRODUTTORE(I) DEL(DEI) PRINCIPIO(I) ATTIVO(I) BIOLOGICO(I) E> PRODUTTORE(I) RESPONSABILE(I) DEL RILASCIO DEI LOTTI,53001.0,True,2
1830,53003,CAP,AnnexII,it,,<Nome e indirizzo del(dei) produttore(i) del(dei) principio(i) attivo(i) biologico(i),53002.0,False,3
1831,53004,CAP,AnnexII,it,,Nome e indirizzo del(dei) produttore(i) responsabile(i) del rilascio dei lotti,53002.0,True,4
1832,53005,CAP,AnnexII,it,B,CONDIZIONI O LIMITAZIONI DI FORNITURA E UTILIZZO ,53001.0,True,5
1833,53006,CAP,AnnexII,it,,Rilascio ufficiale dei lotti,53005.0,False,6
1834,53007,CAP,AnnexII,it,C,ALTRE CONDIZIONI E REQUISITI DELL’AUTORIZZAZIONE ALL’IMMISSIONE IN COMMERCIO,53001.0,True,7
1835,53008,CAP,AnnexII,it,,Rapporti periodici di aggiornamento sulla sicurezza (PSUR),53007.0,True,8
1836,53009,CAP,AnnexII,it,D,CONDIZIONI O LIMITAZIONI PER QUANTO RIGUARDA L’USO SICURO ED EFFICACE DEL MEDICINALE  ,53001.0,True,9
1837,53010,CAP,AnnexII,it,,Piano di gestione del rischio (RMP),53009.0,True,10
1838,53011,CAP,AnnexII,it,,Misure aggiuntive di minimizzazione del rischio,53009.0,False,11
1839,53012,CAP,AnnexII,it,,Obbligo di condurre attività post-autorizzative ,53009.0,False,12
1840,53013,CAP,AnnexII,it,E,OBBLIGO SPECIFICO DI COMPLETARE LE ATTIVITA' POST-AUTORIZZATIVE PER <L’AUTORIZZAZIONE ALL’IMMISSIONE IN COMMERCIO SUBORDINATA A CONDIZIONI> <L’AUTORIZZAZIONE ALL’IMMISSIONE IN COMMERCIO RILASCIATA IN CIRCOSTANZE ECCEZIONALI,53001.0,False,13
1841,54001,CAP,Labelling,it,,ETICHETTATURA,,True,1
1842,54002,CAP,Labelling,it,,INFORMAZIONI DA APPORRE <SUL CONFEZIONAMENTO SECONDARIO> <E> <SUL CONFEZIONAMENTO PRIMARIO>,54001.0,True,2
1843,54003,CAP,Labelling,it,1,DENOMINAZIONE DEL MEDICINALE,54002.0,True,3
1844,54004,CAP,Labelling,it,2,COMPOSIZIONE QUALITATIVA E QUANTITATIVA IN TERMINI DI PRINCIPIO(I) ATTIVO(I),54002.0,True,4
1845,54005,CAP,Labelling,it,3,ELENCO DEGLI ECCIPIENTI,54002.0,True,5
1846,54006,CAP,Labelling,it,4,FORMA FARMACEUTICA E CONTENUTO,54002.0,True,6
1847,54007,CAP,Labelling,it,5,MODO E VIA(E) DI SOMMINISTRAZIONE,54002.0,True,7
1848,54008,CAP,Labelling,it,6,AVVERTENZA PARTICOLARE CHE PRESCRIVA DI TENERE IL MEDICINALE FUORI DALLA VISTA E DALLA PORTATA DEI BAMBINI,54002.0,True,8
1849,54009,CAP,Labelling,it,7,"ALTRA(E) AVVERTENZA(E) PARTICOLARE(I), SE NECESSARIO",54002.0,True,9
1850,54010,CAP,Labelling,it,8,DATA DI SCADENZA,54002.0,True,10
1851,54011,CAP,Labelling,it,9,PRECAUZIONI PARTICOLARI PER LA CONSERVAZIONE,54002.0,True,11
1852,54012,CAP,Labelling,it,10,"PRECAUZIONI PARTICOLARI PER LO SMALTIMENTO DEL MEDICINALE NON UTILIZZATO O DEI RIFIUTI DERIVATI DA TALE MEDICINALE, SE NECESSARIO",54002.0,True,12
1853,54013,CAP,Labelling,it,11,NOME E INDIRIZZO DEL TITOLARE DELL’AUTORIZZAZIONE ALL’IMMISSIONE IN COMMERCIO,54002.0,True,13
1854,54014,CAP,Labelling,it,12,NUMERO(I) DELL’AUTORIZZAZIONE ALL’IMMISSIONE IN COMMERCIO ,54002.0,True,14
1855,54015,CAP,Labelling,it,13,"NUMERO DI LOTTO<, CODICI DELLA DONAZIONE E DEL PRODOTTO>",54002.0,True,15
1856,54016,CAP,Labelling,it,14,CONDIZIONE GENERALE DI FORNITURA,54002.0,True,16
1857,54017,CAP,Labelling,it,15,ISTRUZIONI PER L’USO,54002.0,True,17
1858,54018,CAP,Labelling,it,16,INFORMAZIONI IN BRAILLE,54002.0,True,18
1859,54019,CAP,Labelling,it,17,IDENTIFICATIVO UNICO – CODICE A BARRE BIDIMENSIONALE,54002.0,True,19
1860,54020,CAP,Labelling,it,18,IDENTIFICATIVO UNICO - DATI LEGGIBILI ,54002.0,True,20
1861,54021,CAP,Labelling,it,,INFORMAZIONI MINIME DA APPORRE SU BLISTER O STRIP,54001.0,True,21
1862,54022,CAP,Labelling,it,1,DENOMINAZIONE DEL MEDICINALE,54021.0,True,22
1863,54023,CAP,Labelling,it,2,NOME DEL TITOLARE DELL’AUTORIZZAZIONE ALL’IMMISSIONE IN COMMERCIO,54021.0,True,23
1864,54024,CAP,Labelling,it,3,DATA DI SCADENZA,54021.0,True,24
1865,54025,CAP,Labelling,it,4,"NUMERO DI LOTTO<, CODICI DELLA DONAZIONE E DEL PRODOTTO>",54021.0,True,25
1866,54026,CAP,Labelling,it,5,ALTRO,54021.0,True,26
1867,54027,CAP,Labelling,it,,INFORMAZIONI MINIME DA APPORRE SUI CONFEZIONAMENTI PRIMARI DI PICCOLE DIMENSIONI,54001.0,True,27
1868,54028,CAP,Labelling,it,1,DENOMINAZIONE DEL MEDICINALE E VIA(E) DI SOMMINISTRAZIONE,54027.0,True,28
1869,54029,CAP,Labelling,it,2,MODO DI SOMMINISTRAZIONE,54027.0,True,29
1870,54030,CAP,Labelling,it,3,DATA DI SCADENZA,54027.0,True,30
1871,54031,CAP,Labelling,it,4,"NUMERO DI LOTTO<, CODICI DELLA DONAZIONE E DEL PRODOTTO>",54027.0,True,31
1872,54032,CAP,Labelling,it,5,"CONTENUTO IN PESO, VOLUME O UNITÀ",54027.0,True,32
1873,54033,CAP,Labelling,it,6,ALTRO,54027.0,True,33
1874,55001,CAP,Package leaflet,it,,FOGLIO ILLUSTRATIVO,,True,1
1875,55002,CAP,Package leaflet,it,,q Medicinale sottoposto a monitoraggio addizionale. Ciò permetterà la rapida identificazione di nuove informazioni sulla sicurezza. Lei può contribuire segnalando qualsiasi effetto indesiderato riscontrato durante l’assunzione di questo medicinale. Vedere la fine del paragrafo 4 per le informazioni su come segnalare gli effetti indesiderati.,55001.0,False,2
1876,55003,CAP,Package leaflet,it,,Contenuto di questo foglio,55001.0,True,3
1877,55004,CAP,Package leaflet,it,1,Cos’è X e a cosa serve,55001.0,True,4
1878,55005,CAP,Package leaflet,it,2,Cosa deve sapere prima di <prendere> <usare> X ,55001.0,True,5
1879,55006,CAP,Package leaflet,it,,Non <prenda> <usi> X,55005.0,True,6
1880,55007,CAP,Package leaflet,it,,Avvertenze e precauzioni,55005.0,True,7
1881,55008,CAP,Package leaflet,it,,Bambini <e adolescenti>,55005.0,True,8
1882,55009,CAP,Package leaflet,it,,Altri medicinali e X,55005.0,True,9
1883,55010,CAP,Package leaflet,it,,"X con <cibi> <e> <,> <bevande> <e> <alcol>",55005.0,True,10
1884,55011,CAP,Package leaflet,it,,"Gravidanza <e> <,> allattamento <e fertilità>",55005.0,True,11
1885,55012,CAP,Package leaflet,it,,Guida di veicoli e utilizzo di macchinari,55005.0,True,12
1886,55013,CAP,Package leaflet,it,,X contiene {nome del(degli) eccipiente(i)},55005.0,False,13
1887,55014,CAP,Package leaflet,it,3,Come <prendere> <usare> X,55001.0,True,14
1888,55015,CAP,Package leaflet,it,,Uso nei bambini <e negli adolescenti>,55014.0,False,15
1889,55016,CAP,Package leaflet,it,,Se <prende> <usa> più X di quanto deve,55014.0,False,16
1890,55017,CAP,Package leaflet,it,,Se dimentica di <prendere> <usare> X,55014.0,False,17
1891,55018,CAP,Package leaflet,it,,Se interrompe il trattamento con X,55014.0,False,18
1892,55019,CAP,Package leaflet,it,4,Possibili effetti indesiderati,55001.0,True,19
1893,55020,CAP,Package leaflet,it,,Effetti indesiderati aggiuntivi nei bambini <e negli adolescenti>,55019.0,False,20
1894,55021,CAP,Package leaflet,it,,Segnalazione degli effetti indesiderati,55019.0,True,21
1895,55022,CAP,Package leaflet,it,5,Come conservare X,55001.0,True,22
1896,55023,CAP,Package leaflet,it,6,Contenuto della confezione e altre informazioni,55001.0,True,23
1897,55024,CAP,Package leaflet,it,,Cosa contiene X,55023.0,True,24
1898,55025,CAP,Package leaflet,it,,Descrizione dell’aspetto di X e contenuto della confezione,55023.0,True,25
1899,55026,CAP,Package leaflet,it,,Titolare dell’autorizzazione all’immissione in commercio e produttore,55023.0,True,26
1900,55027,CAP,Package leaflet,it,,"Per ulteriori informazioni su questo medicinale, contatti il rappresentate locale del titolare dell’autorizzazione all’immissione in commercio:",55023.0,False,27
1901,55028,CAP,Package leaflet,it,,Questo foglio illustrativo è stato aggiornato il <{MM/AAAA}><{mese AAAA}>.,55023.0,True,28
1902,55029,CAP,Package leaflet,it,,Altre fonti d’informazioni,55023.0,False,29
1903,55030,CAP,Package leaflet,it,,Le informazioni seguenti sono destinate esclusivamente agli operatori sanitari:,55001.0,False,30
1904,56001,CAP,SmPC,lt,,PREPARATO CHARAKTERISTIKŲ SANTRAUKA,,True,1
1905,56002,CAP,SmPC,lt,,"qVykdoma papildoma šio vaistinio preparato stebėsena. Tai padės greitai nustatyti naują saugumo informaciją. Sveikatos priežiūros specialistai turi pranešti apie bet kokias įtariamas nepageidaujamas reakcijas. Apie tai, kaip pranešti apie nepageidaujamas reakcijas, žr. 4.8 skyriuje.> ",56001.0,False,2
1906,56003,CAP,SmPC,lt,1,VAISTINIO PREPARATO PAVADINIMAS,56001.0,True,3
1907,56004,CAP,SmPC,lt,2,KOKYBINĖ IR KIEKYBINĖ SUDĖTIS,56001.0,True,4
1908,56005,CAP,SmPC,lt,2.1,Bendras aprašymas,56004.0,False,5
1909,56006,CAP,SmPC,lt,2.2,Kokybinė ir kiekybinė sudėtis,56004.0,False,6
1910,56007,CAP,SmPC,lt,,"Pagalbinė (-s) medžiaga (-os), kurios (-ių) poveikis žinomas",56006.0,False,7
1911,56008,CAP,SmPC,lt,3,FARMACINĖ FORMA,56001.0,True,8
1912,56009,CAP,SmPC,lt,4,KLINIKINĖ INFORMACIJA,56001.0,True,9
1913,56010,CAP,SmPC,lt,4.1,Terapinės indikacijos,56009.0,True,10
1914,56011,CAP,SmPC,lt,4.2,Dozavimas ir vartojimo metodas,56009.0,True,11
1915,56012,CAP,SmPC,lt,,Dozavimas,56011.0,True,12
1916,56013,CAP,SmPC,lt,,Vaikų populiacija,56012.0,True,13
1917,56014,CAP,SmPC,lt,,Vartojimo metodas,56011.0,True,14
1918,56015,CAP,SmPC,lt,,Atsargumo priemonės prieš ruošiant ar vartojant šį vaistinį preparatą,56014.0,False,15
1919,56016,CAP,SmPC,lt,4.3,Kontraindikacijos,56009.0,True,16
1920,56017,CAP,SmPC,lt,4.4,Specialūs įspėjimai ir atsargumo priemonės,56009.0,True,17
1921,56018,CAP,SmPC,lt,,Atsekamumas,56017.0,False,18
1922,56019,CAP,SmPC,lt,,Vaikų populiacija,56017.0,False,19
1923,56020,CAP,SmPC,lt,4.5,Sąveika su kitais vaistiniais preparatais ir kitokia sąveika,56009.0,True,20
1924,56021,CAP,SmPC,lt,,Vaikų populiacija,56020.0,False,21
1925,56022,CAP,SmPC,lt,4.6,"Vaisingumas, nėštumo ir žindymo laikotarpis",56009.0,True,22
1926,56023,CAP,SmPC,lt,,Nėštumas,56022.0,False,23
1927,56024,CAP,SmPC,lt,,Žindymas,56022.0,False,24
1928,56025,CAP,SmPC,lt,,Vaisingumas,56022.0,False,25
1929,56026,CAP,SmPC,lt,4.7,Poveikis gebėjimui vairuoti ir valdyti mechanizmus,56009.0,True,26
1930,56027,CAP,SmPC,lt,4.8,Nepageidaujamas poveikis,56009.0,True,27
1931,56028,CAP,SmPC,lt,,Vaikų populiacija,56027.0,False,28
1932,56029,CAP,SmPC,lt,,Pranešimas apie įtariamas nepageidaujamas reakcijas,56027.0,True,29
1933,56030,CAP,SmPC,lt,4.9,Perdozavimas,56009.0,True,30
1934,56031,CAP,SmPC,lt,,Vaikų populiacija,56030.0,False,31
1935,56032,CAP,SmPC,lt,5,FARMAKOLOGINĖS SAVYBĖS,56001.0,True,32
1936,56033,CAP,SmPC,lt,5.1,Farmakodinaminės savybės,56032.0,True,33
1937,56034,CAP,SmPC,lt,,Veikimo mechanizmas,56033.0,False,34
1938,56035,CAP,SmPC,lt,,Farmakodinaminis poveikis,56033.0,False,35
1939,56036,CAP,SmPC,lt,,Klinikinis veiksmingumas ir saugumas,56033.0,False,36
1940,56037,CAP,SmPC,lt,,Vaikų populiacija,56033.0,False,37
1941,56038,CAP,SmPC,lt,5.2,Farmakokinetinės savybės,56032.0,True,38
1942,56039,CAP,SmPC,lt,,Absorbcija,56038.0,False,39
1943,56040,CAP,SmPC,lt,,Pasiskirstymas,56038.0,False,40
1944,56041,CAP,SmPC,lt,,Biotransformacija,56038.0,False,41
1945,56042,CAP,SmPC,lt,,Eliminacija,56038.0,False,42
1946,56043,CAP,SmPC,lt,,Tiesinis / netiesinis pobūdis,56038.0,False,43
1947,56044,CAP,SmPC,lt,,Santykis tarp farmakokinetikos ir farmakodinamikos,56038.0,False,44
1948,56045,CAP,SmPC,lt,5.3,Ikiklinikinių saugumo tyrimų duomenys,56032.0,True,45
1949,56046,CAP,SmPC,lt,,Pavojaus aplinkai vertinimas (PAV),56045.0,False,46
1950,56047,CAP,SmPC,lt,6,FARMACINĖ INFORMACIJA,56001.0,True,47
1951,56048,CAP,SmPC,lt,6.1,Pagalbinių medžiagų sąrašas,56047.0,True,48
1952,56049,CAP,SmPC,lt,6.2,Nesuderinamumas,56047.0,True,49
1953,56050,CAP,SmPC,lt,6.3,Tinkamumo laikas,56047.0,True,50
1954,56051,CAP,SmPC,lt,6.4,Specialios laikymo sąlygos,56047.0,True,51
1955,56052,CAP,SmPC,lt,6.5,Talpyklės pobūdis ir jos turinys <bei speciali vartojimo ar implantavimo įranga>,56047.0,True,52
1956,56053,CAP,SmPC,lt,6.6,Specialūs reikalavimai atliekoms tvarkyti <ir vaistiniam preparatui ruošti>,56047.0,True,53
1957,56054,CAP,SmPC,lt,,Vartojimas vaikų populiacijai,56053.0,False,54
1958,56055,CAP,SmPC,lt,7,REGISTRUOTOJAS,56001.0,True,55
1959,56056,CAP,SmPC,lt,8,REGISTRACIJOS PAŽYMĖJIMO NUMERIS (-IAI),56001.0,True,56
1960,56057,CAP,SmPC,lt,9,REGISTRAVIMO / PERREGISTRAVIMO DATA,56001.0,True,57
1961,56058,CAP,SmPC,lt,10,TEKSTO PERŽIŪROS DATA,56001.0,True,58
1962,56059,CAP,SmPC,lt,11,DOZIMETRIJA,56001.0,False,59
1963,56060,CAP,SmPC,lt,12,RADIOFARMACINIŲ PREPARATŲ RUOŠIMO INSTRUKCIJA,56001.0,False,60
1964,57001,CAP,AnnexII,lt,,II PRIEDAS,,True,1
1965,57002,CAP,AnnexII,lt,A,"<BIOLOGINĖS (-IŲ) VEIKLIOSIOS (-IŲJŲ) MEDŽIAGOS (-Ų) GAMINTOJAS (-AI) IR> GAMINTOJAS (-AI), ATSAKINGAS (-I) UŽ SERIJŲ IŠLEIDIMĄ",57001.0,True,2
1966,57003,CAP,AnnexII,lt,,Biologinės (-ių) veikliosios (-iųjų) medžiagos (-ų) gamintojo (-ų) pavadinimas (-ai) ir adresas (-ai),57002.0,False,3
1967,57004,CAP,AnnexII,lt,,"Gamintojo (-ų), atsakingo (-ų) už serijų išleidimą, pavadinimas (-ai) ir adresas (-ai)",57002.0,True,4
1968,57005,CAP,AnnexII,lt,B,TIEKIMO IR VARTOJIMO SĄLYGOS AR APRIBOJIMAI ,57001.0,True,5
1969,57006,CAP,AnnexII,lt,,Oficialus serijų išleidimas,57005.0,False,6
1970,57007,CAP,AnnexII,lt,C,KITOS SĄLYGOS IR REIKALAVIMAI REGISTRUOTOJUI,57001.0,True,7
1971,57008,CAP,AnnexII,lt,,Periodiškai atnaujinami saugumo protokolai (PASP),57007.0,True,8
1972,57009,CAP,AnnexII,lt,D,"SĄLYGOS AR APRIBOJIMAI, SKIRTI SAUGIAM IR VEIKSMINGAM VAISTINIO PREPARATO VARTOJIMUI UŽTIKRINTI",57001.0,True,9
1973,57010,CAP,AnnexII,lt,,Rizikos valdymo planas (RVP),57009.0,True,10
1974,57011,CAP,AnnexII,lt,,Papildomos rizikos mažinimo priemonės,57009.0,False,11
1975,57012,CAP,AnnexII,lt,,Įpareigojimas vykdyti poregistracines užduotis ,57009.0,False,12
1976,57013,CAP,AnnexII,en,E,SPECIFINIS ĮPAREIGOJIMAS ĮVYKDYTI POREGISTRACINES UŽDUOTIS <SĄLYGINĖS REGISTRACIJOS ATVEJU> <REGISTRACIJOS IŠIMTINĖMIS SĄLYGOMIS ATVEJU,57001.0,False,13
1977,58001,CAP,Labelling,lt,,ŽENKLINIMAS,,True,1
1978,58002,CAP,Labelling,lt,,INFORMACIJA ANT <IŠORINĖS> <IR> <VIDINĖS> PAKUOTĖS,58001.0,True,2
1979,58003,CAP,Labelling,lt,1,VAISTINIO PREPARATO PAVADINIMAS,58002.0,True,3
1980,58004,CAP,Labelling,lt,2,VEIKLIOJI (-IOS) MEDŽIAGA (-OS) IR JOS (-Ų) KIEKIS (-IAI),58002.0,True,4
1981,58005,CAP,Labelling,lt,3,PAGALBINIŲ MEDŽIAGŲ SĄRAŠAS,58002.0,True,5
1982,58006,CAP,Labelling,lt,4,FARMACINĖ FORMA IR KIEKIS PAKUOTĖJE,58002.0,True,6
1983,58007,CAP,Labelling,lt,5,VARTOJIMO METODAS IR BŪDAS (-AI),58002.0,True,7
1984,58008,CAP,Labelling,lt,6,"SPECIALUS ĮSPĖJIMAS, KAD VAISTINĮ PREPARATĄ BŪTINA LAIKYTI VAIKAMS NEPASTEBIMOJE IR NEPASIEKIAMOJE VIETOJE",58002.0,True,8
1985,58009,CAP,Labelling,lt,7,KITAS (-I) SPECIALUS (-ŪS) ĮSPĖJIMAS (-AI) (JEI REIKIA),58002.0,True,9
1986,58010,CAP,Labelling,lt,8,TINKAMUMO LAIKAS,58002.0,True,10
1987,58011,CAP,Labelling,lt,9,SPECIALIOS LAIKYMO SĄLYGOS,58002.0,True,11
1988,58012,CAP,Labelling,lt,10,SPECIALIOS ATSARGUMO PRIEMONĖS DĖL NESUVARTOTO VAISTINIO PREPARATO AR JO ATLIEKŲ TVARKYMO (JEI REIKIA),58002.0,True,12
1989,58013,CAP,Labelling,lt,11,REGISTRUOTOJO PAVADINIMAS IR ADRESAS,58002.0,True,13
1990,58014,CAP,Labelling,lt,12,REGISTRACIJOS PAŽYMĖJIMO NUMERIS (-IAI) ,58002.0,True,14
1991,58015,CAP,Labelling,lt,13,"SERIJOS NUMERIS <, DONACIJA IR PREPARATO KODAI>",58002.0,True,15
1992,58016,CAP,Labelling,lt,14,PARDAVIMO (IŠDAVIMO) TVARKA,58002.0,True,16
1993,58017,CAP,Labelling,lt,15,VARTOJIMO INSTRUKCIJA,58002.0,True,17
1994,58018,CAP,Labelling,lt,16,INFORMACIJA BRAILIO RAŠTU,58002.0,True,18
1995,58019,CAP,Labelling,lt,17,UNIKALUS IDENTIFIKATORIUS – 2D BRŪKŠNINIS KODAS,58002.0,True,19
1996,58020,CAP,Labelling,lt,18,UNIKALUS IDENTIFIKATORIUS – ŽMONĖMS SUPRANTAMI DUOMENYS,58002.0,True,20
1997,58021,CAP,Labelling,lt,,MINIMALI INFORMACIJA ANT LIZDINIŲ PLOKŠTELIŲ ARBA DVISLUOKSNIŲ JUOSTELIŲ,58001.0,True,21
1998,58022,CAP,Labelling,lt,1,VAISTINIO PREPARATO PAVADINIMAS,58021.0,True,22
1999,58023,CAP,Labelling,lt,2,REGISTRUOTOJO PAVADINIMAS,58021.0,True,23
2000,58024,CAP,Labelling,lt,3,TINKAMUMO LAIKAS,58021.0,True,24
2001,58025,CAP,Labelling,lt,4,"SERIJOS NUMERIS <, DONACIJA IR PREPARATO KODAI>",58021.0,True,25
2002,58026,CAP,Labelling,lt,5,KITA,58021.0,True,26
2003,58027,CAP,Labelling,lt,,MINIMALI INFORMACIJA ANT MAŽŲ VIDINIŲ PAKUOČIŲ,58001.0,True,27
2004,58028,CAP,Labelling,lt,1,VAISTINIO PREPARATO PAVADINIMAS IR VARTOJIMO BŪDAS (-AI),58027.0,True,28
2005,58029,CAP,Labelling,lt,2,VARTOJIMO METODAS,58027.0,True,29
2006,58030,CAP,Labelling,lt,3,TINKAMUMO LAIKAS,58027.0,True,30
2007,58031,CAP,Labelling,lt,4,"SERIJOS NUMERIS <, DONACIJA IR PREPARATO KODAI>",58027.0,True,31
2008,58032,CAP,Labelling,lt,5,"KIEKIS (MASĖ, TŪRIS ARBA VIENETAI)",58027.0,True,32
2009,58033,CAP,Labelling,lt,6,KITA,58027.0,True,33
2010,59001,CAP,Package leaflet,lt,,PAKUOTĖS LAPELIS,,True,1
2011,59002,CAP,Package leaflet,lt,,"qVykdoma papildoma šio vaisto stebėsena. Tai padės greitai nustatyti naują saugumo informaciją. Mums galite padėti pranešdami apie bet kokį Jums pasireiškiantį šalutinį poveikį. Apie tai, kaip pranešti apie šalutinį poveikį, žr. 4 skyriaus pabaigoje. ",59001.0,False,2
2012,59003,CAP,Package leaflet,lt,,Apie ką rašoma šiame lapelyje?,59001.0,True,3
2013,59004,CAP,Package leaflet,lt,1,Kas yra X ir kam jis vartojamas,59001.0,True,4
2014,59005,CAP,Package leaflet,lt,2,Kas žinotina prieš vartojant X,59001.0,True,5
2015,59006,CAP,Package leaflet,lt,,X vartoti negalima,59005.0,True,6
2016,59007,CAP,Package leaflet,lt,,Įspėjimai ir atsargumo priemonės,59005.0,True,7
2017,59008,CAP,Package leaflet,lt,,Vaikams <ir paaugliams>,59005.0,True,8
2018,59009,CAP,Package leaflet,lt,,Kiti vaistai ir X,59005.0,True,9
2019,59010,CAP,Package leaflet,lt,,"X vartojimas su <maistu> <ir> <,> <gėrimais> <ir> <alkoholiu>",59005.0,True,10
2020,59011,CAP,Package leaflet,lt,,"Nėštumas <ir> <,> žindymo laikotarpis <ir vaisingumas>",59005.0,True,11
2021,59012,CAP,Package leaflet,lt,,Vairavimas ir mechanizmų valdymas,59005.0,True,12
2022,59013,CAP,Package leaflet,lt,,X sudėtyje yra {pagalbinės (-ių) medžiagos (-ų) pavadinimas (-ai)},59005.0,False,13
2023,59014,CAP,Package leaflet,lt,3,Kaip vartoti X,59001.0,True,14
2024,59015,CAP,Package leaflet,lt,,Vartojimas vaikams <ir paaugliams>,59014.0,False,15
2025,59016,CAP,Package leaflet,lt,,Ką daryti pavartojus per didelę X dozę?,59014.0,False,16
2026,59017,CAP,Package leaflet,lt,,Pamiršus pavartoti X,59014.0,False,17
2027,59018,CAP,Package leaflet,lt,,Nustojus vartoti X,59014.0,False,18
2028,59019,CAP,Package leaflet,lt,4,Galimas šalutinis poveikis,59001.0,True,19
2029,59020,CAP,Package leaflet,lt,,"Kitas šalutinis poveikis, kuris gali pasireikšti vaikams <ir paaugliams>",59019.0,False,20
2030,59021,CAP,Package leaflet,lt,,Pranešimas apie šalutinį poveikį,59019.0,True,21
2031,59022,CAP,Package leaflet,lt,5,Kaip laikyti X,59001.0,True,22
2032,59023,CAP,Package leaflet,lt,6,Pakuotės turinys ir kita informacija,59001.0,True,23
2033,59024,CAP,Package leaflet,lt,,X sudėtis,59023.0,True,24
2034,59025,CAP,Package leaflet,lt,,X išvaizda ir kiekis pakuotėje,59023.0,True,25
2035,59026,CAP,Package leaflet,lt,,Registruotojas ir gamintojas,59023.0,True,26
2036,59027,CAP,Package leaflet,lt,,"Jeigu apie šį vaistą norite sužinoti daugiau, kreipkitės į vietinį registruotojo atstovą:",59023.0,False,27
2037,59028,CAP,Package leaflet,lt,,Šis pakuotės lapelis paskutinį kartą peržiūrėtas <{MMMM m. {mėnesio} mėn.}.>.,59023.0,True,28
2038,59029,CAP,Package leaflet,lt,,Kiti informacijos šaltiniai,59023.0,False,29
2039,59030,CAP,Package leaflet,lt,,Toliau pateikta informacija skirta tik sveikatos priežiūros specialistams.,59001.0,False,30
2040,60001,CAP,SmPC,lv,,ZĀĻU APRAKSTS,,True,1
2041,60002,CAP,SmPC,lv,,"qŠīm zālēm tiek piemērota papildu uzraudzība. Tādējādi būs iespējams ātri identificēt jaunāko informāciju par šo zāļu drošumu. Veselības aprūpes speciālisti tiek lūgti ziņot par jebkādām iespējamām nevēlamām blakusparādībām. Skatīt 4.8. apakšpunktu par to, kā ziņot par nevēlamām blakusparādībām.",60001.0,False,2
2042,60003,CAP,SmPC,lv,1,ZĀĻU NOSAUKUMS,60001.0,True,3
2043,60004,CAP,SmPC,lv,2,KVALITATĪVAIS UN KVANTITATĪVAIS SASTĀVS,60001.0,True,4
2044,60005,CAP,SmPC,lv,2.1,Vispārējs apraksts,60004.0,False,5
2045,60006,CAP,SmPC,lv,2.2,Kvalitatīvais un kvantitatīvais sastāvs,60004.0,False,6
2046,60007,CAP,SmPC,lv,,Palīgviela(-s) ar zināmu iedarbību,60006.0,False,7
2047,60008,CAP,SmPC,lv,3,ZĀĻU FORMA,60001.0,True,8
2048,60009,CAP,SmPC,lv,4,KLĪNISKĀ INFORMĀCIJA ,60001.0,True,9
2049,60010,CAP,SmPC,lv,4.1,Terapeitiskās indikācijas,60009.0,True,10
2050,60011,CAP,SmPC,lv,4.2,Devas un lietošanas veids,60009.0,True,11
2051,60012,CAP,SmPC,lv,,Devas ,60011.0,True,12
2052,60013,CAP,SmPC,lv,,Pediatriskā populācija,60012.0,True,13
2053,60014,CAP,SmPC,lv,,Lietošanas veids,60011.0,True,14
2054,60015,CAP,SmPC,lv,,Piesardzības pasākumi pirms zāļu lietošanas vai rīkošanās ar tām,60014.0,False,15
2055,60016,CAP,SmPC,lv,4.3,Kontrindikācijas ,60009.0,True,16
2056,60017,CAP,SmPC,lv,4.4,Īpaši brīdinājumi un piesardzība lietošanā,60009.0,True,17
2057,60018,CAP,SmPC,lv,,Izsekojamība,60017.0,False,18
2058,60019,CAP,SmPC,lv,,Pediatriskā populācija,60017.0,False,19
2059,60020,CAP,SmPC,lv,4.5,Mijiedarbība ar citām zālēm un citi mijiedarbības veidi,60009.0,True,20
2060,60021,CAP,SmPC,lv,,Pediatriskā populācija,60020.0,False,21
2061,60022,CAP,SmPC,lv,4.6,"Fertilitāte, grūtniecība un barošana ar krūti",60009.0,True,22
2062,60023,CAP,SmPC,lv,,Grūtniecība,60022.0,False,23
2063,60024,CAP,SmPC,lv,,Barošana ar krūti,60022.0,False,24
2064,60025,CAP,SmPC,lv,,Fertilitāte,60022.0,False,25
2065,60026,CAP,SmPC,lv,4.7,Ietekme uz spēju vadīt transportlīdzekļus un apkalpot mehānismus,60009.0,True,26
2066,60027,CAP,SmPC,lv,4.8,Nevēlamās blakusparādības,60009.0,True,27
2067,60028,CAP,SmPC,lv,,Pediatriskā populācija,60027.0,False,28
2068,60029,CAP,SmPC,lv,,Ziņošana par iespējamām nevēlamām blakusparādībām,60027.0,True,29
2069,60030,CAP,SmPC,lv,4.9,Pārdozēšana,60009.0,True,30
2070,60031,CAP,SmPC,lv,,Pediatriskā populācija,60030.0,False,31
2071,60032,CAP,SmPC,lv,5,FARMAKOLOĢISKĀS ĪPAŠĪBAS ,60001.0,True,32
2072,60033,CAP,SmPC,lv,5.1,Farmakodinamiskās īpašības,60032.0,True,33
2073,60034,CAP,SmPC,lv,,Darbības mehānisms,60033.0,False,34
2074,60035,CAP,SmPC,lv,,Farmakodinamiskā iedarbība,60033.0,False,35
2075,60036,CAP,SmPC,lv,,Klīniskā efektivitāte un drošums,60033.0,False,36
2076,60037,CAP,SmPC,lv,,Pediatriskā populācija,60033.0,False,37
2077,60038,CAP,SmPC,lv,5.2,Farmakokinētiskās īpašības,60032.0,True,38
2078,60039,CAP,SmPC,lv,,Uzsūkšanās,60038.0,False,39
2079,60040,CAP,SmPC,lv,,Izkliede,60038.0,False,40
2080,60041,CAP,SmPC,lv,,Biotransformācija,60038.0,False,41
2081,60042,CAP,SmPC,lv,,Eliminācija,60038.0,False,42
2082,60043,CAP,SmPC,lv,,Linearitāte/nelinearitāte,60038.0,False,43
2083,60044,CAP,SmPC,lv,,Farmakokinētiskā(-s)/farmakodinamiskā(-s) attiecība(-s),60038.0,False,44
2084,60045,CAP,SmPC,lv,5.3,Preklīniskie dati par drošumu,60032.0,True,45
2085,60046,CAP,SmPC,lv,,Vides riska novērtējums (VRN,60045.0,False,46
2086,60047,CAP,SmPC,lv,6,FARMACEITISKĀ INFORMĀCIJA,60001.0,True,47
2087,60048,CAP,SmPC,lv,6.1,Palīgvielu saraksts,60047.0,True,48
2088,60049,CAP,SmPC,lv,6.2,Nesaderība,60047.0,True,49
2089,60050,CAP,SmPC,lv,6.3,Uzglabāšanas laiks,60047.0,True,50
2090,60051,CAP,SmPC,lv,6.4,Īpaši uzglabāšanas nosacījumi,60047.0,True,51
2091,60052,CAP,SmPC,lv,6.5,"Iepakojuma veids un saturs <un īpašs aprīkojums lietošanai, ievadīšanai vai implantēšanai>",60047.0,True,52
2092,60053,CAP,SmPC,lv,6.6,Īpaši norādījumi atkritumu likvidēšanai <un citi norādījumi par rīkošanos>,60047.0,True,53
2093,60054,CAP,SmPC,lv,,Lietošana pediatriskā populācijā,60053.0,False,54
2094,60055,CAP,SmPC,lv,7,REĢISTRĀCIJAS APLIECĪBAS ĪPAŠNIEKS,60001.0,True,55
2095,60056,CAP,SmPC,lv,8,REĢISTRĀCIJAS APLIECĪBAS NUMURS(-I) ,60001.0,True,56
2096,60057,CAP,SmPC,lv,9,PIRMĀS REĢISTRĀCIJAS/PĀRREĢISTRĀCIJAS DATUMS,60001.0,True,57
2097,60058,CAP,SmPC,lv,10,TEKSTA PĀRSKATĪŠANAS DATUMS,60001.0,True,58
2098,60059,CAP,SmPC,lv,11,DOZIMETRIJA,60001.0,False,59
2099,60060,CAP,SmPC,lv,12,NORĀDĪJUMI PAR RADIOFARMACEITISKO ZĀĻU SAGATAVOŠANU,60001.0,False,60
2100,61001,CAP,II PIELIKUMS,lv,,II PIELIKUMS,,True,1
2101,61002,CAP,II PIELIKUMS,lv,A,"<BIOLOĢISKI AKTĪVĀS(-O) VIELAS (-U) RAŽOTĀJS(-I) UN> RAŽOTĀJS(-I), KAS ATBILD PAR SĒRIJAS IZLAIDI",61001.0,True,2
2102,61003,CAP,II PIELIKUMS,lv,,Bioloģiski aktīvās(-o) vielas(-u) ražotāja(-u) nosaukums un adrese,61002.0,False,3
2103,61004,CAP,II PIELIKUMS,lv,,"Ražotāja(-u), kas atbild par sērijas izlaidi, nosaukums un adrese",61002.0,True,4
2104,61005,CAP,II PIELIKUMS,lv,B,IZSNIEGŠANAS KĀRTĪBAS UN LIETOŠANAS NOSACĪJUMI VAI IEROBEŽOJUMI,61001.0,True,5
2105,61006,CAP,II PIELIKUMS,lv,,Oficiāla sērijas izlaide,61005.0,False,6
2106,61007,CAP,II PIELIKUMS,lv,C,CITI REĢISTRĀCIJAS NOSACĪJUMI UN PRASĪBAS ,61001.0,True,7
2107,61008,CAP,II PIELIKUMS,lv,,Periodiski atjaunojamais drošuma ziņojums (PSUR),61007.0,True,8
2108,61009,CAP,II PIELIKUMS,lv,D,NOSACĪJUMI VAI IEROBEŽOJUMI ATTIECĪBĀ UZ DROŠU UN EFEKTĪVU ZĀĻU LIETOŠANU  ,61001.0,True,9
2109,61010,CAP,II PIELIKUMS,lv,,Riska pārvaldības plāns (RPP),61009.0,True,10
2110,61011,CAP,II PIELIKUMS,lv,,Papildu riska mazināšanas pasākumi,61009.0,False,11
2111,61012,CAP,II PIELIKUMS,lv,,Saistības veikt pēcreģistrācijas pasākumus,61009.0,False,12
2112,61013,CAP,II PIELIKUMS,lv,E,"ĪPAŠAS SAISTĪBAS, LAI VEIKTU PĒCREĢISTRĀCIJAS PASĀKUMUS <ZĀLĒM, KAS REĢISTRĒTAS AR NOSACĪJUMIEM><ZĀLĒM, KAS REĢISTRĒTAS „IZŅĒMUMA KĀRTĀ”>",61001.0,False,13
2113,62001,CAP,MARĶĒJUMA TEKSTS,lv,,MARĶĒJUMA TEKSTS,,True,1
2114,62002,CAP,MARĶĒJUMA TEKSTS,lv,,"INFORMĀCIJA, KAS JĀNORĀDA UZ <ĀRĒJĀ IEPAKOJUMA > <UN> < UZ TIEŠĀ IEPAKOJUMA>",62001.0,True,2
2115,62003,CAP,MARĶĒJUMA TEKSTS,lv,1,ZĀĻU NOSAUKUMS,62002.0,True,3
2116,62004,CAP,MARĶĒJUMA TEKSTS,lv,2,AKTĪVĀS(-O) VIELAS(-U) NOSAUKUMS(-I) UN DAUDZUMS(-I),62002.0,True,4
2117,62005,CAP,MARĶĒJUMA TEKSTS,lv,3,PALĪGVIELU SARAKSTS,62002.0,True,5
2118,62006,CAP,MARĶĒJUMA TEKSTS,lv,4,ZĀĻU FORMA UN SATURS,62002.0,True,6
2119,62007,CAP,MARĶĒJUMA TEKSTS,lv,5,LIETOŠANAS UN IEVADĪŠANAS VEIDS(-I) ,62002.0,True,7
2120,62008,CAP,MARĶĒJUMA TEKSTS,lv,6,ĪPAŠI BRĪDINĀJUMI PAR ZĀĻU UZGLABĀŠANU BĒRNIEM NEREDZAMĀ UN NEPIEEJAMĀ VIETĀ,62002.0,True,8
2121,62009,CAP,MARĶĒJUMA TEKSTS,lv,7,"CITI ĪPAŠI BRĪDINĀJUMI, JA NEPIECIEŠAMS",62002.0,True,9
2122,62010,CAP,MARĶĒJUMA TEKSTS,lv,8,DERĪGUMA TERMIŅŠ,62002.0,True,10
2123,62011,CAP,MARĶĒJUMA TEKSTS,lv,9,ĪPAŠI UZGLABĀŠANAS NOSACĪJUMI,62002.0,True,11
2124,62012,CAP,MARĶĒJUMA TEKSTS,lv,10,"ĪPAŠI PIESARDZĪBAS PASĀKUMI, IZNĪCINOT NEIZLIETOTĀS ZĀLES VAI IZMANTOTOS MATERIĀLUS, KAS BIJUŠI SASKARĒ AR ŠĪM ZĀLĒM, JA PIEMĒROJAMS",62002.0,True,12
2125,62013,CAP,MARĶĒJUMA TEKSTS,lv,11,REĢISTRĀCIJAS APLIECĪBAS ĪPAŠNIEKA NOSAUKUMS UN ADRESE ,62002.0,True,13
2126,62014,CAP,MARĶĒJUMA TEKSTS,lv,12,REĢISTRĀCIJAS APLIECĪBAS NUMURS(-I),62002.0,True,14
2127,62015,CAP,MARĶĒJUMA TEKSTS,lv,13,"SĒRIJAS NUMURS<, DĀVINĀJUMA UN ZĀĻU KODS>",62002.0,True,15
2128,62016,CAP,MARĶĒJUMA TEKSTS,lv,14,IZSNIEGŠANAS KĀRTĪBA,62002.0,True,16
2129,62017,CAP,MARĶĒJUMA TEKSTS,lv,15,NORĀDĪJUMI PAR LIETOŠANU,62002.0,True,17
2130,62018,CAP,MARĶĒJUMA TEKSTS,lv,16,INFORMĀCIJA BRAILA RAKSTĀ  ,62002.0,True,18
2131,62019,CAP,MARĶĒJUMA TEKSTS,lv,17,UNIKĀLS IDENTIFIKATORS – 2D SVĪTRKODS,62002.0,True,19
2132,62020,CAP,MARĶĒJUMA TEKSTS,lv,18,"UNIKĀLS IDENTIFIKATORS – DATI, KURUS VAR NOLASĪT PERSONA",62002.0,True,20
2133,62021,CAP,MARĶĒJUMA TEKSTS,lv,,"MINIMĀLĀ INFORMĀCIJA, KAS JĀNORĀDA UZ BLISTERA VAI PLĀKSNĪTES",62001.0,True,21
2134,62022,CAP,MARĶĒJUMA TEKSTS,lv,1,ZĀĻU NOSAUKUMS ,62021.0,True,22
2135,62023,CAP,MARĶĒJUMA TEKSTS,lv,2,REĢISTRĀCIJAS APLIECĪBAS ĪPAŠNIEKA NOSAUKUMS ,62021.0,True,23
2136,62024,CAP,MARĶĒJUMA TEKSTS,lv,3,DERĪGUMA TERMIŅŠ ,62021.0,True,24
2137,62025,CAP,MARĶĒJUMA TEKSTS,lv,4,"SĒRIJAS NUMURS<, DĀVINĀJUMA UN ZĀĻU KODS>",62021.0,True,25
2138,62026,CAP,MARĶĒJUMA TEKSTS,lv,5,CITA,62021.0,True,26
2139,62027,CAP,MARĶĒJUMA TEKSTS,lv,,"MINIMĀLĀ INFORMĀCIJA, KAS JĀNORĀDA UZ MAZA IZMĒRA TIEŠĀ IEPAKOJUMA",62001.0,True,27
2140,62028,CAP,MARĶĒJUMA TEKSTS,lv,1,ZĀĻU NOSAUKUMS UN IEVADĪŠANAS VEIDS(-I) ,62027.0,True,28
2141,62029,CAP,MARĶĒJUMA TEKSTS,lv,2,LIETOŠANAS VEIDS,62027.0,True,29
2142,62030,CAP,MARĶĒJUMA TEKSTS,lv,3,DERĪGUMA TERMIŅŠ,62027.0,True,30
2143,62031,CAP,MARĶĒJUMA TEKSTS,lv,4,"SĒRIJAS NUMURS<, DĀVINĀJUMA UN ZĀĻU KODS>",62027.0,True,31
2144,62032,CAP,MARĶĒJUMA TEKSTS,lv,5,"SATURA SVARS, TILPUMS VAI VIENĪBU DAUDZUMS",62027.0,True,32
2145,62033,CAP,MARĶĒJUMA TEKSTS,lv,6,CITA,62027.0,True,33
2146,63001,CAP,LIETOŠANAS INSTRUKCIJA,lv,,LIETOŠANAS INSTRUKCIJA,,True,1
2147,63002,CAP,LIETOŠANAS INSTRUKCIJA,lv,,"qŠīm zālēm tiek piemērota papildu uzraudzība. Tādējādi būs iespējams ātri identificēt jaunāko informāciju par šo zāļu drošumu. Jūs varat palīdzēt, ziņojot par jebkādām novērotajām blakusparādībām. Par to, kā ziņot par blakusparādībām, skatīt 4. punkta beigās.",63001.0,False,2
2148,63003,CAP,LIETOŠANAS INSTRUKCIJA,lv,,Šajā instrukcijā varat uzzināt: ,63001.0,True,3
2149,63004,CAP,LIETOŠANAS INSTRUKCIJA,lv,1,Kas ir X un kādam nolūkam tās/to lieto,63001.0,True,4
2150,63005,CAP,LIETOŠANAS INSTRUKCIJA,lv,2,Kas Jums jāzina pirms X lietošanas,63001.0,True,5
2151,63006,CAP,LIETOŠANAS INSTRUKCIJA,lv,,Nelietojiet X šādos gadījumos<:>,63005.0,True,6
2152,63007,CAP,LIETOŠANAS INSTRUKCIJA,lv,,Brīdinājumi un piesardzība lietošanā,63005.0,True,7
2153,63008,CAP,LIETOŠANAS INSTRUKCIJA,lv,,Bērni un <pusaudži> ,63005.0,True,8
2154,63009,CAP,LIETOŠANAS INSTRUKCIJA,lv,,Citas zāles un X,63005.0,True,9
2155,63010,CAP,LIETOŠANAS INSTRUKCIJA,lv,,"X kopā ar <uzturu> <un> <,> <dzērienu> <un> <alkoholu>",63005.0,True,10
2156,63011,CAP,LIETOŠANAS INSTRUKCIJA,lv,,"Grūtniecība <un> <,> barošana ar krūti <un fertilitāte>",63005.0,True,11
2157,63012,CAP,LIETOŠANAS INSTRUKCIJA,lv,,Transportlīdzekļu vadīšana un mehānismu apkalpošana,63005.0,True,12
2158,63013,CAP,LIETOŠANAS INSTRUKCIJA,lv,,X satur {palīgvielas(-u) nosaukums(-i)},63005.0,False,13
2159,63014,CAP,LIETOŠANAS INSTRUKCIJA,lv,3,Kā lietot X,63001.0,True,14
2160,63015,CAP,LIETOŠANAS INSTRUKCIJA,lv,,Lietošana bērniem <un pusaudžiem>,63014.0,False,15
2161,63016,CAP,LIETOŠANAS INSTRUKCIJA,lv,,Ja esat lietojis X vairāk nekā noteikts,63014.0,False,16
2162,63017,CAP,LIETOŠANAS INSTRUKCIJA,lv,,Ja esat aizmirsis lietot X,63014.0,False,17
2163,63018,CAP,LIETOŠANAS INSTRUKCIJA,lv,,Ja pārtraucat lietot X,63014.0,False,18
2164,63019,CAP,LIETOŠANAS INSTRUKCIJA,lv,4,Iespējamās blakusparādības,63001.0,True,19
2165,63020,CAP,LIETOŠANAS INSTRUKCIJA,lv,,Papildu blakusparādības bērniem <un pusaudžiem>,63019.0,False,20
2166,63021,CAP,LIETOŠANAS INSTRUKCIJA,lv,,Ziņošana par blakusparādībām,63019.0,True,21
2167,63022,CAP,LIETOŠANAS INSTRUKCIJA,lv,5,Kā uzglabāt X,63001.0,True,22
2168,63023,CAP,LIETOŠANAS INSTRUKCIJA,lv,6,Iepakojuma saturs un cita informācija,63001.0,True,23
2169,63024,CAP,LIETOŠANAS INSTRUKCIJA,lv,,Ko X satur,63023.0,True,24
2170,63025,CAP,LIETOŠANAS INSTRUKCIJA,lv,,X ārējais izskats un iepakojums,63023.0,True,25
2171,63026,CAP,LIETOŠANAS INSTRUKCIJA,lv,,Reģistrācijas apliecības īpašnieks un ražotājs,63023.0,True,26
2172,63027,CAP,LIETOŠANAS INSTRUKCIJA,lv,,"Lai saņemtu papildu informāciju par šīm zālēm, lūdzam sazināties ar reģistrācijas apliecības īpašnieka vietējo pārstāvniecību:",63023.0,False,27
2173,63028,CAP,LIETOŠANAS INSTRUKCIJA,lv,,Šī lietošanas instrukcija pēdējo reizi pārskatīta <{MM/GGGG}> <GGGG. gada mēnesis}>.,63023.0,True,28
2174,63029,CAP,LIETOŠANAS INSTRUKCIJA,lv,,Citi informācijas avoti,63023.0,False,29
2175,63030,CAP,LIETOŠANAS INSTRUKCIJA,lv,,Tālāk sniegtā informācija paredzēta tikai veselības aprūpes speciālistiem.,63001.0,False,30
2176,64001,CAP,SmPC,mt,,SOMMARJU TAL-KARATTERISTIĊI TAL-PRODOTT,,True,1
2177,64002,CAP,SmPC,mt,,qDan il-prodott mediċinali huwa suġġett għal monitoraġġ addizzjonali. Dan ser jippermetti identifikazzjoni ta’ malajr ta’ informazzjoni ġdida dwar is-sigurtà. Il-professjonisti tal-kura tas-saħħa huma mitluba jirrappurtaw kwalunkwe reazzjoni avversa suspettata. Ara sezzjoni 4.8 dwar kif għandhom jiġu rappurtati reazzjonijiet avversi.,64001.0,False,2
2178,64003,CAP,SmPC,mt,1,ISEM IL-PRODOTT MEDIĊINALI,64001.0,True,3
2179,64004,CAP,SmPC,mt,2,GĦAMLA KWALITATTIVA U KWANTITATTIVA,64001.0,True,4
2180,64005,CAP,SmPC,mt,2.1,Deskrizzjoni ġenerali,64004.0,False,5
2181,64006,CAP,SmPC,mt,2.2,Għamla kwalitattiva u kwantitattiva,64004.0,False,6
2182,64007,CAP,SmPC,mt,,Eċċipjent(i) b’effett magħruf,64006.0,False,7
2183,64008,CAP,SmPC,mt,3,GĦAMLA FARMAĊEWTIKA,64001.0,True,8
2184,64009,CAP,SmPC,mt,4,TAGĦRIF KLINIKU,64001.0,True,9
2185,64010,CAP,SmPC,mt,4.1,Indikazzjonijiet terapewtiċi,64009.0,True,10
2186,64011,CAP,SmPC,mt,4.2,Pożoloġija u metodu ta’ kif għandu jingħata,64009.0,True,11
2187,64012,CAP,SmPC,mt,,Pożoloġija,64011.0,True,12
2188,64013,CAP,SmPC,mt,,Popolazzjoni pedjatrika,64012.0,True,13
2189,64014,CAP,SmPC,mt,,Metodu ta’ kif għandu jingħata,64011.0,True,14
2190,64015,CAP,SmPC,mt,,Prekawzjonijiet li għandhom jittieħdu qabel tmiss il-prodott mediċinali jew qabel tagћti l-prodott mediċinali,64014.0,False,15
2191,64016,CAP,SmPC,mt,4.3,Kontraindikazzjonijiet,64009.0,True,16
2192,64017,CAP,SmPC,mt,4.4,Twissijiet speċjali u prekawzjonijiet għall-użu,64009.0,True,17
2193,64018,CAP,SmPC,mt,,Traċċabilità,64017.0,False,18
2194,64019,CAP,SmPC,mt,,Popolazzjoni pedjatrika,64017.0,False,19
2195,64020,CAP,SmPC,mt,4.5,Interazzjoni ma’ prodotti mediċinali oħra u forom oħra ta’ interazzjoni,64009.0,True,20
2196,64021,CAP,SmPC,mt,,Popolazzjoni pedjatrika,64020.0,False,21
2197,64022,CAP,SmPC,mt,4.6,"Fertilità, tqala u treddigħ",64009.0,True,22
2198,64023,CAP,SmPC,mt,,Tqala,64022.0,False,23
2199,64024,CAP,SmPC,mt,,Treddigħ,64022.0,False,24
2200,64025,CAP,SmPC,mt,,Fertilità,64022.0,False,25
2201,64026,CAP,SmPC,mt,4.7,Effetti fuq il-ħila biex issuq u tħaddem magni,64009.0,True,26
2202,64027,CAP,SmPC,mt,4.8,Effetti mhux mixtieqa,64009.0,True,27
2203,64028,CAP,SmPC,mt,,Popolazzjoni pedjatrika,64027.0,False,28
2204,64029,CAP,SmPC,mt,,Rappurtar ta’ reazzjonijiet avversi suspettati,64027.0,True,29
2205,64030,CAP,SmPC,mt,4.9,Doża eċċessiva,64009.0,True,30
2206,64031,CAP,SmPC,mt,,Popolazzjoni pedjatrika,64030.0,False,31
2207,64032,CAP,SmPC,mt,5,PROPRJETAJIET FARMAKOLOĠIĊI,64001.0,True,32
2208,64033,CAP,SmPC,mt,5.1,Proprjetajiet farmakodinamiċi,64032.0,True,33
2209,64034,CAP,SmPC,mt,,Mekkaniżmu ta’ azzjoni,64033.0,False,34
2210,64035,CAP,SmPC,mt,,Effetti farmakodinamiċi,64033.0,False,35
2211,64036,CAP,SmPC,mt,,Effikaċja klinika u sigurtà,64033.0,False,36
2212,64037,CAP,SmPC,mt,,Popolazzjoni pedjatrika,64033.0,False,37
2213,64038,CAP,SmPC,mt,5.2,Tagħrif farmakokinetiku,64032.0,True,38
2214,64039,CAP,SmPC,mt,,Assorbiment,64038.0,False,39
2215,64040,CAP,SmPC,mt,,Distribuzzjoni,64038.0,False,40
2216,64041,CAP,SmPC,mt,,Bijotrasformazzjoni,64038.0,False,41
2217,64042,CAP,SmPC,mt,,Eliminazzjoni,64038.0,False,42
2218,64043,CAP,SmPC,mt,,Linearità/nuqqas ta’ linearità,64038.0,False,43
2219,64044,CAP,SmPC,mt,,Relazzjoni(-jiet) farmakokinetika(ċi)/farmakodinamika(ċi),64038.0,False,44
2220,64045,CAP,SmPC,mt,5.3,Tagħrif ta' qabel l-użu kliniku dwar is-sigurtà,64032.0,True,45
2221,64046,CAP,SmPC,mt,,Valutazzjoni tar-riskju ambjentali (ERA),64045.0,False,46
2222,64047,CAP,SmPC,mt,6,TAGĦRIF FARMAĊEWTIKU,64001.0,True,47
2223,64048,CAP,SmPC,mt,6.1,Lista ta’ eċċipjenti,64047.0,True,48
2224,64049,CAP,SmPC,mt,6.2,Inkompatibbiltajiet,64047.0,True,49
2225,64050,CAP,SmPC,mt,6.3,Żmien kemm idum tajjeb il-prodott mediċinali,64047.0,True,50
2226,64051,CAP,SmPC,mt,6.4,Prekawzjonijiet speċjali għall-ħażna,64047.0,True,51
2227,64052,CAP,SmPC,mt,6.5,"In-natura tal-kontenitur u ta’ dak li hemm ġo fih <u apparat speċjali għall-użu, għall- amministrazzjoni jew għall-impjant",64047.0,True,52
2228,64053,CAP,SmPC,mt,6.6,Prekawzjonijiet speċjali għar-rimi u għal immaniġġar ieħor,64047.0,True,53
2229,64054,CAP,SmPC,mt,,Użu fil-popolazzjoni pedjatrika,64053.0,False,54
2230,64055,CAP,SmPC,mt,7,DETENTUR TAL-AWTORIZZAZZJONI GĦAT-TQEGĦID FIS-SUQ,64001.0,True,55
2231,64056,CAP,SmPC,mt,8,NUMRU(I) TAL-AWTORIZZAZZJONI GĦAT-TQEGĦID FIS-SUQ ,64001.0,True,56
2232,64057,CAP,SmPC,mt,9,DATA TAL-EWWEL AWTORIZZAZZJONI/TIĠDID TAL-AWTORIZZAZZJONI,64001.0,True,57
2233,64058,CAP,SmPC,mt,10,DATA TA’ REVIŻJONI TAT-TEST,64001.0,True,58
2234,64059,CAP,SmPC,mt,11,DOŻIMETRIJA,64001.0,False,59
2235,64060,CAP,SmPC,mt,12,ISTRUZZJONIJIET GĦALL-PREPARAZZJONI TA’ PRODOTTI RADJUFARMAĊEWTIĊI,64001.0,False,60
2236,65001,CAP,ANNESS II,mt,,ANNESS II,,True,1
2237,65002,CAP,ANNESS II,mt,A,<MANIFATTUR(I) TAS-SUSTANZA/I) BIJOLOĠIKA(ĊI ATTIVA/I U> MANIFATTUR(I) RESPONSABBLI GĦALL-ĦRUĠ TAL-LOTT,65001.0,True,2
2238,65003,CAP,ANNESS II,mt,,Isem u indirizz tal-manifattur(i) tas-sustanza(i) bijoloġika(ċi attiva/i,65002.0,False,3
2239,65004,CAP,ANNESS II,mt,,Isem u indirizz tal-manifattur(i) responsabbli għall-ħruġ tal-lott,65002.0,True,4
2240,65005,CAP,ANNESS II,mt,B,KONDIZZJONIJIET JEW RESTRIZZJONIJIET RIGWARD IL-PROVVISTA U L-UŻU ,65001.0,True,5
2241,65006,CAP,ANNESS II,mt,,Ħruġ tal-lott uffiċjali,65005.0,False,6
2242,65007,CAP,ANNESS II,mt,C,KONDIZZJONIJIET U REKWIŻITI OĦRA TAL-AWTORIZZAZZJONI GĦAT-TQEGĦID FIS-SUQ,65001.0,True,7
2243,65008,CAP,ANNESS II,mt,,Rapporti perjodiċi aġġornati dwar is-sigurtà (PSURs),65007.0,True,8
2244,65009,CAP,ANNESS II,mt,D,KONDIZZJONIJIET JEW RESTRIZZJONIJIET FIR-RIGWARD TAL-UŻU SIGUR U EFFIKAĊI TAL-PRODOTT MEDIĊINALI ,65001.0,True,9
2245,65010,CAP,ANNESS II,mt,,Pjan tal-ġestjoni tar-riskju (RMP),65009.0,True,10
2246,65011,CAP,ANNESS II,mt,,Miżuri addizzjonali għall-minimizzazzjoni tar-riskji ,65009.0,False,11
2247,65012,CAP,ANNESS II,mt,,Obbligu biex jitwettqu miżuri ta’ wara l-awtorizzazzjoni ,65009.0,False,12
2248,65013,CAP,ANNESS II,mt,E,OBBLIGU SPEĊIFIKU BIEX MIŻURI TA’ WARA L-AWTORIZZAZJONI JIĠU KOMPLUTI GĦAL <L-AWTORIZZAZZJONI GĦAT-TQEGĦID FIS-SUQ KONDIZZJONALI> <L-AWTORIZZAZZJONI GĦAT-TQEGĦID FIS-SUQ TAĦT ĊIRKUSTANZI EĊĊEZZJONALI>,65001.0,False,13
2249,66001,CAP,TIKKETTAR,mt,,TIKKETTAR,,True,1
2250,66002,CAP,TIKKETTAR,mt,,TAGĦRIF LI GĦANDU JIDHER FUQ <IL-PAKKETT TA’ BARRA> <U> <IL-PAKKETT LI JMISS MAL-PRODOTT>,66001.0,True,2
2251,66003,CAP,TIKKETTAR,mt,1,ISEM TAL-PRODOTT MEDIĊINALI,66002.0,True,3
2252,66004,CAP,TIKKETTAR,mt,2,DIKJARAZZJONI TAS-SUSTANZA(I) ATTIVA(I),66002.0,True,4
2253,66005,CAP,TIKKETTAR,mt,3,LISTA TA’ EĊĊIPJENTI,66002.0,True,5
2254,66006,CAP,TIKKETTAR,mt,4,GĦAMLA FARMAĊEWTIKA U KONTENUT,66002.0,True,6
2255,66007,CAP,TIKKETTAR,mt,5,MOD TA’ KIF U MNEJN JINGĦATA,66002.0,True,7
2256,66008,CAP,TIKKETTAR,mt,6,TWISSIJA SPEĊJALI LI L-PRODOTT MEDIĊINALI GĦANDU JINŻAMM FEJN MA JIDHIRX U MA JINTLAĦAQX MIT-TFAL,66002.0,True,8
2257,66009,CAP,TIKKETTAR,mt,7,"TWISSIJA(IET) SPEĊJALI OĦRA, JEKK MEĦTIEĠA",66002.0,True,9
2258,66010,CAP,TIKKETTAR,mt,8,DATA TA’ SKADENZA ,66002.0,True,10
2259,66011,CAP,TIKKETTAR,mt,9,KONDIZZJONIJIET SPEĊJALI TA’ KIF JINĦAŻEN,66002.0,True,11
2260,66012,CAP,TIKKETTAR,mt,10,"PREKAWZJONIJIET SPEĊJALI GĦAR-RIMI TA’ PRODOTTI MEDIĊINALI MHUX UŻATI JEW SKART MINN DAWN IL-PRODOTTI MEDIĊINALI,  JEKK HEMM BŻONN",66002.0,True,12
2261,66013,CAP,TIKKETTAR,mt,11,ISEM U INDIRIZZ TAD-DETENTUR TAL-AWTORIZZAZZJONI GĦAT-TQEGĦID FIS-SUQ ,66002.0,True,13
2262,66014,CAP,TIKKETTAR,mt,12,NUMRU(I) TAL-AWTORIZZAZZJONI GĦAT-TQEGĦID FIS-SUQ,66002.0,True,14
2263,66015,CAP,TIKKETTAR,mt,13,"NUMRU TAL-LOTT <, DONAZZJONI U KOWD TAL-PRODOTT> ",66002.0,True,15
2264,66016,CAP,TIKKETTAR,mt,14,KLASSIFIKAZZJONI ĠENERALI TA’ KIF JINGĦATA,66002.0,True,16
2265,66017,CAP,TIKKETTAR,mt,15,ISTRUZZJONIJIET DWAR L-UŻU,66002.0,True,17
2266,66018,CAP,TIKKETTAR,mt,16,INFORMAZZJONI BIL-BRAILLE,66002.0,True,18
2267,66019,CAP,TIKKETTAR,mt,17,IDENTIFIKATUR UNIKU – BARCODE 2D,66002.0,True,19
2268,66020,CAP,TIKKETTAR,mt,18,IDENTIFIKATUR UNIKU - DATA LI TINQARA MILL-BNIEDEM,66002.0,True,20
2269,66021,CAP,TIKKETTAR,mt,,TAGĦRIF MINIMU LI GĦANDU JIDHER FUQ IL-FOLJI JEW FUQ L-ISTRIXXI,66001.0,True,21
2270,66022,CAP,TIKKETTAR,mt,1,ISEM IL-PRODOTT MEDIĊINALI,66021.0,True,22
2271,66023,CAP,TIKKETTAR,mt,2,ISEM TAD-DETENTUR TAL-AWTORIZZAZZJONI GĦAT-TQEGĦID FIS-SUQ,66021.0,True,23
2272,66024,CAP,TIKKETTAR,mt,3,DATA TA’ SKADENZA,66021.0,True,24
2273,66025,CAP,TIKKETTAR,mt,4,"NUMRU TAL-LOTT <, DONAZZJONI U KOWD TAL-PRODOTT>",66021.0,True,25
2274,66026,CAP,TIKKETTAR,mt,5,OĦRAJN,66021.0,True,26
2275,66027,CAP,TIKKETTAR,mt,,TAGĦRIF MINIMU LI GĦANDU JIDHER FUQ IL-PAKKETTI Ż-ŻGĦAR EWLENIN,66001.0,True,27
2276,66028,CAP,TIKKETTAR,mt,1,ISEM TAL-PRODOTT MEDIĊINALI U MNEJN GĦANDU JINGĦATA,66027.0,True,28
2277,66029,CAP,TIKKETTAR,mt,2,METODU TA’ KIF GĦANDU JINGĦATA,66027.0,True,29
2278,66030,CAP,TIKKETTAR,mt,3,DATA TA’ SKADENZA,66027.0,True,30
2279,66031,CAP,TIKKETTAR,mt,4,"NUMRU TAL-LOTT <, DONAZZJONI U KOWD TAL-PRODOTT>",66027.0,True,31
2280,66032,CAP,TIKKETTAR,mt,5,"IL-KONTENUT SKONT IL-PIŻ, IL-VOLUM, JEW PARTI INDIVIDWALI",66027.0,True,32
2281,66033,CAP,TIKKETTAR,mt,6,OĦRAJN,66027.0,True,33
2282,67001,CAP,FULJETT TA’ TAGĦRIF,mt,,FULJETT TA’ TAGĦRIF,,True,1
2283,67002,CAP,FULJETT TA’ TAGĦRIF,mt,,q Dan il-prodott mediċinali huwa suġġett għal monitoraġġ addizzjonali. Dan ser jippermetti identifikazzjoni ta’ malajr ta’ informazzjoni ġdida dwar is-sigurtà. Inti tista’ tgħin billi tirrapporta kwalunkwe effett sekondarju li jista’ jkollok. Ara t-tmiem ta’ sezzjoni 4 biex tara kif għandek tirrapporta effetti sekondarji. ,67001.0,False,2
2284,67003,CAP,FULJETT TA’ TAGĦRIF,mt,,F’dan il-fuljett,67001.0,True,3
2285,67004,CAP,FULJETT TA’ TAGĦRIF,mt,1,X’inhu X u gћalxiex jintuża,67001.0,True,4
2286,67005,CAP,FULJETT TA’ TAGĦRIF,mt,2,X'għandek tkun taf qabel ma <tieħu> <tuża> X ,67001.0,True,5
2287,67006,CAP,FULJETT TA’ TAGĦRIF,mt,,<Tiħux> <Tużax> X<:>,67005.0,True,6
2288,67007,CAP,FULJETT TA’ TAGĦRIF,mt,,Twissijiet u prekawzjonijiet,67005.0,True,7
2289,67008,CAP,FULJETT TA’ TAGĦRIF,mt,,Tfal <u adolexxenti>,67005.0,True,8
2290,67009,CAP,FULJETT TA’ TAGĦRIF,mt,,Mediċini oħra u X,67005.0,True,9
2291,67010,CAP,FULJETT TA’ TAGĦRIF,mt,,"X ma’ <ikel><u> <,> <xorb> <u> <alkoħol>",67005.0,True,10
2292,67011,CAP,FULJETT TA’ TAGĦRIF,mt,,"Tqala <u> <,> treddigħ <u fertilità>",67005.0,True,11
2293,67012,CAP,FULJETT TA’ TAGĦRIF,mt,,Sewqan u tħaddim ta’ magni,67005.0,True,12
2294,67013,CAP,FULJETT TA’ TAGĦRIF,mt,,X fih {isem tas-sustanza(i) mhux attiva(i)},67005.0,False,13
2295,67014,CAP,FULJETT TA’ TAGĦRIF,mt,3,Kif gћandek <tieћu><tuża> X,67001.0,True,14
2296,67015,CAP,FULJETT TA’ TAGĦRIF,mt,,Użu fit-tfal <u fl-adolexxenti>,67014.0,False,15
2297,67016,CAP,FULJETT TA’ TAGĦRIF,mt,,Jekk <tieħu> <tuża> X aktar milli suppost>,67014.0,False,16
2298,67017,CAP,FULJETT TA’ TAGĦRIF,mt,,Jekk tinsa <tieħu> <tuża> X,67014.0,False,17
2299,67018,CAP,FULJETT TA’ TAGĦRIF,mt,,Jekk tieqaf <tieħu> <tuża> X,67014.0,False,18
2300,67019,CAP,FULJETT TA’ TAGĦRIF,mt,4,Effetti sekondarji possibbli,67001.0,True,19
2301,67020,CAP,FULJETT TA’ TAGĦRIF,mt,,Effetti sekondarji oħra fit-tfal <u l-adolexxenti>,67019.0,False,20
2302,67021,CAP,FULJETT TA’ TAGĦRIF,mt,,Rappurtar tal-effetti sekondarji,67019.0,True,21
2303,67022,CAP,FULJETT TA’ TAGĦRIF,mt,5,Kif taħżen X,67001.0,True,22
2304,67023,CAP,FULJETT TA’ TAGĦRIF,mt,6,Kontenut tal-pakkett u informazzjoni oħra,67001.0,True,23
2305,67024,CAP,FULJETT TA’ TAGĦRIF,mt,,X’fih X,67023.0,True,24
2306,67025,CAP,FULJETT TA’ TAGĦRIF,mt,,Kif jidher X u l-kontenut tal-pakkett,67023.0,True,25
2307,67026,CAP,FULJETT TA’ TAGĦRIF,mt,,Detentur tal-Awtorizzazzjoni għat-Tqegħid fis-Suq u l-Manifattur,67023.0,True,26
2308,67027,CAP,FULJETT TA’ TAGĦRIF,mt,,"Għal kull tagħrif dwar din il-mediċina, jekk jogħġbok ikkuntattja lir-rappreżentant lokali tad-Detentur tal-Awtorizzazzjoni għat-Tqegħid fis-Suq:",67023.0,False,27
2309,67028,CAP,FULJETT TA’ TAGĦRIF,mt,,Dan il-fuljett kien rivedut l-aħħar f’ <{XX/SSSS} ><{xahar SSSS} >.,67023.0,True,28
2310,67029,CAP,FULJETT TA’ TAGĦRIF,mt,,Sorsi oħra ta’ informazzjoni,67023.0,False,29
2311,67030,CAP,FULJETT TA’ TAGĦRIF,mt,,It-tagħrif li jmiss qed jingħata biss għall-professjonisti tal-kura tas-saħħa biss:,67001.0,False,30
2312,68001,CAP,SmPC,nl,,SAMENVATTING VAN DE PRODUCTKENMERKEN,,True,1
2313,68002,CAP,SmPC,nl,,qDit geneesmiddel is onderworpen aan aanvullende monitoring.  Daardoor kan snel nieuwe veiligheidsinformatie worden vastgesteld. Beroepsbeoefenaren in de gezondheidszorg wordt verzocht alle vermoedelijke bijwerkingen te melden. Zie rubriek 4.8 voor het rapporteren van bijwerkingen,68001.0,False,2
2314,68003,CAP,SmPC,nl,1,NAAM VAN HET GENEESMIDDEL,68001.0,True,3
2315,68004,CAP,SmPC,nl,2,KWALITATIEVE EN KWANTITATIEVE SAMENSTELLING,68001.0,True,4
2316,68005,CAP,SmPC,nl,2.1,Algemene beschrijving,68004.0,False,5
2317,68006,CAP,SmPC,nl,2.2,Kwalitatieve en kwantitatieve samenstelling,68004.0,False,6
2318,68007,CAP,SmPC,nl,,Hulpstof(fen) met bekend effect,68006.0,False,7
2319,68008,CAP,SmPC,nl,3,FARMACEUTISCHE VORM,68001.0,True,8
2320,68009,CAP,SmPC,nl,4,KLINISCHE GEGEVENS,68001.0,True,9
2321,68010,CAP,SmPC,nl,4.1,Therapeutische indicaties,68009.0,True,10
2322,68011,CAP,SmPC,nl,4.2,Dosering en wijze van toediening,68009.0,True,11
2323,68012,CAP,SmPC,nl,,Dosering,68011.0,True,12
2324,68013,CAP,SmPC,nl,,Pediatrische patiënten,68012.0,True,13
2325,68014,CAP,SmPC,nl,,Wijze van toediening,68011.0,True,14
2326,68015,CAP,SmPC,nl,,Te nemen voorzorgen voorafgaand aan gebruik of toediening van het geneesmiddel,68014.0,False,15
2327,68016,CAP,SmPC,nl,4.3,Contra-indicaties,68009.0,True,16
2328,68017,CAP,SmPC,nl,4.4,Bijzondere waarschuwingen en voorzorgen bij gebruik,68009.0,True,17
2329,68018,CAP,SmPC,nl,,Terugvinden herkomst,68017.0,False,18
2330,68019,CAP,SmPC,nl,,Pediatrische patiënten,68017.0,False,19
2331,68020,CAP,SmPC,nl,4.5,Interacties met andere geneesmiddelen en andere vormen van interactie,68009.0,True,20
2332,68021,CAP,SmPC,nl,,Pediatrische patiënten,68020.0,False,21
2333,68022,CAP,SmPC,nl,4.6,"Vruchtbaarheid, zwangerschap en borstvoeding",68009.0,True,22
2334,68023,CAP,SmPC,nl,,Zwangerschap,68022.0,False,23
2335,68024,CAP,SmPC,nl,,Borstvoeding,68022.0,False,24
2336,68025,CAP,SmPC,nl,,Vruchtbaarheid,68022.0,False,25
2337,68026,CAP,SmPC,nl,4.7,Beïnvloeding van de rijvaardigheid en het vermogen om machines te bedienen,68009.0,True,26
2338,68027,CAP,SmPC,nl,4.8,Bijwerkingen,68009.0,True,27
2339,68028,CAP,SmPC,nl,,Pediatrische patiënten,68027.0,False,28
2340,68029,CAP,SmPC,nl,,Melding van vermoedelijke bijwerkingen,68027.0,True,29
2341,68030,CAP,SmPC,nl,4.9,Overdosering,68009.0,True,30
2342,68031,CAP,SmPC,nl,,Pediatrische patiënten,68030.0,False,31
2343,68032,CAP,SmPC,nl,5,FARMACOLOGISCHE EIGENSCHAPPEN,68001.0,True,32
2344,68033,CAP,SmPC,nl,5.1,Farmacodynamische eigenschappen,68032.0,True,33
2345,68034,CAP,SmPC,nl,,Werkingsmechanisme,68033.0,False,34
2346,68035,CAP,SmPC,nl,,Farmacodynamische effecten,68033.0,False,35
2347,68036,CAP,SmPC,nl,,Klinische werkzaamheid en veiligheid,68033.0,False,36
2348,68037,CAP,SmPC,nl,,Pediatrische patiënten,68033.0,False,37
2349,68038,CAP,SmPC,nl,5.2,Farmacokinetische eigenschappen,68032.0,True,38
2350,68039,CAP,SmPC,nl,,Absorptie,68038.0,False,39
2351,68040,CAP,SmPC,nl,,Distributie,68038.0,False,40
2352,68041,CAP,SmPC,nl,,Biotransformatie,68038.0,False,41
2353,68042,CAP,SmPC,nl,,Eliminatie,68038.0,False,42
2354,68043,CAP,SmPC,nl,,Lineariteit/non-lineariteit,68038.0,False,43
2355,68044,CAP,SmPC,nl,,Farmacokinetische/farmacodynamische relatie(s),68038.0,False,44
2356,68045,CAP,SmPC,nl,5.3,Gegevens uit het preklinisch veiligheidsonderzoek,68032.0,True,45
2357,68046,CAP,SmPC,nl,,Environmental risk assessment (ERA),68045.0,False,46
2358,68047,CAP,SmPC,nl,6,FARMACEUTISCHE GEGEVENS,68001.0,True,47
2359,68048,CAP,SmPC,nl,6.1,Lijst van hulpstoffen,68047.0,True,48
2360,68049,CAP,SmPC,nl,6.2,Gevallen van onverenigbaarheid,68047.0,True,49
2361,68050,CAP,SmPC,nl,6.3,Houdbaarheid,68047.0,True,50
2362,68051,CAP,SmPC,nl,6.4,Speciale voorzorgsmaatregelen bij bewaren,68047.0,True,51
2363,68052,CAP,SmPC,nl,6.5,"Aard en inhoud van de verpakking <en speciale benodigdheden voor gebruik, toediening of implantatie>",68047.0,True,52
2364,68053,CAP,SmPC,nl,6.6,Speciale voorzorgsmaatregelen voor het verwijderen <en andere instructies>,68047.0,True,53
2365,68054,CAP,SmPC,nl,,Gebruik bij pediatrische patiënten,68053.0,False,54
2366,68055,CAP,SmPC,nl,7,HOUDER VAN DE VERGUNNING VOOR HET IN DE HANDEL BRENGEN,68001.0,True,55
2367,68056,CAP,SmPC,nl,8,NUMMER(S) VAN DE VERGUNNING VOOR HET IN DE HANDEL BRENGEN ,68001.0,True,56
2368,68057,CAP,SmPC,nl,9,DATUM VAN EERSTE VERLENING VAN DE VERGUNNING/VERLENGING VAN DE VERGUNNING,68001.0,True,57
2369,68058,CAP,SmPC,nl,10,DATUM VAN HERZIENING VAN DE TEKST,68001.0,True,58
2370,68059,CAP,SmPC,nl,11,DOSIMETRIE,68001.0,False,59
2371,68060,CAP,SmPC,nl,12,INSTRUCTIES VOOR DE BEREIDING VAN RADIOACTIEVE GENEESMIDDELEN,68001.0,False,60
2372,69001,CAP,BIJLAGE II,nl,,BIJLAGE II,,True,1
2373,69002,CAP,BIJLAGE II,nl,A,<FABRIKANT(EN) VAN DE BIOLOGISCH WERKZAME STOF(FEN) EN >FABRIKANT(EN) VERANTWOORDELIJK VOOR VRIJGIFTE,69001.0,True,2
2374,69003,CAP,BIJLAGE II,nl,,Naam en adres van de fabrikant(en) van de biologisch werkzame stof(fen),69002.0,False,3
2375,69004,CAP,BIJLAGE II,nl,,Naam en adres van de fabrikant(en) verantwoordelijk voor vrijgifte,69002.0,True,4
2376,69005,CAP,BIJLAGE II,nl,B,VOORWAARDEN OF BEPERKINGEN TEN AANZIEN VAN LEVERING EN GEBRUIK,69001.0,True,5
2377,69006,CAP,BIJLAGE II,nl,,Officiële vrijgifte van de batch,69005.0,False,6
2378,69007,CAP,BIJLAGE II,nl,C,ANDERE VOORWAARDEN EN EISEN DIE DOOR DE HOUDER VAN DE HANDELSVERGUNNING MOETEN WORDEN NAGEKOMEN,69001.0,True,7
2379,69008,CAP,BIJLAGE II,nl,,Periodieke veiligheidsverslagen ,69007.0,True,8
2380,69009,CAP,BIJLAGE II,nl,D,VOORWAARDEN OF BEPERKINGEN MET BETREKKING TOT EEN VEILIG EN DOELTREFFEND GEBRUIK VAN HET GENEESMIDDEL,69001.0,True,9
2381,69010,CAP,BIJLAGE II,nl,,Risk management plan (RMP),69009.0,True,10
2382,69011,CAP,BIJLAGE II,nl,,Extra risicobeperkende maatregelen,69009.0,False,11
2383,69012,CAP,BIJLAGE II,nl,,Verplichting tot het nemen van maatregelen na toekenning van de handelsvergunning,69009.0,False,12
2384,69013,CAP,BIJLAGE II,nl,E,SPECIFIEKE VERPLICHTINGEN WAARAAN NA TOEKENNING VAN EEN <VOORWAARDELIJKE VERGUNNING> <VERGUNNING ONDER UITZONDERLIJKE VOORWAARDEN> MOET WORDEN VOLDAAN,69001.0,False,13
2385,70001,CAP,ETIKETTERING,nl,,ETIKETTERING,,True,1
2386,70002,CAP,ETIKETTERING,nl,,GEGEVENS DIE OP <DE BUITENVERPAKKING><EN> <DE PRIMAIRE VERPAKKING> MOETEN WORDEN VERMELD,70001.0,True,2
2387,70003,CAP,ETIKETTERING,nl,1,NAAM VAN HET GENEESMIDDEL,70002.0,True,3
2388,70004,CAP,ETIKETTERING,nl,2,GEHALTE AAN WERKZAME STOF(FEN),70002.0,True,4
2389,70005,CAP,ETIKETTERING,nl,3,LIJST VAN HULPSTOFFEN,70002.0,True,5
2390,70006,CAP,ETIKETTERING,nl,4,FARMACEUTISCHE VORM EN INHOUD,70002.0,True,6
2391,70007,CAP,ETIKETTERING,nl,5,WIJZE VAN GEBRUIK EN TOEDIENINGSWEG(EN),70002.0,True,7
2392,70008,CAP,ETIKETTERING,nl,6,EEN SPECIALE WAARSCHUWING DAT HET GENEESMIDDEL BUITEN HET ZICHT EN BEREIK VAN KINDEREN DIENT TE WORDEN GEHOUDEN,70002.0,True,8
2393,70009,CAP,ETIKETTERING,nl,7,"ANDERE SPECIALE WAARSCHUWING(EN), INDIEN NODIG",70002.0,True,9
2394,70010,CAP,ETIKETTERING,nl,8,UITERSTE GEBRUIKSDATUM,70002.0,True,10
2395,70011,CAP,ETIKETTERING,nl,9,BIJZONDERE VOORZORGSMAATREGELEN VOOR DE BEWARING,70002.0,True,11
2396,70012,CAP,ETIKETTERING,nl,10,BIJZONDERE VOORZORGSMAATREGELEN VOOR HET VERWIJDEREN VAN NIET-GEBRUIKTE GENEESMIDDELEN OF DAARVAN AFGELEIDE AFVALSTOFFEN (INDIEN VAN TOEPASSING),70002.0,True,12
2397,70013,CAP,ETIKETTERING,nl,11,NAAM EN ADRES VAN DE HOUDER VAN DE VERGUNNING VOOR HET IN DE HANDEL BRENGEN,70002.0,True,13
2398,70014,CAP,ETIKETTERING,nl,12,NUMMER(S) VAN DE VERGUNNING VOOR HET IN DE HANDEL BRENGEN ,70002.0,True,14
2399,70015,CAP,ETIKETTERING,nl,13,"PARTIJNUMMER<, IDENTIFICATIE- EN PRODUCTCODES>",70002.0,True,15
2400,70016,CAP,ETIKETTERING,nl,14,ALGEMENE INDELING VOOR DE AFLEVERING,70002.0,True,16
2401,70017,CAP,ETIKETTERING,nl,15,INSTRUCTIES VOOR GEBRUIK,70002.0,True,17
2402,70018,CAP,ETIKETTERING,nl,16,INFORMATIE IN BRAILLE,70002.0,True,18
2403,70019,CAP,ETIKETTERING,nl,17,UNIEK IDENTIFICATIEKENMERK - 2D MATRIXCODE,70002.0,True,19
2404,70020,CAP,ETIKETTERING,nl,18,UNIEK IDENTIFICATIEKENMERK - VOOR MENSEN LEESBARE GEGEVENS,70002.0,True,20
2405,70021,CAP,ETIKETTERING,nl,,GEGEVENS DIE IN IEDER GEVAL OP BLISTERVERPAKKINGEN OF STRIPS MOETEN WORDEN VERMELD,70001.0,True,21
2406,70022,CAP,ETIKETTERING,nl,1,NAAM VAN HET GENEESMIDDEL,70021.0,True,22
2407,70023,CAP,ETIKETTERING,nl,2,NAAM VAN DE HOUDER VAN DE VERGUNNING VOOR HET IN DE HANDEL BRENGEN,70021.0,True,23
2408,70024,CAP,ETIKETTERING,nl,3,UITERSTE GEBRUIKSDATUM,70021.0,True,24
2409,70025,CAP,ETIKETTERING,nl,4,"PARTIJNUMMER<, IDENTIFICATIE- EN PRODUCTCODES>",70021.0,True,25
2410,70026,CAP,ETIKETTERING,nl,5,OVERIGE,70021.0,True,26
2411,70027,CAP,ETIKETTERING,nl,,GEGEVENS DIE IN IEDER GEVAL OP PRIMAIRE KLEINVERPAKKINGEN MOETEN WORDEN VERMELD,70001.0,True,27
2412,70028,CAP,ETIKETTERING,nl,1,NAAM VAN HET GENEESMIDDEL EN DE TOEDIENINGSWEG(EN),70027.0,True,28
2413,70029,CAP,ETIKETTERING,nl,2,NAAM VAN HET GENEESMIDDEL EN DE TOEDIENINGSWEG(EN),70027.0,True,29
2414,70030,CAP,ETIKETTERING,nl,3,UITERSTE GEBRUIKSDATUM,70027.0,True,30
2415,70031,CAP,ETIKETTERING,nl,4,"PARTIJNUMMER<, IDENTIFICATIE- EN PRODUCTCODES>",70027.0,True,31
2416,70032,CAP,ETIKETTERING,nl,5,"INHOUD UITGEDRUKT IN GEWICHT, VOLUME OF EENHEID",70027.0,True,32
2417,70033,CAP,ETIKETTERING,nl,6,OVERIGE,70027.0,True,33
2418,71001,CAP,BIJSLUITER,nl,,BIJSLUITER,,True,1
2419,71002,CAP,BIJSLUITER,nl,,q Dit geneesmiddel is onderworpen aan aanvullende monitoring. Daardoor kan snel nieuwe veiligheidsinformatie worden vastgesteld. U kunt hieraan bijdragen door melding te maken van alle bijwerkingen die u eventueel zou ervaren. Aan het einde van rubriek 4 leest u hoe u dat kunt doen,71001.0,False,2
2420,71003,CAP,BIJSLUITER,nl,,Inhoud van deze bijsluiter,71001.0,True,3
2421,71004,CAP,BIJSLUITER,nl,1,Wat is X en waarvoor wordt dit middel <gebruikt><ingenomen>?,71001.0,True,4
2422,71005,CAP,BIJSLUITER,nl,2,Wanneer mag u dit middel niet <gebruiken><innemen> of moet u er extra voorzichtig mee zijn?,71001.0,True,5
2423,71006,CAP,BIJSLUITER,nl,,Wanneer mag u dit middel niet gebruiken?,71005.0,True,6
2424,71007,CAP,BIJSLUITER,nl,,Wanneer moet u extra voorzichtig zijn met dit middel?,71005.0,True,7
2425,71008,CAP,BIJSLUITER,nl,,Kinderen <en jongeren tot 18 jaar>,71005.0,True,8
2426,71009,CAP,BIJSLUITER,nl,,<Gebruikt u nog andere geneesmiddelen?><Neemt u nog andere geneesmiddelen in?>,71005.0,True,9
2427,71010,CAP,BIJSLUITER,nl,,"Waarop moet u letten met <eten> <en> <,> <drinken> <en> <alcohol>?",71005.0,True,10
2428,71011,CAP,BIJSLUITER,nl,,"Zwangerschap <en> <,> borstvoeding <en vruchtbaarheid>",71005.0,True,11
2429,71012,CAP,BIJSLUITER,nl,,Rijvaardigheid en het gebruik van machines,71005.0,True,12
2430,71013,CAP,BIJSLUITER,nl,,X bevat {naam van de hulpstof(fen)},71005.0,False,13
2431,71014,CAP,BIJSLUITER,nl,3,Hoe <gebruikt u dit middel><neemt u dit middel in>?,71001.0,True,14
2432,71015,CAP,BIJSLUITER,nl,,Gebruik bij kinderen <en jongeren tot 18 jaar>,71014.0,False,15
2433,71016,CAP,BIJSLUITER,nl,,Heeft u te veel van dit middel <gebruikt> <ingenomen>?,71014.0,False,16
2434,71017,CAP,BIJSLUITER,nl,,Bent u vergeten dit middel <te gebruiken> <in te nemen>?,71014.0,False,17
2435,71018,CAP,BIJSLUITER,nl,,Als u stopt met het <innemen> <gebruik> van dit middel,71014.0,False,18
2436,71019,CAP,BIJSLUITER,nl,4,Mogelijke bijwerkingen,71001.0,True,19
2437,71020,CAP,BIJSLUITER,nl,,Extra bijwerkingen die bij kinderen <en jongeren tot 18 jaar> kunnen voorkomen,71019.0,False,20
2438,71021,CAP,BIJSLUITER,nl,,Het melden van bijwerkingen,71019.0,True,21
2439,71022,CAP,BIJSLUITER,nl,5,Hoe bewaart u dit middel?,71001.0,True,22
2440,71023,CAP,BIJSLUITER,nl,6,Inhoud van de verpakking en overige informatie,71001.0,True,23
2441,71024,CAP,BIJSLUITER,nl,,Welke stoffen zitten er in dit middel?,71023.0,True,24
2442,71025,CAP,BIJSLUITER,nl,,Hoe ziet X eruit en hoeveel zit er in een verpakking?,71023.0,True,25
2443,71026,CAP,BIJSLUITER,nl,,Houder van de vergunning voor het in de handel brengen en fabrikant,71023.0,True,26
2444,71027,CAP,BIJSLUITER,nl,,Neem voor alle informatie over dit geneesmiddel contact op met de lokale vertegenwoordiger van de houder van de vergunning voor het in de handel brengen:,71023.0,False,27
2445,71028,CAP,BIJSLUITER,nl,,Deze bijsluiter is voor het laatst goedgekeurd in <{MM/JJJJ}> <{maand JJJJ}>.,71023.0,True,28
2446,71029,CAP,BIJSLUITER,nl,,Andere informatiebronnen,71023.0,False,29
2447,71030,CAP,BIJSLUITER,nl,,De volgende informatie is alleen bestemd voor beroepsbeoefenaren in de gezondheidszorg:,71001.0,False,30
2448,72001,CAP,SmPC,no,,PREPARATOMTALE,,True,1
2449,72002,CAP,SmPC,no,,qDette legemidlet er underlagt særlig overvåking for å oppdage ny sikkerhetsinformasjon så raskt som mulig. Helsepersonell oppfordres til å melde enhver mistenkt bivirkning. Se pkt. 4.8 for informasjon om bivirkningsrapportering.,72001.0,False,2
2450,72003,CAP,SmPC,no,1,LEGEMIDLETS NAVN,72001.0,True,3
2451,72004,CAP,SmPC,no,2,KVALITATIV OG KVANTITATIV SAMMENSETNING,72001.0,True,4
2452,72005,CAP,SmPC,no,2.1,Generell beskrivelse,72004.0,False,5
2453,72006,CAP,SmPC,no,2.2,Kvalitativ og kvantitativ sammensetning,72004.0,False,6
2454,72007,CAP,SmPC,no,,Hjelpestoff(er) med kjent effekt,72006.0,False,7
2455,72008,CAP,SmPC,no,3,LEGEMIDDELFORM,72001.0,True,8
2456,72009,CAP,SmPC,no,4,KLINISKE OPPLYSNINGER,72001.0,True,9
2457,72010,CAP,SmPC,no,4.1,Indikasjon(er),72009.0,True,10
2458,72011,CAP,SmPC,no,4.2,Dosering og administrasjonsmåte,72009.0,True,11
2459,72012,CAP,SmPC,no,,Dosering,72011.0,True,12
2460,72013,CAP,SmPC,no,,Pediatrisk populasjon,72012.0,True,13
2461,72014,CAP,SmPC,no,,Administrasjonsmåte,72011.0,True,14
2462,72015,CAP,SmPC,no,,Forholdsregler før håndtering eller administrering av dette legemidlet,72014.0,False,15
2463,72016,CAP,SmPC,no,4.3,Kontraindikasjoner,72009.0,True,16
2464,72017,CAP,SmPC,no,4.4,Advarsler og forsiktighetsregler,72009.0,True,17
2465,72018,CAP,SmPC,no,,Sporbarhet,72017.0,False,18
2466,72019,CAP,SmPC,no,,Pediatrisk populasjon,72017.0,False,19
2467,72020,CAP,SmPC,no,4.5,Interaksjon med andre legemidler og andre former for interaksjon,72009.0,True,20
2468,72021,CAP,SmPC,no,,Pediatrisk populasjon,72020.0,False,21
2469,72022,CAP,SmPC,no,4.6,"Fertilitet, graviditet og amming",72009.0,True,22
2470,72023,CAP,SmPC,no,,Graviditet,72022.0,False,23
2471,72024,CAP,SmPC,no,,Amming,72022.0,False,24
2472,72025,CAP,SmPC,no,,Fertilitet,72022.0,False,25
2473,72026,CAP,SmPC,no,4.7,Påvirkning av evnen til å kjøre bil og bruke maskiner,72009.0,True,26
2474,72027,CAP,SmPC,no,4.8,Bivirkninger,72009.0,True,27
2475,72028,CAP,SmPC,no,,Pediatrisk populasjon,72027.0,False,28
2476,72029,CAP,SmPC,no,,Melding av mistenkte bivirkninger,72027.0,True,29
2477,72030,CAP,SmPC,no,4.9,Overdosering,72009.0,True,30
2478,72031,CAP,SmPC,no,,Pediatrisk populasjon,72030.0,False,31
2479,72032,CAP,SmPC,no,5,FARMAKOLOGISKE EGENSKAPER,72001.0,True,32
2480,72033,CAP,SmPC,no,5.1,Farmakodynamiske egenskaper,72032.0,True,33
2481,72034,CAP,SmPC,no,,Virkningsmekanisme,72033.0,False,34
2482,72035,CAP,SmPC,no,,Farmakodynamiske effekter,72033.0,False,35
2483,72036,CAP,SmPC,no,,Klinisk effekt og sikkerhet,72033.0,False,36
2484,72037,CAP,SmPC,no,,Pediatrisk populasjon,72033.0,False,37
2485,72038,CAP,SmPC,no,5.2,Farmakokinetiske egenskaper,72032.0,True,38
2486,72039,CAP,SmPC,no,,Absorpsjon,72038.0,False,39
2487,72040,CAP,SmPC,no,,Distribusjon,72038.0,False,40
2488,72041,CAP,SmPC,no,,Biotransformasjon,72038.0,False,41
2489,72042,CAP,SmPC,no,,Eliminasjon,72038.0,False,42
2490,72043,CAP,SmPC,no,,Linearitet/ikke-linearitet,72038.0,False,43
2491,72044,CAP,SmPC,no,,Farmakokinetiske/farmakodynamiske forhold,72038.0,False,44
2492,72045,CAP,SmPC,no,5.3,Prekliniske sikkerhetsdata,72032.0,True,45
2493,72046,CAP,SmPC,no,,"Evaluering av miljørisiko (Environmental risk assessment, ERA)",72045.0,False,46
2494,72047,CAP,SmPC,no,6,FARMASØYTISKE OPPLYSNINGER,72001.0,True,47
2495,72048,CAP,SmPC,no,6.1,Hjelpestoffer,72047.0,True,48
2496,72049,CAP,SmPC,no,6.2,Uforlikeligheter,72047.0,True,49
2497,72050,CAP,SmPC,no,6.3,Holdbarhet,72047.0,True,50
2498,72051,CAP,SmPC,no,6.4,Oppbevaringsbetingelser,72047.0,True,51
2499,72052,CAP,SmPC,no,6.5,"Emballasje (type og innhold) <og spesielt utstyr for bruk, administrering eller implantasjon>",72047.0,True,52
2500,72053,CAP,SmPC,no,6.6,Spesielle forholdsregler for destruksjon <og annen håndtering>,72047.0,True,53
2501,72054,CAP,SmPC,no,,Bruk i den pediatriske populasjonen,72053.0,False,54
2502,72055,CAP,SmPC,no,7,INNEHAVER AV MARKEDSFØRINGSTILLATELSEN,72001.0,True,55
2503,72056,CAP,SmPC,no,8,MARKEDSFØRINGSTILLATELSESNUMMER (NUMRE),72001.0,True,56
2504,72057,CAP,SmPC,no,9,DATO FOR FØRSTE MARKEDSFØRINGSTILLATELSE / SISTE FORNYELSE,72001.0,True,57
2505,72058,CAP,SmPC,no,10,OPPDATERINGSDATO,72001.0,True,58
2506,72059,CAP,SmPC,no,11,DOSIMETRI,72001.0,False,59
2507,72060,CAP,SmPC,no,12,INSTRUKSJONER FOR TILBEREDELSE AV RADIOFARMAKA,72001.0,False,60
2508,73001,CAP,AnnexII,no,,VEDLEGG II,,True,1
2509,73002,CAP,AnnexII,no,A,<TILVIRKER(E) AV BIOLOGISK (E) VIRKESTOFF(ER) OG> TILVIRKER(E) ANSVARLIG FOR BATCH RELEASE,73001.0,True,2
2510,73003,CAP,AnnexII,no,,Navn og adresse til tilvirker(e) av biologisk(e) virkestoff(er),73002.0,False,3
2511,73004,CAP,AnnexII,no,,Navn og adresse til tilvirker(e) ansvarlig for batch release,73002.0,True,4
2512,73005,CAP,AnnexII,no,B,VILKÅR ELLER RESTRIKSJONER VEDRØRENDE LEVERANSE OG BRUK,73001.0,True,5
2513,73006,CAP,AnnexII,no,,Offisiell batch release,73005.0,False,6
2514,73007,CAP,AnnexII,no,C,ANDRE VILKÅR OG KRAV TIL MARKEDSFØRINGSTILLATELSEN,73001.0,True,7
2515,73008,CAP,AnnexII,no,,Periodiske sikkerhetsoppdateringsrapporter (PSUR-er),73007.0,True,8
2516,73009,CAP,AnnexII,no,D,VILKÅR ELLER RESTRIKSJONER VEDRØRENDE SIKKER OG EFFEKTIV BRUK AV LEGEMIDLET,73001.0,True,9
2517,73010,CAP,AnnexII,no,,Risikohåndteringsplan (RMP),73009.0,True,10
2518,73011,CAP,AnnexII,no,,Andre risikominimeringsaktiviteter,73009.0,False,11
2519,73012,CAP,AnnexII,no,,Forpliktelse til å utføre tiltak etter autorisasjon,73009.0,False,12
2520,73013,CAP,AnnexII,en,E,SPESIFIKK FORPLIKTELSE TIL Å FULLFØRE TILTAK ETTER AUTORISASJON FOR <DEN BETINGEDE MARKEDSFØRINGSTILLATELSEN> <MARKEDSFØRINGSTILLATELSEN GITT PÅ SÆRSKILT GRUNNLAG>,73001.0,False,13
2521,74001,CAP,Labelling,no,,MERKING,,True,1
2522,74002,CAP,Labelling,no,,OPPLYSNINGER SOM SKAL ANGIS PÅ <YTRE EMBALLASJE><OG> <INDRE EMBALLASJE>,74001.0,True,2
2523,74003,CAP,Labelling,no,1,LEGEMIDLETS NAVN,74002.0,True,3
2524,74004,CAP,Labelling,no,2,DEKLARASJON AV VIRKESTOFF(ER),74002.0,True,4
2525,74005,CAP,Labelling,no,3,LISTE OVER HJELPESTOFFER,74002.0,True,5
2526,74006,CAP,Labelling,no,4,LEGEMIDDELFORM OG INNHOLD (PAKNINGSSTØRRELSE),74002.0,True,6
2527,74007,CAP,Labelling,no,5,ADMINISTRASJONSMÅTE OG -VEI(ER),74002.0,True,7
2528,74008,CAP,Labelling,no,6,ADVARSEL OM AT LEGEMIDLET SKAL OPPBEVARES UTILGJENGELIG FOR BARN,74002.0,True,8
2529,74009,CAP,Labelling,no,7,EVENTUELLE ANDRE SPESIELLE ADVARSLER,74002.0,True,9
2530,74010,CAP,Labelling,no,8,UTLØPSDATO,74002.0,True,10
2531,74011,CAP,Labelling,no,9,OPPBEVARINGSBETINGELSER,74002.0,True,11
2532,74012,CAP,Labelling,no,10,EVENTUELLE SPESIELLE FORHOLDSREGLER VED DESTRUKSJON AV UBRUKTE LEGEMIDLER ELLER AVFALL,74002.0,True,12
2533,74013,CAP,Labelling,no,11,NAVN OG ADRESSE PÅ INNEHAVEREN AV MARKEDSFØRINGSTILLATELSEN,74002.0,True,13
2534,74014,CAP,Labelling,no,12,MARKEDSFØRINGSTILLATELSESNUMMER (NUMRE),74002.0,True,14
2535,74015,CAP,Labelling,no,13,"PRODUKSJONSNUMMER<, DONASJONS- OG PRODUKTKODER>",74002.0,True,15
2536,74016,CAP,Labelling,no,14,GENERELL KLASSIFIKASJON FOR UTLEVERING,74002.0,True,16
2537,74017,CAP,Labelling,no,15,BRUKSANVISNING,74002.0,True,17
2538,74018,CAP,Labelling,no,16,INFORMASJON PÅ BLINDESKRIFT,74002.0,True,18
2539,74019,CAP,Labelling,no,17,SIKKERHETSANORDNING (UNIK IDENTITET) – TODIMENSJONAL STREKKODE,74002.0,True,19
2540,74020,CAP,Labelling,no,18,SIKKERHETSANORDNING (UNIK IDENTITET) – I ET FORMAT LESBART FOR MENNESKER,74002.0,True,20
2541,74021,CAP,Labelling,no,,MINSTEKRAV TIL OPPLYSNINGER SOM SKAL ANGIS PÅ BLISTER ELLER STRIP,74001.0,True,21
2542,74022,CAP,Labelling,no,1,LEGEMIDLETS NAVN,74021.0,True,22
2543,74023,CAP,Labelling,no,2,NAVN PÅ INNEHAVEREN AV MARKEDSFØRINGSTILLATELSEN,74021.0,True,23
2544,74024,CAP,Labelling,no,3,UTLØPSDATO,74021.0,True,24
2545,74025,CAP,Labelling,no,4,"PRODUKSJONSNUMMER <, DONASJONS- OG PRODUKTKODER>",74021.0,True,25
2546,74026,CAP,Labelling,no,5,ANNET,74021.0,True,26
2547,74027,CAP,Labelling,no,,MINSTEKRAV TIL OPPLYSNINGER SOM SKAL ANGIS PÅ SMÅ INDRE EMBALLASJER,74001.0,True,27
2548,74028,CAP,Labelling,no,1,LEGEMIDLETS NAVN OG ADMINISTRASJONSVEI,74027.0,True,28
2549,74029,CAP,Labelling,no,2,ADMINISTRASJONSMÅTE,74027.0,True,29
2550,74030,CAP,Labelling,no,3,UTLØPSDATO,74027.0,True,30
2551,74031,CAP,Labelling,no,4,"PRODUKSJONSNUMMER<, DONASJONS- OG PRODUKTKODER>",74027.0,True,31
2552,74032,CAP,Labelling,no,5,"INNHOLD ANGITT ETTER VEKT, VOLUM ELLER ANTALL DOSER",74027.0,True,32
2553,74033,CAP,Labelling,no,6,ANNET,74027.0,True,33
2554,75001,CAP,Package leaflet,no,,PAKNINGSVEDLEGG,,True,1
2555,75002,CAP,Package leaflet,no,,qDette legemidlet er underlagt særlig overvåking for å oppdage ny sikkerhetsinformasjon så raskt som mulig. Du kan bidra ved å melde enhver mistenkt bivirkning. Se avsnitt 4 for informasjon om hvordan du melder bivirkninger.,75001.0,False,2
2556,75003,CAP,Package leaflet,no,,I dette pakningsvedlegget finner du informasjon om:,75001.0,True,3
2557,75004,CAP,Package leaflet,no,1,Hva X er og hva det brukes mot,75001.0,True,4
2558,75005,CAP,Package leaflet,no,2,Hva du må vite før du bruker X,75001.0,True,5
2559,75006,CAP,Package leaflet,no,,Bruk ikke X<:>,75005.0,True,6
2560,75007,CAP,Package leaflet,no,,Advarsler og forsiktighetsregler,75005.0,True,7
2561,75008,CAP,Package leaflet,no,,Barn <og ungdom> ,75005.0,True,8
2562,75009,CAP,Package leaflet,no,,Andre legemidler og X,75005.0,True,9
2563,75010,CAP,Package leaflet,no,,"Inntak av X sammen med <mat> <og> <,> <drikke> <og> <alkohol>",75005.0,True,10
2564,75011,CAP,Package leaflet,no,,"Graviditet <og> <,> amming <og fertilitet>",75005.0,True,11
2565,75012,CAP,Package leaflet,no,,Kjøring og bruk av maskiner,75005.0,True,12
2566,75013,CAP,Package leaflet,no,,X inneholder {navn på hjelpestoff(er)},75005.0,False,13
2567,75014,CAP,Package leaflet,no,3,Hvordan du bruker X,75001.0,True,14
2568,75015,CAP,Package leaflet,no,,Bruk hos barn <og ungdom>,75014.0,False,15
2569,75016,CAP,Package leaflet,no,,Dersom du tar for mye av X,75014.0,False,16
2570,75017,CAP,Package leaflet,no,,Dersom du har glemt å ta X,75014.0,False,17
2571,75018,CAP,Package leaflet,no,,Dersom du avbryter behandling med X,75014.0,False,18
2572,75019,CAP,Package leaflet,no,4,Mulige bivirkninger,75001.0,True,19
2573,75020,CAP,Package leaflet,no,,Bivirkninger som kan forekomme hos barn <og ungdom>,75019.0,False,20
2574,75021,CAP,Package leaflet,no,,Melding av bivirkninger,75019.0,True,21
2575,75022,CAP,Package leaflet,no,5,Hvordan du oppbevarer X,75001.0,True,22
2576,75023,CAP,Package leaflet,no,6,Innholdet i pakningen og ytterligere informasjon,75001.0,True,23
2577,75024,CAP,Package leaflet,no,,Sammensetning av X,75023.0,True,24
2578,75025,CAP,Package leaflet,no,,Hvordan X ser ut og innholdet i pakningen,75023.0,True,25
2579,75026,CAP,Package leaflet,no,,Innehaver av markedsføringstillatelsen og tilvirker,75023.0,True,26
2580,75027,CAP,Package leaflet,no,,Ta kontakt med den lokale representanten for innehaveren av markedsføringstillatelsen for ytterligere informasjon om dette legemidlet:,75023.0,False,27
2581,75028,CAP,Package leaflet,no,,Dette pakningsvedlegget ble sist oppdatert <{MM/ÅÅÅÅ}> <{måned ÅÅÅÅ}>.,75023.0,True,28
2582,75029,CAP,Package leaflet,no,,Andre informasjonskilder,75023.0,False,29
2583,75030,CAP,Package leaflet,no,,Påfølgende informasjon er bare beregnet på helsepersonell:,75001.0,False,30
2584,76001,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,,True,1
2585,76002,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,"qNiniejszy produkt leczniczy będzie dodatkowo monitorowany. Umożliwi to szybkie zidentyfikowanie nowych informacji o bezpieczeństwie. Osoby należące do fachowego personelu medycznego powinny zgłaszać wszelkie podejrzewane działania niepożądane. Aby dowiedzieć się, jak zgłaszać działania niepożądane - patrz punkt 4.8.>",76001.0,False,2
2586,76003,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,1,NAZWA PRODUKTU LECZNICZEGO,76001.0,True,3
2587,76004,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,2,SKŁAD JAKOŚCIOWY I ILOŚCIOWY,76001.0,True,4
2588,76005,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,2.1,Opis ogólny,76004.0,False,5
2589,76006,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,2.2,Skład jakościowy i ilościowy,76004.0,False,6
2590,76007,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,<Substancja pomocnicza> <Substancje pomocnicze> o znanym działaniu>,76006.0,False,7
2591,76008,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,3,POSTAĆ FARMACEUTYCZNA,76001.0,True,8
2592,76009,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,4,SZCZEGÓŁOWE DANE KLINICZNE,76001.0,True,9
2593,76010,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,4.1,Wskazania do stosowania,76009.0,True,10
2594,76011,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,4.2,Dawkowanie i sposób podawania,76009.0,True,11
2595,76012,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Dawkowanie,76011.0,True,12
2596,76013,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Dzieci i młodzież,76012.0,True,13
2597,76014,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Sposób podawania,76011.0,True,14
2598,76015,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,"Środki ostrożności, które należy podjąć przed użyciem lub podaniem produktu leczniczego",76014.0,False,15
2599,76016,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,4.3,Przeciwwskazania,76009.0,True,16
2600,76017,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,4.4,Specjalne ostrzeżenia i środki ostrożności dotyczące stosowania,76009.0,True,17
2601,76018,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Identyfikowalność,76017.0,False,18
2602,76019,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Dzieci i młodzież,76017.0,False,19
2603,76020,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,4.5,Interakcje z innymi produktami leczniczymi i inne rodzaje interakcji,76009.0,True,20
2604,76021,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Dzieci i młodzież,76020.0,False,21
2605,76022,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,4.6,"Wpływ na płodność, ciążę i laktację",76009.0,True,22
2606,76023,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Ciąża,76022.0,False,23
2607,76024,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Karmienie piersią,76022.0,False,24
2608,76025,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Płodność,76022.0,False,25
2609,76026,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,4.7,Wpływ na zdolność prowadzenia pojazdów i obsługiwania maszyn,76009.0,True,26
2610,76027,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,4.8,Działania niepożądane,76009.0,True,27
2611,76028,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Dzieci i młodzież,76027.0,False,28
2612,76029,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Zgłaszanie podejrzewanych działań niepożądanych,76027.0,True,29
2613,76030,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,4.9,Przedawkowanie,76009.0,True,30
2614,76031,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Dzieci i młodzież,76030.0,False,31
2615,76032,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,5,WŁAŚCIWOŚCI FARMAKOLOGICZNE,76001.0,True,32
2616,76033,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,5.1,Właściwości farmakodynamiczne,76032.0,True,33
2617,76034,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Mechanizm działania,76033.0,False,34
2618,76035,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Działanie farmakodynamiczne,76033.0,False,35
2619,76036,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Skuteczność kliniczna i bezpieczeństwo stosowania,76033.0,False,36
2620,76037,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Dzieci i młodzież,76033.0,False,37
2621,76038,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,5.2,Właściwości farmakokinetyczne,76032.0,True,38
2622,76039,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Wchłanianie,76038.0,False,39
2623,76040,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Dystrybucja,76038.0,False,40
2624,76041,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Metabolizm,76038.0,False,41
2625,76042,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Eliminacja,76038.0,False,42
2626,76043,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Liniowość lub nieliniowość,76038.0,False,43
2627,76044,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Zależności farmakokinetyczno-farmakodynamiczne,76038.0,False,44
2628,76045,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,5.3,Przedkliniczne dane o bezpieczeństwie,76032.0,True,45
2629,76046,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Ocena ryzyka dla środowiska,76045.0,False,46
2630,76047,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,6,DANE FARMACEUTYCZNE,76001.0,True,47
2631,76048,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,6.1,Wykaz substancji pomocniczych,76047.0,True,48
2632,76049,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,6.2,Niezgodności farmaceutyczne,76047.0,True,49
2633,76050,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,6.3,Okres ważności,76047.0,True,50
2634,76051,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,6.4,Specjalne środki ostrożności podczas przechowywania,76047.0,True,51
2635,76052,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,6.5,"Rodzaj i zawartość opakowania <oraz specjalistyczny sprzęt, służący do używania, podawania lub implantacji>",76047.0,True,52
2636,76053,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,6.6,Specjalne środki ostrożności dotyczące usuwania <i przygotowania produktu leczniczego do stosowania>,76047.0,True,53
2637,76054,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,,Stosowanie u dzieci i młodzieży,76053.0,False,54
2638,76055,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,7,PODMIOT ODPOWIEDZIALNY POSIADAJĄCY POZWOLENIE NA DOPUSZCZENIE DO OBROTU,76001.0,True,55
2639,76056,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,8,<NUMER POZWOLENIA> <NUMERY POZWOLEŃ> NA DOPUSZCZENIE DO OBROTU ,76001.0,True,56
2640,76057,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,9,DATA WYDANIA PIERWSZEGO POZWOLENIA NA DOPUSZCZENIE DO OBROTU I DATA PRZEDŁUŻENIA POZWOLENIA,76001.0,True,57
2641,76058,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,10,DATA ZATWIERDZENIA LUB CZĘŚCIOWEJ ZMIANY TEKSTU CHARAKTERYSTYKI PRODUKTU LECZNICZEGO,76001.0,True,58
2642,76059,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,11,DOZYMETRIA,76001.0,False,59
2643,76060,CAP,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,pl,12,INSTRUKCJA PRZYGOTOWANIA PRODUKTÓW RADIOFARMACEUTYCZNYCH,76001.0,False,60
2644,77001,CAP,ANEKS II,pl,,ANEKS II,,True,1
2645,77002,CAP,ANEKS II,pl,A,<<WYTWÓRCA> <WYTWÓRCY> <BIOLOGICZNEJ SUBSTANCJI CZYNNEJ> <BIOLOGICZNYCH SUBSTANCJI CZYNNYCH> ORAZ> <WYTWÓRCA ODPOWIEDZIALNY> <WYTWÓRCY ODPOWIEDZIALNI> ZA ZWOLNIENIE SERII,77001.0,True,2
2646,77003,CAP,ANEKS II,pl,,Nazwa i adres <wytwórcy> <wytwórców> <biologicznej substancji czynnej> <biologicznych substancji czynnych,77002.0,False,3
2647,77004,CAP,ANEKS II,pl,,Nazwa i adres <wytwórcy odpowiedzialnego> <wytwórców odpowiedzialnych> za zwolnienie serii,77002.0,True,4
2648,77005,CAP,ANEKS II,pl,B,WARUNKI LUB OGRANICZENIA DOTYCZĄCE ZAOPATRZENIA I STOSOWANIA ,77001.0,True,5
2649,77006,CAP,ANEKS II,pl,,Oficjalne zwalnianie serii,77005.0,False,6
2650,77007,CAP,ANEKS II,pl,C,INNE WARUNKI I WYMAGANIA DOTYCZĄCE DOPUSZCZENIA DO OBROTU,77001.0,True,7
2651,77008,CAP,ANEKS II,pl,,"Okresowe raporty o bezpieczeństwie stosowania (ang. Periodic safety update reports, PSURs)",77007.0,True,8
2652,77009,CAP,ANEKS II,pl,D,WARUNKI LUB OGRANICZENIA DOTYCZĄCE BEZPIECZNEGO I SKUTECZNEGO STOSOWANIA PRODUKTU LECZNICZEGO  ,77001.0,True,9
2653,77010,CAP,ANEKS II,pl,,"Plan zarządzania ryzykiem (ang. Risk Management Plan, RMP)",77009.0,True,10
2654,77011,CAP,ANEKS II,pl,,Dodatkowe działania w celu minimalizacji ryzyka,77009.0,False,11
2655,77012,CAP,ANEKS II,pl,,Zobowiązania do wypełnienia po wprowadzeniu do obrotu,77009.0,False,12
2656,77013,CAP,ANEKS II,pl,E,"SZCZEGÓLNE ZOBOWIĄZANIA DO WYKONANIA PO WPROWADZENIU DO OBROTU, GDY POZWOLENIE NA WPROWADZENIE DO OBROTU <JEST UDZIELONE W PROCEDURZE DOPUSZCZENIA WARUNKOWEGO> <JEST UDZIELONE W PROCEDURZE DOPUSZCZENIA W WYJĄTKOWYCH OKOLICZNOŚCIACH>",77001.0,False,13
2657,78001,CAP,OZNAKOWANIE OPAKOWAŃ,pl,,OZNAKOWANIE OPAKOWAŃ,,True,1
2658,78002,CAP,OZNAKOWANIE OPAKOWAŃ,pl,,INFORMACJE ZAMIESZCZANE NA <OPAKOWANIACH ZEWNĘTRZNYCH> <ORAZ> <OPAKOWANIACH BEZPOŚREDNICH>,78001.0,True,2
2659,78003,CAP,OZNAKOWANIE OPAKOWAŃ,pl,1,NAZWA PRODUKTU LECZNICZEGO,78002.0,True,3
2660,78004,CAP,OZNAKOWANIE OPAKOWAŃ,pl,2,ZAWARTOŚĆ <SUBSTANCJI CZYNNEJ> <SUBSTANCJI CZYNNYCH>,78002.0,True,4
2661,78005,CAP,OZNAKOWANIE OPAKOWAŃ,pl,3,WYKAZ SUBSTANCJI POMOCNICZYCH,78002.0,True,5
2662,78006,CAP,OZNAKOWANIE OPAKOWAŃ,pl,4,POSTAĆ FARMACEUTYCZNA I ZAWARTOŚĆ OPAKOWANIA,78002.0,True,6
2663,78007,CAP,OZNAKOWANIE OPAKOWAŃ,pl,5,SPOSÓB I <DROGA> <DROGI> PODANIA,78002.0,True,7
2664,78008,CAP,OZNAKOWANIE OPAKOWAŃ,pl,6,OSTRZEŻENIE DOTYCZĄCE PRZECHOWYWANIA PRODUKTU LECZNICZEGO W MIEJSCU NIEWIDOCZNYM I NIEDOSTĘPNYM DLA DZIECI,78002.0,True,8
2665,78009,CAP,OZNAKOWANIE OPAKOWAŃ,pl,7,"INNE OSTRZEŻENIA SPECJALNE, JEŚLI KONIECZNE",78002.0,True,9
2666,78010,CAP,OZNAKOWANIE OPAKOWAŃ,pl,8,TERMIN WAŻNOŚCI,78002.0,True,10
2667,78011,CAP,OZNAKOWANIE OPAKOWAŃ,pl,9,WARUNKI PRZECHOWYWANIA,78002.0,True,11
2668,78012,CAP,OZNAKOWANIE OPAKOWAŃ,pl,10,"SPECJALNE ŚRODKI OSTROŻNOŚCI DOTYCZĄCE USUWANIA NIEZUŻYTEGO PRODUKTU LECZNICZEGO LUB POCHODZĄCYCH Z NIEGO ODPADÓW, JEŚLI WŁAŚCIWE",78002.0,True,12
2669,78013,CAP,OZNAKOWANIE OPAKOWAŃ,pl,11,NAZWA I ADRES PODMIOTU ODPOWIEDZIALNEGO,78002.0,True,13
2670,78014,CAP,OZNAKOWANIE OPAKOWAŃ,pl,12,<NUMER POZWOLENIA> <NUMERY POZWOLEŃ> NA DOPUSZCZENIE DO OBROTU ,78002.0,True,14
2671,78015,CAP,OZNAKOWANIE OPAKOWAŃ,pl,13,"NUMER SERII<, KODY DONACJI I PRODUKTU>",78002.0,True,15
2672,78016,CAP,OZNAKOWANIE OPAKOWAŃ,pl,14,OGÓLNA KATEGORIA DOSTĘPNOŚCI,78002.0,True,16
2673,78017,CAP,OZNAKOWANIE OPAKOWAŃ,pl,15,INSTRUKCJA UŻYCIA,78002.0,True,17
2674,78018,CAP,OZNAKOWANIE OPAKOWAŃ,pl,16,INFORMACJA PODANA SYSTEMEM BRAILLE’A,78002.0,True,18
2675,78019,CAP,OZNAKOWANIE OPAKOWAŃ,pl,17,NIEPOWTARZALNY IDENTYFIKATOR – KOD 2D,78002.0,True,19
2676,78020,CAP,OZNAKOWANIE OPAKOWAŃ,pl,18,NIEPOWTARZALNY IDENTYFIKATOR – DANE CZYTELNE DLA CZŁOWIEKA,78002.0,True,20
2677,78021,CAP,OZNAKOWANIE OPAKOWAŃ,pl,,MINIMUM INFORMACJI ZAMIESZCZANYCH NA BLISTRACH LUB OPAKOWANIACH FOLIOWYCH,78001.0,True,21
2678,78022,CAP,OZNAKOWANIE OPAKOWAŃ,pl,1,NAZWA PRODUKTU LECZNICZEGO,78021.0,True,22
2679,78023,CAP,OZNAKOWANIE OPAKOWAŃ,pl,2,NAZWA PODMIOTU ODPOWIEDZIALNEGO,78021.0,True,23
2680,78024,CAP,OZNAKOWANIE OPAKOWAŃ,pl,3,TERMIN WAŻNOŚCI,78021.0,True,24
2681,78025,CAP,OZNAKOWANIE OPAKOWAŃ,pl,4,"NUMER SERII<, KODY DONACJI I PRODUKTU>",78021.0,True,25
2682,78026,CAP,OZNAKOWANIE OPAKOWAŃ,pl,5,INNE,78021.0,True,26
2683,78027,CAP,OZNAKOWANIE OPAKOWAŃ,pl,,MINIMUM INFORMACJI ZAMIESZCZANYCH NA MAŁYCH OPAKOWANIACH BEZPOŚREDNICH,78001.0,True,27
2684,78028,CAP,OZNAKOWANIE OPAKOWAŃ,pl,1,NAZWA PRODUKTU LECZNICZEGO I <DROGA> <DROGI> PODANIA,78027.0,True,28
2685,78029,CAP,OZNAKOWANIE OPAKOWAŃ,pl,2,SPOSÓB PODAWANIA,78027.0,True,29
2686,78030,CAP,OZNAKOWANIE OPAKOWAŃ,pl,3,TERMIN WAŻNOŚCI,78027.0,True,30
2687,78031,CAP,OZNAKOWANIE OPAKOWAŃ,pl,4,"NUMER SERII<, KODY DONACJI I PRODUKTU>",78027.0,True,31
2688,78032,CAP,OZNAKOWANIE OPAKOWAŃ,pl,5,"ZAWARTOŚĆ OPAKOWANIA Z PODANIEM MASY, OBJĘTOŚCI LUB LICZBY JEDNOSTEK",78027.0,True,32
2689,78033,CAP,OZNAKOWANIE OPAKOWAŃ,pl,6,INNE,78027.0,True,33
2690,79001,CAP,ULOTKA DLA PACJENTA,pl,,ULOTKA DLA PACJENTA,,True,1
2691,79002,CAP,ULOTKA DLA PACJENTA,pl,,"q Niniejszy produkt leczniczy będzie dodatkowo monitorowany. Umożliwi to szybkie zidentyfikowanie nowych informacji o bezpieczeństwie. Użytkownik leku też może w tym pomóc, zgłaszając wszelkie działania niepożądane, które wystąpiły po zastosowaniu leku. Aby dowiedzieć się, jak zgłaszać działania niepożądane – patrz punkt 4.",79001.0,False,2
2692,79003,CAP,ULOTKA DLA PACJENTA,pl,,Spis treści ulotki,79001.0,True,3
2693,79004,CAP,ULOTKA DLA PACJENTA,pl,1,Co to jest <lek> X i w jakim celu się go stosuje,79001.0,True,4
2694,79005,CAP,ULOTKA DLA PACJENTA,pl,2,Informacje ważne przed <przyjęciem> <zastosowaniem> <leku> X ,79001.0,True,5
2695,79006,CAP,ULOTKA DLA PACJENTA,pl,,Kiedy nie <przyjmować> <stosować> <leku> X,79005.0,True,6
2696,79007,CAP,ULOTKA DLA PACJENTA,pl,,Ostrzeżenia i środki ostrożności ,79005.0,True,7
2697,79008,CAP,ULOTKA DLA PACJENTA,pl,,Dzieci <i młodzież>,79005.0,True,8
2698,79009,CAP,ULOTKA DLA PACJENTA,pl,,<Lek> X a inne leki,79005.0,True,9
2699,79010,CAP,ULOTKA DLA PACJENTA,pl,,"Stosowanie leku X z <jedzeniem> <i> <,> <piciem> <i> <alkoholem>",79005.0,True,10
2700,79011,CAP,ULOTKA DLA PACJENTA,pl,,"Ciąża <i> <,> karmienie piersią <i wpływ na płodność>",79005.0,True,11
2701,79012,CAP,ULOTKA DLA PACJENTA,pl,,Prowadzenie pojazdów i obsługiwanie maszyn,79005.0,True,12
2702,79013,CAP,ULOTKA DLA PACJENTA,pl,,<Lek> X zawiera {<nazwa substancji pomocniczej> <nazwy substancji pomocniczych>},79005.0,False,13
2703,79014,CAP,ULOTKA DLA PACJENTA,pl,3,Jak <przyjmować> <stosować> <lek> X,79001.0,True,14
2704,79015,CAP,ULOTKA DLA PACJENTA,pl,,Stosowanie u dzieci <i młodzieży>,79014.0,False,15
2705,79016,CAP,ULOTKA DLA PACJENTA,pl,,<Przyjęcie> <Zastosowanie> większej niż zalecana dawki <leku> X,79014.0,False,16
2706,79017,CAP,ULOTKA DLA PACJENTA,pl,,Pominięcie <przyjęcia> <zastosowania> <leku> ,79014.0,False,17
2707,79018,CAP,ULOTKA DLA PACJENTA,pl,,Przerwanie <przyjmowania> <stosowania> <leku> X,79014.0,False,18
2708,79019,CAP,ULOTKA DLA PACJENTA,pl,4,Możliwe działania niepożądane,79001.0,True,19
2709,79020,CAP,ULOTKA DLA PACJENTA,pl,,Dodatkowe działania niepożądane u dzieci <i młodzieży>,79019.0,False,20
2710,79021,CAP,ULOTKA DLA PACJENTA,pl,,Zgłaszanie działań niepożądanych,79019.0,True,21
2711,79022,CAP,ULOTKA DLA PACJENTA,pl,5,Jak przechowywać <lek> X,79001.0,True,22
2712,79023,CAP,ULOTKA DLA PACJENTA,pl,6,Zawartość opakowania i inne informacje,79001.0,True,23
2713,79024,CAP,ULOTKA DLA PACJENTA,pl,,Co zawiera <lek> X ,79023.0,True,24
2714,79025,CAP,ULOTKA DLA PACJENTA,pl,,Jak wygląda <lek> X i co zawiera opakowanie,79023.0,True,25
2715,79026,CAP,ULOTKA DLA PACJENTA,pl,,Podmiot odpowiedzialny i wytwórca,79023.0,True,26
2716,79027,CAP,ULOTKA DLA PACJENTA,pl,,W celu uzyskania bardziej szczegółowych informacji dotyczących tego leku należy zwrócić się do miejscowego przedstawiciela podmiotu odpowiedzialnego:,79023.0,False,27
2717,79028,CAP,ULOTKA DLA PACJENTA,pl,,Data ostatniej aktualizacji ulotki: <{MM/RRRR}><{miesiąc RRRR}>.,79023.0,True,28
2718,79029,CAP,ULOTKA DLA PACJENTA,pl,,Inne źródła informacji,79023.0,False,29
2719,79030,CAP,ULOTKA DLA PACJENTA,pl,,Informacje przeznaczone wyłącznie dla fachowego personelu medycznego:,79001.0,False,30
2720,80001,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,,True,1
2721,80002,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,"qEste medicamento está sujeito a monitorização adicional. Isto irá permitir a rápida identificação de nova informação de segurança. Pede-se aos profissionais de saúde que notifiquem quaisquer suspeitas de reações adversas. Para saber como notificar reações adversas, ver secção 4.8.",80001.0,False,2
2722,80003,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,1,NOME DO MEDICAMENTO,80001.0,True,3
2723,80004,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,2,COMPOSIÇÃO QUALITATIVA E QUANTITATIVA,80001.0,True,4
2724,80005,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,2.1,Descrição geral,80004.0,False,5
2725,80006,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,2.2,Composição qualitativa e quantitativa,80004.0,False,6
2726,80007,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Excipiente(s) com efeito conhecido,80006.0,False,7
2727,80008,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,3,FORMA FARMACÊUTICA,80001.0,True,8
2728,80009,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,4,INFORMAÇÕES CLÍNICAS,80001.0,True,9
2729,80010,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,4.1,Indicações terapêuticas,80009.0,True,10
2730,80011,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,4.2,Posologia e modo de administração,80009.0,True,11
2731,80012,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Posologia,80011.0,True,12
2732,80013,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,População pediátrica,80012.0,True,13
2733,80014,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Modo de administração ,80011.0,True,14
2734,80015,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Precauções a ter em conta antes de manusear ou administrar o medicamento,80014.0,False,15
2735,80016,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,4.3,Contraindicações,80009.0,True,16
2736,80017,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,4.4,Advertências e precauções especiais de utilização,80009.0,True,17
2737,80018,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Rastreabilidade,80017.0,False,18
2738,80019,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,População pediátrica,80017.0,False,19
2739,80020,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,4.5,Interações medicamentosas e outras formas de interação,80009.0,True,20
2740,80021,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,População pediátrica,80020.0,False,21
2741,80022,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,4.6,"Fertilidade, gravidez e aleitamento",80009.0,True,22
2742,80023,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Gravidez,80022.0,False,23
2743,80024,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Amamentação,80022.0,False,24
2744,80025,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Fertilidade,80022.0,False,25
2745,80026,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,4.7,Efeitos sobre a capacidade de conduzir e utilizar máquinas,80009.0,True,26
2746,80027,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,4.8,Efeitos indesejáveis,80009.0,True,27
2747,80028,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,População pediátrica,80027.0,False,28
2748,80029,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Notificação de suspeitas de reações adversas,80027.0,True,29
2749,80030,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,4.9,Sobredosagem,80009.0,True,30
2750,80031,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,População pediátrica,80030.0,False,31
2751,80032,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,5,PROPRIEDADES FARMACOLÓGICAS,80001.0,True,32
2752,80033,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,5.1,Propriedades farmacodinâmicas,80032.0,True,33
2753,80034,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Mecanismo de ação,80033.0,False,34
2754,80035,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Efeitos farmacodinâmicos,80033.0,False,35
2755,80036,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Eficácia e segurança clínicas,80033.0,False,36
2756,80037,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,População pediátrica,80033.0,False,37
2757,80038,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,5.2,Propriedades farmacocinéticas,80032.0,True,38
2758,80039,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Absorção,80038.0,False,39
2759,80040,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Distribuição,80038.0,False,40
2760,80041,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Biotransformação,80038.0,False,41
2761,80042,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Eliminação,80038.0,False,42
2762,80043,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Linearidade/não linearidade,80038.0,False,43
2763,80044,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Relação(ões) farmacocinética/farmacodinâmica,80038.0,False,44
2764,80045,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,5.3,Dados de segurança pré-clínica,80032.0,True,45
2765,80046,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Avaliação do risco ambiental (ARA),80045.0,False,46
2766,80047,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,6,INFORMAÇÕES FARMACÊUTICAS,80001.0,True,47
2767,80048,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,6.1,Lista dos excipientes,80047.0,True,48
2768,80049,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,6.2,Incompatibilidades,80047.0,True,49
2769,80050,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,6.3,Prazo de validade,80047.0,True,50
2770,80051,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,6.4,Precauções especiais de conservação,80047.0,True,51
2771,80052,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,6.5,"Natureza e conteúdo do recipiente <e equipamento especial para utilização, administração ou implantação",80047.0,True,52
2772,80053,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,6.6,Precauções especiais de eliminação <e manuseamento>,80047.0,True,53
2773,80054,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,,Utilização na população pediátrica,80053.0,False,54
2774,80055,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,7,TITULAR DA AUTORIZAÇÃO DE INTRODUÇÃO NO MERCADO,80001.0,True,55
2775,80056,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,8,NÚMERO(S) DA AUTORIZAÇÃO DE INTRODUÇÃO NO MERCADO ,80001.0,True,56
2776,80057,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,9,DATA DA PRIMEIRA AUTORIZAÇÃO/RENOVAÇÃO DA AUTORIZAÇÃO DE INTRODUÇÃO NO MERCADO,80001.0,True,57
2777,80058,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,10,DATA DA REVISÃO DO TEXTO,80001.0,True,58
2778,80059,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,11,DOSIMETRIA,80001.0,False,59
2779,80060,CAP,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,pt,12,INSTRUÇÕES PARA A PREPARAÇÃO DE RADIOFÁRMACOS,80001.0,False,60
2780,81001,CAP,ANEXO II,pt,,ANEXO II,,True,1
2781,81002,CAP,ANEXO II,pt,A,FABRICANTE(S) DA(S) SUBSTÂNCIA(S) ATIVA(S) DE ORIGEM BIOLÓGICA E>FABRICANTE(S) RESPONSÁVEL(VEIS) PELA LIBERTAÇÃO DO LOTE,81001.0,True,2
2782,81003,CAP,ANEXO II,pt,,Nome e endereço do(s) fabricante(s) da(s) substância(s) ativa(s) de origem biológica,81002.0,False,3
2783,81004,CAP,ANEXO II,pt,,Nome e endereço do(s) fabricante(s) responsável(veis) pela libertação do lote,81002.0,True,4
2784,81005,CAP,ANEXO II,pt,B,CONDIÇÕES OU RESTRIÇÕES RELATIVAS AO FORNECIMENTO E UTILIZAÇÃO,81001.0,True,5
2785,81006,CAP,ANEXO II,pt,,Libertação oficial do lote,81005.0,False,6
2786,81007,CAP,ANEXO II,pt,C,OUTRAS CONDIÇÕES E REQUISITOS DA AUTORIZAÇÃO DE INTRODUÇÃO NO MERCADO,81001.0,True,7
2787,81008,CAP,ANEXO II,pt,,Relatórios periódicos de segurança (RPS),81007.0,True,8
2788,81009,CAP,ANEXO II,pt,D,CONDIÇÕES OU RESTRIÇÕES RELATIVAS À UTILIZAÇÃO SEGURA E EFICAZ DO MEDICAMENTO  ,81001.0,True,9
2789,81010,CAP,ANEXO II,pt,,Plano de gestão do risco (PGR),81009.0,True,10
2790,81011,CAP,ANEXO II,pt,,Medidas adicionais de minimização do risco,81009.0,False,11
2791,81012,CAP,ANEXO II,pt,,Obrigação de concretizar as medidas de pós-autorização,81009.0,False,12
2792,81013,CAP,ANEXO II,pt,E,OBRIGAÇÕES ESPECÍFICAS PARA COMPLETAR AS MEDIDAS DE PÓS-AUTORIZAÇÃO <DA AUTORIZAÇÃO DE INTRODUÇÃO NO MERCADO CONDICIONAL> <DA AUTORIZAÇÃO DE INTRODUÇÃO NO MERCADO EM CIRCUNSTÂNCIAS EXCECIONAIS>,81001.0,False,13
2793,82001,CAP,ROTULAGEM,pt,,ROTULAGEM,,True,1
2794,82002,CAP,ROTULAGEM,pt,,INDICAÇÕES A INCLUIR <NO ACONDICIONAMENTO SECUNDÁRIO> <E> <NO ACONDICIONAMENTO PRIMÁRIO>,82001.0,True,2
2795,82003,CAP,ROTULAGEM,pt,1,NOME DO MEDICAMENTO,82002.0,True,3
2796,82004,CAP,ROTULAGEM,pt,2,DESCRIÇÃO DA(S) SUBSTÂNCIA(S) ATIVA(S),82002.0,True,4
2797,82005,CAP,ROTULAGEM,pt,3,LISTA DOS EXCIPIENTES,82002.0,True,5
2798,82006,CAP,ROTULAGEM,pt,4,FORMA FARMACÊUTICA E CONTEÚDO,82002.0,True,6
2799,82007,CAP,ROTULAGEM,pt,5,MODO E VIA(S) DE ADMINISTRAÇÃO,82002.0,True,7
2800,82008,CAP,ROTULAGEM,pt,6,ADVERTÊNCIA ESPECIAL DE QUE O MEDICAMENTO DEVE SER MANTIDO FORA DA VISTA E DO ALCANCE DAS CRIANÇAS,82002.0,True,8
2801,82009,CAP,ROTULAGEM,pt,7,"OUTRAS ADVERTÊNCIAS ESPECIAIS, SE NECESSÁRIO",82002.0,True,9
2802,82010,CAP,ROTULAGEM,pt,8,PRAZO DE VALIDADE,82002.0,True,10
2803,82011,CAP,ROTULAGEM,pt,9,CONDIÇÕES ESPECIAIS DE CONSERVAÇÃO,82002.0,True,11
2804,82012,CAP,ROTULAGEM,pt,10,"CUIDADOS ESPECIAIS QUANTO À ELIMINAÇÃO DO MEDICAMENTO NÃO UTILIZADO OU DOS RESÍDUOS PROVENIENTES DESSE MEDICAMENTO, SE APLICÁVEL",82002.0,True,12
2805,82013,CAP,ROTULAGEM,pt,11,NOME E ENDEREÇO DO TITULAR DA AUTORIZAÇÃO DE INTRODUÇÃO NO MERCADO,82002.0,True,13
2806,82014,CAP,ROTULAGEM,pt,12,NÚMERO(S) DA AUTORIZAÇÃO DE INTRODUÇÃO NO MERCADO ,82002.0,True,14
2807,82015,CAP,ROTULAGEM,pt,13,"NÚMERO DO LOTE<, CÓDIGOS DA DÁDIVA E DO PRODUTO>",82002.0,True,15
2808,82016,CAP,ROTULAGEM,pt,14,CLASSIFICAÇÃO QUANTO À DISPENSA AO PÚBLICO,82002.0,True,16
2809,82017,CAP,ROTULAGEM,pt,15,INSTRUÇÕES DE UTILIZAÇÃ,82002.0,True,17
2810,82018,CAP,ROTULAGEM,pt,16,INFORMAÇÃO EM BRAILLE,82002.0,True,18
2811,82019,CAP,ROTULAGEM,pt,17,IDENTIFICADOR ÚNICO – CÓDIGO DE BARRAS 2D,82002.0,True,19
2812,82020,CAP,ROTULAGEM,pt,18,IDENTIFICADOR ÚNICO - DADOS PARA LEITURA HUMANA,82002.0,True,20
2813,82021,CAP,ROTULAGEM,pt,,INDICAÇÕES MÍNIMAS A INCLUIR NAS EMBALAGENS BLISTER OU FITAS CONTENTORAS,82001.0,True,21
2814,82022,CAP,ROTULAGEM,pt,1,NOME DO MEDICAMENTO,82021.0,True,22
2815,82023,CAP,ROTULAGEM,pt,2,NOME DO TITULAR DA AUTORIZAÇÃO DE INTRODUÇÃO NO MERCADO,82021.0,True,23
2816,82024,CAP,ROTULAGEM,pt,3,PRAZO DE VALIDADE,82021.0,True,24
2817,82025,CAP,ROTULAGEM,pt,4,"NÚMERO DO LOTE<, CÓDIGOS DA DÁDIVA E DO PRODUTO>",82021.0,True,25
2818,82026,CAP,ROTULAGEM,pt,5,OUTROS,82021.0,True,26
2819,82027,CAP,ROTULAGEM,pt,,INDICAÇÕES MÍNIMAS A INCLUIR EM PEQUENAS UNIDADES DE ACONDICIONAMENTO PRIMÁRIO,82001.0,True,27
2820,82028,CAP,ROTULAGEM,pt,1,NOME DO MEDICAMENTO E VIA(S) DE ADMINISTRAÇÃO,82027.0,True,28
2821,82029,CAP,ROTULAGEM,pt,2,MODO DE ADMINISTRAÇÃO,82027.0,True,29
2822,82030,CAP,ROTULAGEM,pt,3,PRAZO DE VALIDADE,82027.0,True,30
2823,82031,CAP,ROTULAGEM,pt,4,"NÚMERO DO LOTE<, CÓDIGOS DA DÁDIVA E DO PRODUTO>",82027.0,True,31
2824,82032,CAP,ROTULAGEM,pt,5,"CONTEÚDO EM PESO, VOLUME OU UNIDADE",82027.0,True,32
2825,82033,CAP,ROTULAGEM,pt,6,OUTROS,82027.0,True,33
2826,83001,CAP,FOLHETO INFORMATIVO,pt,,FOLHETO INFORMATIVO,,True,1
2827,83002,CAP,FOLHETO INFORMATIVO,pt,,"q Este medicamento está sujeito a monitorização adicional. Isto irá permitir a rápida identificação de nova informação de segurança. Poderá ajudar, comunicando quaisquer efeitos indesejáveis que tenha. Para saber como comunicar efeitos indesejáveis, veja o final da secção 4.",83001.0,False,2
2828,83003,CAP,FOLHETO INFORMATIVO,pt,,O que contém este folheto:,83001.0,True,3
2829,83004,CAP,FOLHETO INFORMATIVO,pt,1,O que é X e para que é utilizado,83001.0,True,4
2830,83005,CAP,FOLHETO INFORMATIVO,pt,2,O que precisa de saber antes de <tomar> <utilizar> X ,83001.0,True,5
2831,83006,CAP,FOLHETO INFORMATIVO,pt,,Não <tome> <utilize> X,83005.0,True,6
2832,83007,CAP,FOLHETO INFORMATIVO,pt,,Advertências e precauções ,83005.0,True,7
2833,83008,CAP,FOLHETO INFORMATIVO,pt,,Crianças <e adolescentes>,83005.0,True,8
2834,83009,CAP,FOLHETO INFORMATIVO,pt,,Outros medicamentos e X,83005.0,True,9
2835,83010,CAP,FOLHETO INFORMATIVO,pt,,"X com <alimentos> <e> <,> <bebidas> <e> <álcool>",83005.0,True,10
2836,83011,CAP,FOLHETO INFORMATIVO,pt,,"Gravidez <e> <,> amamentação <e fertilidade>",83005.0,True,11
2837,83012,CAP,FOLHETO INFORMATIVO,pt,,Condução de veículos e utilização de máquinas,83005.0,True,12
2838,83013,CAP,FOLHETO INFORMATIVO,pt,,X contém {nome do(s) excipiente(s)},83005.0,False,13
2839,83014,CAP,FOLHETO INFORMATIVO,pt,3,Como <tomar> <utilizar> X,83001.0,True,14
2840,83015,CAP,FOLHETO INFORMATIVO,pt,,Utilização em crianças <e adolescentes>,83014.0,False,15
2841,83016,CAP,FOLHETO INFORMATIVO,pt,,Se <tomar> <utilizar> mais X do que deveria,83014.0,False,16
2842,83017,CAP,FOLHETO INFORMATIVO,pt,,Caso se tenha esquecido de <tomar> <utilizar> X,83014.0,False,17
2843,83018,CAP,FOLHETO INFORMATIVO,pt,,Se parar de <tomar> <utilizar> X,83014.0,False,18
2844,83019,CAP,FOLHETO INFORMATIVO,pt,4,Efeitos indesejáveis possíveis,83001.0,True,19
2845,83020,CAP,FOLHETO INFORMATIVO,pt,,Efeitos indesejáveis adicionais em crianças <e adolescentes>,83019.0,False,20
2846,83021,CAP,FOLHETO INFORMATIVO,pt,,Comunicação de efeitos indesejáveis,83019.0,True,21
2847,83022,CAP,FOLHETO INFORMATIVO,pt,5,Como conservar X,83001.0,True,22
2848,83023,CAP,FOLHETO INFORMATIVO,pt,6,Conteúdo da embalagem e outras informações,83001.0,True,23
2849,83024,CAP,FOLHETO INFORMATIVO,pt,,Qual a composição de X,83023.0,True,24
2850,83025,CAP,FOLHETO INFORMATIVO,pt,,Qual o aspeto de X e conteúdo da embalagem,83023.0,True,25
2851,83026,CAP,FOLHETO INFORMATIVO,pt,,Titular da Autorização de Introdução no Mercado e Fabricante,83023.0,True,26
2852,83027,CAP,FOLHETO INFORMATIVO,pt,,"Para quaisquer informações sobre este medicamento, queira contactar o representante local do Titular da Autorização de Introdução no Mercado:",83023.0,False,27
2853,83028,CAP,FOLHETO INFORMATIVO,pt,,Este folheto foi revisto pela última vez em <{MM/AAAA}><{mês de AAAA}.,83023.0,True,28
2854,83029,CAP,FOLHETO INFORMATIVO,pt,,Outras fontes de informação,83023.0,False,29
2855,83030,CAP,FOLHETO INFORMATIVO,pt,,A informação que se segue destina-se apenas aos profissionais de saúde:,83001.0,False,30
2856,84001,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,REZUMATUL CARACTERISTICILOR PRODUSULUI,,True,1
2857,84002,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,qAcest medicament face obiectul unei monitorizări suplimentare. Acest lucru va permite identificarea rapidă de noi informații referitoare la siguranță. Profesioniștii din domeniul sănătății sunt rugați să raporteze orice reacții adverse suspectate. Vezi pct. 4.8 pentru modul de raportare a reacțiilor adverse.,84001.0,False,2
2858,84003,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,1,DENUMIREA COMERCIALĂ A MEDICAMENTULUI,84001.0,True,3
2859,84004,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,2,COMPOZIȚIA CALITATIVĂ ȘI CANTITATIVĂ,84001.0,True,4
2860,84005,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,2.1,Descriere generală,84004.0,False,5
2861,84006,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,2.2,Compoziția calitativă și cantitativă,84004.0,False,6
2862,84007,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Excipient(ți) cu efect cunoscut,84006.0,False,7
2863,84008,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,3,FORMA FARMACEUTICĂ,84001.0,True,8
2864,84009,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,4,DATE CLINICE,84001.0,True,9
2865,84010,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,4.1,Indicații terapeutice,84009.0,True,10
2866,84011,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,4.2,Doze și mod de administrare,84009.0,True,11
2867,84012,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Doze,84011.0,True,12
2868,84013,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Copii și adolescenți,84012.0,True,13
2869,84014,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Mod de administrare ,84011.0,True,14
2870,84015,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Precauții care trebuie luate înainte de manipularea sau administrarea medicamentului,84014.0,False,15
2871,84016,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,4.3,Contraindicații,84009.0,True,16
2872,84017,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,4.4,Atenționări și precauții speciale pentru utilizare,84009.0,True,17
2873,84018,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Trasabilitate,84017.0,False,18
2874,84019,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Copii și adolescenți,84017.0,False,19
2875,84020,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,4.5,Interacțiuni cu alte medicamente și alte forme de interacțiune,84009.0,True,20
2876,84021,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Copii și adolescenți,84020.0,False,21
2877,84022,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,4.6,"Fertilitatea, sarcina și alăptarea",84009.0,True,22
2878,84023,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Sarcina,84022.0,False,23
2879,84024,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Alăptarea,84022.0,False,24
2880,84025,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Fertilitatea,84022.0,False,25
2881,84026,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,4.7,Efecte asupra capacității de a conduce vehicule și de a folosi utilaje,84009.0,True,26
2882,84027,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,4.8,Reacții adverse,84009.0,True,27
2883,84028,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Copii și adolescenți,84027.0,False,28
2884,84029,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Raportarea reacțiilor adverse suspectate,84027.0,True,29
2885,84030,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,4.9,Supradozaj,84009.0,True,30
2886,84031,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Copii și adolescenți,84030.0,False,31
2887,84032,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,5,PROPRIETĂȚI FARMACOLOGICE,84001.0,True,32
2888,84033,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,5.1,Proprietăți farmacodinamice,84032.0,True,33
2889,84034,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Mecanism de acțiune,84033.0,False,34
2890,84035,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Efecte farmacodinamice,84033.0,False,35
2891,84036,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Eficacitate și siguranță clinică,84033.0,False,36
2892,84037,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Copii și adolescenți,84033.0,False,37
2893,84038,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,5.2,Proprietăți farmacocinetice,84032.0,True,38
2894,84039,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Absorbție,84038.0,False,39
2895,84040,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Distribuție,84038.0,False,40
2896,84041,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Metabolizare,84038.0,False,41
2897,84042,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Eliminare,84038.0,False,42
2898,84043,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Liniaritate/Non-liniaritate,84038.0,False,43
2899,84044,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Relație(i) farmacocinetică(e)/farmacodinamică€,84038.0,False,44
2900,84045,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,5.3,Date preclinice de siguranță,84032.0,True,45
2901,84046,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Evaluarea riscului de mediu (ERM),84045.0,False,46
2902,84047,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,6,PROPRIETĂȚI FARMACEUTICE,84001.0,True,47
2903,84048,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,6.1,Lista excipienților,84047.0,True,48
2904,84049,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,6.2,Incompatibilități,84047.0,True,49
2905,84050,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,6.3,Perioada de valabilitate,84047.0,True,50
2906,84051,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,6.4,Precauții speciale pentru păstrare,84047.0,True,51
2907,84052,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,6.5,"Natura și conținutul ambalajului <și echipamente speciale pentru utilizare, administrare sau implantare>",84047.0,True,52
2908,84053,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,6.6,Precauții speciale pentru eliminarea reziduurilor <și alte instrucțiuni de manipulare>,84047.0,True,53
2909,84054,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,,Utilizare la copii și adolescenți,84053.0,False,54
2910,84055,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,7,DEȚINĂTORUL AUTORIZAȚIEI DE PUNERE PE PIAȚĂ,84001.0,True,55
2911,84056,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,8,NUMĂRUL(ELE) AUTORIZAȚIEI DE PUNERE PE PIAȚĂ ,84001.0,True,56
2912,84057,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,9,DATA PRIMEI AUTORIZĂRI SAU A REÎNNOIRII AUTORIZAȚIEI,84001.0,True,57
2913,84058,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,10,DATA REVIZUIRII TEXTULUI,84001.0,True,58
2914,84059,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,11,DOZIMETRIE,84001.0,False,59
2915,84060,CAP,REZUMATUL CARACTERISTICILOR PRODUSULUI,ro,12,INSTRUCȚIUNI PRIVIND PREPARAREA MEDICAMENTELOR RADIOFARMACEUTICE,84001.0,False,60
2916,85001,CAP,ANEXA II,ro,,ANEXA II,,True,1
2917,85002,CAP,ANEXA II,ro,A,FABRICANTUL(FABRICANȚII) SUBSTANȚEI(LOR) BIOLOGIC ACTIVE ȘI> FABRICANTUL (FABRICANȚII) RESPONSABIL(I) PENTRU ELIBERAREA SERIEI,85001.0,True,2
2918,85003,CAP,ANEXA II,ro,,Numele și adresa fabricantului(fabricanților) substanței(lor) biologic active,85002.0,False,3
2919,85004,CAP,ANEXA II,ro,,Numele și adresa fabricantului(fabricanților) responsabil(i) pentru eliberarea seriei,85002.0,True,4
2920,85005,CAP,ANEXA II,ro,B,CONDIȚII SAU RESTRICȚII PRIVIND FURNIZAREA ȘI UTILIZAREA ,85001.0,True,5
2921,85006,CAP,ANEXA II,ro,,Eliberarea oficială a seriei,85005.0,False,6
2922,85007,CAP,ANEXA II,ro,C,ALTE CONDIȚII ȘI CERINȚE ALE AUTORIZAȚIEI DE PUNERE PE PIAȚĂ,85001.0,True,7
2923,85008,CAP,ANEXA II,ro,,Rapoartele periodice actualizate privind siguranța (RPAS),85007.0,True,8
2924,85009,CAP,ANEXA II,ro,D,CONDIȚII SAU RESTRICȚII CU PRIVIRE LA UTILIZAREA SIGURĂ ȘI EFICACE A MEDICAMENTULUI  ,85001.0,True,9
2925,85010,CAP,ANEXA II,ro,,Planul de management al riscului (PMR),85009.0,True,10
2926,85011,CAP,ANEXA II,ro,,Măsuri suplimentare de reducere la minimum a riscului,85009.0,False,11
2927,85012,CAP,ANEXA II,ro,,Obligații pentru îndeplinirea măsurilor post-autorizare,85009.0,False,12
2928,85013,CAP,ANEXA II,ro,E,OBLIGAȚII SPECIFICE PENTRU ÎNDEPLINIREA MĂSURILOR POST-AUTORIZARE ÎN CAZUL <AUTORIZĂRII PRIN APROBARE CONDIȚIONATĂ><AUTORIZĂRII ÎN CONDIȚII EXCEPȚIONALE>,85001.0,False,13
2929,86001,CAP,ETICHETAREA,ro,,ETICHETAREA,,True,1
2930,86002,CAP,ETICHETAREA,ro,,INFORMAȚII CARE TREBUIE SĂ APARĂ PE <AMBALAJUL SECUNDAR><ȘI><AMBALAJUL PRIMAR>,86001.0,True,2
2931,86003,CAP,ETICHETAREA,ro,1,DENUMIREA COMERCIALĂ A MEDICAMENTULUI,86002.0,True,3
2932,86004,CAP,ETICHETAREA,ro,2,DECLARAREA SUBSTANȚEI(SUBSTANȚELOR) ACTIVE,86002.0,True,4
2933,86005,CAP,ETICHETAREA,ro,3,LISTA EXCIPIENȚILOR,86002.0,True,5
2934,86006,CAP,ETICHETAREA,ro,4,FORMA FARMACEUTICĂ ȘI CONȚINUTUL,86002.0,True,6
2935,86007,CAP,ETICHETAREA,ro,5,MODUL ȘI CALEA(CĂILE) DE ADMINISTRARE,86002.0,True,7
2936,86008,CAP,ETICHETAREA,ro,6,ATENȚIONARE SPECIALĂ PRIVIND FAPTUL CĂ MEDICAMENTUL NU TREBUIE PĂSTRAT LA VEDEREA ȘI ÎNDEMÂNA COPIILOR,86002.0,True,8
2937,86009,CAP,ETICHETAREA,ro,7,"ALTĂ(E) ATENȚIONARE(ĂRI) SPECIALĂ(E), DACĂ ESTE(SUNT) NECESARĂ(E)",86002.0,True,9
2938,86010,CAP,ETICHETAREA,ro,8,DATA DE EXPIRARE,86002.0,True,10
2939,86011,CAP,ETICHETAREA,ro,9,CONDIȚII SPECIALE DE PĂSTRARE,86002.0,True,11
2940,86012,CAP,ETICHETAREA,ro,10,"PRECAUȚII SPECIALE PRIVIND ELIMINAREA MEDICAMENTELOR NEUTILIZATE SAU A MATERIALELOR REZIDUALE PROVENITE DIN ASTFEL DE MEDICAMENTE, DACĂ ESTE CAZUL",86002.0,True,12
2941,86013,CAP,ETICHETAREA,ro,11,NUMELE ȘI ADRESA DEȚINĂTORULUI AUTORIZAȚIEI DE PUNERE PE PIAȚĂ,86002.0,True,13
2942,86014,CAP,ETICHETAREA,ro,12,NUMĂRUL(ELE) AUTORIZAȚIEI DE PUNERE PE PIAȚĂ,86002.0,True,14
2943,86015,CAP,ETICHETAREA,ro,13,"SERIA DE FABRICAȚIE<, CODURILE DONAȚIEI ȘI MEDICAMENTULUI>",86002.0,True,15
2944,86016,CAP,ETICHETAREA,ro,14,CLASIFICARE GENERALĂ PRIVIND MODUL DE ELIBERARE,86002.0,True,16
2945,86017,CAP,ETICHETAREA,ro,15,INSTRUCȚIUNI DE UTILIZARE,86002.0,True,17
2946,86018,CAP,ETICHETAREA,ro,16,INFORMAȚII ÎN BRAILLE,86002.0,True,18
2947,86019,CAP,ETICHETAREA,ro,17,IDENTIFICATOR UNIC - COD DE BARE BIDIMENSIONAL,86002.0,True,19
2948,86020,CAP,ETICHETAREA,ro,18,IDENTIFICATOR UNIC - DATE LIZIBILE PENTRU PERSOANE,86002.0,True,20
2949,86021,CAP,ETICHETAREA,ro,,MINIMUM DE INFORMAȚII CARE TREBUIE SĂ APARĂ PE BLISTER SAU PE FOLIE TERMOSUDATĂ,86001.0,True,21
2950,86022,CAP,ETICHETAREA,ro,1,DENUMIREA COMERCIALĂ A MEDICAMENTULUI,86021.0,True,22
2951,86023,CAP,ETICHETAREA,ro,2,NUMELE DEȚINĂTORULUI AUTORIZAȚIEI DE PUNERE PE PIAȚĂ,86021.0,True,23
2952,86024,CAP,ETICHETAREA,ro,3,DATA DE EXPIRARE,86021.0,True,24
2953,86025,CAP,ETICHETAREA,ro,4,"SERIA DE FABRICAȚIE<, CODURILE DONAȚIEI ȘI MEDICAMENTULUI>",86021.0,True,25
2954,86026,CAP,ETICHETAREA,ro,5,ALTE INFORMAȚII,86021.0,True,26
2955,86027,CAP,ETICHETAREA,ro,,MINIMUM DE INFORMAȚII CARE TREBUIE SĂ APARĂ PE AMBALAJELE PRIMARE MICI,86001.0,True,27
2956,86028,CAP,ETICHETAREA,ro,1,DENUMIREA COMERCIALĂ A MEDICAMENTULUI ȘI CALEA(CĂILE) DE ADMINISTRARE,86027.0,True,28
2957,86029,CAP,ETICHETAREA,ro,2,MODUL DE ADMINISTRARE,86027.0,True,29
2958,86030,CAP,ETICHETAREA,ro,3,DATA DE EXPIRARE,86027.0,True,30
2959,86031,CAP,ETICHETAREA,ro,4,"SERIA DE FABRICAȚIE<, CODURILE DONAȚIEI ȘI MEDICAMENTULUI>",86027.0,True,31
2960,86032,CAP,ETICHETAREA,ro,5,"CONȚINUTUL PE MASĂ, VOLUM SAU UNITATEA DE DOZĂ",86027.0,True,32
2961,86033,CAP,ETICHETAREA,ro,6,ALTE INFORMAȚII,86027.0,True,33
2962,87001,CAP,PROSPECTUL,ro,,PROSPECTUL,,True,1
2963,87002,CAP,PROSPECTUL,ro,,q Acest medicament face obiectul unei monitorizări suplimentare. Acest lucru va permite identificarea rapidă de noi informații referitoare la siguranță. Puteți să fiți de ajutor raportând orice reacții adverse pe care le puteți avea. Vezi ultima parte de la pct. 4 pentru modul de raportare a reacțiilor adverse.,87001.0,False,2
2964,87003,CAP,PROSPECTUL,ro,,Ce găsiți în acest prospect,87001.0,True,3
2965,87004,CAP,PROSPECTUL,ro,1,Ce este X și pentru ce se utilizează,87001.0,True,4
2966,87005,CAP,PROSPECTUL,ro,2,Ce trebuie să știți înainte să <luați><utilizați> X,87001.0,True,5
2967,87006,CAP,PROSPECTUL,ro,,Nu <luați><utilizați> X,87005.0,True,6
2968,87007,CAP,PROSPECTUL,ro,,Atenționări și precauții ,87005.0,True,7
2969,87008,CAP,PROSPECTUL,ro,,Copii <și adolescenți>,87005.0,True,8
2970,87009,CAP,PROSPECTUL,ro,,X împreună cu alte medicamente,87005.0,True,9
2971,87010,CAP,PROSPECTUL,ro,,"X împreună cu <alimente><și><,><băuturi><și><alcool>",87005.0,True,10
2972,87011,CAP,PROSPECTUL,ro,,"Sarcina <și><,> alăptarea <și fertilitatea>",87005.0,True,11
2973,87012,CAP,PROSPECTUL,ro,,Conducerea vehiculelor și folosirea utilajelor,87005.0,True,12
2974,87013,CAP,PROSPECTUL,ro,,X conține {numele excipientului(ților)},87005.0,False,13
2975,87014,CAP,PROSPECTUL,ro,3,Cum să <luați><utilizați> X,87001.0,True,14
2976,87015,CAP,PROSPECTUL,ro,,Utilizarea la copii <și adolescenți>,87014.0,False,15
2977,87016,CAP,PROSPECTUL,ro,,Dacă <luați><utilizați> mai mult X decât trebuie,87014.0,False,16
2978,87017,CAP,PROSPECTUL,ro,,Dacă uitați să <luați><utilizați> X,87014.0,False,17
2979,87018,CAP,PROSPECTUL,ro,,Dacă încetați să <luați><utilizați> X,87014.0,False,18
2980,87019,CAP,PROSPECTUL,ro,4,Reacții adverse posibile,87001.0,True,19
2981,87020,CAP,PROSPECTUL,ro,,Reacții adverse suplimentare la copii <și adolescenți>,87019.0,False,20
2982,87021,CAP,PROSPECTUL,ro,,Raportarea reacțiilor adverse,87019.0,True,21
2983,87022,CAP,PROSPECTUL,ro,5,Cum se păstrează X,87001.0,True,22
2984,87023,CAP,PROSPECTUL,ro,6,Conținutul ambalajului și alte informații,87001.0,True,23
2985,87024,CAP,PROSPECTUL,ro,,Ce conține X ,87023.0,True,24
2986,87025,CAP,PROSPECTUL,ro,,Cum arată X și conținutul ambalajului,87023.0,True,25
2987,87026,CAP,PROSPECTUL,ro,,Deținătorul autorizației de punere pe piață și fabricantul,87023.0,True,26
2988,87027,CAP,PROSPECTUL,ro,,"Pentru orice informații referitoare la acest medicament, vă rugăm să contactați reprezentanța locală a deținătorului autorizației de punere pe piață:",87023.0,False,27
2989,87028,CAP,PROSPECTUL,ro,,Acest prospect a fost revizuit în <{LL/AAAA}><{luna AAAA}>.,87023.0,True,28
2990,87029,CAP,PROSPECTUL,ro,,Alte surse de informații,87023.0,False,29
2991,87030,CAP,PROSPECTUL,ro,,Următoarele informații sunt destinate numai profesioniștilor din domeniul sănătății:,87001.0,False,30
2992,88001,CAP,SmPC,se,,PRODUKTRESUMÉ,,True,1
2993,88002,CAP,SmPC,se,,qDetta läkemedel är föremål för utökad övervakning. Detta kommer att göra det möjligt att snabbt identifiera ny säkerhetsinformation. Hälso- och sjukvårdspersonal uppmanas att rapportera varje misstänkt biverkning. Se avsnitt 4.8 om hur man rapporterar biverkningar.,88001.0,False,2
2994,88003,CAP,SmPC,se,1,LÄKEMEDLETS NAMN,88001.0,True,3
2995,88004,CAP,SmPC,se,2,KVALITATIV OCH KVANTITATIV SAMMANSÄTTNING,88001.0,True,4
2996,88005,CAP,SmPC,se,2.1,Allmän beskrivning,88004.0,False,5
2997,88006,CAP,SmPC,se,2.2,Kvalitativ och kvantitativ sammansättning,88004.0,False,6
2998,88007,CAP,SmPC,se,,Hjälpämne(n) med känd effekt,88006.0,False,7
2999,88008,CAP,SmPC,se,3,LÄKEMEDELSFORM,88001.0,True,8
3000,88009,CAP,SmPC,se,4,KLINISKA UPPGIFTER,88001.0,True,9
3001,88010,CAP,SmPC,se,4.1,Terapeutiska indikationer,88009.0,True,10
3002,88011,CAP,SmPC,se,4.2,Dosering och administreringssätt,88009.0,True,11
3003,88012,CAP,SmPC,se,,Dosering,88011.0,True,12
3004,88013,CAP,SmPC,se,,Pediatrisk population,88012.0,True,13
3005,88014,CAP,SmPC,se,,Administreringssätt,88011.0,True,14
3006,88015,CAP,SmPC,se,,Försiktighetsåtgärder före hantering eller administrering av läkemedlet,88014.0,False,15
3007,88016,CAP,SmPC,se,4.3,Kontraindikationer,88009.0,True,16
3008,88017,CAP,SmPC,se,4.4,Varningar och försiktighet,88009.0,True,17
3009,88018,CAP,SmPC,se,,Spårbarhet,88017.0,False,18
3010,88019,CAP,SmPC,se,,Pediatrisk population,88017.0,False,19
3011,88020,CAP,SmPC,se,4.5,Interaktioner med andra läkemedel och övriga interaktioner,88009.0,True,20
3012,88021,CAP,SmPC,se,,Pediatrisk population,88020.0,False,21
3013,88022,CAP,SmPC,se,4.6,"Fertilitet, graviditet och amning",88009.0,True,22
3014,88023,CAP,SmPC,se,,Graviditet,88022.0,False,23
3015,88024,CAP,SmPC,se,,Amning,88022.0,False,24
3016,88025,CAP,SmPC,se,,Fertilitet,88022.0,False,25
3017,88026,CAP,SmPC,se,4.7,Effekter på förmågan att framföra fordon och använda maskiner,88009.0,True,26
3018,88027,CAP,SmPC,se,4.8,Biverkningar,88009.0,True,27
3019,88028,CAP,SmPC,se,,Pediatrisk population,88027.0,False,28
3020,88029,CAP,SmPC,se,,Rapportering av misstänkta biverkningar,88027.0,True,29
3021,88030,CAP,SmPC,se,4.9,Överdosering,88009.0,True,30
3022,88031,CAP,SmPC,se,,Pediatrisk population,88030.0,False,31
3023,88032,CAP,SmPC,se,5,FARMAKOLOGISKA EGENSKAPER,88001.0,True,32
3024,88033,CAP,SmPC,se,5.1,Farmakodynamiska egenskaper,88032.0,True,33
3025,88034,CAP,SmPC,se,,Verkningsmekanism,88033.0,False,34
3026,88035,CAP,SmPC,se,,Farmakodynamisk effekt,88033.0,False,35
3027,88036,CAP,SmPC,se,,Klinisk effekt och säkerhet,88033.0,False,36
3028,88037,CAP,SmPC,se,,Pediatrisk population,88033.0,False,37
3029,88038,CAP,SmPC,se,5.2,Farmakokinetiska egenskaper,88032.0,True,38
3030,88039,CAP,SmPC,se,,Absorption,88038.0,False,39
3031,88040,CAP,SmPC,se,,Distribution,88038.0,False,40
3032,88041,CAP,SmPC,se,,Metabolism,88038.0,False,41
3033,88042,CAP,SmPC,se,,Eliminering,88038.0,False,42
3034,88043,CAP,SmPC,se,,Linjäritet/icke-linjäritet,88038.0,False,43
3035,88044,CAP,SmPC,se,,Farmakokinetiskt (Farmakokinetiska)/farmakodynamiskt (farmakodynamiska) förhållande(n),88038.0,False,44
3036,88045,CAP,SmPC,se,5.3,Prekliniska säkerhetsuppgifter,88032.0,True,45
3037,88046,CAP,SmPC,se,,Miljöriskbedömning,88045.0,False,46
3038,88047,CAP,SmPC,se,6,FARMACEUTISKA UPPGIFTER,88001.0,True,47
3039,88048,CAP,SmPC,se,6.1,Förteckning över hjälpämnen,88047.0,True,48
3040,88049,CAP,SmPC,se,6.2,Inkompatibiliteter,88047.0,True,49
3041,88050,CAP,SmPC,se,6.3,Hållbarhet,88047.0,True,50
3042,88051,CAP,SmPC,se,6.4,Särskilda förvaringsanvisningar,88047.0,True,51
3043,88052,CAP,SmPC,se,6.5,"Förpackningstyp och innehåll <och utrustning för användning, administrering eller implantation>",88047.0,True,52
3044,88053,CAP,SmPC,se,6.6,Särskilda anvisningar för destruktion <och övrig hantering>,88047.0,True,53
3045,88054,CAP,SmPC,se,,Användning i den pediatriska populationen,88053.0,False,54
3046,88055,CAP,SmPC,se,7,INNEHAVARE AV GODKÄNNANDE FÖR FÖRSÄLJNING,88001.0,True,55
3047,88056,CAP,SmPC,se,8,NUMMER PÅ GODKÄNNANDE FÖR FÖRSÄLJNING ,88001.0,True,56
3048,88057,CAP,SmPC,se,9,DATUM FÖR FÖRSTA GODKÄNNANDE/FÖRNYAT GODKÄNNANDE,88001.0,True,57
3049,88058,CAP,SmPC,se,10,DATUM FÖR ÖVERSYN AV PRODUKTRESUMÉN,88001.0,True,58
3050,88059,CAP,SmPC,se,11,ABSORBERAD DOS OCH EFFEKTIV DOS,88001.0,False,59
3051,88060,CAP,SmPC,se,12,INSTRUKTION FÖR BEREDNING AV RADIOFARMAKA,88001.0,False,60
3052,89001,CAP,AnnexII,se,,BILAGA II,,True,1
3053,89002,CAP,AnnexII,se,A,< TILLVERKARE AV DEN (DE) AKTIVA SUBSTANSEN (SUBSTANSERNA) AV BIOLOGISKT URSPRUNG OCH > TILLVERKARE SOM ANSVARAR FÖR FRISLÄPPANDE AV TILLVERKNINGSSATS,89001.0,True,2
3054,89003,CAP,AnnexII,se,,Namn och adress till tillverkare av aktiv(a) substans(er) av biologiskt ursprung,89002.0,False,3
3055,89004,CAP,AnnexII,se,,Namn och adress till tillverkare som ansvarar för frisläppande av tillverkningssats,89002.0,True,4
3056,89005,CAP,AnnexII,se,B,VILLKOR ELLER BEGRÄNSNINGAR FÖR TILLHANDAHÅLLANDE OCH ANVÄNDNING ,89001.0,True,5
3057,89006,CAP,AnnexII,se,,Officiellt frisläppande av tillverkningssats,89005.0,False,6
3058,89007,CAP,AnnexII,se,C,ÖVRIGA VILLKOR OCH KRAV FÖR GODKÄNNANDET FÖR FÖRSÄLJNING,89001.0,True,7
3059,89008,CAP,AnnexII,se,,Periodiska säkerhetsrapporter,89007.0,True,8
3060,89009,CAP,AnnexII,se,D,VILLKOR ELLER BEGRÄNSNINGAR AVSEENDE EN SÄKER OCH EFFEKTIV ANVÄNDNING AV LÄKEMEDLET  ,89001.0,True,9
3061,89010,CAP,AnnexII,se,,Riskhanteringsplan,89009.0,True,10
3062,89011,CAP,AnnexII,se,,Ytterligare riskminimeringsåtgärder,89009.0,False,11
3063,89012,CAP,AnnexII,se,,Skyldighet att vidta åtgärder efter godkännande för försäljning,89009.0,False,12
3064,89013,CAP,AnnexII,se,E,SÄRSKILDA VILLKOR SOM SKA KOMPLETTERA ÅTAGANDEN EFTER GODKÄNNANDET FÖR FÖRSÄLJNING <FÖR DET VILLKORADE GODKÄNNANDET> <FÖR GODKÄNNANDET I UNDANTAGSFALL>,89001.0,False,13
3065,90001,CAP,Labelling,se,,MÄRKNING,,True,1
3066,90002,CAP,Labelling,se,,UPPGIFTER SOM SKA FINNAS PÅ <YTTRE FÖRPACKNINGEN> <OCH PÅ> <INNERFÖRPACKNINGEN>,90001.0,True,2
3067,90003,CAP,Labelling,se,1,LÄKEMEDLETS NAMN,90002.0,True,3
3068,90004,CAP,Labelling,se,2,DEKLARATION AV AKTIV(A) SUBSTANS(ER),90002.0,True,4
3069,90005,CAP,Labelling,se,3,FÖRTECKNING ÖVER HJÄLPÄMNEN,90002.0,True,5
3070,90006,CAP,Labelling,se,4,LÄKEMEDELSFORM OCH FÖRPACKNINGSSTORLEK,90002.0,True,6
3071,90007,CAP,Labelling,se,5,ADMINISTRERINGSSÄTT OCH ADMINISTRERINGSVÄG,90002.0,True,7
3072,90008,CAP,Labelling,se,6,SÄRSKILD VARNING OM ATT LÄKEMEDLET MÅSTE FÖRVARAS UTOM SYN- OCH RÄCKHÅLL FÖR BARN,90002.0,True,8
3073,90009,CAP,Labelling,se,7,ÖVRIGA SÄRSKILDA VARNINGAR OM SÅ ÄR NÖDVÄNDIGT,90002.0,True,9
3074,90010,CAP,Labelling,se,8,UTGÅNGSDATUM,90002.0,True,10
3075,90011,CAP,Labelling,se,9,SÄRSKILDA FÖRVARINGSANVISNINGAR,90002.0,True,11
3076,90012,CAP,Labelling,se,10,SÄRSKILDA FÖRSIKTIGHETSÅTGÄRDER FÖR DESTRUKTION AV EJ ANVÄNT LÄKEMEDEL OCH AVFALL I FÖREKOMMANDE FALL,90002.0,True,12
3077,90013,CAP,Labelling,se,11,INNEHAVARE AV GODKÄNNANDE FÖR FÖRSÄLJNING (NAMN OCH ADRESS),90002.0,True,13
3078,90014,CAP,Labelling,se,12,NUMMER PÅ GODKÄNNANDE FÖR FÖRSÄLJNING ,90002.0,True,14
3079,90015,CAP,Labelling,se,13,"TILLVERKNINGSSATSNUMMER <, DONATIONS- OCH PRODUKTKODER>",90002.0,True,15
3080,90016,CAP,Labelling,se,14,ALLMÄN KLASSIFICERING FÖR FÖRSKRIVNING,90002.0,True,16
3081,90017,CAP,Labelling,se,15,BRUKSANVISNING,90002.0,True,17
3082,90018,CAP,Labelling,se,16,INFORMATION I PUNKTSKRIFT,90002.0,True,18
3083,90019,CAP,Labelling,se,17,UNIK IDENTITETSBETECKNING – TVÅDIMENSIONELL STRECKKOD ,90002.0,True,19
3084,90020,CAP,Labelling,se,18,UNIK IDENTITETSBETECKNING – I ETT FORMAT LÄSBART FÖR MÄNSKLIGT ÖGA,90002.0,True,20
3085,90021,CAP,Labelling,se,,UPPGIFTER SOM SKA FINNAS PÅ BLISTER ELLER STRIPS,90001.0,True,21
3086,90022,CAP,Labelling,se,1,LÄKEMEDLETS NAMN,90021.0,True,22
3087,90023,CAP,Labelling,se,2,INNEHAVARE AV GODKÄNNANDE FÖR FÖRSÄLJNING,90021.0,True,23
3088,90024,CAP,Labelling,se,3,UTGÅNGSDATUM,90021.0,True,24
3089,90025,CAP,Labelling,se,4,"TILLVERKNINGSSATSNUMMER <, DONATIONS- OCH PRODUKTKODER",90021.0,True,25
3090,90026,CAP,Labelling,se,5,ÖVRIGT,90021.0,True,26
3091,90027,CAP,Labelling,se,,UPPGIFTER SOM SKA FINNAS PÅ SMÅ INRE LÄKEMEDELSFÖRPACKNINGAR,90001.0,True,27
3092,90028,CAP,Labelling,se,1,LÄKEMEDLETS NAMN OCH ADMINISTRERINGSVÄG,90027.0,True,28
3093,90029,CAP,Labelling,se,2,ADMINISTRERINGSSÄTT,90027.0,True,29
3094,90030,CAP,Labelling,se,3,UTGÅNGSDATUM,90027.0,True,30
3095,90031,CAP,Labelling,se,4,"TILLVERKNINGSSATSNUMMER <, DONATIONS- OCH PRODUKTKODER>",90027.0,True,31
3096,90032,CAP,Labelling,se,5,"MÄNGD UTTRYCKT I VIKT, VOLYM ELLER PER ENHET",90027.0,True,32
3097,90033,CAP,Labelling,se,6,ÖVRIGT,90027.0,True,33
3098,91001,CAP,Package leaflet,se,,BIPACKSEDEL,,True,1
3099,91002,CAP,Package leaflet,se,,q Detta läkemedel är föremål för utökad övervakning. Detta kommer att göra det möjligt att snabbt identifiera ny säkerhetsinformation. Du kan hjälpa till genom att rapportera de biverkningar du eventuellt får. Information om hur du rapporterar biverkningar finns i slutet av avsnitt 4. ,91001.0,False,2
3100,91003,CAP,Package leaflet,se,,I denna bipacksedel finns information om följande:,91001.0,True,3
3101,91004,CAP,Package leaflet,se,1,Vad X är och vad det används för,91001.0,True,4
3102,91005,CAP,Package leaflet,se,2,Vad du behöver veta innan du <tar> <använder> X ,91001.0,True,5
3103,91006,CAP,Package leaflet,se,,<Ta> <Använd> inte X<:>,91005.0,True,6
3104,91007,CAP,Package leaflet,se,,Varningar och försiktighet,91005.0,True,7
3105,91008,CAP,Package leaflet,se,,Barn <och ungdomar>,91005.0,True,8
3106,91009,CAP,Package leaflet,se,,Andra läkemedel och X,91005.0,True,9
3107,91010,CAP,Package leaflet,se,,"X med <mat> <och > <,> <dryck> <och> <alkohol>",91005.0,True,10
3108,91011,CAP,Package leaflet,se,,"Graviditet <och> <,> amning <och fertilitet>",91005.0,True,11
3109,91012,CAP,Package leaflet,se,,Körförmåga och användning av maskiner,91005.0,True,12
3110,91013,CAP,Package leaflet,se,,X innehåller {namn på hjälpämne(n)},91005.0,False,13
3111,91014,CAP,Package leaflet,se,3,Hur du <tar> <använder> X,91001.0,True,14
3112,91015,CAP,Package leaflet,se,,Användning för barn <och ungdomar>,91014.0,False,15
3113,91016,CAP,Package leaflet,se,,Om du <har tagit> <använt> för stor mängd av X,91014.0,False,16
3114,91017,CAP,Package leaflet,se,,Om du har glömt att <ta> <använda> X,91014.0,False,17
3115,91018,CAP,Package leaflet,se,,Om du slutar att <ta> <använda>X,91014.0,False,18
3116,91019,CAP,Package leaflet,se,4,Eventuella biverkningar,91001.0,True,19
3117,91020,CAP,Package leaflet,se,,Ytterligare biverkningar hos barn <och ungdomar>,91019.0,False,20
3118,91021,CAP,Package leaflet,se,,Rapportering av biverkningar,91019.0,True,21
3119,91022,CAP,Package leaflet,se,5,Hur X ska förvaras,91001.0,True,22
3120,91023,CAP,Package leaflet,se,6,Förpackningens innehåll och övriga upplysningar,91001.0,True,23
3121,91024,CAP,Package leaflet,se,,Innehållsdeklaration,91023.0,True,24
3122,91025,CAP,Package leaflet,se,,Läkemedlets utseende och förpackningsstorlekar,91023.0,True,25
3123,91026,CAP,Package leaflet,se,,Innehavare av godkännande för försäljning och tillverkare,91023.0,True,26
3124,91027,CAP,Package leaflet,se,,Kontakta ombudet för innehavaren av godkännandet för försäljning om du vill veta mer om detta läkemedel,91023.0,False,27
3125,91028,CAP,Package leaflet,se,,Denna bipacksedel ändrades senast <{MM/ÅÅÅÅ}><{månad ÅÅÅÅ}>.,91023.0,True,28
3126,91029,CAP,Package leaflet,se,,Övriga informationskällor,91023.0,False,29
3127,91030,CAP,Package leaflet,se,,Följande uppgifter är endast avsedda för hälso- och sjukvårdspersonal:,91001.0,False,30
3128,92001,CAP,SmPC,sk,,SÚHRN CHARAKTERISTICKÝCH VLASTNOSTÍ LIEKU,,True,1
3129,92002,CAP,SmPC,sk,,"qTento liek je predmetom ďalšieho monitorovania. To umožní rýchle získanie nových informácií o bezpečnosti. Od zdravotníckych pracovníkov sa vyžaduje, aby hlásili akékoľvek podozrenia na nežiaduce reakcie. Informácie o tom, ako hlásiť nežiaduce reakcie, nájdete v časti 4.8.",92001.0,False,2
3130,92003,CAP,SmPC,sk,1,NÁZOV LIEKU,92001.0,True,3
3131,92004,CAP,SmPC,sk,2,KVALITATÍVNE A KVANTITATÍVNE ZLOŽENIE,92001.0,True,4
3132,92005,CAP,SmPC,sk,2.1,Všeobecný opis,92004.0,False,5
3133,92006,CAP,SmPC,sk,2.2,Kvalitatívne a kvantitatívne zloženie,92004.0,False,6
3134,92007,CAP,SmPC,sk,,Pomocná látka> <Pomocné látky> so známym účinkom,92006.0,False,7
3135,92008,CAP,SmPC,sk,3,LIEKOVÁ FORMA,92001.0,True,8
3136,92009,CAP,SmPC,sk,4,KLINICKÉ ÚDAJE,92001.0,True,9
3137,92010,CAP,SmPC,sk,4.1,Terapeutické indikácie,92009.0,True,10
3138,92011,CAP,SmPC,sk,4.2,Dávkovanie a spôsob podávania,92009.0,True,11
3139,92012,CAP,SmPC,sk,,Dávkovanie,92011.0,True,12
3140,92013,CAP,SmPC,sk,,Pediatrická populácia,92012.0,True,13
3141,92014,CAP,SmPC,sk,,Spôsob podávania,92011.0,True,14
3142,92015,CAP,SmPC,sk,,Opatrenia pred zaobchádzaním alebo podaním lieku,92014.0,False,15
3143,92016,CAP,SmPC,sk,4.3,Kontraindikácie,92009.0,True,16
3144,92017,CAP,SmPC,sk,4.4,Osobitné upozornenia a opatrenia pri používaní,92009.0,True,17
3145,92018,CAP,SmPC,sk,,Sledovateľnosť,92017.0,False,18
3146,92019,CAP,SmPC,sk,,Pediatrická populácia,92017.0,False,19
3147,92020,CAP,SmPC,sk,4.5,Liekové a iné interakcie,92009.0,True,20
3148,92021,CAP,SmPC,sk,,Pediatrická populácia,92020.0,False,21
3149,92022,CAP,SmPC,sk,4.6,"Fertilita, gravidita a laktácia",92009.0,True,22
3150,92023,CAP,SmPC,sk,,Gravidita,92022.0,False,23
3151,92024,CAP,SmPC,sk,,Dojčenie,92022.0,False,24
3152,92025,CAP,SmPC,sk,,Fertilita,92022.0,False,25
3153,92026,CAP,SmPC,sk,4.7,Ovplyvnenie schopnosti viesť vozidlá a obsluhovať stroje,92009.0,True,26
3154,92027,CAP,SmPC,sk,4.8,Nežiaduce účinky,92009.0,True,27
3155,92028,CAP,SmPC,sk,,Pediatrická populácia,92027.0,False,28
3156,92029,CAP,SmPC,sk,,Hlásenie podozrení na nežiaduce reakcie,92027.0,True,29
3157,92030,CAP,SmPC,sk,4.9,Predávkovanie,92009.0,True,30
3158,92031,CAP,SmPC,sk,,Pediatrická populácia,92030.0,False,31
3159,92032,CAP,SmPC,sk,5,FARMAKOLOGICKÉ VLASTNOSTI,92001.0,True,32
3160,92033,CAP,SmPC,sk,5.1,Farmakodynamické vlastnosti,92032.0,True,33
3161,92034,CAP,SmPC,sk,,Mechanizmus účinku,92033.0,False,34
3162,92035,CAP,SmPC,sk,,Farmakodynamické účinky,92033.0,False,35
3163,92036,CAP,SmPC,sk,,Klinická účinnosť a bezpečnosť,92033.0,False,36
3164,92037,CAP,SmPC,sk,,Pediatrická populácia,92033.0,False,37
3165,92038,CAP,SmPC,sk,5.2,Farmakokinetické vlastnosti,92032.0,True,38
3166,92039,CAP,SmPC,sk,,Absorpcia,92038.0,False,39
3167,92040,CAP,SmPC,sk,,Distribúcia,92038.0,False,40
3168,92041,CAP,SmPC,sk,,Biotransformácia,92038.0,False,41
3169,92042,CAP,SmPC,sk,,Eliminácia,92038.0,False,42
3170,92043,CAP,SmPC,sk,,Linearita/nelinearita,92038.0,False,43
3171,92044,CAP,SmPC,sk,,Farmakokinetický/farmakodynamický vzťah,92038.0,False,44
3172,92045,CAP,SmPC,sk,5.3,Predklinické údaje o bezpečnosti,92032.0,True,45
3173,92046,CAP,SmPC,sk,,Hodnotenie environmentálneho rizika (ERA),92045.0,False,46
3174,92047,CAP,SmPC,sk,6,FARMACEUTICKÉ INFORMÁCIE,92001.0,True,47
3175,92048,CAP,SmPC,sk,6.1,Zoznam pomocných látok,92047.0,True,48
3176,92049,CAP,SmPC,sk,6.2,Inkompatibility,92047.0,True,49
3177,92050,CAP,SmPC,sk,6.3,Čas použiteľnosti,92047.0,True,50
3178,92051,CAP,SmPC,sk,6.4,Špeciálne upozornenia na uchovávanie,92047.0,True,51
3179,92052,CAP,SmPC,sk,6.5,"Druh obalu a obsah balenia <a špeciálne zariadenie na použitie, podanie alebo implantáciu>",92047.0,True,52
3180,92053,CAP,SmPC,sk,6.6,Špeciálne opatrenia na likvidáciu <a iné zaobchádzanie s liekom>,92047.0,True,53
3181,92054,CAP,SmPC,sk,,Použitie v pediatrickej populácii,92053.0,False,54
3182,92055,CAP,SmPC,sk,7,DRŽITEĽ ROZHODNUTIA O REGISTRÁCII,92001.0,True,55
3183,92056,CAP,SmPC,sk,8,REGISTRAČNÉ <ČÍSLO> <ČÍSLA>,92001.0,True,56
3184,92057,CAP,SmPC,sk,9,DÁTUM PRVEJ REGISTRÁCIE/PREDĹŽENIA REGISTRÁCIE,92001.0,True,57
3185,92058,CAP,SmPC,sk,10,DÁTUM REVÍZIE TEXTU,92001.0,True,58
3186,92059,CAP,SmPC,sk,11,DOZIMETRIA,92001.0,False,59
3187,92060,CAP,SmPC,sk,12,POKYNY NA PRÍPRAVU RÁDIOFARMÁK,92001.0,False,60
3188,93001,CAP,AnnexII,sk,,PRÍLOHA II,,True,1
3189,93002,CAP,AnnexII,sk,A,<VÝROBCA (VÝROBCOVIA) BIOLOGICKÉHO LIEČIVA (BIOLOGICKÝCH LIEČIV) A>VÝROBCA (VÝROBCOVIA) ZODPOVEDNÝ (ZODPOVEDNÍ) ZA UVOĽNENIE ŠARŽE,93001.0,True,2
3190,93003,CAP,AnnexII,sk,,Názov a adresa výrobcu (výrobcov) biologického liečiva (biologických liečiv),93002.0,False,3
3191,93004,CAP,AnnexII,sk,,Názov a adresa výrobcu (výrobcov) zodpovedného (zodpovedných) za uvoľnenie šarže,93002.0,True,4
3192,93005,CAP,AnnexII,sk,B,PODMIENKY ALEBO OBMEDZENIA TÝKAJÚCE SA VÝDAJA A POUŽITIA ,93001.0,True,5
3193,93006,CAP,AnnexII,sk,,Oficiálne uvoľnenie šarže,93005.0,False,6
3194,93007,CAP,AnnexII,sk,C,ĎALŠIE PODMIENKY A POŽIADAVKY REGISTRÁCIE,93001.0,True,7
3195,93008,CAP,AnnexII,sk,,"Periodicky aktualizované správy o bezpečnosti (Periodic safety update reports, PSUR)",93007.0,True,8
3196,93009,CAP,AnnexII,sk,D,PODMIENKY ALEBO OBMEDZENIA TÝKAJÚCE SA BEZPEČNÉHO A ÚČINNÉHO POUŽÍVANIA LIEKU,93001.0,True,9
3197,93010,CAP,AnnexII,sk,,Plán riadenia rizík (RMP),93009.0,True,10
3198,93011,CAP,AnnexII,sk,,Nadstavbové opatrenia na minimalizáciu rizika,93009.0,False,11
3199,93012,CAP,AnnexII,sk,,Povinnosť vykonať postregistračné opatrenia,93009.0,False,12
3200,93013,CAP,AnnexII,en,E,OSOBITNÉ POŽIADAVKY NA SPLNENIE POSTREGISTRAČNÝCH OPATRENÍ <PRI REGISTRÁCII S PODMIENKOU> <PRI REGISTRÁCII ZA MIMORIADNYCH OKOLNOSTÍ>,93001.0,False,13
3201,94001,CAP,Labelling,sk,,OZNAČENIE OBALU,,True,1
3202,94002,CAP,Labelling,sk,,"ÚDAJE, KTORÉ MAJÚ BYŤ UVEDENÉ NA <VONKAJŠOM OBALE> <A> <VNÚTORNOM OBALE>",94001.0,True,2
3203,94003,CAP,Labelling,sk,1,NÁZOV LIEKU,94002.0,True,3
3204,94004,CAP,Labelling,sk,2,LIEČIVO (LIEČIVÁ),94002.0,True,4
3205,94005,CAP,Labelling,sk,3,ZOZNAM POMOCNÝCH LÁTOK,94002.0,True,5
3206,94006,CAP,Labelling,sk,4,LIEKOVÁ FORMA A OBSAH,94002.0,True,6
3207,94007,CAP,Labelling,sk,5,SPÔSOB A CESTA (CESTY) PODÁVANIA,94002.0,True,7
3208,94008,CAP,Labelling,sk,6,"ŠPECIÁLNE UPOZORNENIE, ŽE LIEK SA MUSÍ UCHOVÁVAŤ MIMO DOHĽADU A DOSAHU DETÍ",94002.0,True,8
3209,94009,CAP,Labelling,sk,7,"INÉ ŠPECIÁLNE UPOZORNENIE (UPOZORNENIA), AK JE TO POTREBNÉ",94002.0,True,9
3210,94010,CAP,Labelling,sk,8,DÁTUM EXSPIRÁCIE,94002.0,True,10
3211,94011,CAP,Labelling,sk,9,ŠPECIÁLNE PODMIENKY NA UCHOVÁVANIE,94002.0,True,11
3212,94012,CAP,Labelling,sk,10,"ŠPECIÁLNE UPOZORNENIA NA LIKVIDÁCIU NEPOUŽITÝCH LIEKOV ALEBO ODPADOV Z NICH VZNIKNUTÝCH, AK JE TO VHODNÉ",94002.0,True,12
3213,94013,CAP,Labelling,sk,11,NÁZOV A ADRESA DRŽITEĽA ROZHODNUTIA O REGISTRÁCII,94002.0,True,13
3214,94014,CAP,Labelling,sk,12,REGISTRAČNÉ <ČÍSLO> <ČÍSLA>,94002.0,True,14
3215,94015,CAP,Labelling,sk,13,"ČÍSLO VÝROBNEJ ŠARŽE<, KÓDY ODBERU A LIEKU>",94002.0,True,15
3216,94016,CAP,Labelling,sk,14,ZATRIEDENIE LIEKU PODĽA SPÔSOBU VÝDAJA,94002.0,True,16
3217,94017,CAP,Labelling,sk,15,POKYNY NA POUŽITIE,94002.0,True,17
3218,94018,CAP,Labelling,sk,16,INFORMÁCIE V BRAILLOVOM PÍSME,94002.0,True,18
3219,94019,CAP,Labelling,sk,17,ŠPECIFICKÝ IDENTIFIKÁTOR – DVOJROZMERNÝ ČIAROVÝ KÓD,94002.0,True,19
3220,94020,CAP,Labelling,sk,18,ŠPECIFICKÝ IDENTIFIKÁTOR – ÚDAJE ČITATEĽNÉ ĽUDSKÝM OKOM,94002.0,True,20
3221,94021,CAP,Labelling,sk,,"MINIMÁLNE ÚDAJE, KTORÉ MAJÚ BYŤ UVEDENÉ NA BLISTROCH ALEBO STRIPOCH",94001.0,True,21
3222,94022,CAP,Labelling,sk,1,NÁZOV LIEKU,94021.0,True,22
3223,94023,CAP,Labelling,sk,2,NÁZOV DRŽITEĽA ROZHODNUTIA O REGISTRÁCII,94021.0,True,23
3224,94024,CAP,Labelling,sk,3,DÁTUM EXSPIRÁCIE,94021.0,True,24
3225,94025,CAP,Labelling,sk,4,"ČÍSLO VÝROBNEJ ŠARŽE<, KÓDY ODBERU A LIEKU>",94021.0,True,25
3226,94026,CAP,Labelling,sk,5,INÉ,94021.0,True,26
3227,94027,CAP,Labelling,sk,,"MINIMÁLNE ÚDAJE, KTORÉ MAJÚ BYŤ UVEDENÉ NA MALOM VNÚTORNOM OBALE",94001.0,True,27
3228,94028,CAP,Labelling,sk,1,NÁZOV LIEKU A CESTA (CESTY) PODÁVANIA,94027.0,True,28
3229,94029,CAP,Labelling,sk,2,SPÔSOB PODÁVANIA,94027.0,True,29
3230,94030,CAP,Labelling,sk,3,DÁTUM EXSPIRÁCIE,94027.0,True,30
3231,94031,CAP,Labelling,sk,4,"ČÍSLO VÝROBNEJ ŠARŽE<, KÓDY ODBERU A LIEKU>",94027.0,True,31
3232,94032,CAP,Labelling,sk,5,"OBSAH V HMOTNOSTNÝCH, OBJEMOVÝCH ALEBO KUSOVÝCH JEDNOTKÁCH",94027.0,True,32
3233,94033,CAP,Labelling,sk,6,INÉ,94027.0,True,33
3234,95001,CAP,Package leaflet,sk,,PÍSOMNÁ INFORMÁCIA PRE POUŽÍVATEĽA,,True,1
3235,95002,CAP,Package leaflet,sk,,"qTento liek je predmetom ďalšieho monitorovania. To umožní rýchle získanie nových informácií o bezpečnosti. Môžete prispieť tým, že nahlásite akékoľvek vedľajšie účinky, ak sa u vás vyskytnú. Informácie o tom, ako hlásiť vedľajšie účinky, nájdete na konci časti 4.",95001.0,False,2
3236,95003,CAP,Package leaflet,sk,,V tejto písomnej informácii sa dozviete:,95001.0,True,3
3237,95004,CAP,Package leaflet,sk,1,Čo je X a na čo sa používa,95001.0,True,4
3238,95005,CAP,Package leaflet,sk,2,"Čo potrebujete vedieť predtým, ako <užijete> <použijete> X",95001.0,True,5
3239,95006,CAP,Package leaflet,sk,,<Neužívajte> <Nepoužívajte> X,95005.0,True,6
3240,95007,CAP,Package leaflet,sk,,Upozornenia a opatrenia,95005.0,True,7
3241,95008,CAP,Package leaflet,sk,,Deti <a dospievajúci>,95005.0,True,8
3242,95009,CAP,Package leaflet,sk,,Iné lieky a X,95005.0,True,9
3243,95010,CAP,Package leaflet,sk,,"X a <jedlo> <a> <,> <nápoje><a><alkohol>",95005.0,True,10
3244,95011,CAP,Package leaflet,sk,,Tehotenstvo <a> <dojčenie> <a plodnosť>,95005.0,True,11
3245,95012,CAP,Package leaflet,sk,,Vedenie vozidiel a obsluha strojov,95005.0,True,12
3246,95013,CAP,Package leaflet,sk,,X obsahuje {názov pomocnej látky(pomocných látok)},95005.0,False,13
3247,95014,CAP,Package leaflet,sk,3,Ako <užívať> <používať> X,95001.0,True,14
3248,95015,CAP,Package leaflet,sk,,Použitie u detí <a dospievajúcich>,95014.0,False,15
3249,95016,CAP,Package leaflet,sk,,"Ak <užijete> <použijete> viac X, ako máte",95014.0,False,16
3250,95017,CAP,Package leaflet,sk,,Ak zabudnete <užiť> <použiť> X,95014.0,False,17
3251,95018,CAP,Package leaflet,sk,,Ak prestanete <užívať> <používať> X,95014.0,False,18
3252,95019,CAP,Package leaflet,sk,4,Možné vedľajšie účinky,95001.0,True,19
3253,95020,CAP,Package leaflet,sk,,Ďalšie vedľajšie účinky u detí <a dospievajúcich>,95019.0,False,20
3254,95021,CAP,Package leaflet,sk,,Hlásenie vedľajších účinkov,95019.0,True,21
3255,95022,CAP,Package leaflet,sk,5,Ako uchovávať X,95001.0,True,22
3256,95023,CAP,Package leaflet,sk,6,Obsah balenia a ďalšie informácie,95001.0,True,23
3257,95024,CAP,Package leaflet,sk,,Čo X obsahuje,95023.0,True,24
3258,95025,CAP,Package leaflet,sk,,Ako vyzerá X a obsah balenia,95023.0,True,25
3259,95026,CAP,Package leaflet,sk,,Držiteľ rozhodnutia o registrácii a výrobca,95023.0,True,26
3260,95027,CAP,Package leaflet,sk,,"Ak potrebujete akúkoľvek informáciu o tomto lieku, kontaktujte miestneho zástupcu držiteľa rozhodnutia o registrácii:",95023.0,False,27
3261,95028,CAP,Package leaflet,sk,,Táto písomná informácia bola naposledy aktualizovaná v <{MM/RRRR}> <{mesiac RRRR}>.,95023.0,True,28
3262,95029,CAP,Package leaflet,sk,,Ďalšie zdroje informácií,95023.0,False,29
3263,95030,CAP,Package leaflet,sk,,Nasledujúca informácia je určená len pre zdravotníckych pracovníkov:,95001.0,False,30
3264,96001,CAP,SmPC,sl,,POVZETEK GLAVNIH ZNAČILNOSTI ZDRAVILA,,True,1
3265,96002,CAP,SmPC,sl,,"qZa to zdravilo se izvaja dodatno spremljanje varnosti. Tako bodo hitreje na voljo nove informacije o njegovi varnosti. Zdravstvene delavce naprošamo, da poročajo o katerem koli domnevnem neželenem učinku zdravila. Glejte poglavje 4.8, kako poročati o neželenih učinkih.",96001.0,False,2
3266,96003,CAP,SmPC,sl,1,IME ZDRAVILA,96001.0,True,3
3267,96004,CAP,SmPC,sl,2,KAKOVOSTNA IN KOLIČINSKA SESTAVA,96001.0,True,4
3268,96005,CAP,SmPC,sl,2.1,Splošen opis,96004.0,False,5
3269,96006,CAP,SmPC,sl,2.2,Kakovostna in količinska sestava,96004.0,False,6
3270,96007,CAP,SmPC,sl,,Pomožna(e) snov(i) z znanim učinkom:,96006.0,False,7
3271,96008,CAP,SmPC,sl,3,FARMACEVTSKA OBLIKA,96001.0,True,8
3272,96009,CAP,SmPC,sl,4,KLINIČNI PODATKI,96001.0,True,9
3273,96010,CAP,SmPC,sl,4.1,Terapevtske indikacije,96009.0,True,10
3274,96011,CAP,SmPC,sl,4.2,Odmerjanje in način uporabe,96009.0,True,11
3275,96012,CAP,SmPC,sl,,Odmerjanje,96011.0,True,12
3276,96013,CAP,SmPC,sl,,Pediatrična populacija,96012.0,True,13
3277,96014,CAP,SmPC,sl,,Način uporabe,96011.0,True,14
3278,96015,CAP,SmPC,sl,,"Previdnostni ukrepi, potrebni pred ravnanjem z zdravilom ali dajanjem zdravila",96014.0,False,15
3279,96016,CAP,SmPC,sl,4.3,Kontraindikacije,96009.0,True,16
3280,96017,CAP,SmPC,sl,4.4,Posebna opozorila in previdnostni ukrepi,96009.0,True,17
3281,96018,CAP,SmPC,sl,,Sledljivost,96017.0,False,18
3282,96019,CAP,SmPC,sl,,Pediatrična populacija,96017.0,False,19
3283,96020,CAP,SmPC,sl,4.5,Medsebojno delovanje z drugimi zdravili in druge oblike interakcij,96009.0,True,20
3284,96021,CAP,SmPC,sl,,Pediatrična populacija,96020.0,False,21
3285,96022,CAP,SmPC,sl,4.6,"Plodnost, nosečnost in dojenje",96009.0,True,22
3286,96023,CAP,SmPC,sl,,Nosečnost,96022.0,False,23
3287,96024,CAP,SmPC,sl,,Dojenje,96022.0,False,24
3288,96025,CAP,SmPC,sl,,Plodnost,96022.0,False,25
3289,96026,CAP,SmPC,sl,4.7,Vpliv na sposobnost vožnje in upravljanja strojev,96009.0,True,26
3290,96027,CAP,SmPC,sl,4.8,Neželeni učinki,96009.0,True,27
3291,96028,CAP,SmPC,sl,,Pediatrična populacija,96027.0,False,28
3292,96029,CAP,SmPC,sl,,Poročanje o domnevnih neželenih učinkih,96027.0,True,29
3293,96030,CAP,SmPC,sl,4.9,Preveliko odmerjanje,96009.0,True,30
3294,96031,CAP,SmPC,sl,,Pediatrična populacija,96030.0,False,31
3295,96032,CAP,SmPC,sl,5,FARMAKOLOŠKE LASTNOSTI,96001.0,True,32
3296,96033,CAP,SmPC,sl,5.1,Farmakodinamične lastnosti,96032.0,True,33
3297,96034,CAP,SmPC,sl,,Mehanizem delovanja,96033.0,False,34
3298,96035,CAP,SmPC,sl,,Farmakodinamični učinki,96033.0,False,35
3299,96036,CAP,SmPC,sl,,Klinična učinkovitost in varnost,96033.0,False,36
3300,96037,CAP,SmPC,sl,,Pediatrična populacija,96033.0,False,37
3301,96038,CAP,SmPC,sl,5.2,Farmakokinetične lastnosti,96032.0,True,38
3302,96039,CAP,SmPC,sl,,Absorpcija,96038.0,False,39
3303,96040,CAP,SmPC,sl,,Porazdelitev,96038.0,False,40
3304,96041,CAP,SmPC,sl,,Biotransformacija,96038.0,False,41
3305,96042,CAP,SmPC,sl,,Izločanje,96038.0,False,42
3306,96043,CAP,SmPC,sl,,Linearnost/nelinearnost,96038.0,False,43
3307,96044,CAP,SmPC,sl,,Farmakokinetično/farmakodinamično razmerje,96038.0,False,44
3308,96045,CAP,SmPC,sl,5.3,Predklinični podatki o varnosti,96032.0,True,45
3309,96046,CAP,SmPC,sl,,Ocena tveganja za okolje,96045.0,False,46
3310,96047,CAP,SmPC,sl,6,FARMACEVTSKI PODATKI,96001.0,True,47
3311,96048,CAP,SmPC,sl,6.1,Seznam pomožnih snovi,96047.0,True,48
3312,96049,CAP,SmPC,sl,6.2,Inkompatibilnosti,96047.0,True,49
3313,96050,CAP,SmPC,sl,6.3,Rok uporabnosti,96047.0,True,50
3314,96051,CAP,SmPC,sl,6.4,Posebna navodila za shranjevanje,96047.0,True,51
3315,96052,CAP,SmPC,sl,6.5,"Vrsta ovojnine in vsebina <ter posebna oprema za uporabo, dajanje ali implantacijo>",96047.0,True,52
3316,96053,CAP,SmPC,sl,6.6,Posebni varnostni ukrepi za odstranjevanje <in ravnanje z zdravilom>,96047.0,True,53
3317,96054,CAP,SmPC,sl,,Uporaba pri pediatrični populaciji,96053.0,False,54
3318,96055,CAP,SmPC,sl,7,IMETNIK DOVOLJENJA ZA PROMET Z ZDRAVILOM,96001.0,True,55
3319,96056,CAP,SmPC,sl,8,ŠTEVILKA (ŠTEVILKE) DOVOLJENJA (DOVOLJENJ) ZA PROMET Z ZDRAVILOM,96001.0,True,56
3320,96057,CAP,SmPC,sl,9,DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Z ZDRAVILOM,96001.0,True,57
3321,96058,CAP,SmPC,sl,10,DATUM ZADNJE REVIZIJE BESEDILA,96001.0,True,58
3322,96059,CAP,SmPC,sl,11,DOZIMETRIJA,96001.0,False,59
3323,96060,CAP,SmPC,sl,12,NAVODILA ZA PRIPRAVO RADIOFARMAKOV,96001.0,False,60
3324,97001,CAP,AnnexII,sl,,PRILOGA II,,True,1
3325,97002,CAP,AnnexII,sl,A,"<PROIZVAJALEC (PROIZVAJALCI) BIOLOŠKE UČINKOVINE (UČINKOVIN) IN> PROIZVAJALEC (PROIZVAJALCI), ODGOVOREN (ODGOVORNI) ZA SPROŠČANJE SERIJ",97001.0,True,2
3326,97003,CAP,AnnexII,sl,,Ime in naslov proizvajalca (proizvajalcev) biološke učinkovine (učinkovin),97002.0,False,3
3327,97004,CAP,AnnexII,sl,,"Ime in naslov proizvajalca (proizvajalcev), odgovornega (odgovornih) za sproščanje serij",97002.0,True,4
3328,97005,CAP,AnnexII,sl,B,POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE,97001.0,True,5
3329,97006,CAP,AnnexII,sl,,Uradna sprostitev serije:,97005.0,False,6
3330,97007,CAP,AnnexII,sl,C,DRUGI POGOJI IN ZAHTEVE DOVOLJENJA ZA PROMET Z ZDRAVILOM,97001.0,True,7
3331,97008,CAP,AnnexII,sl,,Redno posodobljena poročila o varnosti zdravila (PSUR),97007.0,True,8
3332,97009,CAP,AnnexII,sl,D,POGOJI ALI OMEJITVE V ZVEZI Z VARNO IN UČINKOVITO UPORABO ZDRAVILA,97001.0,True,9
3333,97010,CAP,AnnexII,sl,,Načrt za obvladovanje tveganj (RMP),97009.0,True,10
3334,97011,CAP,AnnexII,sl,,Dodatni ukrepi za zmanjševanje tveganj,97009.0,False,11
3335,97012,CAP,AnnexII,sl,,Obveznost izvedbe ukrepov po pridobitvi dovoljenja za promet,97009.0,False,12
3336,97013,CAP,AnnexII,en,E,SPECIFIČNE ZAHTEVE ZA IZPOLNITEV UKREPOV PO PRIDOBITVI <POGOJNEGA DOVOLJENJA ZA PROMET Z ZDRAVILOM> <DOVOLJENJA ZA PROMET Z ZDRAVILOM V IZJEMNIH OKOLIŠČINAH,97001.0,False,13
3337,98001,CAP,Labelling,sl,,OZNAČEVANJE,,True,1
3338,98002,CAP,Labelling,sl,,PODATKI NA <ZUNANJI OVOJNINI> <IN> <PRIMARNI OVOJNINI>,98001.0,True,2
3339,98003,CAP,Labelling,sl,1,IME ZDRAVILA,98002.0,True,3
3340,98004,CAP,Labelling,sl,2,NAVEDBA ENE ALI VEČ UČINKOVIN,98002.0,True,4
3341,98005,CAP,Labelling,sl,3,SEZNAM POMOŽNIH SNOVI,98002.0,True,5
3342,98006,CAP,Labelling,sl,4,FARMACEVTSKA OBLIKA IN VSEBINA,98002.0,True,6
3343,98007,CAP,Labelling,sl,5,POSTOPEK IN POT(I) UPORABE ZDRAVILA,98002.0,True,7
3344,98008,CAP,Labelling,sl,6,POSEBNO OPOZORILO O SHRANJEVANJU ZDRAVILA ZUNAJ DOSEGA IN POGLEDA OTROK,98002.0,True,8
3345,98009,CAP,Labelling,sl,7,"DRUGA POSEBNA OPOZORILA, ČE SO POTREBNA",98002.0,True,9
3346,98010,CAP,Labelling,sl,8,DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA,98002.0,True,10
3347,98011,CAP,Labelling,sl,9,POSEBNA NAVODILA ZA SHRANJEVANJE,98002.0,True,11
3348,98012,CAP,Labelling,sl,10,"POSEBNI VARNOSTNI UKREPI ZA ODSTRANJEVANJE NEUPORABLJENIH ZDRAVIL ALI IZ NJIH NASTALIH ODPADNIH SNOVI, KADAR SO POTREBNI",98002.0,True,12
3349,98013,CAP,Labelling,sl,11,IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM,98002.0,True,13
3350,98014,CAP,Labelling,sl,12,ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET,98002.0,True,14
3351,98015,CAP,Labelling,sl,13,"ŠTEVILKA SERIJE<, ENOTNE OZNAKE DAROVANJA IN IZDELKOV>",98002.0,True,15
3352,98016,CAP,Labelling,sl,14,NAČIN IZDAJANJA ZDRAVILA,98002.0,True,16
3353,98017,CAP,Labelling,sl,15,NAVODILA ZA UPORABO,98002.0,True,17
3354,98018,CAP,Labelling,sl,16,PODATKI V BRAILLOVI PISAVI,98002.0,True,18
3355,98019,CAP,Labelling,sl,17,EDINSTVENA OZNAKA – DVODIMENZIONALNA ČRTNA KODA,98002.0,True,19
3356,98020,CAP,Labelling,sl,18,EDINSTVENA OZNAKA – V BERLJIVI OBLIKI,98002.0,True,20
3357,98021,CAP,Labelling,sl,,"PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA PRETISNEM OMOTU ALI DVOJNEM TRAKU",98001.0,True,21
3358,98022,CAP,Labelling,sl,1,IME ZDRAVILA,98021.0,True,22
3359,98023,CAP,Labelling,sl,2,IME IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM,98021.0,True,23
3360,98024,CAP,Labelling,sl,3,DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA,98021.0,True,24
3361,98025,CAP,Labelling,sl,4,"ŠTEVILKA SERIJE<, ENOTNE OZNAKE DAROVANJA IN IZDELKOV>",98021.0,True,25
3362,98026,CAP,Labelling,sl,5,DRUGI PODATKI,98021.0,True,26
3363,98027,CAP,Labelling,sl,,"PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH",98001.0,True,27
3364,98028,CAP,Labelling,sl,1,IME ZDRAVILA IN POT(I) UPORABE,98027.0,True,28
3365,98029,CAP,Labelling,sl,2,POSTOPEK UPORABE,98027.0,True,29
3366,98030,CAP,Labelling,sl,3,DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA,98027.0,True,30
3367,98031,CAP,Labelling,sl,4,"ŠTEVILKA SERIJE<, ENOTNE OZNAKE DAROVANJA IN IZDELKOV>",98027.0,True,31
3368,98032,CAP,Labelling,sl,5,"VSEBINA, IZRAŽENA Z MASO, PROSTORNINO ALI ŠTEVILOM ENOT",98027.0,True,32
3369,98033,CAP,Labelling,sl,6,DRUGI PODATKI,98027.0,True,33
3370,99001,CAP,Package leaflet,sl,,NAVODILO ZA UPORABO,,True,1
3371,99002,CAP,Package leaflet,sl,,"qZa to zdravilo se izvaja dodatno spremljanje varnosti. Tako bodo hitreje na voljo nove informacije o njegovi varnosti. Tudi sami lahko k temu prispevate tako, da poročate o katerem koli neželenem učinku zdravila, ki bi se utegnil pojaviti pri vas. Glejte na koncu poglavja 4, kako poročati o neželenih učinkih.",99001.0,False,2
3372,99003,CAP,Package leaflet,sl,,Kaj vsebuje navodilo,99001.0,True,3
3373,99004,CAP,Package leaflet,sl,1,Kaj je zdravilo X in za kaj ga uporabljamo,99001.0,True,4
3374,99005,CAP,Package leaflet,sl,2,"Kaj morate vedeti, preden <boste vzeli> <boste uporabili> zdravilo X",99001.0,True,5
3375,99006,CAP,Package leaflet,sl,,Ne <jemljite> <uporabljajte> zdravila X,99005.0,True,6
3376,99007,CAP,Package leaflet,sl,,Opozorila in previdnostni ukrepi,99005.0,True,7
3377,99008,CAP,Package leaflet,sl,,Otroci <in mladostniki>,99005.0,True,8
3378,99009,CAP,Package leaflet,sl,,Druga zdravila in zdravilo X,99005.0,True,9
3379,99010,CAP,Package leaflet,sl,,"Zdravilo X skupaj <s><z> <hrano> <in> <,> <pijačo> <in> <alkoholom>",99005.0,True,10
3380,99011,CAP,Package leaflet,sl,,"Nosečnost <in> <,> dojenje <in plodnost>",99005.0,True,11
3381,99012,CAP,Package leaflet,sl,,Vpliv na sposobnost upravljanja vozil in strojev,99005.0,True,12
3382,99013,CAP,Package leaflet,sl,,Zdravilo X vsebuje {ime pomožne(ih) snovi},99005.0,False,13
3383,99014,CAP,Package leaflet,sl,3,Kako <jemati> <uporabljati> zdravilo X,99001.0,True,14
3384,99015,CAP,Package leaflet,sl,,Uporaba pri otrocih <in mladostnikih>,99014.0,False,15
3385,99016,CAP,Package leaflet,sl,,"Če ste <vzeli> <uporabili> večji odmerek zdravila X, kot bi smeli",99014.0,False,16
3386,99017,CAP,Package leaflet,sl,,Če ste pozabili <vzeti> <uporabiti> zdravilo X,99014.0,False,17
3387,99018,CAP,Package leaflet,sl,,Če ste prenehali <jemati> <uporabljati> zdravilo X,99014.0,False,18
3388,99019,CAP,Package leaflet,sl,4,Možni neželeni učinki,99001.0,True,19
3389,99020,CAP,Package leaflet,sl,,Dodatni neželeni učinki pri otrocih <in mladostnikih>,99019.0,False,20
3390,99021,CAP,Package leaflet,sl,,Poročanje o neželenih učinkih,99019.0,True,21
3391,99022,CAP,Package leaflet,sl,5,Shranjevanje zdravila X,99001.0,True,22
3392,99023,CAP,Package leaflet,sl,6,Vsebina pakiranja in dodatne informacije,99001.0,True,23
3393,99024,CAP,Package leaflet,sl,,Kaj vsebuje zdravilo X,99023.0,True,24
3394,99025,CAP,Package leaflet,sl,,Izgled zdravila X in vsebina pakiranja,99023.0,True,25
3395,99026,CAP,Package leaflet,sl,,Imetnik dovoljenja za promet z zdravilom in proizvajalec,99023.0,True,26
3396,99027,CAP,Package leaflet,sl,,Za vse morebitne nadaljnje informacije o tem zdravilu se lahko obrnete na predstavništvo imetnika dovoljenja za promet z zdravilom:,99023.0,False,27
3397,99028,CAP,Package leaflet,sl,,Navodilo je bilo nazadnje revidirano dne <{MM/LLLL}> <{mesec LLLL}> ,99023.0,True,28
3398,99029,CAP,Package leaflet,sl,,Drugi viri informacij,99023.0,False,29
3399,99030,CAP,Package leaflet,sl,,Naslednje informacije so namenjene samo zdravstvenemu osebju:,99001.0,False,30
3400,100001,NAP,SmPC,bg,,КРАТКА ХАРАКТЕРИСТИКА НА ПРОДУКТА,,True,1
3401,100002,NAP,SmPC,bg,,qТози лекарствен продукт подлежи на допълнително наблюдение. Това ще позволи бързото установяване на нова информация относно безопасността. От медицинските специалисти се изисква да съобщават всяка подозирана нежелана реакция. За начина на съобщаване на нежелани реакции вижте точка 4.8,100001.0,False,2
3402,100003,NAP,SmPC,bg,1,ИМЕ НА ЛЕКАРСТВЕНИЯ ПРОДУКТ,100001.0,True,3
3403,100004,NAP,SmPC,bg,2,КАЧЕСТВЕН И КОЛИЧЕСТВЕН СЪСТАВ,100001.0,True,4
3404,100005,NAP,SmPC,bg,,Помощно(и) вещество(а) с известно действие,100004.0,False,5
3405,100006,NAP,SmPC,bg,3,ЛЕКАРСТВЕНА ФОРМА,100001.0,True,6
3406,100007,NAP,SmPC,bg,4,КЛИНИЧНИ ДАННИ,100001.0,True,7
3407,100008,NAP,SmPC,bg,4.1,Терапевтични показания ,100007.0,True,8
3408,100009,NAP,SmPC,bg,4.2,Дозировка и начин на приложение,100007.0,True,9
3409,100010,NAP,SmPC,bg,,Дозировка,100009.0,True,10
3410,100011,NAP,SmPC,bg,,Педиатрична популация,100010.0,True,11
3411,100012,NAP,SmPC,bg,,Начин на приложение,100009.0,True,12
3412,100013,NAP,SmPC,bg,,"Предпазни мерки, които трябва да бъдат взети преди работа със или приложение на лекарствения продукт",100012.0,False,13
3413,100014,NAP,SmPC,bg,4.3,Противопоказания,100007.0,True,14
3414,100015,NAP,SmPC,bg,4.4,Специални предупреждения и предпазни мерки при употреба,100007.0,True,15
3415,100016,NAP,SmPC,bg,,Проследимост,100015.0,False,16
3416,100017,NAP,SmPC,bg,,Педиатрична популация,100015.0,False,17
3417,100018,NAP,SmPC,bg,4.5,Взаимодействие с други лекарствени продукти и други форми на взаимодействие,100007.0,True,18
3418,100019,NAP,SmPC,bg,,Педиатрична популация,100018.0,False,19
3419,100020,NAP,SmPC,bg,4.6,"Фертилитет, бременност и кърмене",100007.0,True,20
3420,100021,NAP,SmPC,bg,,Бременност,100020.0,False,21
3421,100022,NAP,SmPC,bg,,Кърмене,100020.0,False,22
3422,100023,NAP,SmPC,bg,,Фертилитет,100020.0,False,23
3423,100024,NAP,SmPC,bg,4.7,Ефекти върху способността за шофиране и работа с машини,100007.0,True,24
3424,100025,NAP,SmPC,bg,4.8,Нежелани лекарствени реакции,100007.0,True,25
3425,100026,NAP,SmPC,bg,,Педиатрична популация,100025.0,False,26
3426,100027,NAP,SmPC,bg,,Съобщаване на подозирани нежелани реакции,100025.0,True,27
3427,100028,NAP,SmPC,bg,4.9,Предозиране,100007.0,True,28
3428,100029,NAP,SmPC,bg,,Педиатрична популация,100028.0,False,29
3429,100030,NAP,SmPC,bg,5,ФАРМАКОЛОГИЧНИ СВОЙСТВА,100001.0,True,30
3430,100031,NAP,SmPC,bg,5.1,Фармакодинамични свойства,100030.0,True,31
3431,100032,NAP,SmPC,bg,,Механизъм на действие,100031.0,False,32
3432,100033,NAP,SmPC,bg,,Фармакодинамични ефекти,100031.0,False,33
3433,100034,NAP,SmPC,bg,,Клинична ефикасност и безопасност,100031.0,False,34
3434,100035,NAP,SmPC,bg,,Педиатрична популация,100031.0,False,35
3435,100036,NAP,SmPC,bg,5.2,Фармакокинетични свойства,100030.0,True,36
3436,100037,NAP,SmPC,bg,,Абсорбция,100036.0,False,37
3437,100038,NAP,SmPC,bg,,Разпределение,100036.0,False,38
3438,100039,NAP,SmPC,bg,,Биотрансформация,100036.0,False,39
3439,100040,NAP,SmPC,bg,,Елиминиране,100036.0,False,40
3440,100041,NAP,SmPC,bg,,Линейност/нелинейност,100036.0,False,41
3441,100042,NAP,SmPC,bg,,Връзка(и) фармакокинетика-фармакодинамика,100036.0,False,42
3442,100043,NAP,SmPC,bg,5.3,Предклинични данни за безопасност,100030.0,True,43
3443,100044,NAP,SmPC,bg,,Оценка на риска за околната среда (ERA),100043.0,False,44
3444,100045,NAP,SmPC,bg,6,ФАРМАЦЕВТИЧНИ ДАННИ,100001.0,True,45
3445,100046,NAP,SmPC,bg,6.1,Списък на помощните вещества,100045.0,True,46
3446,100047,NAP,SmPC,bg,6.2,Несъвместимости,100045.0,True,47
3447,100048,NAP,SmPC,bg,6.3,Срок на годност,100045.0,True,48
3448,100049,NAP,SmPC,bg,6.4,Специални условия на съхранение,100045.0,True,49
3449,100050,NAP,SmPC,bg,6.5,Вид и съдържание на опаковката,100045.0,True,50
3450,100051,NAP,SmPC,bg,6.6,Специални предпазни мерки при изхвърляне <и работа>,100045.0,True,51
3451,100052,NAP,SmPC,bg,,Употреба при педиатричната популация,100051.0,False,52
3452,100053,NAP,SmPC,bg,7,ПРИТЕЖАТЕЛ НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,100001.0,True,53
3453,100054,NAP,SmPC,bg,8,НОМЕР(А) НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,100001.0,True,54
3454,100055,NAP,SmPC,bg,9,ДАТА НА ПЪРВО РАЗРЕШАВАНЕ/ПОДНОВЯВАНЕ НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,100001.0,True,55
3455,100056,NAP,SmPC,bg,10,ДАТА НА АКТУАЛИЗИРАНЕ НА ТЕКСТА,100001.0,True,56
3456,100057,NAP,SmPC,bg,11,ДОЗИМЕТРИЯ,100001.0,False,57
3457,100058,NAP,SmPC,bg,12,ИНСТРУКЦИИ ЗА ПРИГОТВЯНЕ НА РАДИОФАРМАЦЕВТИЦИ ,100001.0,False,58
3458,101001,NAP,Labelling,bg,,ДАННИ ВЪРХУ ОПАКОВКАТА,,True,1
3459,101002,NAP,Labelling,bg,,"ДАННИ, КОИТО ТРЯБВА ДА СЪДЪРЖА <ВТОРИЧНАТА ОПАКОВКА> <И> <ПЪРВИЧНАТА ОПАКОВКА>",101001.0,True,2
3460,101003,NAP,Labelling,bg,1,ИМЕ НА ЛЕКАРСТВЕНИЯ ПРОДУКТ,101002.0,True,3
3461,101004,NAP,Labelling,bg,2,ОБЯВЯВАНЕ НА АКТИВНОТО(ИТЕ) ВЕЩЕСТВО(А),101002.0,True,4
3462,101005,NAP,Labelling,bg,3,СПИСЪК НА ПОМОЩНИТЕ ВЕЩЕСТВА,101002.0,True,5
3463,101006,NAP,Labelling,bg,4,ЛЕКАРСТВЕНА ФОРМА И КОЛИЧЕСТВО В ЕДНА ОПАКОВКА,101002.0,True,6
3464,101007,NAP,Labelling,bg,5,НАЧИН НА ПРИЛОЖЕНИЕ И ПЪТ(ИЩА) НА ВЪВЕЖДАНЕ,101002.0,True,7
3465,101008,NAP,Labelling,bg,6,"СПЕЦИАЛНО ПРЕДУПРЕЖДЕНИЕ, ЧЕ ЛЕКАРСТВЕНИЯТ ПРОДУКТ ТРЯБВА ДА СЕ СЪХРАНЯВА НА МЯСТО ДАЛЕЧЕ ОТ ПОГЛЕДА И ДОСЕГА НА ДЕЦА ",101002.0,True,8
3466,101009,NAP,Labelling,bg,7,"ДРУГИ СПЕЦИАЛНИ ПРЕДУПРЕЖДЕНИЯ, АКО Е НЕОБХОДИМО",101002.0,True,9
3467,101010,NAP,Labelling,bg,8,ДАТА НА ИЗТИЧАНЕ НА СРОКА НА ГОДНОСТ,101002.0,True,10
3468,101011,NAP,Labelling,bg,9,СПЕЦИАЛНИ УСЛОВИЯ НА СЪХРАНЕНИЕ,101002.0,True,11
3469,101012,NAP,Labelling,bg,10,"СПЕЦИАЛНИ ПРЕДПАЗНИ МЕРКИ ПРИ ИЗХВЪРЛЯНЕ НА НЕИЗПОЛЗВАНА ЧАСТ ОТ ЛЕКАРСТВЕНИТЕ ПРОДУКТИ ИЛИ ОТПАДЪЧНИ МАТЕРИАЛИ ОТ ТЯХ, АКО СЕ ИЗИСКВАТ ТАКИВА",101002.0,True,12
3470,101013,NAP,Labelling,bg,11,ИМЕ И АДРЕС НА ПРИТЕЖАТЕЛЯ НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,101002.0,True,13
3471,101014,NAP,Labelling,bg,12,НОМЕР(А) НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,101002.0,True,14
3472,101015,NAP,Labelling,bg,13,ПАРТИДЕН НОМЕР,101002.0,True,15
3473,101016,NAP,Labelling,bg,14,НАЧИН НА ОТПУСКАНЕ,101002.0,True,16
3474,101017,NAP,Labelling,bg,15,УКАЗАНИЯ ЗА УПОТРЕБА,101002.0,True,17
3475,101018,NAP,Labelling,bg,16,ИНФОРМАЦИЯ НА БРАЙЛОВА АЗБУКА,101002.0,True,18
3476,101019,NAP,Labelling,bg,17,УНИКАЛЕН ИДЕНТИФИКАТОР — ДВУИЗМЕРЕН БАРКОД,101002.0,True,19
3477,101020,NAP,Labelling,bg,18,УНИКАЛЕН ИДЕНТИФИКАТОР — ДАННИ ЗА ЧЕТЕНЕ ОТ ХОРА,101002.0,True,20
3478,101021,NAP,Labelling,bg,,"МИНИМУМ ДАННИ, КОИТО ТРЯБВА ДА СЪДЪРЖАТ БЛИСТЕРИТЕ И ЛЕНТИТЕ",101001.0,True,21
3479,101022,NAP,Labelling,bg,1,ИМЕ НА ЛЕКАРСТВЕНИЯ ПРОДУКТ,101021.0,True,22
3480,101023,NAP,Labelling,bg,2,ИМЕ НА ПРИТЕЖАТЕЛЯ НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,101021.0,True,23
3481,101024,NAP,Labelling,bg,3,ДАТА НА ИЗТИЧАНЕ НА СРОКА НА ГОДНОСТ,101021.0,True,24
3482,101025,NAP,Labelling,bg,4,ПАРТИДЕН НОМЕР,101021.0,True,25
3483,101026,NAP,Labelling,bg,5,ДРУГО,101021.0,True,26
3484,101027,NAP,Labelling,bg,,"МИНИМУМ ДАННИ, КОИТО ТРЯБВА ДА СЪДЪРЖАТ МАЛКИТЕ ЕДИНИЧНИ ПЪРВИЧНИ ОПАКОВКИ",101001.0,True,27
3485,101028,NAP,Labelling,bg,1,ИМЕ НА ЛЕКАРСТВЕНИЯ ПРОДУКT И ПЪТ(ИЩА) НА ВЪВЕЖДАНЕ,101027.0,True,28
3486,101029,NAP,Labelling,bg,2,НАЧИН НА ПРИЛОЖЕНИЕ,101027.0,True,29
3487,101030,NAP,Labelling,bg,3,ДАТА НА ИЗТИЧАНЕ НА СРОКА НА ГОДНОСТ,101027.0,True,30
3488,101031,NAP,Labelling,bg,4,ПАРТИДЕН НОМЕР,101027.0,True,31
3489,101032,NAP,Labelling,bg,5,"СЪДЪРЖАНИЕ КАТО МАСА, ОБЕМ ИЛИ ЕДИНИЦИ",101027.0,True,32
3490,101033,NAP,Labelling,bg,6,ДРУГО,101027.0,True,33
3491,102001,NAP,Package leaflet,bg,, ЛИСТОВКА,,True,1
3492,102002,NAP,Package leaflet,bg,,"q Този лекарствен продукт подлежи на допълнително наблюдение. Това ще позволи бързото установяване на нова информация относно безопасността. Можете да дадете своя принос като съобщите всяка нежелана реакция, която сте получили. За начина на съобщаване на нежелани реакции вижте края на точка 4. ",102001.0,False,2
3493,102003,NAP,Package leaflet,bg,,Какво съдържа тази листовка,102001.0,True,3
3494,102004,NAP,Package leaflet,bg,1,Какво представлява Х и за какво се използва,102001.0,True,4
3495,102005,NAP,Package leaflet,bg,2,"Какво трябва да знаете, преди да <приемете> <използвате> Х",102001.0,True,5
3496,102006,NAP,Package leaflet,bg,,Не <приемайте> <използвайте> X,102005.0,True,6
3497,102007,NAP,Package leaflet,bg,,Предупреждения и предпазни мерки,102005.0,True,7
3498,102008,NAP,Package leaflet,bg,,Деца <и юноши>,102005.0,True,8
3499,102009,NAP,Package leaflet,bg,,Други лекарства и Х,102005.0,True,9
3500,102010,NAP,Package leaflet,bg,,"X с <храна> <и> <,> <напитки> <и> <алкохол>",102005.0,True,10
3501,102011,NAP,Package leaflet,bg,,"Бременност <и> <,> кърмене <и фертилитет>",102005.0,True,11
3502,102012,NAP,Package leaflet,bg,,Шофиране и работа с машини,102005.0,True,12
3503,102013,NAP,Package leaflet,bg,,X съдържа {име на помощното(ите) вещество(а)},102005.0,False,13
3504,102014,NAP,Package leaflet,bg,3,Как да <приемате> <използвате> Х,102001.0,True,14
3505,102015,NAP,Package leaflet,bg,,Употреба при деца <и юноши>,102014.0,False,15
3506,102016,NAP,Package leaflet,bg,,Ако сте <приели> <използвали> повече от необходимата доза X,102014.0,False,16
3507,102017,NAP,Package leaflet,bg,,Ако сте пропуснали да <приемете> <използвате> X,102014.0,False,17
3508,102018,NAP,Package leaflet,bg,,Ако сте спрели <приема> <употребата> на X,102014.0,False,18
3509,102019,NAP,Package leaflet,bg,4,Възможни нежелани реакции,102001.0,True,19
3510,102020,NAP,Package leaflet,bg,,Допълнителни нежелани реакции при деца <и юноши,102019.0,False,20
3511,102021,NAP,Package leaflet,bg,,Съобщаване на нежелани реакции,102019.0,True,21
3512,102022,NAP,Package leaflet,bg,5,Как да съхранявате X,102001.0,True,22
3513,102023,NAP,Package leaflet,bg,6,Съдържание на опаковката и допълнителна информация,102001.0,True,23
3514,102024,NAP,Package leaflet,bg,,Какво съдържа X,102023.0,True,24
3515,102025,NAP,Package leaflet,bg,,Как изглежда X и какво съдържа опаковката ,102023.0,True,25
3516,102026,NAP,Package leaflet,bg,,Притежател на разрешението за употреба и производител,102023.0,True,26
3517,102027,NAP,Package leaflet,bg,,Този лекарствен продукт е разрешен за употреба в държавите членки на ЕИП под следните имена:,102023.0,False,27
3518,102028,NAP,Package leaflet,bg,,Дата на последно преразглеждане на листовката <{ММ /ГГГГ}> <{месец ГГГГ}>.,102023.0,True,28
3519,102029,NAP,Package leaflet,bg,,Други източници на информация,102023.0,False,29
3520,102030,NAP,Package leaflet,bg,,Посочената по-долу информация е предназначена само за медицински специалисти:,102001.0,False,30
3521,103001,NAP,SmPC,cs,,SOUHRN ÚDAJŮ O PŘÍPRAVKU,,True,1
3522,103002,NAP,SmPC,cs,,"qTento léčivý přípravek podléhá dalšímu sledování. To umožní rychlé získání nových informací o bezpečnosti. Žádáme zdravotnické pracovníky, aby hlásili jakákoli podezření na nežádoucí účinky. Podrobnosti o hlášení nežádoucích účinků viz bod 4.8.",103001.0,False,2
3523,103003,NAP,SmPC,cs,1,NÁZEV PŘÍPRAVKU,103001.0,True,3
3524,103004,NAP,SmPC,cs,2,KVALITATIVNÍ A KVANTITATIVNÍ SLOŽENÍ,103001.0,True,4
3525,103005,NAP,SmPC,cs,,<Pomocná látka> <Pomocné látky> se známým účinkem,103004.0,False,5
3526,103006,NAP,SmPC,cs,3,LÉKOVÁ FORMA,103001.0,True,6
3527,103007,NAP,SmPC,cs,4,KLINICKÉ ÚDAJE,103001.0,True,7
3528,103008,NAP,SmPC,cs,4.1,Terapeutické indikace,103007.0,True,8
3529,103009,NAP,SmPC,cs,4.2,Dávkování a způsob podání,103007.0,True,9
3530,103010,NAP,SmPC,cs,,Dávkování,103009.0,True,10
3531,103011,NAP,SmPC,cs,,Pediatrická populace,103010.0,True,11
3532,103012,NAP,SmPC,cs,,Způsob podání,103009.0,True,12
3533,103013,NAP,SmPC,cs,,"Opatření, která je nutno učinit před zacházením s léčivým přípravkem nebo před jeho podáním",103012.0,False,13
3534,103014,NAP,SmPC,cs,4.3,Kontraindikace,103007.0,True,14
3535,103015,NAP,SmPC,cs,4.4,Zvláštní upozornění a opatření pro použití,103007.0,True,15
3536,103016,NAP,SmPC,cs,,Sledovatelnost,103015.0,False,16
3537,103017,NAP,SmPC,cs,,Pediatrická populace,103015.0,False,17
3538,103018,NAP,SmPC,cs,4.5,Interakce s jinými léčivými přípravky a jiné formy interakce,103007.0,True,18
3539,103019,NAP,SmPC,cs,,Pediatrická populace,103018.0,False,19
3540,103020,NAP,SmPC,cs,4.6,"Fertilita, těhotenství a kojení",103007.0,True,20
3541,103021,NAP,SmPC,cs,,Těhotenství,103020.0,False,21
3542,103022,NAP,SmPC,cs,,Kojení,103020.0,False,22
3543,103023,NAP,SmPC,cs,,Fertilita,103020.0,False,23
3544,103024,NAP,SmPC,cs,4.7,Účinky na schopnost řídit a obsluhovat stroje,103007.0,True,24
3545,103025,NAP,SmPC,cs,4.8,Nežádoucí účinky,103007.0,True,25
3546,103026,NAP,SmPC,cs,,Pediatrická populace,103025.0,False,26
3547,103027,NAP,SmPC,cs,,Hlášení podezření na nežádoucí účinky,103025.0,True,27
3548,103028,NAP,SmPC,cs,4.9,Předávkování,103007.0,True,28
3549,103029,NAP,SmPC,cs,,Pediatrická populace,103028.0,False,29
3550,103030,NAP,SmPC,cs,5,FARMAKOLOGICKÉ VLASTNOSTI,103001.0,True,30
3551,103031,NAP,SmPC,cs,5.1,Farmakodynamické vlastnosti,103030.0,True,31
3552,103032,NAP,SmPC,cs,,Mechanismus účinku,103031.0,False,32
3553,103033,NAP,SmPC,cs,,Farmakodynamické účinky,103031.0,False,33
3554,103034,NAP,SmPC,cs,,Klinická účinnost a bezpečnost,103031.0,False,34
3555,103035,NAP,SmPC,cs,,Pediatrická populace,103031.0,False,35
3556,103036,NAP,SmPC,cs,5.2,Farmakokinetické vlastnosti,103030.0,True,36
3557,103037,NAP,SmPC,cs,,Absorpce,103036.0,False,37
3558,103038,NAP,SmPC,cs,,Distribuce,103036.0,False,38
3559,103039,NAP,SmPC,cs,,Biotransformace,103036.0,False,39
3560,103040,NAP,SmPC,cs,,Eliminace,103036.0,False,40
3561,103041,NAP,SmPC,cs,,Linearita/nelinearita,103036.0,False,41
3562,103042,NAP,SmPC,cs,,Farmakokinetické/farmakodynamické vztahy,103036.0,False,42
3563,103043,NAP,SmPC,cs,5.3,Předklinické údaje vztahující se k bezpečnosti,103030.0,True,43
3564,103044,NAP,SmPC,cs,,Posouzení rizika pro životní prostředí,103043.0,False,44
3565,103045,NAP,SmPC,cs,6,FARMACEUTICKÉ ÚDAJE,103001.0,True,45
3566,103046,NAP,SmPC,cs,6.1,Seznam pomocných látek,103045.0,True,46
3567,103047,NAP,SmPC,cs,6.2,Inkompatibility,103045.0,True,47
3568,103048,NAP,SmPC,cs,6.3,Doba použitelnosti,103045.0,True,48
3569,103049,NAP,SmPC,cs,6.4,Zvláštní opatření pro uchovávání,103045.0,True,49
3570,103050,NAP,SmPC,cs,6.5,Druh obalu a obsah balení,103045.0,True,50
3571,103051,NAP,SmPC,cs,6.6,Zvláštní opatření pro likvidaci přípravku <a pro zacházení s ním>,103045.0,True,51
3572,103052,NAP,SmPC,cs,,Použití u pediatrické populace,103051.0,False,52
3573,103053,NAP,SmPC,cs,7,DRŽITEL ROZHODNUTÍ O REGISTRACI,103001.0,True,53
3574,103054,NAP,SmPC,cs,8,REGISTRAČNÍ ČÍSLO/REGISTRAČNÍ ČÍSLA ,103001.0,True,54
3575,103055,NAP,SmPC,cs,9,DATUM PRVNÍ REGISTRACE/PRODLOUŽENÍ REGISTRACE,103001.0,True,55
3576,103056,NAP,SmPC,cs,10,DATUM REVIZE TEXTU,103001.0,True,56
3577,103057,NAP,SmPC,cs,11,DOZIMETRIE,103001.0,False,57
3578,103058,NAP,SmPC,cs,12,NÁVOD PRO PŘÍPRAVU RADIOFARMAK,103001.0,False,58
3579,104001,NAP,Labelling,cs,,OZNAČENÍ NA OBALU,,True,1
3580,104002,NAP,Labelling,cs,,ÚDAJE UVÁDĚNÉ NA <VNĚJŠÍM OBALU> <A> <VNITŘNÍM OBALU>,104001.0,True,2
3581,104003,NAP,Labelling,cs,1,NÁZEV LÉČIVÉHO PŘÍPRAVKU,104002.0,True,3
3582,104004,NAP,Labelling,cs,2,OBSAH LÉČIVÉ LÁTKY/LÉČIVÝCH LÁTEK,104002.0,True,4
3583,104005,NAP,Labelling,cs,3,SEZNAM POMOCNÝCH LÁTEK,104002.0,True,5
3584,104006,NAP,Labelling,cs,4,LÉKOVÁ FORMA A OBSAH BALENÍ,104002.0,True,6
3585,104007,NAP,Labelling,cs,5,ZPŮSOB A CESTA/CESTY PODÁNÍ,104002.0,True,7
3586,104008,NAP,Labelling,cs,6,"ZVLÁŠTNÍ UPOZORNĚNÍ, ŽE LÉČIVÝ PŘÍPRAVEK MUSÍ BÝT UCHOVÁVÁN MIMO DOHLED A DOSAH DĚTÍ",104002.0,True,8
3587,104009,NAP,Labelling,cs,7,"DALŠÍ ZVLÁŠTNÍ UPOZORNĚNÍ, POKUD JE POTŘEBNÉ",104002.0,True,9
3588,104010,NAP,Labelling,cs,8,POUŽITELNOST,104002.0,True,10
3589,104011,NAP,Labelling,cs,9,ZVLÁŠTNÍ PODMÍNKY PRO UCHOVÁVÁNÍ,104002.0,True,11
3590,104012,NAP,Labelling,cs,10,"ZVLÁŠTNÍ OPATŘENÍ PRO LIKVIDACI NEPOUŽITÝCH LÉČIVÝCH PŘÍPRAVKŮ NEBO ODPADU Z NICH, POKUD JE TO VHODNÉ",104002.0,True,12
3591,104013,NAP,Labelling,cs,11,NÁZEV A ADRESA DRŽITELE ROZHODNUTÍ O REGISTRACI,104002.0,True,13
3592,104014,NAP,Labelling,cs,12,REGISTRAČNÍ ČÍSLO/ČÍSLA,104002.0,True,14
3593,104015,NAP,Labelling,cs,13,ČÍSLO ŠARŽE ,104002.0,True,15
3594,104016,NAP,Labelling,cs,14,KLASIFIKACE PRO VÝDEJ,104002.0,True,16
3595,104017,NAP,Labelling,cs,15,NÁVOD K POUŽITÍ,104002.0,True,17
3596,104018,NAP,Labelling,cs,16,INFORMACE V BRAILLOVĚ PÍSMU,104002.0,True,18
3597,104019,NAP,Labelling,cs,17,JEDINEČNÝ IDENTIFIKÁTOR – 2D ČÁROVÝ KÓD,104002.0,True,19
3598,104020,NAP,Labelling,cs,18,JEDINEČNÝ IDENTIFIKÁTOR – DATA ČITELNÁ OKEM,104002.0,True,20
3599,104021,NAP,Labelling,cs,,MINIMÁLNÍ ÚDAJE UVÁDĚNÉ NA BLISTRECH NEBO STRIPECH,104001.0,True,21
3600,104022,NAP,Labelling,cs,1,NÁZEV LÉČIVÉHO PŘÍPRAVKU,104021.0,True,22
3601,104023,NAP,Labelling,cs,2,NÁZEV DRŽITELE ROZHODNUTÍ O REGISTRACI,104021.0,True,23
3602,104024,NAP,Labelling,cs,3,POUŽITELNOST,104021.0,True,24
3603,104025,NAP,Labelling,cs,4,ČÍSLO ŠARŽE ,104021.0,True,25
3604,104026,NAP,Labelling,cs,5,JINÉ,104021.0,True,26
3605,104027,NAP,Labelling,cs,,MINIMÁLNÍ ÚDAJE UVÁDĚNÉ NA MALÉM VNITŘNÍM OBALU,104001.0,True,27
3606,104028,NAP,Labelling,cs,1,NÁZEV LÉČIVÉHO PŘÍPRAVKU A CESTA/CESTY PODÁNÍ,104027.0,True,28
3607,104029,NAP,Labelling,cs,2,ZPŮSOB PODÁNÍ,104027.0,True,29
3608,104030,NAP,Labelling,cs,3,POUŽITELNOST,104027.0,True,30
3609,104031,NAP,Labelling,cs,4,ČÍSLO ŠARŽE ,104027.0,True,31
3610,104032,NAP,Labelling,cs,5,"OBSAH UDANÝ JAKO HMOTNOST, OBJEM NEBO POČET",104027.0,True,32
3611,104033,NAP,Labelling,cs,6,JINÉ,104027.0,True,33
3612,105001,NAP,Package leaflet,cs,,PŘÍBALOVÁ INFORMACE,,True,1
3613,105002,NAP,Package leaflet,cs,,"qTento přípravek podléhá dalšímu sledování. To umožní rychlé získání nových informací o bezpečnosti. Můžete přispět tím, že nahlásíte jakékoli nežádoucí účinky, které se u Vás vyskytnou. Jak hlásit nežádoucí účinky je popsáno v závěru bodu 4.",105001.0,False,2
3614,105003,NAP,Package leaflet,cs,,Co naleznete v této příbalové informaci,105001.0,True,3
3615,105004,NAP,Package leaflet,cs,1,Co je <přípravek> X a k čemu se používá,105001.0,True,4
3616,105005,NAP,Package leaflet,cs,2,"Čemu musíte věnovat pozornost, než začnete <přípravek> X <užívat> <používat> ",105001.0,True,5
3617,105006,NAP,Package leaflet,cs,,<Neužívejte> <Nepoužívejte> <přípravek> X,105005.0,True,6
3618,105007,NAP,Package leaflet,cs,,Upozornění a opatření ,105005.0,True,7
3619,105008,NAP,Package leaflet,cs,,Děti <a dospívající>,105005.0,True,8
3620,105009,NAP,Package leaflet,cs,,Další léčivé přípravky a <přípravek> X,105005.0,True,9
3621,105010,NAP,Package leaflet,cs,,"<Přípravek> X s <jídlem> <a> <,> <pitím> <a> <alkoholem>",105005.0,True,10
3622,105011,NAP,Package leaflet,cs,,"Těhotenství <a> <,> kojení <a plodnost>",105005.0,True,11
3623,105012,NAP,Package leaflet,cs,,Řízení dopravních prostředků a obsluha strojů,105005.0,True,12
3624,105013,NAP,Package leaflet,cs,,<Přípravek> X obsahuje {název pomocné látky/pomocných látek},105005.0,False,13
3625,105014,NAP,Package leaflet,cs,3,Jak se <přípravek> X <užívá> <používá>,105001.0,True,14
3626,105015,NAP,Package leaflet,cs,,Použití u dětí <a dospívajících>,105014.0,False,15
3627,105016,NAP,Package leaflet,cs,,"Jestliže jste <užil(a)> <použil(a)> více <přípravku>X, než jste měl(a)",105014.0,False,16
3628,105017,NAP,Package leaflet,cs,,Jestliže jste zapomněl(a) <užít> <použít> <přípravek>X,105014.0,False,17
3629,105018,NAP,Package leaflet,cs,,Jestliže jste přestal(a) <užívat> <používat> <přípravek>X,105014.0,False,18
3630,105019,NAP,Package leaflet,cs,4,Možné nežádoucí účinky,105001.0,True,19
3631,105020,NAP,Package leaflet,cs,,Další nežádoucí účinky u dětí <a dospívajících>,105019.0,False,20
3632,105021,NAP,Package leaflet,cs,,Hlášení nežádoucích účinků,105019.0,True,21
3633,105022,NAP,Package leaflet,cs,5,Jak <přípravek> X uchovávat,105001.0,True,22
3634,105023,NAP,Package leaflet,cs,6,Obsah balení a další informace,105001.0,True,23
3635,105024,NAP,Package leaflet,cs,,Co <přípravek> X obsahuje ,105023.0,True,24
3636,105025,NAP,Package leaflet,cs,,Jak<přípravek> X vypadá a co obsahuje toto balení,105023.0,True,25
3637,105026,NAP,Package leaflet,cs,,Držitel rozhodnutí o registraci a výrobce,105023.0,True,26
3638,105027,NAP,Package leaflet,cs,,Tento léčivý přípravek je v členských státech EHP registrován pod těmito názvy:,105023.0,False,27
3639,105028,NAP,Package leaflet,cs,,Tato příbalová informace byla naposledy revidována <{DD. MM. RRRR}> <{MM/RRRR}> <{měsíc RRRR}>.,105023.0,True,28
3640,105029,NAP,Package leaflet,cs,,Další zdroje informací,105023.0,False,29
3641,105030,NAP,Package leaflet,cs,,Následující informace jsou určeny pouze pro zdravotnické pracovníky:,105001.0,False,30
3642,106001,NAP,SmPC,da,,PRODUKTRESUMÉ,,True,1
3643,106002,NAP,SmPC,da,,"qDette lægemiddel er underlagt supplerende overvågning. Dermed kan nye sikkerhedsoplysninger hurtigt tilvejebringes. Sundhedspersoner anmodes om at indberette alle formodede bivirkninger. Se i pkt. 4.8, hvordan bivirkninger indberettes.",106001.0,False,2
3644,106003,NAP,SmPC,da,1,LÆGEMIDLETS NAVN,106001.0,True,3
3645,106004,NAP,SmPC,da,2,KVALITATIV OG KVANTITATIV SAMMENSÆTNING,106001.0,True,4
3646,106005,NAP,SmPC,da,,"Hjælpestof(fer), som behandleren skal være opmærksom på",106004.0,False,5
3647,106006,NAP,SmPC,da,3,LÆGEMIDDELFORM,106001.0,True,6
3648,106007,NAP,SmPC,da,4,KLINISKE OPLYSNINGER,106001.0,True,7
3649,106008,NAP,SmPC,da,4.1,Terapeutiske indikationer,106007.0,True,8
3650,106009,NAP,SmPC,da,4.2,Dosering og administration,106007.0,True,9
3651,106010,NAP,SmPC,da,,Dosering,106009.0,True,10
3652,106011,NAP,SmPC,da,,Pædiatrisk population,106010.0,True,11
3653,106012,NAP,SmPC,da,,Administration,106009.0,True,12
3654,106013,NAP,SmPC,da,,"Sikkerhedsforanstaltninger, der skal tages før håndtering og administration af lægemidlet",106012.0,False,13
3655,106014,NAP,SmPC,da,4.3,Kontraindikationer,106007.0,True,14
3656,106015,NAP,SmPC,da,4.4,Særlige advarsler og forsigtighedsregler vedrørende brugen,106007.0,True,15
3657,106016,NAP,SmPC,da,,Sporbarhed,106015.0,False,16
3658,106017,NAP,SmPC,da,,Pædiatrisk population,106015.0,False,17
3659,106018,NAP,SmPC,da,4.5,Interaktion med andre lægemidler og andre former for interaktion,106007.0,True,18
3660,106019,NAP,SmPC,da,,Pædiatrisk population,106018.0,False,19
3661,106020,NAP,SmPC,da,4.6,"Fertilitet, graviditet og amning",106007.0,True,20
3662,106021,NAP,SmPC,da,,Graviditet,106020.0,False,21
3663,106022,NAP,SmPC,da,,Amning,106020.0,False,22
3664,106023,NAP,SmPC,da,,Fertilitet,106020.0,False,23
3665,106024,NAP,SmPC,da,4.7,Virkning på evnen til at føre motorkøretøj og betjene maskiner,106007.0,True,24
3666,106025,NAP,SmPC,da,4.8,Bivirkninger,106007.0,True,25
3667,106026,NAP,SmPC,da,,Pædiatrisk population,106025.0,False,26
3668,106027,NAP,SmPC,da,,Indberetning af formodede bivirkninger,106025.0,True,27
3669,106028,NAP,SmPC,da,4.9,Overdosering,106007.0,True,28
3670,106029,NAP,SmPC,da,,Pædiatrisk population,106028.0,False,29
3671,106030,NAP,SmPC,da,5,FARMAKOLOGISKE EGENSKABER,106001.0,True,30
3672,106031,NAP,SmPC,da,5.1,Farmakodynamiske egenskaber,106030.0,True,31
3673,106032,NAP,SmPC,da,,Virkningsmekanisme,106031.0,False,32
3674,106033,NAP,SmPC,da,,Farmakodynamisk virkning,106031.0,False,33
3675,106034,NAP,SmPC,da,,Klinisk virkning og sikkerhed,106031.0,False,34
3676,106035,NAP,SmPC,da,,Pædiatrisk population,106031.0,False,35
3677,106036,NAP,SmPC,da,5.2,Farmakokinetiske egenskaber,106030.0,True,36
3678,106037,NAP,SmPC,da,,Absorption,106036.0,False,37
3679,106038,NAP,SmPC,da,,Fordeling,106036.0,False,38
3680,106039,NAP,SmPC,da,,Biotransformation,106036.0,False,39
3681,106040,NAP,SmPC,da,,Elimination,106036.0,False,40
3682,106041,NAP,SmPC,da,,Linearitet/non-linearitet,106036.0,False,41
3683,106042,NAP,SmPC,da,,Farmakokinetiske/farmakodynamiske forhold,106036.0,False,42
3684,106043,NAP,SmPC,da,5.3,Non-kliniske sikkerhedsdata,106030.0,True,43
3685,106044,NAP,SmPC,da,,Miljørisikovurdering,106043.0,False,44
3686,106045,NAP,SmPC,da,6,FARMACEUTISKE OPLYSNINGER,106001.0,True,45
3687,106046,NAP,SmPC,da,6.1,Hjælpestoffer,106045.0,True,46
3688,106047,NAP,SmPC,da,6.2,Uforligeligheder,106045.0,True,47
3689,106048,NAP,SmPC,da,6.3,Opbevaringstid,106045.0,True,48
3690,106049,NAP,SmPC,da,6.4,Særlige opbevaringsforhold,106045.0,True,49
3691,106050,NAP,SmPC,da,6.5,Emballagetype og pakningsstørrelser,106045.0,True,50
3692,106051,NAP,SmPC,da,6.6,Regler for bortskaffelse <og anden håndtering>,106045.0,True,51
3693,106052,NAP,SmPC,da,,Brug i den pædiatriske population,106051.0,False,52
3694,106053,NAP,SmPC,da,7,INDEHAVER AF MARKEDSFØRINGSTILLADELSEN,106001.0,True,53
3695,106054,NAP,SmPC,da,8,MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE),106001.0,True,54
3696,106055,NAP,SmPC,da,9,DATO FOR FØRSTE MARKEDSFØRINGSTILLADELSE/FORNYELSE AF TILLADELSEN,106001.0,True,55
3697,106056,NAP,SmPC,da,10,DATO FOR ÆNDRING AF TEKSTEN,106001.0,True,56
3698,106057,NAP,SmPC,da,11,DOSIMETRI,106001.0,False,57
3699,106058,NAP,SmPC,da,12,INSTRUKTIONER FOR FREMSTILLING AF RADIOAKTIVE LÆGEMIDLER,106001.0,False,58
3700,107001,NAP,ETIKETTERING ,da,,ETIKETTERING ,,True,1
3701,107002,NAP,ETIKETTERING ,da,,"MÆRKNING, DER SKAL ANFØRES <PÅ DEN YDRE EMBALLAGE> <OG> <PÅ DEN INDRE EMBALLAGE>",107001.0,True,2
3702,107003,NAP,ETIKETTERING ,da,1,LÆGEMIDLETS NAVN,107002.0,True,3
3703,107004,NAP,ETIKETTERING ,da,2,ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER,107002.0,True,4
3704,107005,NAP,ETIKETTERING ,da,3,LISTE OVER HJÆLPESTOFFER,107002.0,True,5
3705,107006,NAP,ETIKETTERING ,da,4,LÆGEMIDDELFORM OG INDHOLD (PAKNINGSSTØRRELSE),107002.0,True,6
3706,107007,NAP,ETIKETTERING ,da,5,ANVENDELSESMÅDE OG ADMINISTRATIONSVEJ€,107002.0,True,7
3707,107008,NAP,ETIKETTERING ,da,6,"SÆRLIG ADVARSEL OM, AT LÆGEMIDLET SKAL OPBEVARES UTILGÆNGELIGT FOR BØRN",107002.0,True,8
3708,107009,NAP,ETIKETTERING ,da,7,EVENTUELLE ANDRE SÆRLIGE ADVARSLER,107002.0,True,9
3709,107010,NAP,ETIKETTERING ,da,8,UDLØBSDATO,107002.0,True,10
3710,107011,NAP,ETIKETTERING ,da,9,SÆRLIGE OPBEVARINGSBETINGELSER,107002.0,True,11
3711,107012,NAP,ETIKETTERING ,da,10,EVENTUELLE SÆRLIGE FORHOLDSREGLER VED BORTSKAFFELSE AF IKKE ANVENDT LÆGEMIDDEL SAMT AFFALD HERAF,107002.0,True,12
3712,107013,NAP,ETIKETTERING ,da,11,NAVN OG ADRESSE PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN,107002.0,True,13
3713,107014,NAP,ETIKETTERING ,da,12,MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE),107002.0,True,14
3714,107015,NAP,ETIKETTERING ,da,13,BATCHNUMMER ,107002.0,True,15
3715,107016,NAP,ETIKETTERING ,da,14,GENEREL KLASSIFIKATION FOR UDLEVERING ,107002.0,True,16
3716,107017,NAP,ETIKETTERING ,da,15,INSTRUKTIONER VEDRØRENDE ANVENDELSEN,107002.0,True,17
3717,107018,NAP,ETIKETTERING ,da,16,INFORMATION I BRAILLESKRIFT,107002.0,True,18
3718,107019,NAP,ETIKETTERING ,da,17,ENTYDIG IDENTIFIKATOR – 2D-STREGKODE,107002.0,True,19
3719,107020,NAP,ETIKETTERING ,da,18,ENTYDIG IDENTIFIKATOR - MENNESKELIGT LÆSBARE DATA,107002.0,True,20
3720,107021,NAP,ETIKETTERING ,da,,MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP,107001.0,True,21
3721,107022,NAP,ETIKETTERING ,da,1,LÆGEMIDLETS NAVN,107021.0,True,22
3722,107023,NAP,ETIKETTERING ,da,2,NAVN PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN,107021.0,True,23
3723,107024,NAP,ETIKETTERING ,da,3,UDLØBSDATO,107021.0,True,24
3724,107025,NAP,ETIKETTERING ,da,4,BATCHNUMMER,107021.0,True,25
3725,107026,NAP,ETIKETTERING ,da,5,ANDET,107021.0,True,26
3726,107027,NAP,ETIKETTERING ,da,,MINDSTEKRAV TIL MÆRKNING PÅ SMÅ INDRE EMBALLAGER,107001.0,True,27
3727,107028,NAP,ETIKETTERING ,da,1,LÆGEMIDLETS NAVN OG ADMINISTRATIONSVEJ€,107027.0,True,28
3728,107029,NAP,ETIKETTERING ,da,2,ADMINISTRATIONSMETODE,107027.0,True,29
3729,107030,NAP,ETIKETTERING ,da,3,UDLØBSDATO,107027.0,True,30
3730,107031,NAP,ETIKETTERING ,da,4,BATCHNUMMER,107027.0,True,31
3731,107032,NAP,ETIKETTERING ,da,5,"INDHOLD ANGIVET SOM VÆGT, VOLUMEN ELLER ENHEDER",107027.0,True,32
3732,107033,NAP,ETIKETTERING ,da,6,ANDET,107027.0,True,33
3733,108001,NAP,INDLÆGSSEDDEL,da,,INDLÆGSSEDDEL,,True,1
3734,108002,NAP,INDLÆGSSEDDEL,da,,"q Dette lægemiddel er underlagt supplerende overvågning. Dermed kan der hurtigt tilvejebringes nye oplysninger om sikkerheden. <De> <Du> kan hjælpe ved at indberette alle de bivirkninger, <De> <du> får. Se sidst i <afsnit> <punkt> 4, hvordan <De> <du> indberetter bivirkninger",108001.0,False,2
3735,108003,NAP,INDLÆGSSEDDEL,da,,Oversigt over indlægssedlen,108001.0,True,3
3736,108004,NAP,INDLÆGSSEDDEL,da,1,Virkning og anvendelse,108001.0,True,4
3737,108005,NAP,INDLÆGSSEDDEL,da,2,"Det skal <De> <du> vide, før <De> <du> begynder at <tage> <bruge> {X}",108001.0,True,5
3738,108006,NAP,INDLÆGSSEDDEL,da,,<Tag> <Brug> ikke {X},108005.0,True,6
3739,108007,NAP,INDLÆGSSEDDEL,da,,Advarsler og forsigtighedsregler,108005.0,True,7
3740,108008,NAP,INDLÆGSSEDDEL,da,,Børn <og unge> ,108005.0,True,8
3741,108009,NAP,INDLÆGSSEDDEL,da,,Brug af anden medicin sammen med {X},108005.0,True,9
3742,108010,NAP,INDLÆGSSEDDEL,da,,"Brug af {X} sammen med <mad> <og> <,> <drikke> <og> <alkohol>",108005.0,True,10
3743,108011,NAP,INDLÆGSSEDDEL,da,,"Graviditet <og> <,> amning <og frugtbarhed>",108005.0,True,11
3744,108012,NAP,INDLÆGSSEDDEL,da,,Trafik- og arbejdssikkerhed,108005.0,True,12
3745,108013,NAP,INDLÆGSSEDDEL,da,,"{X} indeholder {nævn de(t) hjælpestof(fer), hvor advarsel er påkrævet}",108005.0,False,13
3746,108014,NAP,INDLÆGSSEDDEL,da,3,Sådan skal <De> <du> <tage> <bruge> {X},108001.0,True,14
3747,108015,NAP,INDLÆGSSEDDEL,da,,Brug til børn <og unge>,108014.0,False,15
3748,108016,NAP,INDLÆGSSEDDEL,da,,Hvis <De> <du> har <taget> <brugt> for meget {X},108014.0,False,16
3749,108017,NAP,INDLÆGSSEDDEL,da,,Hvis <De> <du> har glemt at <tage> <bruge> {X},108014.0,False,17
3750,108018,NAP,INDLÆGSSEDDEL,da,,Hvis <De> <du> holder op med at <tage> <bruge> {X},108014.0,False,18
3751,108019,NAP,INDLÆGSSEDDEL,da,4,Bivirkninger,108001.0,True,19
3752,108020,NAP,INDLÆGSSEDDEL,da,,Hos børn <og unge> kan endvidere ses følgende bivirkninger:,108019.0,False,20
3753,108021,NAP,INDLÆGSSEDDEL,da,,Indberetning af bivirkninger,108019.0,True,21
3754,108022,NAP,INDLÆGSSEDDEL,da,5,Opbevaring,108001.0,True,22
3755,108023,NAP,INDLÆGSSEDDEL,da,6,Pakningsstørrelser og yderligere oplysninger,108001.0,True,23
3756,108024,NAP,INDLÆGSSEDDEL,da,,{X} indeholder:,108023.0,True,24
3757,108025,NAP,INDLÆGSSEDDEL,da,,Udseende og pakningsstørrelser,108023.0,True,25
3758,108026,NAP,INDLÆGSSEDDEL,da,,Indehaver af markedsføringstilladelsen og fremstiller,108023.0,True,26
3759,108027,NAP,INDLÆGSSEDDEL,da,,Dette lægemiddel er godkendt i EEAs medlemslande under følgende navne:,108023.0,False,27
3760,108028,NAP,INDLÆGSSEDDEL,da,,Denne indlægsseddel blev senest ændret <{MM/ÅÅÅÅ}> <{måned ÅÅÅÅ}.>,108023.0,True,28
3761,108029,NAP,INDLÆGSSEDDEL,da,,Andre informationskilder,108023.0,False,29
3762,108030,NAP,INDLÆGSSEDDEL,da,,Nedenstående oplysninger er til læger og sundhedspersonale:,108001.0,False,30
3763,109001,NAP,SmPC,de,,ZUSAMMENFASSUNG DER MERKMALE DES ARZNEIMITTELS,,True,1
3764,109002,NAP,SmPC,de,,"Dieses Arzneimittel unterliegt einer zusätzlichen Überwachung. Dies ermöglicht eine schnelle Identifizierung neuer Erkenntnisse über die Sicherheit. Angehörige von Gesundheitsberufen sind aufgefordert, jeden Verdachtsfall einer Nebenwirkung zu melden. Hinweise zur Meldung von Nebenwirkungen, siehe Abschnitt 4.8.",109001.0,False,2
3765,109003,NAP,SmPC,de,1,BEZEICHNUNG DES ARZNEIMITTELS,109001.0,True,3
3766,109004,NAP,SmPC,de,2,QUALITATIVE UND QUANTITATIVE ZUSAMMENSETZUNG,109001.0,True,4
3767,109005,NAP,SmPC,de,,Sonstige(r) Bestandteil(e) mit bekannter Wirkung,109004.0,False,5
3768,109006,NAP,SmPC,de,3,DARREICHUNGSFORM,109001.0,True,6
3769,109007,NAP,SmPC,de,4,KLINISCHE ANGABEN,109001.0,True,7
3770,109008,NAP,SmPC,de,4.1,Anwendungsgebiete,109007.0,True,8
3771,109009,NAP,SmPC,de,4.2,Dosierung und Art der Anwendung,109007.0,True,9
3772,109010,NAP,SmPC,de,,Dosierung,109009.0,True,10
3773,109011,NAP,SmPC,de,,Kinder und Jugendliche,109010.0,True,11
3774,109012,NAP,SmPC,de,,Art der Anwendung,109009.0,True,12
3775,109013,NAP,SmPC,de,,Vorsichtsmaßnahmen vor / bei der Handhabung bzw. vor / während der Anwendung des Arzneimittels,109012.0,False,13
3776,109014,NAP,SmPC,de,4.3,Gegenanzeigen,109007.0,True,14
3777,109015,NAP,SmPC,de,4.4,Besondere Warnhinweise und Vorsichtsmaßnahmen für die Anwendung,109007.0,True,15
3778,109016,NAP,SmPC,de,,Rückverfolgbarkeit,109015.0,False,16
3779,109017,NAP,SmPC,de,,Kinder und Jugendliche,109015.0,False,17
3780,109018,NAP,SmPC,de,4.5,Wechselwirkungen mit anderen Arzneimitteln und sonstige Wechselwirkungen,109007.0,True,18
3781,109019,NAP,SmPC,de,,Kinder und Jugendliche,109018.0,False,19
3782,109020,NAP,SmPC,de,4.6,"Fertilität, Schwangerschaft und Stillzeit",109007.0,True,20
3783,109021,NAP,SmPC,de,,Schwangerschaft,109020.0,False,21
3784,109022,NAP,SmPC,de,,Stillzeit,109020.0,False,22
3785,109023,NAP,SmPC,de,,Fertilität,109020.0,False,23
3786,109024,NAP,SmPC,de,4.7,Auswirkungen auf die Verkehrstüchtigkeit und die Fähigkeit zum Bedienen von Maschinen,109007.0,True,24
3787,109025,NAP,SmPC,de,4.8,Nebenwirkungen,109007.0,True,25
3788,109026,NAP,SmPC,de,,Kinder und Jugendliche,109025.0,False,26
3789,109027,NAP,SmPC,de,,Meldung des Verdachts auf Nebenwirkungen,109025.0,True,27
3790,109028,NAP,SmPC,de,4.9,Überdosierung,109007.0,True,28
3791,109029,NAP,SmPC,de,,Kinder und Jugendliche,109028.0,False,29
3792,109030,NAP,SmPC,de,5,PHARMAKOLOGISCHE EIGENSCHAFTEN,109001.0,True,30
3793,109031,NAP,SmPC,de,5.1,Pharmakodynamische Eigenschaften,109030.0,True,31
3794,109032,NAP,SmPC,de,,Wirkmechanismus,109031.0,False,32
3795,109033,NAP,SmPC,de,,Pharmakodynamische Wirkungen,109031.0,False,33
3796,109034,NAP,SmPC,de,,Klinische Wirksamkeit und Sicherheit,109031.0,False,34
3797,109035,NAP,SmPC,de,,Kinder und Jugendliche,109031.0,False,35
3798,109036,NAP,SmPC,de,5.2,Pharmakokinetische Eigenschaften,109030.0,True,36
3799,109037,NAP,SmPC,de,,Resorption,109036.0,False,37
3800,109038,NAP,SmPC,de,,Verteilung,109036.0,False,38
3801,109039,NAP,SmPC,de,,Biotransformation,109036.0,False,39
3802,109040,NAP,SmPC,de,,Elimination,109036.0,False,40
3803,109041,NAP,SmPC,de,,Linearität/Nicht-Linearität,109036.0,False,41
3804,109042,NAP,SmPC,de,,Pharmakokinetische/pharmakodynamische Zusammenhänge,109036.0,False,42
3805,109043,NAP,SmPC,de,5.3,Präklinische Daten zur Sicherheit,109030.0,True,43
3806,109044,NAP,SmPC,de,,Beurteilung der Risiken für die Umwelt (Environmental risk assessment [ERA]),109043.0,False,44
3807,109045,NAP,SmPC,de,6,PHARMAZEUTISCHE ANGABEN,109001.0,True,45
3808,109046,NAP,SmPC,de,6.1,Liste der sonstigen Bestandteile,109045.0,True,46
3809,109047,NAP,SmPC,de,6.2,Inkompatibilitäten,109045.0,True,47
3810,109048,NAP,SmPC,de,6.3,Dauer der Haltbarkeit,109045.0,True,48
3811,109049,NAP,SmPC,de,6.4,Besondere Vorsichtsmaßnahmen für die Aufbewahrung,109045.0,True,49
3812,109050,NAP,SmPC,de,6.5,Art und Inhalt des Behältnisses,109045.0,True,50
3813,109051,NAP,SmPC,de,6.6,Besondere Vorsichtsmaßnahmen für die Beseitigung <und sonstige Hinweise zur Handhabung>,109045.0,True,51
3814,109052,NAP,SmPC,de,,Anwendung bei Kindern und Jugendlichen,109051.0,False,52
3815,109053,NAP,SmPC,de,7,INHABER DER ZULASSUNG,109001.0,True,53
3816,109054,NAP,SmPC,de,8,ZULASSUNGSNUMMER(N),109001.0,True,54
3817,109055,NAP,SmPC,de,9,DATUM DER ERTEILUNG DER ZULASSUNG/VERLÄNGERUNG DER ZULASSUNG,109001.0,True,55
3818,109056,NAP,SmPC,de,10,STAND DER INFORMATION,109001.0,True,56
3819,109057,NAP,SmPC,de,11,DOSIMETRIE,109001.0,False,57
3820,109058,NAP,SmPC,de,12,ANWEISUNGEN ZUR ZUBEREITUNG VON RADIOAKTIVEN ARZNEIMITTELN,109001.0,False,58
3821,110001,NAP,Etikettierung,de,,ETIKETTIERUNG ,,True,1
3822,110002,NAP,Etikettierung,de,,ANGABEN <AUF DER ÄUSSEREN UMHÜLLUNG> <UND> <AUF DEM BEHÄLTNIS>,110001.0,True,2
3823,110003,NAP,Etikettierung,de,1,BEZEICHNUNG DES ARZNEIMITTELS,110002.0,True,3
3824,110004,NAP,Etikettierung,de,2,WIRKSTOFF(E),110002.0,True,4
3825,110005,NAP,Etikettierung,de,3,SONSTIGE BESTANDTEILE,110002.0,True,5
3826,110006,NAP,Etikettierung,de,4,DARREICHUNGSFORM UND INHALT,110002.0,True,6
3827,110007,NAP,Etikettierung,de,5,HINWEISE ZUR UND ART(EN) DER ANWENDUNG,110002.0,True,7
3828,110008,NAP,Etikettierung,de,6,"WARNHINWEIS, DASS DAS ARZNEIMITTEL FÜR KINDER UNZUGÄNGLICH AUFZUBEWAHREN IST",110002.0,True,8
3829,110009,NAP,Etikettierung,de,7,"WEITERE WARNHINWEISE, FALLS ERFORDERLICH",110002.0,True,9
3830,110010,NAP,Etikettierung,de,8,VERFALLDATUM,110002.0,True,10
3831,110011,NAP,Etikettierung,de,9,BESONDERE VORSICHTSMASSNAHMEN FÜR DIE AUFBEWAHRUNG,110002.0,True,11
3832,110012,NAP,Etikettierung,de,10,GEGEBENENFALLS BESONDERE VORSICHTSMASSNAHMEN FÜR DIE BESEITIGUNG VON NICHT VERWENDETEM ARZNEIMITTEL ODER DAVON STAMMENDEN ABFALLMATERIALIEN,110002.0,True,12
3833,110013,NAP,Etikettierung,de,11,NAME UND ANSCHRIFT DES PHARMAZEUTISCHEN UNTERNEHMERS,110002.0,True,13
3834,110014,NAP,Etikettierung,de,12,ZULASSUNGSNUMMER(N) ,110002.0,True,14
3835,110015,NAP,Etikettierung,de,13,CHARGENBEZEICHNUNG,110002.0,True,15
3836,110016,NAP,Etikettierung,de,14,VERKAUFSABGRENZUNG,110002.0,True,16
3837,110017,NAP,Etikettierung,de,15,HINWEISE FÜR DEN GEBRAUCH,110002.0,True,17
3838,110018,NAP,Etikettierung,de,16,ANGABEN IN BLINDENSCHRIFT,110002.0,True,18
3839,110019,NAP,Etikettierung,de,17,INDIVIDUELLES ERKENNUNGSMERKMAL – 2D-BARCODE,110002.0,True,19
3840,110020,NAP,Etikettierung,de,18,INDIVIDUELLES ERKENNUNGSMERKMAL – VOM MENSCHEN LESBARES FORMAT,110002.0,True,20
3841,110021,NAP,Etikettierung,de,,MINDESTANGABEN AUF BLISTERPACKUNGEN ODER FOLIENSTREIFEN,110001.0,True,21
3842,110022,NAP,Etikettierung,de,1,BEZEICHNUNG DES ARZNEIMITTELS,110021.0,True,22
3843,110023,NAP,Etikettierung,de,2,NAME DES PHARMAZEUTISCHEN UNTERNEHMERS,110021.0,True,23
3844,110024,NAP,Etikettierung,de,3,VERFALLDATUM,110021.0,True,24
3845,110025,NAP,Etikettierung,de,4,CHARGENBEZEICHNUNG,110021.0,True,25
3846,110026,NAP,Etikettierung,de,5,WEITERE ANGABEN,110021.0,True,26
3847,110027,NAP,Etikettierung,de,,MINDESTANGABEN AUF KLEINEN BEHÄLTNISSEN,110001.0,True,27
3848,110028,NAP,Etikettierung,de,1,BEZEICHNUNG DES ARZNEIMITTELS SOWIE ART(EN) DER ANWENDUNG,110027.0,True,28
3849,110029,NAP,Etikettierung,de,2,HINWEISE ZUR ANWENDUNG,110027.0,True,29
3850,110030,NAP,Etikettierung,de,3,VERFALLDATUM,110027.0,True,30
3851,110031,NAP,Etikettierung,de,4,CHARGENBEZEICHNUNG,110027.0,True,31
3852,110032,NAP,Etikettierung,de,5,"INHALT NACH GEWICHT, VOLUMEN ODER EINHEITEN",110027.0,True,32
3853,110033,NAP,Etikettierung,de,6,WEITERE ANGABEN,110027.0,True,33
3854,111001,NAP,Packungsbeilage,de,,PACKUNGSBEILAGE,,True,1
3855,111002,NAP,Packungsbeilage,de,,"q Dieses Arzneimittel unterliegt einer zusätzlichen Überwachung. Dies ermöglicht eine schnelle Identifizierung neuer Erkenntnisse über die Sicherheit. Sie können dabei helfen, indem Sie jede auftretende Nebenwirkung melden. Hinweise zur Meldung von Nebenwirkungen, siehe Ende Abschnitt 4",111001.0,False,2
3856,111003,NAP,Packungsbeilage,de,,Was in dieser Packungsbeilage steht,111001.0,True,3
3857,111004,NAP,Packungsbeilage,de,1,Was ist X und wofür wird es angewendet?,111001.0,True,4
3858,111005,NAP,Packungsbeilage,de,2,Was sollten Sie vor der <Einnahme> <Anwendung> von X beachten?,111001.0,True,5
3859,111006,NAP,Packungsbeilage,de,,"X darf nicht <eingenommen> <angewendet> werden<,>",111005.0,True,6
3860,111007,NAP,Packungsbeilage,de,,Warnhinweise und Vorsichtsmaßnahmen,111005.0,True,7
3861,111008,NAP,Packungsbeilage,de,,Kinder <und Jugendliche>,111005.0,True,8
3862,111009,NAP,Packungsbeilage,de,,<Einnahme> <Anwendung> von X zusammen mit anderen Arzneimitteln,111005.0,True,9
3863,111010,NAP,Packungsbeilage,de,,"<Einnahme> <Anwendung> von X zusammen mit <Nahrungsmitteln> <und> <,> <Getränken> <und> <Alkohol>",111005.0,True,10
3864,111011,NAP,Packungsbeilage,de,,"Schwangerschaft <und> <,> Stillzeit <und Fortpflanzungsfähigkeit>",111005.0,True,11
3865,111012,NAP,Packungsbeilage,de,,Verkehrstüchtigkeit und Fähigkeit zum Bedienen von Maschinen,111005.0,True,12
3866,111013,NAP,Packungsbeilage,de,,X enthält {Bezeichnung <des> <der> sonstigen Bestandteil(s)(e)},111005.0,False,13
3867,111014,NAP,Packungsbeilage,de,3,Wie ist X <einzunehmen> <anzuwenden>?,111001.0,True,14
3868,111015,NAP,Packungsbeilage,de,,Anwendung bei Kindern <und Jugendlichen>,111014.0,False,15
3869,111016,NAP,Packungsbeilage,de,,"Wenn Sie eine größere Menge von X <eingenommen> <angewendet> haben, als Sie sollten",111014.0,False,16
3870,111017,NAP,Packungsbeilage,de,,Wenn Sie die <Einnahme> <Anwendung> von X vergessen haben,111014.0,False,17
3871,111018,NAP,Packungsbeilage,de,,Wenn Sie die <Einnahme> <Anwendung> von X abbrechen,111014.0,False,18
3872,111019,NAP,Packungsbeilage,de,4,Welche Nebenwirkungen sind möglich?,111001.0,True,19
3873,111020,NAP,Packungsbeilage,de,,Zusätzliche Nebenwirkungen bei Kindern <und Jugendlichen>,111019.0,False,20
3874,111021,NAP,Packungsbeilage,de,,Meldung von Nebenwirkungen,111019.0,True,21
3875,111022,NAP,Packungsbeilage,de,5,Wie ist X aufzubewahren?,111001.0,True,22
3876,111023,NAP,Packungsbeilage,de,6,Inhalt der Packung und weitere Informationen,111001.0,True,23
3877,111024,NAP,Packungsbeilage,de,,Was X enthält,111023.0,True,24
3878,111025,NAP,Packungsbeilage,de,,Wie X aussieht und Inhalt der Packung,111023.0,True,25
3879,111026,NAP,Packungsbeilage,de,,Pharmazeutischer Unternehmer und Hersteller,111023.0,True,26
3880,111027,NAP,Packungsbeilage,de,,Dieses Arzneimittel ist in den Mitgliedsstaaten des Europäischen Wirtschaftsraumes (EWR) unter den folgenden Bezeichnungen zugelassen:,111023.0,False,27
3881,111028,NAP,Packungsbeilage,de,,Diese Packungsbeilage wurde zuletzt überarbeitet im <{MM.JJJJ}> <{Monat JJJJ}>.,111023.0,True,28
3882,111029,NAP,Packungsbeilage,de,,Weitere Informationsquellen,111023.0,False,29
3883,111030,NAP,Packungsbeilage,de,,Die folgenden Informationen sind für medizinisches Fachpersonal bestimmt:,111001.0,False,30
3884,112001,NAP,SmPC,el,,ΠΕΡΙΛΗΨΗ ΤΩΝ ΧΑΡΑΚΤΗΡΙΣΤΙΚΩΝ ΤΟΥ ΠΡΟΪΟΝΤΟΣ,,True,1
3885,112002,NAP,SmPC,el,,qΤο φάρμακο αυτό τελεί υπό συμπληρωματική παρακολούθηση. Αυτό θα επιτρέψει το γρήγορο προσδιορισμό νέων πληροφοριών ασφάλειας. Ζητείται από τους επαγγελματίες υγείας να αναφέρουν οποιεσδήποτε πιθανολογούμενες ανεπιθύμητες ενέργειες. Βλ. παράγραφο 4.8 για τον τρόπο αναφοράς ανεπιθύμητων ενεργειών.,112001.0,False,2
3886,112003,NAP,SmPC,el,1,ΟΝΟΜΑΣΙΑ ΤΟΥ ΦΑΡΜΑΚΕΥΤΙΚΟΥ ΠΡΟΪΟΝΤΟΣ,112001.0,True,3
3887,112004,NAP,SmPC,el,2,ΠΟΙΟΤΙΚΗ ΚΑΙ ΠΟΣΟΤΙΚΗ ΣΥΝΘΕΣΗ,112001.0,True,4
3888,112005,NAP,SmPC,el,,Έκδοχο(α) με γνωστή δράση,112004.0,False,5
3889,112006,NAP,SmPC,el,3,ΦΑΡΜΑΚΟΤΕΧΝΙΚΗ ΜΟΡΦΗ,112001.0,True,6
3890,112007,NAP,SmPC,el,4,ΚΛΙΝΙΚΕΣ ΠΛΗΡΟΦΟΡΙΕΣ,112001.0,True,7
3891,112008,NAP,SmPC,el,4.1,Θεραπευτικές ενδείξεις,112007.0,True,8
3892,112009,NAP,SmPC,el,4.2,Δοσολογία και τρόπος χορήγησης,112007.0,True,9
3893,112010,NAP,SmPC,el,,Δοσολογία,112009.0,True,10
3894,112011,NAP,SmPC,el,,Παιδιατρικός πληθυσμός,112010.0,True,11
3895,112012,NAP,SmPC,el,,Τρόπος χορήγησης,112009.0,True,12
3896,112013,NAP,SmPC,el,,Προφυλάξεις που πρέπει να ληφθούν πριν από τον χειρισμό ή τη χορήγηση του φαρμακευτικού προϊόντος,112012.0,False,13
3897,112014,NAP,SmPC,el,4.3,Αντενδείξεις,112007.0,True,14
3898,112015,NAP,SmPC,el,4.4,Ειδικές προειδοποιήσεις και προφυλάξεις κατά τη χρήση,112007.0,True,15
3899,112016,NAP,SmPC,el,,Ιχνηλασιμότητα,112015.0,False,16
3900,112017,NAP,SmPC,el,,Παιδιατρικός πληθυσμός,112015.0,False,17
3901,112018,NAP,SmPC,el,4.5,Αλληλεπιδράσεις με άλλα φαρμακευτικά προϊόντα και άλλες μορφές αλληλεπίδρασης,112007.0,True,18
3902,112019,NAP,SmPC,el,,Παιδιατρικός πληθυσμός,112018.0,False,19
3903,112020,NAP,SmPC,el,4.6,"Γονιμότητα, κύηση και γαλουχία",112007.0,True,20
3904,112021,NAP,SmPC,el,,Κύηση,112020.0,False,21
3905,112022,NAP,SmPC,el,,Θηλασμός,112020.0,False,22
3906,112023,NAP,SmPC,el,,Γονιμότητα,112020.0,False,23
3907,112024,NAP,SmPC,el,4.7,Επιδράσεις στην ικανότητα οδήγησης και χειρισμού μηχανημάτων,112007.0,True,24
3908,112025,NAP,SmPC,el,4.8,Ανεπιθύμητες ενέργειες,112007.0,True,25
3909,112026,NAP,SmPC,el,,Παιδιατρικός πληθυσμός,112025.0,False,26
3910,112027,NAP,SmPC,el,,Αναφορά πιθανολογούμενων ανεπιθύμητων ενεργειών,112025.0,True,27
3911,112028,NAP,SmPC,el,4.9,Υπερδοσολογία,112007.0,True,28
3912,112029,NAP,SmPC,el,,Παιδιατρικός πληθυσμός,112028.0,False,29
3913,112030,NAP,SmPC,el,5,ΦΑΡΜΑΚΟΛΟΓΙΚΕΣ ΙΔΙΟΤΗΤΕΣ,112001.0,True,30
3914,112031,NAP,SmPC,el,5.1,Φαρμακοδυναμικές ιδιότητες,112030.0,True,31
3915,112032,NAP,SmPC,el,,Μηχανισμός δράσης,112031.0,False,32
3916,112033,NAP,SmPC,el,,Φαρμακοδυναμικές επιδράσεις,112031.0,False,33
3917,112034,NAP,SmPC,el,,Κλινική αποτελεσματικότητα και ασφάλεια,112031.0,False,34
3918,112035,NAP,SmPC,el,,Παιδιατρικός πληθυσμός,112031.0,False,35
3919,112036,NAP,SmPC,el,5.2,Φαρμακοκινητικές ιδιότητες,112030.0,True,36
3920,112037,NAP,SmPC,el,,Απορρόφηση,112036.0,False,37
3921,112038,NAP,SmPC,el,,Κατανομή,112036.0,False,38
3922,112039,NAP,SmPC,el,,Βιομετασχηματισμός,112036.0,False,39
3923,112040,NAP,SmPC,el,,Αποβολή,112036.0,False,40
3924,112041,NAP,SmPC,el,,Γραμμικότητα/μη γραμμικότητα,112036.0,False,41
3925,112042,NAP,SmPC,el,,Φαρμακοκινητικές/φαρμακοδυναμικές σχέσεις,112036.0,False,42
3926,112043,NAP,SmPC,el,5.3,Προκλινικά δεδομένα για την ασφάλεια,112030.0,True,43
3927,112044,NAP,SmPC,el,,Αξιολόγηση περιβαλλοντικού κινδύνου,112043.0,False,44
3928,112045,NAP,SmPC,el,6,ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΠΛΗΡΟΦΟΡΙΕΣ,112001.0,True,45
3929,112046,NAP,SmPC,el,6.1,Κατάλογος εκδόχων,112045.0,True,46
3930,112047,NAP,SmPC,el,6.2,Ασυμβατότητες,112045.0,True,47
3931,112048,NAP,SmPC,el,6.3,Διάρκεια ζωής,112045.0,True,48
3932,112049,NAP,SmPC,el,6.4,Ιδιαίτερες προφυλάξεις κατά τη φύλαξη του προϊόντος,112045.0,True,49
3933,112050,NAP,SmPC,el,6.5,Φύση και συστατικά του περιέκτη,112045.0,True,50
3934,112051,NAP,SmPC,el,6.6,Ιδιαίτερες προφυλάξεις απόρριψης <και άλλος χειρισμός>,112045.0,True,51
3935,112052,NAP,SmPC,el,,Χρήση στον παιδιατρικό πληθυσμό,112051.0,False,52
3936,112053,NAP,SmPC,el,7,ΚΑΤΟΧΟΣ ΤΗΣ ΑΔΕΙΑΣ ΚΥΚΛΟΦΟΡΙΑΣ,112001.0,True,53
3937,112054,NAP,SmPC,el,8,ΑΡΙΘΜΟΣ(ΟΙ) ΑΔΕΙΑΣ ΚΥΚΛΟΦΟΡΙΑΣ,112001.0,True,54
3938,112055,NAP,SmPC,el,9,ΗΜΕΡΟΜΗΝΙΑ ΠΡΩΤΗΣ ΕΓΚΡΙΣΗΣ/ΑΝΑΝΕΩΣΗΣ ΤΗΣ ΑΔΕΙΑΣ,112001.0,True,55
3939,112056,NAP,SmPC,el,10,ΗΜΕΡΟΜΗΝΙΑ ΑΝΑΘΕΩΡΗΣΗΣ ΤΟΥ ΚΕΙΜΕΝΟΥ,112001.0,True,56
3940,112057,NAP,SmPC,el,11,ΔΟΣΙΜΕΤΡΙΑ,112001.0,False,57
3941,112058,NAP,SmPC,el,12,ΟΔΗΓΙΕΣ ΠΑΡΑΣΚΕΥΗΣ ΡΑΔΙΟΦΑΡΜΑΚΩΝ,112001.0,False,58
3942,113001,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,,ΕΠΙΣΗΜΑΝΣΗ,,True,1
3943,113002,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,,ΕΝΔΕΙΞΕΙΣ ΠΟΥ ΠΡΕΠΕΙ ΝΑ ΑΝΑΓΡΑΦΟΝΤΑΙ <ΣΤΗΝ ΕΞΩΤΕΡΙΚΗ ΣΥΣΚΕΥΑΣΙΑ> <ΚΑΙ> < ΣΤΗ ΣΤΟΙΧΕΙΩΔΗ ΣΥΣΚΕΥΑΣΙΑ>,113001.0,True,2
3944,113003,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,1,ΟΝΟΜΑΣΙΑ ΤΟΥ ΦΑΡΜΑΚΕΥΤΙΚΟΥ ΠΡΟΪΟΝΤΟΣ,113002.0,True,3
3945,113004,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,2,ΣΥΝΘΕΣΗ ΣΕ ΔΡΑΣΤΙΚΗ(ΕΣ) ΟΥΣΙΑ(ΕΣ),113002.0,True,4
3946,113005,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,3,ΚΑΤΑΛΟΓΟΣ ΕΚΔΟΧΩΝ,113002.0,True,5
3947,113006,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,4,ΦΑΡΜΑΚΟΤΕΧΝΙΚΗ ΜΟΡΦΗ ΚΑΙ ΠΕΡΙΕΧΟΜΕΝΟ,113002.0,True,6
3948,113007,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,5,ΤΡΟΠΟΣ ΚΑΙ ΟΔΟΣ(ΟΙ) ΧΟΡΗΓΗΣΗΣ,113002.0,True,7
3949,113008,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,6,ΕΙΔΙΚΗ ΠΡΟΕΙΔΟΠΟΙΗΣΗ ΣΥΜΦΩΝΑ ΜΕ ΤΗΝ ΟΠΟΙΑ ΤΟ ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ ΠΡΕΠΕΙ ΝΑ ΦΥΛΑΣΣΕΤΑΙ ΣΕ ΘΕΣΗ ΤΗΝ ΟΠΟΙΑ ΔΕΝ ΒΛΕΠΟΥΝ ΚΑΙ ΔΕΝ ΠΡΟΣΕΓΓΙΖΟΥΝ ΤΑ ΠΑΙΔΙΑ,113002.0,True,8
3950,113009,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,7,"ΑΛΛΗ(ΕΣ) ΕΙΔΙΚΗ(ΕΣ) ΠΡΟΕΙΔΟΠΟΙΗΣΗ(ΕΙΣ), ΕΑΝ ΕΙΝΑΙ ΑΠΑΡΑΙΤΗΤΗ(ΕΣ)",113002.0,True,9
3951,113010,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,8,ΗΜΕΡΟΜΗΝΙΑ ΛΗΞΗΣ,113002.0,True,10
3952,113011,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,9,ΕΙΔΙΚΕΣ ΣΥΝΘΗΚΕΣ ΦΥΛΑΞΗΣ,113002.0,True,11
3953,113012,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,10,"ΙΔΙΑΙΤΕΡΕΣ ΠΡΟΦΥΛΑΞΕΙΣ ΓΙΑ ΤΗΝ ΑΠΟΡΡΙΨΗ ΤΩΝ ΜΗ 
ΧΡΗΣΙΜΟΠΟΙΗΘΕΝΤΩΝ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ Ή ΤΩΝ   
ΥΠΟΛΕΙΜΜΑΤΩΝ ΠΟΥ ΠΡΟΕΡΧΟΝΤΑΙ ΑΠΟ ΑΥΤΑ, ΕΦΟΣΟΝ ΑΠΑΙΤΕΙΤΑΙ",113002.0,True,12
3954,113013,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,11,ΟΝΟΜΑ ΚΑΙ ΔΙΕΥΘΥΝΣΗ ΚΑΤΟΧΟΥ ΤΗΣ ΑΔΕΙΑΣ ΚΥΚΛΟΦΟΡΙΑΣ,113002.0,True,13
3955,113014,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,12,ΑΡΙΘΜΟΣ(ΟΙ) ΑΔΕΙΑΣ ΚΥΚΛΟΦΟΡΙΑΣ,113002.0,True,14
3956,113015,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,13,ΑΡΙΘΜΟΣ ΠΑΡΤΙΔΑΣ,113002.0,True,15
3957,113016,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,14,ΓΕΝΙΚΗ ΚΑΤΑΤΑΞΗ ΓΙΑ ΤΗ ΔΙΑΘΕΣΗ,113002.0,True,16
3958,113017,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,15,ΟΔΗΓΙΕΣ ΧΡΗΣΗΣ,113002.0,True,17
3959,113018,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,16,ΠΛΗΡΟΦΟΡΙΕΣ ΣΕ BRAILLE,113002.0,True,18
3960,113019,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,17,ΜΟΝΑΔΙΚΟΣ ΑΝΑΓΝΩΡΙΣΤΙΚΟΣ ΚΩΔΙΚΟΣ – ΔΙΣΔΙΑΣΤΑΤΟΣ ΓΡΑΜΜΩΤΟΣ ΚΩΔΙΚΑΣ (2D),113002.0,True,19
3961,113020,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,18,ΜΟΝΑΔΙΚΟΣ ΑΝΑΓΝΩΡΙΣΤΙΚΟΣ ΚΩΔΙΚΟΣ – ΔΕΔΟΜΕΝΑ ΑΝΑΓΝΩΣΙΜΑ ΑΠΟ ΤΟΝ ΑΝΘΡΩΠΟ,113002.0,True,20
3962,113021,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,,ΕΛΑΧΙΣΤΕΣ ΕΝΔΕΙΞΕΙΣ ΠΟΥ ΠΡΕΠΕΙ ΝΑ ΑΝΑΓΡΑΦΟΝΤΑΙ ΣΤΙΣ ΣΥΣΚΕΥΑΣΙΕΣ ΚΥΨΕΛΗΣ (BLISTER) Ή ΣΤΙΣ ΤΑΙΝΙΕΣ (STRIPS),113001.0,True,21
3963,113022,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,1,ΟΝΟΜΑΣΙΑ ΤΟΥ ΦΑΡΜΑΚΕΥΤΙΚΟΥ ΠΡΟΪΟΝΤΟΣ,113021.0,True,22
3964,113023,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,2,ΟΝΟΜΑ ΚΑΤΟΧΟΥ ΤΗΣ ΑΔΕΙΑΣ ΚΥΚΛΟΦΟΡΙΑΣ,113021.0,True,23
3965,113024,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,3,ΗΜΕΡΟΜΗΝΙΑ ΛΗΞΗΣ,113021.0,True,24
3966,113025,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,4,ΑΡΙΘΜΟΣ ΠΑΡΤΙΔΑΣ,113021.0,True,25
3967,113026,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,5,ΑΛΛΑ ΣΤΟΙΧΕΙΑ,113021.0,True,26
3968,113027,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,,ΕΛΑΧΙΣΤΕΣ ΕΝΔΕΙΞΕΙΣ ΠΟΥ ΠΡΕΠΕΙ ΝΑ ΑΝΑΓΡΑΦΟΝΤΑΙ ΣΤΙΣ ΜΙΚΡΕΣ ΣΤΟΙΧΕΙΩΔΕΙΣ ΣΥΣΚΕΥΑΣΙΕΣ,113001.0,True,27
3969,113028,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,1,ΟΝΟΜΑΣΙΑ ΤΟΥ ΦΑΡΜΑΚΕΥΤΙΚΟΥ ΠΡΟΪΟΝΤΟΣ ΚΑΙ ΟΔΟΣ(ΟΙ) ΧΟΡΗΓΗΣΗΣ,113027.0,True,28
3970,113029,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,2,ΤΡΟΠΟΣ ΧΟΡΗΓΗΣΗΣ,113027.0,True,29
3971,113030,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,3,ΗΜΕΡΟΜΗΝΙΑ ΛΗΞΗΣ,113027.0,True,30
3972,113031,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,4,ΑΡΙΘΜΟΣ ΠΑΡΤΙΔΑΣ,113027.0,True,31
3973,113032,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,5,"ΠΕΡΙΕΧΟΜΕΝΟ ΚΑΤΑ ΒΑΡΟΣ, ΚΑΤ' ΟΓΚΟ Ή ΚΑΤΑ ΜΟΝΑΔΑ",113027.0,True,32
3974,113033,NAP,ΕΠΙΣΗΜΑΝΣΗ,el,6,ΑΛΛΑ ΣΤΟΙΧΕΙΑ,113027.0,True,33
3975,114001,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,,True,1
3976,114002,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,q Το φάρμακο αυτό τελεί υπό συμπληρωματική παρακολούθηση. Αυτό θα επιτρέψει το γρήγορο προσδιορισμό νέων πληροφοριών ασφάλειας. Μπορείτε να βοηθήσετε μέσω της αναφοράς πιθανών ανεπιθύμητων ενεργειών που ενδεχομένως παρουσιάζετε. Βλ. τέλος της παραγράφου 4 για τον τρόπο αναφοράς ανεπιθύμητων ενεργειών.,114001.0,False,2
3977,114003,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Τι περιέχει το παρόν φύλλο οδηγιών:,114001.0,True,3
3978,114004,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,1,Τι είναι το Χ και ποια είναι η χρήση του,114001.0,True,4
3979,114005,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,2,Τι πρέπει να γνωρίζετε πριν <πάρετε> <χρησιμοποιήσετε> το Χ,114001.0,True,5
3980,114006,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Μην <πάρετε> <χρησιμοποιήσετε> το Χ,114005.0,True,6
3981,114007,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Προειδοποιήσεις και προφυλάξεις,114005.0,True,7
3982,114008,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Παιδιά <και έφηβοι> ,114005.0,True,8
3983,114009,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Άλλα φάρμακα και Χ,114005.0,True,9
3984,114010,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,"Το Χ με <τροφή> <και> <,> <ποτό> <και> <οινοπνευματώδη>",114005.0,True,10
3985,114011,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,"Κύηση<,> <και> θηλασμός <και γονιμότητα>",114005.0,True,11
3986,114012,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Οδήγηση και χειρισμός μηχανημάτων,114005.0,True,12
3987,114013,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Το Χ περιέχει {όνομα(τα) εκδόχου(ων)},114005.0,False,13
3988,114014,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,3,Πώς να <πάρετε> <χρησιμοποιήσετε> το Χ,114001.0,True,14
3989,114015,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Χρήση σε παιδιά> <και εφήβους>,114014.0,False,15
3990,114016,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Εάν <πάρετε> <χρησιμοποιήσετε> μεγαλύτερη δόση Χ από την κανονική,114014.0,False,16
3991,114017,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Εάν ξεχάσετε να <πάρετε> <χρησιμοποιήσετε> το Χ,114014.0,False,17
3992,114018,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Εάν σταματήσετε να <παίρνετε> <χρησιμοποιείτε> το Χ,114014.0,False,18
3993,114019,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,4,Πιθανές ανεπιθύμητες ενέργειες,114001.0,True,19
3994,114020,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Συμπληρωματικές ανεπιθύμητες ενέργειες σε παιδιά <και εφήβους>,114019.0,False,20
3995,114021,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Αναφορά ανεπιθύμητων ενεργειών,114019.0,True,21
3996,114022,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,5,Πώς να φυλάσσετε το  Χ,114001.0,True,22
3997,114023,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,6,Περιεχόμενα της συσκευασίας και λοιπές πληροφορίες,114001.0,True,23
3998,114024,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Τι περιέχει το Χ,114023.0,True,24
3999,114025,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Εμφάνιση του Χ και περιεχόμενα της συσκευασίας,114023.0,True,25
4000,114026,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Κάτοχος Άδειας Κυκλοφορίας και Παρασκευαστής,114023.0,True,26
4001,114027,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Αυτό το φαρμακευτικό προϊόν έχει εγκριθεί στα Κράτη Μέλη του Ευρωπαϊκού Οικονομικού Χώρου (ΕΟΧ) με τις ακόλουθες ονομασίες:,114023.0,False,27
4002,114028,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Το παρόν φύλλο οδηγιών χρήσης αναθεωρήθηκε για τελευταία φορά στις <{ΜΜ/ΕΕΕΕ}> <{μήνας ΕΕΕΕ}.>,114023.0,True,28
4003,114029,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Άλλες πηγές πληροφοριών,114023.0,False,29
4004,114030,NAP,ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ,el,,Οι πληροφορίες που ακολουθούν απευθύνονται μόνο σε επαγγελματίες υγείας:,114001.0,False,30
4005,115001,NAP,SmPC,en,,SUMMARY OF PRODUCT CHARACTERISTICS,,True,1
4006,115002,NAP,SmPC,en,,qThis medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.>,115001.0,False,2
4007,115003,NAP,SmPC,en,1,NAME OF THE MEDICINAL PRODUCT,115001.0,True,3
4008,115004,NAP,SmPC,en,2,QUALITATIVE AND QUANTITATIVE COMPOSITION,115001.0,True,4
4009,115005,NAP,SmPC,en,,Excipient(s) with known effect,115004.0,False,5
4010,115006,NAP,SmPC,en,3,PHARMACEUTICAL FORM,115001.0,True,6
4011,115007,NAP,SmPC,en,4,CLINICAL PARTICULARS,115001.0,True,7
4012,115008,NAP,SmPC,en,4.1,Therapeutic indications,115007.0,True,8
4013,115009,NAP,SmPC,en,4.2,Posology and method of administration,115007.0,True,9
4014,115010,NAP,SmPC,en,,Posology,115009.0,True,10
4015,115011,NAP,SmPC,en,,Paediatric population,115010.0,True,11
4016,115012,NAP,SmPC,en,,Method of administration ,115009.0,True,12
4017,115013,NAP,SmPC,en,,Precautions to be taken before handling or administering the medicinal product,115012.0,False,13
4018,115014,NAP,SmPC,en,4.3,Contraindications,115007.0,True,14
4019,115015,NAP,SmPC,en,4.4,Special warnings and precautions for use,115007.0,True,15
4020,115016,NAP,SmPC,en,,Traceability,115015.0,False,16
4021,115017,NAP,SmPC,en,,Paediatric population,115015.0,False,17
4022,115018,NAP,SmPC,en,4.5,Interaction with other medicinal products and other forms of interaction,115007.0,True,18
4023,115019,NAP,SmPC,en,,Paediatric population,115018.0,False,19
4024,115020,NAP,SmPC,en,4.6,"Fertility, pregnancy and lactation",115007.0,True,20
4025,115021,NAP,SmPC,en,,Pregnancy,115020.0,False,21
4026,115022,NAP,SmPC,en,,Breast-feeding,115020.0,False,22
4027,115023,NAP,SmPC,en,,Fertility,115020.0,False,23
4028,115024,NAP,SmPC,en,4.7,Effects on ability to drive and use machines,115007.0,True,24
4029,115025,NAP,SmPC,en,4.8,Undesirable effects,115007.0,True,25
4030,115026,NAP,SmPC,en,,Paediatric population,115025.0,False,26
4031,115027,NAP,SmPC,en,,Reporting of suspected adverse reactions,115025.0,True,27
4032,115028,NAP,SmPC,en,4.9,Overdose,115007.0,True,28
4033,115029,NAP,SmPC,en,,Paediatric population,115028.0,False,29
4034,115030,NAP,SmPC,en,5,PHARMACOLOGICAL PROPERTIES,115001.0,True,30
4035,115031,NAP,SmPC,en,5.1,Pharmacodynamic properties,115030.0,True,31
4036,115032,NAP,SmPC,en,,Mechanism of action,115031.0,False,32
4037,115033,NAP,SmPC,en,,Pharmacodynamic effects,115031.0,False,33
4038,115034,NAP,SmPC,en,,Clinical efficacy and safety,115031.0,False,34
4039,115035,NAP,SmPC,en,,Paediatric population,115031.0,False,35
4040,115036,NAP,SmPC,en,5.2,Pharmacokinetic properties,115030.0,True,36
4041,115037,NAP,SmPC,en,,Absorption,115036.0,False,37
4042,115038,NAP,SmPC,en,,Distribution,115036.0,False,38
4043,115039,NAP,SmPC,en,,Biotransformation,115036.0,False,39
4044,115040,NAP,SmPC,en,,Elimination,115036.0,False,40
4045,115041,NAP,SmPC,en,,Linearity/non-linearity,115036.0,False,41
4046,115042,NAP,SmPC,en,,Pharmacokinetic/pharmacodynamic relationship(s),115036.0,False,42
4047,115043,NAP,SmPC,en,5.3,Preclinical safety data,115030.0,True,43
4048,115044,NAP,SmPC,en,,Environmental risk assessment (ERA),115043.0,False,44
4049,115045,NAP,SmPC,en,6,PHARMACEUTICAL PARTICULARS,115001.0,True,45
4050,115046,NAP,SmPC,en,6.1,List of excipients,115045.0,True,46
4051,115047,NAP,SmPC,en,6.2,Incompatibilities,115045.0,True,47
4052,115048,NAP,SmPC,en,6.3,Shelf life,115045.0,True,48
4053,115049,NAP,SmPC,en,6.4,Special precautions for storage,115045.0,True,49
4054,115050,NAP,SmPC,en,6.5,Nature and contents of container,115045.0,True,50
4055,115051,NAP,SmPC,en,6.6,Special precautions for disposal <and other handling>,115045.0,True,51
4056,115052,NAP,SmPC,en,,Use in the paediatric population,115051.0,False,52
4057,115053,NAP,SmPC,en,7,MARKETING AUTHORISATION HOLDER,115001.0,True,53
4058,115054,NAP,SmPC,en,8,MARKETING AUTHORISATION NUMBER(S),115001.0,True,54
4059,115055,NAP,SmPC,en,9,DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION,115001.0,True,55
4060,115056,NAP,SmPC,en,10,DATE OF REVISION OF THE TEXT,115001.0,True,56
4061,115057,NAP,SmPC,en,11,DOSIMETRY,115001.0,False,57
4062,115058,NAP,SmPC,en,12,INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS,115001.0,False,58
4063,116001,NAP,Labelling,en,,LABELLING ,,True,1
4064,116002,NAP,Labelling,en,,PARTICULARS TO APPEAR ON <THE OUTER PACKAGING> <AND> <THE IMMEDIATE PACKAGING>,116001.0,True,2
4065,116003,NAP,Labelling,en,1,NAME OF THE MEDICINAL PRODUCT,116002.0,True,3
4066,116004,NAP,Labelling,en,2,STATEMENT OF ACTIVE SUBSTANCE(S),116002.0,True,4
4067,116005,NAP,Labelling,en,3,LIST OF EXCIPIENTS,116002.0,True,5
4068,116006,NAP,Labelling,en,4,PHARMACEUTICAL FORM AND CONTENTS,116002.0,True,6
4069,116007,NAP,Labelling,en,5,METHOD AND ROUTE(S) OF ADMINISTRATION,116002.0,True,7
4070,116008,NAP,Labelling,en,6,SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN,116002.0,True,8
4071,116009,NAP,Labelling,en,7,"OTHER SPECIAL WARNING(S), IF NECESSARY",116002.0,True,9
4072,116010,NAP,Labelling,en,8,EXPIRY DATE,116002.0,True,10
4073,116011,NAP,Labelling,en,9,SPECIAL STORAGE CONDITIONS,116002.0,True,11
4074,116012,NAP,Labelling,en,10,"SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE",116002.0,True,12
4075,116013,NAP,Labelling,en,11,NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER,116002.0,True,13
4076,116014,NAP,Labelling,en,12,MARKETING AUTHORISATION NUMBER(S) ,116002.0,True,14
4077,116015,NAP,Labelling,en,13,BATCH NUMBER,116002.0,True,15
4078,116016,NAP,Labelling,en,14,GENERAL CLASSIFICATION FOR SUPPLY,116002.0,True,16
4079,116017,NAP,Labelling,en,15,INSTRUCTIONS ON USE,116002.0,True,17
4080,116018,NAP,Labelling,en,16,INFORMATION IN BRAILLE,116002.0,True,18
4081,116019,NAP,Labelling,en,17,UNIQUE IDENTIFIER – 2D BARCODE,116002.0,True,19
4082,116020,NAP,Labelling,en,18,UNIQUE IDENTIFIER - HUMAN READABLE DATA,116002.0,True,20
4083,116021,NAP,Labelling,en,,MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS,116001.0,True,21
4084,116022,NAP,Labelling,en,1,NAME OF THE MEDICINAL PRODUCT,116021.0,True,22
4085,116023,NAP,Labelling,en,2,NAME OF THE MARKETING AUTHORISATION HOLDER,116021.0,True,23
4086,116024,NAP,Labelling,en,3,EXPIRY DATE,116021.0,True,24
4087,116025,NAP,Labelling,en,4,BATCH NUMBER,116021.0,True,25
4088,116026,NAP,Labelling,en,5,OTHER,116021.0,True,26
4089,116027,NAP,Labelling,en,,MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS,116001.0,True,27
4090,116028,NAP,Labelling,en,1,NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION,116027.0,True,28
4091,116029,NAP,Labelling,en,2,METHOD OF ADMINISTRATION,116027.0,True,29
4092,116030,NAP,Labelling,en,3,EXPIRY DATE,116027.0,True,30
4093,116031,NAP,Labelling,en,4,BATCH NUMBER,116027.0,True,31
4094,116032,NAP,Labelling,en,5,"CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT",116027.0,True,32
4095,116033,NAP,Labelling,en,6,OTHER,116027.0,True,33
4096,117001,NAP,Package leaflet,en,,PACKAGE LEAFLET,,True,1
4097,117002,NAP,Package leaflet,en,,q This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.,117001.0,False,2
4098,117003,NAP,Package leaflet,en,,What is in this leaflet,117001.0,True,3
4099,117004,NAP,Package leaflet,en,1,What X is and what it is used for,117001.0,True,4
4100,117005,NAP,Package leaflet,en,2,What you need to know before you <take> <use> X ,117001.0,True,5
4101,117006,NAP,Package leaflet,en,,Do not <take> <use> X,117005.0,True,6
4102,117007,NAP,Package leaflet,en,,Warnings and precautions ,117005.0,True,7
4103,117008,NAP,Package leaflet,en,,Children <and adolescents>,117005.0,True,8
4104,117009,NAP,Package leaflet,en,,Other medicines and X,117005.0,True,9
4105,117010,NAP,Package leaflet,en,,"X with <food> <and> <,> <drink> <and> <alcohol>",117005.0,True,10
4106,117011,NAP,Package leaflet,en,,"Pregnancy <and> <,> breast-feeding <and fertility>",117005.0,True,11
4107,117012,NAP,Package leaflet,en,,Driving and using machines,117005.0,True,12
4108,117013,NAP,Package leaflet,en,,X contains {name the excipient(s)},117005.0,False,13
4109,117014,NAP,Package leaflet,en,3,How to <take> <use> X ,117001.0,True,14
4110,117015,NAP,Package leaflet,en,,Use in children <and adolescents>,117014.0,False,15
4111,117016,NAP,Package leaflet,en,,If you <take> <use> more X than you should,117014.0,False,16
4112,117017,NAP,Package leaflet,en,,If you forget to <take> <use> X>,117014.0,False,17
4113,117018,NAP,Package leaflet,en,,If you stop <taking> <using> X>,117014.0,False,18
4114,117019,NAP,Package leaflet,en,4,Possible side effects,117001.0,True,19
4115,117020,NAP,Package leaflet,en,,Additional side effects in children <and adolescents>,117019.0,False,20
4116,117021,NAP,Package leaflet,en,,Reporting of side effects,117019.0,True,21
4117,117022,NAP,Package leaflet,en,5,How to store X,117001.0,True,22
4118,117023,NAP,Package leaflet,en,6,Contents of the pack and other information,117001.0,True,23
4119,117024,NAP,Package leaflet,en,,What X contains ,117023.0,True,24
4120,117025,NAP,Package leaflet,en,,What X looks like and contents of the pack,117023.0,True,25
4121,117026,NAP,Package leaflet,en,,Marketing Authorisation Holder <and Manufacturer>,117023.0,True,26
4122,117027,NAP,Package leaflet,en,,This medicinal product is authorised in the Member States of the EEA under the following names :,117023.0,False,27
4123,117028,NAP,Package leaflet,en,,This leaflet was last revised in <{MM/YYYY}><{month YYYY}>.,117023.0,True,28
4124,117029,NAP,Package leaflet,en,,Other sources of information,117023.0,False,29
4125,117030,NAP,Package leaflet,en,,The following information is intended for healthcare professionals only:,117001.0,False,30
4126,118001,NAP,SmPC,es,,FICHA TÉCNICA O RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO,,True,1
4127,118002,NAP,SmPC,es,,"qEste medicamento está sujeto a seguimiento adicional, lo que agilizará la detección de nueva información sobre su seguridad. Se invita a los profesionales sanitarios a notificar las sospechas de reacciones adversas. Ver  la sección 4.8, en la que se incluye información sobre cómo notificarlas.",118001.0,False,2
4128,118003,NAP,SmPC,es,1,NOMBRE DEL MEDICAMENTO,118001.0,True,3
4129,118004,NAP,SmPC,es,2,COMPOSICIÓN CUALITATIVA Y CUANTITATIVA,118001.0,True,4
4130,118005,NAP,SmPC,es,,Excipiente(s) con efecto conocido,118004.0,False,5
4131,118006,NAP,SmPC,es,3,FORMA FARMACÉUTICA,118001.0,True,6
4132,118007,NAP,SmPC,es,4,DATOS CLÍNICOS,118001.0,True,7
4133,118008,NAP,SmPC,es,4.1,Indicaciones terapéuticas,118007.0,True,8
4134,118009,NAP,SmPC,es,4.2,Posología y forma de administración,118007.0,True,9
4135,118010,NAP,SmPC,es,,Posología,118009.0,True,10
4136,118011,NAP,SmPC,es,,Población pediátrica,118010.0,True,11
4137,118012,NAP,SmPC,es,,Forma de administración ,118009.0,True,12
4138,118013,NAP,SmPC,es,,Precauciones que se deben tomar antes de manipular o administrar el medicamento,118012.0,False,13
4139,118014,NAP,SmPC,es,4.3,Contraindicaciones,118007.0,True,14
4140,118015,NAP,SmPC,es,4.4,Advertencias y precauciones especiales de empleo,118007.0,True,15
4141,118016,NAP,SmPC,es,,Trazabilidad,118015.0,False,16
4142,118017,NAP,SmPC,es,,Población pediátrica,118015.0,False,17
4143,118018,NAP,SmPC,es,4.5,Interacción con otros medicamentos y otras formas de interacción,118007.0,True,18
4144,118019,NAP,SmPC,es,,Población pediátrica,118018.0,False,19
4145,118020,NAP,SmPC,es,4.6,"Fertilidad, embarazo y lactancia",118007.0,True,20
4146,118021,NAP,SmPC,es,,Embarazo,118020.0,False,21
4147,118022,NAP,SmPC,es,,Lactancia,118020.0,False,22
4148,118023,NAP,SmPC,es,,Fertilidad,118020.0,False,23
4149,118024,NAP,SmPC,es,4.7,Efectos sobre la capacidad para conducir y utilizar máquinas,118007.0,True,24
4150,118025,NAP,SmPC,es,4.8,Reacciones adversas,118007.0,True,25
4151,118026,NAP,SmPC,es,,Población pediátrica,118025.0,False,26
4152,118027,NAP,SmPC,es,,Notificación de sospechas de reacciones adversas,118025.0,True,27
4153,118028,NAP,SmPC,es,4.9,Sobredosis,118007.0,True,28
4154,118029,NAP,SmPC,es,,Población pediátrica,118028.0,False,29
4155,118030,NAP,SmPC,es,5,PROPIEDADES FARMACOLÓGICAS,118001.0,True,30
4156,118031,NAP,SmPC,es,5.1,Propiedades farmacodinámicas,118030.0,True,31
4157,118032,NAP,SmPC,es,,Mecanismo de acción,118031.0,False,32
4158,118033,NAP,SmPC,es,,Efectos farmacodinámicos,118031.0,False,33
4159,118034,NAP,SmPC,es,,Eficacia clínica y seguridad,118031.0,False,34
4160,118035,NAP,SmPC,es,,Población pediátrica,118031.0,False,35
4161,118036,NAP,SmPC,es,5.2,Propiedades farmacocinéticas,118030.0,True,36
4162,118037,NAP,SmPC,es,,Absorción,118036.0,False,37
4163,118038,NAP,SmPC,es,,Distribución,118036.0,False,38
4164,118039,NAP,SmPC,es,,Biotransformación,118036.0,False,39
4165,118040,NAP,SmPC,es,,Eliminación,118036.0,False,40
4166,118041,NAP,SmPC,es,,Linealidad/No linealidad,118036.0,False,41
4167,118042,NAP,SmPC,es,,Relación(es) farmacocinéticas/farmacodinámica(s),118036.0,False,42
4168,118043,NAP,SmPC,es,5.3,Datos preclínicos sobre seguridad,118030.0,True,43
4169,118044,NAP,SmPC,es,,"Evaluación del riesgo medioambiental (ERA, por sus siglas en inglés)",118043.0,False,44
4170,118045,NAP,SmPC,es,6,DATOS FARMACÉUTICOS,118001.0,True,45
4171,118046,NAP,SmPC,es,6.1,Lista de excipientes,118045.0,True,46
4172,118047,NAP,SmPC,es,6.2,Incompatibilidades,118045.0,True,47
4173,118048,NAP,SmPC,es,6.3,Periodo de validez,118045.0,True,48
4174,118049,NAP,SmPC,es,6.4,Precauciones especiales de conservación,118045.0,True,49
4175,118050,NAP,SmPC,es,6.5,Naturaleza y contenido del envase,118045.0,True,50
4176,118051,NAP,SmPC,es,6.6,Precauciones especiales de eliminación <y otras manipulaciones>,118045.0,True,51
4177,118052,NAP,SmPC,es,,Uso en la población pediátrica ,118051.0,False,52
4178,118053,NAP,SmPC,es,7,TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN,118001.0,True,53
4179,118054,NAP,SmPC,es,8,NÚMERO(S) DE AUTORIZACIÓN DE COMERCIALIZACIÓN ,118001.0,True,54
4180,118055,NAP,SmPC,es,9,FECHA DE LA PRIMERA AUTORIZACIÓN/RENOVACIÓN DE LA AUTORIZACIÓN,118001.0,True,55
4181,118056,NAP,SmPC,es,10,FECHA DE LA REVISIÓN DEL TEXTO,118001.0,True,56
4182,118057,NAP,SmPC,es,11,DOSIMETRÍA,118001.0,False,57
4183,118058,NAP,SmPC,es,12,INSTRUCCIONES PARA LA PREPARACIÓN DE RADIOFÁRMACOS,118001.0,False,58
4184,119001,NAP,Labelling,es,,ETIQUETADO,,True,1
4185,119002,NAP,Labelling,es,,INFORMACIÓN QUE DEBE FIGURAR EN <EL EMBALAJE EXTERIOR><Y><EL ACONDICIONAMIENTO PRIMARIO>,119001.0,True,2
4186,119003,NAP,Labelling,es,1,NOMBRE DEL MEDICAMENTO,119002.0,True,3
4187,119004,NAP,Labelling,es,2,PRINCIPIO(S) ACTIVO(S),119002.0,True,4
4188,119005,NAP,Labelling,es,3,LISTA DE EXCIPIENTES,119002.0,True,5
4189,119006,NAP,Labelling,es,4,FORMA FARMACÉUTICA Y CONTENIDO DEL ENVASE,119002.0,True,6
4190,119007,NAP,Labelling,es,5,FORMA Y VÍA(S) DE ADMINISTRACIÓN,119002.0,True,7
4191,119008,NAP,Labelling,es,6,ADVERTENCIA ESPECIAL DE QUE EL MEDICAMENTO DEBE MANTENERSE FUERA DE LA VISTA Y DEL ALCANCE DE LOS NIÑOS,119002.0,True,8
4192,119009,NAP,Labelling,es,7,"OTRA(S) ADVERTENCIA(S) ESPECIAL(ES), SI ES NECESARIO",119002.0,True,9
4193,119010,NAP,Labelling,es,8,FECHA DE CADUCIDAD,119002.0,True,10
4194,119011,NAP,Labelling,es,9,CONDICIONES ESPECIALES DE CONSERVACIÓN,119002.0,True,11
4195,119012,NAP,Labelling,es,10,"PRECAUCIONES ESPECIALES DE ELIMINACIÓN DEL MEDICAMENTO NO UTILIZADO Y DE LOS MATERIALES DERIVADOS DE SU USO, CUANDO CORRESPONDA",119002.0,True,12
4196,119013,NAP,Labelling,es,11,NOMBRE Y DIRECCIÓN DEL TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN,119002.0,True,13
4197,119014,NAP,Labelling,es,12,NÚMERO(S) DE AUTORIZACIÓN DE COMERCIALIZACIÓN ,119002.0,True,14
4198,119015,NAP,Labelling,es,13,NÚMERO DE LOTE,119002.0,True,15
4199,119016,NAP,Labelling,es,14,CONDICIONES GENERALES DE DISPENSACIÓN,119002.0,True,16
4200,119017,NAP,Labelling,es,15,INSTRUCCIONES DE USO,119002.0,True,17
4201,119018,NAP,Labelling,es,16,INFORMACIÓN EN BRAILLE,119002.0,True,18
4202,119019,NAP,Labelling,es,17,IDENTIFICADOR ÚNICO - CÓDIGO DE BARRAS 2D,119002.0,True,19
4203,119020,NAP,Labelling,es,18,IDENTIFICADOR ÚNICO - INFORMACIÓN EN CARACTERES VISUALES,119002.0,True,20
4204,119021,NAP,Labelling,es,,INFORMACIÓN MÍNIMA A INCLUIR EN BLÍSTERES O TIRAS,119001.0,True,21
4205,119022,NAP,Labelling,es,1,NOMBRE DEL MEDICAMENTO,119021.0,True,22
4206,119023,NAP,Labelling,es,2,NOMBRE DEL TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN,119021.0,True,23
4207,119024,NAP,Labelling,es,3,FECHA DE CADUCIDAD,119021.0,True,24
4208,119025,NAP,Labelling,es,4,NÚMERO DE LOTE,119021.0,True,25
4209,119026,NAP,Labelling,es,5,OTROS,119021.0,True,26
4210,119027,NAP,Labelling,es,,INFORMACIÓN MÍNIMA QUE DEBE INCLUIRSE EN PEQUEÑOS ACONDICIONAMIENTOS PRIMARIOS,119001.0,True,27
4211,119028,NAP,Labelling,es,1,NOMBRE DEL MEDICAMENTO Y VÍA(S) DE ADMINISTRACIÓN,119027.0,True,28
4212,119029,NAP,Labelling,es,2,FORMA DE ADMINISTRACIÓN,119027.0,True,29
4213,119030,NAP,Labelling,es,3,FECHA DE CADUCIDAD,119027.0,True,30
4214,119031,NAP,Labelling,es,4,NÚMERO DE LOTE,119027.0,True,31
4215,119032,NAP,Labelling,es,5,"CONTENIDO EN PESO, EN VOLUMEN O EN UNIDADES",119027.0,True,32
4216,119033,NAP,Labelling,es,6,OTROS,119027.0,True,33
4217,120001,NAP,Package leaflet,es,,PROSPECTO,,True,1
4218,120002,NAP,Package leaflet,es,,"q Este medicamento está sujeto a seguimiento adicional, lo que agilizará la detección de nueva información sobre su seguridad. Puede contribuir comunicando los efectos adversos que pudiera usted tener. La parte final de la sección 4 incluye información sobre cómo comunicar estos efectos adversos.",120001.0,False,2
4219,120003,NAP,Package leaflet,es,,Contenido del prospecto,120001.0,True,3
4220,120004,NAP,Package leaflet,es,1,Qué es X y para qué se utiliza,120001.0,True,4
4221,120005,NAP,Package leaflet,es,2,Qué necesita saber antes de empezar a <tomar><usar> X,120001.0,True,5
4222,120006,NAP,Package leaflet,es,,No <tome><use> X,120005.0,True,6
4223,120007,NAP,Package leaflet,es,,Advertencias y precauciones ,120005.0,True,7
4224,120008,NAP,Package leaflet,es,,Niños <y adolescentes>,120005.0,True,8
4225,120009,NAP,Package leaflet,es,,Otros medicamentos y X,120005.0,True,9
4226,120010,NAP,Package leaflet,es,,"<Uso><Toma> de X con <alimentos><y><,><bebidas><y><alcohol>",120005.0,True,10
4227,120011,NAP,Package leaflet,es,,"Embarazo <y><,> lactancia <y fertilidad>",120005.0,True,11
4228,120012,NAP,Package leaflet,es,,Conducción y uso de máquinas,120005.0,True,12
4229,120013,NAP,Package leaflet,es,,X contiene {nombre del (de los) excipiente(s)},120005.0,False,13
4230,120014,NAP,Package leaflet,es,3,Cómo <tomar><usar> X,120001.0,True,14
4231,120015,NAP,Package leaflet,es,,Uso en niños <y adolescentes>,120014.0,False,15
4232,120016,NAP,Package leaflet,es,,Si <toma><usa> más X del que debe,120014.0,False,16
4233,120017,NAP,Package leaflet,es,,Si olvidó <tomar><usar> X,120014.0,False,17
4234,120018,NAP,Package leaflet,es,,Si interrumpe el tratamiento con X,120014.0,False,18
4235,120019,NAP,Package leaflet,es,4,Posibles efectos adversos,120001.0,True,19
4236,120020,NAP,Package leaflet,es,,Otros efectos adversos en niños <y adolescentes>,120019.0,False,20
4237,120021,NAP,Package leaflet,es,,Comunicación de efectos adversos,120019.0,True,21
4238,120022,NAP,Package leaflet,es,5,Conservación de X,120001.0,True,22
4239,120023,NAP,Package leaflet,es,6,Contenido del envase e información adicional,120001.0,True,23
4240,120024,NAP,Package leaflet,es,,Composición de X ,120023.0,True,24
4241,120025,NAP,Package leaflet,es,,Aspecto del producto y contenido del envase,120023.0,True,25
4242,120026,NAP,Package leaflet,es,,Titular de la autorización de comercialización y responsable de la fabricación,120023.0,True,26
4243,120027,NAP,Package leaflet,es,,Este medicamento está autorizado en los estados miembros del Espacio Económico Europeo con los siguientes nombres:,120023.0,False,27
4244,120028,NAP,Package leaflet,es,,Fecha de la última revisión de este prospecto: <{MM/AAAA}><{mes AAAA}>.,120023.0,True,28
4245,120029,NAP,Package leaflet,es,,Otras fuentes de información,120023.0,False,29
4246,120030,NAP,Package leaflet,es,,Esta información está destinada únicamente a profesionales sanitarios:,120001.0,False,30
4247,121001,NAP,SmPC,et,,RAVIMI OMADUSTE KOKKUVÕTE,,True,1
4248,121002,NAP,SmPC,et,,"qSellele ravimile kohaldatakse täiendavat järelevalvet, mis võimaldab kiiresti tuvastada uut ohutusteavet. Tervishoiutöötajatel palutakse teatada kõigist võimalikest kõrvaltoimetest. Kõrvaltoimetest teatamise kohta vt lõik 4.8.>",121001.0,False,2
4249,121003,NAP,SmPC,et,1,RAVIMPREPARAADI NIMETUS,121001.0,True,3
4250,121004,NAP,SmPC,et,2,KVALITATIIVNE JA KVANTITATIIVNE KOOSTIS,121001.0,True,4
4251,121005,NAP,SmPC,et,,Teadaolevat toimet omav(ad) abiaine(d),121004.0,False,5
4252,121006,NAP,SmPC,et,3,RAVIMVORM,121001.0,True,6
4253,121007,NAP,SmPC,et,4,KLIINILISED ANDMED,121001.0,True,7
4254,121008,NAP,SmPC,et,4.1,Näidustused,121007.0,True,8
4255,121009,NAP,SmPC,et,4.2,Annustamine ja manustamisviis,121007.0,True,9
4256,121010,NAP,SmPC,et,,Annustamine,121009.0,True,10
4257,121011,NAP,SmPC,et,,Lapsed,121010.0,True,11
4258,121012,NAP,SmPC,et,,Manustamisviis,121009.0,True,12
4259,121013,NAP,SmPC,et,,Enne ravimi käsitsemist või manustamist tuleb järgida ettevaatusabinõusid,121012.0,False,13
4260,121014,NAP,SmPC,et,4.3,Vastunäidustused,121007.0,True,14
4261,121015,NAP,SmPC,et,4.4,Erihoiatused ja ettevaatusabinõud kasutamisel,121007.0,True,15
4262,121016,NAP,SmPC,et,,Jälgitavus,121015.0,False,16
4263,121017,NAP,SmPC,et,,Lapsed,121015.0,False,17
4264,121018,NAP,SmPC,et,4.5,Koostoimed teiste ravimitega ja muud koostoimed,121007.0,True,18
4265,121019,NAP,SmPC,et,,Lapsed,121018.0,False,19
4266,121020,NAP,SmPC,et,4.6,"Fertiilsus, rasedus ja imetamine",121007.0,True,20
4267,121021,NAP,SmPC,et,,Rasedus,121020.0,False,21
4268,121022,NAP,SmPC,et,,Imetamine,121020.0,False,22
4269,121023,NAP,SmPC,et,,Fertiilsus,121020.0,False,23
4270,121024,NAP,SmPC,et,4.7,Toime reaktsioonikiirusele,121007.0,True,24
4271,121025,NAP,SmPC,et,4.8,Kõrvaltoimed,121007.0,True,25
4272,121026,NAP,SmPC,et,,Lapsed,121025.0,False,26
4273,121027,NAP,SmPC,et,,Võimalikest kõrvaltoimetest teatamine,121025.0,True,27
4274,121028,NAP,SmPC,et,4.9,Üleannustamine,121007.0,True,28
4275,121029,NAP,SmPC,et,,Lapsed,121028.0,False,29
4276,121030,NAP,SmPC,et,5,FARMAKOLOOGILISED OMADUSED,121001.0,True,30
4277,121031,NAP,SmPC,et,5.1,Farmakodünaamilised omadused,121030.0,True,31
4278,121032,NAP,SmPC,et,,Toimemehhanism,121031.0,False,32
4279,121033,NAP,SmPC,et,,Farmakodünaamilised toimed,121031.0,False,33
4280,121034,NAP,SmPC,et,,Kliiniline efektiivsus ja ohutus,121031.0,False,34
4281,121035,NAP,SmPC,et,,Lapsed,121031.0,False,35
4282,121036,NAP,SmPC,et,5.2,Farmakokineetilised omadused,121030.0,True,36
4283,121037,NAP,SmPC,et,,Imendumine,121036.0,False,37
4284,121038,NAP,SmPC,et,,Jaotumine,121036.0,False,38
4285,121039,NAP,SmPC,et,,Biotransformatsioon,121036.0,False,39
4286,121040,NAP,SmPC,et,,Eritumine,121036.0,False,40
4287,121041,NAP,SmPC,et,,Lineaarsus/mittelineaarsus,121036.0,False,41
4288,121042,NAP,SmPC,et,,Farmakokineetilised/farmakodünaamilised toimed,121036.0,False,42
4289,121043,NAP,SmPC,et,5.3,Prekliinilised ohutusandmed,121030.0,True,43
4290,121044,NAP,SmPC,et,,Keskkonnariski hindamine,121043.0,False,44
4291,121045,NAP,SmPC,et,6,FARMATSEUTILISED ANDMED,121001.0,True,45
4292,121046,NAP,SmPC,et,6.1,Abiainete loetelu,121045.0,True,46
4293,121047,NAP,SmPC,et,6.2,Sobimatus,121045.0,True,47
4294,121048,NAP,SmPC,et,6.3,Kõlblikkusaeg,121045.0,True,48
4295,121049,NAP,SmPC,et,6.4,Säilitamise eritingimused,121045.0,True,49
4296,121050,NAP,SmPC,et,6.5,Pakendi iseloomustus ja sisu,121045.0,True,50
4297,121051,NAP,SmPC,et,6.6,Erihoiatused ravimpreparaadi hävitamiseks <ja käsitlemiseks>,121045.0,True,51
4298,121052,NAP,SmPC,et,,Kasutamine lastel,121051.0,False,52
4299,121053,NAP,SmPC,et,7,MÜÜGILOA HOIDJA,121001.0,True,53
4300,121054,NAP,SmPC,et,8,MÜÜGILOA NUMBER (NUMBRID) ,121001.0,True,54
4301,121055,NAP,SmPC,et,9,ESMASE MÜÜGILOA VÄLJASTAMISE/MÜÜGILOA UUENDAMISE KUUPÄEV,121001.0,True,55
4302,121056,NAP,SmPC,et,10,TEKSTI LÄBIVAATAMISE KUUPÄEV,121001.0,True,56
4303,121057,NAP,SmPC,et,11,DOSIMEETRIA,121001.0,False,57
4304,121058,NAP,SmPC,et,12,RADIOFARMATSEUTILISE PREPARAADI VALMISTAMISE JUHEND,121001.0,False,58
4305,122001,NAP,Labelling,et,,PAKENDI MÄRGISTUS,,True,1
4306,122002,NAP,Labelling,et,,<VÄLISPAKENDIL> <JA> <SISEPAKENDIL> PEAVAD OLEMA JÄRGMISED ANDMED,122001.0,True,2
4307,122003,NAP,Labelling,et,1,RAVIMPREPARAADI NIMETUS,122002.0,True,3
4308,122004,NAP,Labelling,et,2,TOIMEAINE(TE) SISALDUS,122002.0,True,4
4309,122005,NAP,Labelling,et,3,ABIAINED,122002.0,True,5
4310,122006,NAP,Labelling,et,4,RAVIMVORM JA PAKENDI SUURUS,122002.0,True,6
4311,122007,NAP,Labelling,et,5,MANUSTAMISVIIS JA -TEE(D),122002.0,True,7
4312,122008,NAP,Labelling,et,6,"ERIHOIATUS, ET RAVIMIT TULEB HOIDA LASTE EEST VARJATUD JA KÄTTESAAMATUS KOHAS",122002.0,True,8
4313,122009,NAP,Labelling,et,7,TEISED ERIHOIATUSED (VAJADUSEL),122002.0,True,9
4314,122010,NAP,Labelling,et,8,KÕLBLIKKUSAEG,122002.0,True,10
4315,122011,NAP,Labelling,et,9,SÄILITAMISE ERITINGIMUSED,122002.0,True,11
4316,122012,NAP,Labelling,et,10,"ERINÕUDED KASUTAMATA JÄÄNUD RAVIMPREPARAADI VÕI SELLEST TEKKINUD JÄÄTMEMATERJALI HÄVITAMISEKS, VASTAVALT VAJADUSELE",122002.0,True,12
4317,122013,NAP,Labelling,et,11,MÜÜGILOA HOIDJA NIMI JA AADRESS,122002.0,True,13
4318,122014,NAP,Labelling,et,12,MÜÜGILOA NUMBER (NUMBRID),122002.0,True,14
4319,122015,NAP,Labelling,et,13,PARTII NUMBER,122002.0,True,15
4320,122016,NAP,Labelling,et,14,RAVIMI VÄLJASTAMISTINGIMUSED,122002.0,True,16
4321,122017,NAP,Labelling,et,15,KASUTUSJUHEND,122002.0,True,17
4322,122018,NAP,Labelling,et,16,TEAVE BRAILLE’ KIRJAS (PUNKTKIRJAS),122002.0,True,18
4323,122019,NAP,Labelling,et,17,AINULAADNE IDENTIFIKAATOR – 2D-vöötkood,122002.0,True,19
4324,122020,NAP,Labelling,et,18,AINULAADNE IDENTIFIKAATOR – INIMLOETAVAD ANDMED,122002.0,True,20
4325,122021,NAP,Labelling,et,,"MINIMAALSED ANDMED, MIS PEAVAD OLEMA BLISTER- VÕI RIBAPAKENDIL",122001.0,True,21
4326,122022,NAP,Labelling,et,1,RAVIMPREPARAADI NIMETUS,122021.0,True,22
4327,122023,NAP,Labelling,et,2,MÜÜGILOA HOIDJA NIMI,122021.0,True,23
4328,122024,NAP,Labelling,et,3,KÕLBLIKKUSAEG,122021.0,True,24
4329,122025,NAP,Labelling,et,4,PARTII NUMBER ,122021.0,True,25
4330,122026,NAP,Labelling,et,5,MUU,122021.0,True,26
4331,122027,NAP,Labelling,et,,"MINIMAALSED ANDMED, MIS PEAVAD OLEMA VÄIKESEL VAHETUL SISEPAKENDIL",122001.0,True,27
4332,122028,NAP,Labelling,et,1,RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE(D),122027.0,True,28
4333,122029,NAP,Labelling,et,2,MANUSTAMISVIIS,122027.0,True,29
4334,122030,NAP,Labelling,et,3,KÕLBLIKKUSAEG,122027.0,True,30
4335,122031,NAP,Labelling,et,4,PARTII NUMBER ,122027.0,True,31
4336,122032,NAP,Labelling,et,5,"PAKENDI SISU KAALU, MAHU VÕI ÜHIKUTE JÄRGI",122027.0,True,32
4337,122033,NAP,Labelling,et,6,MUU,122027.0,True,33
4338,123001,NAP,Package leaflet,et,,PAKENDI INFOLEHT,,True,1
4339,123002,NAP,Package leaflet,et,,"qSellele ravimile kohaldatakse täiendavat järelevalvet, mis võimaldab kiiresti tuvastada uut ohutusteavet. Te saate sellele kaasa aidata, teatades ravimi kõigist võimalikest kõrvaltoimetest. Kõrvaltoimetest teatamise kohta vt lõik 4.> ",123001.0,False,2
4340,123003,NAP,Package leaflet,et,,Infolehe sisukord,123001.0,True,3
4341,123004,NAP,Package leaflet,et,1,Mis ravim on X ja milleks seda kasutatakse,123001.0,True,4
4342,123005,NAP,Package leaflet,et,2,Mida on vaja teada enne X’i <võtmist> <kasutamist> ,123001.0,True,5
4343,123006,NAP,Package leaflet,et,,X’i ei tohi <võtta> <kasutada>,123005.0,True,6
4344,123007,NAP,Package leaflet,et,,Hoiatused ja ettevaatusabinõud,123005.0,True,7
4345,123008,NAP,Package leaflet,et,,Lapsed <ja noorukid>,123005.0,True,8
4346,123009,NAP,Package leaflet,et,,Muud ravimid ja X,123005.0,True,9
4347,123010,NAP,Package leaflet,et,,"X koos <toidu> <ja> <,> <joogi> <ja> <alkoholiga>",123005.0,True,10
4348,123011,NAP,Package leaflet,et,,"Rasedus <ja> <,> imetamine <ja viljakus>",123005.0,True,11
4349,123012,NAP,Package leaflet,et,,Autojuhtimine ja masinatega töötamine,123005.0,True,12
4350,123013,NAP,Package leaflet,et,,X sisaldab {abiaine(te) nimetus},123005.0,False,13
4351,123014,NAP,Package leaflet,et,3,Kuidas X’i <võtta> <kasutada>,123001.0,True,14
4352,123015,NAP,Package leaflet,et,,Kasutamine lastel <ja noorukitel>,123014.0,False,15
4353,123016,NAP,Package leaflet,et,,"Kui te <võtate> <kasutate> X’i rohkem, kui ette nähtud",123014.0,False,16
4354,123017,NAP,Package leaflet,et,,Kui te unustate X’i <võtta> <kasutada>,123014.0,False,17
4355,123018,NAP,Package leaflet,et,,Kui te lõpetate X’i <võtmise> <kasutamise>,123014.0,False,18
4356,123019,NAP,Package leaflet,et,4,Võimalikud kõrvaltoimed,123001.0,True,19
4357,123020,NAP,Package leaflet,et,,Täiendavad kõrvaltoimed lastel <ja noorukitel>,123019.0,False,20
4358,123021,NAP,Package leaflet,et,,Kõrvaltoimetest teatamine,123019.0,True,21
4359,123022,NAP,Package leaflet,et,5,Kuidas X’i säilitada,123001.0,True,22
4360,123023,NAP,Package leaflet,et,6,Pakendi sisu ja muu teave,123001.0,True,23
4361,123024,NAP,Package leaflet,et,,Mida X sisaldab,123023.0,True,24
4362,123025,NAP,Package leaflet,et,,Kuidas X välja näeb ja pakendi sisu,123023.0,True,25
4363,123026,NAP,Package leaflet,et,,Müügiloa hoidja ja tootja,123023.0,True,26
4364,123027,NAP,Package leaflet,et,,See ravimpreparaat on saanud müügiloa Euroopa Majanduspiirkonna liikmesriikides järgmiste nimetustega:,123023.0,False,27
4365,123028,NAP,Package leaflet,et,,Infoleht on viimati uuendatud <KK.AAAA> <kuu AAAA>.,123023.0,True,28
4366,123029,NAP,Package leaflet,et,,Muud teabeallikad,123023.0,False,29
4367,123030,NAP,Package leaflet,et,,Järgmine teave on ainult tervishoiutöötajatele:,123001.0,False,30
4368,124001,NAP,SmPC,fi,,VALMISTEYHTEENVETO,,True,1
4369,124002,NAP,SmPC,fi,,"qTähän lääkevalmisteeseen kohdistuu lisäseuranta. Tällä tavalla voidaan havaita nopeasti turvallisuutta koskevaa uutta tietoa. Terveydenhuollon ammattilaisia pyydetään ilmoittamaan epäillyistä lääkkeen haittavaikutuksista. Ks. kohdasta 4.8, miten haittavaikutuksista ilmoitetaan.",124001.0,False,2
4370,124003,NAP,SmPC,fi,1,LÄÄKEVALMISTEEN NIMI,124001.0,True,3
4371,124004,NAP,SmPC,fi,2,VAIKUTTAVAT AINEET JA NIIDEN MÄÄRÄT,124001.0,True,4
4372,124005,NAP,SmPC,fi,,"Apuaine(et), joiden vaikutus tunnetaan",124004.0,False,5
4373,124006,NAP,SmPC,fi,3,LÄÄKEMUOTO,124001.0,True,6
4374,124007,NAP,SmPC,fi,4,KLIINISET TIEDOT,124001.0,True,7
4375,124008,NAP,SmPC,fi,4.1,Käyttöaiheet,124007.0,True,8
4376,124009,NAP,SmPC,fi,4.2,Annostus ja antotapa,124007.0,True,9
4377,124010,NAP,SmPC,fi,,Annostus,124009.0,True,10
4378,124011,NAP,SmPC,fi,,Pediatriset potilaat,124010.0,True,11
4379,124012,NAP,SmPC,fi,,Antotapa,124009.0,True,12
4380,124013,NAP,SmPC,fi,,Ennen lääkkeen käsittelyä tai antoa huomioon otettavat varotoimet,124012.0,False,13
4381,124014,NAP,SmPC,fi,4.3,Vasta-aiheet,124007.0,True,14
4382,124015,NAP,SmPC,fi,4.4,Varoitukset ja käyttöön liittyvät varotoimet,124007.0,True,15
4383,124016,NAP,SmPC,fi,,Jäljitettävyys,124015.0,False,16
4384,124017,NAP,SmPC,fi,,Pediatriset potilaat,124015.0,False,17
4385,124018,NAP,SmPC,fi,4.5,Yhteisvaikutukset muiden lääkevalmisteiden kanssa sekä muut yhteisvaikutukset,124007.0,True,18
4386,124019,NAP,SmPC,fi,,Pediatriset potilaat,124018.0,False,19
4387,124020,NAP,SmPC,fi,4.6,"Hedelmällisyys, raskaus ja imetys",124007.0,True,20
4388,124021,NAP,SmPC,fi,,Raskaus,124020.0,False,21
4389,124022,NAP,SmPC,fi,,Imetys,124020.0,False,22
4390,124023,NAP,SmPC,fi,,Hedelmällisyys,124020.0,False,23
4391,124024,NAP,SmPC,fi,4.7,Vaikutus ajokykyyn ja koneidenkäyttökykyyn,124007.0,True,24
4392,124025,NAP,SmPC,fi,4.8,Haittavaikutukset,124007.0,True,25
4393,124026,NAP,SmPC,fi,,Pediatriset potilaat,124025.0,False,26
4394,124027,NAP,SmPC,fi,,Epäillyistä haittavaikutuksista ilmoittaminen,124025.0,True,27
4395,124028,NAP,SmPC,fi,4.9,Yliannostus,124007.0,True,28
4396,124029,NAP,SmPC,fi,,Pediatriset potilaat,124028.0,False,29
4397,124030,NAP,SmPC,fi,5,FARMAKOLOGISET OMINAISUUDET,124001.0,True,30
4398,124031,NAP,SmPC,fi,5.1,Farmakodynamiikka,124030.0,True,31
4399,124032,NAP,SmPC,fi,,Vaikutusmekanismi,124031.0,False,32
4400,124033,NAP,SmPC,fi,,Farmakodynaamiset vaikutukset,124031.0,False,33
4401,124034,NAP,SmPC,fi,,Kliininen teho ja turvallisuus,124031.0,False,34
4402,124035,NAP,SmPC,fi,,Pediatriset potilaat,124031.0,False,35
4403,124036,NAP,SmPC,fi,5.2,Farmakokinetiikka,124030.0,True,36
4404,124037,NAP,SmPC,fi,,Imeytyminen,124036.0,False,37
4405,124038,NAP,SmPC,fi,,Jakautuminen,124036.0,False,38
4406,124039,NAP,SmPC,fi,,Biotransformaatio,124036.0,False,39
4407,124040,NAP,SmPC,fi,,Eliminaatio,124036.0,False,40
4408,124041,NAP,SmPC,fi,,Lineaarisuus/ei-lineaarisuus,124036.0,False,41
4409,124042,NAP,SmPC,fi,,Farmakokineettiset/farmakodynaamiset suhteet,124036.0,False,42
4410,124043,NAP,SmPC,fi,5.3,Prekliiniset tiedot turvallisuudesta,124030.0,True,43
4411,124044,NAP,SmPC,fi,,Ympäristöön kohdistuvien riskien arviointi,124043.0,False,44
4412,124045,NAP,SmPC,fi,6,FARMASEUTTISET TIEDOT,124001.0,True,45
4413,124046,NAP,SmPC,fi,6.1,Apuaineet,124045.0,True,46
4414,124047,NAP,SmPC,fi,6.2,Yhteensopimattomuudet,124045.0,True,47
4415,124048,NAP,SmPC,fi,6.3,Kestoaika,124045.0,True,48
4416,124049,NAP,SmPC,fi,6.4,Säilytys ,124045.0,True,49
4417,124050,NAP,SmPC,fi,6.5,Pakkaustyyppi ja pakkauskoko (pakkauskoot),124045.0,True,50
4418,124051,NAP,SmPC,fi,6.6,Erityiset varotoimet hävittämiselle <ja muut käsittelyohjeet>,124045.0,True,51
4419,124052,NAP,SmPC,fi,,Käyttö pediatrisille potilaille,124051.0,False,52
4420,124053,NAP,SmPC,fi,7,MYYNTILUVAN HALTIJA,124001.0,True,53
4421,124054,NAP,SmPC,fi,8,MYYNTILUVAN NUMERO(T),124001.0,True,54
4422,124055,NAP,SmPC,fi,9,MYYNTILUVAN MYÖNTÄMISPÄIVÄMÄÄRÄ/UUDISTAMISPÄIVÄMÄÄRÄ,124001.0,True,55
4423,124056,NAP,SmPC,fi,10,TEKSTIN MUUTTAMISPÄIVÄMÄÄRÄ,124001.0,True,56
4424,124057,NAP,SmPC,fi,11,DOSIMETRIA ,124001.0,False,57
4425,124058,NAP,SmPC,fi,12,RADIOFARMASEUTTISTEN VALMISTEIDEN VALMISTUSOHJEET,124001.0,False,58
4426,125001,NAP,Labelling,fi,,MYYNTIPÄÄLLYSMERKINNÄT,,True,1
4427,125002,NAP,Labelling,fi,,<ULKOPAKKAUKSESSA> <JA> <SISÄPAKKAUKSESSA> ON OLTAVA SEURAAVAT MERKINNÄT,125001.0,True,2
4428,125003,NAP,Labelling,fi,1,LÄÄKEVALMISTEEN NIMI,125002.0,True,3
4429,125004,NAP,Labelling,fi,2,VAIKUTTAVA(T) AINE(ET),125002.0,True,4
4430,125005,NAP,Labelling,fi,3,LUETTELO APUAINEISTA,125002.0,True,5
4431,125006,NAP,Labelling,fi,4,LÄÄKEMUOTO JA SISÄLLÖN MÄÄRÄ,125002.0,True,6
4432,125007,NAP,Labelling,fi,5,ANTOTAPA JA TARVITTAESSA ANTOREITTI (ANTOREITIT),125002.0,True,7
4433,125008,NAP,Labelling,fi,6,ERITYISVAROITUS VALMISTEEN SÄILYTTÄMISESTÄ POISSA LASTEN ULOTTUVILTA JA NÄKYVILTÄ,125002.0,True,8
4434,125009,NAP,Labelling,fi,7,"MUU ERITYISVAROITUS (MUUT ERITYISVAROITUKSET), JOS TARPEEN",125002.0,True,9
4435,125010,NAP,Labelling,fi,8,VIIMEINEN KÄYTTÖPÄIVÄMÄÄRÄ,125002.0,True,10
4436,125011,NAP,Labelling,fi,9,ERITYISET SÄILYTYSOLOSUHTEET,125002.0,True,11
4437,125012,NAP,Labelling,fi,10,"ERITYISET VAROTOIMET KÄYTTÄMÄTTÖMIEN LÄÄKEVALMISTEIDEN TAI NIISTÄ PERÄISIN OLEVAN JÄTEMATERIAALIN HÄVITTÄMISEKSI, JOS TARPEEN",125002.0,True,12
4438,125013,NAP,Labelling,fi,11,MYYNTILUVAN HALTIJAN NIMI JA OSOITE,125002.0,True,13
4439,125014,NAP,Labelling,fi,12,MYYNTILUVAN NUMERO(T),125002.0,True,14
4440,125015,NAP,Labelling,fi,13,ERÄNUMERO ,125002.0,True,15
4441,125016,NAP,Labelling,fi,14,YLEINEN TOIMITTAMISLUOKITTELU,125002.0,True,16
4442,125017,NAP,Labelling,fi,15,KÄYTTÖOHJEET,125002.0,True,17
4443,125018,NAP,Labelling,fi,16,TIEDOT PISTEKIRJOITUKSELLA ,125002.0,True,18
4444,125019,NAP,Labelling,fi,17,YKSILÖLLINEN TUNNISTE – 2D-VIIVAKOODI,125002.0,True,19
4445,125020,NAP,Labelling,fi,18,YKSILÖLLINEN TUNNISTE – LUETTAVISSA OLEVAT TIEDOT,125002.0,True,20
4446,125021,NAP,Labelling,fi,,LÄPIPAINOPAKKAUKSISSA TAI LEVYISSÄ ON OLTAVA VÄHINTÄÄN SEURAAVAT MERKINNÄT,125001.0,True,21
4447,125022,NAP,Labelling,fi,1,LÄÄKEVALMISTEEN NIMI,125021.0,True,22
4448,125023,NAP,Labelling,fi,2,MYYNTILUVAN HALTIJAN NIMI,125021.0,True,23
4449,125024,NAP,Labelling,fi,3,VIIMEINEN KÄYTTÖPÄIVÄMÄÄRÄ,125021.0,True,24
4450,125025,NAP,Labelling,fi,4,ERÄNUMERO,125021.0,True,25
4451,125026,NAP,Labelling,fi,5,MUUTA,125021.0,True,26
4452,125027,NAP,Labelling,fi,,PIENISSÄ SISÄPAKKAUKSISSA ON OLTAVA VÄHINTÄÄN SEURAAVAT MERKINNÄT,125001.0,True,27
4453,125028,NAP,Labelling,fi,1,LÄÄKEVALMISTEEN NIMI JA TARVITTAESSA ANTOREITTI (ANTOREITIT),125027.0,True,28
4454,125029,NAP,Labelling,fi,2,ANTOTAPA,125027.0,True,29
4455,125030,NAP,Labelling,fi,3,VIIMEINEN KÄYTTÖPÄIVÄMÄÄRÄ,125027.0,True,30
4456,125031,NAP,Labelling,fi,4,ERÄNUMERO,125027.0,True,31
4457,125032,NAP,Labelling,fi,5,"SISÄLLÖN MÄÄRÄ PAINONA, TILAVUUTENA TAI YKSIKKÖINÄ",125027.0,True,32
4458,125033,NAP,Labelling,fi,6,MUUTA,125027.0,True,33
4459,126001,NAP,Package leaflet,fi,,PAKKAUSSELOSTE,,True,1
4460,126002,NAP,Package leaflet,fi,,"q Tähän lääkevalmisteeseen kohdistuu lisäseuranta. Tällä tavalla voidaan havaita nopeasti turvallisuutta koskevaa uutta tietoa. Voit auttaa ilmoittamalla kaikista mahdollisesti saamistasi haittavaikutuksista. Ks. kohdan 4 lopusta, miten haittavaikutuksista ilmoitetaan",126001.0,False,2
4461,126003,NAP,Package leaflet,fi,,Tässä pakkausselosteessa kerrotaan:,126001.0,True,3
4462,126004,NAP,Package leaflet,fi,1,Mitä X on ja mihin sitä käytetään,126001.0,True,4
4463,126005,NAP,Package leaflet,fi,2,"Mitä sinun on tiedettävä, ennen kuin <otat> <käytät> <X:ää> <X-valmistetta>",126001.0,True,5
4464,126006,NAP,Package leaflet,fi,,Älä <ota> <käytä> <X:ää> <X-valmistetta>,126005.0,True,6
4465,126007,NAP,Package leaflet,fi,,Varoitukset ja varotoimet,126005.0,True,7
4466,126008,NAP,Package leaflet,fi,,Lapset <ja nuoret>,126005.0,True,8
4467,126009,NAP,Package leaflet,fi,,Muut lääkevalmisteet ja X,126005.0,True,9
4468,126010,NAP,Package leaflet,fi,,"X <ruuan> <ja> <,> <juoman> <ja> <alkoholin> kanssa",126005.0,True,10
4469,126011,NAP,Package leaflet,fi,,"Raskaus <ja> <,> imetys <ja hedelmällisyys>",126005.0,True,11
4470,126012,NAP,Package leaflet,fi,,Ajaminen ja koneiden käyttö,126005.0,True,12
4471,126013,NAP,Package leaflet,fi,,X sisältää {apuaineen(apuaineiden) nimi(nimet)},126005.0,False,13
4472,126014,NAP,Package leaflet,fi,3,Miten <X:ää> <X-valmistetta> <otetaan> <käytetään>,126001.0,True,14
4473,126015,NAP,Package leaflet,fi,,Käyttö lapsille <ja nuorille>,126014.0,False,15
4474,126016,NAP,Package leaflet,fi,,Jos <otat> <käytät> enemmän <X:ää> <X-valmistetta> kuin sinun pitäisi,126014.0,False,16
4475,126017,NAP,Package leaflet,fi,,Jos unohdat <ottaa> <käyttää> <X:ää> <X-valmistetta>,126014.0,False,17
4476,126018,NAP,Package leaflet,fi,,Jos lopetat <X:n> <X-valmisteen> <oton> <käytön>,126014.0,False,18
4477,126019,NAP,Package leaflet,fi,4,Mahdolliset haittavaikutukset,126001.0,True,19
4478,126020,NAP,Package leaflet,fi,,Muut haittavaikutukset lapsilla <ja nuorilla>,126019.0,False,20
4479,126021,NAP,Package leaflet,fi,,Haittavaikutuksista ilmoittaminen,126019.0,True,21
4480,126022,NAP,Package leaflet,fi,5,<X:n> <X-valmisteen> säilyttäminen,126001.0,True,22
4481,126023,NAP,Package leaflet,fi,6,Pakkauksen sisältö ja muuta tietoa,126001.0,True,23
4482,126024,NAP,Package leaflet,fi,,Mitä X sisältää,126023.0,True,24
4483,126025,NAP,Package leaflet,fi,,Lääkevalmisteen kuvaus ja pakkauskoko (-koot),126023.0,True,25
4484,126026,NAP,Package leaflet,fi,,Myyntiluvan haltija ja valmistaja,126023.0,True,26
4485,126027,NAP,Package leaflet,fi,,Tällä lääkevalmisteella on myyntilupa Euroopan talousalueeseen kuuluvissa jäsenvaltioissa seuraavilla kauppanimillä:,126023.0,False,27
4486,126028,NAP,Package leaflet,fi,,Tämä pakkausseloste on tarkistettu viimeksi <{KK.VVVV}> <{kuukausi VVVV}>.,126023.0,True,28
4487,126029,NAP,Package leaflet,fi,,Muut tiedonlähteet,126023.0,False,29
4488,126030,NAP,Package leaflet,fi,,Seuraavat tiedot on tarkoitettu vain terveydenhuollon ammattilaisille:,126001.0,False,30
4489,127001,NAP,SmPC,fr,,RÉSUMÉ DES CARACTÉRISTIQUES DU PRODUIT,,True,1
4490,127002,NAP,SmPC,fr,,qCe médicament fait l'objet d'une surveillance supplémentaire qui permettra l'identification rapide de nouvelles informations relatives à la sécurité. Les professionnels de la santé déclarent tout effet indésirable suspecté. Voir rubrique 4.8 pour les modalités de déclaration des effets indésirables.>,127001.0,False,2
4491,127003,NAP,SmPC,fr,1,DÉNOMINATION DU MÉDICAMENT,127001.0,True,3
4492,127004,NAP,SmPC,fr,2,COMPOSITION QUALITATIVE ET QUANTITATIVE,127001.0,True,4
4493,127005,NAP,SmPC,fr,,Excipient(s) à effet notoire:,127004.0,False,5
4494,127006,NAP,SmPC,fr,3,FORME PHARMACEUTIQUE,127001.0,True,6
4495,127007,NAP,SmPC,fr,4,INFORMATIONS CLINIQUES,127001.0,True,7
4496,127008,NAP,SmPC,fr,4.1,Indications thérapeutiques,127007.0,True,8
4497,127009,NAP,SmPC,fr,4.2,Posologie et mode d’administration,127007.0,True,9
4498,127010,NAP,SmPC,fr,,Posologie,127009.0,True,10
4499,127011,NAP,SmPC,fr,,Population pédiatrique,127010.0,True,11
4500,127012,NAP,SmPC,fr,,Mode d’administration,127009.0,True,12
4501,127013,NAP,SmPC,fr,,Précautions à prendre avant la manipulation ou l’administration du médicament,127012.0,False,13
4502,127014,NAP,SmPC,fr,4.3,Contre-indications,127007.0,True,14
4503,127015,NAP,SmPC,fr,4.4,Mises en garde spéciales et précautions d’emploi,127007.0,True,15
4504,127016,NAP,SmPC,fr,,Traçabilité,127015.0,False,16
4505,127017,NAP,SmPC,fr,,Population pédiatrique,127015.0,False,17
4506,127018,NAP,SmPC,fr,4.5,Interactions avec d’autres médicaments et autres formes d’interactions,127007.0,True,18
4507,127019,NAP,SmPC,fr,,Population pédiatrique,127018.0,False,19
4508,127020,NAP,SmPC,fr,4.6,"Fertilité, grossesse et allaitement",127007.0,True,20
4509,127021,NAP,SmPC,fr,,Grossesse,127020.0,False,21
4510,127022,NAP,SmPC,fr,,Allaitement,127020.0,False,22
4511,127023,NAP,SmPC,fr,,Fertilité,127020.0,False,23
4512,127024,NAP,SmPC,fr,4.7,Effets sur l’aptitude à conduire des véhicules et à utiliser des machines,127007.0,True,24
4513,127025,NAP,SmPC,fr,4.8,Effets indésirables,127007.0,True,25
4514,127026,NAP,SmPC,fr,,Population pédiatrique,127025.0,False,26
4515,127027,NAP,SmPC,fr,,Déclaration des effets indésirables suspectés,127025.0,True,27
4516,127028,NAP,SmPC,fr,4.9,Surdosage,127007.0,True,28
4517,127029,NAP,SmPC,fr,,Population pédiatrique,127028.0,False,29
4518,127030,NAP,SmPC,fr,5,PROPRIÉTÉS PHARMACOLOGIQUES,127001.0,True,30
4519,127031,NAP,SmPC,fr,5.1,Propriétés pharmacodynamiques ,127030.0,True,31
4520,127032,NAP,SmPC,fr,,Mécanisme d’action,127031.0,False,32
4521,127033,NAP,SmPC,fr,,Effets pharmacodynamiques,127031.0,False,33
4522,127034,NAP,SmPC,fr,,Efficacité et sécurité cliniques,127031.0,False,34
4523,127035,NAP,SmPC,fr,,Population pédiatrique,127031.0,False,35
4524,127036,NAP,SmPC,fr,5.2,Propriétés pharmacocinétiques,127030.0,True,36
4525,127037,NAP,SmPC,fr,,Absorption,127036.0,False,37
4526,127038,NAP,SmPC,fr,,Distribution,127036.0,False,38
4527,127039,NAP,SmPC,fr,,Biotransformation,127036.0,False,39
4528,127040,NAP,SmPC,fr,,Élimination,127036.0,False,40
4529,127041,NAP,SmPC,fr,,Linéarité/non-linéarité,127036.0,False,41
4530,127042,NAP,SmPC,fr,,Relations pharmacocinétique/pharmacodynamique,127036.0,False,42
4531,127043,NAP,SmPC,fr,5.3,Données de sécurité préclinique,127030.0,True,43
4532,127044,NAP,SmPC,fr,,Évaluation du risque environnemental,127043.0,False,44
4533,127045,NAP,SmPC,fr,6,DONNÉES PHARMACEUTIQUES,127001.0,True,45
4534,127046,NAP,SmPC,fr,6.1,Liste des excipients,127045.0,True,46
4535,127047,NAP,SmPC,fr,6.2,Incompatibilités,127045.0,True,47
4536,127048,NAP,SmPC,fr,6.3,Durée de conservation,127045.0,True,48
4537,127049,NAP,SmPC,fr,6.4,Précautions particulières de conservation,127045.0,True,49
4538,127050,NAP,SmPC,fr,6.5,Nature et contenu de l’emballage extérieur,127045.0,True,50
4539,127051,NAP,SmPC,fr,6.6,Précautions particulières d’élimination <et manipulation>,127045.0,True,51
4540,127052,NAP,SmPC,fr,,Utilisation dans la population pédiatrique,127051.0,False,52
4541,127053,NAP,SmPC,fr,7,TITULAIRE DE L’AUTORISATION DE MISE SUR LE MARCHÉ,127001.0,True,53
4542,127054,NAP,SmPC,fr,8,NUMÉRO(S) D’AUTORISATION DE MISE SUR LE MARCHÉ ,127001.0,True,54
4543,127055,NAP,SmPC,fr,9,DATE DE PREMIÈRE AUTORISATION/DE RENOUVELLEMENT DE L’AUTORISATION,127001.0,True,55
4544,127056,NAP,SmPC,fr,10,DATE DE MISE À JOUR DU TEXTE,127001.0,True,56
4545,127057,NAP,SmPC,fr,11,DOSIMÉTRIE,127001.0,False,57
4546,127058,NAP,SmPC,fr,12,INSTRUCTIONS POUR LA PRÉPARATION DES RADIOPHARMACEUTIQUES,127001.0,False,58
4547,128001,NAP,Labelling,fr,,ÉTIQUETAGE,,True,1
4548,128002,NAP,Labelling,fr,,MENTIONS DEVANT FIGURER SUR <L’EMBALLAGE EXTÉRIEUR> <ET SUR> <LE CONDITIONNEMENT PRIMAIRE>,128001.0,True,2
4549,128003,NAP,Labelling,fr,1,DÉNOMINATION DU MÉDICAMENT,128002.0,True,3
4550,128004,NAP,Labelling,fr,2,COMPOSITION EN SUBSTANCE(S) ACTIVE(S),128002.0,True,4
4551,128005,NAP,Labelling,fr,3,LISTE DES EXCIPIENTS,128002.0,True,5
4552,128006,NAP,Labelling,fr,4,FORME PHARMACEUTIQUE ET CONTENU,128002.0,True,6
4553,128007,NAP,Labelling,fr,5,MODE ET VOIE(S) D’ADMINISTRATION,128002.0,True,7
4554,128008,NAP,Labelling,fr,6,MISE EN GARDE SPÉCIALE INDIQUANT QUE LE MÉDICAMENT DOIT ÊTRE CONSERVÉ HORS DE VUE ET DE PORTÉE DES ENFANTS,128002.0,True,8
4555,128009,NAP,Labelling,fr,7,"AUTRE(S) MISE(S) EN GARDE SPÉCIALE(S), SI NÉCESSAIRE",128002.0,True,9
4556,128010,NAP,Labelling,fr,8,DATE DE PÉREMPTION,128002.0,True,10
4557,128011,NAP,Labelling,fr,9,PRÉCAUTIONS PARTICULIÈRES DE CONSERVATION,128002.0,True,11
4558,128012,NAP,Labelling,fr,10,PRÉCAUTIONS PARTICULIÈRES D’ÉLIMINATION DES MÉDICAMENTS NON UTILISÉS OU DES DÉCHETS PROVENANT DE CES MÉDICAMENTS S’IL Y A LIEU,128002.0,True,12
4559,128013,NAP,Labelling,fr,11,NOM ET ADRESSE DU TITULAIRE DE L’AUTORISATION DE MISE SUR LE MARCHÉ,128002.0,True,13
4560,128014,NAP,Labelling,fr,12,NUMÉRO(S) D’AUTORISATION DE MISE SUR LE MARCHÉ,128002.0,True,14
4561,128015,NAP,Labelling,fr,13,NUMÉRO DU LOT,128002.0,True,15
4562,128016,NAP,Labelling,fr,14,CONDITIONS DE PRESCRIPTION ET DE DÉLIVRANCE,128002.0,True,16
4563,128017,NAP,Labelling,fr,15,INDICATIONS D’UTILISATION,128002.0,True,17
4564,128018,NAP,Labelling,fr,16,INFORMATIONS EN BRAILLE,128002.0,True,18
4565,128019,NAP,Labelling,fr,17,IDENTIFIANT UNIQUE - CODE-BARRES 2D,128002.0,True,19
4566,128020,NAP,Labelling,fr,18,IDENTIFIANT UNIQUE - DONNÉES LISIBLES PAR LES HUMAINS,128002.0,True,20
4567,128021,NAP,Labelling,fr,,MENTIONS MINIMALES DEVANT FIGURER SUR LES PLAQUETTES OU LES FILMS THERMOSOUDÉS,128001.0,True,21
4568,128022,NAP,Labelling,fr,1,DÉNOMINATION DU MÉDICAMENT,128021.0,True,22
4569,128023,NAP,Labelling,fr,2,NOM DU TITULAIRE DE L’AUTORISATION DE MISE SUR LE MARCHÉ,128021.0,True,23
4570,128024,NAP,Labelling,fr,3,DATE DE PÉREMPTION,128021.0,True,24
4571,128025,NAP,Labelling,fr,4,NUMÉRO DU LOT,128021.0,True,25
4572,128026,NAP,Labelling,fr,5,AUTRE,128021.0,True,26
4573,128027,NAP,Labelling,fr,,MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES,128001.0,True,27
4574,128028,NAP,Labelling,fr,1,DÉNOMINATION DU MÉDICAMENT ET VOIE(S) D’ADMINISTRATION,128027.0,True,28
4575,128029,NAP,Labelling,fr,2,MODE D’ADMINISTRATION,128027.0,True,29
4576,128030,NAP,Labelling,fr,3,DATE DE PÉREMPTION,128027.0,True,30
4577,128031,NAP,Labelling,fr,4,NUMÉRO DU LOT,128027.0,True,31
4578,128032,NAP,Labelling,fr,5,"CONTENU EN POIDS, VOLUME OU UNITÉ",128027.0,True,32
4579,128033,NAP,Labelling,fr,6,AUTRE,128027.0,True,33
4580,129001,NAP,Package leaflet,fr,,NOTICE,,True,1
4581,129002,NAP,Package leaflet,fr,,qCe médicament fait l'objet d'une surveillance supplémentaire qui permettra l'identification rapide de nouvelles informations relatives à la sécurité. Vous pouvez y contribuer en signalant tout effet indésirable que vous observez. Voir en fin de rubrique 4 comment déclarer les effets indésirables. ,129001.0,False,2
4582,129003,NAP,Package leaflet,fr,,Que contient cette notice?:,129001.0,True,3
4583,129004,NAP,Package leaflet,fr,1,Qu’est-ce que X et dans quels cas est-il utilisé,129001.0,True,4
4584,129005,NAP,Package leaflet,fr,2,Quelles sont les informations à connaître avant <de prendre> <d’utiliser> ,129001.0,True,5
4585,129006,NAP,Package leaflet,fr,,<Ne prenez> <N’utilisez> jamais X,129005.0,True,6
4586,129007,NAP,Package leaflet,fr,,Avertissements et précautions ,129005.0,True,7
4587,129008,NAP,Package leaflet,fr,,Enfants <et adolescents>,129005.0,True,8
4588,129009,NAP,Package leaflet,fr,,Autres médicaments et X,129005.0,True,9
4589,129010,NAP,Package leaflet,fr,,"X avec <des aliments> <et> <,> <boissons> <et> <de l’alcool>",129005.0,True,10
4590,129011,NAP,Package leaflet,fr,,"Grossesse <et> <,> allaitement <et fertilité>",129005.0,True,11
4591,129012,NAP,Package leaflet,fr,,Conduite de véhicules et utilisation de machines,129005.0,True,12
4592,129013,NAP,Package leaflet,fr,,X contient {nommer le/les excipient(s)},129005.0,False,13
4593,129014,NAP,Package leaflet,fr,3,Comment <prendre> <utiliser> X,129001.0,True,14
4594,129015,NAP,Package leaflet,fr,,Utilisation chez les enfants <et les adolescents>,129014.0,False,15
4595,129016,NAP,Package leaflet,fr,,Si vous avez <pris> <utilisé> plus de X que vous n’auriez dû,129014.0,False,16
4596,129017,NAP,Package leaflet,fr,,Si vous oubliez <de prendre> <d’utiliser> X,129014.0,False,17
4597,129018,NAP,Package leaflet,fr,,Si vous arrêtez <de prendre> <d’utiliser> X,129014.0,False,18
4598,129019,NAP,Package leaflet,fr,4,Quels sont les effets indésirables éventuels?,129001.0,True,19
4599,129020,NAP,Package leaflet,fr,,Effets indésirables supplémentaires chez les enfants <et les adolescents>,129019.0,False,20
4600,129021,NAP,Package leaflet,fr,,Déclaration des effets secondaires,129019.0,True,21
4601,129022,NAP,Package leaflet,fr,5,Comment conserver X,129001.0,True,22
4602,129023,NAP,Package leaflet,fr,6,Contenu de l’emballage et autres informations,129001.0,True,23
4603,129024,NAP,Package leaflet,fr,,Ce que contient X ,129023.0,True,24
4604,129025,NAP,Package leaflet,fr,,Comment se présente X et contenu de l’emballage extérieur,129023.0,True,25
4605,129026,NAP,Package leaflet,fr,,Titulaire de l’Autorisation de mise sur le marché et fabricant,129023.0,True,26
4606,129027,NAP,Package leaflet,fr,,Ce médicament est autorisé dans les Etats membres de l'Espace Economique Européen sous les noms suivants :,129023.0,False,27
4607,129028,NAP,Package leaflet,fr,,La dernière date à laquelle cette notice a été révisée est <{MM/AAAA}> <{mois AAAA}.>,129023.0,True,28
4608,129029,NAP,Package leaflet,fr,,Autres sources d’informations,129023.0,False,29
4609,129030,NAP,Package leaflet,fr,,Les informations suivantes sont destinées exclusivement aux professionnels de la santé:,129001.0,False,30
4610,130001,NAP,SmPC,hr,,SAŽETAK OPISA SVOJSTAVA LIJEKA,,True,1
4611,130002,NAP,SmPC,hr,,qOvaj je lijek pod dodatnim praćenjem. Time se omogućuje brzo otkrivanje novih sigurnosnih informacija. Od zdravstvenih radnika se traži da prijave svaku sumnju na nuspojavu za ovaj lijek. Za postupak prijavljivanja nuspojava vidjeti dio 4.8.,130001.0,False,2
4612,130003,NAP,SmPC,hr,1,NAZIV LIJEKA,130001.0,True,3
4613,130004,NAP,SmPC,hr,2,KVALITATIVNI I KVANTITATIVNI SASTAV,130001.0,True,4
4614,130005,NAP,SmPC,hr,,Pomoćna(e) tvar(i) s poznatim učinkom,130004.0,False,5
4615,130006,NAP,SmPC,hr,3,FARMACEUTSKI OBLIK,130001.0,True,6
4616,130007,NAP,SmPC,hr,4,KLINIČKI PODACI,130001.0,True,7
4617,130008,NAP,SmPC,hr,4.1,Terapijske indikacije,130007.0,True,8
4618,130009,NAP,SmPC,hr,4.2,Doziranje i način primjene,130007.0,True,9
4619,130010,NAP,SmPC,hr,,Doziranje,130009.0,True,10
4620,130011,NAP,SmPC,hr,,Pedijatrijska populacija,130010.0,True,11
4621,130012,NAP,SmPC,hr,,Način primjene,130009.0,True,12
4622,130013,NAP,SmPC,hr,,Mjere opreza koje je potrebno poduzeti prije rukovanja ili primjene lijeka.,130012.0,False,13
4623,130014,NAP,SmPC,hr,4.3,Kontraindikacije,130007.0,True,14
4624,130015,NAP,SmPC,hr,4.4,Posebna upozorenja i mjere opreza pri uporabi,130007.0,True,15
4625,130016,NAP,SmPC,hr,,Sljedivost,130015.0,False,16
4626,130017,NAP,SmPC,hr,,Pedijatrijska populacija,130015.0,False,17
4627,130018,NAP,SmPC,hr,4.5,Interakcije s drugim lijekovima i drugi oblici interakcija,130007.0,True,18
4628,130019,NAP,SmPC,hr,,Pedijatrijska populacija,130018.0,False,19
4629,130020,NAP,SmPC,hr,4.6,"Plodnost, trudnoća i dojenje",130007.0,True,20
4630,130021,NAP,SmPC,hr,,Trudnoća,130020.0,False,21
4631,130022,NAP,SmPC,hr,,Dojenje,130020.0,False,22
4632,130023,NAP,SmPC,hr,,Plodnost,130020.0,False,23
4633,130024,NAP,SmPC,hr,4.7,Utjecaj na sposobnost upravljanja vozilima i rada sa strojevima,130007.0,True,24
4634,130025,NAP,SmPC,hr,4.8,Nuspojave,130007.0,True,25
4635,130026,NAP,SmPC,hr,,Pedijatrijska populacija,130025.0,False,26
4636,130027,NAP,SmPC,hr,,Prijavljivanje sumnji na nuspojavu,130025.0,True,27
4637,130028,NAP,SmPC,hr,4.9,Predoziranje,130007.0,True,28
4638,130029,NAP,SmPC,hr,,Pedijatrijska populacija,130028.0,False,29
4639,130030,NAP,SmPC,hr,5,FARMAKOLOŠKA SVOJSTVA,130001.0,True,30
4640,130031,NAP,SmPC,hr,5.1,Farmakodinamička svojstva,130030.0,True,31
4641,130032,NAP,SmPC,hr,,Mehanizam djelovanja,130031.0,False,32
4642,130033,NAP,SmPC,hr,,Farmakodinamički učinci,130031.0,False,33
4643,130034,NAP,SmPC,hr,,Klinička djelotvornost i sigurnost,130031.0,False,34
4644,130035,NAP,SmPC,hr,,Pedijatrijska populacija,130031.0,False,35
4645,130036,NAP,SmPC,hr,5.2,Farmakokinetička svojstva,130030.0,True,36
4646,130037,NAP,SmPC,hr,,Apsorpcija,130036.0,False,37
4647,130038,NAP,SmPC,hr,,Distribucija,130036.0,False,38
4648,130039,NAP,SmPC,hr,,Biotransformacija,130036.0,False,39
4649,130040,NAP,SmPC,hr,,Eliminacija,130036.0,False,40
4650,130041,NAP,SmPC,hr,,Linearnost/nelinearnost,130036.0,False,41
4651,130042,NAP,SmPC,hr,,Farmakokinetički/farmakodinamički odnos(i),130036.0,False,42
4652,130043,NAP,SmPC,hr,5.3,Neklinički podaci o sigurnosti primjene,130030.0,True,43
4653,130044,NAP,SmPC,hr,,Procjena rizika za okoliš (ERA),130043.0,False,44
4654,130045,NAP,SmPC,hr,6,FARMACEUTSKI PODACI,130001.0,True,45
4655,130046,NAP,SmPC,hr,6.1,Popis pomoćnih tvari,130045.0,True,46
4656,130047,NAP,SmPC,hr,6.2,Inkompatibilnosti,130045.0,True,47
4657,130048,NAP,SmPC,hr,6.3,Rok valjanosti,130045.0,True,48
4658,130049,NAP,SmPC,hr,6.4,Posebne mjere pri čuvanju lijeka,130045.0,True,49
4659,130050,NAP,SmPC,hr,6.5,Vrsta i sadržaj spremnika,130045.0,True,50
4660,130051,NAP,SmPC,hr,6.6,Posebne mjere za zbrinjavanje <i druga rukovanja lijekom>,130045.0,True,51
4661,130052,NAP,SmPC,hr,,Primjena u pedijatrijskoj populaciji,130051.0,False,52
4662,130053,NAP,SmPC,hr,7,NOSITELJ ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET,130001.0,True,53
4663,130054,NAP,SmPC,hr,8,BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET,130001.0,True,54
4664,130055,NAP,SmPC,hr,9,DATUM PRVOG ODOBRENJA / DATUM OBNOVE ODOBRENJA,130001.0,True,55
4665,130056,NAP,SmPC,hr,10,DATUM REVIZIJE TEKSTA,130001.0,True,56
4666,130057,NAP,SmPC,hr,11,DOZIMETRIJA,130001.0,False,57
4667,130058,NAP,SmPC,hr,12,UPUTE ZA PRIPREMU RADIOFARMACEUTIKA,130001.0,False,58
4668,131001,NAP,Labelling,hr,,OZNAČIVANJE,,True,1
4669,131002,NAP,Labelling,hr,,PODACI KOJI SE MORAJU NALAZITI NA < VANJSKOM PAKIRANJU> <I> <UNUTARNJEM PAKIRANJU>,131001.0,True,2
4670,131003,NAP,Labelling,hr,1,NAZIV LIJEKA,131002.0,True,3
4671,131004,NAP,Labelling,hr,2,NAVOĐENJE DJELATNE(IH) TVARI,131002.0,True,4
4672,131005,NAP,Labelling,hr,3,POPIS POMOĆNIH TVARI,131002.0,True,5
4673,131006,NAP,Labelling,hr,4,FARMACEUTSKI OBLIK I SADRŽAJ,131002.0,True,6
4674,131007,NAP,Labelling,hr,5,NAČIN I PUT(EVI) PRIMJENE LIJEKA,131002.0,True,7
4675,131008,NAP,Labelling,hr,6,POSEBNO UPOZORENJE O ČUVANJU LIJEKA IZVAN POGLEDA I DOHVATA DJECE,131002.0,True,8
4676,131009,NAP,Labelling,hr,7,"DRUGO(A) POSEBNO(A) UPOZORENJE(A), AKO JE POTREBNO",131002.0,True,9
4677,131010,NAP,Labelling,hr,8,ROK VALJANOSTI,131002.0,True,10
4678,131011,NAP,Labelling,hr,9,POSEBNE MJERE ČUVANJA,131002.0,True,11
4679,131012,NAP,Labelling,hr,10,"POSEBNE MJERE ZA ZBRINJAVANJE NEISKORIŠTENOG LIJEKA ILI OTPADNIH MATERIJALA KOJI POTJEČU OD LIJEKA, AKO JE POTREBNO",131002.0,True,12
4680,131013,NAP,Labelling,hr,11,NAZIV I ADRESA NOSITELJA ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET,131002.0,True,13
4681,131014,NAP,Labelling,hr,12,BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET,131002.0,True,14
4682,131015,NAP,Labelling,hr,13,BROJ SERIJE,131002.0,True,15
4683,131016,NAP,Labelling,hr,14,NAČIN IZDAVANJA LIJEKA,131002.0,True,16
4684,131017,NAP,Labelling,hr,15,UPUTE ZA UPORABU,131002.0,True,17
4685,131018,NAP,Labelling,hr,16,PODACI NA BRAILLEOVOM PISMU,131002.0,True,18
4686,131019,NAP,Labelling,hr,17,JEDINSTVENI IDENTIFIKATOR – 2D BARKOD,131002.0,True,19
4687,131020,NAP,Labelling,hr,18,JEDINSTVENI IDENTIFIKATOR – PODACI ČITLJIVI LJUDSKIM OKOM,131002.0,True,20
4688,131021,NAP,Labelling,hr,,PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP,131001.0,True,21
4689,131022,NAP,Labelling,hr,1,NAZIV LIJEKA,131021.0,True,22
4690,131023,NAP,Labelling,hr,2,NAZIV NOSITELJA ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET,131021.0,True,23
4691,131024,NAP,Labelling,hr,3,ROK VALJANOSTI,131021.0,True,24
4692,131025,NAP,Labelling,hr,4,BROJ SERIJE,131021.0,True,25
4693,131026,NAP,Labelling,hr,5,DRUGO,131021.0,True,26
4694,131027,NAP,Labelling,hr,,PODACI KOJE MORA NAJMANJE SADRŽAVATI MALO UNUTARNJE PAKIRANJE,131001.0,True,27
4695,131028,NAP,Labelling,hr,1,NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA,131027.0,True,28
4696,131029,NAP,Labelling,hr,2,NAČIN PRIMJENE LIJEKA,131027.0,True,29
4697,131030,NAP,Labelling,hr,3,ROK VALJANOSTI,131027.0,True,30
4698,131031,NAP,Labelling,hr,4,BROJ SERIJE,131027.0,True,31
4699,131032,NAP,Labelling,hr,5,"SADRŽAJ PO TEŽINI, VOLUMENU ILI DOZNOJ JEDINICI LIJEKA",131027.0,True,32
4700,131033,NAP,Labelling,hr,6,DRUGO,131027.0,True,33
4701,132001,NAP,Package leaflet,hr,,UPUTA O LIJEKU,,True,1
4702,132002,NAP,Package leaflet,hr,,"q Ovaj je lijek pod dodatnim praćenjem. Time se omogućuje brzo otkrivanje novih sigurnosnih informacija. Prijavom svih sumnji na nuspojavu i Vi možete pomoći. Za postupak prijavljivanja nuspojava, pogledajte dio 4.",132001.0,False,2
4703,132003,NAP,Package leaflet,hr,,Što se nalazi u ovoj uputi:,132001.0,True,3
4704,132004,NAP,Package leaflet,hr,1,Što je X i za što se koristi,132001.0,True,4
4705,132005,NAP,Package leaflet,hr,2,Što morate znati prije nego počnete <uzimati> <primjenjivati> X,132001.0,True,5
4706,132006,NAP,Package leaflet,hr,,Nemojte <uzimati> <primjenjivati> X,132005.0,True,6
4707,132007,NAP,Package leaflet,hr,,Upozorenja i mjere opreza ,132005.0,True,7
4708,132008,NAP,Package leaflet,hr,,Djeca <i adolescenti>,132005.0,True,8
4709,132009,NAP,Package leaflet,hr,,Drugi lijekovi i X,132005.0,True,9
4710,132010,NAP,Package leaflet,hr,,"X s <hranom> <i> <,> <pićem> <i> <alkoholom>",132005.0,True,10
4711,132011,NAP,Package leaflet,hr,,"Trudnoća <i> <,> dojenje <i plodnost>",132005.0,True,11
4712,132012,NAP,Package leaflet,hr,,Upravljanje vozilima i strojevima,132005.0,True,12
4713,132013,NAP,Package leaflet,hr,,X sadrži {naziv pomoćne(ih) tvari},132005.0,False,13
4714,132014,NAP,Package leaflet,hr,3,Kako <uzimati> <primjenjivati> X,132001.0,True,14
4715,132015,NAP,Package leaflet,hr,,Primjena u djece <i adolescenata>,132014.0,False,15
4716,132016,NAP,Package leaflet,hr,,Ako <uzmete> <primijenite> više X nego što ste trebali,132014.0,False,16
4717,132017,NAP,Package leaflet,hr,,Ako ste zaboravili <uzeti> <primijeniti> X,132014.0,False,17
4718,132018,NAP,Package leaflet,hr,,Ako prestanete <uzimati> <primjenjivati> X,132014.0,False,18
4719,132019,NAP,Package leaflet,hr,4,Moguće nuspojave,132001.0,True,19
4720,132020,NAP,Package leaflet,hr,,Dodatne nuspojave u djece <i adolescenata>,132019.0,False,20
4721,132021,NAP,Package leaflet,hr,,Prijavljivanje nuspojava,132019.0,True,21
4722,132022,NAP,Package leaflet,hr,5,Kako čuvati X,132001.0,True,22
4723,132023,NAP,Package leaflet,hr,6,Sadržaj pakiranja i druge informacije,132001.0,True,23
4724,132024,NAP,Package leaflet,hr,,Što X sadrži ,132023.0,True,24
4725,132025,NAP,Package leaflet,hr,,Kako X izgleda i sadržaj pakiranja,132023.0,True,25
4726,132026,NAP,Package leaflet,hr,,Nositelj odobrenja za stavljanje lijeka u promet i proizvođač,132023.0,True,26
4727,132027,NAP,Package leaflet,hr,,Ovaj lijek je odobren u državama članicama Europskog gospodarskog prostora (EGP) pod sljedećim nazivima:,132023.0,False,27
4728,132028,NAP,Package leaflet,hr,,Ova uputa je zadnji puta revidirana u <{MM/GGGG}> <{mjesec GGGG}>.,132023.0,True,28
4729,132029,NAP,Package leaflet,hr,,Ostali izvori informacija,132023.0,False,29
4730,132030,NAP,Package leaflet,hr,,Sljedeće informacije namijenjene su samo zdravstvenim radnicima:,132001.0,False,30
4731,133001,NAP,SmPC,hu,,ALKALMAZÁSI ELŐÍRÁS,,True,1
4732,133002,NAP,SmPC,hu,,"qEz a gyógyszer fokozott felügyelet alatt áll, mely lehetővé teszi az új gyógyszerbiztonsági információk gyors azonosítását. Az egészségügyi szakembereket arra kérjük, hogy jelentsenek bármilyen feltételezett mellékhatást. A mellékhatások jelentésének módjairól a 4.8 pontban kaphatnak további tájékoztatást.",133001.0,False,2
4733,133003,NAP,SmPC,hu,1,A GYÓGYSZER NEVE,133001.0,True,3
4734,133004,NAP,SmPC,hu,2,MINŐSÉGI ÉS MENNYISÉGI ÖSSZETÉTEL,133001.0,True,4
4735,133005,NAP,SmPC,hu,,Ismert hatású segédanyag(ok),133004.0,False,5
4736,133006,NAP,SmPC,hu,3,GYÓGYSZERFORMA,133001.0,True,6
4737,133007,NAP,SmPC,hu,4,KLINIKAI JELLEMZŐK,133001.0,True,7
4738,133008,NAP,SmPC,hu,4.1,Terápiás javallatok,133007.0,True,8
4739,133009,NAP,SmPC,hu,4.2,Adagolás és alkalmazás,133007.0,True,9
4740,133010,NAP,SmPC,hu,,Adagolás,133009.0,True,10
4741,133011,NAP,SmPC,hu,,Gyermekek és serdülők,133010.0,True,11
4742,133012,NAP,SmPC,hu,,Az alkalmazás módja,133009.0,True,12
4743,133013,NAP,SmPC,hu,,Óvintézkedések a gyógyszer felhasználása vagy alkalmazása előtt,133012.0,False,13
4744,133014,NAP,SmPC,hu,4.3,Ellenjavallatok,133007.0,True,14
4745,133015,NAP,SmPC,hu,4.4,Különleges figyelmeztetések és az alkalmazással kapcsolatos óvintézkedések,133007.0,True,15
4746,133016,NAP,SmPC,hu,,Nyomonkövethetőség,133015.0,False,16
4747,133017,NAP,SmPC,hu,,Gyermekek és serdülők,133015.0,False,17
4748,133018,NAP,SmPC,hu,4.5,Gyógyszerkölcsönhatások és egyéb interakciók,133007.0,True,18
4749,133019,NAP,SmPC,hu,,Gyermekek és serdülők,133018.0,False,19
4750,133020,NAP,SmPC,hu,4.6,"Termékenység, terhesség és szoptatás",133007.0,True,20
4751,133021,NAP,SmPC,hu,,Terhesség,133020.0,False,21
4752,133022,NAP,SmPC,hu,,Szoptatás,133020.0,False,22
4753,133023,NAP,SmPC,hu,,Termékenység,133020.0,False,23
4754,133024,NAP,SmPC,hu,4.7,A készítmény hatásai a gépjárművezetéshez és a gépek kezeléséhez szükséges képességekre,133007.0,True,24
4755,133025,NAP,SmPC,hu,4.8,"Nemkívánatos hatások, mellékhatások",133007.0,True,25
4756,133026,NAP,SmPC,hu,,Gyermekek és serdülők,133025.0,False,26
4757,133027,NAP,SmPC,hu,,Feltételezett mellékhatások bejelentése,133025.0,True,27
4758,133028,NAP,SmPC,hu,4.9,Túladagolás,133007.0,True,28
4759,133029,NAP,SmPC,hu,,Gyermekek és serdülők,133028.0,False,29
4760,133030,NAP,SmPC,hu,5,FARMAKOLÓGIAI TULAJDONSÁGOK,133001.0,True,30
4761,133031,NAP,SmPC,hu,5.1,Farmakodinámiás tulajdonságok,133030.0,True,31
4762,133032,NAP,SmPC,hu,,Hatásmechanizmus,133031.0,False,32
4763,133033,NAP,SmPC,hu,,Farmakodinámiás hatások,133031.0,False,33
4764,133034,NAP,SmPC,hu,,Klinikai hatásosság és biztonságosság,133031.0,False,34
4765,133035,NAP,SmPC,hu,,Gyermekek és serdülők,133031.0,False,35
4766,133036,NAP,SmPC,hu,5.2,Farmakokinetikai tulajdonságok,133030.0,True,36
4767,133037,NAP,SmPC,hu,,Felszívódá,133036.0,False,37
4768,133038,NAP,SmPC,hu,,Eloszlás,133036.0,False,38
4769,133039,NAP,SmPC,hu,,Biotranszformáció,133036.0,False,39
4770,133040,NAP,SmPC,hu,,Elimináció,133036.0,False,40
4771,133041,NAP,SmPC,hu,,Linearitás/nem-linearitás,133036.0,False,41
4772,133042,NAP,SmPC,hu,,Farmakokinetikai/farmakodinámiás összefüggés(ek),133036.0,False,42
4773,133043,NAP,SmPC,hu,5.3,A preklinikai biztonságossági vizsgálatok eredményei,133030.0,True,43
4774,133044,NAP,SmPC,hu,,Környezeti kockázatbecslés,133043.0,False,44
4775,133045,NAP,SmPC,hu,6,GYÓGYSZERÉSZETI JELLEMZŐK,133001.0,True,45
4776,133046,NAP,SmPC,hu,6.1,Segédanyagok felsorolása,133045.0,True,46
4777,133047,NAP,SmPC,hu,6.2,Inkompatibilitások,133045.0,True,47
4778,133048,NAP,SmPC,hu,6.3,Felhasználhatósági időtartam,133045.0,True,48
4779,133049,NAP,SmPC,hu,6.4,Különleges tárolási előírások,133045.0,True,49
4780,133050,NAP,SmPC,hu,6.5,Csomagolás típusa és kiszerelése,133045.0,True,50
4781,133051,NAP,SmPC,hu,6.6,"A megsemmisítésre vonatkozó különleges óvintézkedések <és egyéb, a készítmény kezelésével kapcsolatos információk>",133045.0,True,51
4782,133052,NAP,SmPC,hu,,Alkalmazása gyermekek és serdülők esetén,133051.0,False,52
4783,133053,NAP,SmPC,hu,7,A FORGALOMBA HOZATALI ENGEDÉLY JOGOSULTJA,133001.0,True,53
4784,133054,NAP,SmPC,hu,8,A FORGALOMBA HOZATALI ENGEDÉLY SZÁMA(I),133001.0,True,54
4785,133055,NAP,SmPC,hu,9,A FORGALOMBA HOZATALI ENGEDÉLY ELSŐ KIADÁSÁNAK/ MEGÚJÍTÁSÁNAK DÁTUMA,133001.0,True,55
4786,133056,NAP,SmPC,hu,10,A SZÖVEG ELLENŐRZÉSÉNEK DÁTUMA,133001.0,True,56
4787,133057,NAP,SmPC,hu,11,VÁRHATÓ SUGÁRTERHELÉS,133001.0,False,57
4788,133058,NAP,SmPC,hu,12,RADIOAKTÍV GYÓGYSZEREK ELKÉSZÍTÉSÉRE VONATKOZÓ ÚTMUTATÁSOK,133001.0,False,58
4789,134001,NAP,Labelling,hu,,CÍMKESZÖVEG,,True,1
4790,134002,NAP,Labelling,hu,,<KÜLSŐ CSOMAGOLÁSON><ÉS><A KÖZVETLEN CSOMAGOLÁSON> FELTÜNTETENDŐ ADATOK,134001.0,True,2
4791,134003,NAP,Labelling,hu,1,A GYÓGYSZER NEVE,134002.0,True,3
4792,134004,NAP,Labelling,hu,2,HATÓANYAG(OK) MEGNEVEZÉSE,134002.0,True,4
4793,134005,NAP,Labelling,hu,3,SEGÉDANYAGOK FELSOROLÁSA,134002.0,True,5
4794,134006,NAP,Labelling,hu,4,GYÓGYSZERFORMA ÉS TARTALOM,134002.0,True,6
4795,134007,NAP,Labelling,hu,5,AZ ALKALMAZÁSSAL KAPCSOLATOS TUDNIVALÓK ÉS AZ ALKALMAZÁS MÓDJA(I),134002.0,True,7
4796,134008,NAP,Labelling,hu,6,"KÜLÖN FIGYELMEZTETÉS, MELY SZERINT A GYÓGYSZERT GYERMEKEKTŐL ELZÁRVA KELL TARTANI",134002.0,True,8
4797,134009,NAP,Labelling,hu,7,"TOVÁBBI FIGYELMEZTETÉS(EK), AMENNYIBEN SZÜKSÉGES",134002.0,True,9
4798,134010,NAP,Labelling,hu,8,LEJÁRATI IDŐ,134002.0,True,10
4799,134011,NAP,Labelling,hu,9,KÜLÖNLEGES TÁROLÁSI ELŐÍRÁSOK,134002.0,True,11
4800,134012,NAP,Labelling,hu,10,"KÜLÖNLEGES ÓVINTÉZKEDÉSEK A FEL NEM HASZNÁLT GYÓGYSZEREK VAGY AZ ILYEN TERMÉKEKBŐL KELETKEZETT HULLADÉKANYAGOK ÁRTALMATLANNÁ TÉTELÉRE, HA ILYENEKRE SZÜKSÉG VAN",134002.0,True,12
4801,134013,NAP,Labelling,hu,11,A FORGALOMBA HOZATALI ENGEDÉLY JOGOSULTJÁNAK NEVE ÉS CÍME,134002.0,True,13
4802,134014,NAP,Labelling,hu,12,A FORGALOMBA HOZATALI ENGEDÉLY SZÁMA(I),134002.0,True,14
4803,134015,NAP,Labelling,hu,13,A GYÁRTÁSI TÉTEL SZÁMA,134002.0,True,15
4804,134016,NAP,Labelling,hu,14,A GYÓGYSZER RENDELHETŐSÉGE,134002.0,True,16
4805,134017,NAP,Labelling,hu,15,AZ ALKALMAZÁSRA VONATKOZÓ UTASÍTÁSOK,134002.0,True,17
4806,134018,NAP,Labelling,hu,16,BRAILLE ÍRÁSSAL FELTÜNTETETT INFORMÁCIÓK,134002.0,True,18
4807,134019,NAP,Labelling,hu,17,EGYEDI AZONOSÍTÓ – 2D VONALKÓD,134002.0,True,19
4808,134020,NAP,Labelling,hu,18,EGYEDI AZONOSÍTÓ OLVASHATÓ FORMÁTUMA,134002.0,True,20
4809,134021,NAP,Labelling,hu,,A BUBORÉKCSOMAGOLÁSON VAGY A FÓLIACSÍKON MINIMÁLISAN FELTÜNTETENDŐ ADATOK,134001.0,True,21
4810,134022,NAP,Labelling,hu,1,A GYÓGYSZER NEVE,134021.0,True,22
4811,134023,NAP,Labelling,hu,2,A FORGALOMBA HOZATALI ENGEDÉLY JOGOSULTJÁNAK NEVE,134021.0,True,23
4812,134024,NAP,Labelling,hu,3,LEJÁRATI IDŐ,134021.0,True,24
4813,134025,NAP,Labelling,hu,4,A GYÁRTÁSI TÉTEL SZÁMA,134021.0,True,25
4814,134026,NAP,Labelling,hu,5,EGYÉB INFORMÁCIÓK,134021.0,True,26
4815,134027,NAP,Labelling,hu,,A KIS KÖZVETLEN CSOMAGOLÁSI EGYSÉGEKEN MINIMÁLISAN FELTÜNTETENDŐ ADATOK,134001.0,True,27
4816,134028,NAP,Labelling,hu,1,A GYÓGYSZER NEVE ÉS AZ ALKALMAZÁS MÓDJA(I),134027.0,True,28
4817,134029,NAP,Labelling,hu,2,AZ ALKALMAZÁSSAL KAPCSOLATOS TUDNIVALÓK,134027.0,True,29
4818,134030,NAP,Labelling,hu,3,LEJÁRATI IDŐ,134027.0,True,30
4819,134031,NAP,Labelling,hu,4,A GYÁRTÁSI TÉTEL SZÁMA,134027.0,True,31
4820,134032,NAP,Labelling,hu,5,"A TARTALOM SÚLYRA, TÉRFOGATRA, VAGY EGYSÉGRE VONATKOZTATVA",134027.0,True,32
4821,134033,NAP,Labelling,hu,6,EGYÉB INFORMÁCIÓK,134027.0,True,33
4822,135001,NAP,Package leaflet,hu,,BETEGTÁJÉKOZTATÓ,,True,1
4823,135002,NAP,Package leaflet,hu,,"qEz a gyógyszer fokozott felügyelet alatt áll, mely lehetővé teszi az új gyógyszerbiztonsági információk gyors azonosítását. Ehhez Ön is hozzájárulhat a tudomására jutó bármilyen mellékhatás bejelentésével. 
A mellékhatások jelentésének módjairól a 4. pont végén (Mellékhatások bejelentése) talál további tájékoztatást.",135001.0,False,2
4824,135003,NAP,Package leaflet,hu,,A betegtájékoztató tartalma:,135001.0,True,3
4825,135004,NAP,Package leaflet,hu,1,Milyen típusú gyógyszer az X és milyen betegségek esetén alkalmazható?,135001.0,True,4
4826,135005,NAP,Package leaflet,hu,2,Tudnivalók az X <szedése><alkalmazása> előtt,135001.0,True,5
4827,135006,NAP,Package leaflet,hu,,Ne <szedje><alkalmazza> az X-et<:>,135005.0,True,6
4828,135007,NAP,Package leaflet,hu,,Figyelmeztetések és óvintézkedések,135005.0,True,7
4829,135008,NAP,Package leaflet,hu,,Gyermekek <és serdülők>,135005.0,True,8
4830,135009,NAP,Package leaflet,hu,,Egyéb gyógyszerek és a(z) X,135005.0,True,9
4831,135010,NAP,Package leaflet,hu,,"Az X egyidejű <bevétele><alkalmazása><étellel><és><,><itallal><és><alkohollal>",135005.0,True,10
4832,135011,NAP,Package leaflet,hu,,"Terhesség <és><,>  szoptatás  < és termékenység>",135005.0,True,11
4833,135012,NAP,Package leaflet,hu,,A készítmény hatásai a gépjárművezetéshez és a gépek kezeléséhez szükséges képességekre,135005.0,True,12
4834,135013,NAP,Package leaflet,hu,,Az X {segédanyag(ok) neve}-t tartalmaz,135005.0,False,13
4835,135014,NAP,Package leaflet,hu,3,Hogyan kell <szedni><alkalmazni> az X-et?,135001.0,True,14
4836,135015,NAP,Package leaflet,hu,,Alkalmazása gyermekeknél <és serdülőknél>,135014.0,False,15
4837,135016,NAP,Package leaflet,hu,,Ha az előírtnál több X-et <vett be><alkalmazott>,135014.0,False,16
4838,135017,NAP,Package leaflet,hu,,Ha elfelejtette <bevenni><alkalmazni> az X-et,135014.0,False,17
4839,135018,NAP,Package leaflet,hu,,Ha idő előtt abbahagyja az X <szedését><alkalmazását>,135014.0,False,18
4840,135019,NAP,Package leaflet,hu,4,Lehetséges mellékhatások,135001.0,True,19
4841,135020,NAP,Package leaflet,hu,,További mellékhatások gyermekeknél <és serdülőknél>,135019.0,False,20
4842,135021,NAP,Package leaflet,hu,,Mellékhatások bejelentése,135019.0,True,21
4843,135022,NAP,Package leaflet,hu,5,Hogyan kell az X-et tárolni?,135001.0,True,22
4844,135023,NAP,Package leaflet,hu,6,A csomagolás tartalma és egyéb információk,135001.0,True,23
4845,135024,NAP,Package leaflet,hu,,Mit tartalmaz az X?,135023.0,True,24
4846,135025,NAP,Package leaflet,hu,,Milyen az X külleme és mit tartalmaz a csomagolás?,135023.0,True,25
4847,135026,NAP,Package leaflet,hu,,A forgalomba hozatali engedély jogosultja és a gyártó,135023.0,True,26
4848,135027,NAP,Package leaflet,hu,,Ezt a gyógyszert az Európai Gazdasági Térség tagállamaiban az alábbi neveken engedélyezték:,135023.0,False,27
4849,135028,NAP,Package leaflet,hu,,A betegtájékoztató legutóbbi felülvizsgálatának dátuma:<{ÉÉÉÉ. hónap}>,135023.0,True,28
4850,135029,NAP,Package leaflet,hu,,Egyéb információforrások,135023.0,False,29
4851,135030,NAP,Package leaflet,hu,,Az alábbi információk kizárólag egészségügyi szakembereknek szólnak:,135001.0,False,30
4852,136001,NAP,SmPC,ic,,SAMANTEKT Á EIGINLEIKUM LYFS,,True,1
4853,136002,NAP,SmPC,ic,,qÞetta lyf er undir sérstöku eftirliti til að nýjar upplýsingar um öryggi lyfsins komist fljótt og örugglega til skila. Heilbrigðisstarfsmenn eru hvattir til að tilkynna allar aukaverkanir sem grunur er um að tengist lyfinu. Í kafla 4.8 eru upplýsingar um hvernig tilkynna á aukaverkanir.,136001.0,False,2
4854,136003,NAP,SmPC,ic,1,HEITI LYFS,136001.0,True,3
4855,136004,NAP,SmPC,ic,2,INNIHALDSLÝSING,136001.0,True,4
4856,136005,NAP,SmPC,ic,,Hjálparefni með þekkta verkun,136004.0,False,5
4857,136006,NAP,SmPC,ic,3,LYFJAFORM,136001.0,True,6
4858,136007,NAP,SmPC,ic,4,KLÍNÍSKAR UPPLÝSINGAR,136001.0,True,7
4859,136008,NAP,SmPC,ic,4.1,Ábendingar,136007.0,True,8
4860,136009,NAP,SmPC,ic,4.2,Skammtar og lyfjagjöf,136007.0,True,9
4861,136010,NAP,SmPC,ic,,Skammtar,136009.0,True,10
4862,136011,NAP,SmPC,ic,,Börn,136010.0,True,11
4863,136012,NAP,SmPC,ic,,Lyfjagjöf,136009.0,True,12
4864,136013,NAP,SmPC,ic,,Varúðarráðstafanir sem þarf að gera áður en lyfið er meðhöndlað eða gefið,136012.0,False,13
4865,136014,NAP,SmPC,ic,4.3,Frábendingar,136007.0,True,14
4866,136015,NAP,SmPC,ic,4.4,Sérstök varnaðarorð og varúðarreglur við notkun,136007.0,True,15
4867,136016,NAP,SmPC,ic,,Rekjanleiki,136015.0,False,16
4868,136017,NAP,SmPC,ic,,Börn,136015.0,False,17
4869,136018,NAP,SmPC,ic,4.5,Milliverkanir við önnur lyf og aðrar milliverkanir,136007.0,True,18
4870,136019,NAP,SmPC,ic,,Börn,136018.0,False,19
4871,136020,NAP,SmPC,ic,4.6,"Frjósemi, meðganga og brjóstagjöf",136007.0,True,20
4872,136021,NAP,SmPC,ic,,Meðganga,136020.0,False,21
4873,136022,NAP,SmPC,ic,,Brjóstagjöf,136020.0,False,22
4874,136023,NAP,SmPC,ic,,Frjósemi,136020.0,False,23
4875,136024,NAP,SmPC,ic,4.7,Áhrif á hæfni til aksturs og notkunar véla,136007.0,True,24
4876,136025,NAP,SmPC,ic,4.8,Aukaverkanir,136007.0,True,25
4877,136026,NAP,SmPC,ic,,Börn,136025.0,False,26
4878,136027,NAP,SmPC,ic,,Tilkynning aukaverkana sem grunur er um að tengist lyfinu,136025.0,True,27
4879,136028,NAP,SmPC,ic,4.9,Ofskömmtun,136007.0,True,28
4880,136029,NAP,SmPC,ic,,Börn,136028.0,False,29
4881,136030,NAP,SmPC,ic,5,LYFJAFRÆÐILEGAR UPPLÝSINGAR,136001.0,True,30
4882,136031,NAP,SmPC,ic,5.1,Lyfhrif,136030.0,True,31
4883,136032,NAP,SmPC,ic,,Verkunarháttur,136031.0,False,32
4884,136033,NAP,SmPC,ic,,Lyfhrif,136031.0,False,33
4885,136034,NAP,SmPC,ic,,Verkun og öryggi,136031.0,False,34
4886,136035,NAP,SmPC,ic,,Börn,136031.0,False,35
4887,136036,NAP,SmPC,ic,5.2,Lyfjahvörf,136030.0,True,36
4888,136037,NAP,SmPC,ic,,Frásog,136036.0,False,37
4889,136038,NAP,SmPC,ic,,Dreifing,136036.0,False,38
4890,136039,NAP,SmPC,ic,,Umbrot,136036.0,False,39
4891,136040,NAP,SmPC,ic,,Brotthvarf,136036.0,False,40
4892,136041,NAP,SmPC,ic,,Línulegt/ólínulegt samband,136036.0,False,41
4893,136042,NAP,SmPC,ic,,Tengsl lyfjahvarfa og lyfhrifa,136036.0,False,42
4894,136043,NAP,SmPC,ic,5.3,Forklínískar upplýsingar,136030.0,True,43
4895,136044,NAP,SmPC,ic,,Mat á áhættu fyrir lífríkið,136043.0,False,44
4896,136045,NAP,SmPC,ic,6,LYFJAGERÐARFRÆÐILEGAR UPPLÝSINGAR,136001.0,True,45
4897,136046,NAP,SmPC,ic,6.1,Hjálparefni,136045.0,True,46
4898,136047,NAP,SmPC,ic,6.2,Ósamrýmanleiki,136045.0,True,47
4899,136048,NAP,SmPC,ic,6.3,Geymsluþol,136045.0,True,48
4900,136049,NAP,SmPC,ic,6.4,Sérstakar varúðarreglur við geymslu,136045.0,True,49
4901,136050,NAP,SmPC,ic,6.5,Gerð íláts og innihald,136045.0,True,50
4902,136051,NAP,SmPC,ic,6.6,Sérstakar varúðarráðstafanir við förgun <og önnur meðhöndlun>,136045.0,True,51
4903,136052,NAP,SmPC,ic,,Ef lyfið er notað handa börnum,136051.0,False,52
4904,136053,NAP,SmPC,ic,7,MARKAÐSLEYFISHAFI,136001.0,True,53
4905,136054,NAP,SmPC,ic,8,MARKAÐSLEYFISNÚMER,136001.0,True,54
4906,136055,NAP,SmPC,ic,9,DAGSETNING FYRSTU ÚTGÁFU MARKAÐSLEYFIS / ENDURNÝJUNAR MARKAÐSLEYFIS,136001.0,True,55
4907,136056,NAP,SmPC,ic,10,DAGSETNING ENDURSKOÐUNAR TEXTANS,136001.0,True,56
4908,136057,NAP,SmPC,ic,11,GEISLUNARMÆLINGAR,136001.0,False,57
4909,136058,NAP,SmPC,ic,12,LEIÐBEININGAR UM BLÖNDUN GEISLAVIRKRA LYFJA,136001.0,False,58
4910,137001,NAP,Labelling,ic,,ÁLETRANIR,,True,1
4911,137002,NAP,Labelling,ic,,UPPLÝSINGAR SEM EIGA AÐ KOMA FRAM Á <YTRI UMBÚÐUM> <OG> <INNRI UMBÚÐUM>,137001.0,True,2
4912,137003,NAP,Labelling,ic,1,HEITI LYFS,137002.0,True,3
4913,137004,NAP,Labelling,ic,2,VIRK(T) EFNI,137002.0,True,4
4914,137005,NAP,Labelling,ic,3,HJÁLPAREFNI,137002.0,True,5
4915,137006,NAP,Labelling,ic,4,LYFJAFORM OG INNIHALD,137002.0,True,6
4916,137007,NAP,Labelling,ic,5,AÐFERÐ VIÐ LYFJAGJÖF OG ÍKOMULEIÐ(IR),137002.0,True,7
4917,137008,NAP,Labelling,ic,6,SÉRSTÖK VARNAÐARORÐ UM AÐ LYFIÐ SKULI GEYMT ÞAR SEM BÖRN HVORKI NÁ TIL NÉ SJÁ,137002.0,True,8
4918,137009,NAP,Labelling,ic,7,"ÖNNUR SÉRSTÖK VARNAÐARORÐ, EF MEÐ ÞARF",137002.0,True,9
4919,137010,NAP,Labelling,ic,8,FYRNINGARDAGSETNING,137002.0,True,10
4920,137011,NAP,Labelling,ic,9,SÉRSTÖK GEYMSLUSKILYRÐI,137002.0,True,11
4921,137012,NAP,Labelling,ic,10,SÉRSTAKAR VARÚÐARRÁÐSTAFANIR VIÐ FÖRGUN LYFJALEIFA EÐA ÚRGANGS VEGNA LYFSINS ÞAR SEM VIÐ Á,137002.0,True,12
4922,137013,NAP,Labelling,ic,11,NAFN OG HEIMILISFANG MARKAÐSLEYFISHAFA,137002.0,True,13
4923,137014,NAP,Labelling,ic,12,MARKAÐSLEYFISNÚMER,137002.0,True,14
4924,137015,NAP,Labelling,ic,13,LOTUNÚMER,137002.0,True,15
4925,137016,NAP,Labelling,ic,14,AFGREIÐSLUTILHÖGUN,137002.0,True,16
4926,137017,NAP,Labelling,ic,15,NOTKUNARLEIÐBEININGAR,137002.0,True,17
4927,137018,NAP,Labelling,ic,16,UPPLÝSINGAR MEÐ BLINDRALETRI,137002.0,True,18
4928,137019,NAP,Labelling,ic,17,EINKVÆMT AUÐKENNI – TVÍVÍTT STRIKAMERKI,137002.0,True,19
4929,137020,NAP,Labelling,ic,18,EINKVÆMT AUÐKENNI – UPPLÝSINGAR SEM FÓLK GETUR LESIÐ,137002.0,True,20
4930,137021,NAP,Labelling,ic,,LÁGMARKS UPPLÝSINGAR SEM SKULU KOMA FRAM Á ÞYNNUM EÐA STRIMLUM,137001.0,True,21
4931,137022,NAP,Labelling,ic,1,HEITI LYFS,137021.0,True,22
4932,137023,NAP,Labelling,ic,2,NAFN MARKAÐSLEYFISHAFA,137021.0,True,23
4933,137024,NAP,Labelling,ic,3,FYRNINGARDAGSETNING,137021.0,True,24
4934,137025,NAP,Labelling,ic,4,LOTUNÚMER,137021.0,True,25
4935,137026,NAP,Labelling,ic,5,ANNAÐ,137021.0,True,26
4936,137027,NAP,Labelling,ic,,LÁGMARKS UPPLÝSINGAR SEM SKULU KOMA FRAM Á INNRI UMBÚÐUM LÍTILLA EININGA,137001.0,True,27
4937,137028,NAP,Labelling,ic,1,HEITI LYFS OG ÍKOMULEIÐ(IR),137027.0,True,28
4938,137029,NAP,Labelling,ic,2,AÐFERÐ VIÐ LYFJAGJÖF,137027.0,True,29
4939,137030,NAP,Labelling,ic,3,FYRNINGARDAGSETNING,137027.0,True,30
4940,137031,NAP,Labelling,ic,4,LOTUNÚMER,137027.0,True,31
4941,137032,NAP,Labelling,ic,5,"INNIHALD TILGREINT SEM ÞYNGD, RÚMMÁL EÐA FJÖLDI EININGA",137027.0,True,32
4942,137033,NAP,Labelling,ic,6,ANNAÐ,137027.0,True,33
4943,138001,NAP,Package leaflet,ic,,FYLGISEÐILL,,True,1
4944,138002,NAP,Package leaflet,ic,,q Þetta lyf er undir sérstöku eftirliti til að nýjar upplýsingar um öryggi lyfsins komist fljótt og örugglega til skila. Allir geta hjálpað til við þetta með því að tilkynna aukaverkanir sem koma fram. Aftast í kafla 4 eru upplýsingar um hvernig tilkynna á aukaverkanir.,138001.0,False,2
4945,138003,NAP,Package leaflet,ic,,Í fylgiseðlinum eru eftirfarandi kaflar:,138001.0,True,3
4946,138004,NAP,Package leaflet,ic,1,Upplýsingar um X og við hverju það er notað,138001.0,True,4
4947,138005,NAP,Package leaflet,ic,2,Áður en byrjað er að nota X,138001.0,True,5
4948,138006,NAP,Package leaflet,ic,,Ekki má nota X,138005.0,True,6
4949,138007,NAP,Package leaflet,ic,,Varnaðarorð og varúðarreglur,138005.0,True,7
4950,138008,NAP,Package leaflet,ic,,Börn <og unglingar>,138005.0,True,8
4951,138009,NAP,Package leaflet,ic,,Notkun annarra lyfja samhliða X,138005.0,True,9
4952,138010,NAP,Package leaflet,ic,,"Notkun X með <mat> <eða> <,> <drykk> <eða> <áfengi>",138005.0,True,10
4953,138011,NAP,Package leaflet,ic,,"Meðganga <og> <,> brjóstagjöf <og frjósemi>",138005.0,True,11
4954,138012,NAP,Package leaflet,ic,,Akstur og notkun véla,138005.0,True,12
4955,138013,NAP,Package leaflet,ic,,X inniheldur {tilgreinið viðkomandi hjálparefni},138005.0,False,13
4956,138014,NAP,Package leaflet,ic,3,Hvernig nota á X,138001.0,True,14
4957,138015,NAP,Package leaflet,ic,,Notkun handa börnum <og unglingum>,138014.0,False,15
4958,138016,NAP,Package leaflet,ic,,Ef <tekinn> <notaður> er stærri skammtur en mælt er fyrir um,138014.0,False,16
4959,138017,NAP,Package leaflet,ic,,Ef gleymist að <taka> <nota> X,138014.0,False,17
4960,138018,NAP,Package leaflet,ic,,Ef hætt er að nota X,138014.0,False,18
4961,138019,NAP,Package leaflet,ic,4,Hugsanlegar aukaverkanir,138001.0,True,19
4962,138020,NAP,Package leaflet,ic,,Aðrar aukaverkanir sem geta komið fyrir hjá börnum <og unglingum>,138019.0,False,20
4963,138021,NAP,Package leaflet,ic,,Tilkynning aukaverkana,138019.0,True,21
4964,138022,NAP,Package leaflet,ic,5,Hvernig geyma á X,138001.0,True,22
4965,138023,NAP,Package leaflet,ic,6,Pakkningar og aðrar upplýsingar,138001.0,True,23
4966,138024,NAP,Package leaflet,ic,,X inniheldur,138023.0,True,24
4967,138025,NAP,Package leaflet,ic,,Lýsing á útliti X og pakkningastærðir,138023.0,True,25
4968,138026,NAP,Package leaflet,ic,,Markaðsleyfishafi og framleiðandi,138023.0,True,26
4969,138027,NAP,Package leaflet,ic,,Þetta lyf hefur markaðsleyfi í löndum Evrópska efnahagssvæðisins undir eftirfarandi heitum:,138023.0,False,27
4970,138028,NAP,Package leaflet,ic,,Þessi fylgiseðill var síðast uppfærður <{MM/ÁÁÁÁ}> <í {mánuður ÁÁÁÁ}>.,138023.0,True,28
4971,138029,NAP,Package leaflet,ic,,Upplýsingar sem hægt er að nálgast annars staðar,138023.0,False,29
4972,138030,NAP,Package leaflet,ic,,Eftirfarandi upplýsingar eru einungis ætlaðar heilbrigðisstarfsmönnum:,138001.0,False,30
4973,139001,NAP,SmPC,it,,RIASSUNTO DELLE CARATTERISTICHE DEL PRODOTTO,,True,1
4974,139002,NAP,SmPC,it,,qMedicinale sottoposto a monitoraggio addizionale. Ciò permetterà la rapida identificazione di nuove informazioni sulla sicurezza. Agli operatori sanitari è richiesto di segnalare qualsiasi reazione avversa sospetta. Vedere paragrafo 4.8 per informazioni sulle modalità di segnalazione delle reazioni avverse.>,139001.0,False,2
4975,139003,NAP,SmPC,it,1,DENOMINAZIONE DEL MEDICINALE,139001.0,True,3
4976,139004,NAP,SmPC,it,2,COMPOSIZIONE QUALITATIVA E QUANTITATIVA,139001.0,True,4
4977,139005,NAP,SmPC,it,,Eccipiente(i) con effetti noti,139004.0,False,5
4978,139006,NAP,SmPC,it,3,FORMA FARMACEUTICA,139001.0,True,6
4979,139007,NAP,SmPC,it,4,INFORMAZIONI CLINICHE,139001.0,True,7
4980,139008,NAP,SmPC,it,4.1,Indicazioni terapeutiche,139007.0,True,8
4981,139009,NAP,SmPC,it,4.2,Posologia e modo di somministrazione,139007.0,True,9
4982,139010,NAP,SmPC,it,,Posologia,139009.0,True,10
4983,139011,NAP,SmPC,it,,Popolazione pediatrica,139010.0,True,11
4984,139012,NAP,SmPC,it,,Modo di somministrazione,139009.0,True,12
4985,139013,NAP,SmPC,it,,Precauzioni che devono essere prese prima della manipolazione o della somministrazione del medicinale,139012.0,False,13
4986,139014,NAP,SmPC,it,4.3,Controindicazioni,139007.0,True,14
4987,139015,NAP,SmPC,it,4.4,Avvertenze speciali e precauzioni d’impiego,139007.0,True,15
4988,139016,NAP,SmPC,it,,Tracciabilità,139015.0,False,16
4989,139017,NAP,SmPC,it,,Popolazione pediatrica,139015.0,False,17
4990,139018,NAP,SmPC,it,4.5,Interazioni con altri medicinali ed altre forme d’interazione,139007.0,True,18
4991,139019,NAP,SmPC,it,,Popolazione pediatrica,139018.0,False,19
4992,139020,NAP,SmPC,it,4.6,"Fertilità, gravidanza e allattamento",139007.0,True,20
4993,139021,NAP,SmPC,it,,Gravidanza,139020.0,False,21
4994,139022,NAP,SmPC,it,,Allattamento,139020.0,False,22
4995,139023,NAP,SmPC,it,,Fertilità,139020.0,False,23
4996,139024,NAP,SmPC,it,4.7,Effetti sulla capacità di guidare veicoli e sull’uso di macchinari,139007.0,True,24
4997,139025,NAP,SmPC,it,4.8,Effetti indesiderati,139007.0,True,25
4998,139026,NAP,SmPC,it,,Popolazione pediatrica,139025.0,False,26
4999,139027,NAP,SmPC,it,,Segnalazione delle reazioni avverse sospette,139025.0,True,27
5000,139028,NAP,SmPC,it,4.9,Sovradosaggio,139007.0,True,28
5001,139029,NAP,SmPC,it,,Popolazione pediatrica,139028.0,False,29
5002,139030,NAP,SmPC,it,5,PROPRIETÀ FARMACOLOGICHE,139001.0,True,30
5003,139031,NAP,SmPC,it,5.1,Proprietà farmacodinamiche,139030.0,True,31
5004,139032,NAP,SmPC,it,,Meccanismo d’azione,139031.0,False,32
5005,139033,NAP,SmPC,it,,Effetti farmacodinamici,139031.0,False,33
5006,139034,NAP,SmPC,it,,Efficacia e sicurezza clinica,139031.0,False,34
5007,139035,NAP,SmPC,it,,Popolazione pediatrica,139031.0,False,35
5008,139036,NAP,SmPC,it,5.2,Proprietà farmacocinetiche,139030.0,True,36
5009,139037,NAP,SmPC,it,,Assorbimento,139036.0,False,37
5010,139038,NAP,SmPC,it,,Distribuzione,139036.0,False,38
5011,139039,NAP,SmPC,it,,Biotrasformazione,139036.0,False,39
5012,139040,NAP,SmPC,it,,Eliminazione,139036.0,False,40
5013,139041,NAP,SmPC,it,,Linearità/Non linearità,139036.0,False,41
5014,139042,NAP,SmPC,it,,Relazione(i) farmacocinetica(che)/farmacodinamica(che),139036.0,False,42
5015,139043,NAP,SmPC,it,5.3,Dati preclinici di sicurezza,139030.0,True,43
5016,139044,NAP,SmPC,it,,"Valutazione del rischio ambientale (Environmental risk assessment, ERA)",139043.0,False,44
5017,139045,NAP,SmPC,it,6,INFORMAZIONI FARMACEUTICHE,139001.0,True,45
5018,139046,NAP,SmPC,it,6.1,Elenco degli eccipienti,139045.0,True,46
5019,139047,NAP,SmPC,it,6.2,Incompatibilità,139045.0,True,47
5020,139048,NAP,SmPC,it,6.3,Periodo di validità,139045.0,True,48
5021,139049,NAP,SmPC,it,6.4,Precauzioni particolari per la conservazione,139045.0,True,49
5022,139050,NAP,SmPC,it,6.5,Natura e contenuto del contenitore,139045.0,True,50
5023,139051,NAP,SmPC,it,6.6,Precauzioni particolari per lo smaltimento <e la manipolazione>,139045.0,True,51
5024,139052,NAP,SmPC,it,,Uso nella popolazione pediatrica,139051.0,False,52
5025,139053,NAP,SmPC,it,7,TITOLARE DELL’AUTORIZZAZIONE ALL’IMMISSIONE IN COMMERCIO,139001.0,True,53
5026,139054,NAP,SmPC,it,8,NUMERO(I) DELL’AUTORIZZAZIONE ALL’IMMISSIONE IN COMMERCIO ,139001.0,True,54
5027,139055,NAP,SmPC,it,9,DATA DELLA PRIMA AUTORIZZAZIONE/RINNOVO DELL’AUTORIZZAZIONE,139001.0,True,55
5028,139056,NAP,SmPC,it,10,DATA DI REVISIONE DEL TESTO,139001.0,True,56
5029,139057,NAP,SmPC,it,11,DOSIMETRIA,139001.0,False,57
5030,139058,NAP,SmPC,it,12,ISTRUZIONI PER LA PREPARAZIONE DI RADIOFARMACI,139001.0,False,58
5031,140001,NAP,Labelling,it,,ETICHETTATURA,,True,1
5032,140002,NAP,Labelling,it,,INFORMAZIONI DA APPORRE <SUL CONFEZIONAMENTO SECONDARIO> <E> <SUL CONFEZIONAMENTO PRIMARIO>,140001.0,True,2
5033,140003,NAP,Labelling,it,1,DENOMINAZIONE DEL MEDICINALE,140002.0,True,3
5034,140004,NAP,Labelling,it,2,COMPOSIZIONE QUALITATIVA E QUANTITATIVA IN TERMINI DI PRINCIPIO(I) ATTIVO(I),140002.0,True,4
5035,140005,NAP,Labelling,it,3,ELENCO DEGLI ECCIPIENTI,140002.0,True,5
5036,140006,NAP,Labelling,it,4,FORMA FARMACEUTICA E CONTENUTO,140002.0,True,6
5037,140007,NAP,Labelling,it,5,MODO E VIA(E) DI SOMMINISTRAZIONE,140002.0,True,7
5038,140008,NAP,Labelling,it,6,AVVERTENZA PARTICOLARE CHE PRESCRIVA DI TENERE IL MEDICINALE FUORI DALLA VISTA E DALLA PORTATA DEI BAMBINI,140002.0,True,8
5039,140009,NAP,Labelling,it,7,"ALTRA(E) AVVERTENZA(E) PARTICOLARE(I), SE NECESSARIO",140002.0,True,9
5040,140010,NAP,Labelling,it,8,DATA DI SCADENZA,140002.0,True,10
5041,140011,NAP,Labelling,it,9,PRECAUZIONI PARTICOLARI PER LA CONSERVAZIONE,140002.0,True,11
5042,140012,NAP,Labelling,it,10,"PRECAUZIONI PARTICOLARI PER LO SMALTIMENTO DEL MEDICINALE NON UTILIZZATO O DEI RIFIUTI DERIVATI DA TALE MEDICINALE, SE NECESSARIO",140002.0,True,12
5043,140013,NAP,Labelling,it,11,NOME E INDIRIZZO DEL TITOLARE DELL’AUTORIZZAZIONE ALL’IMMISSIONE IN COMMERCIO,140002.0,True,13
5044,140014,NAP,Labelling,it,12,NUMERO(I) DELL’AUTORIZZAZIONE ALL’IMMISSIONE IN COMMERCIO ,140002.0,True,14
5045,140015,NAP,Labelling,it,13,NUMERO DI LOTTO,140002.0,True,15
5046,140016,NAP,Labelling,it,14,CONDIZIONE GENERALE DI FORNITURA,140002.0,True,16
5047,140017,NAP,Labelling,it,15,ISTRUZIONI PER L’USO,140002.0,True,17
5048,140018,NAP,Labelling,it,16,INFORMAZIONI IN BRAILLE,140002.0,True,18
5049,140019,NAP,Labelling,it,17,IDENTIFICATIVO UNICO – CODICE A BARRE BIDIMENSIONALE,140002.0,True,19
5050,140020,NAP,Labelling,it,18,IDENTIFICATIVO UNICO - DATI LEGGIBILI ,140002.0,True,20
5051,140021,NAP,Labelling,it,,INFORMAZIONI MINIME DA APPORRE SU BLISTER O STRIP,140001.0,True,21
5052,140022,NAP,Labelling,it,1,DENOMINAZIONE DEL MEDICINALE,140021.0,True,22
5053,140023,NAP,Labelling,it,2,NOME DEL TITOLARE DELL’AUTORIZZAZIONE ALL’IMMISSIONE IN COMMERCIO,140021.0,True,23
5054,140024,NAP,Labelling,it,3,DATA DI SCADENZA,140021.0,True,24
5055,140025,NAP,Labelling,it,4,NUMERO DI LOTTO,140021.0,True,25
5056,140026,NAP,Labelling,it,5,ALTRO,140021.0,True,26
5057,140027,NAP,Labelling,it,,INFORMAZIONI MINIME DA APPORRE SUI CONFEZIONAMENTI PRIMARI DI PICCOLE DIMENSIONI,140001.0,True,27
5058,140028,NAP,Labelling,it,1,DENOMINAZIONE DEL MEDICINALE E VIA(E) DI SOMMINISTRAZIONE,140027.0,True,28
5059,140029,NAP,Labelling,it,2,MODO DI SOMMINISTRAZIONE,140027.0,True,29
5060,140030,NAP,Labelling,it,3,DATA DI SCADENZA,140027.0,True,30
5061,140031,NAP,Labelling,it,4,NUMERO DI LOTTO,140027.0,True,31
5062,140032,NAP,Labelling,it,5,"CONTENUTO IN PESO, VOLUME O UNITÀ",140027.0,True,32
5063,140033,NAP,Labelling,it,6,ALTRO,140027.0,True,33
5064,141001,NAP,Package leaflet,it,,FOGLIO ILLUSTRATIVO,,True,1
5065,141002,NAP,Package leaflet,it,,q Medicinale sottoposto a monitoraggio addizionale. Ciò permetterà la rapida identificazione di nuove informazioni sulla sicurezza. Lei può contribuire segnalando qualsiasi effetto indesiderato riscontrato durante l’assunzione di questo medicinale. Vedere la fine del paragrafo 4 per le informazioni su come segnalare gli effetti indesiderati.,141001.0,False,2
5066,141003,NAP,Package leaflet,it,,Contenuto di questo foglio,141001.0,True,3
5067,141004,NAP,Package leaflet,it,1,Cos’è X e a cosa serve,141001.0,True,4
5068,141005,NAP,Package leaflet,it,2,Cosa deve sapere prima di <prendere> <usare> X ,141001.0,True,5
5069,141006,NAP,Package leaflet,it,,Non <prenda> <usi> X,141005.0,True,6
5070,141007,NAP,Package leaflet,it,,Avvertenze e precauzioni,141005.0,True,7
5071,141008,NAP,Package leaflet,it,,Bambini <e adolescenti>,141005.0,True,8
5072,141009,NAP,Package leaflet,it,,Altri medicinali e X,141005.0,True,9
5073,141010,NAP,Package leaflet,it,,"X con <cibi> <e> <,> <bevande> <e> <alcol>",141005.0,True,10
5074,141011,NAP,Package leaflet,it,,"Gravidanza <e> <,> allattamento <e fertilità>",141005.0,True,11
5075,141012,NAP,Package leaflet,it,,Guida di veicoli e utilizzo di macchinari,141005.0,True,12
5076,141013,NAP,Package leaflet,it,,X contiene {nome del(degli) eccipiente(i)},141005.0,False,13
5077,141014,NAP,Package leaflet,it,3,Come <prendere> <usare> X,141001.0,True,14
5078,141015,NAP,Package leaflet,it,,Uso nei bambini <e negli adolescenti>,141014.0,False,15
5079,141016,NAP,Package leaflet,it,,Se <prende> <usa> più X di quanto deve,141014.0,False,16
5080,141017,NAP,Package leaflet,it,,Se dimentica di <prendere> <usare> X,141014.0,False,17
5081,141018,NAP,Package leaflet,it,,Se interrompe il trattamento con X,141014.0,False,18
5082,141019,NAP,Package leaflet,it,4,Possibili effetti indesiderati,141001.0,True,19
5083,141020,NAP,Package leaflet,it,,Effetti indesiderati aggiuntivi nei bambini <e negli adolescenti>,141019.0,False,20
5084,141021,NAP,Package leaflet,it,,Segnalazione degli effetti indesiderati,141019.0,True,21
5085,141022,NAP,Package leaflet,it,5,Come conservare X,141001.0,True,22
5086,141023,NAP,Package leaflet,it,6,Contenuto della confezione e altre informazioni,141001.0,True,23
5087,141024,NAP,Package leaflet,it,,Cosa contiene X,141023.0,True,24
5088,141025,NAP,Package leaflet,it,,Descrizione dell’aspetto di X e contenuto della confezione,141023.0,True,25
5089,141026,NAP,Package leaflet,it,,Titolare dell’autorizzazione all’immissione in commercio e produttore,141023.0,True,26
5090,141027,NAP,Package leaflet,it,,Questo medicinale è autorizzato negli Stati Membri dello Spazio economico europeo con le seguenti denominazioni:,141023.0,False,27
5091,141028,NAP,Package leaflet,it,,Questo foglio illustrativo è stato aggiornato il <{MM/AAAA}><{mese AAAA}>.,141023.0,True,28
5092,141029,NAP,Package leaflet,it,,Altre fonti d’informazioni,141023.0,False,29
5093,141030,NAP,Package leaflet,it,,Le informazioni seguenti sono destinate esclusivamente agli operatori sanitari:,141001.0,False,30
5094,142001,NAP,SmPC,lt,,PREPARATO CHARAKTERISTIKŲ SANTRAUKA,,True,1
5095,142002,NAP,SmPC,lt,,"qVykdoma papildoma šio vaistinio preparato stebėsena. Tai padės greitai nustatyti naują saugumo informaciją. Sveikatos priežiūros specialistai turi pranešti apie bet kokias įtariamas nepageidaujamas reakcijas. Apie tai, kaip pranešti apie nepageidaujamas reakcijas, žr. 4.8 skyriuje.> ",142001.0,False,2
5096,142003,NAP,SmPC,lt,1,VAISTINIO PREPARATO PAVADINIMAS,142001.0,True,3
5097,142004,NAP,SmPC,lt,2,KOKYBINĖ IR KIEKYBINĖ SUDĖTIS,142001.0,True,4
5098,142005,NAP,SmPC,lt,,"Pagalbinė (-s) medžiaga (-os), kurios (-ių) poveikis žinomas",142004.0,False,5
5099,142006,NAP,SmPC,lt,3,FARMACINĖ FORMA,142001.0,True,6
5100,142007,NAP,SmPC,lt,4,KLINIKINĖ INFORMACIJA,142001.0,True,7
5101,142008,NAP,SmPC,lt,4.1,Terapinės indikacijos,142007.0,True,8
5102,142009,NAP,SmPC,lt,4.2,Dozavimas ir vartojimo metodas,142007.0,True,9
5103,142010,NAP,SmPC,lt,,Dozavimas,142009.0,True,10
5104,142011,NAP,SmPC,lt,,Vaikų populiacija,142010.0,True,11
5105,142012,NAP,SmPC,lt,,Vartojimo metodas,142009.0,True,12
5106,142013,NAP,SmPC,lt,,Atsargumo priemonės prieš ruošiant ar vartojant šį vaistinį preparatą,142012.0,False,13
5107,142014,NAP,SmPC,lt,4.3,Kontraindikacijos,142007.0,True,14
5108,142015,NAP,SmPC,lt,4.4,Specialūs įspėjimai ir atsargumo priemonės,142007.0,True,15
5109,142016,NAP,SmPC,lt,,Atsekamumas,142015.0,False,16
5110,142017,NAP,SmPC,lt,,Vaikų populiacija,142015.0,False,17
5111,142018,NAP,SmPC,lt,4.5,Sąveika su kitais vaistiniais preparatais ir kitokia sąveika,142007.0,True,18
5112,142019,NAP,SmPC,lt,,Vaikų populiacija,142018.0,False,19
5113,142020,NAP,SmPC,lt,4.6,"Vaisingumas, nėštumo ir žindymo laikotarpis",142007.0,True,20
5114,142021,NAP,SmPC,lt,,Nėštumas,142020.0,False,21
5115,142022,NAP,SmPC,lt,,Žindymas,142020.0,False,22
5116,142023,NAP,SmPC,lt,,Vaisingumas,142020.0,False,23
5117,142024,NAP,SmPC,lt,4.7,Poveikis gebėjimui vairuoti ir valdyti mechanizmus,142007.0,True,24
5118,142025,NAP,SmPC,lt,4.8,Nepageidaujamas poveikis,142007.0,True,25
5119,142026,NAP,SmPC,lt,,Vaikų populiacija,142025.0,False,26
5120,142027,NAP,SmPC,lt,,Pranešimas apie įtariamas nepageidaujamas reakcijas,142025.0,True,27
5121,142028,NAP,SmPC,lt,4.9,Perdozavimas,142007.0,True,28
5122,142029,NAP,SmPC,lt,,Vaikų populiacija,142028.0,False,29
5123,142030,NAP,SmPC,lt,5,FARMAKOLOGINĖS SAVYBĖS,142001.0,True,30
5124,142031,NAP,SmPC,lt,5.1,Farmakodinaminės savybės,142030.0,True,31
5125,142032,NAP,SmPC,lt,,Veikimo mechanizmas,142031.0,False,32
5126,142033,NAP,SmPC,lt,,Farmakodinaminis poveikis,142031.0,False,33
5127,142034,NAP,SmPC,lt,,Klinikinis veiksmingumas ir saugumas,142031.0,False,34
5128,142035,NAP,SmPC,lt,,Vaikų populiacija,142031.0,False,35
5129,142036,NAP,SmPC,lt,5.2,Farmakokinetinės savybės,142030.0,True,36
5130,142037,NAP,SmPC,lt,,Absorbcija,142036.0,False,37
5131,142038,NAP,SmPC,lt,,Pasiskirstymas,142036.0,False,38
5132,142039,NAP,SmPC,lt,,Biotransformacija,142036.0,False,39
5133,142040,NAP,SmPC,lt,,Eliminacija,142036.0,False,40
5134,142041,NAP,SmPC,lt,,Tiesinis / netiesinis pobūdis,142036.0,False,41
5135,142042,NAP,SmPC,lt,,Santykis tarp farmakokinetikos ir farmakodinamikos,142036.0,False,42
5136,142043,NAP,SmPC,lt,5.3,Ikiklinikinių saugumo tyrimų duomenys,142030.0,True,43
5137,142044,NAP,SmPC,lt,,Pavojaus aplinkai vertinimas (PAV),142043.0,False,44
5138,142045,NAP,SmPC,lt,6,FARMACINĖ INFORMACIJA,142001.0,True,45
5139,142046,NAP,SmPC,lt,6.1,Pagalbinių medžiagų sąrašas,142045.0,True,46
5140,142047,NAP,SmPC,lt,6.2,Nesuderinamumas,142045.0,True,47
5141,142048,NAP,SmPC,lt,6.3,Tinkamumo laikas,142045.0,True,48
5142,142049,NAP,SmPC,lt,6.4,Specialios laikymo sąlygos,142045.0,True,49
5143,142050,NAP,SmPC,lt,6.5,Talpyklės pobūdis ir jos turinys,142045.0,True,50
5144,142051,NAP,SmPC,lt,6.6,Specialūs reikalavimai atliekoms tvarkyti <ir vaistiniam preparatui ruošti>,142045.0,True,51
5145,142052,NAP,SmPC,lt,,Vartojimas vaikų populiacijai,142051.0,False,52
5146,142053,NAP,SmPC,lt,7,REGISTRUOTOJAS,142001.0,True,53
5147,142054,NAP,SmPC,lt,8,REGISTRACIJOS PAŽYMĖJIMO NUMERIS (-IAI),142001.0,True,54
5148,142055,NAP,SmPC,lt,9,REGISTRAVIMO / PERREGISTRAVIMO DATA,142001.0,True,55
5149,142056,NAP,SmPC,lt,10,TEKSTO PERŽIŪROS DATA,142001.0,True,56
5150,142057,NAP,SmPC,lt,11,DOZIMETRIJA,142001.0,False,57
5151,142058,NAP,SmPC,lt,12,RADIOFARMACINIŲ PREPARATŲ RUOŠIMO INSTRUKCIJA,142001.0,False,58
5152,143001,NAP,Labelling,lt,,ŽENKLINIMAS,,True,1
5153,143002,NAP,Labelling,lt,,INFORMACIJA ANT <IŠORINĖS> <IR> <VIDINĖS> PAKUOTĖS,143001.0,True,2
5154,143003,NAP,Labelling,lt,1,VAISTINIO PREPARATO PAVADINIMAS,143002.0,True,3
5155,143004,NAP,Labelling,lt,2,VEIKLIOJI (-IOS) MEDŽIAGA (-OS) IR JOS (-Ų) KIEKIS (-IAI),143002.0,True,4
5156,143005,NAP,Labelling,lt,3,PAGALBINIŲ MEDŽIAGŲ SĄRAŠAS,143002.0,True,5
5157,143006,NAP,Labelling,lt,4,FARMACINĖ FORMA IR KIEKIS PAKUOTĖJE,143002.0,True,6
5158,143007,NAP,Labelling,lt,5,VARTOJIMO METODAS IR BŪDAS (-AI),143002.0,True,7
5159,143008,NAP,Labelling,lt,6,"SPECIALUS ĮSPĖJIMAS, KAD VAISTINĮ PREPARATĄ BŪTINA LAIKYTI VAIKAMS NEPASTEBIMOJE IR NEPASIEKIAMOJE VIETOJE",143002.0,True,8
5160,143009,NAP,Labelling,lt,7,KITAS (-I) SPECIALUS (-ŪS) ĮSPĖJIMAS (-AI) (JEI REIKIA),143002.0,True,9
5161,143010,NAP,Labelling,lt,8,TINKAMUMO LAIKAS,143002.0,True,10
5162,143011,NAP,Labelling,lt,9,SPECIALIOS LAIKYMO SĄLYGOS,143002.0,True,11
5163,143012,NAP,Labelling,lt,10,SPECIALIOS ATSARGUMO PRIEMONĖS DĖL NESUVARTOTO VAISTINIO PREPARATO AR JO ATLIEKŲ TVARKYMO (JEI REIKIA),143002.0,True,12
5164,143013,NAP,Labelling,lt,11,REGISTRUOTOJO PAVADINIMAS IR ADRESAS,143002.0,True,13
5165,143014,NAP,Labelling,lt,12,REGISTRACIJOS PAŽYMĖJIMO NUMERIS (-IAI) ,143002.0,True,14
5166,143015,NAP,Labelling,lt,13,SERIJOS NUMERIS,143002.0,True,15
5167,143016,NAP,Labelling,lt,14,PARDAVIMO (IŠDAVIMO) TVARKA,143002.0,True,16
5168,143017,NAP,Labelling,lt,15,VARTOJIMO INSTRUKCIJA,143002.0,True,17
5169,143018,NAP,Labelling,lt,16,INFORMACIJA BRAILIO RAŠTU,143002.0,True,18
5170,143019,NAP,Labelling,lt,17,UNIKALUS IDENTIFIKATORIUS – 2D BRŪKŠNINIS KODAS,143002.0,True,19
5171,143020,NAP,Labelling,lt,18,UNIKALUS IDENTIFIKATORIUS – ŽMONĖMS SUPRANTAMI DUOMENYS,143002.0,True,20
5172,143021,NAP,Labelling,lt,,MINIMALI INFORMACIJA ANT LIZDINIŲ PLOKŠTELIŲ ARBA DVISLUOKSNIŲ JUOSTELIŲ,143001.0,True,21
5173,143022,NAP,Labelling,lt,1,VAISTINIO PREPARATO PAVADINIMAS,143021.0,True,22
5174,143023,NAP,Labelling,lt,2,REGISTRUOTOJO PAVADINIMAS,143021.0,True,23
5175,143024,NAP,Labelling,lt,3,TINKAMUMO LAIKAS,143021.0,True,24
5176,143025,NAP,Labelling,lt,4,SERIJOS NUMERIS,143021.0,True,25
5177,143026,NAP,Labelling,lt,5,KITA,143021.0,True,26
5178,143027,NAP,Labelling,lt,,MINIMALI INFORMACIJA ANT MAŽŲ VIDINIŲ PAKUOČIŲ,143001.0,True,27
5179,143028,NAP,Labelling,lt,1,VAISTINIO PREPARATO PAVADINIMAS IR VARTOJIMO BŪDAS (-AI),143027.0,True,28
5180,143029,NAP,Labelling,lt,2,VARTOJIMO METODAS,143027.0,True,29
5181,143030,NAP,Labelling,lt,3,TINKAMUMO LAIKAS,143027.0,True,30
5182,143031,NAP,Labelling,lt,4,SERIJOS NUMERIS,143027.0,True,31
5183,143032,NAP,Labelling,lt,5,"KIEKIS (MASĖ, TŪRIS ARBA VIENETAI)",143027.0,True,32
5184,143033,NAP,Labelling,lt,6,KITA,143027.0,True,33
5185,144001,NAP,Package leaflet,lt,,PAKUOTĖS LAPELIS,,True,1
5186,144002,NAP,Package leaflet,lt,,"qVykdoma papildoma šio vaisto stebėsena. Tai padės greitai nustatyti naują saugumo informaciją. Mums galite padėti pranešdami apie bet kokį Jums pasireiškiantį šalutinį poveikį. Apie tai, kaip pranešti apie šalutinį poveikį, žr. 4 skyriaus pabaigoje. ",144001.0,False,2
5187,144003,NAP,Package leaflet,lt,,Apie ką rašoma šiame lapelyje?,144001.0,True,3
5188,144004,NAP,Package leaflet,lt,1,Kas yra X ir kam jis vartojamas,144001.0,True,4
5189,144005,NAP,Package leaflet,lt,2,Kas žinotina prieš vartojant X,144001.0,True,5
5190,144006,NAP,Package leaflet,lt,,X vartoti negalima,144005.0,True,6
5191,144007,NAP,Package leaflet,lt,,Įspėjimai ir atsargumo priemonės,144005.0,True,7
5192,144008,NAP,Package leaflet,lt,,Vaikams <ir paaugliams>,144005.0,True,8
5193,144009,NAP,Package leaflet,lt,,Kiti vaistai ir X,144005.0,True,9
5194,144010,NAP,Package leaflet,lt,,"X vartojimas su <maistu> <ir> <,> <gėrimais> <ir> <alkoholiu>",144005.0,True,10
5195,144011,NAP,Package leaflet,lt,,"Nėštumas <ir> <,> žindymo laikotarpis <ir vaisingumas>",144005.0,True,11
5196,144012,NAP,Package leaflet,lt,,Vairavimas ir mechanizmų valdymas,144005.0,True,12
5197,144013,NAP,Package leaflet,lt,,X sudėtyje yra {pagalbinės (-ių) medžiagos (-ų) pavadinimas (-ai)},144005.0,False,13
5198,144014,NAP,Package leaflet,lt,3,Kaip vartoti X,144001.0,True,14
5199,144015,NAP,Package leaflet,lt,,Vartojimas vaikams <ir paaugliams>,144014.0,False,15
5200,144016,NAP,Package leaflet,lt,,Ką daryti pavartojus per didelę X dozę?,144014.0,False,16
5201,144017,NAP,Package leaflet,lt,,Pamiršus pavartoti X,144014.0,False,17
5202,144018,NAP,Package leaflet,lt,,Nustojus vartoti X,144014.0,False,18
5203,144019,NAP,Package leaflet,lt,4,Galimas šalutinis poveikis,144001.0,True,19
5204,144020,NAP,Package leaflet,lt,,"Kitas šalutinis poveikis, kuris gali pasireikšti vaikams <ir paaugliams>",144019.0,False,20
5205,144021,NAP,Package leaflet,lt,,Pranešimas apie šalutinį poveikį,144019.0,True,21
5206,144022,NAP,Package leaflet,lt,5,Kaip laikyti X,144001.0,True,22
5207,144023,NAP,Package leaflet,lt,6,Pakuotės turinys ir kita informacija,144001.0,True,23
5208,144024,NAP,Package leaflet,lt,,X sudėtis,144023.0,True,24
5209,144025,NAP,Package leaflet,lt,,X išvaizda ir kiekis pakuotėje,144023.0,True,25
5210,144026,NAP,Package leaflet,lt,,Registruotojas ir gamintojas,144023.0,True,26
5211,144027,NAP,Package leaflet,lt,,Šis vaistas EEE valstybėse narėse registruotas tokiais pavadinimais:,144023.0,False,27
5212,144028,NAP,Package leaflet,lt,,Šis pakuotės lapelis paskutinį kartą peržiūrėtas <{MMMM m. {mėnesio} mėn.}.>.,144023.0,True,28
5213,144029,NAP,Package leaflet,lt,,Kiti informacijos šaltiniai,144023.0,False,29
5214,144030,NAP,Package leaflet,lt,,Toliau pateikta informacija skirta tik sveikatos priežiūros specialistams.,144001.0,False,30
5215,145001,NAP,SmPC,lv,,ZĀĻU APRAKSTS,,True,1
5216,145002,NAP,SmPC,lv,,"qŠīm zālēm tiek piemērota papildu uzraudzība. Tādējādi būs iespējams ātri identificēt jaunāko informāciju par šo zāļu drošumu. Veselības aprūpes speciālisti tiek lūgti ziņot par jebkādām iespējamām nevēlamām blakusparādībām. Skatīt 4.8. apakšpunktu par to, kā ziņot par nevēlamām blakusparādībām.",145001.0,False,2
5217,145003,NAP,SmPC,lv,1,ZĀĻU NOSAUKUMS,145001.0,True,3
5218,145004,NAP,SmPC,lv,2,KVALITATĪVAIS UN KVANTITATĪVAIS SASTĀVS,145001.0,True,4
5219,145005,NAP,SmPC,lv,,Palīgviela(-s) ar zināmu iedarbību,145004.0,False,5
5220,145006,NAP,SmPC,lv,3,ZĀĻU FORMA,145001.0,True,6
5221,145007,NAP,SmPC,lv,4,KLĪNISKĀ INFORMĀCIJA ,145001.0,True,7
5222,145008,NAP,SmPC,lv,4.1,Terapeitiskās indikācijas,145007.0,True,8
5223,145009,NAP,SmPC,lv,4.2,Devas un lietošanas veids,145007.0,True,9
5224,145010,NAP,SmPC,lv,,Devas ,145009.0,True,10
5225,145011,NAP,SmPC,lv,,Pediatriskā populācija,145010.0,True,11
5226,145012,NAP,SmPC,lv,,Lietošanas veids,145009.0,True,12
5227,145013,NAP,SmPC,lv,,Piesardzības pasākumi pirms zāļu lietošanas vai rīkošanās ar tām,145012.0,False,13
5228,145014,NAP,SmPC,lv,4.3,Kontrindikācijas ,145007.0,True,14
5229,145015,NAP,SmPC,lv,4.4,Īpaši brīdinājumi un piesardzība lietošanā,145007.0,True,15
5230,145016,NAP,SmPC,lv,,Izsekojamība,145015.0,False,16
5231,145017,NAP,SmPC,lv,,Pediatriskā populācija,145015.0,False,17
5232,145018,NAP,SmPC,lv,4.5,Mijiedarbība ar citām zālēm un citi mijiedarbības veidi,145007.0,True,18
5233,145019,NAP,SmPC,lv,,Pediatriskā populācija,145018.0,False,19
5234,145020,NAP,SmPC,lv,4.6,"Fertilitāte, grūtniecība un barošana ar krūti",145007.0,True,20
5235,145021,NAP,SmPC,lv,,Grūtniecība,145020.0,False,21
5236,145022,NAP,SmPC,lv,,Barošana ar krūti,145020.0,False,22
5237,145023,NAP,SmPC,lv,,Fertilitāte,145020.0,False,23
5238,145024,NAP,SmPC,lv,4.7,Ietekme uz spēju vadīt transportlīdzekļus un apkalpot mehānismus,145007.0,True,24
5239,145025,NAP,SmPC,lv,4.8,Nevēlamās blakusparādības,145007.0,True,25
5240,145026,NAP,SmPC,lv,,Pediatriskā populācija,145025.0,False,26
5241,145027,NAP,SmPC,lv,,Ziņošana par iespējamām nevēlamām blakusparādībām,145025.0,True,27
5242,145028,NAP,SmPC,lv,4.9,Pārdozēšana,145007.0,True,28
5243,145029,NAP,SmPC,lv,,Pediatriskā populācija,145028.0,False,29
5244,145030,NAP,SmPC,lv,5,FARMAKOLOĢISKĀS ĪPAŠĪBAS ,145001.0,True,30
5245,145031,NAP,SmPC,lv,5.1,Farmakodinamiskās īpašības,145030.0,True,31
5246,145032,NAP,SmPC,lv,,Darbības mehānisms,145031.0,False,32
5247,145033,NAP,SmPC,lv,,Farmakodinamiskā iedarbība,145031.0,False,33
5248,145034,NAP,SmPC,lv,,Klīniskā efektivitāte un drošums,145031.0,False,34
5249,145035,NAP,SmPC,lv,,Pediatriskā populācija,145031.0,False,35
5250,145036,NAP,SmPC,lv,5.2,Farmakokinētiskās īpašības,145030.0,True,36
5251,145037,NAP,SmPC,lv,,Uzsūkšanās,145036.0,False,37
5252,145038,NAP,SmPC,lv,,Izkliede,145036.0,False,38
5253,145039,NAP,SmPC,lv,,Biotransformācija,145036.0,False,39
5254,145040,NAP,SmPC,lv,,Eliminācija,145036.0,False,40
5255,145041,NAP,SmPC,lv,,Linearitāte/nelinearitāte,145036.0,False,41
5256,145042,NAP,SmPC,lv,,Farmakokinētiskā(-s)/farmakodinamiskā(-s) attiecība(-s),145036.0,False,42
5257,145043,NAP,SmPC,lv,5.3,Preklīniskie dati par drošumu,145030.0,True,43
5258,145044,NAP,SmPC,lv,,Vides riska novērtējums (VRN,145043.0,False,44
5259,145045,NAP,SmPC,lv,6,FARMACEITISKĀ INFORMĀCIJA,145001.0,True,45
5260,145046,NAP,SmPC,lv,6.1,Palīgvielu saraksts,145045.0,True,46
5261,145047,NAP,SmPC,lv,6.2,Nesaderība,145045.0,True,47
5262,145048,NAP,SmPC,lv,6.3,Uzglabāšanas laiks,145045.0,True,48
5263,145049,NAP,SmPC,lv,6.4,Īpaši uzglabāšanas nosacījumi,145045.0,True,49
5264,145050,NAP,SmPC,lv,6.5,Iepakojuma veids un saturs,145045.0,True,50
5265,145051,NAP,SmPC,lv,6.6,Īpaši norādījumi atkritumu likvidēšanai <un citi norādījumi par rīkošanos>,145045.0,True,51
5266,145052,NAP,SmPC,lv,,Lietošana pediatriskā populācijā,145051.0,False,52
5267,145053,NAP,SmPC,lv,7,REĢISTRĀCIJAS APLIECĪBAS ĪPAŠNIEKS,145001.0,True,53
5268,145054,NAP,SmPC,lv,8,REĢISTRĀCIJAS APLIECĪBAS NUMURS(-I) ,145001.0,True,54
5269,145055,NAP,SmPC,lv,9,PIRMĀS REĢISTRĀCIJAS/PĀRREĢISTRĀCIJAS DATUMS,145001.0,True,55
5270,145056,NAP,SmPC,lv,10,TEKSTA PĀRSKATĪŠANAS DATUMS,145001.0,True,56
5271,145057,NAP,SmPC,lv,11,DOZIMETRIJA,145001.0,False,57
5272,145058,NAP,SmPC,lv,12,NORĀDĪJUMI PAR RADIOFARMACEITISKO ZĀĻU SAGATAVOŠANU,145001.0,False,58
5273,146001,NAP,MARĶĒJUMA TEKSTS,lv,,MARĶĒJUMA TEKSTS,,True,1
5274,146002,NAP,MARĶĒJUMA TEKSTS,lv,,"INFORMĀCIJA, KAS JĀNORĀDA UZ <ĀRĒJĀ IEPAKOJUMA > <UN> < UZ TIEŠĀ IEPAKOJUMA>",146001.0,True,2
5275,146003,NAP,MARĶĒJUMA TEKSTS,lv,1,ZĀĻU NOSAUKUMS,146002.0,True,3
5276,146004,NAP,MARĶĒJUMA TEKSTS,lv,2,AKTĪVĀS(-O) VIELAS(-U) NOSAUKUMS(-I) UN DAUDZUMS(-I),146002.0,True,4
5277,146005,NAP,MARĶĒJUMA TEKSTS,lv,3,PALĪGVIELU SARAKSTS,146002.0,True,5
5278,146006,NAP,MARĶĒJUMA TEKSTS,lv,4,ZĀĻU FORMA UN SATURS,146002.0,True,6
5279,146007,NAP,MARĶĒJUMA TEKSTS,lv,5,LIETOŠANAS UN IEVADĪŠANAS VEIDS(-I) ,146002.0,True,7
5280,146008,NAP,MARĶĒJUMA TEKSTS,lv,6,ĪPAŠI BRĪDINĀJUMI PAR ZĀĻU UZGLABĀŠANU BĒRNIEM NEREDZAMĀ UN NEPIEEJAMĀ VIETĀ,146002.0,True,8
5281,146009,NAP,MARĶĒJUMA TEKSTS,lv,7,"CITI ĪPAŠI BRĪDINĀJUMI, JA NEPIECIEŠAMS",146002.0,True,9
5282,146010,NAP,MARĶĒJUMA TEKSTS,lv,8,DERĪGUMA TERMIŅŠ,146002.0,True,10
5283,146011,NAP,MARĶĒJUMA TEKSTS,lv,9,ĪPAŠI UZGLABĀŠANAS NOSACĪJUMI,146002.0,True,11
5284,146012,NAP,MARĶĒJUMA TEKSTS,lv,10,"ĪPAŠI PIESARDZĪBAS PASĀKUMI, IZNĪCINOT NEIZLIETOTĀS ZĀLES VAI IZMANTOTOS MATERIĀLUS, KAS BIJUŠI SASKARĒ AR ŠĪM ZĀLĒM, JA PIEMĒROJAMS",146002.0,True,12
5285,146013,NAP,MARĶĒJUMA TEKSTS,lv,11,REĢISTRĀCIJAS APLIECĪBAS ĪPAŠNIEKA NOSAUKUMS UN ADRESE ,146002.0,True,13
5286,146014,NAP,MARĶĒJUMA TEKSTS,lv,12,REĢISTRĀCIJAS APLIECĪBAS NUMURS(-I),146002.0,True,14
5287,146015,NAP,MARĶĒJUMA TEKSTS,lv,13,SĒRIJAS NUMURS,146002.0,True,15
5288,146016,NAP,MARĶĒJUMA TEKSTS,lv,14,IZSNIEGŠANAS KĀRTĪBA,146002.0,True,16
5289,146017,NAP,MARĶĒJUMA TEKSTS,lv,15,NORĀDĪJUMI PAR LIETOŠANU,146002.0,True,17
5290,146018,NAP,MARĶĒJUMA TEKSTS,lv,16,INFORMĀCIJA BRAILA RAKSTĀ  ,146002.0,True,18
5291,146019,NAP,MARĶĒJUMA TEKSTS,lv,17,UNIKĀLS IDENTIFIKATORS – 2D SVĪTRKODS,146002.0,True,19
5292,146020,NAP,MARĶĒJUMA TEKSTS,lv,18,"UNIKĀLS IDENTIFIKATORS – DATI, KURUS VAR NOLASĪT PERSONA",146002.0,True,20
5293,146021,NAP,MARĶĒJUMA TEKSTS,lv,,"MINIMĀLĀ INFORMĀCIJA, KAS JĀNORĀDA UZ BLISTERA VAI PLĀKSNĪTES",146001.0,True,21
5294,146022,NAP,MARĶĒJUMA TEKSTS,lv,1,ZĀĻU NOSAUKUMS ,146021.0,True,22
5295,146023,NAP,MARĶĒJUMA TEKSTS,lv,2,REĢISTRĀCIJAS APLIECĪBAS ĪPAŠNIEKA NOSAUKUMS ,146021.0,True,23
5296,146024,NAP,MARĶĒJUMA TEKSTS,lv,3,DERĪGUMA TERMIŅŠ ,146021.0,True,24
5297,146025,NAP,MARĶĒJUMA TEKSTS,lv,4,SĒRIJAS NUMURS,146021.0,True,25
5298,146026,NAP,MARĶĒJUMA TEKSTS,lv,5,CITA,146021.0,True,26
5299,146027,NAP,MARĶĒJUMA TEKSTS,lv,,"MINIMĀLĀ INFORMĀCIJA, KAS JĀNORĀDA UZ MAZA IZMĒRA TIEŠĀ IEPAKOJUMA",146001.0,True,27
5300,146028,NAP,MARĶĒJUMA TEKSTS,lv,1,ZĀĻU NOSAUKUMS UN IEVADĪŠANAS VEIDS(-I) ,146027.0,True,28
5301,146029,NAP,MARĶĒJUMA TEKSTS,lv,2,LIETOŠANAS VEIDS,146027.0,True,29
5302,146030,NAP,MARĶĒJUMA TEKSTS,lv,3,DERĪGUMA TERMIŅŠ,146027.0,True,30
5303,146031,NAP,MARĶĒJUMA TEKSTS,lv,4,SĒRIJAS NUMURS,146027.0,True,31
5304,146032,NAP,MARĶĒJUMA TEKSTS,lv,5,"SATURA SVARS, TILPUMS VAI VIENĪBU DAUDZUMS",146027.0,True,32
5305,146033,NAP,MARĶĒJUMA TEKSTS,lv,6,CITA,146027.0,True,33
5306,147001,NAP,LIETOŠANAS INSTRUKCIJA,lv,,LIETOŠANAS INSTRUKCIJA,,True,1
5307,147002,NAP,LIETOŠANAS INSTRUKCIJA,lv,,"qŠīm zālēm tiek piemērota papildu uzraudzība. Tādējādi būs iespējams ātri identificēt jaunāko informāciju par šo zāļu drošumu. Jūs varat palīdzēt, ziņojot par jebkādām novērotajām blakusparādībām. Par to, kā ziņot par blakusparādībām, skatīt 4. punkta beigās.",147001.0,False,2
5308,147003,NAP,LIETOŠANAS INSTRUKCIJA,lv,,Šajā instrukcijā varat uzzināt: ,147001.0,True,3
5309,147004,NAP,LIETOŠANAS INSTRUKCIJA,lv,1,Kas ir X un kādam nolūkam tās/to lieto,147001.0,True,4
5310,147005,NAP,LIETOŠANAS INSTRUKCIJA,lv,2,Kas Jums jāzina pirms X lietošanas,147001.0,True,5
5311,147006,NAP,LIETOŠANAS INSTRUKCIJA,lv,,Nelietojiet X šādos gadījumos<:>,147005.0,True,6
5312,147007,NAP,LIETOŠANAS INSTRUKCIJA,lv,,Brīdinājumi un piesardzība lietošanā,147005.0,True,7
5313,147008,NAP,LIETOŠANAS INSTRUKCIJA,lv,,Bērni un <pusaudži> ,147005.0,True,8
5314,147009,NAP,LIETOŠANAS INSTRUKCIJA,lv,,Citas zāles un X,147005.0,True,9
5315,147010,NAP,LIETOŠANAS INSTRUKCIJA,lv,,"X kopā ar <uzturu> <un> <,> <dzērienu> <un> <alkoholu>",147005.0,True,10
5316,147011,NAP,LIETOŠANAS INSTRUKCIJA,lv,,"Grūtniecība <un> <,> barošana ar krūti <un fertilitāte>",147005.0,True,11
5317,147012,NAP,LIETOŠANAS INSTRUKCIJA,lv,,Transportlīdzekļu vadīšana un mehānismu apkalpošana,147005.0,True,12
5318,147013,NAP,LIETOŠANAS INSTRUKCIJA,lv,,X satur {palīgvielas(-u) nosaukums(-i)},147005.0,False,13
5319,147014,NAP,LIETOŠANAS INSTRUKCIJA,lv,3,Kā lietot X,147001.0,True,14
5320,147015,NAP,LIETOŠANAS INSTRUKCIJA,lv,,Lietošana bērniem <un pusaudžiem>,147014.0,False,15
5321,147016,NAP,LIETOŠANAS INSTRUKCIJA,lv,,Ja esat lietojis X vairāk nekā noteikts,147014.0,False,16
5322,147017,NAP,LIETOŠANAS INSTRUKCIJA,lv,,Ja esat aizmirsis lietot X,147014.0,False,17
5323,147018,NAP,LIETOŠANAS INSTRUKCIJA,lv,,Ja pārtraucat lietot X,147014.0,False,18
5324,147019,NAP,LIETOŠANAS INSTRUKCIJA,lv,4,Iespējamās blakusparādības,147001.0,True,19
5325,147020,NAP,LIETOŠANAS INSTRUKCIJA,lv,,Papildu blakusparādības bērniem <un pusaudžiem>,147019.0,False,20
5326,147021,NAP,LIETOŠANAS INSTRUKCIJA,lv,,Ziņošana par blakusparādībām,147019.0,True,21
5327,147022,NAP,LIETOŠANAS INSTRUKCIJA,lv,5,Kā uzglabāt X,147001.0,True,22
5328,147023,NAP,LIETOŠANAS INSTRUKCIJA,lv,6,Iepakojuma saturs un cita informācija,147001.0,True,23
5329,147024,NAP,LIETOŠANAS INSTRUKCIJA,lv,,Ko X satur,147023.0,True,24
5330,147025,NAP,LIETOŠANAS INSTRUKCIJA,lv,,X ārējais izskats un iepakojums,147023.0,True,25
5331,147026,NAP,LIETOŠANAS INSTRUKCIJA,lv,,Reģistrācijas apliecības īpašnieks un ražotājs,147023.0,True,26
5332,147027,NAP,LIETOŠANAS INSTRUKCIJA,lv,,Šīs zāles Eiropas Ekonomikas zonas (EEZ) dalībvalstīs ir reģistrētas ar šādiem nosaukumiem:,147023.0,False,27
5333,147028,NAP,LIETOŠANAS INSTRUKCIJA,lv,,Šī lietošanas instrukcija pēdējo reizi pārskatīta <{MM/GGGG}> <GGGG. gada mēnesis}>.,147023.0,True,28
5334,147029,NAP,LIETOŠANAS INSTRUKCIJA,lv,,Citi informācijas avoti,147023.0,False,29
5335,147030,NAP,LIETOŠANAS INSTRUKCIJA,lv,,Tālāk sniegtā informācija paredzēta tikai veselības aprūpes speciālistiem.,147001.0,False,30
5336,148001,NAP,SmPC,mt,,SOMMARJU TAL-KARATTERISTIĊI TAL-PRODOTT,,True,1
5337,148002,NAP,SmPC,mt,,qDan il-prodott mediċinali huwa suġġett għal monitoraġġ addizzjonali. Dan ser jippermetti identifikazzjoni ta’ malajr ta’ informazzjoni ġdida dwar is-sigurtà. Il-professjonisti tal-kura tas-saħħa huma mitluba jirrappurtaw kwalunkwe reazzjoni avversa suspettata. Ara sezzjoni 4.8 dwar kif għandhom jiġu rappurtati reazzjonijiet avversi.,148001.0,False,2
5338,148003,NAP,SmPC,mt,1,ISEM IL-PRODOTT MEDIĊINALI,148001.0,True,3
5339,148004,NAP,SmPC,mt,2,GĦAMLA KWALITATTIVA U KWANTITATTIVA,148001.0,True,4
5340,148005,NAP,SmPC,mt,,Eċċipjent(i) b’effett magħruf,148004.0,False,5
5341,148006,NAP,SmPC,mt,3,GĦAMLA FARMAĊEWTIKA,148001.0,True,6
5342,148007,NAP,SmPC,mt,4,TAGĦRIF KLINIKU,148001.0,True,7
5343,148008,NAP,SmPC,mt,4.1,Indikazzjonijiet terapewtiċi,148007.0,True,8
5344,148009,NAP,SmPC,mt,4.2,Pożoloġija u metodu ta’ kif għandu jingħata,148007.0,True,9
5345,148010,NAP,SmPC,mt,,Pożoloġija,148009.0,True,10
5346,148011,NAP,SmPC,mt,,Popolazzjoni pedjatrika,148010.0,True,11
5347,148012,NAP,SmPC,mt,,Metodu ta’ kif għandu jingħata,148009.0,True,12
5348,148013,NAP,SmPC,mt,,Prekawzjonijiet li għandhom jittieħdu qabel tmiss il-prodott mediċinali jew qabel tagћti l-prodott mediċinali,148012.0,False,13
5349,148014,NAP,SmPC,mt,4.3,Kontraindikazzjonijiet,148007.0,True,14
5350,148015,NAP,SmPC,mt,4.4,Twissijiet speċjali u prekawzjonijiet għall-użu,148007.0,True,15
5351,148016,NAP,SmPC,mt,,Traċċabilità,148015.0,False,16
5352,148017,NAP,SmPC,mt,,Popolazzjoni pedjatrika,148015.0,False,17
5353,148018,NAP,SmPC,mt,4.5,Interazzjoni ma’ prodotti mediċinali oħra u forom oħra ta’ interazzjoni,148007.0,True,18
5354,148019,NAP,SmPC,mt,,Popolazzjoni pedjatrika,148018.0,False,19
5355,148020,NAP,SmPC,mt,4.6,"Fertilità, tqala u treddigħ",148007.0,True,20
5356,148021,NAP,SmPC,mt,,Tqala,148020.0,False,21
5357,148022,NAP,SmPC,mt,,Treddigħ,148020.0,False,22
5358,148023,NAP,SmPC,mt,,Fertilità,148020.0,False,23
5359,148024,NAP,SmPC,mt,4.7,Effetti fuq il-ħila biex issuq u tħaddem magni,148007.0,True,24
5360,148025,NAP,SmPC,mt,4.8,Effetti mhux mixtieqa,148007.0,True,25
5361,148026,NAP,SmPC,mt,,Popolazzjoni pedjatrika,148025.0,False,26
5362,148027,NAP,SmPC,mt,,Rappurtar ta’ reazzjonijiet avversi suspettati,148025.0,True,27
5363,148028,NAP,SmPC,mt,4.9,Doża eċċessiva,148007.0,True,28
5364,148029,NAP,SmPC,mt,,Popolazzjoni pedjatrika,148028.0,False,29
5365,148030,NAP,SmPC,mt,5,PROPRJETAJIET FARMAKOLOĠIĊI,148001.0,True,30
5366,148031,NAP,SmPC,mt,5.1,Proprjetajiet farmakodinamiċi,148030.0,True,31
5367,148032,NAP,SmPC,mt,,Mekkaniżmu ta’ azzjoni,148031.0,False,32
5368,148033,NAP,SmPC,mt,,Effetti farmakodinamiċi,148031.0,False,33
5369,148034,NAP,SmPC,mt,,Effikaċja klinika u sigurtà,148031.0,False,34
5370,148035,NAP,SmPC,mt,,Popolazzjoni pedjatrika,148031.0,False,35
5371,148036,NAP,SmPC,mt,5.2,Tagħrif farmakokinetiku,148030.0,True,36
5372,148037,NAP,SmPC,mt,,Assorbiment,148036.0,False,37
5373,148038,NAP,SmPC,mt,,Distribuzzjoni,148036.0,False,38
5374,148039,NAP,SmPC,mt,,Bijotrasformazzjoni,148036.0,False,39
5375,148040,NAP,SmPC,mt,,Eliminazzjoni,148036.0,False,40
5376,148041,NAP,SmPC,mt,,Linearità/nuqqas ta’ linearità,148036.0,False,41
5377,148042,NAP,SmPC,mt,,Relazzjoni(-jiet) farmakokinetika(ċi)/farmakodinamika(ċi),148036.0,False,42
5378,148043,NAP,SmPC,mt,5.3,Tagħrif ta' qabel l-użu kliniku dwar is-sigurtà,148030.0,True,43
5379,148044,NAP,SmPC,mt,,Valutazzjoni tar-riskju ambjentali (ERA),148043.0,False,44
5380,148045,NAP,SmPC,mt,6,TAGĦRIF FARMAĊEWTIKU,148001.0,True,45
5381,148046,NAP,SmPC,mt,6.1,Lista ta’ eċċipjenti,148045.0,True,46
5382,148047,NAP,SmPC,mt,6.2,Inkompatibbiltajiet,148045.0,True,47
5383,148048,NAP,SmPC,mt,6.3,Żmien kemm idum tajjeb il-prodott mediċinali,148045.0,True,48
5384,148049,NAP,SmPC,mt,6.4,Prekawzjonijiet speċjali għall-ħażna,148045.0,True,49
5385,148050,NAP,SmPC,mt,6.5,In-natura tal-kontenitur u ta’ dak li hemm ġo fih,148045.0,True,50
5386,148051,NAP,SmPC,mt,6.6,Prekawzjonijiet speċjali għar-rimi u għal immaniġġar ieħor,148045.0,True,51
5387,148052,NAP,SmPC,mt,,Użu fil-popolazzjoni pedjatrika,148051.0,False,52
5388,148053,NAP,SmPC,mt,7,DETENTUR TAL-AWTORIZZAZZJONI GĦAT-TQEGĦID FIS-SUQ,148001.0,True,53
5389,148054,NAP,SmPC,mt,8,NUMRU(I) TAL-AWTORIZZAZZJONI GĦAT-TQEGĦID FIS-SUQ ,148001.0,True,54
5390,148055,NAP,SmPC,mt,9,DATA TAL-EWWEL AWTORIZZAZZJONI/TIĠDID TAL-AWTORIZZAZZJONI,148001.0,True,55
5391,148056,NAP,SmPC,mt,10,DATA TA’ REVIŻJONI TAT-TEST,148001.0,True,56
5392,148057,NAP,SmPC,mt,11,DOŻIMETRIJA,148001.0,False,57
5393,148058,NAP,SmPC,mt,12,ISTRUZZJONIJIET GĦALL-PREPARAZZJONI TA’ PRODOTTI RADJUFARMAĊEWTIĊI,148001.0,False,58
5394,149001,NAP,Labelling,mt,,TIKKETTAR,,True,1
5395,149002,NAP,Labelling,mt,,TAGĦRIF LI GĦANDU JIDHER FUQ <IL-PAKKETT TA’ BARRA> <U> <IL-PAKKETT LI JMISS MAL-PRODOTT>,149001.0,True,2
5396,149003,NAP,Labelling,mt,1,ISEM TAL-PRODOTT MEDIĊINALI,149002.0,True,3
5397,149004,NAP,Labelling,mt,2,DIKJARAZZJONI TAS-SUSTANZA(I) ATTIVA(I),149002.0,True,4
5398,149005,NAP,Labelling,mt,3,LISTA TA’ EĊĊIPJENTI,149002.0,True,5
5399,149006,NAP,Labelling,mt,4,GĦAMLA FARMAĊEWTIKA U KONTENUT,149002.0,True,6
5400,149007,NAP,Labelling,mt,5,MOD TA’ KIF U MNEJN JINGĦATA,149002.0,True,7
5401,149008,NAP,Labelling,mt,6,TWISSIJA SPEĊJALI LI L-PRODOTT MEDIĊINALI GĦANDU JINŻAMM FEJN MA JIDHIRX U MA JINTLAĦAQX MIT-TFAL,149002.0,True,8
5402,149009,NAP,Labelling,mt,7,"TWISSIJA(IET) SPEĊJALI OĦRA, JEKK MEĦTIEĠA",149002.0,True,9
5403,149010,NAP,Labelling,mt,8,DATA TA’ SKADENZA ,149002.0,True,10
5404,149011,NAP,Labelling,mt,9,KONDIZZJONIJIET SPEĊJALI TA’ KIF JINĦAŻEN,149002.0,True,11
5405,149012,NAP,Labelling,mt,10,"PREKAWZJONIJIET SPEĊJALI GĦAR-RIMI TA’ PRODOTTI MEDIĊINALI MHUX UŻATI JEW SKART MINN DAWN IL-PRODOTTI MEDIĊINALI,  JEKK HEMM BŻONN",149002.0,True,12
5406,149013,NAP,Labelling,mt,11,ISEM U INDIRIZZ TAD-DETENTUR TAL-AWTORIZZAZZJONI GĦAT-TQEGĦID FIS-SUQ ,149002.0,True,13
5407,149014,NAP,Labelling,mt,12,NUMRU(I) TAL-AWTORIZZAZZJONI GĦAT-TQEGĦID FIS-SUQ,149002.0,True,14
5408,149015,NAP,Labelling,mt,13,NUMRU TAL-LOTT ,149002.0,True,15
5409,149016,NAP,Labelling,mt,14,KLASSIFIKAZZJONI ĠENERALI TA’ KIF JINGĦATA,149002.0,True,16
5410,149017,NAP,Labelling,mt,15,ISTRUZZJONIJIET DWAR L-UŻU,149002.0,True,17
5411,149018,NAP,Labelling,mt,16,INFORMAZZJONI BIL-BRAILLE,149002.0,True,18
5412,149019,NAP,Labelling,mt,17,IDENTIFIKATUR UNIKU – BARCODE 2D,149002.0,True,19
5413,149020,NAP,Labelling,mt,18,IDENTIFIKATUR UNIKU - DATA LI TINQARA MILL-BNIEDEM,149002.0,True,20
5414,149021,NAP,Labelling,mt,,TAGĦRIF MINIMU LI GĦANDU JIDHER FUQ IL-FOLJI JEW FUQ L-ISTRIXXI,149001.0,True,21
5415,149022,NAP,Labelling,mt,1,ISEM IL-PRODOTT MEDIĊINALI,149021.0,True,22
5416,149023,NAP,Labelling,mt,2,ISEM TAD-DETENTUR TAL-AWTORIZZAZZJONI GĦAT-TQEGĦID FIS-SUQ,149021.0,True,23
5417,149024,NAP,Labelling,mt,3,DATA TA’ SKADENZA,149021.0,True,24
5418,149025,NAP,Labelling,mt,4,NUMRU TAL-LOTT ,149021.0,True,25
5419,149026,NAP,Labelling,mt,5,OĦRAJN,149021.0,True,26
5420,149027,NAP,Labelling,mt,,TAGĦRIF MINIMU LI GĦANDU JIDHER FUQ IL-PAKKETTI Ż-ŻGĦAR EWLENIN,149001.0,True,27
5421,149028,NAP,Labelling,mt,1,ISEM TAL-PRODOTT MEDIĊINALI U MNEJN GĦANDU JINGĦATA,149027.0,True,28
5422,149029,NAP,Labelling,mt,2,METODU TA’ KIF GĦANDU JINGĦATA,149027.0,True,29
5423,149030,NAP,Labelling,mt,3,DATA TA’ SKADENZA,149027.0,True,30
5424,149031,NAP,Labelling,mt,4,NUMRU TAL-LOTT ,149027.0,True,31
5425,149032,NAP,Labelling,mt,5,"IL-KONTENUT SKONT IL-PIŻ, IL-VOLUM, JEW PARTI INDIVIDWALI",149027.0,True,32
5426,149033,NAP,Labelling,mt,6,OĦRAJN,149027.0,True,33
5427,150001,NAP,Package leaflet,mt,,FULJETT TA’ TAGĦRIF,,True,1
5428,150002,NAP,Package leaflet,mt,,q Dan il-prodott mediċinali huwa suġġett għal monitoraġġ addizzjonali. Dan ser jippermetti identifikazzjoni ta’ malajr ta’ informazzjoni ġdida dwar is-sigurtà. Inti tista’ tgħin billi tirrapporta kwalunkwe effett sekondarju li jista’ jkollok. Ara t-tmiem ta’ sezzjoni 4 biex tara kif għandek tirrapporta effetti sekondarji. ,150001.0,False,2
5429,150003,NAP,Package leaflet,mt,,F’dan il-fuljett,150001.0,True,3
5430,150004,NAP,Package leaflet,mt,1,X’inhu X u gћalxiex jintuża,150001.0,True,4
5431,150005,NAP,Package leaflet,mt,2,X'għandek tkun taf qabel ma <tieħu> <tuża> X ,150001.0,True,5
5432,150006,NAP,Package leaflet,mt,,<Tiħux> <Tużax> X<:>,150005.0,True,6
5433,150007,NAP,Package leaflet,mt,,Twissijiet u prekawzjonijiet,150005.0,True,7
5434,150008,NAP,Package leaflet,mt,,Tfal <u adolexxenti>,150005.0,True,8
5435,150009,NAP,Package leaflet,mt,,Mediċini oħra u X,150005.0,True,9
5436,150010,NAP,Package leaflet,mt,,"X ma’ <ikel><u> <,> <xorb> <u> <alkoħol>",150005.0,True,10
5437,150011,NAP,Package leaflet,mt,,"Tqala <u> <,> treddigħ <u fertilità>",150005.0,True,11
5438,150012,NAP,Package leaflet,mt,,Sewqan u tħaddim ta’ magni,150005.0,True,12
5439,150013,NAP,Package leaflet,mt,,X fih {isem tas-sustanza(i) mhux attiva(i)},150005.0,False,13
5440,150014,NAP,Package leaflet,mt,3,Kif gћandek <tieћu><tuża> X,150001.0,True,14
5441,150015,NAP,Package leaflet,mt,,Użu fit-tfal <u fl-adolexxenti>,150014.0,False,15
5442,150016,NAP,Package leaflet,mt,,Jekk <tieħu> <tuża> X aktar milli suppost>,150014.0,False,16
5443,150017,NAP,Package leaflet,mt,,Jekk tinsa <tieħu> <tuża> X,150014.0,False,17
5444,150018,NAP,Package leaflet,mt,,Jekk tieqaf <tieħu> <tuża> X,150014.0,False,18
5445,150019,NAP,Package leaflet,mt,4,Effetti sekondarji possibbli,150001.0,True,19
5446,150020,NAP,Package leaflet,mt,,Effetti sekondarji oħra fit-tfal <u l-adolexxenti>,150019.0,False,20
5447,150021,NAP,Package leaflet,mt,,Rappurtar tal-effetti sekondarji,150019.0,True,21
5448,150022,NAP,Package leaflet,mt,5,Kif taħżen X,150001.0,True,22
5449,150023,NAP,Package leaflet,mt,6,Kontenut tal-pakkett u informazzjoni oħra,150001.0,True,23
5450,150024,NAP,Package leaflet,mt,,X’fih X,150023.0,True,24
5451,150025,NAP,Package leaflet,mt,,Kif jidher X u l-kontenut tal-pakkett,150023.0,True,25
5452,150026,NAP,Package leaflet,mt,,Detentur tal-Awtorizzazzjoni għat-Tqegħid fis-Suq u l-Manifattur,150023.0,True,26
5453,150027,NAP,Package leaflet,mt,,Dan il-prodott mediinali huwa awtorizzat fl-istati membri ta' l-EEA b'dawn l-ismijiet :,150023.0,False,27
5454,150028,NAP,Package leaflet,mt,,Dan il-fuljett kien rivedut l-aħħar f’ <{XX/SSSS} ><{xahar SSSS} >.,150023.0,True,28
5455,150029,NAP,Package leaflet,mt,,Sorsi oħra ta’ informazzjoni,150023.0,False,29
5456,150030,NAP,Package leaflet,mt,,It-tagħrif li jmiss qed jingħata biss għall-professjonisti tal-kura tas-saħħa biss:,150001.0,False,30
5457,151001,NAP,SmPC,nl,,SAMENVATTING VAN DE PRODUCTKENMERKEN,,True,1
5458,151002,NAP,SmPC,nl,,qDit geneesmiddel is onderworpen aan aanvullende monitoring.  Daardoor kan snel nieuwe veiligheidsinformatie worden vastgesteld. Beroepsbeoefenaren in de gezondheidszorg wordt verzocht alle vermoedelijke bijwerkingen te melden. Zie rubriek 4.8 voor het rapporteren van bijwerkingen,151001.0,False,2
5459,151003,NAP,SmPC,nl,1,NAAM VAN HET GENEESMIDDEL,151001.0,True,3
5460,151004,NAP,SmPC,nl,2,KWALITATIEVE EN KWANTITATIEVE SAMENSTELLING,151001.0,True,4
5461,151005,NAP,SmPC,nl,,Hulpstof(fen) met bekend effect,151004.0,False,5
5462,151006,NAP,SmPC,nl,3,FARMACEUTISCHE VORM,151001.0,True,6
5463,151007,NAP,SmPC,nl,4,KLINISCHE GEGEVENS,151001.0,True,7
5464,151008,NAP,SmPC,nl,4.1,Therapeutische indicaties,151007.0,True,8
5465,151009,NAP,SmPC,nl,4.2,Dosering en wijze van toediening,151007.0,True,9
5466,151010,NAP,SmPC,nl,,Dosering,151009.0,True,10
5467,151011,NAP,SmPC,nl,,Pediatrische patiënten,151010.0,True,11
5468,151012,NAP,SmPC,nl,,Wijze van toediening,151009.0,True,12
5469,151013,NAP,SmPC,nl,,Te nemen voorzorgen voorafgaand aan gebruik of toediening van het geneesmiddel,151012.0,False,13
5470,151014,NAP,SmPC,nl,4.3,Contra-indicaties,151007.0,True,14
5471,151015,NAP,SmPC,nl,4.4,Bijzondere waarschuwingen en voorzorgen bij gebruik,151007.0,True,15
5472,151016,NAP,SmPC,nl,,Terugvinden herkomst,151015.0,False,16
5473,151017,NAP,SmPC,nl,,Pediatrische patiënten,151015.0,False,17
5474,151018,NAP,SmPC,nl,4.5,Interacties met andere geneesmiddelen en andere vormen van interactie,151007.0,True,18
5475,151019,NAP,SmPC,nl,,Pediatrische patiënten,151018.0,False,19
5476,151020,NAP,SmPC,nl,4.6,"Vruchtbaarheid, zwangerschap en borstvoeding",151007.0,True,20
5477,151021,NAP,SmPC,nl,,Zwangerschap,151020.0,False,21
5478,151022,NAP,SmPC,nl,,Borstvoeding,151020.0,False,22
5479,151023,NAP,SmPC,nl,,Vruchtbaarheid,151020.0,False,23
5480,151024,NAP,SmPC,nl,4.7,Beïnvloeding van de rijvaardigheid en het vermogen om machines te bedienen,151007.0,True,24
5481,151025,NAP,SmPC,nl,4.8,Bijwerkingen,151007.0,True,25
5482,151026,NAP,SmPC,nl,,Pediatrische patiënten,151025.0,False,26
5483,151027,NAP,SmPC,nl,,Melding van vermoedelijke bijwerkingen,151025.0,True,27
5484,151028,NAP,SmPC,nl,4.9,Overdosering,151007.0,True,28
5485,151029,NAP,SmPC,nl,,Pediatrische patiënten,151028.0,False,29
5486,151030,NAP,SmPC,nl,5,FARMACOLOGISCHE EIGENSCHAPPEN,151001.0,True,30
5487,151031,NAP,SmPC,nl,5.1,Farmacodynamische eigenschappen,151030.0,True,31
5488,151032,NAP,SmPC,nl,,Werkingsmechanisme,151031.0,False,32
5489,151033,NAP,SmPC,nl,,Farmacodynamische effecten,151031.0,False,33
5490,151034,NAP,SmPC,nl,,Klinische werkzaamheid en veiligheid,151031.0,False,34
5491,151035,NAP,SmPC,nl,,Pediatrische patiënten,151031.0,False,35
5492,151036,NAP,SmPC,nl,5.2,Farmacokinetische eigenschappen,151030.0,True,36
5493,151037,NAP,SmPC,nl,,Absorptie,151036.0,False,37
5494,151038,NAP,SmPC,nl,,Distributie,151036.0,False,38
5495,151039,NAP,SmPC,nl,,Biotransformatie,151036.0,False,39
5496,151040,NAP,SmPC,nl,,Eliminatie,151036.0,False,40
5497,151041,NAP,SmPC,nl,,Lineariteit/non-lineariteit,151036.0,False,41
5498,151042,NAP,SmPC,nl,,Farmacokinetische/farmacodynamische relatie(s),151036.0,False,42
5499,151043,NAP,SmPC,nl,5.3,Gegevens uit het preklinisch veiligheidsonderzoek,151030.0,True,43
5500,151044,NAP,SmPC,nl,,Environmental risk assessment (ERA),151043.0,False,44
5501,151045,NAP,SmPC,nl,6,FARMACEUTISCHE GEGEVENS,151001.0,True,45
5502,151046,NAP,SmPC,nl,6.1,Lijst van hulpstoffen,151045.0,True,46
5503,151047,NAP,SmPC,nl,6.2,Gevallen van onverenigbaarheid,151045.0,True,47
5504,151048,NAP,SmPC,nl,6.3,Houdbaarheid,151045.0,True,48
5505,151049,NAP,SmPC,nl,6.4,Speciale voorzorgsmaatregelen bij bewaren,151045.0,True,49
5506,151050,NAP,SmPC,nl,6.5,Aard en inhoud van de verpakking,151045.0,True,50
5507,151051,NAP,SmPC,nl,6.6,Speciale voorzorgsmaatregelen voor het verwijderen <en andere instructies>,151045.0,True,51
5508,151052,NAP,SmPC,nl,,Gebruik bij pediatrische patiënten,151051.0,False,52
5509,151053,NAP,SmPC,nl,7,HOUDER VAN DE VERGUNNING VOOR HET IN DE HANDEL BRENGEN,151001.0,True,53
5510,151054,NAP,SmPC,nl,8,NUMMER(S) VAN DE VERGUNNING VOOR HET IN DE HANDEL BRENGEN ,151001.0,True,54
5511,151055,NAP,SmPC,nl,9,DATUM VAN EERSTE VERLENING VAN DE VERGUNNING/VERLENGING VAN DE VERGUNNING,151001.0,True,55
5512,151056,NAP,SmPC,nl,10,DATUM VAN HERZIENING VAN DE TEKST,151001.0,True,56
5513,151057,NAP,SmPC,nl,11,DOSIMETRIE,151001.0,False,57
5514,151058,NAP,SmPC,nl,12,INSTRUCTIES VOOR DE BEREIDING VAN RADIOACTIEVE GENEESMIDDELEN,151001.0,False,58
5515,152001,NAP,Labelling,nl,,ETIKETTERING,,True,1
5516,152002,NAP,Labelling,nl,,GEGEVENS DIE OP <DE BUITENVERPAKKING><EN> <DE PRIMAIRE VERPAKKING> MOETEN WORDEN VERMELD,152001.0,True,2
5517,152003,NAP,Labelling,nl,1,NAAM VAN HET GENEESMIDDEL,152002.0,True,3
5518,152004,NAP,Labelling,nl,2,GEHALTE AAN WERKZAME STOF(FEN),152002.0,True,4
5519,152005,NAP,Labelling,nl,3,LIJST VAN HULPSTOFFEN,152002.0,True,5
5520,152006,NAP,Labelling,nl,4,FARMACEUTISCHE VORM EN INHOUD,152002.0,True,6
5521,152007,NAP,Labelling,nl,5,WIJZE VAN GEBRUIK EN TOEDIENINGSWEG(EN),152002.0,True,7
5522,152008,NAP,Labelling,nl,6,EEN SPECIALE WAARSCHUWING DAT HET GENEESMIDDEL BUITEN HET ZICHT EN BEREIK VAN KINDEREN DIENT TE WORDEN GEHOUDEN,152002.0,True,8
5523,152009,NAP,Labelling,nl,7,"ANDERE SPECIALE WAARSCHUWING(EN), INDIEN NODIG",152002.0,True,9
5524,152010,NAP,Labelling,nl,8,UITERSTE GEBRUIKSDATUM,152002.0,True,10
5525,152011,NAP,Labelling,nl,9,BIJZONDERE VOORZORGSMAATREGELEN VOOR DE BEWARING,152002.0,True,11
5526,152012,NAP,Labelling,nl,10,BIJZONDERE VOORZORGSMAATREGELEN VOOR HET VERWIJDEREN VAN NIET-GEBRUIKTE GENEESMIDDELEN OF DAARVAN AFGELEIDE AFVALSTOFFEN (INDIEN VAN TOEPASSING),152002.0,True,12
5527,152013,NAP,Labelling,nl,11,NAAM EN ADRES VAN DE HOUDER VAN DE VERGUNNING VOOR HET IN DE HANDEL BRENGEN,152002.0,True,13
5528,152014,NAP,Labelling,nl,12,NUMMER(S) VAN DE VERGUNNING VOOR HET IN DE HANDEL BRENGEN ,152002.0,True,14
5529,152015,NAP,Labelling,nl,13,PARTIJNUMMER,152002.0,True,15
5530,152016,NAP,Labelling,nl,14,ALGEMENE INDELING VOOR DE AFLEVERING,152002.0,True,16
5531,152017,NAP,Labelling,nl,15,INSTRUCTIES VOOR GEBRUIK,152002.0,True,17
5532,152018,NAP,Labelling,nl,16,INFORMATIE IN BRAILLE,152002.0,True,18
5533,152019,NAP,Labelling,nl,17,UNIEK IDENTIFICATIEKENMERK - 2D MATRIXCODE,152002.0,True,19
5534,152020,NAP,Labelling,nl,18,UNIEK IDENTIFICATIEKENMERK - VOOR MENSEN LEESBARE GEGEVENS,152002.0,True,20
5535,152021,NAP,Labelling,nl,,GEGEVENS DIE IN IEDER GEVAL OP BLISTERVERPAKKINGEN OF STRIPS MOETEN WORDEN VERMELD,152001.0,True,21
5536,152022,NAP,Labelling,nl,1,NAAM VAN HET GENEESMIDDEL,152021.0,True,22
5537,152023,NAP,Labelling,nl,2,NAAM VAN DE HOUDER VAN DE VERGUNNING VOOR HET IN DE HANDEL BRENGEN,152021.0,True,23
5538,152024,NAP,Labelling,nl,3,UITERSTE GEBRUIKSDATUM,152021.0,True,24
5539,152025,NAP,Labelling,nl,4,PARTIJNUMMER,152021.0,True,25
5540,152026,NAP,Labelling,nl,5,OVERIGE,152021.0,True,26
5541,152027,NAP,Labelling,nl,,GEGEVENS DIE IN IEDER GEVAL OP PRIMAIRE KLEINVERPAKKINGEN MOETEN WORDEN VERMELD,152001.0,True,27
5542,152028,NAP,Labelling,nl,1,NAAM VAN HET GENEESMIDDEL EN DE TOEDIENINGSWEG(EN),152027.0,True,28
5543,152029,NAP,Labelling,nl,2,NAAM VAN HET GENEESMIDDEL EN DE TOEDIENINGSWEG(EN),152027.0,True,29
5544,152030,NAP,Labelling,nl,3,UITERSTE GEBRUIKSDATUM,152027.0,True,30
5545,152031,NAP,Labelling,nl,4,PARTIJNUMMER,152027.0,True,31
5546,152032,NAP,Labelling,nl,5,"INHOUD UITGEDRUKT IN GEWICHT, VOLUME OF EENHEID",152027.0,True,32
5547,152033,NAP,Labelling,nl,6,OVERIGE,152027.0,True,33
5548,153001,NAP,Package leaflet,nl,,BIJSLUITER,,True,1
5549,153002,NAP,Package leaflet,nl,,q Dit geneesmiddel is onderworpen aan aanvullende monitoring. Daardoor kan snel nieuwe veiligheidsinformatie worden vastgesteld. U kunt hieraan bijdragen door melding te maken van alle bijwerkingen die u eventueel zou ervaren. Aan het einde van rubriek 4 leest u hoe u dat kunt doen,153001.0,False,2
5550,153003,NAP,Package leaflet,nl,,Inhoud van deze bijsluiter,153001.0,True,3
5551,153004,NAP,Package leaflet,nl,1,Wat is X en waarvoor wordt dit middel <gebruikt><ingenomen>?,153001.0,True,4
5552,153005,NAP,Package leaflet,nl,2,Wanneer mag u dit middel niet <gebruiken><innemen> of moet u er extra voorzichtig mee zijn?,153001.0,True,5
5553,153006,NAP,Package leaflet,nl,,Wanneer mag u dit middel niet gebruiken?,153005.0,True,6
5554,153007,NAP,Package leaflet,nl,,Wanneer moet u extra voorzichtig zijn met dit middel?,153005.0,True,7
5555,153008,NAP,Package leaflet,nl,,Kinderen <en jongeren tot 18 jaar>,153005.0,True,8
5556,153009,NAP,Package leaflet,nl,,<Gebruikt u nog andere geneesmiddelen?><Neemt u nog andere geneesmiddelen in?>,153005.0,True,9
5557,153010,NAP,Package leaflet,nl,,"Waarop moet u letten met <eten> <en> <,> <drinken> <en> <alcohol>?",153005.0,True,10
5558,153011,NAP,Package leaflet,nl,,"Zwangerschap <en> <,> borstvoeding <en vruchtbaarheid>",153005.0,True,11
5559,153012,NAP,Package leaflet,nl,,Rijvaardigheid en het gebruik van machines,153005.0,True,12
5560,153013,NAP,Package leaflet,nl,,X bevat {naam van de hulpstof(fen)},153005.0,False,13
5561,153014,NAP,Package leaflet,nl,3,Hoe <gebruikt u dit middel><neemt u dit middel in>?,153001.0,True,14
5562,153015,NAP,Package leaflet,nl,,Gebruik bij kinderen <en jongeren tot 18 jaar>,153014.0,False,15
5563,153016,NAP,Package leaflet,nl,,Heeft u te veel van dit middel <gebruikt> <ingenomen>?,153014.0,False,16
5564,153017,NAP,Package leaflet,nl,,Bent u vergeten dit middel <te gebruiken> <in te nemen>?,153014.0,False,17
5565,153018,NAP,Package leaflet,nl,,Als u stopt met het <innemen> <gebruik> van dit middel,153014.0,False,18
5566,153019,NAP,Package leaflet,nl,4,Mogelijke bijwerkingen,153001.0,True,19
5567,153020,NAP,Package leaflet,nl,,Extra bijwerkingen die bij kinderen <en jongeren tot 18 jaar> kunnen voorkomen,153019.0,False,20
5568,153021,NAP,Package leaflet,nl,,Het melden van bijwerkingen,153019.0,True,21
5569,153022,NAP,Package leaflet,nl,5,Hoe bewaart u dit middel?,153001.0,True,22
5570,153023,NAP,Package leaflet,nl,6,Inhoud van de verpakking en overige informatie,153001.0,True,23
5571,153024,NAP,Package leaflet,nl,,Welke stoffen zitten er in dit middel?,153023.0,True,24
5572,153025,NAP,Package leaflet,nl,,Hoe ziet X eruit en hoeveel zit er in een verpakking?,153023.0,True,25
5573,153026,NAP,Package leaflet,nl,,Houder van de vergunning voor het in de handel brengen en fabrikant,153023.0,True,26
5574,153027,NAP,Package leaflet,nl,,Dit medicijn is geregistreerd in lidstaten van de EEA onder de volgende namen:,153023.0,False,27
5575,153028,NAP,Package leaflet,nl,,Deze bijsluiter is voor het laatst goedgekeurd in <{MM/JJJJ}> <{maand JJJJ}>.,153023.0,True,28
5576,153029,NAP,Package leaflet,nl,,Andere informatiebronnen,153023.0,False,29
5577,153030,NAP,Package leaflet,nl,,De volgende informatie is alleen bestemd voor beroepsbeoefenaren in de gezondheidszorg:,153001.0,False,30
5578,154001,NAP,SmPC,no,,PREPARATOMTALE,,True,1
5579,154002,NAP,SmPC,no,,qDette legemidlet er underlagt særlig overvåking for å oppdage ny sikkerhetsinformasjon så raskt som mulig. Helsepersonell oppfordres til å melde enhver mistenkt bivirkning. Se pkt. 4.8 for informasjon om bivirkningsrapportering.,154001.0,False,2
5580,154003,NAP,SmPC,no,1,LEGEMIDLETS NAVN,154001.0,True,3
5581,154004,NAP,SmPC,no,2,KVALITATIV OG KVANTITATIV SAMMENSETNING,154001.0,True,4
5582,154005,NAP,SmPC,no,,Hjelpestoff(er) med kjent effekt,154004.0,False,5
5583,154006,NAP,SmPC,no,3,LEGEMIDDELFORM,154001.0,True,6
5584,154007,NAP,SmPC,no,4,KLINISKE OPPLYSNINGER,154001.0,True,7
5585,154008,NAP,SmPC,no,4.1,Indikasjon(er),154007.0,True,8
5586,154009,NAP,SmPC,no,4.2,Dosering og administrasjonsmåte,154007.0,True,9
5587,154010,NAP,SmPC,no,,Dosering,154009.0,True,10
5588,154011,NAP,SmPC,no,,Pediatrisk populasjon,154010.0,True,11
5589,154012,NAP,SmPC,no,,Administrasjonsmåte,154009.0,True,12
5590,154013,NAP,SmPC,no,,Forholdsregler før håndtering eller administrering av dette legemidlet,154012.0,False,13
5591,154014,NAP,SmPC,no,4.3,Kontraindikasjoner,154007.0,True,14
5592,154015,NAP,SmPC,no,4.4,Advarsler og forsiktighetsregler,154007.0,True,15
5593,154016,NAP,SmPC,no,,Sporbarhet,154015.0,False,16
5594,154017,NAP,SmPC,no,,Pediatrisk populasjon,154015.0,False,17
5595,154018,NAP,SmPC,no,4.5,Interaksjon med andre legemidler og andre former for interaksjon,154007.0,True,18
5596,154019,NAP,SmPC,no,,Pediatrisk populasjon,154018.0,False,19
5597,154020,NAP,SmPC,no,4.6,"Fertilitet, graviditet og amming",154007.0,True,20
5598,154021,NAP,SmPC,no,,Graviditet,154020.0,False,21
5599,154022,NAP,SmPC,no,,Amming,154020.0,False,22
5600,154023,NAP,SmPC,no,,Fertilitet,154020.0,False,23
5601,154024,NAP,SmPC,no,4.7,Påvirkning av evnen til å kjøre bil og bruke maskiner,154007.0,True,24
5602,154025,NAP,SmPC,no,4.8,Bivirkninger,154007.0,True,25
5603,154026,NAP,SmPC,no,,Pediatrisk populasjon,154025.0,False,26
5604,154027,NAP,SmPC,no,,Melding av mistenkte bivirkninger,154025.0,True,27
5605,154028,NAP,SmPC,no,4.9,Overdosering,154007.0,True,28
5606,154029,NAP,SmPC,no,,Pediatrisk populasjon,154028.0,False,29
5607,154030,NAP,SmPC,no,5,FARMAKOLOGISKE EGENSKAPER,154001.0,True,30
5608,154031,NAP,SmPC,no,5.1,Farmakodynamiske egenskaper,154030.0,True,31
5609,154032,NAP,SmPC,no,,Virkningsmekanisme,154031.0,False,32
5610,154033,NAP,SmPC,no,,Farmakodynamiske effekter,154031.0,False,33
5611,154034,NAP,SmPC,no,,Klinisk effekt og sikkerhet,154031.0,False,34
5612,154035,NAP,SmPC,no,,Pediatrisk populasjon,154031.0,False,35
5613,154036,NAP,SmPC,no,5.2,Farmakokinetiske egenskaper,154030.0,True,36
5614,154037,NAP,SmPC,no,,Absorpsjon,154036.0,False,37
5615,154038,NAP,SmPC,no,,Distribusjon,154036.0,False,38
5616,154039,NAP,SmPC,no,,Biotransformasjon,154036.0,False,39
5617,154040,NAP,SmPC,no,,Eliminasjon,154036.0,False,40
5618,154041,NAP,SmPC,no,,Linearitet/ikke-linearitet,154036.0,False,41
5619,154042,NAP,SmPC,no,,Farmakokinetiske/farmakodynamiske forhold,154036.0,False,42
5620,154043,NAP,SmPC,no,5.3,Prekliniske sikkerhetsdata,154030.0,True,43
5621,154044,NAP,SmPC,no,,"Evaluering av miljørisiko (Environmental risk assessment, ERA)",154043.0,False,44
5622,154045,NAP,SmPC,no,6,FARMASØYTISKE OPPLYSNINGER,154001.0,True,45
5623,154046,NAP,SmPC,no,6.1,Hjelpestoffer,154045.0,True,46
5624,154047,NAP,SmPC,no,6.2,Uforlikeligheter,154045.0,True,47
5625,154048,NAP,SmPC,no,6.3,Holdbarhet,154045.0,True,48
5626,154049,NAP,SmPC,no,6.4,Oppbevaringsbetingelser,154045.0,True,49
5627,154050,NAP,SmPC,no,6.5,Emballasje (type og innhold) ,154045.0,True,50
5628,154051,NAP,SmPC,no,6.6,Spesielle forholdsregler for destruksjon <og annen håndtering>,154045.0,True,51
5629,154052,NAP,SmPC,no,,Bruk i den pediatriske populasjonen,154051.0,False,52
5630,154053,NAP,SmPC,no,7,INNEHAVER AV MARKEDSFØRINGSTILLATELSEN,154001.0,True,53
5631,154054,NAP,SmPC,no,8,MARKEDSFØRINGSTILLATELSESNUMMER (NUMRE),154001.0,True,54
5632,154055,NAP,SmPC,no,9,DATO FOR FØRSTE MARKEDSFØRINGSTILLATELSE / SISTE FORNYELSE,154001.0,True,55
5633,154056,NAP,SmPC,no,10,OPPDATERINGSDATO,154001.0,True,56
5634,154057,NAP,SmPC,no,11,DOSIMETRI,154001.0,False,57
5635,154058,NAP,SmPC,no,12,INSTRUKSJONER FOR TILBEREDELSE AV RADIOFARMAKA,154001.0,False,58
5636,155001,NAP,Labelling,no,,MERKING,,True,1
5637,155002,NAP,Labelling,no,,OPPLYSNINGER SOM SKAL ANGIS PÅ <YTRE EMBALLASJE><OG> <INDRE EMBALLASJE>,155001.0,True,2
5638,155003,NAP,Labelling,no,1,LEGEMIDLETS NAVN,155002.0,True,3
5639,155004,NAP,Labelling,no,2,DEKLARASJON AV VIRKESTOFF(ER),155002.0,True,4
5640,155005,NAP,Labelling,no,3,LISTE OVER HJELPESTOFFER,155002.0,True,5
5641,155006,NAP,Labelling,no,4,LEGEMIDDELFORM OG INNHOLD (PAKNINGSSTØRRELSE),155002.0,True,6
5642,155007,NAP,Labelling,no,5,ADMINISTRASJONSMÅTE OG -VEI(ER),155002.0,True,7
5643,155008,NAP,Labelling,no,6,ADVARSEL OM AT LEGEMIDLET SKAL OPPBEVARES UTILGJENGELIG FOR BARN,155002.0,True,8
5644,155009,NAP,Labelling,no,7,EVENTUELLE ANDRE SPESIELLE ADVARSLER,155002.0,True,9
5645,155010,NAP,Labelling,no,8,UTLØPSDATO,155002.0,True,10
5646,155011,NAP,Labelling,no,9,OPPBEVARINGSBETINGELSER,155002.0,True,11
5647,155012,NAP,Labelling,no,10,EVENTUELLE SPESIELLE FORHOLDSREGLER VED DESTRUKSJON AV UBRUKTE LEGEMIDLER ELLER AVFALL,155002.0,True,12
5648,155013,NAP,Labelling,no,11,NAVN OG ADRESSE PÅ INNEHAVEREN AV MARKEDSFØRINGSTILLATELSEN,155002.0,True,13
5649,155014,NAP,Labelling,no,12,MARKEDSFØRINGSTILLATELSESNUMMER (NUMRE),155002.0,True,14
5650,155015,NAP,Labelling,no,13,PRODUKSJONSNUMMER,155002.0,True,15
5651,155016,NAP,Labelling,no,14,GENERELL KLASSIFIKASJON FOR UTLEVERING,155002.0,True,16
5652,155017,NAP,Labelling,no,15,BRUKSANVISNING,155002.0,True,17
5653,155018,NAP,Labelling,no,16,INFORMASJON PÅ BLINDESKRIFT,155002.0,True,18
5654,155019,NAP,Labelling,no,17,SIKKERHETSANORDNING (UNIK IDENTITET) – TODIMENSJONAL STREKKODE,155002.0,True,19
5655,155020,NAP,Labelling,no,18,SIKKERHETSANORDNING (UNIK IDENTITET) – I ET FORMAT LESBART FOR MENNESKER,155002.0,True,20
5656,155021,NAP,Labelling,no,,MINSTEKRAV TIL OPPLYSNINGER SOM SKAL ANGIS PÅ BLISTER ELLER STRIP,155001.0,True,21
5657,155022,NAP,Labelling,no,1,LEGEMIDLETS NAVN,155021.0,True,22
5658,155023,NAP,Labelling,no,2,NAVN PÅ INNEHAVEREN AV MARKEDSFØRINGSTILLATELSEN,155021.0,True,23
5659,155024,NAP,Labelling,no,3,UTLØPSDATO,155021.0,True,24
5660,155025,NAP,Labelling,no,4,PRODUKSJONSNUMMER,155021.0,True,25
5661,155026,NAP,Labelling,no,5,ANNET,155021.0,True,26
5662,155027,NAP,Labelling,no,,MINSTEKRAV TIL OPPLYSNINGER SOM SKAL ANGIS PÅ SMÅ INDRE EMBALLASJER,155001.0,True,27
5663,155028,NAP,Labelling,no,1,LEGEMIDLETS NAVN OG ADMINISTRASJONSVEI,155027.0,True,28
5664,155029,NAP,Labelling,no,2,ADMINISTRASJONSMÅTE,155027.0,True,29
5665,155030,NAP,Labelling,no,3,UTLØPSDATO,155027.0,True,30
5666,155031,NAP,Labelling,no,4,PRODUKSJONSNUMMER,155027.0,True,31
5667,155032,NAP,Labelling,no,5,"INNHOLD ANGITT ETTER VEKT, VOLUM ELLER ANTALL DOSER",155027.0,True,32
5668,155033,NAP,Labelling,no,6,ANNET,155027.0,True,33
5669,156001,NAP,Package leaflet,no,,PAKNINGSVEDLEGG,,True,1
5670,156002,NAP,Package leaflet,no,,qDette legemidlet er underlagt særlig overvåking for å oppdage ny sikkerhetsinformasjon så raskt som mulig. Du kan bidra ved å melde enhver mistenkt bivirkning. Se avsnitt 4 for informasjon om hvordan du melder bivirkninger.,156001.0,False,2
5671,156003,NAP,Package leaflet,no,,I dette pakningsvedlegget finner du informasjon om:,156001.0,True,3
5672,156004,NAP,Package leaflet,no,1,Hva X er og hva det brukes mot,156001.0,True,4
5673,156005,NAP,Package leaflet,no,2,Hva du må vite før du bruker X,156001.0,True,5
5674,156006,NAP,Package leaflet,no,,Bruk ikke X<:>,156005.0,True,6
5675,156007,NAP,Package leaflet,no,,Advarsler og forsiktighetsregler,156005.0,True,7
5676,156008,NAP,Package leaflet,no,,Barn <og ungdom> ,156005.0,True,8
5677,156009,NAP,Package leaflet,no,,Andre legemidler og X,156005.0,True,9
5678,156010,NAP,Package leaflet,no,,"Inntak av X sammen med <mat> <og> <,> <drikke> <og> <alkohol>",156005.0,True,10
5679,156011,NAP,Package leaflet,no,,"Graviditet <og> <,> amming <og fertilitet>",156005.0,True,11
5680,156012,NAP,Package leaflet,no,,Kjøring og bruk av maskiner,156005.0,True,12
5681,156013,NAP,Package leaflet,no,,X inneholder {navn på hjelpestoff(er)},156005.0,False,13
5682,156014,NAP,Package leaflet,no,3,Hvordan du bruker X,156001.0,True,14
5683,156015,NAP,Package leaflet,no,,Bruk hos barn <og ungdom>,156014.0,False,15
5684,156016,NAP,Package leaflet,no,,Dersom du tar for mye av X,156014.0,False,16
5685,156017,NAP,Package leaflet,no,,Dersom du har glemt å ta X,156014.0,False,17
5686,156018,NAP,Package leaflet,no,,Dersom du avbryter behandling med X,156014.0,False,18
5687,156019,NAP,Package leaflet,no,4,Mulige bivirkninger,156001.0,True,19
5688,156020,NAP,Package leaflet,no,,Bivirkninger som kan forekomme hos barn <og ungdom>,156019.0,False,20
5689,156021,NAP,Package leaflet,no,,Melding av bivirkninger,156019.0,True,21
5690,156022,NAP,Package leaflet,no,5,Hvordan du oppbevarer X,156001.0,True,22
5691,156023,NAP,Package leaflet,no,6,Innholdet i pakningen og ytterligere informasjon,156001.0,True,23
5692,156024,NAP,Package leaflet,no,,Sammensetning av X,156023.0,True,24
5693,156025,NAP,Package leaflet,no,,Hvordan X ser ut og innholdet i pakningen,156023.0,True,25
5694,156026,NAP,Package leaflet,no,,Innehaver av markedsføringstillatelsen og tilvirker,156023.0,True,26
5695,156027,NAP,Package leaflet,no,,Dette legemidlet er godkjent i EØS-landene med følgende navn:,156023.0,False,27
5696,156028,NAP,Package leaflet,no,,Dette pakningsvedlegget ble sist oppdatert <{MM/ÅÅÅÅ}> <{måned ÅÅÅÅ}>.,156023.0,True,28
5697,156029,NAP,Package leaflet,no,,Andre informasjonskilder,156023.0,False,29
5698,156030,NAP,Package leaflet,no,,Påfølgende informasjon er bare beregnet på helsepersonell:,156001.0,False,30
5699,157001,NAP,SmPC,pl,,CHARAKTERYSTYKA PRODUKTU LECZNICZEGO,,True,1
5700,157002,NAP,SmPC,pl,,"qNiniejszy produkt leczniczy będzie dodatkowo monitorowany. Umożliwi to szybkie zidentyfikowanie nowych informacji o bezpieczeństwie. Osoby należące do fachowego personelu medycznego powinny zgłaszać wszelkie podejrzewane działania niepożądane. Aby dowiedzieć się, jak zgłaszać działania niepożądane - patrz punkt 4.8.>",157001.0,False,2
5701,157003,NAP,SmPC,pl,1,NAZWA PRODUKTU LECZNICZEGO,157001.0,True,3
5702,157004,NAP,SmPC,pl,2,SKŁAD JAKOŚCIOWY I ILOŚCIOWY,157001.0,True,4
5703,157005,NAP,SmPC,pl,,<Substancja pomocnicza> <Substancje pomocnicze> o znanym działaniu>,157004.0,False,5
5704,157006,NAP,SmPC,pl,3,POSTAĆ FARMACEUTYCZNA,157001.0,True,6
5705,157007,NAP,SmPC,pl,4,SZCZEGÓŁOWE DANE KLINICZNE,157001.0,True,7
5706,157008,NAP,SmPC,pl,4.1,Wskazania do stosowania,157007.0,True,8
5707,157009,NAP,SmPC,pl,4.2,Dawkowanie i sposób podawania,157007.0,True,9
5708,157010,NAP,SmPC,pl,,Dawkowanie,157009.0,True,10
5709,157011,NAP,SmPC,pl,,Dzieci i młodzież,157010.0,True,11
5710,157012,NAP,SmPC,pl,,Sposób podawania,157009.0,True,12
5711,157013,NAP,SmPC,pl,,"Środki ostrożności, które należy podjąć przed użyciem lub podaniem produktu leczniczego",157012.0,False,13
5712,157014,NAP,SmPC,pl,4.3,Przeciwwskazania,157007.0,True,14
5713,157015,NAP,SmPC,pl,4.4,Specjalne ostrzeżenia i środki ostrożności dotyczące stosowania,157007.0,True,15
5714,157016,NAP,SmPC,pl,,Identyfikowalność,157015.0,False,16
5715,157017,NAP,SmPC,pl,,Dzieci i młodzież,157015.0,False,17
5716,157018,NAP,SmPC,pl,4.5,Interakcje z innymi produktami leczniczymi i inne rodzaje interakcji,157007.0,True,18
5717,157019,NAP,SmPC,pl,,Dzieci i młodzież,157018.0,False,19
5718,157020,NAP,SmPC,pl,4.6,"Wpływ na płodność, ciążę i laktację",157007.0,True,20
5719,157021,NAP,SmPC,pl,,Ciąża,157020.0,False,21
5720,157022,NAP,SmPC,pl,,Karmienie piersią,157020.0,False,22
5721,157023,NAP,SmPC,pl,,Płodność,157020.0,False,23
5722,157024,NAP,SmPC,pl,4.7,Wpływ na zdolność prowadzenia pojazdów i obsługiwania maszyn,157007.0,True,24
5723,157025,NAP,SmPC,pl,4.8,Działania niepożądane,157007.0,True,25
5724,157026,NAP,SmPC,pl,,Dzieci i młodzież,157025.0,False,26
5725,157027,NAP,SmPC,pl,,Zgłaszanie podejrzewanych działań niepożądanych,157025.0,True,27
5726,157028,NAP,SmPC,pl,4.9,Przedawkowanie,157007.0,True,28
5727,157029,NAP,SmPC,pl,,Dzieci i młodzież,157028.0,False,29
5728,157030,NAP,SmPC,pl,5,WŁAŚCIWOŚCI FARMAKOLOGICZNE,157001.0,True,30
5729,157031,NAP,SmPC,pl,5.1,Właściwości farmakodynamiczne,157030.0,True,31
5730,157032,NAP,SmPC,pl,,Mechanizm działania,157031.0,False,32
5731,157033,NAP,SmPC,pl,,Działanie farmakodynamiczne,157031.0,False,33
5732,157034,NAP,SmPC,pl,,Skuteczność kliniczna i bezpieczeństwo stosowania,157031.0,False,34
5733,157035,NAP,SmPC,pl,,Dzieci i młodzież,157031.0,False,35
5734,157036,NAP,SmPC,pl,5.2,Właściwości farmakokinetyczne,157030.0,True,36
5735,157037,NAP,SmPC,pl,,Wchłanianie,157036.0,False,37
5736,157038,NAP,SmPC,pl,,Dystrybucja,157036.0,False,38
5737,157039,NAP,SmPC,pl,,Metabolizm,157036.0,False,39
5738,157040,NAP,SmPC,pl,,Eliminacja,157036.0,False,40
5739,157041,NAP,SmPC,pl,,Liniowość lub nieliniowość,157036.0,False,41
5740,157042,NAP,SmPC,pl,,Zależności farmakokinetyczno-farmakodynamiczne,157036.0,False,42
5741,157043,NAP,SmPC,pl,5.3,Przedkliniczne dane o bezpieczeństwie,157030.0,True,43
5742,157044,NAP,SmPC,pl,,Ocena ryzyka dla środowiska,157043.0,False,44
5743,157045,NAP,SmPC,pl,6,DANE FARMACEUTYCZNE,157001.0,True,45
5744,157046,NAP,SmPC,pl,6.1,Wykaz substancji pomocniczych,157045.0,True,46
5745,157047,NAP,SmPC,pl,6.2,Niezgodności farmaceutyczne,157045.0,True,47
5746,157048,NAP,SmPC,pl,6.3,Okres ważności,157045.0,True,48
5747,157049,NAP,SmPC,pl,6.4,Specjalne środki ostrożności podczas przechowywania,157045.0,True,49
5748,157050,NAP,SmPC,pl,6.5,Rodzaj i zawartość opakowania,157045.0,True,50
5749,157051,NAP,SmPC,pl,6.6,Specjalne środki ostrożności dotyczące usuwania <i przygotowania produktu leczniczego do stosowania>,157045.0,True,51
5750,157052,NAP,SmPC,pl,,Stosowanie u dzieci i młodzieży,157051.0,False,52
5751,157053,NAP,SmPC,pl,7,PODMIOT ODPOWIEDZIALNY POSIADAJĄCY POZWOLENIE NA DOPUSZCZENIE DO OBROTU,157001.0,True,53
5752,157054,NAP,SmPC,pl,8,<NUMER POZWOLENIA> <NUMERY POZWOLEŃ> NA DOPUSZCZENIE DO OBROTU ,157001.0,True,54
5753,157055,NAP,SmPC,pl,9,DATA WYDANIA PIERWSZEGO POZWOLENIA NA DOPUSZCZENIE DO OBROTU I DATA PRZEDŁUŻENIA POZWOLENIA,157001.0,True,55
5754,157056,NAP,SmPC,pl,10,DATA ZATWIERDZENIA LUB CZĘŚCIOWEJ ZMIANY TEKSTU CHARAKTERYSTYKI PRODUKTU LECZNICZEGO,157001.0,True,56
5755,157057,NAP,SmPC,pl,11,DOZYMETRIA,157001.0,False,57
5756,157058,NAP,SmPC,pl,12,INSTRUKCJA PRZYGOTOWANIA PRODUKTÓW RADIOFARMACEUTYCZNYCH,157001.0,False,58
5757,158001,NAP,Labelling,pl,,OZNAKOWANIE OPAKOWAŃ,,True,1
5758,158002,NAP,Labelling,pl,,INFORMACJE ZAMIESZCZANE NA <OPAKOWANIACH ZEWNĘTRZNYCH> <ORAZ> <OPAKOWANIACH BEZPOŚREDNICH>,158001.0,True,2
5759,158003,NAP,Labelling,pl,1,NAZWA PRODUKTU LECZNICZEGO,158002.0,True,3
5760,158004,NAP,Labelling,pl,2,ZAWARTOŚĆ <SUBSTANCJI CZYNNEJ> <SUBSTANCJI CZYNNYCH>,158002.0,True,4
5761,158005,NAP,Labelling,pl,3,WYKAZ SUBSTANCJI POMOCNICZYCH,158002.0,True,5
5762,158006,NAP,Labelling,pl,4,POSTAĆ FARMACEUTYCZNA I ZAWARTOŚĆ OPAKOWANIA,158002.0,True,6
5763,158007,NAP,Labelling,pl,5,SPOSÓB I <DROGA> <DROGI> PODANIA,158002.0,True,7
5764,158008,NAP,Labelling,pl,6,OSTRZEŻENIE DOTYCZĄCE PRZECHOWYWANIA PRODUKTU LECZNICZEGO W MIEJSCU NIEWIDOCZNYM I NIEDOSTĘPNYM DLA DZIECI,158002.0,True,8
5765,158009,NAP,Labelling,pl,7,"INNE OSTRZEŻENIA SPECJALNE, JEŚLI KONIECZNE",158002.0,True,9
5766,158010,NAP,Labelling,pl,8,TERMIN WAŻNOŚCI,158002.0,True,10
5767,158011,NAP,Labelling,pl,9,WARUNKI PRZECHOWYWANIA,158002.0,True,11
5768,158012,NAP,Labelling,pl,10,"SPECJALNE ŚRODKI OSTROŻNOŚCI DOTYCZĄCE USUWANIA NIEZUŻYTEGO PRODUKTU LECZNICZEGO LUB POCHODZĄCYCH Z NIEGO ODPADÓW, JEŚLI WŁAŚCIWE",158002.0,True,12
5769,158013,NAP,Labelling,pl,11,NAZWA I ADRES PODMIOTU ODPOWIEDZIALNEGO,158002.0,True,13
5770,158014,NAP,Labelling,pl,12,<NUMER POZWOLENIA> <NUMERY POZWOLEŃ> NA DOPUSZCZENIE DO OBROTU ,158002.0,True,14
5771,158015,NAP,Labelling,pl,13,NUMER SERII,158002.0,True,15
5772,158016,NAP,Labelling,pl,14,OGÓLNA KATEGORIA DOSTĘPNOŚCI,158002.0,True,16
5773,158017,NAP,Labelling,pl,15,INSTRUKCJA UŻYCIA,158002.0,True,17
5774,158018,NAP,Labelling,pl,16,INFORMACJA PODANA SYSTEMEM BRAILLE’A,158002.0,True,18
5775,158019,NAP,Labelling,pl,17,NIEPOWTARZALNY IDENTYFIKATOR – KOD 2D,158002.0,True,19
5776,158020,NAP,Labelling,pl,18,NIEPOWTARZALNY IDENTYFIKATOR – DANE CZYTELNE DLA CZŁOWIEKA,158002.0,True,20
5777,158021,NAP,Labelling,pl,,MINIMUM INFORMACJI ZAMIESZCZANYCH NA BLISTRACH LUB OPAKOWANIACH FOLIOWYCH,158001.0,True,21
5778,158022,NAP,Labelling,pl,1,NAZWA PRODUKTU LECZNICZEGO,158021.0,True,22
5779,158023,NAP,Labelling,pl,2,NAZWA PODMIOTU ODPOWIEDZIALNEGO,158021.0,True,23
5780,158024,NAP,Labelling,pl,3,TERMIN WAŻNOŚCI,158021.0,True,24
5781,158025,NAP,Labelling,pl,4,NUMER SERII,158021.0,True,25
5782,158026,NAP,Labelling,pl,5,INNE,158021.0,True,26
5783,158027,NAP,Labelling,pl,,MINIMUM INFORMACJI ZAMIESZCZANYCH NA MAŁYCH OPAKOWANIACH BEZPOŚREDNICH,158001.0,True,27
5784,158028,NAP,Labelling,pl,1,NAZWA PRODUKTU LECZNICZEGO I <DROGA> <DROGI> PODANIA,158027.0,True,28
5785,158029,NAP,Labelling,pl,2,SPOSÓB PODAWANIA,158027.0,True,29
5786,158030,NAP,Labelling,pl,3,TERMIN WAŻNOŚCI,158027.0,True,30
5787,158031,NAP,Labelling,pl,4,NUMER SERII,158027.0,True,31
5788,158032,NAP,Labelling,pl,5,"ZAWARTOŚĆ OPAKOWANIA Z PODANIEM MASY, OBJĘTOŚCI LUB LICZBY JEDNOSTEK",158027.0,True,32
5789,158033,NAP,Labelling,pl,6,INNE,158027.0,True,33
5790,159001,NAP,Package leaflet,pl,,ULOTKA DLA PACJENTA,,True,1
5791,159002,NAP,Package leaflet,pl,,"q Niniejszy produkt leczniczy będzie dodatkowo monitorowany. Umożliwi to szybkie zidentyfikowanie nowych informacji o bezpieczeństwie. Użytkownik leku też może w tym pomóc, zgłaszając wszelkie działania niepożądane, które wystąpiły po zastosowaniu leku. Aby dowiedzieć się, jak zgłaszać działania niepożądane – patrz punkt 4.",159001.0,False,2
5792,159003,NAP,Package leaflet,pl,,Spis treści ulotki,159001.0,True,3
5793,159004,NAP,Package leaflet,pl,1,Co to jest <lek> X i w jakim celu się go stosuje,159001.0,True,4
5794,159005,NAP,Package leaflet,pl,2,Informacje ważne przed <przyjęciem> <zastosowaniem> <leku> X ,159001.0,True,5
5795,159006,NAP,Package leaflet,pl,,Kiedy nie <przyjmować> <stosować> <leku> X,159005.0,True,6
5796,159007,NAP,Package leaflet,pl,,Ostrzeżenia i środki ostrożności ,159005.0,True,7
5797,159008,NAP,Package leaflet,pl,,Dzieci <i młodzież>,159005.0,True,8
5798,159009,NAP,Package leaflet,pl,,<Lek> X a inne leki,159005.0,True,9
5799,159010,NAP,Package leaflet,pl,,"Stosowanie leku X z <jedzeniem> <i> <,> <piciem> <i> <alkoholem>",159005.0,True,10
5800,159011,NAP,Package leaflet,pl,,"Ciąża <i> <,> karmienie piersią <i wpływ na płodność>",159005.0,True,11
5801,159012,NAP,Package leaflet,pl,,Prowadzenie pojazdów i obsługiwanie maszyn,159005.0,True,12
5802,159013,NAP,Package leaflet,pl,,<Lek> X zawiera {<nazwa substancji pomocniczej> <nazwy substancji pomocniczych>},159005.0,False,13
5803,159014,NAP,Package leaflet,pl,3,Jak <przyjmować> <stosować> <lek> X,159001.0,True,14
5804,159015,NAP,Package leaflet,pl,,Stosowanie u dzieci <i młodzieży>,159014.0,False,15
5805,159016,NAP,Package leaflet,pl,,<Przyjęcie> <Zastosowanie> większej niż zalecana dawki <leku> X,159014.0,False,16
5806,159017,NAP,Package leaflet,pl,,Pominięcie <przyjęcia> <zastosowania> <leku> ,159014.0,False,17
5807,159018,NAP,Package leaflet,pl,,Przerwanie <przyjmowania> <stosowania> <leku> X,159014.0,False,18
5808,159019,NAP,Package leaflet,pl,4,Możliwe działania niepożądane,159001.0,True,19
5809,159020,NAP,Package leaflet,pl,,Dodatkowe działania niepożądane u dzieci <i młodzieży>,159019.0,False,20
5810,159021,NAP,Package leaflet,pl,,Zgłaszanie działań niepożądanych,159019.0,True,21
5811,159022,NAP,Package leaflet,pl,5,Jak przechowywać <lek> X,159001.0,True,22
5812,159023,NAP,Package leaflet,pl,6,Zawartość opakowania i inne informacje,159001.0,True,23
5813,159024,NAP,Package leaflet,pl,,Co zawiera <lek> X ,159023.0,True,24
5814,159025,NAP,Package leaflet,pl,,Jak wygląda <lek> X i co zawiera opakowanie,159023.0,True,25
5815,159026,NAP,Package leaflet,pl,,Podmiot odpowiedzialny i wytwórca,159023.0,True,26
5816,159027,NAP,Package leaflet,pl,,Ten produkt leczniczy jest dopuszczony do obrotu w krajach członkowskich Europejskiego Obszaru Gospodarczego pod następującymi nazwami:,159023.0,False,27
5817,159028,NAP,Package leaflet,pl,,Data ostatniej aktualizacji ulotki: <{MM/RRRR}><{miesiąc RRRR}>.,159023.0,True,28
5818,159029,NAP,Package leaflet,pl,,Inne źródła informacji,159023.0,False,29
5819,159030,NAP,Package leaflet,pl,,Informacje przeznaczone wyłącznie dla fachowego personelu medycznego:,159001.0,False,30
5820,160001,NAP,SmPC,pt,,RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO,,True,1
5821,160002,NAP,SmPC,pt,,"qEste medicamento está sujeito a monitorização adicional. Isto irá permitir a rápida identificação de nova informação de segurança. Pede-se aos profissionais de saúde que notifiquem quaisquer suspeitas de reações adversas. Para saber como notificar reações adversas, ver secção 4.8.",160001.0,False,2
5822,160003,NAP,SmPC,pt,1,NOME DO MEDICAMENTO,160001.0,True,3
5823,160004,NAP,SmPC,pt,2,COMPOSIÇÃO QUALITATIVA E QUANTITATIVA,160001.0,True,4
5824,160005,NAP,SmPC,pt,,Excipiente(s) com efeito conhecido,160004.0,False,5
5825,160006,NAP,SmPC,pt,3,FORMA FARMACÊUTICA,160001.0,True,6
5826,160007,NAP,SmPC,pt,4,INFORMAÇÕES CLÍNICAS,160001.0,True,7
5827,160008,NAP,SmPC,pt,4.1,Indicações terapêuticas,160007.0,True,8
5828,160009,NAP,SmPC,pt,4.2,Posologia e modo de administração,160007.0,True,9
5829,160010,NAP,SmPC,pt,,Posologia,160009.0,True,10
5830,160011,NAP,SmPC,pt,,População pediátrica,160010.0,True,11
5831,160012,NAP,SmPC,pt,,Modo de administração ,160009.0,True,12
5832,160013,NAP,SmPC,pt,,Precauções a ter em conta antes de manusear ou administrar o medicamento,160012.0,False,13
5833,160014,NAP,SmPC,pt,4.3,Contraindicações,160007.0,True,14
5834,160015,NAP,SmPC,pt,4.4,Advertências e precauções especiais de utilização,160007.0,True,15
5835,160016,NAP,SmPC,pt,,Rastreabilidade,160015.0,False,16
5836,160017,NAP,SmPC,pt,,População pediátrica,160015.0,False,17
5837,160018,NAP,SmPC,pt,4.5,Interações medicamentosas e outras formas de interação,160007.0,True,18
5838,160019,NAP,SmPC,pt,,População pediátrica,160018.0,False,19
5839,160020,NAP,SmPC,pt,4.6,"Fertilidade, gravidez e aleitamento",160007.0,True,20
5840,160021,NAP,SmPC,pt,,Gravidez,160020.0,False,21
5841,160022,NAP,SmPC,pt,,Amamentação,160020.0,False,22
5842,160023,NAP,SmPC,pt,,Fertilidade,160020.0,False,23
5843,160024,NAP,SmPC,pt,4.7,Efeitos sobre a capacidade de conduzir e utilizar máquinas,160007.0,True,24
5844,160025,NAP,SmPC,pt,4.8,Efeitos indesejáveis,160007.0,True,25
5845,160026,NAP,SmPC,pt,,População pediátrica,160025.0,False,26
5846,160027,NAP,SmPC,pt,,Notificação de suspeitas de reações adversas,160025.0,True,27
5847,160028,NAP,SmPC,pt,4.9,Sobredosagem,160007.0,True,28
5848,160029,NAP,SmPC,pt,,População pediátrica,160028.0,False,29
5849,160030,NAP,SmPC,pt,5,PROPRIEDADES FARMACOLÓGICAS,160001.0,True,30
5850,160031,NAP,SmPC,pt,5.1,Propriedades farmacodinâmicas,160030.0,True,31
5851,160032,NAP,SmPC,pt,,Mecanismo de ação,160031.0,False,32
5852,160033,NAP,SmPC,pt,,Efeitos farmacodinâmicos,160031.0,False,33
5853,160034,NAP,SmPC,pt,,Eficácia e segurança clínicas,160031.0,False,34
5854,160035,NAP,SmPC,pt,,População pediátrica,160031.0,False,35
5855,160036,NAP,SmPC,pt,5.2,Propriedades farmacocinéticas,160030.0,True,36
5856,160037,NAP,SmPC,pt,,Absorção,160036.0,False,37
5857,160038,NAP,SmPC,pt,,Distribuição,160036.0,False,38
5858,160039,NAP,SmPC,pt,,Biotransformação,160036.0,False,39
5859,160040,NAP,SmPC,pt,,Eliminação,160036.0,False,40
5860,160041,NAP,SmPC,pt,,Linearidade/não linearidade,160036.0,False,41
5861,160042,NAP,SmPC,pt,,Relação(ões) farmacocinética/farmacodinâmica,160036.0,False,42
5862,160043,NAP,SmPC,pt,5.3,Dados de segurança pré-clínica,160030.0,True,43
5863,160044,NAP,SmPC,pt,,Avaliação do risco ambiental (ARA),160043.0,False,44
5864,160045,NAP,SmPC,pt,6,INFORMAÇÕES FARMACÊUTICAS,160001.0,True,45
5865,160046,NAP,SmPC,pt,6.1,Lista dos excipientes,160045.0,True,46
5866,160047,NAP,SmPC,pt,6.2,Incompatibilidades,160045.0,True,47
5867,160048,NAP,SmPC,pt,6.3,Prazo de validade,160045.0,True,48
5868,160049,NAP,SmPC,pt,6.4,Precauções especiais de conservação,160045.0,True,49
5869,160050,NAP,SmPC,pt,6.5,Natureza e conteúdo do recipiente,160045.0,True,50
5870,160051,NAP,SmPC,pt,6.6,Precauções especiais de eliminação <e manuseamento>,160045.0,True,51
5871,160052,NAP,SmPC,pt,,Utilização na população pediátrica,160051.0,False,52
5872,160053,NAP,SmPC,pt,7,TITULAR DA AUTORIZAÇÃO DE INTRODUÇÃO NO MERCADO,160001.0,True,53
5873,160054,NAP,SmPC,pt,8,NÚMERO(S) DA AUTORIZAÇÃO DE INTRODUÇÃO NO MERCADO ,160001.0,True,54
5874,160055,NAP,SmPC,pt,9,DATA DA PRIMEIRA AUTORIZAÇÃO/RENOVAÇÃO DA AUTORIZAÇÃO DE INTRODUÇÃO NO MERCADO,160001.0,True,55
5875,160056,NAP,SmPC,pt,10,DATA DA REVISÃO DO TEXTO,160001.0,True,56
5876,160057,NAP,SmPC,pt,11,DOSIMETRIA,160001.0,False,57
5877,160058,NAP,SmPC,pt,12,INSTRUÇÕES PARA A PREPARAÇÃO DE RADIOFÁRMACOS,160001.0,False,58
5878,161001,NAP,Labelling,pt,,ROTULAGEM,,True,1
5879,161002,NAP,Labelling,pt,,INDICAÇÕES A INCLUIR <NO ACONDICIONAMENTO SECUNDÁRIO> <E> <NO ACONDICIONAMENTO PRIMÁRIO>,161001.0,True,2
5880,161003,NAP,Labelling,pt,1,NOME DO MEDICAMENTO,161002.0,True,3
5881,161004,NAP,Labelling,pt,2,DESCRIÇÃO DA(S) SUBSTÂNCIA(S) ATIVA(S),161002.0,True,4
5882,161005,NAP,Labelling,pt,3,LISTA DOS EXCIPIENTES,161002.0,True,5
5883,161006,NAP,Labelling,pt,4,FORMA FARMACÊUTICA E CONTEÚDO,161002.0,True,6
5884,161007,NAP,Labelling,pt,5,MODO E VIA(S) DE ADMINISTRAÇÃO,161002.0,True,7
5885,161008,NAP,Labelling,pt,6,ADVERTÊNCIA ESPECIAL DE QUE O MEDICAMENTO DEVE SER MANTIDO FORA DA VISTA E DO ALCANCE DAS CRIANÇAS,161002.0,True,8
5886,161009,NAP,Labelling,pt,7,"OUTRAS ADVERTÊNCIAS ESPECIAIS, SE NECESSÁRIO",161002.0,True,9
5887,161010,NAP,Labelling,pt,8,PRAZO DE VALIDADE,161002.0,True,10
5888,161011,NAP,Labelling,pt,9,CONDIÇÕES ESPECIAIS DE CONSERVAÇÃO,161002.0,True,11
5889,161012,NAP,Labelling,pt,10,"CUIDADOS ESPECIAIS QUANTO À ELIMINAÇÃO DO MEDICAMENTO NÃO UTILIZADO OU DOS RESÍDUOS PROVENIENTES DESSE MEDICAMENTO, SE APLICÁVEL",161002.0,True,12
5890,161013,NAP,Labelling,pt,11,NOME E ENDEREÇO DO TITULAR DA AUTORIZAÇÃO DE INTRODUÇÃO NO MERCADO,161002.0,True,13
5891,161014,NAP,Labelling,pt,12,NÚMERO(S) DA AUTORIZAÇÃO DE INTRODUÇÃO NO MERCADO ,161002.0,True,14
5892,161015,NAP,Labelling,pt,13,NÚMERO DO LOTE,161002.0,True,15
5893,161016,NAP,Labelling,pt,14,CLASSIFICAÇÃO QUANTO À DISPENSA AO PÚBLICO,161002.0,True,16
5894,161017,NAP,Labelling,pt,15,INSTRUÇÕES DE UTILIZAÇÃ,161002.0,True,17
5895,161018,NAP,Labelling,pt,16,INFORMAÇÃO EM BRAILLE,161002.0,True,18
5896,161019,NAP,Labelling,pt,17,IDENTIFICADOR ÚNICO – CÓDIGO DE BARRAS 2D,161002.0,True,19
5897,161020,NAP,Labelling,pt,18,IDENTIFICADOR ÚNICO - DADOS PARA LEITURA HUMANA,161002.0,True,20
5898,161021,NAP,Labelling,pt,,INDICAÇÕES MÍNIMAS A INCLUIR NAS EMBALAGENS BLISTER OU FITAS CONTENTORAS,161001.0,True,21
5899,161022,NAP,Labelling,pt,1,NOME DO MEDICAMENTO,161021.0,True,22
5900,161023,NAP,Labelling,pt,2,NOME DO TITULAR DA AUTORIZAÇÃO DE INTRODUÇÃO NO MERCADO,161021.0,True,23
5901,161024,NAP,Labelling,pt,3,PRAZO DE VALIDADE,161021.0,True,24
5902,161025,NAP,Labelling,pt,4,NÚMERO DO LOTE,161021.0,True,25
5903,161026,NAP,Labelling,pt,5,OUTROS,161021.0,True,26
5904,161027,NAP,Labelling,pt,,INDICAÇÕES MÍNIMAS A INCLUIR EM PEQUENAS UNIDADES DE ACONDICIONAMENTO PRIMÁRIO,161001.0,True,27
5905,161028,NAP,Labelling,pt,1,NOME DO MEDICAMENTO E VIA(S) DE ADMINISTRAÇÃO,161027.0,True,28
5906,161029,NAP,Labelling,pt,2,MODO DE ADMINISTRAÇÃO,161027.0,True,29
5907,161030,NAP,Labelling,pt,3,PRAZO DE VALIDADE,161027.0,True,30
5908,161031,NAP,Labelling,pt,4,NÚMERO DO LOTE,161027.0,True,31
5909,161032,NAP,Labelling,pt,5,"CONTEÚDO EM PESO, VOLUME OU UNIDADE",161027.0,True,32
5910,161033,NAP,Labelling,pt,6,OUTROS,161027.0,True,33
5911,162001,NAP,Package leaflet,pt,,FOLHETO INFORMATIVO,,True,1
5912,162002,NAP,Package leaflet,pt,,"q Este medicamento está sujeito a monitorização adicional. Isto irá permitir a rápida identificação de nova informação de segurança. Poderá ajudar, comunicando quaisquer efeitos indesejáveis que tenha. Para saber como comunicar efeitos indesejáveis, veja o final da secção 4.",162001.0,False,2
5913,162003,NAP,Package leaflet,pt,,O que contém este folheto:,162001.0,True,3
5914,162004,NAP,Package leaflet,pt,1,O que é X e para que é utilizado,162001.0,True,4
5915,162005,NAP,Package leaflet,pt,2,O que precisa de saber antes de <tomar> <utilizar> X ,162001.0,True,5
5916,162006,NAP,Package leaflet,pt,,Não <tome> <utilize> X,162005.0,True,6
5917,162007,NAP,Package leaflet,pt,,Advertências e precauções ,162005.0,True,7
5918,162008,NAP,Package leaflet,pt,,Crianças <e adolescentes>,162005.0,True,8
5919,162009,NAP,Package leaflet,pt,,Outros medicamentos e X,162005.0,True,9
5920,162010,NAP,Package leaflet,pt,,"X com <alimentos> <e> <,> <bebidas> <e> <álcool>",162005.0,True,10
5921,162011,NAP,Package leaflet,pt,,"Gravidez <e> <,> amamentação <e fertilidade>",162005.0,True,11
5922,162012,NAP,Package leaflet,pt,,Condução de veículos e utilização de máquinas,162005.0,True,12
5923,162013,NAP,Package leaflet,pt,,X contém {nome do(s) excipiente(s)},162005.0,False,13
5924,162014,NAP,Package leaflet,pt,3,Como <tomar> <utilizar> X,162001.0,True,14
5925,162015,NAP,Package leaflet,pt,,Utilização em crianças <e adolescentes>,162014.0,False,15
5926,162016,NAP,Package leaflet,pt,,Se <tomar> <utilizar> mais X do que deveria,162014.0,False,16
5927,162017,NAP,Package leaflet,pt,,Caso se tenha esquecido de <tomar> <utilizar> X,162014.0,False,17
5928,162018,NAP,Package leaflet,pt,,Se parar de <tomar> <utilizar> X,162014.0,False,18
5929,162019,NAP,Package leaflet,pt,4,Efeitos indesejáveis possíveis,162001.0,True,19
5930,162020,NAP,Package leaflet,pt,,Efeitos indesejáveis adicionais em crianças <e adolescentes>,162019.0,False,20
5931,162021,NAP,Package leaflet,pt,,Comunicação de efeitos indesejáveis,162019.0,True,21
5932,162022,NAP,Package leaflet,pt,5,Como conservar X,162001.0,True,22
5933,162023,NAP,Package leaflet,pt,6,Conteúdo da embalagem e outras informações,162001.0,True,23
5934,162024,NAP,Package leaflet,pt,,Qual a composição de X,162023.0,True,24
5935,162025,NAP,Package leaflet,pt,,Qual o aspeto de X e conteúdo da embalagem,162023.0,True,25
5936,162026,NAP,Package leaflet,pt,,Titular da Autorização de Introdução no Mercado e Fabricante,162023.0,True,26
5937,162027,NAP,Package leaflet,pt,,Este medicamento encontra-se autorizado nos Estados Membros do Espaço Económico Europeu (EEE) com os seguintes nomes:,162023.0,False,27
5938,162028,NAP,Package leaflet,pt,,Este folheto foi revisto pela última vez em <{MM/AAAA}><{mês de AAAA}.,162023.0,True,28
5939,162029,NAP,Package leaflet,pt,,Outras fontes de informação,162023.0,False,29
5940,162030,NAP,Package leaflet,pt,,A informação que se segue destina-se apenas aos profissionais de saúde:,162001.0,False,30
5941,163001,NAP,SmPC,ro,,REZUMATUL CARACTERISTICILOR PRODUSULUI,,True,1
5942,163002,NAP,SmPC,ro,,qAcest medicament face obiectul unei monitorizări suplimentare. Acest lucru va permite identificarea rapidă de noi informații referitoare la siguranță. Profesioniștii din domeniul sănătății sunt rugați să raporteze orice reacții adverse suspectate. Vezi pct. 4.8 pentru modul de raportare a reacțiilor adverse.,163001.0,False,2
5943,163003,NAP,SmPC,ro,1,DENUMIREA COMERCIALĂ A MEDICAMENTULUI,163001.0,True,3
5944,163004,NAP,SmPC,ro,2,COMPOZIȚIA CALITATIVĂ ȘI CANTITATIVĂ,163001.0,True,4
5945,163005,NAP,SmPC,ro,,Excipient(ți) cu efect cunoscut,163004.0,False,5
5946,163006,NAP,SmPC,ro,3,FORMA FARMACEUTICĂ,163001.0,True,6
5947,163007,NAP,SmPC,ro,4,DATE CLINICE,163001.0,True,7
5948,163008,NAP,SmPC,ro,4.1,Indicații terapeutice,163007.0,True,8
5949,163009,NAP,SmPC,ro,4.2,Doze și mod de administrare,163007.0,True,9
5950,163010,NAP,SmPC,ro,,Doze,163009.0,True,10
5951,163011,NAP,SmPC,ro,,Copii și adolescenți,163010.0,True,11
5952,163012,NAP,SmPC,ro,,Mod de administrare ,163009.0,True,12
5953,163013,NAP,SmPC,ro,,Precauții care trebuie luate înainte de manipularea sau administrarea medicamentului,163012.0,False,13
5954,163014,NAP,SmPC,ro,4.3,Contraindicații,163007.0,True,14
5955,163015,NAP,SmPC,ro,4.4,Atenționări și precauții speciale pentru utilizare,163007.0,True,15
5956,163016,NAP,SmPC,ro,,Trasabilitate,163015.0,False,16
5957,163017,NAP,SmPC,ro,,Copii și adolescenți,163015.0,False,17
5958,163018,NAP,SmPC,ro,4.5,Interacțiuni cu alte medicamente și alte forme de interacțiune,163007.0,True,18
5959,163019,NAP,SmPC,ro,,Copii și adolescenți,163018.0,False,19
5960,163020,NAP,SmPC,ro,4.6,"Fertilitatea, sarcina și alăptarea",163007.0,True,20
5961,163021,NAP,SmPC,ro,,Sarcina,163020.0,False,21
5962,163022,NAP,SmPC,ro,,Alăptarea,163020.0,False,22
5963,163023,NAP,SmPC,ro,,Fertilitatea,163020.0,False,23
5964,163024,NAP,SmPC,ro,4.7,Efecte asupra capacității de a conduce vehicule și de a folosi utilaje,163007.0,True,24
5965,163025,NAP,SmPC,ro,4.8,Reacții adverse,163007.0,True,25
5966,163026,NAP,SmPC,ro,,Copii și adolescenți,163025.0,False,26
5967,163027,NAP,SmPC,ro,,Raportarea reacțiilor adverse suspectate,163025.0,True,27
5968,163028,NAP,SmPC,ro,4.9,Supradozaj,163007.0,True,28
5969,163029,NAP,SmPC,ro,,Copii și adolescenți,163028.0,False,29
5970,163030,NAP,SmPC,ro,5,PROPRIETĂȚI FARMACOLOGICE,163001.0,True,30
5971,163031,NAP,SmPC,ro,5.1,Proprietăți farmacodinamice,163030.0,True,31
5972,163032,NAP,SmPC,ro,,Mecanism de acțiune,163031.0,False,32
5973,163033,NAP,SmPC,ro,,Efecte farmacodinamice,163031.0,False,33
5974,163034,NAP,SmPC,ro,,Eficacitate și siguranță clinică,163031.0,False,34
5975,163035,NAP,SmPC,ro,,Copii și adolescenți,163031.0,False,35
5976,163036,NAP,SmPC,ro,5.2,Proprietăți farmacocinetice,163030.0,True,36
5977,163037,NAP,SmPC,ro,,Absorbție,163036.0,False,37
5978,163038,NAP,SmPC,ro,,Distribuție,163036.0,False,38
5979,163039,NAP,SmPC,ro,,Metabolizare,163036.0,False,39
5980,163040,NAP,SmPC,ro,,Eliminare,163036.0,False,40
5981,163041,NAP,SmPC,ro,,Liniaritate/Non-liniaritate,163036.0,False,41
5982,163042,NAP,SmPC,ro,,Relație(i) farmacocinetică(e)/farmacodinamică€,163036.0,False,42
5983,163043,NAP,SmPC,ro,5.3,Date preclinice de siguranță,163030.0,True,43
5984,163044,NAP,SmPC,ro,,Evaluarea riscului de mediu (ERM),163043.0,False,44
5985,163045,NAP,SmPC,ro,6,PROPRIETĂȚI FARMACEUTICE,163001.0,True,45
5986,163046,NAP,SmPC,ro,6.1,Lista excipienților,163045.0,True,46
5987,163047,NAP,SmPC,ro,6.2,Incompatibilități,163045.0,True,47
5988,163048,NAP,SmPC,ro,6.3,Perioada de valabilitate,163045.0,True,48
5989,163049,NAP,SmPC,ro,6.4,Precauții speciale pentru păstrare,163045.0,True,49
5990,163050,NAP,SmPC,ro,6.5,Natura și conținutul ambalajului,163045.0,True,50
5991,163051,NAP,SmPC,ro,6.6,Precauții speciale pentru eliminarea reziduurilor <și alte instrucțiuni de manipulare>,163045.0,True,51
5992,163052,NAP,SmPC,ro,,Utilizare la copii și adolescenți,163051.0,False,52
5993,163053,NAP,SmPC,ro,7,DEȚINĂTORUL AUTORIZAȚIEI DE PUNERE PE PIAȚĂ,163001.0,True,53
5994,163054,NAP,SmPC,ro,8,NUMĂRUL(ELE) AUTORIZAȚIEI DE PUNERE PE PIAȚĂ ,163001.0,True,54
5995,163055,NAP,SmPC,ro,9,DATA PRIMEI AUTORIZĂRI SAU A REÎNNOIRII AUTORIZAȚIEI,163001.0,True,55
5996,163056,NAP,SmPC,ro,10,DATA REVIZUIRII TEXTULUI,163001.0,True,56
5997,163057,NAP,SmPC,ro,11,DOZIMETRIE,163001.0,False,57
5998,163058,NAP,SmPC,ro,12,INSTRUCȚIUNI PRIVIND PREPARAREA MEDICAMENTELOR RADIOFARMACEUTICE,163001.0,False,58
5999,164001,NAP,Labelling,ro,,ETICHETAREA,,True,1
6000,164002,NAP,Labelling,ro,,INFORMAȚII CARE TREBUIE SĂ APARĂ PE <AMBALAJUL SECUNDAR><ȘI><AMBALAJUL PRIMAR>,164001.0,True,2
6001,164003,NAP,Labelling,ro,1,DENUMIREA COMERCIALĂ A MEDICAMENTULUI,164002.0,True,3
6002,164004,NAP,Labelling,ro,2,DECLARAREA SUBSTANȚEI(SUBSTANȚELOR) ACTIVE,164002.0,True,4
6003,164005,NAP,Labelling,ro,3,LISTA EXCIPIENȚILOR,164002.0,True,5
6004,164006,NAP,Labelling,ro,4,FORMA FARMACEUTICĂ ȘI CONȚINUTUL,164002.0,True,6
6005,164007,NAP,Labelling,ro,5,MODUL ȘI CALEA(CĂILE) DE ADMINISTRARE,164002.0,True,7
6006,164008,NAP,Labelling,ro,6,ATENȚIONARE SPECIALĂ PRIVIND FAPTUL CĂ MEDICAMENTUL NU TREBUIE PĂSTRAT LA VEDEREA ȘI ÎNDEMÂNA COPIILOR,164002.0,True,8
6007,164009,NAP,Labelling,ro,7,"ALTĂ(E) ATENȚIONARE(ĂRI) SPECIALĂ(E), DACĂ ESTE(SUNT) NECESARĂ(E)",164002.0,True,9
6008,164010,NAP,Labelling,ro,8,DATA DE EXPIRARE,164002.0,True,10
6009,164011,NAP,Labelling,ro,9,CONDIȚII SPECIALE DE PĂSTRARE,164002.0,True,11
6010,164012,NAP,Labelling,ro,10,"PRECAUȚII SPECIALE PRIVIND ELIMINAREA MEDICAMENTELOR NEUTILIZATE SAU A MATERIALELOR REZIDUALE PROVENITE DIN ASTFEL DE MEDICAMENTE, DACĂ ESTE CAZUL",164002.0,True,12
6011,164013,NAP,Labelling,ro,11,NUMELE ȘI ADRESA DEȚINĂTORULUI AUTORIZAȚIEI DE PUNERE PE PIAȚĂ,164002.0,True,13
6012,164014,NAP,Labelling,ro,12,NUMĂRUL(ELE) AUTORIZAȚIEI DE PUNERE PE PIAȚĂ,164002.0,True,14
6013,164015,NAP,Labelling,ro,13,SERIA DE FABRICAȚIE,164002.0,True,15
6014,164016,NAP,Labelling,ro,14,CLASIFICARE GENERALĂ PRIVIND MODUL DE ELIBERARE,164002.0,True,16
6015,164017,NAP,Labelling,ro,15,INSTRUCȚIUNI DE UTILIZARE,164002.0,True,17
6016,164018,NAP,Labelling,ro,16,INFORMAȚII ÎN BRAILLE,164002.0,True,18
6017,164019,NAP,Labelling,ro,17,IDENTIFICATOR UNIC - COD DE BARE BIDIMENSIONAL,164002.0,True,19
6018,164020,NAP,Labelling,ro,18,IDENTIFICATOR UNIC - DATE LIZIBILE PENTRU PERSOANE,164002.0,True,20
6019,164021,NAP,Labelling,ro,,MINIMUM DE INFORMAȚII CARE TREBUIE SĂ APARĂ PE BLISTER SAU PE FOLIE TERMOSUDATĂ,164001.0,True,21
6020,164022,NAP,Labelling,ro,1,DENUMIREA COMERCIALĂ A MEDICAMENTULUI,164021.0,True,22
6021,164023,NAP,Labelling,ro,2,NUMELE DEȚINĂTORULUI AUTORIZAȚIEI DE PUNERE PE PIAȚĂ,164021.0,True,23
6022,164024,NAP,Labelling,ro,3,DATA DE EXPIRARE,164021.0,True,24
6023,164025,NAP,Labelling,ro,4,SERIA DE FABRICAȚIE,164021.0,True,25
6024,164026,NAP,Labelling,ro,5,ALTE INFORMAȚII,164021.0,True,26
6025,164027,NAP,Labelling,ro,,MINIMUM DE INFORMAȚII CARE TREBUIE SĂ APARĂ PE AMBALAJELE PRIMARE MICI,164001.0,True,27
6026,164028,NAP,Labelling,ro,1,DENUMIREA COMERCIALĂ A MEDICAMENTULUI ȘI CALEA(CĂILE) DE ADMINISTRARE,164027.0,True,28
6027,164029,NAP,Labelling,ro,2,MODUL DE ADMINISTRARE,164027.0,True,29
6028,164030,NAP,Labelling,ro,3,DATA DE EXPIRARE,164027.0,True,30
6029,164031,NAP,Labelling,ro,4,SERIA DE FABRICAȚIE,164027.0,True,31
6030,164032,NAP,Labelling,ro,5,"CONȚINUTUL PE MASĂ, VOLUM SAU UNITATEA DE DOZĂ",164027.0,True,32
6031,164033,NAP,Labelling,ro,6,ALTE INFORMAȚII,164027.0,True,33
6032,165001,NAP,Package leaflet,ro,,PROSPECTUL,,True,1
6033,165002,NAP,Package leaflet,ro,,q Acest medicament face obiectul unei monitorizări suplimentare. Acest lucru va permite identificarea rapidă de noi informații referitoare la siguranță. Puteți să fiți de ajutor raportând orice reacții adverse pe care le puteți avea. Vezi ultima parte de la pct. 4 pentru modul de raportare a reacțiilor adverse.,165001.0,False,2
6034,165003,NAP,Package leaflet,ro,,Ce găsiți în acest prospect,165001.0,True,3
6035,165004,NAP,Package leaflet,ro,1,Ce este X și pentru ce se utilizează,165001.0,True,4
6036,165005,NAP,Package leaflet,ro,2,Ce trebuie să știți înainte să <luați><utilizați> X,165001.0,True,5
6037,165006,NAP,Package leaflet,ro,,Nu <luați><utilizați> X,165005.0,True,6
6038,165007,NAP,Package leaflet,ro,,Atenționări și precauții ,165005.0,True,7
6039,165008,NAP,Package leaflet,ro,,Copii <și adolescenți>,165005.0,True,8
6040,165009,NAP,Package leaflet,ro,,X împreună cu alte medicamente,165005.0,True,9
6041,165010,NAP,Package leaflet,ro,,"X împreună cu <alimente><și><,><băuturi><și><alcool>",165005.0,True,10
6042,165011,NAP,Package leaflet,ro,,"Sarcina <și><,> alăptarea <și fertilitatea>",165005.0,True,11
6043,165012,NAP,Package leaflet,ro,,Conducerea vehiculelor și folosirea utilajelor,165005.0,True,12
6044,165013,NAP,Package leaflet,ro,,X conține {numele excipientului(ților)},165005.0,False,13
6045,165014,NAP,Package leaflet,ro,3,Cum să <luați><utilizați> X,165001.0,True,14
6046,165015,NAP,Package leaflet,ro,,Utilizarea la copii <și adolescenți>,165014.0,False,15
6047,165016,NAP,Package leaflet,ro,,Dacă <luați><utilizați> mai mult X decât trebuie,165014.0,False,16
6048,165017,NAP,Package leaflet,ro,,Dacă uitați să <luați><utilizați> X,165014.0,False,17
6049,165018,NAP,Package leaflet,ro,,Dacă încetați să <luați><utilizați> X,165014.0,False,18
6050,165019,NAP,Package leaflet,ro,4,Reacții adverse posibile,165001.0,True,19
6051,165020,NAP,Package leaflet,ro,,Reacții adverse suplimentare la copii <și adolescenți>,165019.0,False,20
6052,165021,NAP,Package leaflet,ro,,Raportarea reacțiilor adverse,165019.0,True,21
6053,165022,NAP,Package leaflet,ro,5,Cum se păstrează X,165001.0,True,22
6054,165023,NAP,Package leaflet,ro,6,Conținutul ambalajului și alte informații,165001.0,True,23
6055,165024,NAP,Package leaflet,ro,,Ce conține X ,165023.0,True,24
6056,165025,NAP,Package leaflet,ro,,Cum arată X și conținutul ambalajului,165023.0,True,25
6057,165026,NAP,Package leaflet,ro,,Deținătorul autorizației de punere pe piață și fabricantul,165023.0,True,26
6058,165027,NAP,Package leaflet,ro,,Acest medicament este autorizat în Statele Membre ale Spaţiului Economic European sub următoarele denumiri comerciale:,165023.0,False,27
6059,165028,NAP,Package leaflet,ro,,Acest prospect a fost revizuit în <{LL/AAAA}><{luna AAAA}>.,165023.0,True,28
6060,165029,NAP,Package leaflet,ro,,Alte surse de informații,165023.0,False,29
6061,165030,NAP,Package leaflet,ro,,Următoarele informații sunt destinate numai profesioniștilor din domeniul sănătății:,165001.0,False,30
6062,166001,NAP,SmPC,se,,PRODUKTRESUMÉ,,True,1
6063,166002,NAP,SmPC,se,,qDetta läkemedel är föremål för utökad övervakning. Detta kommer att göra det möjligt att snabbt identifiera ny säkerhetsinformation. Hälso- och sjukvårdspersonal uppmanas att rapportera varje misstänkt biverkning. Se avsnitt 4.8 om hur man rapporterar biverkningar.,166001.0,False,2
6064,166003,NAP,SmPC,se,1,LÄKEMEDLETS NAMN,166001.0,True,3
6065,166004,NAP,SmPC,se,2,KVALITATIV OCH KVANTITATIV SAMMANSÄTTNING,166001.0,True,4
6066,166005,NAP,SmPC,se,,Hjälpämne(n) med känd effekt,166004.0,False,5
6067,166006,NAP,SmPC,se,3,LÄKEMEDELSFORM,166001.0,True,6
6068,166007,NAP,SmPC,se,4,KLINISKA UPPGIFTER,166001.0,True,7
6069,166008,NAP,SmPC,se,4.1,Terapeutiska indikationer,166007.0,True,8
6070,166009,NAP,SmPC,se,4.2,Dosering och administreringssätt,166007.0,True,9
6071,166010,NAP,SmPC,se,,Dosering,166009.0,True,10
6072,166011,NAP,SmPC,se,,Pediatrisk population,166010.0,True,11
6073,166012,NAP,SmPC,se,,Administreringssätt,166009.0,True,12
6074,166013,NAP,SmPC,se,,Försiktighetsåtgärder före hantering eller administrering av läkemedlet,166012.0,False,13
6075,166014,NAP,SmPC,se,4.3,Kontraindikationer,166007.0,True,14
6076,166015,NAP,SmPC,se,4.4,Varningar och försiktighet,166007.0,True,15
6077,166016,NAP,SmPC,se,,Spårbarhet,166015.0,False,16
6078,166017,NAP,SmPC,se,,Pediatrisk population,166015.0,False,17
6079,166018,NAP,SmPC,se,4.5,Interaktioner med andra läkemedel och övriga interaktioner,166007.0,True,18
6080,166019,NAP,SmPC,se,,Pediatrisk population,166018.0,False,19
6081,166020,NAP,SmPC,se,4.6,"Fertilitet, graviditet och amning",166007.0,True,20
6082,166021,NAP,SmPC,se,,Graviditet,166020.0,False,21
6083,166022,NAP,SmPC,se,,Amning,166020.0,False,22
6084,166023,NAP,SmPC,se,,Fertilitet,166020.0,False,23
6085,166024,NAP,SmPC,se,4.7,Effekter på förmågan att framföra fordon och använda maskiner,166007.0,True,24
6086,166025,NAP,SmPC,se,4.8,Biverkningar,166007.0,True,25
6087,166026,NAP,SmPC,se,,Pediatrisk population,166025.0,False,26
6088,166027,NAP,SmPC,se,,Rapportering av misstänkta biverkningar,166025.0,True,27
6089,166028,NAP,SmPC,se,4.9,Överdosering,166007.0,True,28
6090,166029,NAP,SmPC,se,,Pediatrisk population,166028.0,False,29
6091,166030,NAP,SmPC,se,5,FARMAKOLOGISKA EGENSKAPER,166001.0,True,30
6092,166031,NAP,SmPC,se,5.1,Farmakodynamiska egenskaper,166030.0,True,31
6093,166032,NAP,SmPC,se,,Verkningsmekanism,166031.0,False,32
6094,166033,NAP,SmPC,se,,Farmakodynamisk effekt,166031.0,False,33
6095,166034,NAP,SmPC,se,,Klinisk effekt och säkerhet,166031.0,False,34
6096,166035,NAP,SmPC,se,,Pediatrisk population,166031.0,False,35
6097,166036,NAP,SmPC,se,5.2,Farmakokinetiska egenskaper,166030.0,True,36
6098,166037,NAP,SmPC,se,,Absorption,166036.0,False,37
6099,166038,NAP,SmPC,se,,Distribution,166036.0,False,38
6100,166039,NAP,SmPC,se,,Metabolism,166036.0,False,39
6101,166040,NAP,SmPC,se,,Eliminering,166036.0,False,40
6102,166041,NAP,SmPC,se,,Linjäritet/icke-linjäritet,166036.0,False,41
6103,166042,NAP,SmPC,se,,Farmakokinetiskt (Farmakokinetiska)/farmakodynamiskt (farmakodynamiska) förhållande(n),166036.0,False,42
6104,166043,NAP,SmPC,se,5.3,Prekliniska säkerhetsuppgifter,166030.0,True,43
6105,166044,NAP,SmPC,se,,Miljöriskbedömning,166043.0,False,44
6106,166045,NAP,SmPC,se,6,FARMACEUTISKA UPPGIFTER,166001.0,True,45
6107,166046,NAP,SmPC,se,6.1,Förteckning över hjälpämnen,166045.0,True,46
6108,166047,NAP,SmPC,se,6.2,Inkompatibiliteter,166045.0,True,47
6109,166048,NAP,SmPC,se,6.3,Hållbarhet,166045.0,True,48
6110,166049,NAP,SmPC,se,6.4,Särskilda förvaringsanvisningar,166045.0,True,49
6111,166050,NAP,SmPC,se,6.5,Förpackningstyp och innehåll ,166045.0,True,50
6112,166051,NAP,SmPC,se,6.6,Särskilda anvisningar för destruktion <och övrig hantering>,166045.0,True,51
6113,166052,NAP,SmPC,se,,Användning i den pediatriska populationen,166051.0,False,52
6114,166053,NAP,SmPC,se,7,INNEHAVARE AV GODKÄNNANDE FÖR FÖRSÄLJNING,166001.0,True,53
6115,166054,NAP,SmPC,se,8,NUMMER PÅ GODKÄNNANDE FÖR FÖRSÄLJNING ,166001.0,True,54
6116,166055,NAP,SmPC,se,9,DATUM FÖR FÖRSTA GODKÄNNANDE/FÖRNYAT GODKÄNNANDE,166001.0,True,55
6117,166056,NAP,SmPC,se,10,DATUM FÖR ÖVERSYN AV PRODUKTRESUMÉN,166001.0,True,56
6118,166057,NAP,SmPC,se,11,ABSORBERAD DOS OCH EFFEKTIV DOS,166001.0,False,57
6119,166058,NAP,SmPC,se,12,INSTRUKTION FÖR BEREDNING AV RADIOFARMAKA,166001.0,False,58
6120,167001,NAP,Labelling,se,,MÄRKNING,,True,1
6121,167002,NAP,Labelling,se,,UPPGIFTER SOM SKA FINNAS PÅ <YTTRE FÖRPACKNINGEN> <OCH PÅ> <INNERFÖRPACKNINGEN>,167001.0,True,2
6122,167003,NAP,Labelling,se,1,LÄKEMEDLETS NAMN,167002.0,True,3
6123,167004,NAP,Labelling,se,2,DEKLARATION AV AKTIV(A) SUBSTANS(ER),167002.0,True,4
6124,167005,NAP,Labelling,se,3,FÖRTECKNING ÖVER HJÄLPÄMNEN,167002.0,True,5
6125,167006,NAP,Labelling,se,4,LÄKEMEDELSFORM OCH FÖRPACKNINGSSTORLEK,167002.0,True,6
6126,167007,NAP,Labelling,se,5,ADMINISTRERINGSSÄTT OCH ADMINISTRERINGSVÄG,167002.0,True,7
6127,167008,NAP,Labelling,se,6,SÄRSKILD VARNING OM ATT LÄKEMEDLET MÅSTE FÖRVARAS UTOM SYN- OCH RÄCKHÅLL FÖR BARN,167002.0,True,8
6128,167009,NAP,Labelling,se,7,ÖVRIGA SÄRSKILDA VARNINGAR OM SÅ ÄR NÖDVÄNDIGT,167002.0,True,9
6129,167010,NAP,Labelling,se,8,UTGÅNGSDATUM,167002.0,True,10
6130,167011,NAP,Labelling,se,9,SÄRSKILDA FÖRVARINGSANVISNINGAR,167002.0,True,11
6131,167012,NAP,Labelling,se,10,SÄRSKILDA FÖRSIKTIGHETSÅTGÄRDER FÖR DESTRUKTION AV EJ ANVÄNT LÄKEMEDEL OCH AVFALL I FÖREKOMMANDE FALL,167002.0,True,12
6132,167013,NAP,Labelling,se,11,INNEHAVARE AV GODKÄNNANDE FÖR FÖRSÄLJNING (NAMN OCH ADRESS),167002.0,True,13
6133,167014,NAP,Labelling,se,12,NUMMER PÅ GODKÄNNANDE FÖR FÖRSÄLJNING ,167002.0,True,14
6134,167015,NAP,Labelling,se,13,TILLVERKNINGSSATSNUMMER ,167002.0,True,15
6135,167016,NAP,Labelling,se,14,ALLMÄN KLASSIFICERING FÖR FÖRSKRIVNING,167002.0,True,16
6136,167017,NAP,Labelling,se,15,BRUKSANVISNING,167002.0,True,17
6137,167018,NAP,Labelling,se,16,INFORMATION I PUNKTSKRIFT,167002.0,True,18
6138,167019,NAP,Labelling,se,17,UNIK IDENTITETSBETECKNING – TVÅDIMENSIONELL STRECKKOD ,167002.0,True,19
6139,167020,NAP,Labelling,se,18,UNIK IDENTITETSBETECKNING – I ETT FORMAT LÄSBART FÖR MÄNSKLIGT ÖGA,167002.0,True,20
6140,167021,NAP,Labelling,se,,UPPGIFTER SOM SKA FINNAS PÅ BLISTER ELLER STRIPS,167001.0,True,21
6141,167022,NAP,Labelling,se,1,LÄKEMEDLETS NAMN,167021.0,True,22
6142,167023,NAP,Labelling,se,2,INNEHAVARE AV GODKÄNNANDE FÖR FÖRSÄLJNING,167021.0,True,23
6143,167024,NAP,Labelling,se,3,UTGÅNGSDATUM,167021.0,True,24
6144,167025,NAP,Labelling,se,4,TILLVERKNINGSSATSNUMMER ,167021.0,True,25
6145,167026,NAP,Labelling,se,5,ÖVRIGT,167021.0,True,26
6146,167027,NAP,Labelling,se,,UPPGIFTER SOM SKA FINNAS PÅ SMÅ INRE LÄKEMEDELSFÖRPACKNINGAR,167001.0,True,27
6147,167028,NAP,Labelling,se,1,LÄKEMEDLETS NAMN OCH ADMINISTRERINGSVÄG,167027.0,True,28
6148,167029,NAP,Labelling,se,2,ADMINISTRERINGSSÄTT,167027.0,True,29
6149,167030,NAP,Labelling,se,3,UTGÅNGSDATUM,167027.0,True,30
6150,167031,NAP,Labelling,se,4,TILLVERKNINGSSATSNUMMER ,167027.0,True,31
6151,167032,NAP,Labelling,se,5,"MÄNGD UTTRYCKT I VIKT, VOLYM ELLER PER ENHET",167027.0,True,32
6152,167033,NAP,Labelling,se,6,ÖVRIGT,167027.0,True,33
6153,168001,NAP,Package leaflet,se,,BIPACKSEDEL,,True,1
6154,168002,NAP,Package leaflet,se,,q Detta läkemedel är föremål för utökad övervakning. Detta kommer att göra det möjligt att snabbt identifiera ny säkerhetsinformation. Du kan hjälpa till genom att rapportera de biverkningar du eventuellt får. Information om hur du rapporterar biverkningar finns i slutet av avsnitt 4. ,168001.0,False,2
6155,168003,NAP,Package leaflet,se,,I denna bipacksedel finns information om följande:,168001.0,True,3
6156,168004,NAP,Package leaflet,se,1,Vad X är och vad det används för,168001.0,True,4
6157,168005,NAP,Package leaflet,se,2,Vad du behöver veta innan du <tar> <använder> X ,168001.0,True,5
6158,168006,NAP,Package leaflet,se,,<Ta> <Använd> inte X<:>,168005.0,True,6
6159,168007,NAP,Package leaflet,se,,Varningar och försiktighet,168005.0,True,7
6160,168008,NAP,Package leaflet,se,,Barn <och ungdomar>,168005.0,True,8
6161,168009,NAP,Package leaflet,se,,Andra läkemedel och X,168005.0,True,9
6162,168010,NAP,Package leaflet,se,,"X med <mat> <och > <,> <dryck> <och> <alkohol>",168005.0,True,10
6163,168011,NAP,Package leaflet,se,,"Graviditet <och> <,> amning <och fertilitet>",168005.0,True,11
6164,168012,NAP,Package leaflet,se,,Körförmåga och användning av maskiner,168005.0,True,12
6165,168013,NAP,Package leaflet,se,,X innehåller {namn på hjälpämne(n)},168005.0,False,13
6166,168014,NAP,Package leaflet,se,3,Hur du <tar> <använder> X,168001.0,True,14
6167,168015,NAP,Package leaflet,se,,Användning för barn <och ungdomar>,168014.0,False,15
6168,168016,NAP,Package leaflet,se,,Om du <har tagit> <använt> för stor mängd av X,168014.0,False,16
6169,168017,NAP,Package leaflet,se,,Om du har glömt att <ta> <använda> X,168014.0,False,17
6170,168018,NAP,Package leaflet,se,,Om du slutar att <ta> <använda>X,168014.0,False,18
6171,168019,NAP,Package leaflet,se,4,Eventuella biverkningar,168001.0,True,19
6172,168020,NAP,Package leaflet,se,,Ytterligare biverkningar hos barn <och ungdomar>,168019.0,False,20
6173,168021,NAP,Package leaflet,se,,Rapportering av biverkningar,168019.0,True,21
6174,168022,NAP,Package leaflet,se,5,Hur X ska förvaras,168001.0,True,22
6175,168023,NAP,Package leaflet,se,6,Förpackningens innehåll och övriga upplysningar,168001.0,True,23
6176,168024,NAP,Package leaflet,se,,Innehållsdeklaration,168023.0,True,24
6177,168025,NAP,Package leaflet,se,,Läkemedlets utseende och förpackningsstorlekar,168023.0,True,25
6178,168026,NAP,Package leaflet,se,,Innehavare av godkännande för försäljning och tillverkare,168023.0,True,26
6179,168027,NAP,Package leaflet,se,,Detta läkemedel är godkänt inom Europeiska ekonomiska samarbetsområdet under namnen:,168023.0,False,27
6180,168028,NAP,Package leaflet,se,,Denna bipacksedel ändrades senast <{MM/ÅÅÅÅ}><{månad ÅÅÅÅ}>.,168023.0,True,28
6181,168029,NAP,Package leaflet,se,,Övriga informationskällor,168023.0,False,29
6182,168030,NAP,Package leaflet,se,,Följande uppgifter är endast avsedda för hälso- och sjukvårdspersonal:,168001.0,False,30
6183,169001,NAP,SmPC,sk,,SÚHRN CHARAKTERISTICKÝCH VLASTNOSTÍ LIEKU,,True,1
6184,169002,NAP,SmPC,sk,,"qTento liek je predmetom ďalšieho monitorovania. To umožní rýchle získanie nových informácií o bezpečnosti. Od zdravotníckych pracovníkov sa vyžaduje, aby hlásili akékoľvek podozrenia na nežiaduce reakcie. Informácie o tom, ako hlásiť nežiaduce reakcie, nájdete v časti 4.8.",169001.0,False,2
6185,169003,NAP,SmPC,sk,1,NÁZOV LIEKU,169001.0,True,3
6186,169004,NAP,SmPC,sk,2,KVALITATÍVNE A KVANTITATÍVNE ZLOŽENIE,169001.0,True,4
6187,169005,NAP,SmPC,sk,,Pomocná látka> <Pomocné látky> so známym účinkom,169004.0,False,5
6188,169006,NAP,SmPC,sk,3,LIEKOVÁ FORMA,169001.0,True,6
6189,169007,NAP,SmPC,sk,4,KLINICKÉ ÚDAJE,169001.0,True,7
6190,169008,NAP,SmPC,sk,4.1,Terapeutické indikácie,169007.0,True,8
6191,169009,NAP,SmPC,sk,4.2,Dávkovanie a spôsob podávania,169007.0,True,9
6192,169010,NAP,SmPC,sk,,Dávkovanie,169009.0,True,10
6193,169011,NAP,SmPC,sk,,Pediatrická populácia,169010.0,True,11
6194,169012,NAP,SmPC,sk,,Spôsob podávania,169009.0,True,12
6195,169013,NAP,SmPC,sk,,Opatrenia pred zaobchádzaním alebo podaním lieku,169012.0,False,13
6196,169014,NAP,SmPC,sk,4.3,Kontraindikácie,169007.0,True,14
6197,169015,NAP,SmPC,sk,4.4,Osobitné upozornenia a opatrenia pri používaní,169007.0,True,15
6198,169016,NAP,SmPC,sk,,Sledovateľnosť,169015.0,False,16
6199,169017,NAP,SmPC,sk,,Pediatrická populácia,169015.0,False,17
6200,169018,NAP,SmPC,sk,4.5,Liekové a iné interakcie,169007.0,True,18
6201,169019,NAP,SmPC,sk,,Pediatrická populácia,169018.0,False,19
6202,169020,NAP,SmPC,sk,4.6,"Fertilita, gravidita a laktácia",169007.0,True,20
6203,169021,NAP,SmPC,sk,,Gravidita,169020.0,False,21
6204,169022,NAP,SmPC,sk,,Dojčenie,169020.0,False,22
6205,169023,NAP,SmPC,sk,,Fertilita,169020.0,False,23
6206,169024,NAP,SmPC,sk,4.7,Ovplyvnenie schopnosti viesť vozidlá a obsluhovať stroje,169007.0,True,24
6207,169025,NAP,SmPC,sk,4.8,Nežiaduce účinky,169007.0,True,25
6208,169026,NAP,SmPC,sk,,Pediatrická populácia,169025.0,False,26
6209,169027,NAP,SmPC,sk,,Hlásenie podozrení na nežiaduce reakcie,169025.0,True,27
6210,169028,NAP,SmPC,sk,4.9,Predávkovanie,169007.0,True,28
6211,169029,NAP,SmPC,sk,,Pediatrická populácia,169028.0,False,29
6212,169030,NAP,SmPC,sk,5,FARMAKOLOGICKÉ VLASTNOSTI,169001.0,True,30
6213,169031,NAP,SmPC,sk,5.1,Farmakodynamické vlastnosti,169030.0,True,31
6214,169032,NAP,SmPC,sk,,Mechanizmus účinku,169031.0,False,32
6215,169033,NAP,SmPC,sk,,Farmakodynamické účinky,169031.0,False,33
6216,169034,NAP,SmPC,sk,,Klinická účinnosť a bezpečnosť,169031.0,False,34
6217,169035,NAP,SmPC,sk,,Pediatrická populácia,169031.0,False,35
6218,169036,NAP,SmPC,sk,5.2,Farmakokinetické vlastnosti,169030.0,True,36
6219,169037,NAP,SmPC,sk,,Absorpcia,169036.0,False,37
6220,169038,NAP,SmPC,sk,,Distribúcia,169036.0,False,38
6221,169039,NAP,SmPC,sk,,Biotransformácia,169036.0,False,39
6222,169040,NAP,SmPC,sk,,Eliminácia,169036.0,False,40
6223,169041,NAP,SmPC,sk,,Linearita/nelinearita,169036.0,False,41
6224,169042,NAP,SmPC,sk,,Farmakokinetický/farmakodynamický vzťah,169036.0,False,42
6225,169043,NAP,SmPC,sk,5.3,Predklinické údaje o bezpečnosti,169030.0,True,43
6226,169044,NAP,SmPC,sk,,Hodnotenie environmentálneho rizika (ERA),169043.0,False,44
6227,169045,NAP,SmPC,sk,6,FARMACEUTICKÉ INFORMÁCIE,169001.0,True,45
6228,169046,NAP,SmPC,sk,6.1,Zoznam pomocných látok,169045.0,True,46
6229,169047,NAP,SmPC,sk,6.2,Inkompatibility,169045.0,True,47
6230,169048,NAP,SmPC,sk,6.3,Čas použiteľnosti,169045.0,True,48
6231,169049,NAP,SmPC,sk,6.4,Špeciálne upozornenia na uchovávanie,169045.0,True,49
6232,169050,NAP,SmPC,sk,6.5,Druh obalu a obsah balenia,169045.0,True,50
6233,169051,NAP,SmPC,sk,6.6,Špeciálne opatrenia na likvidáciu <a iné zaobchádzanie s liekom>,169045.0,True,51
6234,169052,NAP,SmPC,sk,,Použitie v pediatrickej populácii,169051.0,False,52
6235,169053,NAP,SmPC,sk,7,DRŽITEĽ ROZHODNUTIA O REGISTRÁCII,169001.0,True,53
6236,169054,NAP,SmPC,sk,8,REGISTRAČNÉ <ČÍSLO> <ČÍSLA>,169001.0,True,54
6237,169055,NAP,SmPC,sk,9,DÁTUM PRVEJ REGISTRÁCIE/PREDĹŽENIA REGISTRÁCIE,169001.0,True,55
6238,169056,NAP,SmPC,sk,10,DÁTUM REVÍZIE TEXTU,169001.0,True,56
6239,169057,NAP,SmPC,sk,11,DOZIMETRIA,169001.0,False,57
6240,169058,NAP,SmPC,sk,12,POKYNY NA PRÍPRAVU RÁDIOFARMÁK,169001.0,False,58
6241,170001,NAP,Labelling,sk,,OZNAČENIE OBALU,,True,1
6242,170002,NAP,Labelling,sk,,"ÚDAJE, KTORÉ MAJÚ BYŤ UVEDENÉ NA <VONKAJŠOM OBALE> <A> <VNÚTORNOM OBALE>",170001.0,True,2
6243,170003,NAP,Labelling,sk,1,NÁZOV LIEKU,170002.0,True,3
6244,170004,NAP,Labelling,sk,2,LIEČIVO (LIEČIVÁ),170002.0,True,4
6245,170005,NAP,Labelling,sk,3,ZOZNAM POMOCNÝCH LÁTOK,170002.0,True,5
6246,170006,NAP,Labelling,sk,4,LIEKOVÁ FORMA A OBSAH,170002.0,True,6
6247,170007,NAP,Labelling,sk,5,SPÔSOB A CESTA (CESTY) PODÁVANIA,170002.0,True,7
6248,170008,NAP,Labelling,sk,6,"ŠPECIÁLNE UPOZORNENIE, ŽE LIEK SA MUSÍ UCHOVÁVAŤ MIMO DOHĽADU A DOSAHU DETÍ",170002.0,True,8
6249,170009,NAP,Labelling,sk,7,"INÉ ŠPECIÁLNE UPOZORNENIE (UPOZORNENIA), AK JE TO POTREBNÉ",170002.0,True,9
6250,170010,NAP,Labelling,sk,8,DÁTUM EXSPIRÁCIE,170002.0,True,10
6251,170011,NAP,Labelling,sk,9,ŠPECIÁLNE PODMIENKY NA UCHOVÁVANIE,170002.0,True,11
6252,170012,NAP,Labelling,sk,10,"ŠPECIÁLNE UPOZORNENIA NA LIKVIDÁCIU NEPOUŽITÝCH LIEKOV ALEBO ODPADOV Z NICH VZNIKNUTÝCH, AK JE TO VHODNÉ",170002.0,True,12
6253,170013,NAP,Labelling,sk,11,NÁZOV A ADRESA DRŽITEĽA ROZHODNUTIA O REGISTRÁCII,170002.0,True,13
6254,170014,NAP,Labelling,sk,12,REGISTRAČNÉ <ČÍSLO> <ČÍSLA>,170002.0,True,14
6255,170015,NAP,Labelling,sk,13,ČÍSLO VÝROBNEJ ŠARŽE,170002.0,True,15
6256,170016,NAP,Labelling,sk,14,ZATRIEDENIE LIEKU PODĽA SPÔSOBU VÝDAJA,170002.0,True,16
6257,170017,NAP,Labelling,sk,15,POKYNY NA POUŽITIE,170002.0,True,17
6258,170018,NAP,Labelling,sk,16,INFORMÁCIE V BRAILLOVOM PÍSME,170002.0,True,18
6259,170019,NAP,Labelling,sk,17,ŠPECIFICKÝ IDENTIFIKÁTOR – DVOJROZMERNÝ ČIAROVÝ KÓD,170002.0,True,19
6260,170020,NAP,Labelling,sk,18,ŠPECIFICKÝ IDENTIFIKÁTOR – ÚDAJE ČITATEĽNÉ ĽUDSKÝM OKOM,170002.0,True,20
6261,170021,NAP,Labelling,sk,,"MINIMÁLNE ÚDAJE, KTORÉ MAJÚ BYŤ UVEDENÉ NA BLISTROCH ALEBO STRIPOCH",170001.0,True,21
6262,170022,NAP,Labelling,sk,1,NÁZOV LIEKU,170021.0,True,22
6263,170023,NAP,Labelling,sk,2,NÁZOV DRŽITEĽA ROZHODNUTIA O REGISTRÁCII,170021.0,True,23
6264,170024,NAP,Labelling,sk,3,DÁTUM EXSPIRÁCIE,170021.0,True,24
6265,170025,NAP,Labelling,sk,4,ČÍSLO VÝROBNEJ ŠARŽE,170021.0,True,25
6266,170026,NAP,Labelling,sk,5,INÉ,170021.0,True,26
6267,170027,NAP,Labelling,sk,,"MINIMÁLNE ÚDAJE, KTORÉ MAJÚ BYŤ UVEDENÉ NA MALOM VNÚTORNOM OBALE",170001.0,True,27
6268,170028,NAP,Labelling,sk,1,NÁZOV LIEKU A CESTA (CESTY) PODÁVANIA,170027.0,True,28
6269,170029,NAP,Labelling,sk,2,SPÔSOB PODÁVANIA,170027.0,True,29
6270,170030,NAP,Labelling,sk,3,DÁTUM EXSPIRÁCIE,170027.0,True,30
6271,170031,NAP,Labelling,sk,4,ČÍSLO VÝROBNEJ ŠARŽE,170027.0,True,31
6272,170032,NAP,Labelling,sk,5,"OBSAH V HMOTNOSTNÝCH, OBJEMOVÝCH ALEBO KUSOVÝCH JEDNOTKÁCH",170027.0,True,32
6273,170033,NAP,Labelling,sk,6,INÉ,170027.0,True,33
6274,171001,NAP,Package leaflet,sk,,PÍSOMNÁ INFORMÁCIA PRE POUŽÍVATEĽA,,True,1
6275,171002,NAP,Package leaflet,sk,,"qTento liek je predmetom ďalšieho monitorovania. To umožní rýchle získanie nových informácií o bezpečnosti. Môžete prispieť tým, že nahlásite akékoľvek vedľajšie účinky, ak sa u vás vyskytnú. Informácie o tom, ako hlásiť vedľajšie účinky, nájdete na konci časti 4.",171001.0,False,2
6276,171003,NAP,Package leaflet,sk,,V tejto písomnej informácii sa dozviete:,171001.0,True,3
6277,171004,NAP,Package leaflet,sk,1,Čo je X a na čo sa používa,171001.0,True,4
6278,171005,NAP,Package leaflet,sk,2,"Čo potrebujete vedieť predtým, ako <užijete> <použijete> X",171001.0,True,5
6279,171006,NAP,Package leaflet,sk,,<Neužívajte> <Nepoužívajte> X,171005.0,True,6
6280,171007,NAP,Package leaflet,sk,,Upozornenia a opatrenia,171005.0,True,7
6281,171008,NAP,Package leaflet,sk,,Deti <a dospievajúci>,171005.0,True,8
6282,171009,NAP,Package leaflet,sk,,Iné lieky a X,171005.0,True,9
6283,171010,NAP,Package leaflet,sk,,"X a <jedlo> <a> <,> <nápoje><a><alkohol>",171005.0,True,10
6284,171011,NAP,Package leaflet,sk,,Tehotenstvo <a> <dojčenie> <a plodnosť>,171005.0,True,11
6285,171012,NAP,Package leaflet,sk,,Vedenie vozidiel a obsluha strojov,171005.0,True,12
6286,171013,NAP,Package leaflet,sk,,X obsahuje {názov pomocnej látky(pomocných látok)},171005.0,False,13
6287,171014,NAP,Package leaflet,sk,3,Ako <užívať> <používať> X,171001.0,True,14
6288,171015,NAP,Package leaflet,sk,,Použitie u detí <a dospievajúcich>,171014.0,False,15
6289,171016,NAP,Package leaflet,sk,,"Ak <užijete> <použijete> viac X, ako máte",171014.0,False,16
6290,171017,NAP,Package leaflet,sk,,Ak zabudnete <užiť> <použiť> X,171014.0,False,17
6291,171018,NAP,Package leaflet,sk,,Ak prestanete <užívať> <používať> X,171014.0,False,18
6292,171019,NAP,Package leaflet,sk,4,Možné vedľajšie účinky,171001.0,True,19
6293,171020,NAP,Package leaflet,sk,,Ďalšie vedľajšie účinky u detí <a dospievajúcich>,171019.0,False,20
6294,171021,NAP,Package leaflet,sk,,Hlásenie vedľajších účinkov,171019.0,True,21
6295,171022,NAP,Package leaflet,sk,5,Ako uchovávať X,171001.0,True,22
6296,171023,NAP,Package leaflet,sk,6,Obsah balenia a ďalšie informácie,171001.0,True,23
6297,171024,NAP,Package leaflet,sk,,Čo X obsahuje,171023.0,True,24
6298,171025,NAP,Package leaflet,sk,,Ako vyzerá X a obsah balenia,171023.0,True,25
6299,171026,NAP,Package leaflet,sk,,Držiteľ rozhodnutia o registrácii a výrobca,171023.0,True,26
6300,171027,NAP,Package leaflet,sk,,Liek je schválený v členských štátoch Európskeho hospodárskeho priestoru (EHP) pod nasledovnými názvami:,171023.0,False,27
6301,171028,NAP,Package leaflet,sk,,Táto písomná informácia bola naposledy aktualizovaná v <{MM/RRRR}> <{mesiac RRRR}>.,171023.0,True,28
6302,171029,NAP,Package leaflet,sk,,Ďalšie zdroje informácií,171023.0,False,29
6303,171030,NAP,Package leaflet,sk,,Nasledujúca informácia je určená len pre zdravotníckych pracovníkov:,171001.0,False,30
6304,172001,NAP,SmPC,sl,,POVZETEK GLAVNIH ZNAČILNOSTI ZDRAVILA,,True,1
6305,172002,NAP,SmPC,sl,,"qZa to zdravilo se izvaja dodatno spremljanje varnosti. Tako bodo hitreje na voljo nove informacije o njegovi varnosti. Zdravstvene delavce naprošamo, da poročajo o katerem koli domnevnem neželenem učinku zdravila. Glejte poglavje 4.8, kako poročati o neželenih učinkih.",172001.0,False,2
6306,172003,NAP,SmPC,sl,1,IME ZDRAVILA,172001.0,True,3
6307,172004,NAP,SmPC,sl,2,KAKOVOSTNA IN KOLIČINSKA SESTAVA,172001.0,True,4
6308,172005,NAP,SmPC,sl,,Pomožna(e) snov(i) z znanim učinkom:,172004.0,False,5
6309,172006,NAP,SmPC,sl,3,FARMACEVTSKA OBLIKA,172001.0,True,6
6310,172007,NAP,SmPC,sl,4,KLINIČNI PODATKI,172001.0,True,7
6311,172008,NAP,SmPC,sl,4.1,Terapevtske indikacije,172007.0,True,8
6312,172009,NAP,SmPC,sl,4.2,Odmerjanje in način uporabe,172007.0,True,9
6313,172010,NAP,SmPC,sl,,Odmerjanje,172009.0,True,10
6314,172011,NAP,SmPC,sl,,Pediatrična populacija,172010.0,True,11
6315,172012,NAP,SmPC,sl,,Način uporabe,172009.0,True,12
6316,172013,NAP,SmPC,sl,,"Previdnostni ukrepi, potrebni pred ravnanjem z zdravilom ali dajanjem zdravila",172012.0,False,13
6317,172014,NAP,SmPC,sl,4.3,Kontraindikacije,172007.0,True,14
6318,172015,NAP,SmPC,sl,4.4,Posebna opozorila in previdnostni ukrepi,172007.0,True,15
6319,172016,NAP,SmPC,sl,,Sledljivost,172015.0,False,16
6320,172017,NAP,SmPC,sl,,Pediatrična populacija,172015.0,False,17
6321,172018,NAP,SmPC,sl,4.5,Medsebojno delovanje z drugimi zdravili in druge oblike interakcij,172007.0,True,18
6322,172019,NAP,SmPC,sl,,Pediatrična populacija,172018.0,False,19
6323,172020,NAP,SmPC,sl,4.6,"Plodnost, nosečnost in dojenje",172007.0,True,20
6324,172021,NAP,SmPC,sl,,Nosečnost,172020.0,False,21
6325,172022,NAP,SmPC,sl,,Dojenje,172020.0,False,22
6326,172023,NAP,SmPC,sl,,Plodnost,172020.0,False,23
6327,172024,NAP,SmPC,sl,4.7,Vpliv na sposobnost vožnje in upravljanja strojev,172007.0,True,24
6328,172025,NAP,SmPC,sl,4.8,Neželeni učinki,172007.0,True,25
6329,172026,NAP,SmPC,sl,,Pediatrična populacija,172025.0,False,26
6330,172027,NAP,SmPC,sl,,Poročanje o domnevnih neželenih učinkih,172025.0,True,27
6331,172028,NAP,SmPC,sl,4.9,Preveliko odmerjanje,172007.0,True,28
6332,172029,NAP,SmPC,sl,,Pediatrična populacija,172028.0,False,29
6333,172030,NAP,SmPC,sl,5,FARMAKOLOŠKE LASTNOSTI,172001.0,True,30
6334,172031,NAP,SmPC,sl,5.1,Farmakodinamične lastnosti,172030.0,True,31
6335,172032,NAP,SmPC,sl,,Mehanizem delovanja,172031.0,False,32
6336,172033,NAP,SmPC,sl,,Farmakodinamični učinki,172031.0,False,33
6337,172034,NAP,SmPC,sl,,Klinična učinkovitost in varnost,172031.0,False,34
6338,172035,NAP,SmPC,sl,,Pediatrična populacija,172031.0,False,35
6339,172036,NAP,SmPC,sl,5.2,Farmakokinetične lastnosti,172030.0,True,36
6340,172037,NAP,SmPC,sl,,Absorpcija,172036.0,False,37
6341,172038,NAP,SmPC,sl,,Porazdelitev,172036.0,False,38
6342,172039,NAP,SmPC,sl,,Biotransformacija,172036.0,False,39
6343,172040,NAP,SmPC,sl,,Izločanje,172036.0,False,40
6344,172041,NAP,SmPC,sl,,Linearnost/nelinearnost,172036.0,False,41
6345,172042,NAP,SmPC,sl,,Farmakokinetično/farmakodinamično razmerje,172036.0,False,42
6346,172043,NAP,SmPC,sl,5.3,Predklinični podatki o varnosti,172030.0,True,43
6347,172044,NAP,SmPC,sl,,Ocena tveganja za okolje,172043.0,False,44
6348,172045,NAP,SmPC,sl,6,FARMACEVTSKI PODATKI,172001.0,True,45
6349,172046,NAP,SmPC,sl,6.1,Seznam pomožnih snovi,172045.0,True,46
6350,172047,NAP,SmPC,sl,6.2,Inkompatibilnosti,172045.0,True,47
6351,172048,NAP,SmPC,sl,6.3,Rok uporabnosti,172045.0,True,48
6352,172049,NAP,SmPC,sl,6.4,Posebna navodila za shranjevanje,172045.0,True,49
6353,172050,NAP,SmPC,sl,6.5,Vrsta ovojnine in vsebina ,172045.0,True,50
6354,172051,NAP,SmPC,sl,6.6,Posebni varnostni ukrepi za odstranjevanje <in ravnanje z zdravilom>,172045.0,True,51
6355,172052,NAP,SmPC,sl,,Uporaba pri pediatrični populaciji,172051.0,False,52
6356,172053,NAP,SmPC,sl,7,IMETNIK DOVOLJENJA ZA PROMET Z ZDRAVILOM,172001.0,True,53
6357,172054,NAP,SmPC,sl,8,ŠTEVILKA (ŠTEVILKE) DOVOLJENJA (DOVOLJENJ) ZA PROMET Z ZDRAVILOM,172001.0,True,54
6358,172055,NAP,SmPC,sl,9,DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Z ZDRAVILOM,172001.0,True,55
6359,172056,NAP,SmPC,sl,10,DATUM ZADNJE REVIZIJE BESEDILA,172001.0,True,56
6360,172057,NAP,SmPC,sl,11,DOZIMETRIJA,172001.0,False,57
6361,172058,NAP,SmPC,sl,12,NAVODILA ZA PRIPRAVO RADIOFARMAKOV,172001.0,False,58
6362,173001,NAP,Labelling,sl,,OZNAČEVANJE,,True,1
6363,173002,NAP,Labelling,sl,,PODATKI NA <ZUNANJI OVOJNINI> <IN> <PRIMARNI OVOJNINI>,173001.0,True,2
6364,173003,NAP,Labelling,sl,1,IME ZDRAVILA,173002.0,True,3
6365,173004,NAP,Labelling,sl,2,NAVEDBA ENE ALI VEČ UČINKOVIN,173002.0,True,4
6366,173005,NAP,Labelling,sl,3,SEZNAM POMOŽNIH SNOVI,173002.0,True,5
6367,173006,NAP,Labelling,sl,4,FARMACEVTSKA OBLIKA IN VSEBINA,173002.0,True,6
6368,173007,NAP,Labelling,sl,5,POSTOPEK IN POT(I) UPORABE ZDRAVILA,173002.0,True,7
6369,173008,NAP,Labelling,sl,6,POSEBNO OPOZORILO O SHRANJEVANJU ZDRAVILA ZUNAJ DOSEGA IN POGLEDA OTROK,173002.0,True,8
6370,173009,NAP,Labelling,sl,7,"DRUGA POSEBNA OPOZORILA, ČE SO POTREBNA",173002.0,True,9
6371,173010,NAP,Labelling,sl,8,DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA,173002.0,True,10
6372,173011,NAP,Labelling,sl,9,POSEBNA NAVODILA ZA SHRANJEVANJE,173002.0,True,11
6373,173012,NAP,Labelling,sl,10,"POSEBNI VARNOSTNI UKREPI ZA ODSTRANJEVANJE NEUPORABLJENIH ZDRAVIL ALI IZ NJIH NASTALIH ODPADNIH SNOVI, KADAR SO POTREBNI",173002.0,True,12
6374,173013,NAP,Labelling,sl,11,IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM,173002.0,True,13
6375,173014,NAP,Labelling,sl,12,ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET,173002.0,True,14
6376,173015,NAP,Labelling,sl,13,ŠTEVILKA SERIJE,173002.0,True,15
6377,173016,NAP,Labelling,sl,14,NAČIN IZDAJANJA ZDRAVILA,173002.0,True,16
6378,173017,NAP,Labelling,sl,15,NAVODILA ZA UPORABO,173002.0,True,17
6379,173018,NAP,Labelling,sl,16,PODATKI V BRAILLOVI PISAVI,173002.0,True,18
6380,173019,NAP,Labelling,sl,17,EDINSTVENA OZNAKA – DVODIMENZIONALNA ČRTNA KODA,173002.0,True,19
6381,173020,NAP,Labelling,sl,18,EDINSTVENA OZNAKA – V BERLJIVI OBLIKI,173002.0,True,20
6382,173021,NAP,Labelling,sl,,"PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA PRETISNEM OMOTU ALI DVOJNEM TRAKU",173001.0,True,21
6383,173022,NAP,Labelling,sl,1,IME ZDRAVILA,173021.0,True,22
6384,173023,NAP,Labelling,sl,2,IME IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM,173021.0,True,23
6385,173024,NAP,Labelling,sl,3,DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA,173021.0,True,24
6386,173025,NAP,Labelling,sl,4,ŠTEVILKA SERIJE,173021.0,True,25
6387,173026,NAP,Labelling,sl,5,DRUGI PODATKI,173021.0,True,26
6388,173027,NAP,Labelling,sl,,"PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH",173001.0,True,27
6389,173028,NAP,Labelling,sl,1,IME ZDRAVILA IN POT(I) UPORABE,173027.0,True,28
6390,173029,NAP,Labelling,sl,2,POSTOPEK UPORABE,173027.0,True,29
6391,173030,NAP,Labelling,sl,3,DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA,173027.0,True,30
6392,173031,NAP,Labelling,sl,4,ŠTEVILKA SERIJE,173027.0,True,31
6393,173032,NAP,Labelling,sl,5,"VSEBINA, IZRAŽENA Z MASO, PROSTORNINO ALI ŠTEVILOM ENOT",173027.0,True,32
6394,173033,NAP,Labelling,sl,6,DRUGI PODATKI,173027.0,True,33
6395,174001,NAP,Package leaflet,sl,,NAVODILO ZA UPORABO,,True,1
6396,174002,NAP,Package leaflet,sl,,"qZa to zdravilo se izvaja dodatno spremljanje varnosti. Tako bodo hitreje na voljo nove informacije o njegovi varnosti. Tudi sami lahko k temu prispevate tako, da poročate o katerem koli neželenem učinku zdravila, ki bi se utegnil pojaviti pri vas. Glejte na koncu poglavja 4, kako poročati o neželenih učinkih.",174001.0,False,2
6397,174003,NAP,Package leaflet,sl,,Kaj vsebuje navodilo,174001.0,True,3
6398,174004,NAP,Package leaflet,sl,1,Kaj je zdravilo X in za kaj ga uporabljamo,174001.0,True,4
6399,174005,NAP,Package leaflet,sl,2,"Kaj morate vedeti, preden <boste vzeli> <boste uporabili> zdravilo X",174001.0,True,5
6400,174006,NAP,Package leaflet,sl,,Ne <jemljite> <uporabljajte> zdravila X,174005.0,True,6
6401,174007,NAP,Package leaflet,sl,,Opozorila in previdnostni ukrepi,174005.0,True,7
6402,174008,NAP,Package leaflet,sl,,Otroci <in mladostniki>,174005.0,True,8
6403,174009,NAP,Package leaflet,sl,,Druga zdravila in zdravilo X,174005.0,True,9
6404,174010,NAP,Package leaflet,sl,,"Zdravilo X skupaj <s><z> <hrano> <in> <,> <pijačo> <in> <alkoholom>",174005.0,True,10
6405,174011,NAP,Package leaflet,sl,,"Nosečnost <in> <,> dojenje <in plodnost>",174005.0,True,11
6406,174012,NAP,Package leaflet,sl,,Vpliv na sposobnost upravljanja vozil in strojev,174005.0,True,12
6407,174013,NAP,Package leaflet,sl,,Zdravilo X vsebuje {ime pomožne(ih) snovi},174005.0,False,13
6408,174014,NAP,Package leaflet,sl,3,Kako <jemati> <uporabljati> zdravilo X,174001.0,True,14
6409,174015,NAP,Package leaflet,sl,,Uporaba pri otrocih <in mladostnikih>,174014.0,False,15
6410,174016,NAP,Package leaflet,sl,,"Če ste <vzeli> <uporabili> večji odmerek zdravila X, kot bi smeli",174014.0,False,16
6411,174017,NAP,Package leaflet,sl,,Če ste pozabili <vzeti> <uporabiti> zdravilo X,174014.0,False,17
6412,174018,NAP,Package leaflet,sl,,Če ste prenehali <jemati> <uporabljati> zdravilo X,174014.0,False,18
6413,174019,NAP,Package leaflet,sl,4,Možni neželeni učinki,174001.0,True,19
6414,174020,NAP,Package leaflet,sl,,Dodatni neželeni učinki pri otrocih <in mladostnikih>,174019.0,False,20
6415,174021,NAP,Package leaflet,sl,,Poročanje o neželenih učinkih,174019.0,True,21
6416,174022,NAP,Package leaflet,sl,5,Shranjevanje zdravila X,174001.0,True,22
6417,174023,NAP,Package leaflet,sl,6,Vsebina pakiranja in dodatne informacije,174001.0,True,23
6418,174024,NAP,Package leaflet,sl,,Kaj vsebuje zdravilo X,174023.0,True,24
6419,174025,NAP,Package leaflet,sl,,Izgled zdravila X in vsebina pakiranja,174023.0,True,25
6420,174026,NAP,Package leaflet,sl,,Imetnik dovoljenja za promet z zdravilom in proizvajalec,174023.0,True,26
6421,174027,NAP,Package leaflet,sl,,Zdravilo je v državah članicah EGP pridobilo dovoljenje za promet z naslednjimi imeni:,174023.0,False,27
6422,174028,NAP,Package leaflet,sl,,Navodilo je bilo nazadnje revidirano dne <{MM/LLLL}> <{mesec LLLL}> ,174023.0,True,28
6423,174029,NAP,Package leaflet,sl,,Drugi viri informacij,174023.0,False,29
6424,174030,NAP,Package leaflet,sl,,Naslednje informacije so namenjene samo zdravstvenemu osebju:,174001.0,False,30
